EuropeanJournalofHumanGenetics(2020)28:798–1016 https://doi.org/10.1038/s41431-020-00741-5 ABSTRACTS COLLECTION Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: e-Posters ©EuropeanSocietyofHumanGenetics2020.Modiﬁedfromtheconferencewebsiteandpublishedwithpermission2020 Volume 28 | Supplement 1 Virtual Conference June 6-9, 2020 Sponsorship:Publication ofthis supplement was sponsored by theEuropean Society ofHuman Genetics. All content was reviewed and approved by the ESHG Scientiﬁc Programme Committee, which held full responsibility for the abstract 1234567890();,:1234567890();,: sDeilseccltoiosunsr.eInformation:Inordertohelpreadersformtheirownjudgmentsofpotentialbiasinpublishedabstracts,authors are asked to declare any competing ﬁnancial interests. Contributions of up to EUR 10 000.- (Ten thousand Euros, or equivalent value in kind) per year per company are considered “Modest”. Contributions above EUR 10 000.- per year are considered “Signiﬁcant”. Presenting authors are indicated with bold typeface in the contributor lists. e-Posters improve the prevention and treatment of congenital malformations. E-P01 Reproductive Genetics/Prenatal Genetics Material and methods: The data from Medical Genetic Center Register was analyzing by the MedCalc 15.8 E-P01.07 program. Epidemiological monitoring of congenital malforma- Results: The incidence rate of congenital malformations tions in Yakutia from 2007 to 2018 over a 12-year period averaged 29.4 cases per 1000 newborns with a standard deviation of 2.9. It’s high A.I.Fedorov1,A.L.Sukhomyasova1,2,A.N.Sleptsov2,1,N. indicator In Russia (>20 ‰). At this period, the average R. Maksimova1 annual number of births was 15725.7 (SD 1174.3). The high frequencies of malformations in 2012, 2017 and 2018 1Research Laboratory “Molecular Medicine and Human was observing (Table 1). The observed differences are Genetics”, Medical Institute, M. K. Ammosov North- statistically signiﬁcantly (p < 0.05). Eastern Federal University, Yakutsk, Russian Federation, 2Medical Genetic Center, Republican Hospital №1 – Table 1. Congenital malformations prevalence “NationalMedicalCenter”,Yakutsk,RussianFederation Years Incidenceswith95%CI Introduction: Congenital malformations represent an 2007 0.0296(0.02694-0.03246) urgent problem that affects the structure of infant and child 2008 0.02734(0.02479-0.03008) mortality. In Yakutia, the prevalence of congenital mal- 2009 0.02743(0.02492-0.03012) formations is recording in Register of Medical Genetic 2010 0.02893(0.02636-0.03168) Center, Republican Hospital №1 - “National Medical 2011 0.02981(0.02723-0.03258) Center”. The purpose of epidemiological monitoring is to 2012 0.03336(0.03067-0.03622)Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 799 and rs560654095. The frequency of the rs34957925 minor Years Incidenceswith95%CI variant in the endometriosis group corresponded its rate in European populations. The frequency of the minor 2013 0.0273(0.02485-0.02992) rs560654095 variant was 0.061 (G-0.00001, 1000 2014 0.02704(0.02463-0.02963) Genomes). 2015 0.02527(0.02289-0.02783) Conclusions: We did not found statistically signiﬁcant 2016 0.02977(0.0271-0.03263) differences in allele frequencies ofEM patients and control 2017 0.03265(0.02973-0.03579) groups for the polymorphic variants the WNT7A, TWIST1 2018 0.03464(0.03154-0.03797) and WNT4 genes. In endometriosis patients a high representation (6%) of the rs560654095 minor allele was Conclusion: Thus, Yakutia is region with a high found. The HOXA10 gene product binds to the β-actin frequency of congenital malformations, and in recent years promoter and regulates its expression in the endometrium. an increase the frequency of their registration. The Furtherstudiesareinprogresstocheckthisunusualﬁnding. prevalence of congenital malformations is vary at approx- ThisworkwasﬁnanciallysupportedbytheRussianScience imate intervals of 4-5 years and increase tendency may Foundation (No. 19-15-00108) persist for several years because improved diagnostic N.S. Osinovskaya: None. N.Y. Shved: None. O.V. methods. Malysheva: None. M.I. Yarmolinskaya: None. V.S. Research is part of the project FSRG-2020-0014 “Arctic Baranov: None. Genomics: epidemiology, heredity and pathology”. A.I. Fedorov: None. A.L. Sukhomyasova: None. A.N. E-P01.12 Sleptsov: None. N.R. Maksimova: None. NFE2L2 and JUN transcription study in fetal and maternal tissues of women with pregnancy loss in the E-P01.09 ﬁrst trimester Analysis of the minor allele frequency of WNT7A (rs2639607), WNT4 (rs7521902), TWIST1 (rs4721745) E. Mashkina, K. Kovalenko and HOXA10 gene (exon2) in women with presumably hereditary forms of endometriosis. Southern Federal University, Rostov-on-Don, Russian Federation N.S.Osinovskaya1,2,N.Y.Shved1,O.V.Malysheva1,M.I. Yarmolinskaya1, V. S. Baranov1 Background: The cells constantly interact with many sig- naling molecules. This leads to dynamic changes in the 1Ott’s Scientiﬁc Research Institute of Obstetrics, Gynecol- spectrum of expressed genes. Nrf2 and JUN are transcrip- ogy and Reproductology, St. Petersburg, Russian Federa- tion factors that are involved in maintaining intracellular tion, 2North-Western State Medical University named after redoxhomeostasis,whichisnecessaryforcellsproliferation I.I. Mechnikov, Saint-Petersburg, Russian Federation and differentiation. These transcription factors activate the antioxidantdefenseofcellsfromoxidativestress.Incurrent Introduction: According to GWAS, over 100 genes are work, we investigated the expression of NFE2L2, JUN, associated with development of endometriosis (EM) - SOD1 genes in chorionic and decidual tissues after spon- common gynecologic disorder. The present work was taneous abortion compared to normal ﬁrst trimester devoted to the study of exon 2 polymorphism in HOXA10 pregnancies. geneaswellasthefrequencyofminorallelicvariantsofthe Materialsandmethods:Samplesofchorionictissueand WNT7A, WNT4, TWIST1 genes. decidua were taken after surgical termination of normally Materials and methods: DNA samples extracted from progressing pregnancies and spontaneous abortion in 5-9 peripheralbloodof41patientswithlaparoscopicallyproved week of gestation. RNA expression was analyzed using endometriosis and 43 ones from the control cohort were quantitative real-time PCR method. Data were analyzed used.Real-timePCRwasappliedtoanalyzeallelicvariants using the 2-ΔΔCT method. of the WNT7A, WNT4, TWIST1 genes. Sanger sequencing Results: The transcription level of the NFE2L2, JUN, of the 2nd exon of the HOXA10 gene was performed in 41 SOD1 genes is signiﬁcantly higher in decidual tissue cells patients with proved endometriosis. compared to chorion cells during normal pregnancy Results: The frequencies of the minor variants: (p<0.0001). Thus, the tissue-speciﬁc transcription level of rs12639607 (WNT7A), rs4721745 (TWIST1), rs7521902 the NFE2L2, JUN, SOD1 genes has been revealed for (WNT4) corresponded its rate in European populations. In physiological pregnancy. The correlation in the mRNA the HOXA10 gene, we identiﬁed two variants: rs34957925 levels of the JUN, NFE2L2 and SOD1 genes was detected800 J.delPicchia indecidua.Inchorionictissueduringnormalpregnancy,the This report stresses the importance of molecular diagnosis levelofmRNAoftheSOD1geneisdirectlyproportionalto in IP for genetic counseling of the entire family. the mRNA of the NFE2L2 gene (r=0.81 p=0.0002). With S. Koka: None. O. Lobel: None. E. Zivi: None. Z. Ben- miscarriage the level of mRNA of the JUN gene in the Neriah: None. A. Frumkin: None. O. Weiss: None. S. chorionic tissue is signiﬁcantly higher compared to the Zeligson: None. R. Segel: None. control. Conclusion: The results demonstrated that high JUN E-P01.18 transcription level in chorionic tissue could be associated Reciprocal 7p deletion-7q duplication in a malformed with miscarriage in ﬁrst trimester of pregnancy. fetus due to maternal inversion of chromosome 7 - E. Mashkina: None. K. Kovalenko: None. cytogenetic and microarray analysis E-P01.14 M. Hristova-Savova1, R. Bozhilova2, V. Peycheva2, PrenataldiagnosisofXq28microdeletionincludingexon E. Dimova3, K. Belemezova1, S. Yovinska1, M. Rizov1, 10 of IKBKG gene in male fetus with increased nuchal P. Chaveeva1, A. Shterev1, R. Kaneva2, I. Dimova1,2 translucency and hydrops and a family history of Incontinentia Pigmenti 1SAGBAL "Dr Shterev", Soﬁa, Bulgaria, 2Molecular MedicineCenter,MedicalUniversitySoﬁa,Soﬁa,Bulgaria, S.Koka1,O.Lobel1,E.Zivi1,Z.Ben-Neriah1,A.Frumkin2, 3RWTH, Aachen, Germany O. Weiss1, S. Zeligson1, R. Segel1 Pericentricinversionsoccurinhumanwithafrequencyof 1Shaare Zedek Medical Center, Jerusalem, Israel, 1-2%ofgeneralpopulation.Thesebalancedchromosomal 2Cytogenetics Lab, Department of Genetics, Hadassah rearrangements do not cause any problem for the carrier, Medical Center, Jerusalem, Israel but during meiosis there is a risk of inversion loop for- mation in the offspring leading to de novo duplication, Introduction: Incontinentia Pigmenti (IP), is an X-linked deletionoracombinationofboth[duplicationq/deletionp dominant Male-lethal disorder, caused by devastating (dup q/del p) or del q/dup p]. Signiﬁcant numbers of mutations in IKBKG gene. A recurrent exon 4_10 deletion recombinants are produced when the inverted segment in the IKBKG gene accounts for 60 to 80% of IP-causing size is >50% of the total length of the affected chromo- mutations,butotherpointmutationsalong thegeneaswell some. We report here a case of prenatal diagnostics of a as exon 10 (which include the zinc-ﬁnger domain) trun- fetus with multiple anomalies: severe growth retardation, cating mutation were described previously. enlarged third ventricle, agenesis of ductus venosus, and Materials and methods: Chromosomal Microarray cystofthebloodcord.Cytogeneicanalysiswasperformed Analysis (CMA) was performed in chorionic villi sample after amniocentesis and pathologic duplication of chro- of aborted pregnancy of fetus with increased nuchal mosome 7q was revealed. To clarify the aberration we translucency and hydrops, and his 31 years old healthy made array CGH analysis; the results showed combined mother. aberrations: 3.96 Mbp deletion of 7p (arr[hg19] Results: CMA of the fetus found a 34kbp deletion on 7p22.3p22.2(54,185-4,017,864)x1) and 47 Mbp duplica- Xq28 chromosome including at least exon 10 of IKBKG tion of 7q (7q31.1q36.3(111,668,521-159,118,566)x3). gene - arr[hg19]Xq28(153,792,620-153,826,362)x0. Preli- We tested the parents by cytogenetic analysis in a minary results show that the healthy mother carries the meantime. The mother was revealed to be a carrier of deletion in a mosaic state. Family history includes another pericentric inversion in chromosome 7 - 46,XX,inv(7) termination of pregnancy of a male fetus with increased (p22;q31). Thus, we clarify the genetic diagnosis in the nuchaltranslucency,twospontaneousearlyabortions,agirl fetus - the recombinant chromosome 7 [rec(7)dup(7q)inv with suspected clinical diagnosis of IP and one health boy. (7)(p22q31)mat] must have arisen through meiotic Therecurrentexon4_10deletioninIKBKGwaspreviously crossing-over between the inverted chromosome and the excluded in the symptomatic girl. normal chromosome 7 in the maternal germline. Conclu- Conclusions: Here we describe a 34kbp deletion on sion: Array CGH is the most powerful technique in Xq28 chromosome including exon 10 of IKBKG gene determining the exact size and boundaries of the unba- inherited from a healthy mother as a cause for increased lanced segments in case of rearranged chromosomes and, nuchal translucency and hydrops in male fetus with family in combination with parental cytogenetic analysis, for history suspicious for familial IP. The deletion segregation providing the adequate genetic counselling. in the family is now in progress and we believe it will M. Hristova-Savova: None. R. Bozhilova: None. V. explain the girl phenotype as well as the obstetric history. Peycheva: None. E. Dimova: None. K. Belemezova: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 801 S. Yovinska: None. M. Rizov: None. P. Chaveeva: None. K. Kartvelishvili: None. N. Pirtskhelani: None. N. A. Shterev: None. R. Kaneva: None. I. Dimova: None. Kochiashvili: None. L. Makhaldiani: None. E-P01.19 E-P01.20 The impact of maternal inherited thrombophilia on Panels of genetic tests in infertile men with severe intra uterine growth restriction spermatogenic failure K. Kartvelishvili1,2, N. Pirtskhelani2,3, N. Kochiashvili2, S. Yovinska1, M. Hristova-Savova1, K. Belemezova1, L. Makhaldiani4 M. Rizov1, T. Milachich1, T. Timeva1, P. Andreeva1, D. Savova1, M. Yunakova1, A. Shterev1, I. Dimova2 1Tbilisi State Medical University, Tbilisi, Georgia, 2National Forensics Bureau/Forensic Biology (DNA) 1SAGBAL “D Shterev”, Soﬁa, Bulgaria, 2SAGBAL Department, Tbilisi, Georgia, 3Tbilisi Open University, “D Shterev”; Department of Medical genetics, Medical Tbilisi, Georgia, 4K. Eristavi National Center of Experi- University Soﬁa, Bulgaria, Soﬁa, Bulgaria mental and Clinical Surgery, Tbilisi, Georgia Weofferedinourclinicsdifferentkindsofgeneticanalyses Introduction: Intrauterine growth restriction (IUGR) is with the aim to clarify diagnosis in men with severe sper- deﬁned as estimated fetal weight below gestational age. matogenicfailure.Wehaveperformedcytogeneticanalysis Inherited thrombophilia is a blood coagulation disorder, in 770 men attending reproductive clinics (group I), 88 which predisposes to thrombosis. Since the placenta is rich withconﬁrmed diagnosisof oligoastenozoospermia (group inbloodvessels,itisreasonabletoinferthatclotformation II) and 43 with conﬁrmed azoospermia (group III). within the placental vasculature may result in placental Numerical sex chromosomal aberrations (incl. mosaicism) insufﬁciency, intrauterine growth restriction and other were found in 3.3% of group I, 3.4% of group II (mainly complications. polysomy Y) and 9.3% of group III (mainly Klinefelter Aim:Theaimofthisstudywastodeterminetheintensity syndrome); female karyotype was diagnosed in 0.6% of of connection between inherited thrombophilia (Factor V men. Structural chromosomal aberrations (mainly translo- Leiden, Prothrombin G20210A and MTHFR C677T gene cations)weredetectedin1.2%ofgroupI,3.4%ofgroupII mutations) and IUGR. and none of group III. Chromosomal heteromorphism was Materials and methods: 48 Georgian women with revealed, respectively, in 13%, 13.6% and 11.5%. DNA pregnancy complication (IUGR of unknown origin) and analysis for 10 pathogens (CT, MG, MH, UP, UU, TV, 100 controls (women with three or more uncomplicated NG, TP, HS1 and 2) was performed in ejaculate of men pregnancies) were investigated for detection of inherited witholigoastenozoospermiaandazoospermia.Thetestwas thrombophilia by PCR analyses. positive in 61.5% of azoospermic men and in 21% of oli- Results: Relationships between IUGR and FVL (12.5% goastenozoospermic (p<0.01) as double infection was in patients and 0% in control; χ2(1,N=148)=13.028, revealed in 38% and 12%, respectively (p<0.05). The sta- p=0.001) and Prothrombin (8.33% in patients and 1% in tistically higher frequency was established for Ureaplasma control; χ2(1,N=148)=5.343, p=0.038) mutations were parvum (54% vs 15%) and Herpes simplex (23% vs 3%). signiﬁcant. Relationship between IUGR and MTHFR Genotyping for 24 mutations and IVS 8 intron poly- mutation (6.25% in patients and 1% in control; χ2(1, morphism in CFTR gene was performed in 52 men with N=148)=3.399, p=0.1) was weak. The combined double severe male factor. Both delf508 mutation and IVS 8 5T and triple mutations were seen in 4 cases, which was not was found in 5.8% of the analyzed men. In conclusion, by seen in control group. It is important to note that 46 applying all of the above mentioned analyses in 52 men (95.83%) patients had a history of other pregnancy withseveremalefactor,wewereabletomakediagnosisin complications and thrombosis, 19(39.53%) patients had a 60% of them. history of stillbirth. S. Yovinska: None. M. Hristova-Savova: None. K. Conclusion: There are few studies concerning the Belemezova: None. M. Rizov: None. T. Milachich: None. association between IUGR and thrombophilia. Our study T.Timeva:None.P.Andreeva:None.D.Savova:None.M. reconﬁrms impact of studied mutations (totally 23%) on Yunakova: None. A. Shterev: None. I. Dimova: None. IUGR. Further research will help to clarify who should receive thromboprophylaxis to prevent adverse pregnancy E-P01.21 outcomes in women with inherited thrombophilia. Recurrent congenital microcephaly: a case report802 J.delPicchia M. N. Komnenić Radovanović1, I. Novaković2, M. Rizov1, K. Belemezova1, M. Hristova-Savova1, G.Čuturilo3,2,J.RumlStojanović3,B.Petrović1,O.Kontić- S. Yovinska1, T. Milachich2, G. Ganeva3, T. Timeva3,4, Vučinić1,2 A. Shterev3, I. Dimova1 1Clinic for gynecology and obstretrics, Clinical centre of 1Genetics laboratory, SAGBAL “Dr Shterev”, Soﬁa, Serbia, Belgrade, Serbia, 2Faculty of Medicine, University Bulgaria, Soﬁa, Bulgaria, 2IVF laboratory, SAGBAL “Dr of Belgrade, Serbia, Belgrade, Serbia, 3University Chil- Shterev”, Soﬁa, Bulgaria, Soﬁa, Bulgaria, 3SAGBAL “Dr dren’s Hospital, Belgrade, Serbia, Belgrade, Serbia Shterev”, Soﬁa, Bulgaria, Soﬁa, Bulgaria, 4“Angel Kan- chev” University of Ruse, Ruse, Bulgaria Introduction:Wereportthecaseofacouplewiththreelost pregnancies,twowithprimarycongenitalmicrocephaly(the Structural chromosomal abnormalities are responsible for ﬁrst and the third pregnancy, both with male fetuses). The different reproductive issues such as infertility and secondpregnancyendedasamissedabortion.Karyotyping recurrent pregnancy loss. Polymorphic variations are was perfomed to the couple and results were normal kar- known to occur in the general population. They include yotypes. Couple negated the family burden, but X-linked varyingsizesofheterochromatinblocks,satelliteorrepeat and primary autosomal recessive microcephaly was sequence regions and inversions. However, previous stu- suspected. dies have reported that heterochromatin polymorphisms Materials and methods: After fetal ultrasonogram aremorefrequentininfertilemen.Thismaybeassociated showing recurrent primary microcephaly in the third with infertility and unsuccessful pregnancy. Pre- pregnancy, fetal blood sample obtained by cordocentesis. implantation genetic testing for aneuploidy (PGT-A) is a The sample was used for standard cytogenetic analysis, common method in the assisted reproduction techniques aCGH and clinical exome next generation sequencing. (ART) to determine the genetic status of human embryos. Results: The fetal karyotyping showed a normal male In the presented case we report an infertile couple with karyotype (46,XY), conﬁrmed by aCGH analysis. Clinical recurrent implantation failures (RIF). Karyotyping by G- exome testing and bioinformatic analysis of the genes banding of cultured peripheral blood lymphocytes was known to be associated with microcephaly and similar performedonbothpatients.Aftertheanalysis,inthemale pathological conditions detected pathogenic and likely partner was detected heterochromatin polymorphism, pathogenic variant in the ASPM (abnormal spindle-like karyotype- 46, XY, 9qh+. After genetic counseling, microcephaly-associated) gene. Pathogenic variant was PGD-A was used. For detection of chromosomal imbal- ASPM c.7324C> T, known stop gained mutation with ancesalaser-assistedbiopsywasperformedonblastocyst conﬁrmed maternal origin. Likely pathogenic variant was stage embryos followed by whole genome ampliﬁcation newely described fremeshift deletion ASPM c.10148 delC, (WGA) and next generation sequencing (NGS) was with conﬁrmed paternal origin. performed according to manufacturer’s instructions. 6 Conclusions: Comprehensive genetic testing of affected embryos were biopsied and analyzed. None of the fetus showed compound heterozygous mutations in ASPM embryoswaseuploid.Variousaberrations-fromsingleto gene, designed as MCPH5 (microcephaly primary heredi- complex monosomies and trisomies, were detected. Due tary)locus.Anautosomalrecessivepatternofinheritanceof to the lack of an euploid embryo, transfer was not per- the detected mutations is most likely involved in the formed. This case report is a good example for the formation of primary congenital microcephaly. reproductive failures at carriers of chromosomal hetero- Patients are genetically informed about the mode of chromatin polymorphisms. NGS allows screening of all inheritance of these mutations, possibility of prenatal 24 chromosomes. It’s effective, ensuring a high level of testing, as well as of the possibility of in vitro fertilization conﬁdence in the results and subsequent selection of for the purpose of preimplantation genetic diagnosis of euploid embryos for transfer. detected mutations. M. Rizov: None. K. Belemezova: None. M. Hristova- M.N. Komnenić Radovanović: None. I. Novaković: Savova: None. S. Yovinska: None. T. Milachich: None. G. None. G. Čuturilo: None. J. Ruml Stojanović: None. B. Ganeva: None. T. Timeva: None. A. Shterev: None. I. Petrović: None. O. Kontić-Vučinić: None. Dimova: None. E-P01.24 E-P01.25 PGT-Abecauseofmale9qhchromosomalheteromorph- Chromosomal centromeric polymorphisms and couple ism revealed only unbalanced embryos infertilityAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 803 P.Gkika1,D.Athanasiou1,P.Symeonidis2,F.Gkaitatzi2,E. We report on a non-consanguineous couple who presented Kontomanolis2, N. Koutlaki2, T. S. Lialiaris1 in the 25th week of their second pregnancy. The fetus showed mild cerebral ventriculomegaly, hypoplasia of 1DemokritusUniversityofThrace,MedicalSchool,Deptof the cerebellum and a peculiar posture of the ﬁngers Genetics,Alexandroupolis,Greece,2DemokritusUniversity without further abnormalities. Family history revealed that of Thrace, Medical School, Dept of Obstetrics & Gynecol- his1.5yearoldsisterpostnatallyshowedaﬁxedpostureof ogy, University Hospital of Alexandroupolis,, Alexandrou- the ﬁngers and a general developmental delay but no polis, Greece diagnostics had been done so far. In order to exclude tris- omy 18, the couple decided for amniocentesis. Array-ana- Introduction: A possible association between the appear- lysis showed a gain of 14.7Mb inthe chromosomalregion ance of pericentric chromosomal polymorphisms in cyto- 3p25.1-p26.3 and a loss of 5.3 Mb in 6q27 not visible in genetic examinations and idiopathic reproductive failure in conventional karyotype (GTG-banding, 400 bands). The northeastern Greek population was examined. sister clinically exhibits a striking similarity with features Material and methods: Lymphocyte cultures of periph- already described in partial trisomy 3p like hypertelorism, eral blood from 150 individuals, mainly couples, were round face, short neck, down slanting palpebral ﬁssures, harvested and processed according to standard laboratory psychomotordelayandbehavioralproblems.Chromosomal protocols. The samples were visualized using C-banding analysis and array-analysis were performed and technique. At least 15 metaphases were analyzed visually revealed the same abnormalities as in the fetus. We there- per case, and 5 of them were karyotyped using MetaSys- foresuspectedabalancedtranslocationinoneoftheparents tems Ikaros software and a Zeiss Axio Imager. Z.2 and indeed the mother carries a balanced reciprocal trans- microscope. location (46,XX,t(3;6)(p25.1;q27)). Despite the clinical Results:Chromosomalvariationsincentromereareaof1,9 variability, the parents felt reassured because they did not and16chromosomeswereidentiﬁedin115of150individuals experiencetheirdaughterasahandicappedchild.Therefore, with failed reproductive clinical histories. After dividing the they decided to continue pregnancy. Our case illustrates, results by gender, a higher frequency of the chromosome 9 that minor ﬁndings in prenatal ultrasound and detailed polymorphism was observed in women. The frequency of family history may be crucial in prenatal diagnosis. More- chromosomal polymorphismsin chromosome 1 and 16were over, it stresses the importance of array-analysis in the broadly similar for both genders. As for the couples, we prenatal setting. We postulate that genetic counselling observed that appearance of chromosomal centromeric should be offered early in pregnancy to all families with polymorphisms in both partners was signiﬁcantly higher, retarded children. reaching a considerable number of 74%. U.Siebers-Renelt:None.I.vanDeest:None.J.Steinhard: Conclusions: Increasing evidence from our research has None. C. Müller-Hofstede: None. Y. Stratis: None. A. conﬁrmed that infertility and subfertility are closely related Bohring: None. A. Röpke: None. to chromosomal polymorphisms as 80 % of the patients were identiﬁed with a centromeric chromosomal variation. E-P01.29 Nevertheless, their mechanism and reason of appearance is Expression Proﬁle of Complement Activation at yet unclear and to explain the potential reasoning and the Decidual Tissue in Patients with Recurrent meaningofthisphenomenonfurtherstudieswillbeneeded. Pregnancy Loss P. Gkika: None. D. Athanasiou: None. P. Symeonidis: None. F. Gkaitatzi: None. E. Kontomanolis: None. N. I. Yilmaz1, P. Ata1, N. Karakas2, E. Buyukbayrak2 Koutlaki: None. T.S. Lialiaris: None. 1MarmaraUniversitySchoolofMedicineMedicalGenetics, E-P01.26 Istanbul, Turkey, 2Marmara University School of Medicine Prenatal detection of a 3p-duplication / 6q-deletion by Dept of Obstetrics and Gynecology, Istanbul, Turkey array-Analysis not visible in GTG-banding Recurrent pregnancy losses (RPL) are seen in approxi- U. Siebers-Renelt1, I. van Deest2, J. Steinhard2, C. Müller- mately 1% of fertile women. RPL are deﬁned as sponta- Hofstede1, Y. Stratis1, A. Bohring1, A. Röpke1 neous and terminating at least two or more consecutive pregnancies, seen in 0.5-3% of all pregnancies. Damage in 1Institut für Humangenetik, University Hospital, Muenster, decidual tissue occuring with the effect of maternal anti- Germany, 2Zentrum für Pränatalmedizin, Muenster, bodies, has a contribution of complement activation. Germany Seventeen percent of women with at least 2 recurrent804 J.delPicchia abortionsandthirtysevenpercentofthosewithmorethan3 patients’ sera. Patient group had higher progesterone level abortions were detected in idiopathic RPL patients having and lower TSH level compared to controls. We evaluated no autoimmune background. The complement system, is a theexpressionlevelofProgesteroneReceptorGene(PGR), ﬁrst defense mechanism towards unwanted pathogens and and downstream genes; Inositol 1,4,5-Trisphosphate host elements. Decay accelerating factor (DAF,CD55), Receptor Type 3 (ITPR3), Extracellular Signal-Regulated MAC inhibitory protein (MAC-IP,CD59) and membrane Kinase 1 (MAPK1) and Proline Rich Transmembrane co-factor protein (MCP,CD46) are major complement Protein 2 (PRRT2) of the decidual tissue. The expression inhibitory proteins which are highly expressed in normal analysis using CFX real-time PCR platform were done placenta. Herein, we had nine women with spontaneous throughQiagenGeneGlobeassaytool.Internalcontrolgene abortion as our control group and seventeen women with was GAPDH for analysis. As a preliminary ﬁnding, PGR RPL as our study group. TSH, T3, T4, and progesterone, gene expression level was diminished in our case group also C3, C4 serum levels were determined. Since CD55, comparedtothatofcontrols.Conversely,ITPR3expression CD46 and CD59 of fetal trophoblast and maternal tissues was elevated and there was a slight increase in MAPK1 are crucial to provide tissue homeostasis, we analyzed the gene expression in patients compared to controls (p>0.05). expressionofthesegenesusingCFXreal-timePCRsetting. As protective effect of progesterone on decidual tissue is ThestatisticalanalysisaccordingtoaverageCTvalueswere strongly associated with expression of PGR and its down- done through Qiagen GeneGlobe assay tool. As a pre- stream genes, possible future treatment targets could be liminary ﬁnding of this research, CD55 expression level identiﬁed for RPL. was reasonably elevated at decidual tissues of our cases P. Ata: None. I. Yilmaz: None. N. Karakas: None. compared to that of controls. Although, CD46 expression A. Eren: None. E. Buyukbayrak: None. levels weredifferentamong twogroups,thedifference was not remarkable as CD55 expression (p>0.05). To support E-P01.32 pregnancy in RPL, regulation of complement activation MaternalpathogenicKCNQ1variantandpredisposition might be crucial. to recurrent fetal loss I. Yilmaz: None. P. Ata: None. N. Karakas: None. E. Buyukbayrak: None. L. Kasak1, K. Rull1,2, T. Yang3, D. Roden3, M. Laan1 E-P01.31 1Institute of Biomedicine and Translational Medicine, Progesterone Receptivity and Expression of Progester- UniversityofTartu,Tartu,Estonia,2Women’sClinic,Tartu one Triggered Genes at the Decidual Tissue in Patients University Hospital, Tartu, Estonia, 3Departments of with Recurrent Pregnancy Loss. Medicine, Pharmacology and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, P.Ata1,I.Yilmaz1,N.Karakas2,A.Eren3,E.Buyukbayrak2 United States 1MarmaraUniversitySchoolofMedicineMedicalGenetics, Introduction: Recurrent pregnancy loss (RPL) concerns Istanbul, Turkey, 2Marmara University School of Medicine up to 5% of women of childbearing age. Up to 25% of Dept of Obstetrics and Gynecology, Istanbul, Turkey, 3Koc RPL cases remain idiopathic, suggesting a possible mono- University College of Sciences Molecular Biology and genic origin. The study aimed to identify the genetic cause Genetics, Istanbul, Turkey of idiopathic late RPL in a family with multiple mis- carriages without fetal malformations or chromosomal Recurrent pregnancy losses (RPL) are deﬁned as sponta- abnormalities. neous termination of at least two or more consecutive Materialsandmethods:Exomesequencingwasapplied pregnancies. It accounts 0.5-3% of all pregnancies. Its to three miscarried fetuses and the mother, who had etiology is still unknown in about half of the cases. Since experienced ﬁve live births, intersected by three early progesterone stabilizes endometrial tissue, it affects decid- pregnancy losses, and six fetal deaths. Interestingly, 4/5 ual tissue during differentiation by changing the expres- karyotyped fetal losses had a normal female karyotype, sivity of different genes. Progesterone unresponsiveness whereas all but one live-born children are male. duetodecreasedexpressionofitsreceptoranddownstream Results: The miscarried conceptuses do not share any genes,ratherthanhormonedeﬁciencymayeffectthefateof rare single nucleotide variants not detected in live-born pregnancy itself. Herein, nine women with spontaneous children. However, the mother carries a KCNQ1 p. abortionascontrolgroups,andseventeenwomenwithRPL Val173Aspsubstitution(rs199472695),previouslyreported as our case group were analyzed; and TSH, T3,T4, pro- in a patient with long QT syndrome (LQTS; gesterone, and C3,C4 levels were determined in the PMID:16414944). KCNQ1 protein forms potassiumAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 805 channelsandregulatesthecardiacactionpotentialduration. Postmortem radiographical and histopathological ﬁndings Consistent with a recent epidemiological study were consistent with Diastrophic Dysplasia. (PMID:31520628), mothers carrying pathogenic heterozy- Discussion: Targeted FGFR3 mutation testing, based on gous variants in LQTS genes have an elevated risk of fetal themother’sphenotype,wouldhavemissedtheDiastrophic deathregardlessofthecarrierstatusofthefetus.Functional Dysplasia diagnosis in the fetus, preventing informed assay conﬁrmed pathogenicity of the p.Val173Asp variant. decision for this pregnancy and proper genetic counselling The mutant channel signiﬁcantly reduced total activating for the family. Therefore, this case highlights the utility of anddeactivatingcurrents,withdramaticallypositiveshiftof exome sequencing for complex overlapping prenatal voltage dependence of activation by ~10 mV. phenotypes such as skeletal dysplasia, and underscores the Conclusions: Dysfunction of KCNQ1 contributes not contributionofpostmortempathologicalexaminationtothe only to the risk of sudden death from LQTS, but also as a phenotype- genotypecorrelation, which isessential for the maternal risk factor to RPL. The exact molecular mechan- correct interpretation of exome sequencing results. ism behind this effect is still to be clariﬁed. G. Christopoulou: None. A. Oikonomaki: None. S. Funding: Estonian Research Council grant IUT34-12 Samara: None. A. Xefteris: None. A. Κonstantinidou: L. Kasak: None. K. Rull: None. T. Yang: None. None. P. Constantoulakis: None. D. Roden: None. M. Laan: None. E-P01.34 E-P01.33 Homozygous hypomorphic SOX9 mutation in two 46, Prenatal diagnosis of a complex skeletal dysplasia case XY sisters without skeletal malformations deciphered by exome sequencing and postmortem pathological examination S. Ledig1, A. Tewes1, T. Özdemir2, A. Bohring1, P. Wieacker1 G. Christopoulou1, A. Oikonomaki1, S. Samara1, A. Xefteris2, A. Κonstantinidou3, P. Constantoulakis1 1Institute for Human Genetics, Münster, Germany, 2Department of Medical Genetics, Izmir, Turkey 1Genotypos Science Labs MSA, Athens, Greece, 2Euroge- netica S.A., Thessaloniki, Greece, 3Department of Pathol- Haploinsufﬁciency of the SOX9 gene in humans causes the ogy,Unit ofPerinatal Pathology,National &Kapodistrian skeletal malformation syndrome campomelic dysplasia University of Athens (NKUA), Athens, Greece (CD), which is a semilethal disorder characterised by con- genital bowing of the long bones, cleft palate, absence of Introduction: We present a prenatal and postmortem olfactory bulbs and tracts, heart and renal malformations, diagnosisofdiastrophicdysplasia(DD)inafetusconceived hypoplastic lungs, narrow thoracic cage, and delayed bone by a mother with hypochondroplasia. age. CD patients generally die from respiratory distress. Materials and methods: Prenatal testing at 13 weeks Together with the bone disease 75% of CD-patients show gestationwasrequestedduetoamaternalhypochondropla- testicular dysgenesis leading to sex reversal. Here, we sia phenotype of unknown genetic background. Clinical describe two sisters with the suspicion of non-syndromic exome sequencing was performed on DNA extracted from XY DSD (disorder of sexual development) and no signs of chorionic villi and maternal blood, using Sophia Genetics’ skeletalmalformations.CausativemutationsinSRY,NR5A1 Clinical Exome Solution v2. Following preparations andDHHhavebeenexcludedbySanger-sequencingbefore according to the manufacturer’s protocol, DNA libraries whole-exome-sequencing was performed and surprisingly were sequenced on an Illumina NextSeq-500 genetic revealed in both sisters homozygosity for undescribed var- analyser.Dataprocessing,variantcallingandpre-classiﬁca- iant c.1518C>G p.(Leu506Val) in SOX9. The consanguine tion were conducted by SOPHiA DDM® bioinformatics parents are heterozygous for c.1518C>G p.(Leu506Val) in pipelines. SOX9. Functional characterization of SOX9 c.1518C>G p. Results: A FGFR3 pathogenic variant was identiﬁed in (Leu506Val) by luciferase assay showed no decrease of the mother, conﬁrming her phenotype; this variant was not transactivating function on Col2a1 promotor in contrast to detected in the fetus. However, one maternally inherited two SOX9 mutations (c.347C>T p.(Ala116Val) and pathogenic and one of unknown signiﬁcance SLC26A2 c.358C>Tp.(Arg120Cys))knowntobeassociatedwithCD, variants were identiﬁed, related, according to the literature, explaining the non-skeletal phenotype of our patients. to four distinct genetic skeletal dysplasias of various Therefore, we suggest that SOX9 variant c.1518C>G p. severity and prognosis. On 2nd trimester ultrasound the (Leu506Val) is a hypomorphic mutation that causes XY fetus presented short long bones and, following clinical DSD without raising any SOX9 related skeletal phenotype. genetic counselling, the pregnancy was terminated.806 J.delPicchia S. Ledig: None. A. Tewes: None. T. Özdemir: None. A. Introduction: Wlaker-Warburg syndrome (WWS) is Bohring: None. P. Wieacker: None. clinically deﬁned as congenital muscular dystrophy acom- panied by a variety of brain and eye malformations. E-P01.35 Its represents the most severe clinical phenotype in a Vascular endothelial growth factor serum level during spectrumofalpha-dystroglycanposttranslationalproccesing pregnancy and VEGF rs2010963 polymorphism among abnormalities, wich share adefect inlaminin bindin glycan women with congenital heart defects in the fetus synthesis. Homozygotics or compound heterozygotics mutations in several genes had been described as causative Y. Sharhorodska1,2,3, I. Haiboniuk1, A. Malahova1, for WWS, but very low cases with complete homozygotics U. Dorofeyeva3, O. Shkolnyk1, H. Makukh1 delections. Here we described two cases of prenatal diag- nosis in a couple with complete CRPPA gene delection. In 1Institute of Heredetary Pathology NAMS, Lviv, Ukraine, the ﬁrst pregnancy, amniocentesis was done for genetics 2Danylo Halytsky Lviv National Medical University, Lviv, prenatal diagnosis, when by eco at 16 gestation week, was Ukraine, 3Medical Center Intersono Medicover Group, detected absence of cerebellar vermis, megacisterna magna Lviv, Ukraine with occipital bone defects and. At a second pregnancy chorionic villis sampling was performed at 12 The aim of the study to determine serum level of vascular gestation week. endothelial growth factor (VEGF) during pregnancy as a Materials and methods: Karyotype was performed with possible diagnostic marker of congenital heart defects in the standar methods. Comparative genomic hybridation offspring.Materialsandmethods.Theserumconcentrationof (CGH-Array) was performed with the Agilent platform, VEGF by ELISA was measured among 24 pregnant women suplied by PerkinElmer. (term 20-30 weeks of gestation) with prenatally diagnosed Results: In the ﬁrst fetus, the fetal Karyotype was congenital heart defects (CHDs) in fеtus. For control group normal (46,XX), but the CGH-Array detected an homo- we studied the serum of 45 pregnant women without com- zygotic 354,58 Kb delecttion at 7p21.2. CGH-Array of plicated genetic and obstetric history. For the analysis of both parents presented the same chromosomal microdelec- rs2010963VEGFthePCR-RFLPmethodwasused.Results. tion in heterozygosis and was recomended genetic MaternalVEGF405GGgenotypewassigniﬁcantlycorrelated prenatal diagnosis for another pregnancies. In the next with congenital heart defects of the fеtus (p=0.017, OR = pregnancy, chorionic villis sample was analided with de 3.45 (95% CI: 1.22 - 9.72)). In the CHD group, compared same reults; normal karyotype (46,XY) and homozygotic with controls, VEGF serum levels were signiﬁcantly higher 354,58 Kb delection at 7p21,2. In both cases the gestation (285.6±4.5 vs. 268,0±5,2 pg/mL, p=0.029). The VEGF was ﬁnised. serumlevelinpregnantwomenwithgenotypeVEGF405GG Conclusions: The use of CGH-Array in prenatal was higher compare with another genotypes group 405GC diagnosis when ecograﬁcs anomalies are detected is the and405CC.Conclusions.Ourstudysuggests thatevaluation election method for detection of chromosomal microdelec- of VEGF serum level during pregnancy may provide prog- tions and microduplications. nostic data, andhelp identify patients who would have CHD M. Perez Sanchez: None. M. Bellido díaz: None. T. De offetus.Mothersrs2010963VEGFgenotypemayplayarole Haro Romero.: None. A. González Ramírez: None. in the susceptibility of conhenital heart defects in offspring. Y. Sharhorodska: None. I. Haiboniuk: None. A. Mala- E-P01.37 hova: None. U. Dorofeyeva: None. O. Shkolnyk: None. H. Fetal mosaicism in dichorionic twin pregnancies: Makukh: None. challenges for accurate diagnosis and results interpretation E-P01.36 Detection of complete delection of CRRPA gene in E. Margarit1,2, M. Vallecillos1, M. Rubio1, I. Madrigal1,2, prenatal CGH-Array performer by eco anomalies. A C. Badenas1,2, A. Soler1,2 case report. 1HOSPITAL CLÍNIC, BARCELONA, Spain, 2IDIBAPS, M.PerezSanchez1,M.Bellidodíaz1,T.DeHaroRomero.1, Barcelona, Spain A. González Ramírez2 The risk of fetal structural abnormalities and chromosomal 1Servicio Andaluz de Salud (SAS)., Granada, Spain, aneuploidy is increased in twin pregnancies compared with 2FIBAO., Granada, Spain singleton gestations. In many cases, the chromosomeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 807 constitution of twin fetuses is discordant, so an accurate E-P02 Sensory Disorders (Eye, Ear, Pain) prenatal diagnosis is needed. We report two dichorionic/dia- mniotic twin pregnancies presenting with ultrasound anoma- lies affecting only one of the fetuses (fetus B). A chorionic E-P02.04 villussample(CVS)wasobtained separately foreachone of Congenital bilateral iris coloboma in a patient with thefetuses,allowingindividualanalysestodeterminepossible 16q23.1q23.2 deletion chromosomalabnormalities.Inbothcases,sampleswereﬁrst analyzed by QF-PCR to detect possible common aneu- B. Aleksiūnienė1, B. Tumienė1, R. Strupaitė–Šileikienė2, A. ploidies.Inthreeofthefetuses,anXchromosomeaneuploidy Utkus1 in mosaic form was detected. Additional analyses by con- ventionalcytogenetics,QF-PCRand/orarraywereperformed 1DepartmentofHumanandMedicalGeneticsofInstituteof ﬁrstinCVSandlaterinamnioticﬂuid(AF)samplesinorder Biomedical Sciences, Faculty of Medicine, Vilnius Uni- to interpretate the results, detecting possible conﬁned pla- versity,Vilnius,Lithuania,2CentreofEyeDiseases,Vilnius centalmosaicismandallowingadeﬁnitivediagnosisforeach UniversityHospitalSantarosKlinikos, Vilnius, Lithuania fetus. Detailed results and possible embryological interpreta- tions are presented. Clinical and molecular characterization of rare chromoso- mal abnormalities helps to detect the candidate genes for congenitalanomalies.Congenitalocularcolobomaisabirth FetusA FetusB defect caused by abnormal development of the eye during CASE1 embryogenesis. We report on a 33-year-old man with Ultrasound1 normalfetal edema+increasednuchalfold bilateral congenital coloboma of the iris at 6 o‘clock. The structure +ductusagenesis patient has a high myopia and myopic astigmatism, BCVA QF-PCR mos90%X/ mos10%X/90%XX ofBE-0,7.Choroidal neviofbotheyeswerealsonoticed. (CVS) 10%XX He has no other speciﬁc complaints as photophobia or CVS-short 45,X - nictalopia, the color vision is full. There were no dys- culture morphic signs or developmental issues. Chromosomal CVS-long mos45,X[3]/46, - microarray analysis using the HumanCytoSNP-12v2.1 culture XX[27] BeadChip (Illumina Inc., San Diego, CA, USA) was per- Array(CVS) - mos10%X/90%XX QF-PCR(AF) ≈XX X formed and revealed a 2.96 Mb in size deletion in the 16q23.1q23.2 region, arr[GRCh37]16q23.1q23.2 AF-culture mos45,X[2]/46, 45,X[20] XX[78] (78473430_81434676)×1. The deleted region encompasses Control normalfetal subcutaneousedema+ascitis 12 protein-coding genes, including 5 disease-associated ultrasound structure genes WWOX, MAF, GCSH, BCO1 and GAN. Three genes CASE2 WWOX, GCSH and GAN are associated with autosomal Ultrasound1 normalfetal edema+increasedNT+reverse recessive disorders. MAF is associated with Ayme-Gripp structure ductusvenosus syndrome and various types of cataracts. BCO1 encodes QF-PCR mosX/ XX beta-carotene oxygenase 1, which is a key enzyme in the (CVS) XXorXXX production of vitamin A from carotenoids. Deﬁciency of CVS-long 45,X 46,XX,+11,der(11;22)(p10;q10) this enzyme results in hypercarotenemia and secondary culture vitamin A deﬁciency. We speculate that haploinsufﬁciency Array(CVS) mosX/ dup11p of BCO1 may be related to congenital bilateral iris colo- XXorXXX boma in our patient. QF-PCR(AF) XX - B. Aleksiūnienė:None. B. Tumienė:None. R. Strupaitė– Array(AF) XX - Šileikienė: None. A. Utkus: None. Control normalfetal nofetalactivity ultrasound structure E-P02.07 First reported case of Doyne Honeycomb Retinal E.Margarit:None.M.Vallecillos:None.M.Rubio:None. Dystrophy (Malattia Leventinese/Autosomal Dominant I. Madrigal: None. C. Badenas: None. A. Soler: None. Drusen) in Scandinavia808 J.delPicchia I. N. Sheyanth1,2,3, M. B. Petersen1,2,3, L. P. Kiruparajan4, as well as grants already received); Signiﬁcant; The Obel S. K. Abildgaard4 Family Foundation. L.P. Kiruparajan: None. S.K. Abildgaard: None. 1Research and Knowledge Center in Sensory Genetics, Aalborg, Denmark, 2Department of Clinical Medicine, E-P02.08 Aalborg University, Aalborg, Denmark, 3Department of LOXL1 and CACNA1A SNPs associated with exfolia- Clinical Genetics, Aalborg University Hospital, Aalborg, tion syndrome susceptibility in a sample of Northern Denmark, 4Department of Ophthalmology, Aalborg Uni- Spanishpopulation,revealedbyhigh-resolutionmelting versity Hospital, Aalborg, Denmark analysis. Introduction: Doyne Honeycomb Retinal Dystrophy L.Escudero-Arrarás1,A.Lara1,M.Rodríguez-Hidalgo1,T. (DHRD)/ Malattia Leventinese (ML) is an autosomal Alberdi2, A. Basasoro2, I. Rodríguez-Agirretxe2,3,4, dominant, progressive eye disorder characterized by mas- J. Mendicute2, J. Ruiz Ederra1,4 sivecentralretinaldrusen often partly coalescent forming a characteristichoneycombpattern.Debutofvisionlossoften 1Biodonostia Health Research Institute, San Sebastián, occurs in mid-early adulthood and the degree varies. A Spain,2DepartmentofOphthalmology,DonostiaUniversity single mutation in EFEMP1c.1033C>T p.(Arg345Trp) has Hospital, San Sebastián, Spain, 3Instituto Clínico-Quirúr- been identiﬁed as the cause. gico de Oftalmología, Bilbao, Spain, 4RETICS OFTARED, Materials and methods: We report a 57-year-old NationalInstituteofHealthCarlosIII,MinistryofEconomy Scandinavian woman of non-consanguineous Danish Cau- and Competitiveness, Madrid, Spain casian parents presenting with vision loss and metamor- phopsia. Ophthalmological examination revealed massive Introduction: Exfoliation syndrome (XFS) is a systemic harddrusenonbotheyesinthemacularregionandnasalto disease associated with age and characterized by the for- the disc as well as macular hyperpigmentation. Optical mationanddepositionofawhitishﬁbrillarsubstanceinthe coherence tomography on the left eye showed partly anterior segment ofthe eye. XFS is a multifactorial disease affected foveal conﬁguration with slightly increased foveal with genetic and non-genetic factors associated. LOXL1 thickness. The patient was clinically diagnosed with and CACNA1A are the main genes associated with an DHRD/ML and followed annually with stable conditions. increased risk. Ten years later reduced visual acuity primarily on the left Materialsandmethods:Highresolutionmelting(HRM) eye and increased atrophy with subretinal ﬂuid were is a simple and high-throughput assay, which has been observed. Anti-vascular endothelial growth factor (anti- widely applied in sequence polymorphism identiﬁcation. VEGF) was administrated, but without effect. Family OurmaingoalwastotestthesuitabilityofHRManalysisas history revealed no other cases of reduced vision. a genetic screening technique for XFS. We analyzed 26 Diagnostic next generation sequencing of seven genes XFS patients and 52 controls. We analyzed LOXL1 (Amplexa FleckRet7 Panel) associated with ﬂecked retina (rs1048661, rs3825942, rs2165241, rs16958477, was performed at Amplexa Genetics using NovaSeq 6000. rs12914489, rs11638944, rs7173049) and CACNA1A The mutation was veriﬁed by bidirectional Sanger (rs4926244) genes. Detected variants were conﬁrmed by sequencing. Sanger sequencing. Results: Aknown pathogenic mutation NM_001039348 Results: The allelic and genotypic frequencies of the (EFEMP1): c.1033C>T, p.(Arg345Trp) previously seen in SNPs are shown in the Table 1. Most XFS SNP were relation to DHRD/ML was identiﬁed in a heterozygote properly resolved by this technique, with the exception of state in the index. No other causative variants were rs1048661 and rs3825942. This is like due to the high identiﬁed. percentage of CG (~70%) surrounding these SNP. Conclusion: To our knowledge this case represents the Conclusion: Our method provides a genotyping strategy ﬁrst molecular genetically veriﬁed case of DHRD/ML in for identifying individuals with XFS-SNPs in a cost- Scandinavia. Grants: The Obel Family Foundation effective way for most variants analyzed. I.N. Sheyanth: B. Research Grant (principal investigator, LEA is supported by fellowships from Fundación Jesús collaborator or consultant and pending grants as well as deGangoitiBarreraandfromtheHealthDepartmentofthe grants already received); Signiﬁcant; The Obel Family Basque Government (2018111062 and MTVD19/BD/006). Foundation. M.B. Petersen: B. Research Grant (principal Supported by grants from the ISCIII and FEDER (PI18/ investigator, collaborator or consultant and pending grants 00507) and BEGISARE.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 809 Table 1. Allelic and genotypic frequencies for the most homozygotes for STRC gene deletion, B) eight were com- prevalent SNPs in LOXL1 and CACNA1A. pound heterozygotes for STRC gene deletion and point inactivating mutation and C) three were compound hetero- SNP XFS Controls SNP XFS Controls SNP XFS Controls SNP XFS Controls (n=24) (n=52) (n=24) (n=52) (n=24) (n=52) (n=24) (n=52) zygotes for point inactivating mutations. Other biallelic rs2165241 rs1048661 rs16958477 rs11638944 pathogenic mutations were detected in genes MYO15A (six Allele Allele Allele Allele C 0.885 0.702 G 0.923 0.933 A 0.788 0.865 C 0.942 0.981 patients), LOXHD1 (ﬁve patients), TMPRSS3 (ﬁve T 0.115 0.298 T 0.077 0.067 C 0.212 0.135 G 0.058 0.019 patients), CDH23 (four patients), OTOG (two patients). Genotype Genotype Genotype Genotype Other genes with biallelic pathogenic mutations were CC 0.808 0.673 GG 0.885 0.885 AA 0.731 0.577 CC 0.885 0.962 CT 0.154 0.058 GT 0.077 0.096 AC 0.269 0.423 CG 0.115 0.038 detected only once among patients. Supported by AZV 16- TT 0.038 0.269 TT 0.038 0.019 CC 0 0 GG 0 0 31173A. rs4926244 rs3825942 rs12914489 rs7173049 Allele Allele Allele Allele D. Šafka Brožková: None. S. Poisson Marková: None. J. T 0.971 0.981 G 1 0.981 G 0.808 0.827 A 0.981 0.942 Laštůvková: None. D. Rašková: None. A. Uhrová Mészár- C 0.029 0.019 A 0 0.019 A 0.192 0.173 G 0.019 0.058 Genotype Genotype Genotype Genotype osová: None. P. Seeman: None. TT 0.942 0.962 GG 1 0.962 GG 0.615 0.654 AA 0.962 0.885 TC 0.058 0.038 GA 0 0.038 GA 0.385 0.346 AG 0.038 0.115 CC 0 0 AA 0 0 AA 0 0 GG 0 0 E-P02.12 Possible digenic inheritance of mutations in OTOG and OTOGL as cause of prelingual mild hearing loss L. Escudero-Arrarás: None. A. Lara: None. M. Rodrí- guez-Hidalgo:None.T.Alberdi:None.A.Basasoro:None. M. Sinnema1, V. Vernimmen1, H. Yntema2 I. Rodríguez-Agirretxe: None. J. Mendicute: None. J. Ruiz Ederra: None. 1Department of Clinical Genetics, MUMC, Maastricht, Netherlands, 2Department of Human Genetics, Radboud E-P02.11 University Medical Centre, Nijmegen, Netherlands Overview of mutations causing early nonsyndromic hearing loss among Czech patients with excluded Normal 0 21 false false false NL X-NONE X-NONE /* pathogenic mutations in GJB2 gene. Style Deﬁnitions */ table.MsoNormalTable {mso-style- name:Standaardtabel; mso-tstyle-rowband-size:0; mso- D. Šafka Brožková1, S. Poisson Marková1, J. Laštůvková2, tstyle-colband-size:0; mso-style-noshow:yes; mso-style- D. Rašková3, A. Uhrová Mészárosová1, P. Seeman1 priority:99;mso-style-parent:"";mso-padding-alt:0cm5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin- 12nd Faculty of Medicine, Charles University and Uni- right:0cm; mso-para-margin-bottom:10.0pt; mso-para-mar- versity Hospital Motol, Prague, Czech Republic, 2Depart- gin-left:0cm; line-height:115%; mso-pagination:widow- ment of Medical Genetics, Masaryk Hospital in Usti nad orphan; font-size:11.0pt; font-family:“Calibri”,“sans-serif”; Labem, Regional Corporation, Usti nad Labem, Czech mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor- Republic, 3Centre for Medical Genetics and Reproductive latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font: Medicine, Gennet,, Prague, Czech Republic minor-latin; mso-fareast-language:EN-US;} Background: Autosomalrecessivenon-syndromichearingloss(DFNB)is Nonsyndromic autosomal recessive hearing loss is a het- a genetically heterogeneous disorder. OTOG and OTOGL erogeneous disease where over 80 genes has been reported were identiﬁed as autosomal recessive hearing loss genes. tobeassociatedwith.Weexaminedagroupofpatientswith Patient: We describe a 20-year old girl with moderate pre- early/prelingual nonsyndromic hearing loss (NSHL) in lingual hearing loss. Whole exome sequencing showed a whichweexcludedpathogenicmutationsinGJB2gene.We pathogenic nonsense mutation in the OTOG gene examined421unrelatedpatientsfordeletionsofSTRCgene (c.2500C>T) and a partial gene deletion of the with quantitative comparative ﬂuorescent PCR (QCF PCR) OTOGL gene (deletion exon 9-41). Additional and201unrelatedpatientswith nextgenerationsequencing Sanger sequencing of both genes did not show a second by custom designed NSHL gene panel. We discovered the mutation in one of the genes. The father of the proband is disease cause in 54 patients, from which 43 we diagnosed the only family member with the same audiologic withNSHLpanelexamination(21.4%).Themostfrequent proﬁle. Co-segregation between the hearing loss type of nonsyndromic hearing loss is DFNB16, caused by phenotype and the potential causative mutations was ver- biallelic mutations in the STRC gene and detected to be a iﬁed in all family members by Sanger sequencing. cause of hearing loss in 23 patients, almost half of the Father and daughter are the only family members with the clariﬁed patients (43%). The spectrum of STRC gene combination of the OTOG and OTOGL mutation. Conclu- mutations was as follows; A) twelve patients were sions: We identiﬁed heterozygous mutations in OTOG810 J.delPicchia and OTOGL in a girl and her father with prelingual Gene Variant Protein Zygosity Relateddisease hearing loss. OTOG and OTOGL show striking similarities in terms of structure, expression as well as clinical pheno- p. type.Tothebestofourknowledge,thisistheﬁrstreportof (Val4980Ala) LRP5 c.442C>T p.(Gln148*) Heterozygosity Osteopetrosis possible biallellic inheritance of mutations in OTOG and Dominant1 OTOGL. TNC c.5317G>A p. Heterozygosity DFNA56 (Val1773Met) M. Sinnema: None. V. Vernimmen: None. H. Yntema: HK1 c.60+2T>A p.? Homozygosity Neuropathy None. hereditary sensorimotor (RusseType) E-P02.13 USH1G c.742C>T p.(Gln248*) Homozygosity UsherSyndrome Whole exome sequencing in hearing loss Mexican type1G family cases M. Arenas-Sordo1, P. Linares Mendoza1, J. Doll2, P. M. Arenas-Sordo: None. P. Linares Mendoza: None. J. Bahena2, M. Hofrichter2, B. Vona2, K. Peñuelas-Romero1, Doll: None. P. Bahena: None. M. Hofrichter: None. B. T. Haaf2 Vona: None. K. Peñuelas-Romero: None. T. Haaf: None. 1Instituto Nacional de Rehablitacion, Mexico City, Mexico, E-P02.14 2Institute of Human Genetics, Julius Maximilians Univer- Mutational spectrum of the SLC26A4 gene and its sity, Würzburg, Germany contribution to the etiology of hearing loss in the indigenous peoples of Southern Siberia (Russia) Introduction: Congenital hearing loss is one of the most frequent and genetically heterogeneous sensory diseases in V.Y.Danilchenko1,M.V.Zytsar1,M.S.Bady-Khoo2,E.A. humans. Its prevalence is 1-2 per 1000 live newborns. Maslova1,3, A. A. Bondar4, I. V. Morozov3,4, N. A. Globally, the GJB2 gene is responsible for almost 20% of Barashkov5,6, O. L. Posukh1,3 congenitalhearinglossbutinMexicoitislower.Mutations in about 200 other genes have been associated. Current 1Institute of Cytology and Genetics, Siberian Branch of studies of new generation sequencing (NGS) has a diag- Russian Academy of Sciences, Novosibirsk, Russian Fed- nostic rate of about 40%. eration, 2Perinatal Center of the Republic of Tyva, Kyzyl, Material and method: Ten familial cases of bilateral Russian Federation, 3Novosibirsk State University, Novosi- sensorineural hearing loss, severe to profound, non- birsk, Russian Federation, 4Institute of Chemical Biology syndromic, with complete audiological studies and tomo- andFundamentalMedicine,SiberianBranchoftheRussian graphic image of the ear, were studied. Sanger sequencing Academy of Sciences, Novosibirsk, Russian Federation, of GJB2 was done and when no pathogenic variants were 5Yakut Scientiﬁc Centre of Complex Medical Problems, found in this gene, WES was performed. Yakutsk, Russian Federation, 6M.K. Ammosov North-East- Results:1patientpresentedpathogenic variants ofGJB2 ern Federal University, Yakutsk, Russian Federation (c.139G> T and c.551G> C), the rest of the results are shown in the table. In 4 patients, the origin of the hearing Introduction: Mutations in the SLC26A4 gene (7q22-q31) loss could not be determined. The results found, for the leadtorecessivelyinheriteddeafness(DFNB4)andPendred most part, are those expected according to what is reported syndrome.Morethan500pathogenicSLC26A4-variantsare inother populations, especially variants in genes that cause currently revealed in deaf patients in different populations Usher syndrome. worldwide. This study aimed to investigate the SLC26A4 Conclusion: The aetiological diagnosis of hearing loss pathogeniccontributionindeafnesswithunknownetiology requires theclinical study ofpatients andtheirfamiliesand in patients belonging to indigenous peoples of Southern molecular studies, starting with the one with the highest Siberia: Tuvinians (the Tyva Republic) and Altaians (the prevalence to subsequently move to the different possibi- Altai Republic). lities.Itisnotpossibletodatetoknowtheetiologyin100% Materialsandmethods:Thestudyincluded232patients of cases. (171Tuvinians, 61Altaians) with hearing loss ofunknown etiology. Analysis of the SLC26A4 complete sequence including all 21 exons and ﬂanking regions was performed Gene Variant Protein Zygosity Relateddisease by Sanger sequencing. GPR98 c.5167C>G/ p. Compound Ushersyndrome Results: High contribution of the SLC26A4 mutations in c.14939T>C (Pro1723Ala)/ Heterozygosity type2C deafnesswasfoundinTuvinianpatients(28.2%)incontrastAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 811 to Altaian patients (4.3%). Both known (c.170C>A, c.919- Results: Affymetrix CytoScan Xon array: A mean of 56 2A>G, c.2027T>A, c.2034+1G>A, c.2168A>G) and CNVs/patient, both positive control and 10 potentially several novel pathogenic variants as well as a wide range disease-causing CNVs were detected. Agilent Custom ofbenignvariantswerefoundintheSLC26A4sequencesof array:Ameanof8CNVs/patient,onlyonepositivecontrol patients. High frequency of mutation c.919-2A>G in and 6 potentially disease-causing CNVs were found. Tuvinians (69.9% of all mutant alleles detected in patients Conclusions: ACA are easier to analyze, since their and carrier frequency reaching to 5.1% in controls) is results derive from only 123 IRD genes. Moreover, they probably due to the founder effect. include information from both exonic and intronic regions. Conclusion: This is the ﬁrst study to address the In contrast, ACX delivers information of CNV throughout SLC26A4 mutations contribution in deafness in Siberian the whole genome, with most probes enriched on exonic populations. Contrast differences in the proportion of regions.Thereforeinformationfromexonsismorerobustin deafness caused by SLC26A4 mutations were revealed in ACXarrays.Asageneralconclusion,AffymetrixCytoScan TuviniansandAltaiansdespiteoftheirrelatedethnicityand Xon arrays have more sensitivity but less speciﬁcity than close residence of these indigenous peoples of Southern our customized Agilent CGH array. Siberia. Obtained data signiﬁcantly contribute to the MRHissupportedbyafellowshipfromGobiernoVasco, SLC26A4 allelic diversity worldwide. Spain (Pre-2019-1-0325). Work supported by grants from StudywassupportedbyProjects#0259-2019-0010-C-01, the ISCIII and fondos FEDER (PI17/01413), from Depar- #0324-2019-0041-C-01 and RFBR grants #17-29- tamento de Salud of Gobierno Vasco (2018111062 and 06016_oﬁ-m, #20-015-00328_a. MTVD19/BD/006) and from BEGISARE. V.Y.Danilchenko:None.M.V.Zytsar:None.M.S.Bady- M. Rodríguez-Hidalgo: None. M. Ezquerra-Inchausti: Khoo:None.E.A.Maslova:None.A.A.Bondar:None.I.V. None. A. Lara-López: None. L. Escudero-Arrarás: None. Morozov: None. N.A. Barashkov: None. O.L. M.Galdós:None.G.Garay-Aramburu:None.C.Cruchaga: Posukh: None. None. C. Irigoyen: None. J. Ruiz-Ederra: None. E-P02.16 E-P02.17 Copynumbervariationanalysisinagroupofpreviously How prepare a corneal epithelium for cone-related unsolved patients with inherited retinal dystrophies: a transcriptomic proﬁle assessment in keratoconus? comparative study K. Jaskiewicz1, M. Maleszka-Kurpiel2,3, M. Rydzanicz4, M. Rodríguez-Hidalgo1, M. Ezquerra-Inchausti1, R. Ploski4, M. Gajecka1,5 A. Lara-López1, L. Escudero-Arrarás1, M. Galdós2, G.Garay-Aramburu3,C.Cruchaga4,C.Irigoyen1,5,J.Ruiz- 1Institute of Human Genetics, Poznan, Poland, 2Optegra Ederra1,6 Eye Health Care Clinic, Poznan, Poland, 3Chair of Ophthalmology and Optometry, Poznan University of 1IIS Biodonostia, San Sebastián, Spain, 2Cruces University MedicalSciences,Poznan,Poland,4DepartmentofMedical Hospital, Bilbao, Spain, 3Araba University Hospital, Genetics, Medical University of Warsaw, Warsaw, Poland, Vitoria-Gasteiz, Spain, 4Washington University School of 5Department of Genetics and Pharmaceutical Microbiol- Medicine, St. Louis, MO, United States, 5Donostia Uni- ogy, Poznan University of Medical Sciences, Poznan, versity Hospital, San Sebastián, Spain, 6RETICS Poland OFTARED, Madrid, Spain Introduction: Keratoconus is a multifactorial eye ectasia Introduction: Inherited retinal dystrophies (IRD) are an affecting 1 per 2000 individuals worldwide, characterized heterogeneousgroupofdiseaseswith>250genesinvolved. by pathological cone formation decentered from pupil axis. Despitesubstantialprogressinmasssequencingtechniques, Because all corneal layers are involved in disease progres- the genetic cause of 35-45% of the cases of IRD is still sion we aimed to establish a protocol for transcriptomic unknown.SincetheparticipationofCNVsisinvolvedinat proﬁle based on three distinct corneal epithelium regions. least 1 in 13 patients, here we present the results of ana- Materialsandmethods:The 10corneal epitheliabefore lyzingCNVinacohortofBasquepatientsusing2different the corneal cross-linking procedure were stampted to approaches. maintain correct orientation for cutting on microscope Materials and methods: 48 IRD patients and 2 positive slides with light microscope’s control. As non-keratoconus controls were analyzed. We compared 2 hybridization control 5 myopia patients undergoing refractive error arrays: Affymetrix CytoScan Xon arrays (ACX) and correction were included. From each corneal epithelium AgilentCustomarrays(ACA),with123IRDrelatedgenes. the central, middle, and periphery corneal region samples812 J.delPicchia were proceeded based on epithelial thickness mapping and mutationinTUBB4Bgene,whichcausesArgtoCyschange corneal tomography maps. The RNA samples were at391amino acidposition. Themutationwas absentinthe extracted using Norgen Biotek kits (Single Cell RNA sample of the unaffected family member. The clinical PuriﬁcationKit,RNA/DNA/ProteinPuriﬁcationPlusMicro evaluation of the ﬁndings reveals that the mutation fulﬁlls Kit),andRNAquality/quantitywerecompered(RNA6000 the criteria of pathogenic mutation and the clinical Pico Kit, Agilent). symptoms of the affected family members matches to Results: Study design included evaluation of unaffected Leber congenital amaurosis syndrome, which has been curvature of cornea and different physiological/functional previously correlated to this TUBB4B mutation. states of epithelial cells from keratoconus cone and non- Conclusion: Our unique ﬁndings with three affected cone corneal regions. After protocol establishment we family members carrying the TUBB4B mutation highlights obtained high quality RNA for RNA-seq libraries the importance of next generation sequencing in the preparation. discovery of new pathogenic variants and in diagnosis of Conclusions: The corneal material proceeded in accor- rare disorders; additionally, it will be important knowledge dance with the presented protocol will allow for detailed in gene therapy even in ophthalmology and otology. This keratoconus epithelium study involving the phenotypical work was supported by the grant NSRP K119540 and andtranscriptionalassessmentsofkeratoconusprogression. GINOP-2.3.2-15-2016-00039. Support: The National Science Centre grant no. 2018/31/ A.Maasz:None.R.Ripszam:None.A.Zsigmond:None. B/NZ5/03280. Co-ﬁnanced by the European Social Fund J. Bene: None. A. Gyenesei: None. B. Melegh: None. K. within the framework of the Operational Programme Hadzsiev: None. Knowledge Education Development, a non-competition project ‘International scholarship exchange of doctoral E-P02.20 students and academic staff’, implemented within the Mutational analysis of the most frequent genes in framework of the Action speciﬁed in the application No. Romanian patients with congenital non-syndromic POWR.03.03.03.00-00-00-PN13/18. hearing loss K. Jaskiewicz: None. M. Maleszka-Kurpiel: None. M. Rydzanicz: None. R. Ploski: None. M. Gajecka: None. I. Resmerita1, S. Cozma2, M. Panzaru1, E. Gorduza1, R. Popescu1, L. Radulescu2, L. Butnariu1, C. Rusu1 E-P02.18 Beta tubulin gene mutation in association with con- 1University of Medicine and Pharmacy “Grigore T. Popa” genital Leber herediter amaurosis syndrome Iasi - Medical Genetics Department, Iasi, Romania, 2Uni- versityofMedicineandPharmacy“GrigoreT.Popa”Iasi- A. Maasz1,2, R. Ripszam1,2, A. Zsigmond1,2, J. Bene1,2, ENT Department, Iasi, Romania A. Gyenesei2, B. Melegh1,2, K. Hadzsiev1,2 Introduction:Hearinglossisthemostcommoncongenital 1UniversityofPecs,DepartmentofMedicalGenetics,Pecs, sensory impairment worldwide, with a genetic etiology in Hungary,2SzentagothaiResearchCentre,Pecs,Hungary more than 60% of the cases. It is estimated that more than 70locimaycontributetonon-syndromicdeafness,themost Introduction: Beta-tubulin 4B isotype is one of the sub- commonly involved genes being GJB2, GJB3, GJA1, units of microtubules, which is responsible for the main- MYO6, SLC26A4, POU3F4. The knowledge on the pre- tenance of microtubules stability. The beta-tubulin 4B valence of mutations in a certain population allows the protein is encoded by TUBB4B gene located on chromo- development of adjusted screening programs. some 9. Genetic defects of microtubules have been asso- Materials and methods: We included in this study 144 ciated with several disorders like tubulinopathies, which unrelatedRomanianswithnon-syndromiccongenitalsevere show huge heterogeneity. In TUBB4B gene, only a few to profound hearing loss (NSHL). All of the individuals mutations have been identiﬁed to have implications in dis- were screened by Multiplex ligation-dependent probe orders, so far. ampliﬁcation (MLPA) for mutations in GJB2, GJB3, Patients and methods: The authors report a Hungarian GJB6, WFS1 and POU3F4 genes, and Sanger sequencing familywithundiagnosedraredisorder.Thefamilymembers for variants in GJB2 gene. suffer from also ophthalmologic and otologic impairments. Results: We found 54 homozygotes or compound Theauthorsanalyzedtheprobandandheraffectedchildren heterozygotesindividuals(38%)and14carriersofdifferent and the unaffected mother of the proband using whole mutations on GJB2 gene. In the study group we found a genome sequencing (WGS). The authors found that all of total of 10 different mutations in GJB2 gene. The 35delG theaffectedfamilymemberscarrythec.1171C>Tmissense wasthemostcommonformofmutationthatwaspresentinAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 813 23outof54(43%)mutatedalleles.Thenextfrequenttypes pathogenicity of genetic alterations identify the variant as of mutation were WT313del14, IVS1 and c.71G>A. We potentially pathogenic. also found 2 patients with mutations in WFS1 gene. Funding: NSP “Young Scientists and Postdoctoral Conclusions: The etiology of deafness is an additional Fellows” argument, besides audiological tests, for early treatment D.R. Pencheva: None. K. Kamenarova: None. (best choice being cochlear implant) and an essential K. Mihova: None. V. Petkova: None. I. Dimova: None. element for the correct management of the individuals. M. Nacheva: None. V. Mitev: None. R. Kaneva: None. Moreover,identiﬁcationofthegeneticbasisofhearingloss in a child facilitates correct genetic counselling with E-P02.27 adequate molecular testing of the parents and subsequent The utility of whole-exome sequencing in establishing prenatal diagnosis. speciﬁc diagnosis in three cases with syndromic I. Resmerita: None. S. Cozma: None. M. Panzaru: None. cataracts E.Gorduza:None.R.Popescu:None.L.Radulescu:None. L. Butnariu: None. C. Rusu: None. P. Liskova, L. Dudakova, J. Moravikova, M. Magner, T. Honzik E-P02.24 Next-generation sequencing for germline mutation First Faculty of Medicine, Prague, Czech Republic analysis in patients with retinoblastoma Introduction: Congenital and juvenile cataracts can be D.R.Pencheva,K.Kamenarova,K.Mihova,V.Petkova,I. associatedwitharangeofsystemicsigns.Hereinweaimto Dimova, M. Nacheva, V. Mitev, R. Kaneva report results of molecular genetic investigation in six probands with syndromic cataracts without a deﬁnitive Genome Diagnostics Laboratory, Molecular Medicine clinical diagnosis. Center, Department of Medical Chemistry and Biochem- Materials and methods: Whole exome sequencing istry, Medical Faculty, Medical University of Soﬁa, Soﬁa, (WES) was performed in all index cases. Variants with Bulgaria minorallelefrequencylessthan0.005aspergnomADv.2 were ﬁltered and those located in genes listed in database Introduction: Retinoblastoma is the most common pedia- Cat-Map were given a priority for further evaluation. tric ocular tumor affecting the retina, initiated mainly by Conventional sequencing was used to conﬁrm the mutations in the tumor suppressor gene RB1. Both heredi- presence of the variants and for segregation analysis tary and sporadic forms of the disease are known. within the families. Variant-classiﬁcation was based on Materialsandmethods:Inthecurrentstudyweincluded the American College of Medical Genetics and Genomics two Bulgarian patients diagnosed with retinoblastoma. DNA guidelines. was isolated from blood. Next-generation sequencing was Results: One proband carried a heterozygous variant performedonMiSeq/IlluminaplatformwithTruSightCancer c.3491delinCOL2A1predictedtointerferewithpre-mRNA panel including 94 cancer related genes. splicing. Subsequent re-evaluation of his clinical data Results:Wefoundtwoheterozygousprobablypathogenic conﬁrmed the diagnosis of Stickler syndrome, which was variants both in RB1, encoding RB transcription corepres- also present in the mother. One proband had a de novo sor 1: c.2606C>T (p.Pro869Leu; rs775273085) in exon 25 arising heterozygous variant c.512T>G; p.(Leu171Trp) in and c.1960+1G>C in intron 19 of the RB1 gene. MYH9 allowing to make a diagnosis of MYH9-related Conclusions:The missense variant c.2606C> T (p. disease. The third case had a known heterozygous change Pro869Leu)inexon25isoflowfrequencyinthepopulation c.284G>C; p.(Gly95Ala) in RIT1 causing Noonan syn- (oneheterozygoteC/TisdetectedingnomAD,1/251337). drome. His mother was subsequently found to be also Thismutationwasalsodetectedinaheterozygouscondition mildly affected. No possibly pathogenic variant was in the mother of the patient, who was diagnosed with renal identiﬁed in three other probands. angiomyolipoma with focal hemorrhages and micro necro- Conclusions: WES allowed for providing deﬁnitive sis.Theothervariantc.1960+1G>Cfoundinintron19is diagnosis in three probands with syndromic cataracts. Our new for data bases. Single-point replacements of G>A and study shows that there is a need for raising awareness G>Tinthesamepositionhavebeenshowntobepathogenic among healthcare professionals regarding variable associa- in patients with retinoblastoma. According to the program tion of many syndromes with congenital or juvenile usedtoevaluatetheeffectofintronvariants,replacementof cataracts. Supported by AZV 17-30500A. c.1960 + 1G> C would affect mRNA splicing (ADA score P. Liskova: None. L. Dudakova: None. J. Moravikova: 0.99).All ofthesix commonly used programsto assessthe None. M. Magner: None. T. Honzik: None.814 J.delPicchia E-P02.29 E-P02.30 Clinical exome sequencing reveals Usher syndrome Usher syndrome type 3 in Russian population: 6 ﬁrst pathogenic PCDH15 and ADGRV1 variants in two reported cases. pedigrees with hearing and vision loss M. E. Ivanova1,2, E. R. Lozier3, V. S. Kaimonov2, I. V. K. Kamenarova1, S. Cherninkova2, K. Mihova1, Mironova2, E. A. Pomerantseva2, F. A. Konovalov3, A. A. F. Shakola1, V. Mitev1, R. Kaneva1 Isaev2 1Molecular Medicine Center, Medical University – Soﬁa, 1Oftalmic, Moscow, Russian Federation, 2Genetico, Mos- Soﬁa, Bulgaria, 2Department of Neurology, University cow, Russian Federation, 3Clinical bioinformatics labora- Hospital Alexandrovska, Medical University – Soﬁa, tory, Moscow, Russian Federation Bulgaria, Soﬁa, Bulgaria Introduction: Usher syndrome is one of the most frequent Introduction: Usher syndrome (USH) is a rare disorder reasons of combined blindness and deafness. There are causingretinitispigmentosa(RP),andsensorineuralhearing three types of Usher syndrome, type 3 is mild and can be loss. Due to the phenotypic and genetic heterogeneity of clinically evaluated quite accurately. There is no known this disease, the best method to screen the causative muta- effective treatment of Usher syndrome type 3. tionsisbyhigh-throughputsequencing.Bynext-generation Materials and methods: 120 patients with isolated and sequencing of clinical exome including known USH-cau- syndromic retinitis pigmentosa participated in the study sative genes, we aimed to identify the disease-causing under NCT03901391 clinical trial protocol. Out of 120 mutation in two USH-pedigrees. cases six were CLRN1 conﬁrmed. Complete ophthalmolo- Materials and methods: Using Illumina® platform, we gic,ENT,andvestibularmedicaltestsweredoneforclinical identiﬁed two pathogenic variants in two USH genes characterization. WES, Sanger sequencing were provided (PCDH15 and ADGRV1) segregating with vision and for genetic analysis and diagnosis conﬁrmation. hearing loss in two unrelated Bulgarian families. Results: 6 patients (4 male, 2 female) aged 30.2±6.9 Results: In a USH-family, an affected woman was yrs were diagnosed with CLRN1 associated retinopathy homozygous for a splice-site mutation in PCDH15 whichshowedclassicalretinitispigmentosabonespiculesin (c.3983+1G>T,p.?), predicted to cause splice error - a the peripheral retina combined with hearing loss starting known mutation for USH type-1F. Ophthalmological from early childhood. Four patients were having mild examination of the patient conﬁrmed typical RP and myopia and two were having emmetropia. Four of these prompted a corrected USH type diagnosis. Patient’s patients were unrelated to each other and two were sibs unaffected parents and brother were heterozygous for (brother and sister). All of the patients had c.567T>G p. the mutation. In an unrelated clinical case, two siblings Tyr189*mutationinhomozygousstate,whichprobablycan withRPwerehomozygousforanovelnonsensemutation denote the founder effect on the territory of Russia. inADGRV1(c.5709G>A,p.Trp1903*),predictedtocreate Conclusions: There were no previouslydescribed and a very premature stop codon and shortened protein. published Usher syndrome type 3 clinical cases in Russia Clinical follow-up subsequently conﬁrmed pre-existing conﬁrmed with CLRN1 gene mutations. There might be hearing loss since early childhood in the two patients, attractive perspectives for the treatment strategies for such resultinginareassigneddiagnosisofUSH.Asymptomatic groupofpatientsnotonlybecauseCLRN1genehasonly6 parents and brother were heterozygous carriers of the exonsand mRNA is relatively short (2,39 kb), but also mutation. because mutation is homogenous and includes only Conclusions:WehaverecruitedtwopedigreeswithUSH c.567T>G p.Tyr189* mutation in homozygous state. and found homozygous mutations in PCDH15 and Funding: Charity fund Con-nection. ADGRV1.Theproteinsencodedbythesegenesarethought M.E.Ivanova:None.E.R.Lozier:None.V.S.Kaimonov: tointeractwithoneanothertoformanetworkinthesensory None. I.V. Mironova: None. E.A. Pomerantseva: None. F. cells of the retina and inner ear. Grant references: D01- A. Konovalov: None. A.A. Isaev: None. 285/17.12.2019/D-230/17.12.2019/NSF/MES and КП-06- Н33/12/ NSF/MES. E-P03InternalOrgans&Endocrinology(Lung,Kidney, K. Kamenarova: None. S. Cherninkova: None. K. Liver, Gastrointestinal) Mihova: None. F. Shakola: None. V. Mitev: None. R. Kaneva: None. E-P03.01 Hyperaldosteronism in a patient with ATP1A1 deﬁciencyAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 815 S.Gisladottir,H.Gisladottir,J.J.Jonsson,H.T.Bjornsson Introduction: Familial neurohypophyseal diabetes insipi- dus is a rare disease producedby a deﬁciency in the secre- University Hospital of Iceland, Reykjavik, Iceland tion of antidiuretic hormone and is caused by mutations inthe AVP-NPII gene. Wereportapatientwithepisodesofhypertensivecrisisand Materials and methods: Clinical, biochemical and lactic acidosis from infancy. These episodes were found to genetic characterization of a group ofpatients clinically be related to hyperaldosteronism and ill treatable with diagnosed with Familial neurohypophyseal diabetes insipi- conventional blood pressure medication. At four months dus. TheAVP-NPII gene was screened for mutations by old, she was diagnosed with pulmonary hypertension and polymerase chain reaction followed bydirect Sanger refractory seizures. She also has developmental delay sequencing in 15 different unrelated families from Spain. compounded by multiple brain infarcts. She is treated with Results: The 15 probands presented with polyuria and alpha-agonists and ACE-inhibitors and responds well. She polydipsia as the most importantsymptom at the time of is also receiving anticonvulsants and PDE inhibitors. WGS diagnosis. In these patients, the disease was diagnosed at was performed for her in 2017 which identiﬁed a hetero- amedian of 6 years of age (range: 0.75 - 48 years). We zygous missense variant, p.Asp897Asn, in the ATP1A1 observed 11 presumed pathogenicvariants in 15 families: 8 gene (in the extracellular domain) that encodes for the missense,1nonsenseand2smalldeletionsof3nucleotides. Alpha-1 isoform of the Na(+)/K(+)-ATPase, which helps FouroftheAVP-NPIIvariantswerenovel(p.(Tyr21Cys),p. establish electrochemical gradient over plasma membranes. (Gly45Ser), p.(Cys75Tyr),p.(Gly88Cys)). In2018similarvariantsweredescribedintheATP1A1gene Conclusions:WefoundautosomaldominantFNDIinthe inthreechildren(allintheintramembranousdomain).Their 15 probands studied due tolikely pathogenic variants in the phenotype has been described as a new disease called AVP-NPII gene conﬁrming the clinical diagnosis. Fourof hypomagnesemia, seizures and mental retardation 2 the AVP-NPII variants were novel. (MIM#618314) but none of these patients have hyper- A. Garcia: None. L. Madariaga: None. G. Pérez de aldosteronism. Our patient has demonstrated mild hypo- Nanclares: None. A. Vela: None. I. Rica: None. magnesemia as well as seizures and developmental delay. S. Gaztambide: None. R. Martinez: None. I. Martinez de Interestingly, somatic ATP1A1 disease causing variants, LaPiscina: None. I. Urrutia: None. A. Aguayo: None. have been found in aldosterone-producing adenomas. O. Velasco: None. L. Castaño: None. Additionallyin2018,variantsinthegenewerefoundtobe a novel cause of Charcot-Marie-Tooth syndrome (all in the E-P03.05 intracellular domain), so this gene can lead to multiple The intriguing role of bitter taste receptor TAS2R38 in phenotypes,whichcoulddifferdependingonthelocationof primary ciliary dyskinesia “PCD” the variants in the domains of the protein. We propose that her episodes of hypertensive crisis and hyperaldosteronism A. Robino1, G. Girotto2, U. Ambrosetti3, G. Piatti4 maybeanexpansionofthephenotypeoranoveladditional phenotype related to this gene. 1IRCCS-Burlo Garofolo Children Hospital, Trieste, Italy, S. Gisladottir: None. H. Gisladottir: None. J.J. Jonsson: 2IRCCS-Burlo Garofolo Children Hospital-University of None. H.T. Bjornsson: None. Trieste,Trieste,Italy,3IRCCSCa’Granda,AudiologyUnit- University of Milan, Milano, Italy, 4IRCCS Ca’ Granda, E-P03.04 Bronchopneumology Unit-University of Milan, Milano, Novel variants in the AVP-NPII gene associated with Italy neurohypophyseal diabetes insipidus PCD is arare genetic disease dueto malfunctioningand/or A. Garcia1, L. Madariaga1,2,3, G. Pérez de Nanclares1, altered ultrastructure of motile cilia leading to recurrent A. Vela1,3,2, I. Rica1,2, S. Gaztambide1,2,3, R. Martinez1, respiratory infections of upper and lower airways. Chronic I. Martinez de LaPiscina1, I. Urrutia1, A. Aguayo1, rhinosinusitis and bronchiectasis are very common in PCD O. Velasco4, L. Castaño1,2,3 patients. Recently, it has been shown the presence of taste receptors in the respiratory tract and the possible involve- 1IISBiocrucesBizkaia,CIBERDEM,CIBERER,Barakaldo, mentofbittertastereceptorTAS2R38gene,insusceptibility Spain, 2Hospital Universitario Cruces, Barakaldo, Spain, torespiratory infections and rhinosinusitis. The aim of this 3UPV/EHU, Leioa, Spain, 4IIS Biocruces Bizkaia, Bara- study is to evaluate the frequency of TAS2R38 poly- kaldo, Spain morphisms in PCD patients and their possible correlations with clinical outcomes of the disease. Genetic and816 J.delPicchia phenotypic data of 35 PCD patients were collected. Clin- with R1158X mutation, deletion of exons 18-20 in three ical evaluation includes: number of respiratory infections patients with F508del mutation and in one with R334W, per year and pathogens; Lund McKay score; number of deletionofexons2and3intwopatientswithF508del,two lung lobes involved; modiﬁed Bhalla score. As regards deletions of exons 2 and 13 in one patient. The last ﬁnding genetic data, 3 polymorphisms (rs1726866,rs713598, is novel and not described in databases. The clinical rs10246939) within TAS2R38 gene were analyzed and presentation of CF in all of them was with early onset (in patients classiﬁed as PAV/PAV, PAV/AVI and AVI/AVI. the ﬁrst year of life), meconium ileus, failure to thrive, A signiﬁcant difference in the distribution of TAS2R38 pancreatic insufﬁciency, chronic obstructive lung disease haplotype between patients with and without neonatal and abnormal sweat test levels. respiratorydistressemerged(p-value=0.01).Inparticular,a Conclusion:Weestablishedthatoverallfrequencyofthe lower percentage of PAV/PAV individuals showed a high large deletions in our patients is about 1% from all number of pulmonary exacerbations (≥ 2/year) (p- mutations that we found in CFTR gene. It must be kept in value=0.04) compared to those with AVI/AVI and AVI/ mind that >99% of all known point mutations have allele PAV haplotypes. Moreover, no patients homozygous for frequencies that are below 0.1%. Therefore we believe that PAV/PAV haplotype presented with any chronic coloniza- it is suitable to use MLPA of CFTR gene for routine tion by Pseudomonas aeruginosa thus supporting the pos- molecular diagnostics of CF. sible role of TAS2R38 in susceptibility to respiratory N. Yaneva: None. M. Libik: None. G. Petrova: None. infections. In conclusion, here we report, for the ﬁrst time, I. Bradinova: None. M. Nikolova: None. M. Macek: None. a possible association of TAS2R38 polymorphisms with A. Savov: None. PCD phenotype. A larger collection of patients is in pro- gress and updated results will be presented and discussed. E-P03.07 A. Robino: None. G. Girotto: None. U. Ambrosetti: Differential molecular diagnosis of Cystic ﬁbrosis and None. G. Piatti: None. Shwachman-Diamond syndrom E-P03.06 M. Kazaryan1,2, T. Adyan2,1, A. Polyakov2 Clinics and genetics in CF patients with large deletions 1RNRMU, Moscow, Russian Federation, 2Research Centre N. Yaneva1, M. Libik2, G. Petrova3, I. Bradinova1, M. for Medical Genetics, Moscow, Russian Federation Nikolova4, M. Macek2, A. Savov1 Cystic ﬁbrosis (CF) and Shwachman-Diamond syndrome 1National Genetic Laboratory, University Hospital of (SDS) are autosomal recessive disorders, associated with Obstetrics and Gynecology “Maichin Dom”, Soﬁa, Bul- mutations in CFTR and SBDS genes respectively. CF and garia, 2Department of Biology and Medical Genetics, SDS have general symptom - exocrine pancreatic insufﬁ- Charles University-2nd Faculty of Medicine and Motol ciency. This study aims to describe the possibility of mis- University Hospital, Prague, Czech Republic, 3Pediatric diagnosis in case of conditions with common symptoms, cilinic, UMHAT "Alexandrovska", Soﬁa; Pediatric depart- such as CF and SDS. The ﬁrst cohort of 94 patients aged ment, Medical University of Soﬁa, Soﬁa, Bulgaria, 4Pedia- from 0 to 40 years with primary SDS diagnosis were tric clinic, UMHAT“Sveta Marina“, Varna; Medical investigated for the presence of 30 CFTR gene mutations Univcersity Varna, Varna, Bulgaria that are most frequent in Russian Federation. The second cohort of 361 patients with primary CF diagnosis was Introduction:Cysticﬁbrosis(CF)isthemostcommonlife- analyzed for the presence of 2 common SBDS gene muta- shortening condition with autosomal recessive inheritance. tions (this sample was divided into 2groups:246 probands It is associated with at least one mutation on each allele on agedfrom0to5yearsand115probandsagedfrom6to10 CF transmembrane conductance regulator (CFTR). After years). MLPA-method was used to determine point muta- screeningforpointmutationsandsmallindel,usingSanger tions; deletion/insertion mutations were tested by multiplex sequencing and NGS, in some patients the second disease AFLP-method and automated sequencing as well. We causing mutation remains unidentiﬁed. identiﬁed one heterozygous carrier of F508del mutation in Materials and methods: We performed MLPA analysis the CFTR gene in SDS sample (sequencing of the entire for detection of large deletions and duplications in CFTR coding region of this gene and MLPA-analysis did not gene,using P091MLPA MRCHollandkit inagroup of44 reveal a second pathogenic variant in this patient). In a CF patients with only one mutation. group of 0-5 years CF patients 4 probands were found to Results:TheMLPAscreeningdetectedlargedeletionsin have both mutations in the SBDS gene and one proband eight patients (18%): deletion of exons 4-11 in one patient have1heterozygousmutation.Inagroupof6-10yearsCFAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 817 patients only 1 proband had both mutations. Our results treatmentwiththyroidhormoneandthatfuturepregnancies demonstratethatpatientswithsuspectedCFandundetected should be carefully monitored for the presence of prenatal mutations in the CFTR gene are necessary to differential goiter. diagnosis with a SDS. N.Zdraveska:None.V.Anastasovska:None.N.Schoen- M. Kazaryan: None. T. Adyan: None. A. Polyakov: makers: None. A. Nicholas: None. M. Kocova: None. None. E-P03.10 E-P03.08 Molecular investigation of Cystic Fibrosis: CFTR Thyroid peroxidase (TPO) mutations in Macedonian mutation spectrum among Greek population patients with congenital hypothyroidism M. Argyraki, M. Chatziapostolou, S. Vittas N. Zdraveska1, V. Anastasovska1, N. Schoenmakers2, A. Nicholas2, M. Kocova1 DNA - Diagnosis N Analysis Laboratory, Thessaloniki, Greece 1UniversityChildren’sHospitalSkopje,Skopje,Macedonia, The Former Yugoslav Republic of, 2University of Cam- Introduction: Cystic Fibrosis (CF) represents the second bridge Metabolic Research Laboratories, Wellcome Trust- mostcommoncongenitaldisorderamongGreekpopulation. Medical Research Council Institute of Metabolic Science, Approximately 4-5% of Greek population represents Addenbrooke’s Hospital, Cambridge, United Kingdom asymptomatic CF mutation carriers. This in conjunction with the limited knowledge about this disease necessitates Introduction: Congenital hypothyroidism (CH) due to the implementation of carrier screening programs. thyroiddyshormonogenesisisaheterogenicdisordercaused Materials and methods: The study population consisted by impairment in any stage of the thyroid hormone bio- of 485 Greek individuals screened for CF mutations. We synthesis pathway. Mutations in seven genes may be used a targeted NGS to sequence all CFTR gene coding associatedwiththyroiddyshormonogenesis:SLC5A5(NIS), regions, intron/exon splice sites and UTRs, combined with SCL26A4 (PDS), TG, TPO, DUOX2, DUOXA2, and IYD MLPA analysis. (DHEAL1). Defects in thyroid peroxidase (TPO) gene are Results: Molecular analysis showed that 96 indivi- reported as the most frequent cause of dyshormonogenesis duals (19.8%) represent CF mutation carriers, consisting with permanent CH characterized with permanent total of 24 individuals (4.75%) carrying typical CF-causing iodide organiﬁcation defect. mutations, 38 individuals (7.52%) carrying CFTR-RD Methods:Acomprehensive,phenotype-driven,approach (CFTR-related disorders) mutations and 38 individuals was used to identify underlying mutations in Macedonian (7.52%)carryingvariantsofuncertainsigniﬁcance(VOUS). cohort of CH patients, by sequentially screening known Seven cases of complex alleles that carry two mutations dyshormonogenesis-associated genes. Genomic DNA was were also observed, a factor that can complicate CFTR extracted from peripheral blood leukocytes, and Sanger diagnosisandclinicalevaluation.Themostcommontypical sequencing was used to screen for TPO gene mutations in mutation identiﬁed in 15 carriers was ΔF508, followed by all coding exons and exon/intron boundaries ampliﬁed by 621+1G>T mutation occurring in 3 carriers. Likewise, PCR speciﬁc primers. R75Q mutation represents the most common CFTR-RD Results:AnalysisoftheTPOgenerevealed variantsin3 mutation identiﬁed (8 carriers), followed by L997F and cases including 2 siblings who each harboured a hetero- R1162L (found in 6 and 4 carriers respectively). Lastly, zygous frameshift variant, p.A397Pfs*77, inherited from a c.2620-15C>G mutation was identiﬁed in 11 carriers, euthyroid father. An unrelated case was compound hetero- representing the most common VOUS mutation in the zygous for a maternally inherited missense mutation, p. population studied. R438H, and a paternally inherited frameshift variant, p. Discussion: Aim ofthecurrentstudy was toestimatethe E17Dfs*77. All 3 cases exhibited severe CH at diagnosis, CFTR mutation spectrum and the prevalence of CF with signiﬁcantly elevated serum TSH values (mean: mutation carriers among Greek population. Accurate 103mU/L, range >75-159mU/L) and low fT4 values knowledge of CF mutation spectrum provides information (mean<4ug/dl). Goitre was diagnosed on the neonatal for CF prevention programs and may prove particularly thyroidultrasoundandduringfoetalultrasoundexamination important for providing more sufﬁcient genetic counselling in the third case. to the Greek population. Conclusion: Finding TPO gene mutations in a neonate M. Argyraki: None. M. Chatziapostolou: None. with CH indicates that the subject will require life-long S. Vittas: None.818 J.delPicchia E-P03.13 E-P03.14 Correlationof10SNPpolymorphismsinmodiﬁergenes The c.7G>A variant in EHHADH associated with (TNF, GST, HFE) with phenotype of Slovak cystic Fanconi renotubular syndrome is also responsible for ﬁbrosis (CF) patients hepatic failure E. Tóthová Tarová1, A. Soltysova2, A. Ficek3,P. Celec4,5,3, P. Rollier1,2, M. Barth1, V. Milon1, N. Gueguen1, C. Bris1, H. Kayserova6, L. Kádasi3,2 L. Damaj2, A. Ryckewaert3, S. Odent2, V. Procaccio1, A. Ziegler1, D. Bonneau1 1Department of Biology, Faculty of Education, J. Selye University, Komárno, Slovakia, 2Institute of Molecular 1Department of Biochemistry and Genetics, Angers Uni- Physiology and Genetics, Slovak Academy of Sciences, versity Hospital, Angers, France, 2Department of Clinical Bratislava, Slovakia, 3Department of Molecular Biology, Genetics, Rennes University Hospital, Rennes, France, Comenius University, Bratislava, Slovakia, 4Institute of 3Department of Pediatrics, Rennes University Hospital, Pathological Physiology, Faculty of Medicine, Comenius Rennes, France University, Bratislava, Slovakia, 5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Introduction: EHHADH was ﬁrst associated to a human Bratislava, Slovakia, 6Center of Cystic Fibrosis, Depart- disease by Klootwijk et al. in 2014 who reported that the ment of Pediatric Pneumology, University Hospital, pathogenic variant c.7G>A;p.E3K was responsible for an Bratislava, Slovakia isolated Fanconi renotubularsyndrome. Thisvariantcauses an addressing defect of this peroxisomal protein leading to Cystic ﬁbrosis (CF) is still the most serious autosomal its abnormal localization to mitochondria. We report a recessive disease in the white population despite second case harbouring the same mutation in EHHADH as improved treatment of CF patients. More than 2000 that previously reported who was affected with a broader identiﬁed mutations have been previously described in phenotype including recurrent hypoglycemia and hepatic theCFTRgene.EveninCFpatientswithidenticalCFTR cytolysis associated to Fanconi syndrome. genotypes, there are a large number of serious lung Materials and methods: Recruitment of the patient, diseases and other symptoms. Environment and poly- exomesequencingandfunctionalanalyseswerecarriedout morphisms in other genes play a particularly important at the Angers University Hospital. role in the phenotypic modiﬁcation of disease. The main Results: At 4 months of age, the individual presented aim of our study was the correlation analysis of 10 SNP with hypoglycemia, ketonuria, lactic acidosis and hepatic polymorphisms/variants in selected modiﬁer genes cytolysis. Subsequently, he presented recurrent episodes of (TNFα, GSTM, GSTP, GSTT and HFE) and subsequent vomiting and/or diarrhea with hypoglycemia after long correlation analysis with clinical symptoms of patients, fasting requiring glucose infusions. Additional features mainly spirometry measurements of lung function. To included severe Fanconi tubulopathy with glucosuria, identify these polymorphisms, we used methods such as tubular proteinuria, hypouricemia, and nephrocalcinosis. PCR and direct sequencing. Our results show a sig- Mitochondrial respiratory chain analyses performed on niﬁcant association of the TNFα gene polymorphism hepatocytes showed a decreased activity of complex I and (rs1800629) with cardiomyopathy, another polymorph- IV, including a 70% decrease in complex IV/citrate ism (rs361525) with hypoalbuminemia and distal synthase ratio which was conﬁrmed by the decrease of the obstructive syndrome, and two other polymorphisms same complexes using Western blot analyses. Exome (rs1800630, rs1799724) with bacterial infections of analysis evidenced the missense mutation c.7G>A;p.E3K Pseudomonas aeruginosa. The GSTT1 gene show sig- in EHHADH. This mutation was inherited from the father niﬁcant association with the nasal polyps, GSTP1 gene who was asymptomatic at age 54. (rs1695) with a worse pulmonary function by vital Conclusions:Weexpandthephenotypicspectrumofthe capacity of lung (FEV ), also HFE gene polymorphism c.7G>A mutation in EHHADH with the description of 1 (rs1799945)withworsepulmonaryfunction(FEV ).Our hepatic failure, including cytolysis and hypoglycemic 1 results can be used as a prognostic marker in the treat- episodes,associatedwithFanconitubulopathy.Thisdisease ment of CF patients. isanautosomaldominantdisorderwithagreatvariabilityin E.Tóthová Tarová:None.A.Soltysova:None.A.Ficek: expression. None. P. Celec: None. H. Kayserova: None. L. P. Rollier: None. M. Barth: None. V. Milon: None. Kádasi: None. N. Gueguen: None. C. Bris: None. L. Damaj: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 819 A.Ryckewaert:None.S.Odent:None.V.Procaccio:None. E. Lausch: None. D. Matheisl: None. R. Hentschel: None. A. Ziegler: None. D. Bonneau: None. M. Pohl: None. M. Schmidts: None. E-P03.15 E-P03.18 Renal phenotype expansion in known syndromes using Juvenile nephronophthisis due to NPHP1 homozygous whole exome sequencing deletion revealed by whole exome sequencing I. Schüle1, K. Häffner1,2, J. Kracht1, G. Ruzaike1, G. Christopoulou1, A. Oikonomaki1, S. Samara1, S. E. Lausch1, D. Matheisl1, R. Hentschel1, M. Pohl1, Bournazos1, C. Melexopoulou2, J. Boletis2, P. M. Schmidts1 Constantoulakis1 1Clinic for General Pediatrics, Adolescent Medicine and 1Genotypos Science Labs MSA, Athens, Greece, 2Depart- Neonatology, University of Freiburg, Freiburg im Breis- ment of Nephrology and Renal Transplantation, Laiko gau,Germany,2ClinicforInternalMedicineIVNephrology Hospital, Athens, Greece and General Medicine, University of Freiburg, Freiburg, Germany Introduction: Renal failure is a major cause of morbidity and mortality worldwide and revealing a potential genetic Background: Patients with rare syndromes often background is essential for the patients’ management and have mutations in genes that are not covered by organ families’ counselling. speciﬁc NGS Panels. Whole exome sequencing (WES) Materials and methods: A 17-year-old female with helps ﬁnding the underlying genetic cause of end-stage tubulointerstitial nephritis was referred for whole exome renal disease (ESRD) especially in patients with extrarenal sequencing(WES).WESwasperformedonDNAextracted features. from peripheral blood, using the Twist Human Exome Methodsandresults:WereporttwocaseswithESRDin Core-v2 kit (Twist Bioscience). Following preparations patients with extrarenal organ involvement. A 14 year old according to the manufacturer’s protocol, libraries were boy with a history of perinatal asphyxia presented with a sequenced on an Illumina NextSeq-500 genetic analyser. ﬁrst seizure and ESRD. In addition he showed a Data processing, variant calling and pre-classiﬁcation were psychomotor developmental retardation, muscular hypoto- conducted by SOPHiA DDM® bioinformatics pipelines. nia and facial dysmorphism. The second patient was a MultiplexLigation-dependentProbeAmpliﬁcation(MLPA) newborn with congenital kidney failure, cleft palate, was performed (P387-C1, Coffalyser net, MRC-HOL- microcephaly, hypothyroidism and also facial dysmorph- LAND) to further conﬁrm results. ism. WES revealed a heterozygous variant in the KANSL1 Results: No pathogenic/likely pathogenic SNVs/Indels gene (c.1284delA:p.V428fs) in the 14 year old patient not were detected, related to the phenotype. Gene coverage detected in the mother (father unavailable) and a hetero- analysis revealed a homozygous NPHP1 whole gene zygous de novo variant in the KMT2D gene (c.C8434T:p. deletion, subsequently conﬁrmed by MLPA. Deletions Q2812X) in the newborn. Both variants have not been including at least NPHP1 are associated with Juveline previously described in literature. nephronophthisis, which is in concordance with the Discussion: KANSL1 and KMT2D mutations cause phenotype. Parental DNA MLPA analyses revealed Koolen-de Vries and Kabuki Syndrome. While clinical NPHP1 heterozygous deletions in both, whereas the features observed in our patients ﬁt well with those proband’ssisterwascompletelynormalthus,substantiating conditions, renal disease is extraordinarily severe in our inheritance and further guiding the selection of the cases:noESRDhasbeenpreviouslyreportedforKoolen-de appropriate family member for possible kidney Vries Syndrome and likewise, congenital ESRD has not transplantation. beendescribedintheliteratureforKabukisyndromesofar. Discussion: Optimization in WES protocols allows Our ﬁndings extend the kidney phenotype in these greater conﬁdence in calling copy number variations. syndromes and show the utility of WES to unravel the By applying this approach, deﬁnite diagnosis of cause of ESRD in children that would be missed by gene the nephropathy was achieved, otherwise challenging panel based NGS. with traditional methods. Whole exome sequencing I.Schüle:None.K.Häffner:B.ResearchGrant(principal permits a large number of genes investigated, for different investigator, collaborator or consultant and pending grants types of variants, establishing diagnosis and leading to as well as grants already received); Signiﬁcant; Green- accurateandtimelydecisionsforthepatient’sandfamilies’ ovationBiotechGmbh.J.Kracht:None.G.Ruzaike:None. healthcare.820 J.delPicchia G.Christopoulou:None.A.Oikonomaki:None.S.Samara: M.M. Litvinova: None. T.V. Filippova: None. D.V. None. S. Bournazos: None. C. Melexopoulou: None. J. Svetlichnaya: None. S.Z. Nuralieva: None. A.D. Matsvay: Boletis: None. P. Constantoulakis: None. None. K. Khaﬁzov: None. E-P03.19 E-P03.20 Polymorphisms of calcium metabolism genes associated A rare presentation of NPHP3 nephronophthisis with kidney stone disease in Russian population L. Ramos1,2, S. Fernandes1, C. S. Rosas1, M.M.Litvinova1,2,T.V.Filippova1,D.V.Svetlichnaya1,S. A. C. Marinhas3,4, T. Luís5,4, S. Ferreira6, C. Gomes4 Z. Nuralieva1, A. D. Matsvay3, K. Khaﬁzov3 1Medical Genetics Unit, Hospital Pediátrico, Centro 1I.M. Sechenov First Moscow State Medical University HospitalareUniversitáriodeCoimbra,Coimbra,Portugal, (Sechenov University), Moscow, Russian Federation, 2The 2Faculty of Health Sciences, Universidade da Beira Loginov Moscow Clinical Scientiﬁc Center of Moscow Interior, Covilhã, Portugal, 3Pediatric Unit, Hospital HealthDepartment,Moscow,RussianFederation,3“Center Pediátrico, Centro Hospitalar e Universitário de Coimbra, of Strategic Planning” of the Ministry of Health of the Coimbra, Portugal, 4Pediatric Nephrology Unit, Hospital Russian Federation, Moscow, Russian Federation Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 5Pediatric Unit, Centro Hospitalar do Introduction: Kidney stone disease (KSD) is an urgent Baixo Vouga, Aveiro, Portugal, 6Pediatric Hepatology problem of modern medicine due to high prevalence and Unit, Hospital Pediátrico, Centro Hospitalar e Universi- recurrence rate of the pathology. The particular scientiﬁc tário de Coimbra, Coimbra, Portugal interest is currently focused on the genetic mechanisms of urolithiasis. The aim of this study was to investigate an Introduction: Nephronophthisis (NPHP) is an autosomal association between polymorphic loci of the calcium recessive cystic kidney disease that usually progresses to metabolism genes and the risk of KSD development in end-stagerenaldisease(ESRD).Itiscausedbymutationsin Russian population. genes that encode proteins involved in the function of pri- Materials and methods: Based on the analysis of mary cilia, basal bodies and centrosomes, resulting in renal scientiﬁcliteratureandgenomicdatabases,thelist ofgenes and extrarenal manifestations. Prenatal history of oligohy- and polymorphisms associated with KSD in different dramnios and kidney cysts can be present. Infantile type of countries was formed. The information was obtained from NPHP develops ESRD in the ﬁrst three years of age and is case-control studies and GWAS. Finally, we formed a the most severe form. It is usually caused by mutations in genetic panel which included SNPs of VDR, CASR, NPHP2 and NPHP3 genes. CALCR, SLC34A1, CLDN14, TRPV5, TRPV6, KLOTHO, Objective: We intend to demonstrate how difﬁcult the ORAI1, ALPL, RGS14, OPN, MGP, PLAU, AQP1, DGKH genotype/phenotype correlation in NPHP is, and reinforce genes. The study group consisted of 77 patients with KSD. the use of gene panel or exome in this disease. The control group included76personswithout urolithiasis. Materials and methods: Report of clinical manifesta- Genetic analysis was carried out by next generation tions, laboratory examination and imaging data in family sequencing using the Ion S5 platform. We also studied related foetus and child with different features of NPHP. A the presence of familial cases of KSD in the NGS panel for cholestasis was performed. observed group. Results: Previously healthy child presents pruritus and Results: Among patients with KSD 54% had family laboratory examination with renal/liver dysfunction at the history of urolithiasis, 44% had recurrent course of the ageof21months.Ultrasoundshowednormal-sizedkidneys disease. 9 SNPs in 4 genes showed statistically signiﬁcant with cysts and absent hepatobiliar, pancreatic or cardiac association with KSD: rs219781, rs219780, rs219779, changes.Theﬁrstpregnancyoftheparentswascomplicated rs219778, rs219777, rs1544410, rs731236, rs11746443, due to nephromegaly with microcysts and anamnios - the rs6486795.Theoddsratiorangedfrom1.2to2.5depending diagnosisofNPHPwasevoked.TheNGSpanelidentiﬁeda on polymorphism. homozygous NPHP3 variant, c.3601G>T p.(Glu1201*), Conclusions: Targeted genetic panel for detecting the and molecular testing to her consanguineous parents is genetic predisposition to urolithiasis was designed and being performed. validated. Polymorphic loci of genes CLDN14, VDR, Conclusion: NPHP is characterized by a signiﬁcant SLC34A1, and ORAI1 are associated with KSD in Russian genetic and clinical heterogeneity. Gene panel or exome is population. the most appropriate approach when NPHP is suspected.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 821 The etiologic diagnosis is important for management and havebeen previously reportedfor PHOX2B,andhighlights genetic counselling. the variability in clinical expression and disease severity of L. Ramos: None.S. Fernandes: None. C.S. Rosas: None. non-PARM mutations. A.C. Marinhas: None. T. Luís: None. S. Ferreira: None. C. I. Borg: None. M. Pace Bardon: None. N. Pace: None. Gomes: None. E-P03.22 E-P03.21 GeNepher:buildingadata-andbiobankfor(suspected) A novel pathological variant in the PHOX2B gene hereditary renal disease associated with a respiratory/ Hirschsprung phenotype in a three-generation family L. R. Claus1, F. Boulogne2, M. R. Lilien1, M.B.Rookmaaker1,A.vanderZwaag1,T.Q.Nguyen1,M. I. Borg1,2, M. Pace Bardon3, N. Pace4,5 C.Verhaar1,N.V.A.M.Knoers2,P.Deelen1,2,L.Franke2, M. H. de Borst2, A. M. van Eerde1 1Department of Pathology, University of Malta, Msida, Malta, 2Medical Genetics Unit, Department of Pathology, 1University Medical Center Utrecht, Utrecht, Netherlands, Mater Dei Hospital, Msida, Malta, 3Department of 2UniversityMedicalCenterGroningen,Groningen,Nether- Medicine, Mater Dei Hospital, Msida, Malta, 4Department lands ofAnatomy,UniversityofMalta,Msida,Malta,5Centrefor Molecular Medicine and Biobanking, University of Malta, Introduction: A substantial part of patients with renal Msida, Malta disease has an undiscovered monogenic cause. The timely awareness of a potential genetic etiology in kidney disease Introduction: Mutations in the PHOX2B gene cause con- patients has profound implications for diagnosis and sub- genital central hypoventilation syndrome (CCHS), a rare sequent care pathways, for family members (e.g. in pre- autonomic nervous system dysfunction disorder char- symptomatic testing and family donation) and for options acterised by a decreased ventilatory response to hypercap- regarding establishing a family. nia. Affected subjects require lifelong ventilatory support, Methods: We will set-up the GeNepher Data- and and develop hypoventilation during the non-REM phase of Biobank. Dutch patients with known and suspected heredi- sleep where autonomic control of breathing predominates. taryrenaldiseaseareeligibleforinclusion.Informedconsent CCHS may be isolated or associated with disorders char- will cover use of available medical data, use of available acterised by defective migration/differentiation of neural DNA/sequencing data and in selected cases consent for crest derivatives, including aganglionic megacolon or additional blood sampling, skin biopsy or urine collection. milder gastrointestinal phenotypes, such as constipation. The GeNepher Data- and Biobank will be used to: MostcasesofCCHSarede-novo,causedbyheterozygosity for polyalanine repeat expansion mutations (PARMs) in 1. Answer questions regarding etiology. In unsolved exon 3. The remaining 10% of cases are due to hetero- caseswewillperformadd-onanalysestoidentifynew zygous non-PARM missense, nonsense or frameshift candidate genes for renal disease. In order to mutations. optimally identify new candidates, and to gain new Methodology: We describe a three-generation Maltese- insights, we are developing a kidney speciﬁc gene Caucasian family with a variable CCHS/Hirschsprung network using kidney derived RNA-sequencing data. phenotype, characterised by chronic constipation, three Ultimately we will perform functional studies to siblings with Hirschsprung disease necessitating surgery validateplausiblecandidates.InGeNepherthereisan and chronic hypoxia requiring non-invasive ventilation. infrastructure for return of relevant ﬁndings. Results:BidirectionalsequencingofPHOX2Brevealeda 2. Study modiﬁers of progressive renal disease like novel heterozygous c.241+2delT splice variant that segre- NPHP1-nephronophtisis. gateswiththeCCHS/Hirschsprungphenotypeinthefamily. 3. Contact patients for opportunities in treatment devel- The deletion lies in the donor splice site of exon 1 and has opment or when diagnose speciﬁc trials are started or not been reported in literature or genomic databases. treatment is approved. Bioinformatic analysispredicts thatthemutationwill result inskippingofexon1andtheformationofanon-functional Results: Inclusions will start in Q2 of 2020. protein product. The mutation is pathogenic according to Conclusions: The GeNepher Data- and Biobank will ACMG, PVS1, PM2 and PP1 criteria. improve diagnosis of renal disease by identifying genetic Conclusion:Thisreportexpandsthemutationalspectrum causes,provideinsightintopathophysiologyandcontribute of PHOX2B. It is signiﬁcant as no splice-site mutations to development of new therapies.822 J.delPicchia Grant references: Dutch Kidney Foundation, Kolff conﬁrmedthatp.(T125M)isafoundermutation.Thisstudy Postdoc Senior Grant was supported grant PI17/00153 co-ﬁnanced by the ISCIII- L.R. Claus: None. F. Boulogne: None. M.R. Lilien: Subdirección General de Evaluación y Fomento de la None. M.B. Rookmaaker: None. A. van der Zwaag: None. InvestigaciónandtheERDF“AnotherwaytobuildEurope”. T.Q. Nguyen: None. M.C. Verhaar: None. N.V.A.M. E.Córdoba-Lanús:None.A.Perdomo-Ramírez:None.G. Knoers: None. P. Deelen: None. L. Franke: None. M.H. Mura-Escorche: None. S. Carinelli: None. E. Ramos- de Borst: None. A.M. van Eerde: None. Trujillo: None. F. Claverie-Martín: None. E-P03.23 E-P03.25 Founder effect of SLC2A9 mutation p.(T125M) in Molecular study of Wilson disease in a Spanish cohort Spanish families with hereditary renal hipouricemia type 2 M. Antolin1, I. Paramanov1, P. Fernandez1, L. Iranzo1, D. Martinez1, E. García-Arumí1,2, E. Tizzano1 E. Córdoba-Lanús1,2, A. Perdomo-Ramírez1, G. Mura-Escorche1,3, S. Carinelli1, E. Ramos-Trujillo1, 1Department of Clinical and Molecular Genetics and F. Claverie-Martín1 Medicine Genetics Group, VHIR, University Hospital Vall d’Hebron, Barcelona, Spain, 2CIBERER, Centro de Inves- 1Unidad de Investigación, Hospital Universitario Nuestra tigaciónBiomédicaenReddeEnfermedadesRaras,ISCIII, Señora de Candelaria, Santa Cruz de Tenerife, Spain, Madrid, Spain 2IUETSPC, Universidad de La Laguna, Santa Cruz de Tenerife,Spain,3UniversidaddeLaLaguna,SantaCruzde Introduction:Wilsondisease(WD)isadisordercausedby Tenerife, Spain biallelic pathogenic variants in ATP7B gene, resulting in abnormal copper metabolism and deposition, leading to a Introduction: Renal hypouricemia (RHUC) is a rare combination of hepatic, neurologic, and psychiatric fea- inherited disorder characterized by impaired urate reab- tures. Diagnosis is conﬁrmed by molecular analysis of sorption in the proximal tubule. Some patients may present ATP7B gene. severe complications such as exercise-induced acute renal Materials and methods: 34 patients with WD were failureandnephrolithiasis.RHUCiscausedbyinactivating studied using two long range PCR (exon 2-9; exon 10-21 mutations in the SLC22A12 (RHUC type 1) or SLC2A9 ATP7B gene). Fragmentation, indexing, library preparation (RHUC type 2) genes, which encode urate transporters (NEBNextUltraDNAlibraryprepkit)andsequencingina URAT1andGLUT9,respectively.Recently,we found that MiSeq platform (Illumina) were performed. Exon 1 was mutation c.374C>T, p.(T125M) is recurrent in Spanish analysed by Sanger sequencing. familieswithRHUC2.Therefore,wehypothesizedthatthis Results: Genetic diagnosis was achieved in 18 WD might be due to a founder effect. patients whereas only one pathogenic variant was found in Methods: Thirteen new patients with RHUC were 5.Familiarstudieshaveallowedtheidentiﬁcationof2WD analyzed by sequencing the SLC22A12 and SLC2A9 patients before clinical manifestations. 86% of the variants coding exons. To determine whether patients with the p. were described as pathogenic whereas 14% were not (T125M) mutation had a common p.(T125M)-linked described previously. A prevalent ATP7B allelic variant, haplotype a SNPs-haplotype analysis was performed. A p.(Met645Arg),wasfoundin5patients(28%),intranswith total of nine patients from apparently unrelated families other allelic variants. The splicing mutation c.1708-1G>A were included in this analysis. Six informative SNPs were was found in 3 patients (17%) whereas the c.1708-1G>C analyzed by PCR ampliﬁcation from genomic DNA and was found in one (6%), all in homozygous state. The most direct sequencing. prevalentpathogenicvariantinEuropep.(His1069Gln)was Results: Seven patients carried SLC22A12 mutation p. found in heterozygosis in 2 patients, representing only the (T467M),andsixpresentedtherecurrentSLC2A9mutation 4,4 % of pathogenic alleles in our cohort. p.(T125M).Allelescarryingthep.(T125M)mutationshared Conclusions: The most common allelic variant among a common SNP haplotype. Every patient harboring this our WD patients was p.(Met645Arg) followed by the mutation in homozygous state had a common haplotype splicing variant c.1708-1G>A. Familiar genetic study of (0.7 frequency), G-A-C-T-G-T-C-T (mutant allelein bold). WD by NGS allows the molecular diagnosis of asympto- WhilethehaplotypeG-G-C-C-G-T-Cwasthemostfrequent matic patients and prevent disease. between controls (0.42). M. Antolin: None. I. Paramanov: None. P. Fernandez: Conclusions: Mutation p.(T125M) is the most common None. L. Iranzo: None. D. Martinez: None. E. García- variantinSpanishpatientswithRHUC2.Haplotypeanalysis Arumí: None. E. Tizzano: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 823 E-P04 Skeletal, Connetive Tissue, Ectodermal and Skin G. Wurpts15, S. Moebus16, P. M. Krawitz3, J. Stingl17, B. Disorders Sachs*15,18, M. M. Nöthen*1, * equally shared E-P04.02 1InstituteofHumanGenetics,UniversityofBonn,Schoolof The ﬁrst missense mutation in CSTA gene causes Acral Medicine & University Hospital Bonn, Bonn, Germany, Peeling Skin Syndrome in a Turkish family, Review of 2Center for Human Genetics, University of Marburg, the literature Marburg, Germany, 3Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany, A. C. Ceylan1, S. Emre2, G. G. Ceylan1 4Department of Otorhinolaryngology - Head and Neck Surgery and Audiology, University Hospital of Copenha- 1Yildirim BeyazitUniversity MedicalSchool Department of gen, Rigshospitalet F-2071, Copenhagen, Denmark, Medical Genetics, Ankara, Turkey, 2Yildirim Beyazit 5Department of Clinical Genetics, Odense University University Medical School Department of Dermatology, Hospital, Odense, Denmark, 6Research Unit of Dermato- Ankara, Turkey Venerology, Clinical Institute, University of Southern Denmark, Odense, Denmark, 7Department of Medical Introduction: Acral Peeling Skin Syndrome (APSS) is a Sciences, Clinical Pharmacology and Science for Life rare, autosomal recessive genodermatosis. The disease is Laboratory, Uppsala University, Uppsala, Sweden, characterized by superﬁcial peeling of the corniﬁed epi- 8Department of Medical Sciences, Clinical Chemistry, dermallayer.Skinfragilityoftenaffectshandsandfeet.Itis Uppsala University, Uppsala, Sweden, 9Uppsala Clinical most commonly caused by mutations in the TGM5 Research Center, Uppsala, Sweden, 10Department of (*603805).CSTA(*184600)rarelycausesAPSS.Weintend Dermatology and Allergy, Comprehensive Allergy Center, to invest if there is a new mutation in genes related Hannover Medical School, Hannover, Germany, 11Depart- with APSS. ment of Dermatology, SLK Hospital Heilbronn, Heilbronn, Materialsandmethods:Twosiblingswerepresentedus Germany, 12Department of Dermatology and Venerology, because of chronic and superﬁcial itchy skin lesions. After Medical University of Graz, Graz, Austria, 13Clinic and the dermatological examinations, clinical exome solution- Polyclinic for Dermatology and Allergology, University was performed for the molecular diagnosis of one of the Hospital Bonn, Bonn, Germany, 14Department of Otorhi- patients. Sanger sequencing was performed for the other nolaryngology, Head and Neck Surgery, Ulm University patient to ﬁnd if there is the same mutation. Medical Center, Ulm, Germany, 15Department of Derma- Results: A novel homozygote missense mutation was tology and Allergology, Aachen Comprehensive Allergy found in CSTA gene in both of the siblings. This variant Center, University Hospital of RWTH Aachen, Aachen, fulﬁlls PM1, PM2, PP3 and PP4, and should therefore be Germany, 16Centre of Urban Epidemiology, Institute of regarded as a likely pathogenic according to the joint Medical Informatics, Biometry, and Epidemiology, Uni- consensus recommendation of the ACMG and AMP. versity of Essen, Essen, Germany, 17Institute for Clinical Conclusion: Peeling skin syndromes appears to be Pharmacology, University Hospital of RWTH Aachen, heterogeneous clinically and genetically. Inhere, we report Aachen, Germany, 18Federal Institute for Drugs and sixth family with a novel homozygote missense CSTA Medical Devices, Research Division, Bonn, Germany mutationandclinicalﬁndings.Itisshownthatdifferenttype of CSTA mutations can also cause APSS unlike previously Angioedema are known adverse drug reactions of ACE reported cases, and will contribute to better illumination of inhibitors (ACEi) that can become a potentially life-threa- the phenotype regarding with the literature review. tening event. Results of previous research suggest that A.C. Ceylan: None. S. Emre: None. G.G. Ceylan: None. susceptibility to ACEi induced angioedema (ACEi AE) is dependentonageneticpredispositionandnon-geneticrisk E-P04.03 factors. However, as the biological mechanisms contribut- Molecular genetic investigation of ACE inhibitor ing to these angioedema are still largely unknown, further induced angioedema research is needed. The aim of the present study was to investigatecommonandraregeneticvariationinACEiAE C. Mathey1, A. F. Forstner1,2, C. Maj3, O. Borisov3, patients. In a targeted sequencing approach, we investi- E. R. Rassmussen4, A. Bygum5,6, C. von Buchwald4, gated the occurrence rate of known pathogenic mutations M. Wadelius7, P. Hallberg7, M. Karawajczyk8, associated with monogenic forms of angioedema in 69 N. Eriksson7,9, B. Wedi10, D. Wieczorek10, P. M. Amann11, German and 68 Danish patients with ACEi AE. All sam- H.Löfﬂer11,L.Koch12,C.Schöfﬂ12,N.Evertz13,J.Greve14, ples were sequenced on an Illumina NextSeq platform using single molecule molecular inversion probes. In824 J.delPicchia addition, all samples were genotyped on the Illumina Chelyabinsk, Russian Federation, 10Department of sports Inﬁnium Global Screening Array to identify common medicine and physical rehabilitation, Ural state university genetic variants contributing to angioedema risk under of physical culture, Chelyabinsk, Russian Federation, ACEi. Analysis of the sequencing data revealed no known 11Department of Physical Education, Gdansk University pathogenic mutations in genes associated with the mono- of Physical Education and Sport, Gdansk, Poland genic forms of angioedema. However, we identiﬁed 19 other rare (MAF≤0.05), non-synonymous variants for ACL rupture is one of severe multifactorial injuries. The which a contribution to ACEi AE risk cannot be excluded. ACTN3rs1815739polymorphismaffectmusclestructureand Qualitycontrolandimputationofthearraydataiscurrently metabolism and it has been associated with muscle injuries. ongoing.Furthermore,wearecurrentlyapplyingtheabove Resistancetofatigueandmusclestiffnessareconsideredrisk investigation strategies to an independent Swedish sample factorsforACLinjury.Theaimofourstudywastodetermine (n=77). Follow-up of the variants identiﬁed by targeted theinﬂuenceofACTN3rs1815739onACLruptureinItalian, sequencing in larger patient samples as well as subsequent Japanese, Polish and Russian population samples. A total of biostatistics/-informatics analyses of the GWAS data will 1706subjects(n=596ACLrupturepatients(cases);n=1113 help to gain further insights into the underlying molecular controls) from Italy (n=52 cases; n=81 controls), Japan mechanisms of ACEi AE. (n=74cases;n=395controls),Poland(n=237cases;n=230 C.Mathey:None.A.F.Forstner:None.C.Maj:None.O. controls) and Russia (n=233 cases; n=407 controls) partici- Borisov: None. E.R. Rassmussen: None. A. Bygum: None. pated in the study. DNA samples were genotyped by Taq- C. von Buchwald: None. M. Wadelius: None. P. Hallberg: Man. R packages were used for statistical analysis. The None.M.Karawajczyk:None.N.Eriksson:None.B.Wedi: genotype distributions of all control groups were in HWE. None.D.Wieczorek:None.P.M.Amann:None.H.Löfﬂer: Since the Italian, Polish and Russian samples had similar None.L.Koch:None.C.Schöfﬂ:None.N.Evertz:None.J. genotypedistributions(allp>0.05)theywerepooledtogether Greve: None. G. Wurpts: None. S. Moebus: None. P.M. (European cases and controls). Krawitz: None. J. Stingl: None. B. Sachs*: None. M.M. Genotypesdistribution(%andcounts)inEuropeanandJapanesecase Nöthen*: None. andcontrolsgroups RR RX XX E-P04.04 ACTN3 rs1815739 polymorphism is associated with Europeancases(n=522) 0,370(193) 0,500(261) 0,130(68) anterior cruciate ligament (ACL) rupture in physically Europeancontrols(n=718) 0,372(267) 0,450(323) 0,178(128) activepeoplefromItalian,Japanese,PolishandRussian Japanesecases(n=74) 0,270(20) 0,527(39) 0,203(15) cohorts Japanesecontrols(n=395) 0,220(87) 0,463(183) 0,316(125) V. Pushkarev1,2,3, N. Kikuchi4, H. Kumagai5, N. Kamiya6, E. Miyamoto-Mikami7, N. Fuku7, C. Calò8, M. Massidda8, Signiﬁcant differences in ACTN3 rs1815739 genotype D. Dyatlov9, E. Bykov10, P. Cieszczyk11 frequencies were found between cases and controls in the European sample (Fisher’s Exact Test, p=0,048). The XX 1Medical Genetic Centre “Progen”, Moscow, Russian genotype was underrepresented in the cases (odds ratio Federation, 2Moscow Center of Advanced Sport Technol- (OR)=0.69; 95% conﬁdence interval (CI), 0.50-0.95, ogies, Moscow, Russian Federation, 3Genetic laboratory, P=0.021) in comparison with controls. The same trend Ural State University of Physical Culture, Chelyabinsk, hasbeenshowedbetweencasesandcontrolsintheJapanese Russian Federation, 4Department of Training Science, population (OR = 0.55; 95% CI, 0.30-1.006, P = 0.05). Nippon Sport Science University, Tokyo, Japan, 5Graduate The XX ACTN3 rs1815739 seems to protect against ACL School of Health and Sports Science, Juntendo University, rupture in three European and Japanese cohorts. Chiba, Japan and Reseach fellow of Japanese Society for V. Pushkarev: None. N. Kikuchi: None. H. Kumagai: the Promotion of Science, Tokyo, Japan, 6Faculty of Budo None. N. Kamiya: None. E. Miyamoto-Mikami: None. N. and Sport Studies, Tenri University, Nara, Japan, 7Grad- Fuku: None. C. Calò: None. M. Massidda: None. D. uate School of Health and Sports Science, Juntendo Dyatlov: None. E. Bykov: None. P. Cieszczyk: None. University, Chiba, Japan, 8Department of Environmental and Life Science, University of Cagliary, Calgary, Italy, E-P04.05 9Department of the Theory of Physical Culture and Congenital contractural arachnodactyly syndrome in Biomechanics, Ural State University of Physical Culture, Polish family with c.4216T/c variant in FBN2 gene.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 825 M.A.Malarska,H.Moczulska,K.Antosik,P.Jakiel,P.M. Medical University, Yerevan, Armenia, 11Kurume Univer- Pachniak, M. Borowiec sity School of Medicine, Kurume, Japan, 12Wakayama Medical University, Wakayama, Japan, 13ViennaLab Diag- Department of Clinical Genetics, Lodz, Poland nostics, Vienna, Austria, 14Fondazione IRCCS Policlinico SanMatteo,Pavia,Italy,15KazusaDNAResearchInstitute, The congenital contractural arachnodactyly (CCA, Beals Kisarazu, Japan, 16Hacettepe University, Ankara, Turkey, syndrome, OMIM: 121050) is an autosomal dominant 17Center of Medical Genetics and Primary health Care, condition including contractures, crumpled ears, arachno- Yerevan State Medical University, Yerevan, Armenia, dactyly, dolichostenomelia, scoliosis and pectus defor- 18European Molecular Quality Network (EMQN), Manche- mities. The congenital contractural arachnodactyly has ster Centre for Genomic Medicine, St Mary’s Hospital, overlapping features with the Marfan syndrome. Both Manchester, United Kingdom, 19University of Groningen, syndromes result from mutations in genes from the ﬁbrillin University Medical Center Groningen, Groningen, Nether- family, FBN1 and FBN2 respectively. We identiﬁed the lands, 20INSERM, Montpellier, France c.4216T>CvariantintheFBN2geneinaPolishfamilywith thecongenitalcontracturalarachnodactyly.Thevariationin Introduction: A growing number of monogenic autoin- phenotypic expression was high in the family. In some ﬂammatorydiseases(AIDs)hasbeenidentiﬁedsince1997. subjects there was only an arachnodactyly, but in others Their clinical diagnosis remains a challenge in face of there were many features like severe kyphoscoliosis with overlapping inﬂammatory symptoms. The previous guide- dolichostenomelia, arachnodactyly, camptodactyly, talipes lines for genetic testing of AIDs were limited to Sanger equinovarus and ureteropelvic junction obstruction. We based diagnosis of four prototypic recurrent fevers (MEFV, found for the ﬁrst time a hydronephrosis in the congenital MVK, TNFRSF1A, and NLRP3 genes). Revised guidelines contractural arachnodactyly syndrome. There were no cru- employingnextgenerationsequencing(NGS)areneededto pledearintheanalysedfamily.Thec.4216T>Cvarianthad improve diagnosis and precision of AIDs treatment. been previously found in a Chinese family with modest Methods: Based on a survey regarding gene scope and family variation in phenotypic expression. Our observation available methodology in AIDs laboratories (Rowczenio et al, conﬁrmstherelationshipbetweenc.4216T>Cvariantinthe 2019), and on annotation of AIDs gene variants by experts’ FBN2 gene and the congenital contractural arachnodactyly. consensus(vanGijnetal,2018;Infeversdatabase),adraftof M.A. Malarska: None. H. Moczulska: None. K. Antosik: recommendationswaswrittenbyEuropeanMolecularGenetics None. P. Jakiel: None. P.M. Pachniak: None. M. Quality Network members. The recommendations were Borowiec: None. discussed by a panel of experts of the International Society for Systemic AIDs (ISSAID) during a consensus meeting. E-P04.06 Results: Four additional disease genes are recommended ISSAID and EMQN best practice guidelines for gene for the core screen of auto-inﬂammatory diseases (ADA2, panel based diagnosis of autoinﬂammatory diseases NOD2,PSTPIP1,andTNFAIP3).Theinitialscreen,eithera single gene or panel screen is oriented by the clinical Y.Shinar1,I.Ceccherini2,D.Rowczenio3,I.Aksentijevich4, autoinﬂammatory suspicion. In overt cases complementary J.Arostegui5,6,E.Ben-Chétrit7,G.Boursier8,M.Gattorno9, methods to identify large deletions or insertions (i.e. copy H. Hayrapetyan10, H. Ida11, N. Kanazawa12, H. J. number variation) or search for somatic mosaicism are Lachmann3, A. Mensa-Vilaro5, R. Nishikomori11, C. recommended. A genotype table based on the 5-category Oberkanins13, L. Obici14, O. Ohara15, S. Ozen16, T. variantpathogenicityclassiﬁcationwithdistinctionbetween Sarkisian17, K. Sheils18, N. Wolstenholme18, E. Zonneveld- rare/novel or common variants of unknown signiﬁcance, Huijssoon19, I. Touitou20, M. E. van Gijn19 and consideration of dose effect, provides the clinical signiﬁcance of prototypic genotypes per gene and disease. 1ShebaMedicalCenter,RamatGan,Israel,2IRCCSIstituto Conclusions: These guidelines will improve the practice Giannina Gaslini, Genova, Italy, 3UCL Medical School, of AIDs diagnosis provided by the medical community. E- London, United Kingdom, 4National Human Genome Rare-3 grant 9003037603. Research Institute, Bethesda, MD, United States, 5Hospital Y. Shinar: None. I. Ceccherini: None. D. Rowczenio: Clínic, Barcelona, Spain, 6Institut d’Investigacions Biomè- None. I. Aksentijevich: None. J. Arostegui: None. E. Ben- diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Chétrit: None. G. Boursier: None. M. Gattorno: None. 7Hadassah-Hebrew University Medical Center, Jerusalem, H. Hayrapetyan: None. H. Ida: None. N. Kanazawa: None. Israel, 8CHU Montpellier, Univ Montpellier, Montpellier, H.J. Lachmann: None. A. Mensa-Vilaro: None. R. Nishi- France, 9IRCCS G. Gaslini, Genova, Italy, 10Center of komori: None. C. Oberkanins: None. L. Obici: None. Medical Genetics and Primary Health Care, Yerevan State O. Ohara: None. S. Ozen: None. T. Sarkisian: None.826 J.delPicchia K. Sheils: None. N. Wolstenholme: None. E. Zonneveld- M. C. Martínez-Romero1,2,3, M. Barreda-Sánchez1,3, Huijssoon: None. I. Touitou: None. M.E. van Gijn: None. M.E.Pérez-Tomás1,M.J.Ballesta-Martínez1,2,3,V.López- González1,4,2, M. J. Sánchez-Soler1,2,3, A. T. Serrano- E-P04.08 TGDS pathogenic variants cause Catel-Man- Antón1,2,4, L. Rodríguez-Peña1, M. E. Hernández1, T. zke syndrome without Manzke dysostosis Martínez-Menchón1,4, P. Sánchez-Pedreño1,4, G. Glover1,2, P. Carbonell1,2, V. Cabello-Chaves5, Grupo de F. Boschann1, K. Stuurman2, C. de Bruin3, M. van Investigación Español de Displasias Ectodérmicas, E. Slegtenhorst2, H. van Duyvenvoorde4, S. Kant2,4, N. Ehmke1 Guillén-Navarro1,2,4 1Charité-Universitaetsmedizin Berlin, Berlin, Germany, 1Sección de Genética Molecular (Centro de Bioquímica y 2Department ofClinicalGenetics,ErasmusMC,University GenéticaClínica),SeccióndeGenéticaMédica(Serviciode Medical Center Rotterdam, Rotterdam, Netherlands, Pediatría), Servicio de Medicina Interna y Servicio de 3Department of Pediatric Endocrinology, Leiden Uni, Dermatología. Hospital Clínico Universitario Virgen de la Rotterdam, Netherlands, 4Department of Clinical Genetics, Arrixaca. Instituto Murcia, Murcia, Spain, 2CIBERER, Leiden University Medical Center, Leiden, Netherlands Centro de Investigación Biomédica en Red de Enferme- dades Raras, Instituto de Salud Carlos III, Madrid, Spain, Introduction: Catel-Manzke syndrome, also known as 3Cátedra de Genética Médica. UCAM- Universidad micrognathia-digital-syndrome, is characterized by the com- Católica de Murcia, Murcia, Spain, 4Departamentos de bination of the two cardinal features Pierre-Robin sequence Pediatría y Dermatología. Facultad de Medicina. UMU- (with or without cleft palate) and bilateral hyperphalangism. Universidad de Murcia, Murcia, Spain, 5Servicio de Hyperphalangism is caused by an accessory ossiﬁcation Nefrología. Hospital Universitario Virgen del Rocío, center in the second metacarpo-phalangeal joint leading to Sevilla, Spain radial deviation and ulnar clinodactyly of the index ﬁngers. Individuals without one of the two major hallmarks or with Introduction: HELIX syndrome (OMIM#617671) is an additional hand malformations have been described as aty- autosomal recessive genetic disorder, described in 2017, pical or Catel-Manzke-like syndrome. Biallelic pathogenic characterized by hypohidrosis, electrolyte imbalance, lacri- variants in TGDS have been described in nine individuals mal glands dysfunction, ichthyosis, and xerostomia; and including one fetus with Catel-Manzke syndrome. associated with pathogenic variants in CLDN10 gene that Material and methods: We performed trio exome encodes a member of claudins proteins (integral membrane sequencing in two individuals who presented with dis- components of tight junction). So far, only 4 families have proportionate short stature, micrognathia as well as mild been reported. bilateralradialdeviationandulnarclinodactylyoftheindex Materials and methods: Subjects. Two Spanish adult ﬁngers, but without radiological signs of hyperphalangism. brothers (41/38 years old) born to consanguineous parents Results: We found known pathogenic variants in TGDS presenting with a long history of hypohidrosis, dry skin, in both individuals. The two individuals described here are alacrimia and xerostomia, diagnosed as ectodermal dyspla- the ﬁrst with conﬁrmed TGDS pathogenic variants who sia(ED).ComplementaryexamsshowedrenallossofNaCl present with almost normal hand radiographs and therefore with secondary hyperaldosteronism, hypercalcemia, hyper- do not show one of the clinical hallmarks of Catel-Manzke magnesemia and hypokalemia. Genetic analysis. CLDN10 syndrome.Inaddition,disproportionateshortstaturehasnot gene was designed with Primer3 software for all coding been described as a feature of Catel-Manzke syndrome. exons. Sanger sequencing was performed using BigDye Conclusion:Ourﬁndingsextendthephenotypicspectrum terminator (Life-Technologies), analysed in ABI3130 ofCatel-Manzkesyndrome.TGDS-associatedCatel-Manzke Genetic Analyser (Applied-Biosystems) and aligned with syndrome should be considered in individuals with mild human reference genome GRCh37/hg19; the identiﬁed ulnar clinodactyly and radial deviation of the index ﬁngers variant was segregated in progenitors. even without radiological evidence of hyperphalangism. Results: The sequence analysis revealed a frameshift F. Boschann: None. K. Stuurman: None. C. de Bruin: genetic variant in CLDN10 (NM_006984.4): None. M. van Slegtenhorst: None. H. van Duyvenvoorde: c.322_329del8/p.Gly108fs, in exon 2, in homozygosity in None. S. Kant: None. N. Ehmke: None. bothaffectedbrothersandinheterozygosityinparents.This variant, not previously described, was found in a highly E-P04.09 conserved region by in silico prediction software, being A novel pathogenic variant in the CLDN10 gene categorized as pathogenic. associated with HELIX syndrome Conclusions: 1. A new CLDN10A pathogenic variant associatedtoHELIXsyndromeintheﬁrstSpanishaffectedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 827 family is described, supporting the implication of this gene 36m respectively. whole- exome sequencing test was done in this rare disorder.2. Clinical manifestations such as for the patient. The results showed a novel homozygous lacrimal dysfunction, xerostomia and electrolyte imbalance mutation(c.533-1G>A)inexon6oftheLTBP4gene.After in suspected ED without speciﬁc molecular diagnosis are this observation we perform the Sanger sequencing for his the clue for HELIX syndrome. parents. As a result, his parents have a heterozygous This project has been funded by ISCIII-Madrid-Spain- mutation in the same gene and same location. This ﬁnding FEDER (PI/14/01259 and PI/17/00796) and AADE. can be useful in genetic counseling of cutis laxa in this M.C. Martínez-Romero: None. M. Barreda-Sánchez: family. None. M.E. Pérez-Tomás: None. M.J. Ballesta-Martínez: M.Mazaheri:None.M.yavari:None.R.Mirjalili:None. None. V. López-González: None. M.J. Sánchez-Soler: A. Razavi: None. None. A.T. Serrano-Antón: None. L. Rodríguez-Peña: None. M.E. Hernández: None. T. Martínez-Menchón: E-P04.11 None. P. Sánchez-Pedreño: None. G. Glover: None. P. Analysis of xenobiotics biotransformation and DNA Carbonell: None. V. Cabello-Chaves: None. E. Guillén- repair genes as factors of etiology and pathogenesisin Navarro: None. children with congenital spine deformities E-P04.10 S.Khalchitsky1,M.Sogoyan1,S.Vissarionov1,A.Dmitriev2 Identiﬁcation a novel mutation of LTBP4 gene in a patient with congenital cutis laxa: a case report 1The Turner Scientiﬁc Research Institute for Children`s Orthopedics, Saint-Petersburg, Russian Federation, 2Insti- M. Mazaheri1,2, M. yavari3, R. Mirjalili2, A. Razavi3 tute of Experimental Medicine, Saint-Petersburg, Russian Federation 1Shahid Sadoughi University of Medical Sciences, Yazd, Iran, Islamic Republic of, 2Mother and Newborn Health Introduction: Spine congenital curvatures formed as a Research Center Shahid Sadoughi University of Medical result of anomalies in the development of vertebral bodies Sciences,Yazd,IRAN.,Yazd,Iran,IslamicRepublicof,3Dr. leadstosevereandrigiddeformitiesofthespinalcolumnin Mazaheri’s Medical Genetics lab Yazd, IRAN., Yazd, Iran, the adolescent age and are often accompanied by irrever- Islamic Republic of sible neurologic disorders. There for genetic markers study of the congenital malformations is an important and Normal 0 false false false EN-US X-NONE FA /* Style urgent task. Deﬁnitions */ table.MsoNormalTable {mso-style-name:"- Materials and methods: The study of 200 children with Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-col- congenitalspinedeformities(CSD)and96healthychildren band-size:0; mso-style-noshow:yes; mso-style-priority:99; without pathology of the spine was carried out. Molecular mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; diagnostics was carried out by analysis of multiple mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; polymorphic regions in the genes of detoxiﬁcation and mso-pagination:widow-orphan; font-size:10.0pt; font- DNA repair. Genotyping of the gene polymorphism was family:"Times New Roman","serif";} Cutis laxa is a rare performed using polymerase chain reaction. disorder characterized by degenerative changes in elastic Results: The polymorphisms of the genes CYP1A2, ﬁbres.Congenitalcutislaxaismorecommonthanacquired GSTM1, GSTT1, GSTP1, NAT2, XRCC1, XRCC3 and their cutis laxa. The recessively inherited form is severe and frequency distribution among patients with CSD and morefrequent.Cutislaxaaffectsallracesandboththesexes control group were investigated. Signiﬁcant differences in equally. LTBP4, an extracellular protein that is closely the distribution of genotypes compared with the control relatedtoﬁbrillins,consistsofepidermalgrowthfactor-like group were found in the polymorphic regions of the genes domains interspersed with four 8-cys domains (including a CYP1A2, GSTM1,GSTT1,NAT2, XRCC3.However,inthe hybrid domain). The third 8-cys domain covalently binds GSTP1 and XRCC1 genes, no signiﬁcant differences the small latent TGFβ1 complex. A proline -rich hinge between the CSD patients and the control group was region provides ⋯exibility to the protein. The N-terminus observed. of LTBP4 binds to the microibrillar structures. A 4-month- Conclusions: All patients with congenital spine defor- old full term normally delivered neonate was referred with mities had signiﬁcant changes in some candidate genes complaints of respiratory distress from his birth. Physical alleles. Itwas foundthat thenumberofminor alleles inthe examination revealed laxity of the skin and heart problem genes under investigation correlate with the severity of and swelling around the eyes. Length, weight, and head congenital deformity and the variability of vertebral circumference percentiles at birth were 55cm, 4100 gr and anomalies. It was determined that in children with828 J.delPicchia combined defects in the spine development, there is a variants in MYH3. The American Journal of Human greater number of mutations compared to children with Genetics, 102, 1115-1125. isolated vertebral anomalies. A.P. Vasconcelos: None. F. Ayala: None. I. Alonso: S. Khalchitsky: None. M. Sogoyan: None. S. Vissario- None. M. Leão: None. nov: None. A. Dmitriev: None. E-P04.13 E-P04.12 Case report: cellular interference highlights an unusual Another family with compound heterozygosity for X-linked mode of inheritance and seemingly genetic variants in MYH3 paradox in craniofrontonasal dysplasia A. P. Vasconcelos1, F. Ayala2, I. Alonso3,4, M. Leão1 J. Ronez, S. Morlot, B. Schlegelberger, H. Wallaschek 1Department of Medical Genetics, Centro Hospitalar Uni- DepartmentofHumanGenetics,HannoverMedicalSchool, versitárioSãoJoão,Porto,Portugal,2DepartmentofMedical Hannover, Germany Genetics, Universidade Estadual de Campinas, Campinas, Brazil,3IBMC-InstituteforMolecularandCellBiology,i3S- Introduction: craniofrontonasal dysplasia is a rare form of Instituto deInvestigaçãoeInovação emSaúde,Universidade frontonasaldysplasiacausedbymutationsintheEFNB1gene do Porto, Porto, Portugal, 4Genetyca-ICM, Instituto de on the X chromosome. EFNB1 encodes for ephrin-B1, a Estudos Celulares e Moleculares, Porto, Portugal transmembraneligandoftheEphBreceptorwithcrucialroles in cell migration and pattern formation during skeletal devel- Contractures, pterygia, and variable skeletal fusions syn- opment. The phenotype is more pronounced in females, who drome 1B (CPSKF1B) (OMIM #618469) is an autosomal characteristically present with frontonasal dysplasia and cor- recessive disorder, characterized by contractures of prox- onar craniosynostosis, while the manifestation in males is imalanddistaljoints,multiplepterygiainvolvingtheneck, usually milder, often only characterized by hypertelorism. elbows,ﬁngers,and/orknees,andvariablevertebral,carpal Case report: We, here, present an 11-week-old girl who and tarsal fusions, ﬁrstly described by Cameron-Christie presented with dysmorphic facies. Leading characteristics et al. All those patients, displaying remarkable phenotypic were plagiocephaly, hypertelorism, a cleft palate, slanted variability,werecompoundheterozygousforvariantsinthe eyes, dysplastic ears and a broad nasal bridge. Molecular MYH3 gene (Cameron-Christie et al., 2018). We describe genetic analyses of the girl revealed a pathogenic de novo an 11 years-old male patient, born from non-con- nonsense variant in the EFNB1 gene, which triggers sanguineous parents, with no relevant family history, nonsense mediated decay. whosephenotypewasconsistentwithCPSKF1B,including Background:Femaleswithaheterozygousmutationinthe arthrogryposis of the hips, knees and elbows, multiple EFNB1 gene usually display a more severe phenotype than pterygia, severe scoliosis and vertebral fusions at cervical, hemizygous males. The embryonal X-inactivation leads to a dorsal,lumbarandlumbosacrallevels.Attheageof9there heterogenicpopulationofcellseitherexpressing themutated was no radiological evidence of carpal synostosis. Addi- or the wildtype allele, disrupting the correct formation of tionally, he has triangular shaped face, low-set ears, bilat- boundaries within the frontal bone precursors during eral down slanted palpebral ﬁssures, ptosis, and embryogenesis. Hemizygous males display a homogenous micrognatia.Geneticanalysisidentiﬁedthreeheterozygous cell population, since no functional ephrin-B1 can be variants in MYH3 [NM_002470.3: c.5072del,p.(Ala1691- producedatall,inwhichcaseotherephrin-Bfamilymembers Valfs*52) in exon 35; c.749G>A,p.(Arg250Gln) and are likely to compensate by assuming ephrin-B1 function. c.787G>T,p.(Asp263Tyr) in the same allele in exon 9]. Conclusion:Due tocellularinterference,craniofrontona- Genetic testing of his parents identiﬁed the ﬁrst of these sal dysplasia does not follow a classic Mendelian mode of variants in the mother and the others in the father, sug- inheritance. Our case report is a good example for this gesting an autosomal recessive pattern of inheritance. Our mechanism and highlights the need to be aware of such patientpresentsseveraldysmorphicfeaturesnotpreviously unusual modes of inheritance in genetic counselling. reported by Cameron-Christie et al. References: J. Ronez: None. S. Morlot: None. B. Schlegelberger: CAMERON-CHRISTIE, S. R., WELLS, C. F., SIMON, None. H. Wallaschek: None. M., WESSELS, M., TANG, C. Z., WEI, W., TAKEI, R., AARTS-TESSELAAR, C., SANDARADURA, S. & SIL- E-P04.15 LENCE, D. O. 2018. Recessive Spondylocarpotarsal Heterozygous 7q32.3-q35 deletion causes syndromic synostosis syndrome due to compound heterozygosity for craniosynostosisAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 829 E. Bukowska-Olech1, D. Simon2, D. Larysz3, Norway, 3Helse Vest, Bergen, Norway, 4Department of A. Jamsheer1,2 Pediatrics, Helse Førde, Førde, Norway, 5Department of Clinical Science, Universtity of Bergen, Bergen, Norway, 1Department of Medical Genetics, Poznan University of 6DepartmentofOrthopedicSurgery,HelseBergen,Bergen, Medical Sciences, Poznan, Poland, 2Centers for Medical Norway, 7Department of Clinical Medicine, University of Genetics GENESIS, Poznan, Poland, 3Department of Bergen,Bergen,Norway,8MassachusettsGeneralHospital, Radiotherapy, The Maria Skłodowska Curie Memorial Boston, MA, United States, 9Stanley Center for Psychiatric Cancer Centre and Institute of Oncology, Gliwice Branch, Research, Harvard/MIT, Boston, MA, United States, Gliwice, Poland, Gliwice, Poland 10Department of Radiology, University Hospital of North Norway, Tromsø, Norway, 11Department of Clinical Background: The most commonly recognisable syndromes Medicine, University of Tromsø, Tromsø, Norway with craniosynostosis (CS) are regarded as monogenic dis- ordersandresultfromdifferentpathogenicvariantsaffecting Introduction:Developmentaldysplasiaofthehip(DDH) genes, that encode ﬁbroblast growth factor receptors is a congenital condition affecting 2-3% of all infants (1). (FGFRs)suchasFGFR1, FGFR2, and FGFR3. However,a DDHincreasestheriskofosteoarthritisandisthecauseof couple of studies have also pointed to copy number varia- 30% of all total hip arthroplasties in adults < 40 years of tions (CNVs) as molecular causes of syndromic CS. age (2). We aim to explore the genetic background of Materials and methods: The female patient with DDH in order to improve diagnosis and personaliz psychomotor delay, intellectual disability and multiple CS treatment. and her healthy parents were subjected to standard Materials and method: We conducted a structured karyotyping analysis. Next, we have implemented array PubMed-search and added selected studies from our comparative genomic hybridisation (array CGH) for the archives. A total of 66 papers were included for detailed proband (SurePrint G3 Human CGH Microarray 4×180; review. In addition, we are conducting a heritability AgilentTechnologies),followedbymicroarray-basedgenes analysis in the Norwegian Twin Registry using Falconer’s expression proﬁling (one-color SurePrint G3 Unrestricted method. GE 8x60K microarray; Agilent Technologies). Results: The results of the heritability analyses will be Results: Karyotyping analysis revealed a heterozygous presented at the conference. Similar studies have found a deletiononchromosome7(der7).Furthermore,withtheuseof heritability of ~80%. The literature review revealed that array CGH, we have shown, that the aberration was 12.782 the majority of published papers on the genetics of DDH Mb in size and mapped to locus 7q32.3-q35 (HG19 – were mostly underpowered for detection of any associa- chr7:131521826-144304164). The CNV encompassed 143 tion. One large genome wide association study has been genesincludingtheBRAF,thatencodesB-Raf.B-rafbelongs published, establishing GDF5 as a plausible risk factor. to one of the molecules involved in RAS/MAPK pathway. Thisstudyfoundasinglenucleotidepolymorphism-based Conclusion:OurﬁndingsupportsthecontributionofCNVs heritability of 55%, however GDF5 only explains tosyndromicCSdevelopment.Wealsopointedtotheexisting ~1.5% (3). interaction between RAS and FGFs signaling cascades and Conclusion: DDH is known to be congenital and conclude that dysregulation of those intracellular pathways heritable, with family occurrence of DDH already included maygiverisetoCS.Finally,westronglysuggestscreeningof as a risk factor in most screening programs. Despite this, RAS-associatedgenesinpatientswithNoonan-likesyndrome high quality genetic research is scarce, and no genetic risk andskullabnormalities.Thisworkwassupportedbythegrant factors have been soundly established, prompting the need fromthePolishNationalScienceCentre,PolandUMO-2016/ for more research. 23/N/NZ5/02577 to Ewelina Bukowska-Olech. (1) Rosendahl et al, 1996, Pediatric Radiology (2) E. Bukowska-Olech: None. D. Simon: None. D. Larysz: Engesæteretal,2011,ActaOrthopaedica(3)Hatzikotoulas None. A. Jamsheer: None. et al, 2018, Communications Biology Grants: Helse Vest (F-12550-D11544) E-P04.16 K.K.Jacobsen:None.L.B.Laborie:None.H.Kristensen: Genetic risk factors for hip dysplasia None. A. Schäfer: None. T. Gundersen: None. T. Zayats: None. K. Rosendahl: None. K. K. Jacobsen1, L. B. Laborie2,3, H. Kristensen4,5, A. Schäfer4, T. Gundersen6,7, T. Zayats8,9, K. Rosendahl10,11 E-P04.17 Ectodermal Dysplasia Type 4: Phenotype-Genotype 1Department of Orthopedic Surgery, Helse Førde, Førde, Correlation Norway,2Department ofRadiology,Helse Bergen,Bergen,830 J.delPicchia A.Ozaydin1,G.Gencebay2,A.KalayciYigin1,M.T.Alay1, Ehlers-Danlos syndrome (EDS) is a generic term for a M. Seven1 clinically and genetically heterogeneous group of con- nective tissue disorders. According to the clinical picture 1Department of Medical Genetics, Cerrahpasa Medical and underlying genetic mutation 13 subtypes are dis- Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, tinguished.Wesawourprobandasaﬁveyearoldgirlwith 2Department of Skin and Venereal Diseases, Cerrahpasa severe periodontitis and premature loss of several teeth. MedicalFaculty,IstanbulUniversity-Cerrahpasa,Istanbul, Moreovershedisplayedashortstature,jointhypermobility, Turkey chronicpain,recurrentluxationofkneecaps,ﬂatfeet,asoft and hyperelastic skin with multiple subcutaneous papules, Introduction: Ectodermal dysplasia is a rare hereditary easy bruising, and pretibial hyperpigmentation. Due to diseasethatischaracterizedbyellipticalnoduleslocatedon those signs and symptoms EDS was suspected and genetic the hair shaft. Fragile hair ﬁbers are found in the temporal testing brought about. NGS analysis of 44 connective tis- and occipital region, resulting in alopecia. Patients are sue-relatedgenesrevealedapathogenicframeshiftmutation usually normal at birth, but the hair becomes fragile in the in COL5A1, conﬁrming the diagnosis Classical EDS. This ﬁrst few months of life. In severe cases, eyebrows, eye- diagnosis was consistent with the proband’s joint and skin lashes, and other body hairs may also be affected. The related phenotype, yet did not explain her severe dental disease can be isolated to the scalp, and may be accom- phenotype. As the dental status was highly suggestive of panied by tooth and nail disorders. Ectodermal dysplasia is periodontalEDS,analysisoftheunderlyinggenesC1Rand generally caused by mutations in KRT81, KRT83, KRT85 C1Swasperformed.Thedetectionofapathogenicmissense and KRT86 genes. mutation in C1R conﬁrmed the additional diagnosis peri- Clinical Findings and Method: In the physical exam- odontal EDS. Analysis of the parents showed the COL5A1 ination of mother and her three children; localized mutation being maternally inherited whereas the C1R alopecia, brittle hair-body hair and nail dystrophy were mutation occured de novo. Our patient’s mother experi- detected and ectodermal dysplasia was considered. DNA enced many signs of Classical EDS already in her child- was isolated from peripheral blood samples of mother and hood,yetthisdiagnosiswasneversuspectedinherbeforeit her children. Due to the pre-diagnosis of ectodermal was conﬁrmed in her daughter. To our knowledge, this is dysplasia clinical exom analysis was performed in the the ﬁrst reported case of Classical and Periodontal Ehlers- KRT gene family. Danlos Syndrome in one single person. Result: As a result of the analysis, the change of c. F. Stock: None. M.R. Hanisch: None. S. Lechner: None. G565A(p.D189N)inexon2ofKRT85geneinmotherand S. Biskup: None. A. Bohring: None. herchildrenwasdetectedasheterozygousandconﬁrmedby Sangersequencing.Thischangewasevaluatedaccordingto E-P04.19 the American College of Medical Genetics criteria and Role of TANGO1 gene in hypermobile type of Ehlers- compared with genetic databases. Danlos syndrome Conclusion:Asaresultoftheevaluation,itisconsidered asavariantofunknownclinicalsigniﬁcance(VUS)andasa A. Junkiert-Czarnecka, M. Pilarska-Deltow, A. Bak, pathological variant in silico databases. M. Heise, O. Haus A. Ozaydin: None. G. Gencebay: None. A. Kalayci Yigin: None. M.T. Alay: None. M. Seven: None. Department of Clinical Genetics Nicolaus Copernicus University, Bydgoszcz, Poland E-P04.18 AcaseofClassicalandconcomitantPeriodontalEhlers- Introduction: Hypermobile Ehlers-Danlos syndrome Danlos syndrome (hEDS)isanon-inﬂammatory,autosomalconnectivetissue disorder. It is perhaps the most common hereditary con- F. Stock1, M. R. Hanisch2, S. Lechner3, S. Biskup3, nective tissue disorder with a prevalence estimate at about A. Bohring1 1/5000. hEDS unlike other types of EDS, has no known genetic etiology. One of disfunctions in hEDS patients’ 1Institut für Humangenetik, Universitätsklinikum Münster, cells is impaired transport of extracellular matrix proteins Münster, Germany, 2Klinik für Mund-, Kiefer- und from cells to intercellular space. Protein taking part in this Gesichtschirurgie, Universitätsklinikum Münster, Münster, process is TANGO1 encoded by TANGO1 gene. The aim Germany, 3Praxis für Humangenetik Tübingen, Tübingen, ofstudyisasequencinganalysisofTANGO1geneandalso Germany the evaluation of the potential role of detected variants inAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 831 these gene on their role in the etiology of the hypermobile withOtopalatodigitalSpectrumDisorder,Dyggve-Melchior- type of Ehlers-Danlos syndrome. Clausensyndrome,Immuno-osseusdysplasiaSchimketype, Methods: The study was carried out in a group of 100 Acromesomelic dysplasia, Spondyloepimetaphyseal displa- patientswithhypermobiletypeofEhlers-Danlossyndrome. sia with joint laxity type 2, Osteogenesis imperfecta, Control group consisted of 100 persons from general Osteopetrosis autosomal recessive type 1, Hypochondropla- population. Sequencing analysis of gene TANGO1 was sia, Mucolypidosis type IV, Mucopolisaccharidosis type performed using Sanger sequencing technique. Results IIIA, Craniofrontonasal dysplasia, Oculo-dento-digital dys- Among 100 hEDS patients in two c.1099A>T (p. plasia, Crouzon syndrome, Craniosynostosis type 3, Short Thr367Ser) variant and in next three patients c.2637C>A sature - brachydactyly - intellectual developmental disabil- (p.Asp879Glu) variant were detected. All patients were not ities - seizures syndrome, 3MC syndrome, Trichorhinopha- mutation carriers of other connective tissue protein coding langealsyndromeandotherrareskeletaldisorders.Inseven genes (previous study). According to ACMG guideline cases we performed prenatal diagnosis. variants were evaluated as VUS. Conclusion: To what extent early genomic diagnosis Conclusion: This study is the next small step in the prevents additional unnecessary diagnostics and the oppor- recognition and understanding of the complex picture of tunity for anticipatory guidance-related management in hEDS. Analysis of genes encoding of ECM protein carrier patients with skeletal dysplasia? We tried to answer this may be a new approach to evaluate genetic background of questionbasedontheﬁrstexperiencesinoursinglegenetic hypermobile type of Ehlers-Danlos syndrome. This inves- outpatient clinic. This study represent the pilot study with tigation was ﬁnanced by grant of National Science Centre an aim to establish the multidisciplinary skeletal dysplasia Poland (2018/29/N/NZ5/00345). Center. A.Junkiert-Czarnecka:None.M.Pilarska-Deltow:None. M.Mijovic:None.J.RumlStojanovic:None.A.Miletic: A. Bak: None. M. Heise: None. O. Haus: None. None. B. Bosankic: None. H. Janeski: None. B. Peterlin: None. A. Maver: None. G. Cuturilo: None. E-P04.20 Skeletal dysplasia in the era of genomic testing: ﬁrst E-P04.21 experience of a single genetic outpatient clinic Identiﬁcation of rare mutation in ext2 gene among from Serbia patients with multiple hereditary exostoses M.Mijovic1,J.RumlStojanovic1,A.Miletic1,B.Bosankic1, A. Yakovleva, A. Danilova, M. Savvina, D. Petukhova, H. Janeski1, B. Peterlin2, A. Maver2, G. Cuturilo1,3 A. Sukhomyasova, N. Maksimova 1University Children’s Hospital, Department of Clinical North-Eastern Federal University, Yakutsk, Russian Fed- Genetics, Belgrade, Serbia, 2Clinical Institute of Medical eration Genetics, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3Faculty of Medicine, University of Belgrade, Multiple hereditary exostoses (MHE) is an autosomal domi- Belgrade, Serbia nant hereditary disorder and the prevalence in various populations ranges is estimated from 1-2 per 100 Introduction: Skeletal dysplasia are very heterogeneous thousand people or 1 in 7000 orthopedic patients. According groupofgeneticdisorders,forwhichinmostcasesgenomic todataobtainedfromthe“registerofhereditaryandcongenital testing (NGS technology) is the ﬁrst-choice method in pathologyoftherepublicofSakha(Yakutia)”80patientsand genetic testing. We want to present our diagnostic rate, their relatives from different ethnic groups were registered. distribution of frequencies between subgroups from classi- Geneticanalysiswasconductedfor65patientswithMHEand ﬁcation of skeletal dysplasia and we try to give an answer their relatives from 30 unrelated families. Next-generation about impact of diagnosis. sequencing(NGS)andSangersequencingmethodswereused. Materials and methods: We present our results for The EXT2 gene from a patient with MHE was sequenced pediatricpatientswithdifferentskeletaldysplasiawhowere usingNGSmethod.Theanalysisrevealednonsense mutation ﬁrst assessed in genetic outpatient clinic at Department of c.751>T(p.Gln251*)inexon5ofEXT2geneinheterozygous Clinical Genetics, University Children’s Hospital in Bel- conditionanditalsowereconﬁrmedintherest79patientsand grade and referred for diagnostic whole exome sequencing their relatives by the Sanger’s sequencing method. This (WES), from 2015 to 2019. WES was performed for all 51 mutation was found and conﬁrmed in 16 patients from four patients. familieswithMHE.Thus,fortheﬁrsttimeintheRepublicof Results: Causative gene variants were identiﬁed in 38 Sakha(Yakutia),amoleculargeneticstudyoftheEXT2gene patients (74.5%, n=38/51). We have diagnosed patient(s) wasperformedinpatientswithMHEandtheirrelatives.Arare832 J.delPicchia nonsensemutationc.751C>T(NM_001178083)wasdetected sensibility and reliability, as well as it enables discarding inexon5oftheEXT2gene,whichleadstothereplacementof aneuploidy, for example a possible Klinefelter karyotype. thecodingcodonwithastopcodonatthe251positionofthe J. Fortuño: None. M. Oliva: None. I. Royo: None. M. protein (p.Gln251 *, NP_001171554). In the future, the Flores: None. A. Torrents: None. F. Martínez: None. N. diagnosticofthismutationcanbeincludedintheprogramof Pérez: None. C. Camprubí: None. genetic testing for medical and genetic counseling. The research is supported by the project FSRG-2020-0014 E-P04.23 “GenomicofArctic:epidemiology,hereditaryandpathology” Agenesis of corpus callosum - a new phenotypic aspect A. Yakovleva: None. A. Danilova: None. M. Savvina: in ﬁbrodysplasia ossiﬁcans progressiva? None. D. Petukhova: None. A. Sukhomyasova: None. N. Maksimova: None. N. Meier, N. Knoll, S. Kleiner, M. Ritthaler, E. Wohlleber, J. Kohlhase E-P04.22 Mosaicism in the PHEX gene. Is it more common than SYNLAB MVZ Humangenetik Freiburg GmbH, Freiburg, we thought? Germany J. Fortuño1, M. Oliva1, I. Royo1, M. Flores1, A. Torrents1, Introduction: Mutations in ACVR1 cause ﬁbrodysplasia F. Martínez2, N. Pérez2, C. Camprubí1 ossiﬁcans progressiva (FOP). The classical clinical feature of FOP is progressive heterotopic ossiﬁcation, but affected 1Reference Laboratory, L’Hospitalet de Llobregat, Spain, individualsoftendisplayﬁrsttoeandthumbmalformations. 2Hospital Universitario Nuestra Señora de Candelaria, Wereportonaoneyearoldpatientwithmotordevelopment Santa Cruz de Tenerife, Spain delay,corpuscallosumagenesis,bilateralhanddeformities, hypospadias and bilateral agenesis of the ﬁrst toes. Smith- Introduction: Familial X-linked hypophosphatemic rickets Lemli-Opitz syndrome had been suspected as the cause for (XLHR)isdeﬁnedasagroup ofdisorderscharacterizedby limb malformations and hypospadias, and the child was rickets with bone deformities, short stature, dental anoma- referred to genetics in order to rule out or to conﬁrm this lies, hypophosphatemia and increased activity of serum diagnosis. alkaline phosphatases. According to the bibliography, Material and Methods: normal results for 7-dehydro- pathogenicvariantsinthePHEXgenearethemostcommon cholesterol levels made Smith-Lemli-Opitz syndrome cause of XLHR and only a few cases of mosaicism have unlikely, and we suspected a submicroscopic chromosomal been described worldwide. We present two unrelated Can- anomalyoranunknownsyndromeastheunderlyingcause. ary Islands (Spain) family cases referred with XLHR clin- We performed karyotyping and CGH, which revealed ical suspicion in whom mosaic variants have been normal results, followed by whole exome identiﬁed. sequencing (WES). Materials and methods: Genomic DNA was isolated Results:WESdetectedaheterozygousdenovovariantin from EDTA blood using a standard protocol. Next ACVR1: c.1067G>A, p.G356D. A literature search showed Generation Sequencing (NGS) was used to analyse PHEX that patients with absent ﬁrst toes and mild brain gene in the probands. Sanger sequencing was used to abnormalities were previously reported in FOP, but perform the study in the mother’s proband. agenesisofthecorpuscallosumhadnotyetbeenobserved. Results:Inonefamily,anonsensepathogenicvariant(p. Furthermore, hypospadias was reported once in an atypical Gln394Ter) was found in mosaicism in the proband. In the case of FOP. other family, the proband was hemizygous for a missense Conclusions: The combination of ﬁrst toe anomalies, variantofuncertainsigniﬁcance(VUS)(p.Ala267Glu).The especially agenesis of ﬁrst toes, in combination with family analysis reveals that his unaffected mother was hypospadias and brain malformations may be the clinical mosaic. presentation of FOP before the characteristic heterotopic Conclusions: To our knowledge, the identiﬁed cases are ossiﬁcations appear. Agenesis of corpus callosum may be the ﬁrst families with mosaic variants in PHEX gene part of the phenotypic spectrum of FOP. The diagnosis of reported in Spain. In the genetic counselling context, the FOPpriortotheﬁrstheterotopicossiﬁcationcanleadtoan “recurrence” of mosaicism in PHEX gene, emphasize to improved clinical management to prevent early heterotopic consider unaffected males as possible mosaic carriers. The ossiﬁcations in the child. advantage of performing PHEX gene analysis by NGS is N. Meier: None. N. Knoll: None. S. Kleiner: None. M. noteworthy:itallowsdetectionofmosaicvariantswithhigh Ritthaler: None. E. Wohlleber: None. J. Kohlhase: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 833 E-P04.24 canaidininterpretingnewvariantsandpromoteappropriate GDF5 clinical and molecular spectrum: expanding genetic counselling. current knowledge on genotype-phenotype correlations D. Guadagnolo: None. M. Genovesi: None. E. March- ionni: None. S. Bernardo: None. A. Giovannetti: None. N. D. Guadagnolo1, M. Genovesi1, E. Marchionni1, Panzironi:None.A.Traversa:None.F.DiPalma:None.G. S. Bernardo1, A. Giovannetti2, N. Panzironi1, A.Traversa2, Mastromoro: None. P. Palumbo: None. M. Carella: None. F. Di Palma1, G. Mastromoro1, P. Palumbo3, M. Carella3, T. Mazza: None. V. Caputo: None. A. Pizzuti: None. T. Mazza4, V. Caputo1, A. Pizzuti1 E-P04.25 1Department of Experimental Medicine, Sapienza Univer- IdentiﬁcationandcharacterizationofaGLMNsplicesite sity of Rome, Italy, Rome, Italy, 2Laboratory of Clinical variant in a three-generation-family with glomuvenous Genomics, Fondazione IRCCS Casa Sollievo della Soffer- malformations enza,SanGiovanniRotondo,Italy,3LaboratoryofMedical Genetics, Fondazione IRCCS Casa Sollievo della Soffer- D. Skowronek1, M. Hebebrand2, R. Erber3, A. Agaimy3, enza, Rome, Italy, 4Laboratory of Bioinformatics, Fonda- C. Zweier2, U. Felbor1, M. Rath1 zione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy 1Department of Human Genetics, University Medicine Greifswald, and Interfaculty Institute of Genetics and Introduction: Brachydactyly is a bone development Functional Genomics, University of Greifswald, Greifs- abnormality presenting with variable phenotype and dif- wald, Germany, 2Institute of Human Genetics, Friedrich- ferent transmission patterns. Mutations in GDF5 (growth/ Alexander-Universität Erlangen-Nürnberg, Erlangen, Ger- differentiation factor 5, MIM: 601146) gene account for a many, 3Institute of Pathology, University Hospital Erlan- signiﬁcantamountofcases.A3-generationfamilyshowing gen, Comprehensive Cancer Center Erlangen-EMN, isolated brachydactyly was studied. The proband and his Friedrich-Alexander University Erlangen-Nürnberg grandfather showed features of C and A1 brachydactyly (FAU), Erlangen, Germany types, his mother showed only subtle signs. Materials and methods: Whole Exome Sequencing Introduction: Glomuvenous malformations (GVMs) are (WES) was performed on the two affected individuals. An painful vascular lesions with distended venous lumina that in-depthanalysisofGDF5genotype-phenotypecorrelations are surrounded by multiple layers of smooth-muscle-like was performed through literature reviewing and retrieving glomus cells. Familial GVMs (OMIM: 138000) are inher- information from several databases to elucidate GDF5 ited in an autosomal dominant manner and associated with related molecular pathogenic mechanisms. loss-of-function germline variants in the GLMN gene. Results: WES analysis disclosed a known pathogenic Material and Methods: We here describe the natural variant in GDF5 (NM_000557.4:c.157dupC), segregating history of GVM disease in a three-generation family and with the phenotype. The frameshift variant was previously reportontheidentiﬁcationandcharacterization ofaGLMN associated with Brachydactyly type C in heterozygosis and splice site mutation by NGS gene panel sequencing and the severe Grebe chondrodysplasia in homozygosis. We transcript analysis. extended and updated the spectrum of GDF5 genotype- Results: At ﬁrst clinical examination, the 16-year-old phenotype correlations. In total, ﬁfty pathogenic mutations male index patient presented multiple, sharply deﬁned were associated with nine clinical phenotypes and auto- bluishpapulesonvariouslocations.His35-year-oldmother somal dominant and recessive transmissions even for the had approximately ten papules clustering on her back and samephenotype.Presentationsrangefromseveredefectsin his7-year-oldmaternalhalf-sisterpresentedwithtwobluish limb morphogenesis to conditions with redundant ossiﬁca- papulesonher neck. The index patient’s maternal aunt and tion.Weproposethatthisclinical gradientcanbelinkedto grandfather were also reported to have one or two bluish a continuum of GDF5-activity variation, with variable loss spots each. Using NGS gene panel sequencing, we ofGDF5-activityunderlyingbonedevelopmentdefects,and identiﬁed the heterozygous splice site variant c.1299 gain-of-functionmutationscausingdisorderswithexcessive +1G>A in the GLMN gene of the index case which had bone formation. notbeenreportedintheliteraturebefore.Heterozygosityfor Conclusions: Our in-depthanalysison GDF5 pathogeni- thesubstitutionatthedonorsplice siteofexon14wasalso city mechanisms furtherly supports that mutation and shown for the index patient’s mother and maternal half- zygosity backgrounds resulting in the same level of GDF5 sister. A GLMN transcript analysis ﬁnally veriﬁed that this activity may lead to similar phenotypes. This information variantcausesout-of-frameskippingofexon14.Following834 J.delPicchia thelatestACMGguidelinesforvariantinterpretation,itwas Conclusions: Considering the results of the study, we classiﬁed as pathogenic for autosomal dominant GVM. cannot exclude that the genes we identiﬁed may have a Conclusion:Thethree-generation-familyreportedhereis pathogenic effect, forming the hEDS phenotype. The a testimony for the variable expressivity of GVMs, best research was partly supported by project 558-2019-0012 explained by Knudson’s two-hit model. (№АААА-А19-119021290033-1) of FSBSI «D.O. Ott D. Skowronek: None. M. Hebebrand: None. R. Erber: Research Institute of Obstetrics, Gynaecology and None. A. Agaimy: None. C. Zweier: None. U. Felbor: Reproductology». None. M. Rath: None. T.I. Kadurina: None. L.R. Lonishin: None. E.A. Sereb- ryakova: None. L.N. Abbakumova: None. A.S. E-P04.26 Glotov: None. Identiﬁcationofnovelcandidategenesforthehypermo- bile type of Ehlers-Danlos Syndrome E-P04.27 Genotype-phenotype correlations in hereditary multiple T. I. Kadurina1, L. R. Lonishin2, E. A. Serebryakova1,3, exostoses L. N. Abbakumova4, A. S. Glotov3 I. Akalin1, K. Kurosawa2, B. Yeter3, E. Akbas4, 1North-Western State Medical University named after I.I. G. Nishimura5, W. Wuyts6, N. H. Elcioglu3 Mechnikov, St. Petersburg, Russian Federation, 2Peter the GreatSt.PetersburgPolytechnicUniversity,St.Petersburg, 1Istanbul Medeniyet University, Faculty of Medicine, Russian Federation, 3D.O. Ott Research Institute of Department of Medical Genetics, Istanbul, Turkey, 2Kana- Obstetrics, Gynecology and Reproductology, St. Peters- gawa Children’s Medical Center, Department of Medical burg, Russian Federation, 4Saint-Petersburg State Pedia- Genetics,Yokohoma,Japan,3Marmara University,Faculty tric Medical University, Russia, St. Petersburg, Russian of Medicine, Department of Pediatric Genetics, Istanbul, Federation Turkey, 4Istanbul Medeniyet University, Faculty of Medi- cine, Istanbul, Turkey, 5Center for Intractable Diseases, Introduction: There has been valuable progress in Saitama Medical University Hospital, Saitama, Japan, the use of different molecular diagnostic technologies to 6Department of Respiratory Diseases, University Hospitals clarify the classiﬁcation of the hypermobile type of Ehlers- Leuven, Leuven, Belgium Danlos Syndrome (hEDS). Diagnosis of hEDS is only based on clinical criteria, due to the absence of an Hereditary Multiple Exostoses (HME) is a complex heredi- identiﬁedgeneandaprotein,thusthemainobjectivewasto tarymusculoskeletaldisorderdiagnosedateitherpediatricor identify possible molecular genetic causes of hEDS adult age. HME is characterized by progressive exophytic development. osseous projections that form next to the growth plates of Materials and methods: For research, genomic DNA many skeletal elements, including long bones, ribs and samples of unrelated patients with hEDS were used (9 vertebrae. In addition to pain and functional problems par- females and 23 males). In all cases, the diagnosis was ticular forehand deformities are main complaints of the established by international recommendations for 2017 patients in the clinics that the treatment is restricted to sur- EDS. Whole-exome sequencing was performed on a gical excision of the lesions. The main complication is HiSeq2500. Assessment of the pathogenicity of the development of osteochondromas. Mutations in EXT1 or identiﬁed variants was based on the recommendations of EXT2genesthatencodeglycosyltransferasesareresponsible ACMG and Sherloc on the interpretation of data obtained for the disease and represented locus heterogeneity. None- by the next-generation sequencing method. theless,genotype-phenotypeinterventionsarestillimportant Results: As a result of the pathogenicity assessment, 7 wepresented20HMEcasesamong9familiesanddiscussed pathogenic and 5 probably pathogenic variants were genotype-phenotype correlations. This project has been identiﬁed in the encoding regions of the ABCA4, ABCC9, founded by The Scientiﬁc And Technological Research CBS, CCDC8, FIG4, GJB2, HGD, KRT14, LMNA, Council Of Turkey (TUBITAK; Project #217S675) MEFV, PROM1, RYR1, SLC26A2 and USH2A genes in I. Akalin: None. K. Kurosawa: None. B. Yeter: None. E. the heterozygous state. Also, 15 genes were selected with Akbas:None. G. Nishimura: None. W. Wuyts: None. N.H. variants of unknown clinical signiﬁcance based on data on Elcioglu: None. protein expression and high speciﬁcity of physical interac- tions among themselves that may be involved in the E-P04.28 development of hEDS. Recurrent bone pain - more than tumors and inﬂammationAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 835 M. M. Khelifa1, S. V. Hardenberg1, B. Auber1, B. Introduction: Hereditary ichthyosis is common name for Schlegelberger1, S. Mukodzi2, J. Wiens2, A. K. Bergmann1 many dry and scaly skin disorders ranging in frequency fromcommontoveryrare.Clinicalgenealogicalanalysisof 1MedizinischeHochschule Hannover, Hannover,Germany, hereditary forms of ichthyosis (from 1989 to 2018) are 2Klinikum Wolfsburg, Wolfsburg, Germany conducted in the Republic of Sakha (Yakutia), Russia. Materials and methods: Data was collected from the Hyperostosis-hyperphosphatemia syndrome (HHS) and genetic history of patients of the “Republican Genetic hyperphosphatemic familial tumoral calcinosis (HFTC) Register of Hereditary and Congenital Pathology of the are the clinical manifestations of a rare autosomal reces- Republic of Sakha (Yakutia)” of the Medical Genetics sive disease caused by the inactivation of the ﬁbroblast Center of the Republican hospital №1 “National center of growth factor 23 (FGF23), Polypeptide N-Acet- medicine”. ylgalactosaminyltransferase3(GALNT3)orKlothogenes, Results: The number of patients with ichthyosis is 126 which in turn leads to an elevated blood phosphate level patients (104 families) according to the genetic register of resulting mainly from an excessive proximal renal tubular Yakutia according to date of 2018. The frequency of phosphatereabsorption.Wereportthecaseofa5-year-old ichthyosiswasabout1/7675,prevalenceis13,0to100000. female of healthy non-consanguineous parents of German Gender: 94 men (74.6%), 32 women (25.4%). Ethnicity: and Italian descent. She initially presented with recurrent Yakut-109(86.5%),Russian-17(13.5%).Infourfamilies lower leg pain. Bone biopsy was inconclusive, as well as affected patients of both genders and in ten cases only infectious work-up. Imaging identiﬁed a diaphyseal males.Allpatientshaddryness,peelingoftheskin.Insome sclerosisand hyperostosis oftheribs. Hyperphosphatemia cases, more severe symptoms were noted in the form of was observed. Thus, panel diagnostics of the genes pityriasis peeling, follicular keratosis. The manifestation FGF23, GALNT3 and KL was performed. Two hetero- varied from birth to adolescence. zygous variants in GALNT3 (NM_004482.3) were identi- Conclusions: It is difﬁcult to establish the type of ﬁed, one previously undescribed missense variant inheritance and further medical and genetic counseling c.782G>A p.(Arg261Gln), classiﬁed as a variant of because of genetic heterogeneity and the similarity of the uncertain signiﬁcance. Protein-modeling of this variant clinical features of ichthyosis. Thus, there is a strong need suggested the disruption of GALNT3 activity, leading to inahighlyspeciﬁcdiagnosticmethodandin-depthresearch an increased inactivation of the phosphaturic hormone study for precise diagnosis, treatment and prevention of FGF23 causing HHS/HFTC. The second variant these diseases. Project: FSRG-2020-0014 “Genomics of c.803dupC p.(Thr269Asnfs*3) was previously described Arctics: epidemiology, hereditary and pathology” inaHHS/HFTCpatientandclassiﬁedaslikelypathogenic V.M.Sofronova:None.A.L.Sukhomyasova:None.N.R. (ACMG guidelines). In HHS/HFTC, no genotype-pheno- Maksimova: None. type correlation was described so far, and suggested treatment regimes are heterogeneous. Thus, in addition to E-P04.31 the detailed case, we present an overview of genotype- Jeune Syndrome with a novel DYNC2H1 mutation phenotype correlation and a collection of follow-up descriptionsofdiseasecoursesonpatientsreportedbefore N.H.Elcioglu1,B.Yeter1,J.Y.Xue2,Z.Wang2,L.Guo2,G. 2015. In conclusion, we aim to raise awareness of HHS/ Nishimura3, S. Ikegawa2 HFTC as a syndrome presenting primary with bone pain and radiographic changes. 1Department of Pediatric Genetics, Marmara University M.M. Khelifa: None. S.V. Hardenberg: None. B. Auber: MedicalSchool,Istanbul,Turkey,2LaboratoryofBoneand None. B. Schlegelberger: None. S. Mukodzi: None. J. Joint Diseases, Center for Integrative Medical Sciences, Wiens: None. A.K. Bergmann: None. RIKEN, Tokyo, Japan, 3Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan EN-P04.29 Clinical and genealogical characteristics of hereditary Jeune Asphyxiating Thoracic Dystrophy(OMIM%208500, forms of ichthyosis in the Republic of Sakha (Yakutia) ATD, Short-rib thoracic dysplasia with or without poly- dactyly) is an autosomal recessive skeletal dysplasia char- V. M. Sofronova, A. L. Sukhomyasova, N. R. Maksimova acterized by short stature and pulmonary hypoplasia secondary to the small thoracic cage. Polydactyly, glo- North-Eastern Federal University, Yakutsk, Russian Fed- merular sclerosis, biliary dysgenesis, hirshprung disease, eration retinal dysplasia and cardiac defects are the other ﬁndings. Here, we will a male patient who was diagnosed as Jeune836 J.delPicchia syndrome at the age of 3 month-old. He was born to a 28 Bencodinggene(FLNB).FLNBisanessentialcytoskeletal years old G3P3L3 mother by ceserean section with a birth protein which is thought to play a key role in bone mor- weight of2685 gat36 weeksofgestation. His birth length phogenesis. However, the skeletal phenotype of Larsen was 44.5 cm, head circumference was 35 cm. He was syndrome has not yet been characterized in details. hospitalized in a newborn intensive care unit for 3 months Materials and methods: A case-study. Two Caucasian due to respiratory distress. Except that the parents were far women (mother and daughter; age 63 and 33 years) with bloodrelatedtherewasnoparticularfamilialhistory.Inhis Larsen syndrome carrying a novel FLNB c.688G>T, p. last follow-up at the age of 4.5 years, his measurements (Val230Phe) variant were included. A bone morphologic were weight:14kg(-1.9 sds), height:97cm(-2.4 sds), evaluation was performed including DXA-scanning and HC:50cm(10-25p). The patient had a narrow thorax and high-resolution peripheral quantitative tomography (HR- pectus carinatum. On the radiographs, horizontal and short pQCT scan) evaluating their bone microstructure. Further- ribs, hypoplastic iliac wings and horizontal acetabulum more, an iliac crest bone biopsy from the mother was were detected. Mild sleep apnea was deﬁned in poly- evaluated by µCT. somnography. A novel homozygous missense mutation c. Results:Bothwomenshowedsignsof severe osteoporo- G6439T in the DYNC2H1 gene was detected on exome sis. The HR-pQCT scan showed a low estimated bone sequencing for the etiologicall cause. Jeune syndrome is a strengthandvolumedensityaswellasdecreasedtrabecular genetically heterogeneous disease nearly forty genes have numbercomparedtodatafromapopulation-basedgroupof been identiﬁed and deﬁned as ciliopathy. There may be Danish women. The µCT analysis of the bone biopsy slight to moderate short stature although respiratory difﬁ- showed similar trabecular changes. The porosity of the culties eventuate in all survivors. Moreover, laboratory cortical bone was found to be normal or decreased in both evaluation of urine/blood, abdominal US, spirometry and the HR-pQCT and the µCT analysis. ophtalmological exam should be recommended for renal, Conclusions: Our ﬁndings include an early onset of hepatic and eye involvement severe osteoporosis, which is likely due to structural N.H.Elcioglu:None.B.Yeter:None.J.Y.Xue:None.Z. changes in the trabecular bone compartment. On the other Wang: None. L. Guo: None. G. Nishimura: None. S. hand,thecorticalbonecompartmentshowsnoosteoporotic Ikegawa: None. characteristics. This highlights that the investigated FLNB variant may have a very different effect on the trabecular E-P04.33 and cortical compartments. Severe osteoporosis in Larsen syndrome: genetic and T.M. Juul: None. C. Ejersted: None. L. Folkestad: None. bone morphological investigations - a case report K. Brusgaard: None. S. Hansen: None. C.M. Andreasen: None. L.K. Thomsen: None. J.S. Thomsen: None. T.L. T.M.Juul1,2,C.Ejersted3,L.Folkestad2,3,K.Brusgaard1,2, Andersen: None. A.L. Frederiksen: None. S. Hansen4,5, C. M. Andreasen6, L. K. Thomsen6, J. S. Thomsen7, T. L. Andersen2,7,8, A. L. Frederiksen1,2,9 E-P04.35 Maffucci syndrome-like manifestations deciphered as a 1Dept. of Clinical Genetics, Odense University Hospital, compound heterozygote of Gronblad-Strandberg syn- Odense, Denmark, 2Dept. of Clinical Research, Faculty of drome by exome sequencing. Health, University of Southern Denmark, Odense, Den- mark, 3Dept. of Endocrinology M, Odense University A. Ikonomidis1, E. Oikonomidou2, A. Malamidou2, Hospital, Odense, Denmark, 4Dept. of Medicine, Hospital A. Arampatzi2, N. Peroulis2, K. Krapis3, T. Konstantoula3, of South West, Esbjerg, Denmark, 5Dept. of Regional P. Katsiaﬁloudis3, A. Papadogoulas3, M. Hatzimichail3, HealthResearch,UniversityofSouthernDenmark,Odense, T. Zafeiridis3, E. Neou3, D. Papadopoulos3, Denmark, 6Clinical Cell Biology, Dept. of Pathology, P. Papamichalis3, S. Karagiannis3, A. Komnos3, Odense University Hospital, Odense, Denmark, 7Dept. of K. Karakousis3, A. Xefteris2 Biomedicine, Aarhus University, Aarhus, Denmark, 8Dept. of Forensic Medicine, Aarhus University Hospital, Aarhus, 1Eurogenetica Thessalias, Larissa, Greece, 2Eurogenetica, Denmark, 9Dept. of Clinical Genetics, Aalborg University Thessaloniki, Greece, 3Koutlimpanio General Hospital of Hospital, Aalborg, Denmark Larissa, Larissa, Greece Introduction: Larsen syndrome is a genetic condition Introduction: Exome sequencing is a state of the art characterized by facial dysmorphology and skeletal defor- technique that may clarify the genotype of complex over- mities. The syndrome has a dominant inheritance and is lapping phenotypes. We present a case of a female with a caused by heterozygous pathogenic variants in the Filamin typicalclinicalphenotypeofMaffuccisyndromewhichwasAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 837 ﬁnally deciphered as a compound heterozygote of Gron- connective tissue disorder characterized by a combination blad-Strandberg syndrome. of cardiovascular, musculoskeletal, ophthalmic and pul- Materialsandmethods:A20-year-oldfemalesuspected monary manifestations. The wide clinical variability of this of Maffucci syndrome presented multiple cartilage defor- disorder can make its recognition difﬁcult. Diagnosis is mities as well as hemangiomas and lymphangiomas usually established based on the deﬁned clinical criteria of disseminated along her body. Clinical exome sequencing the Ghent-2 nosology. Approximately 1800 pathogenic or was performed onthe DNA extracted from patient’sblood, likelypathogenicvariantshavebeenidentiﬁedinFBN1,the using Sophia Genetics’ Clinical Exome Solution v2. majority of which are speciﬁc to a single family, and 25% Following preparations according to the manufacturer’s occurring de novo. Somatic and/or germline mosaicism protocol, DNA libraries were sequenced on an Illumina have been reported in rare cases. NextSeq-500 genetic analyser. Data processing, variant Here we describe an asymptomatic 50-year-old female calling and pre-classiﬁcation were conducted by SOPHiA who presented for genetic counselling after her two DDM® bioinformatics pipelines. daughters, from different partners, were both diagnosed Results: The patient carried wild-type isocitrate dehy- with MS. A known pathogenic variant, c.1693C>T, p. drogenase1(IDH1)andisocitratedehydrogenase2(IDH2) Arg565* in FBN1 (NM_000138.4), was conﬁrmed in both alleles related to Maffucci syndrome. Instead, she was affectedhalf-siblings.However,targetedSangersequencing found to be a compound heterozygote for ATP-binding- for this variant was negative in the mother. Repeat testing cassette-subfamily-C-member-6 gene (ABCC6) related to via Next-Generation-Sequencing (NGS) of FBN1 was pseudoxanthoma elasticum or Gronblad-Strandberg syn- offered to the patient. drome.In particular, shecarriedthe pathogenic c.1652T>C NGS analysis of FBN1 revealed the presence of the (Phe551Ser) mutation and the c.2836C>A (Leu946Ile) variant in 9% of the sequencing reads. This is well below mutation which is of debatable pathogenicity. the allele frequency expected for a heterozygous germline Conclusions: Exome sequencing revealed a compound variant (~50%). Based on the family history, this variant heterozygote with Gronblad-Strandberg syndrome initially was reported at a mosaic level of 9%. suspected to present a case of Maffucci syndrome. These results are consistent with somatic and germline Pseudoxanthoma elasticum leads to mineralization of skin, mosaicisminthispatient.Therecurrenceriskforanyfuture eye, cardiovascular and gastrointestinal systems and offspring isnowknownto be up to50%. Additionally, she commonly present with papules in the skin and/or with has been referred to Cardiology and Genetics to assess for angioid streaks of the retina. Thus, in a great extent, the any clinical manifestations of MS in herself. clinical manifestations are in discordance with the under- A. Schaffer: None. L. Huang: None. O. Jarinova: None. lying genotype which suggests a novel phenotypic S. Hewson: None. R. Aul: None. J. McGowan-Jordan: manifestation of Gronblad-Strandberg syndrome. None. A. Smith: None. L. Bronicki: None. A. Ikonomidis: None. E. Oikonomidou: None. A. Malamidou:None.A.Arampatzi:None.N.Peroulis:None. E-P04.37 K. Krapis: None. T. Konstantoula: None. P. Katsiaﬁloudis: Next Generation Sequencing in Marfan syndrome: rare None. A. Papadogoulas: None. M. Hatzimichail: None. T. genetic variants improve genotype phenotype Zafeiridis: None. E. Neou: None. D. Papadopoulos: None. correlation P. Papamichalis: None. S. Karagiannis: None. A. Komnos: None. K. Karakousis: None. A. Xefteris: None. N. Marinakis, C. Sofocleous, E. Tsoutsou, D. Veltra, M. Sviggou, J. Traeger-Synodinos, E. Fryssira E-P04.36 AcasereportofsomaticmosaicismforaFBN1nonsense National & Kapodistrian University of Athens, Athens, variant Greece A.Schaffer1,L.Huang1,O.Jarinova1,S.Hewson2,R.Aul2, Introduction: Marfan syndrome (MFS) is an autosomal J. McGowan-Jordan1, A. Smith1, L. Bronicki1 dominantdisorderofconnectivetissuewithaprevalenceof 1per5000individuals.MFSischaracterizedbyearlyaortic 1Department of Genetics, Children’s Hospital of Eastern thoracic dilatations/aneurysms, defects of the skeletal and Ontario, Ottawa, ON, Canada, 2Department of Genetics, ocular systems, tall stature, arachnodactyly, pectus exca- Hospital for Sick Children, Toronto, ON, Canada vatum, joint hypermobility and ectopia lentis. Mutations in the Fibrillin-1 gene (FBN1) are the most common cause of Marfan syndrome (MS) is an autosomal dominant disorder MFS.Nevertheless,mutationsinothergenes(e.g.TGFBR1, caused by mutations in the ﬁbrillin-1 gene (FBN1). It is a FLNA, COL5A1, SLC2A10, ADAMTSL4, CBS, SMAD3,838 J.delPicchia TGFB2, MED12, FBN2, PLOD1, BMPR2 etc.) have also small for gestational age with dysmorphic facial features, beenassociatedwithMFS.Newtechnologies,suchasNext skeletalabnormalities,arthrogryposis,andhypoplasticlabia Generation Sequencing, contribute to the identiﬁcation of majora, without typical webbing. known and novel mutations in these genes. Results: WES analysis was conducted after negative Materials and methods: Clinical information and ﬁndings in karyotype, MLPA screening for microdeletions, peripheral blood samples were collected from 25 patients subtelomeric deletions and duplications, urinary GAGs, with Marfan or Marfan-like phenotype and heart defects. NGS for congenital arthrogryposes. Two pathogenic DNA extraction and Whole Exome Sequencing (WES), variants were identiﬁed in the CHRNG gene, c.241C>T analysingapproximately19.000genesdispersedthroughout previously reported in homozygous state in patient with a the genome-were applied. similarclinicalpicture,andc.1143G>Awhichhasnotbeen Results: WES analysis revealed positive results in 17 previously described. patients, accomplishing a diagnostic yield of 68%. Causa- Conclusions: Polimalformative syndromes including tive alterations included 14 known and novel pathogenic skeletal defects, and joint contractures, even without the variants in the FBN1 gene, 1 in the FBN2 gene, 1 in the typical webbing, should be tested for Escobar variants of BMPR2 gene and 1 in the SLC2A10 gene. MPS,becausestandardarthrogryposisgenepanelscanmiss Conclusion: WES can support deﬁnitive diagnosis in the diagnosis. patients with Marfan or Marfan-like phenotypes, contribut- H. Kathom: None. D. Avdjieva-Tzavella: None. ing to precise prognosis, systematic monitoring, and when T. Delchev: None. S. Atemin: None. T. Todorov: None. appropriate, identiﬁcation of other family members. NGS A. Maver: None. B. Peterlin: None. V. Mitev: None. supports marked improvement in diagnostic-yield for A. Todorova: None. numerous inherited disorders including Marfan Syndrome, especiallyinthecaseofnonFBN1variants.Thestudywas E-P04.40 carried out as part of the Erasmus+ project:N-GeneS Compound heterozygous variant in NBAS as a case of N. Marinakis: None. C. Sofocleous: None. E. Tsoutsou: bone fragility by the type of osteogenesis imperfecta None. D. Veltra: None. M. Sviggou: None. J. Traeger- Synodinos: None. E. Fryssira: None. D. A. Petukhova1, E. Gurinova2, A. Sukhomyasova1,2, N. Maksimova1 E-P04.39 AnovelpathogenicvariantintheCHRNGgenelinkedto 1Research Laboratory “Molecular Medicine and Human Escobar variant of multiple pterygium syndrome Genetics”, Medical Institute, M. K. Ammosov North- Eastern Federal University, Yakutsk, Russian Federation, H. Kathom1, D. Avdjieva-Tzavella1, T. Delchev1, 2Medical Genetic Center, Republican Hospital №1 – S. Atemin2,3, T. Todorov3, A. Maver4, B. Peterlin4, «NationalMedicalCenter»,Yakutsk,RussianFederation V. Mitev2, A. Todorova2,3 Introduction: Biallelic mutations in the NBAS gene have 1University paediatric hospital "prof. Ivan Mitev", Soﬁa, been reported to cause three different clinical signs: short Bulgaria,2DepartmentofMedicalChemistryandBiochem- stature with optic nerve atrophy and Pelger-Huët anomaly istry, Medical University Soﬁa, Soﬁa, Bulgaria, 3Genetic (SOPH) syndrome, infantile liver failure syndrome 2 Medico-Diagnostic Laboratory “Genica”, Soﬁa, Bulgaria, (ILFS2) and a combined severe phenotype including both 4Clinical Institute of Medical Genetics, UMC Ljubljana, SOPH and ILFS2 features. Ljubljana, Slovenia MaterialandMethods:Here,wedescribeacaseofa6- year-old Yakut girl who presented with clinical signs of Introduction: Multiple pterygium syndromes (MPS) com- SOPH syndrome, acute liver failure (ALF) and bone prise a group of multiple congenital anomaly disorders fragility by the type of osteogenesis imperfecta (OI). characterized by webbing (pterygia) of the neck, elbows, Targeted panel sequencing for 494 genes of connective and/or knees and joint contractures (arthrogryposis)a. The tissuediseaseswasperformedonourpatient.Topredictthe multiple pterygium syndromes are phenotypically and protein-damaging effects of the suspected pathogenic genetically heterogeneous but are traditionally divided into variationsinNBAS,threedifferentsoftwareprogramswere prenatally lethal and nonlethal (Escobar) types. In this used: Polyphen-2, SIFT, MutationTaster. report we present a case of Escobar type MPS with novel Results:Themoleculargeneticstudyrevealedtheknown pathogenic variant in CHRNG. heterozygous variant c.5741G>A (p.Arg1914His) in 45 Materialsandmethods:Wepresenta25monthsoldgirl exonofNBAS.Also,in23exonofNBASwasidentiﬁeda from ﬁfth pregnancy with complications. She was born previously unreported missense heterozygous variantAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 839 c.2535G>T (p.Trp845Cys). Mutation affect evolutionarily parenttriosusingXHMM,CoNIFERandEXCAVATOR2. conserved amino acid residues and predicted to be highly Deﬁning XHMM as primary algorithm we established a damaging. ﬁltering pipeline considering sample wide frequency, de Conclusion: Timely health care of patients with such a novo status, calling intersection (CoNIFER and/or EXCA- setofclinical spectrumofSOPHsyndrome, ALFandbone VATOR2), annotation to RefSeq-genes, overlap with fragility can contribute to establishment coordinated multi- regions of segmental duplications and population fre- specialty management of the patient focusing on the health quency. CNVs were validated using qPCR. Three interest- problems issues through childhood. ingdenovoCNVswereidentiﬁed:A86kbdeletiononChr8 Grant:ThestudyissupportedbytheMinistryEducation inannsCL/Ppatient,a16MbdeletiononChr1inannsCPO and Science of Russian Federation (Project No. FSRG- patient, and an 877kb duplication on Chr2 in an nsCPO 2020-0014 “Genomics of Arctic: epidemiology, hereditary patient. Interesting candidate genes at these loci are LHX8, and pathology”). DLX1andDLX2,allsuggestedtocontributetocraniofacial D.A. Petukhova: None. E. Gurinova: None. A. Sukho- development:TargetedmutationsofLhx8inmiceleadtoan myasova: None. N. Maksimova: None. isolated cleft palate. In embryonic mice Dlx1 and Dlx2 are expressed in both the maxillary and the mandibular com- E-P04.43 ponent of the ﬁrst pharyngeal arches, and Dlx1/2-/- mutant Nonsyndromic orofacial clefts - Identifying putative mice exhibit a cleft palate. Our results indicate that rare causative genes by CNV analysis of whole exome highly penetrant CNVs can contribute nsCL/P and nsCPO sequencing data risk.Toachievemoreevidenceforourﬁndings,replication studies in larger patient/control cohorts are essential. S. Hölzel1, N. Ishorst1, C. Greve1, F. Degenhardt1, D. S. Hölzel: None. N. Ishorst: None. C. Greve: None. F. Drichel2, C. Maj3, M. Nothnagel2, J. Y. Hehir-Kwa4, J. A. Degenhardt: None. D. Drichel: None. C. Maj: None. M. Veltman4,5, T. Kruse6, H. Reutter1,7, S. Nowak1, C. Nothnagel: None. J.Y. Hehir-Kwa: None. J.A. Veltman: Carels8,9, I. van Rooij10, K. U. Ludwig1, E. Mangold1 None.T. Kruse:None.H.Reutter:None.S.Nowak:None. C. Carels: None. I. van Rooij: None. K.U. Ludwig: None. 1InstituteofHumanGenetics,UniversityofBonn,Schoolof E. Mangold: None. Medicine and University Hospital Bonn, Bonn, Germany, 2Cologne Center for Genomics, University of Cologne, E-P04.44 Cologne, Germany, 3Institute for Genomic Statistics and Glis3expressioninworkingmodelmurineosteoarthritis Bioinformatics,UniversityofBonn,SchoolofMedicineand University Hospital Bonn, Bonn, Germany, 4Departmentof E. Rothzerg Human Genetics, Donders Institute, Radboud University Medical Center, Nijmegen, Netherlands, 5Institute of University of Western Australia, Perth, Australia Genetic Medicine, Newcastle University, Newcastle-upon- Tyne, United Kingdom, 6Department of Orthodontics, Osteoarthritis (OA) is characterised by cartilage degrada- University of Cologne, Cologne, Germany, 7Department tion, hypertrophy and inﬂammation. Chondrocytes are the of Neonatology, Children’s Hospital, University of Bonn, only cells normally found in cartilage, producing and Bonn, Germany, 8Department of Human Genetics, KU maintaining the cartilaginous matrix. Chondrocyte hyper- Leuven,Leuven,Belgium,9Orthodontics,UniversityHospi- trophy is an essential process required for endochondral talsKULeuven,Leuven,Belgium,10DepartmentforHealth ossiﬁcation in mammals and it is also plays a role in the Evidence, Radboud Institute for Health Sciences, Radboud developmentofOA.Furthermore,geneticfactorshavebeen university medical center, Nijmegen, Netherlands found to be strong determinants of OA and are likely to operate via chondrocyte function. I previously identiﬁed Nonsyndromic cleft lip with/without palate (nsCL/P) and some novel candidate murine genes with a potential role in cleft palate only (nsCPO) are frequent congenital mal- OApathophysiology.However,oneofthecandidategenes, formations with high heritability estimates. Common risk Glis3, has showed a potential by expressed in hypertrophic loci explain only some of their heritability. Rare, highly chondrocytes in OA knee joints obtained from the colla- penetrant copy number variations (CNVs) encompassing borative cross mouse model, using immunohistochemistry. possiblecleftingsusceptibilitygenesmightpartiallyexplain In conclusion, this study has implicated several molecular the missing heritability. Aim of this study was to identify mechanism in the pathogenesis of cartilage degeneration, such genes by detecting de novo CNVs from whole-exome thus improving our understanding of OA and offering sequencing (WES) trio data. CNVs were called from WES potential molecular targets for novel therapeutic dataof50nsCL/Pand43nsCPOCentralEuropeanpatient/ approaches.840 J.delPicchia E. Rothzerg: None. E-P04.49 E-P04.47 Molecular genetic diagnostic in skeletal disorders - a AnovelhomozygousSLURP1variantinaboywithMal Western Romanian delineation de Meleda born to non-consanguineous parents I. E. Jurca- Simina1,2, A. Chirita-Emandi1,2, S. B. Gram1,2, J. Blechingberg3, K. Brusgaard1,2, N. Andreescu1,2, C. L. Șerban1,3, C. Zimbru1, M. Puiu1,2 A. Bygum4,2, L. B. Ousager1,2 1CenterofGenomicMedicineinVictorBabesUniversityof 1Department of Clinical Genetics, Odense University Medicine and Pharmacy, Timisoara, Romania, 2Depart- Hospital, Odense, Denmark, 2Department of Clinical ment of Medical Genetics, Louis Turcanu Emergency Research, University of Southern Denmark, Odense, Den- Hospital for Children, Timișoara, Romania, 3Functional mark, 3Department of Clinical Genetics, Aarhus University Sciences Department, University of Medicine and Phar- Hospital, Aarhus, Denmark, 4Department of Dermatology macy Victor Babes, Timișoara, Romania and Allergy Centre, Odense University Hospital, Odense, Denmark Introduction: Genetic skeletal disorders(GSD) represent a heterogeneous and large group, widening the more the Introduction: Mal de Meleda (MDM) is an autosomal sequencing technology thrives. We aim to contribute by recessive disorder characterized by transgredient hyperker- describing the regional Romanian cohort of patients with atosis and erythema of palms and soles with well-demar- GSD and their molecular features. cated borders. There might also be symptoms as Methods: The clinical workup was performed for each hyperhidrosis, macerations and malodour due to secondary affectedindividual.NGSwas performed using theIllumina bacterial infections. Associated perioral erythema, brachy- TruSight One (4813 genes) and TruSight Cardio (174 dactyly, scaly plaques on elbows and knees as well as nail genes) Sequencing Panels on MiSeq Illumina platform, as dystrophy has also been described. The disease presents by amplicon-based approach, but also PCR and Sanger early in childhood and has a progressive cause. MDM is were used. associated with variants in SLURP1. The HGMD database Results and discussions: 110 patients with GSD includes 23 different variants in SLURP1 related to MDM phenotypic component addressed the Genetics department or palmoplantar keratoderma. (July 2015–December 2019). 54.55% had conﬁrmed Material & methods: A 4-year-old boy presented with diagnosis, while 30.9% were tested negative for the anapproximatelytwo-yearhistoryoferythema,scalingand suspected disorder and 14.55% were not tested. 10% were diffuse, yellowish, transgredient keratoderma of palms and found with variants of uncertain signiﬁcance, needing soles.Hehadassociatedinterdigitalmacerations,dystrophia further testing. According to the Mortier’s et al. 2019 ofseveralnailsandrecurrentfungalandbacterialinfections. revision of nosology and classiﬁcation of GSD, we have He was born as the second child of non-consanguineous foundthefollowingcategoriesofdisorders:25%ofpatients parents and there was no family history of similar skin with overgrowth syndromes with skeletal involvement disease. The parents were from families living in different (Marfan, Loeys-Dietz, Congenital contractural arachnodac- regionsofDenmark.Genetictestingwasperformedusinga tyly), 10% with lysosomal storage diseases with skeletal next-generation sequencing-based gene panel targeting 28 involvement (Mucopolysaccharidosis), 5% with Limb genes related to palmoplantar keratoderma. hypoplasia–reduction defects group (Fanconi anemia and Results: A homozygous nonsense variant was identiﬁed Cornelia de Lange), 4% with Osteogenesis imperfecta and in SLURP1 (c.259del, p.(Ala87Profs*4)). The variant, decreased bone density, 2% with Brachydactylies with predicted to result in a premature stop codon, has not extraskeletal manifestations (Cofﬁn Siris) and unique previously been reported. A more distal frameshift variant patients in other several disorders like Spondyloperipheral has, however, been reported as disease-causing supporting dysplasia, Atelosteogenesis type 3, Chondroectodermal interpretation of the variant as likely pathogenic. The dysplasia, Asphyxiating thoracic dysplasia, etc. parents were heterozygous for the variant. Conclusion: Skeletal disorders are rare entities needing Conclusion: We identiﬁed a novel homozygous variant proﬁcient clinical and imagistic workup to reach diagnosis. in SLURP1 in a Caucasian boy with MDM, who was born We provide our Center’s diagnostic yields in GSD together to non-consanguineous parents. withparticularitiesanddiscussionsonourcohortofpatients. S.B. Gram: None. J. Blechingberg: None. K. Brusgaard: I.E.Jurca-Simina:D.SpeakersBureau/Honoraria(speak- None. A. Bygum: None. L.B. Ousager: None. ers bureau, symposia, and expert witness); Modest; Sanoﬁ. Other; Modest; Sanoﬁ, Takeda. A. Chirita-Emandi: Other;Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 841 Modest; Sanoﬁ, Takeda. N. Andreescu: Other; Modest; E-P04.51 Sanoﬁ, Takeda. C.L. Șerban: None. C. Zimbru: None. M. Further clinical and molecular delineation of spondylo- Puiu: Other; Modest; Sanoﬁ, Takeda. costal dysostosis type 3 E-P04.50 S. L. Schuhmann1, H. Koller2, H. Sticht3, C. Kraus1, M. A case report of a patient diagnosed with two skeletal Krumbiegel1, S. Uebe1, A. Ekici1, A. Reis1, C. T. Thiel1 dysplasias: osteogenesis imperfecta and pseudoachondroplasia 1Institute of Human Genetics, Friedrich-Alexander-Univer- sität Erlangen-Nürnberg FAU, Erlangen, Germany, 2Klini- L. Kievisiene1, M. Sukys1, R. Traberg1, R. Simonaityte2, kum rechts der Isar, Technische Universität München, V. Asmoniene1 Munich, Germany, 3Institute of Biochemistry, Friedrich- Alexander-Universität Erlangen-Nürnberg FAU, Erlangen, 1Department of Genetics and Molecular Medicine, Lithua- Germany nian University of Health Sciences, Kaunas, Lithuania, 2DepartmentofPediatricSurgery,LithuanianUniversityof Spondylocostal dysostosis (SCDO) is a heterogeneous Health Sciences, Kaunas, Lithuania group of rare spine disorders deﬁned by multiple vertebral segmentation defects and rib anomalies. Patients present Wepresentacasereportofa7yearsoldboy,theonlychild with shortenedtrunk inproportion toheightand signiﬁcant born to a man with osteogenesis imperfecta (OI) and a scoliosis. Seven subtypes of SCDO have been identiﬁed woman suspected to have pseudoachondroplasia, later on based on deleterious variants in one affected gene each conﬁrmed to have COMP gene pathogenic heterozygous (DLL3, MESP2, LFNG, HES7, TBX6, RIPPLY2, DMRT2), variant(c.1393G>C,p.Gly465Arg).Sincebirth,patienthad of mostly autosomal recessive inheritance. Most subtypes seven spontaneous fractures, predominantly in the lower include only few cases, like SCDO3 (LFNG) where only limbs. At the age of seven the patient exhibited dis- two affected individuals are reported to date with a total of proportionately short-limb short stature with height mea- three variants. sured96cm;<3rdpercentile.Thepatienthadbrachydactyly Inalargestudyongeneticcausesofskeletaldysplasiawe and ligamentous laxity with deformity of the lower limbs. recognized a 17-year-old individual from healthy consan- He also had characteristic radiological changes of pseu- guineous parents with severe vertebral segmentation doachondroplasia: short tubular bones with widened and defects, rib and further non skeletal anomalies including deformedmetaphysesandvertebralanomalies.Dualenergy solitary pelvic kidney, uterine dysgenesis, absence epilepsy x-rayabsorptiometrydetectedosteoporosis.Nextgeneration and inner ear deafness. Performing WES we identiﬁed a sequencing was performed for the patient, OI genes and homozygous missense variant c.59C>T, p.(Thr20Ile) in COMP gene known familial variant were analysed. It con- LFNG,neitherpreviouslydescribedinSCDO3patients,nor ﬁrmed the same pathogenic variant of COMP gene and in listedingeneticdatabases.Bothparentswereheterozygous. COL1A2 gene two heterozygous variants were found The variant is predicted to destabilize a hydrogen bond (c.2317C>T, p.Pro773Ser and c.2329_2331delCGT, p. leading to an impairment of protein function, likewise Arg777del). The former was considered to be variant of previously described variants inactivating the protein with uncertain signiﬁcance because in silico predictors assessed altered Notch signaling. it as benign, while the latter was assigned to be likely While the two previously reported cases had isolated pathogenic because computational predictors assessed it as skeletal anomalies the here reported individual presented pathogenic. None of these variants were described in with various additional symptoms. As no other variants populationdatabases.BothofCOL1A2variantswerefound were identiﬁed neither in the exome nor in CMA we in father’s COL1A2 gene, meaning that they locate in the hypothesize that the phenotypic spectrum of this syndrome same allele.It remains unclearif these variants are disease- canbemuchbroader,perhapsdependingonthelocalization causing since neither of fathers’ family members were and nature of the affected variant, although we cannot affected with OI. Therefore, further sequencing of father’s exclude a blended phenotype due to an undetected ﬁrst-degreefamilymemberswillbeperformedtoconﬁrmif additional variant. these variants are truly de novo. S.L. Schuhmann: None. H. Koller: None. H. Sticht: L.Kievisiene:None.M.Sukys:None.R.Traberg:None. None. C. Kraus: None. M. Krumbiegel: None. S. Uebe: R. Simonaityte: None. V. Asmoniene: None. None. A. Ekici: None. A. Reis: None. C.T. Thiel: None.842 J.delPicchia E-P04.52 M. van den Born1, M. Joosten1, P. Schut1, J. Cornette1, First reported case of Steel syndrome in the European A. van der Hout2, G. Mortier3 population: a novel homozygous mutation in COL27A1 1Erasmus MC, Rotterdam, Netherlands, 2University Medi- E. Kritioti1,2,3, A. Theodosiou1, N. Nicolaou2, A. calCentreGroningen,Groningen,Netherlands,3University Alexandrou1, I. Papaevripidou1, E. Efstathiou4, V. of Antwerp, Antwerp, Belgium Christophidou-Anastasiadou5, C. Sismani1,3, G. A. Tanteles2 Todiagnoseaspeciﬁclethalskeletaldysplasiapurelybased on ultrasound data can be quite challenging in a prenatal 1Cytogenetics and Genomics Department, The Cyprus setting. However, molecular testing of fetal DNA in com- Institute of Neurology and Genetics, Nicosia, Cyprus, bination with radiographic evaluation and autopsy post- 2Clinical Genetics Department, The Cyprus Institute of delivery usually allows the clinician to come up with a Neurology and Genetics, Nicosia, Cyprus, 3The Cyprus speciﬁcdiagnosis.Wereportacaseofplatyspondyliclethal School of Molecular Medicine, The Cyprus Institute of skeletal dysplasia, Torrance type (PLSD-T) that was initi- Neurology and Genetics, Nicosia, Cyprus, 4Pediatric ally diagnosed as achondrogenesis type 1A. Advanced Department, Larnaca General Hospital, Larnaca, Cyprus, ultrasound at 20 weeks of gestation showed, in addition to 5Clinical Genetics Department, Archbishop Makarios III generalizededema,shortenedandcurvedlongboneswitha Medical Centre, Nicosia, Cyprus thoracic–ACratioof0.68.At29weeksofgestation amale neonate was born who died directly after birth. Achon- Steel syndrome is an autosomal recessive disorder that drogenesis type 1A was initially suggested based on the primarily affects the skeletal system causing a variety of ultrasound abnormalities and clinical examination post- manifestations. Sixteen individuals with Steel syndrome, natally. Radiographs showed skeletal abnormalities remi- mainly Puerto Ricans (11/16), were previously reported to niscentofachondrogenesistype1A:severemicromeliawith carry bi-allelic mutations in the COL27A1 gene. Here, we ﬂared and cupped metaphyses, relatively large head, short present the ﬁrst patient with Steel syndrome in Europe and ilia and delayed vertebrae ossiﬁcation. All genes (TRIP11, the sixth non-Puerto Rican carrying a novel homozygous SLC26A2 and COL2A1) causing the different forms of mutationinCOL27A1.Thepatientisa4-year-oldboyborn achondrogenesis (IA;IB;II) were sequenced. In TRIP11, to non-consanguineous healthy parents, with dysmorphic only heterozygosity for a class 3 variant was identiﬁed and facial features, absent hip ossiﬁcation centres, external no variant could be identiﬁed on the other allele. However, rotation of both feet, relatively short stature, mild skin aclass4variantp.(lle1389dup),inCOL2A1wasidentiﬁed syndactyly, short mid phalanges and bilateral sensorineural in the portion coding for the C-propeptide of type II col- hearing loss. Whole exome sequencing (WES) revealed a lagen. This ﬁnding led to the diagnosis of PLSD-Torrance novel homozygous missense variant [chr9.hg:19: type. This case demonstrates the phenotypical overlap g.116982108G>A; c.2409G>A; p.(Gly802Glu)] in between achondrogenesis type 1A and Torrance dysplasia. COL27A1(NM_032888.4).Thehomozygousmutationwas M. van den Born: None. M. Joosten: None. P. Schut: conﬁrmed by Sanger sequencinginthe proband and carrier None. J. Cornette: None. A. van der Hout: None. G. status was conﬁrmed in both parents and his unaffected Mortier: None. sibling. According to online and in-house minor allele fre- quency (MAF) databases, this is the ﬁrst COL27A1 muta- E-P04.55 tion reported in the European population. Additional Novel variant in the EZH2 gene causing Weaver screening of healthy Greek-Cypriot individuals was thus syndrome performed, which did not reveal any additional carriers in the population for the variant in question. E. M. Vaiteniene1, L. Cimbalistiene1,2, G. Zukauskaite1, E. Kritioti: None. A. Theodosiou: None. N. Nicolaou: A. Utkus1 None. A. Alexandrou: None. I. Papaevripidou: None. E. Efstathiou:None.V.Christophidou-Anastasiadou:None.C. 1Department of Human and Medical Genetics, Institute of Sismani: None. G.A. Tanteles: None. Biomedical Sciences, Faculty of Medicine, Vilnius Uni- E-P04.53 versity, Vilnius, Lithuania, 2Centre for Medical Genetics, Platyspondylic dysplasia, Torrance type resembling Vilnius University Hospital Santaros Klinikos, Vilnius, achondrogenesis type 1A LithuaniaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 843 Background: Overgrowth syndromes frequently share Obstetrics and Gynaecology, Erasmus MC, University overlapping manifestations and are difﬁcult to diagnose Medical Center Rotterdam, Rotterdam, Netherlands based on clinical features. Accurate diagnosis is important for prognosis and correct tumour surveillance program and Introduction: X-linked dominant chondrodysplasia punc- can be achieved with next-generation sequencing. tata (CDPX2) is an inherited condition present almost Results: A 4-year-old girl presenting with excessive exclusively in females, characterized by skeletal dysplasia, growthofprenatalonset,advancedboneage,macrocephaly, skin defects and congenital cataracts and caused byheter- development delay, intellectual disability, generalized sei- ozygous pathogenic variants in the EBP gene. Prenatal zuresandpeculiarfacewasreferredtoourclinic.Shewasa ultrasound diagnosis has been reported in some cases after third child in a healthy non-consanguineous family, born detection of asymmetric shortening of the long bones with prematurely at36weeksgestationwith birthweight3100 g cartilagestippling,representingfociofcalciﬁcation,usually and height 58 cm. Her karyotype revealed interstitial in the second trimester of pregnancy. inversion46,XX,inv(X)(p22;q28)whichwasinheritedfrom Materials and methods: A female fetus was diagnosed herhealthymother.Nopathogenicvariantswereobservedin with asymmetric bilateral short long bones and stippling of theNSD1gene.Attheageof22years,herheightis195cm, theproximalepiphysesofthehumerusbyprenatalultrasound weight140kg;limitedshoulder,elbowandwristmovement, examinationat21weeksofgestation.Absenceofnasalbones kyphosis, hypertrophic soft tissue around knees were wasalsoobservedpreviouslyat13weeks.Amniocentesiswas observed besides previously mentioned features. Her IQ performed for molecular analysis through array CGH and a score is 40. Next-generation sequencing for known over- 531 genes NGS panel for skeletal dysplasia. The pregnancy growth conditions revealed a novel missense heterozygous was terminated at 23weeks of gestation. Fetal gross EZH2 mutation c.373G>A (NM_004456.4:c.[373G>A]; examination, postnatal X-rays and steroid chromatography [373=], NP_004447.2:p.(Glu125Lys) within exon 5. Based in amniotic liquid were performed to assist in the diagnosis. on 11 in silico tools of pathogenicity prediction detected Results:TheNGSskeletaldysplasiapanelidentiﬁedade variant was characterized as pathogenic. In addition to the novo heterozygous missense variant c.388G>A p. typical ﬁndings of Weaver syndrome, our patient has (Gly130Arg), in the EBP gene. This variant was not polythelia, atrial septal defect and lumbar spinal stenosis. reportedintheliteraturenoringnomADorotherdatabases Conclusion: An increasing number of diagnoses with and in silico analysis predicts it as likely pathogenic. next-generation sequencing helps to gather more phenoty- Conclusions: To our knowledge this is a novel EBP pic information, improve management and surveillance of pathogenic variant, albeit missense variants changing the overgrowth syndromes. This example also highlights the same Gly130 have been previously associated to CDPX2. importance of periodic case reviews for patients not CDPX2 should be a diagnosis to bear in mind when short diagnosed on initial testing as more information becomes fetal long bones and stippling are present in second available in the medical literature. trimester of pregnancy. E.M. Vaiteniene: None. L. Cimbalistiene: None. G. M.N. Laço: None. M. Branco: None. M. Joosten: None. Zukauskaite: None. A. Utkus: None. P. DeKoninck: None. E. Galhano: None. F. Ramos: None. E-P04.56 E-P05 Cardiovascular Disorders Novel pathogenic variant inEBPgene is associated to X-linked dominant chondrodysplasia punctata in a E-P05.01 female fetus. A new missense variant in ABCA1 gene, p.Ala2058Gly, in a myocardial infarction patient. M. N. Laço1,2,3, M. Branco4, M. Joosten5, P. DeKoninck6, E. Galhano4, F. Ramos1,4 R. Pan-Lizcano1, L. Nunez1, P. Pinon2, X. Flores2, G. Aldama2, R. Calvino2, N. Blanco-Menendez1, 1Medical Genetics Unit, Hospital Pediátrico, Centro N. Vazquez-Gonzalez3, J. M. Vazquez-Rodriguez3, HospitalareUniversitáriodeCoimbra,Coimbra,Portugal, M. Hermida-Prieto1 2Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 3Faculty of Health Sciences, University of Beira 1Cardiology Research Group. Instituto de Investigación Interior, Covilhã, Portugal, 4Prenatal Diagnosis Center, Biomédica de A Coruña (INIBIC)-CHUAC-UDC, A Maternidade Bissaya Barreto, Centro Hospitalar e Uni- Coruña, Spain, 2Department of Cardiology, Complexo versitário de Coimbra, Coimbra, Portugal, 5Department of Hospitalario Universitario A Coruna (CHUAC)-INIBIC, A ClinicalGenetics,ErasmusMC,UniversityMedicalCenter Coruña, Spain, A Coruña, Spain, 3Department of Cardiol- Rotterdam, Rotterdam, Netherlands, 6Department of ogy, Complexo Hospitalario Universitario de A Coruña844 J.delPicchia (CHUAC)-CIBERCV, Instituto de Investigación Biomédica deACoruña(INIBIC),UniversidaddeACoruña(UDC),A Many ACTA2 missense variants are associated with Coruña, Spain aortic dissection but their role is still controversial. We describe a 53 year old male proband with a history of Background: Acute myocardial infarction (AMI) is a sudden death (maternal grandmother) and thoracic aortic complex multifactorial and polygenic disorder that leads aneurysminthefather.Theprobandbicycled regularlyand the causes of death in Western societies. However, experiencedabortedcardiacarrestattheageof52duringa the understanding of the genetic contribution to ischemic normal daylight activity. ECG showed transient ischemic heart diseases is very limited. It has been suggested that patterns with increased troponin-T values. A CT scan variants in genes related to pathways involved in athero- demonstratedatypeAaorticdissection(AD)notinvolving thrombosis could increase the risk of development cardiac coronary arteries, surgically corrected without complica- events. tions. During the follow up, occasional seizures were Methods: Genetic variants in 24 genes which encoded observed,successfullytreatedwithLevetiracetam.Ajmaline proteins related to pathways involved in atherothrombosis challengetestresultednegative,noarterialtortuosityneither wereanalyzedbynextgenerationsequencingin24patients signs of intracranial vessel involvement have been demon- with AMI. Mutation found was conﬁrmed by Sanger strated byAngio MRI.Theproband wasstudiedwith NGS sequencing.Visualizationofthemutationusingpdbviewer including panels for Brugada syndrome, LQTS and AD and in silico prediction of the effects produced by the genes. Only the c.1004C>T (p.Pro335Leu) heterozygous mutation(MutationTester,SNAP2,SIFT2,Polyphen,PhD- missense variant in the ACTA2 gene was found. Proband’s SNP) were performed. only daughter is asymptomatic, negative at clinical eva- Results: In one patient, p.Ala2058Gly was identiﬁed in luation and does not carry the paternal variant. No other ABCA1 gene that encodes the ATP-binding cassette relatives are available to date. The c.1004C>T (p.Pro335- transporter 1, which is crucial in the initial step of high- Leu)intheACTA2geneispredictedtobe“pathogenic”by density lipoprotein (HDL) formation and in reverse several bioinformatics tools, but to date its clinical sig- cholesterol transport. All the in silico tools used suggested niﬁcance is still uncertain. This case suggests the impor- a pathological role of this variant. tance to consider clinical history in VUS evaluation for Conclusion: Our results are in concordance with speciﬁc conditions. Further studies are required to clarify previously reports that associated different variants in the role of ACTA2 missense variants in type A aortic ABCA1 gene with an increased risk of coronary artery dissections. disease and ischemic heart disease. Thus, mutations E.Micaglio:None.S.Benedetti:None.S.Marelli:None. in ABCA1 gene could have a role in the development of A.G.Pini:None.R.Cotugno:None.M.M.Monasky:None. AMI. Funding Acknowledgements: This work was G. Ciconte: None. P. Carrera: None. C. Pappone: None. supported by a grant from Instituto de Salud Carlos III (PI18/01737) and a non-conditional grant from Abbott E-P05.03 Vascular. Molecular diagnosis of primary hypoalphalipoproteine- R. Pan-Lizcano: None. L. Nunez: None. P. Pinon: None. mia disease by Next Generation Sequencing X. Flores: None. G. Aldama: None. R. Calvino: None. N. Blanco-Menendez: None. N. Vazquez-Gonzalez: None. J. E. Sevilla, C. Rodríguez Jiménez, J. Sanguino, A. Carazo, M. Vazquez-Rodriguez: None. M. Hermida-Prieto: None. V. Fernández-Montaño, I. Rueda-Arenas, F. Arrieta, S. Rodríguez-Nóvoa E-P05.02 VUS or non VUS in ACTA2? INGEMM, Madrid, Spain E. Micaglio1, S. Benedetti2, S. Marelli3, A. G. Pini3, Introduction: Hypoalphalipoproteinemia primary 2 (# R.Cotugno1,M.M.Monasky1,G.Ciconte1,P.Carrera2,C. 618463), is generally an autosomal recessive disorder Pappone1 associatedwithextremelylowlevelsofapoA-IandHDL-C in serum and, in most of the patients, premature athero- 1Arrhythmology and Clinical Electrophysiology, IRCCS sclerotic cardiovascular disease, xanthomas and corneal Policlinico San Donato, San Donato Milanese, Italy, opacities1.Currently,30familieshavebeendescribed.This 2Laboratory of Clinical Molecular Biology and Cytoge- disease is caused by pathogenic variants in APOA1 gene netics, IRCCS Ospedale San Raffaele, Milan, Italy, 3Car- (MIM107680)thatcodefortheApolipoproteinA-I(apoA- diovascular Genetics, IRCCS Policlinico San Donato, San I), the major structural component of HDL. Herein we Donato Milanese, ItalyAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 845 report a case of a male with suspicious of METABOL-v2 of 411 genes. LDL isolated from patient hypoalphalipoproteinemia. and the control were incubated with HepG2 cells. Uptake Materials and methods: A 58-year-old woman with and binding were measured by ﬂow cytometry in order to xanthomas, corneal clouding and familial history of determine the impact of APOB variant. isquemic cardiopathy, was remitted to our service for Results: A variant of unknown signiﬁcance (VUS) was genetic testing. The patient had extremely low levels of found in APOB_exon26_ NM_000384.2:c.11401T>A;p. apoA-I (<16.0 mg/dL) and HDL-C (6 mg/dL) in serum. (Ser3801Thr) in silico study showed damaging and Genesinvolvedincholesterolmetabolismwereanalyzedby conservation. However the LDL isolated of patient had NextGenerationSequence(NGS)usingacustomizedpanel thesame impact inuptake andbinding inLDLR ofHepG2 of 411 genes related with metabolic diseases. cells that the LDL isolated of control. Results: The frameshift mutation APOA1_NM_ Conclusions: This variant had conﬂict in the interpreta- 000039.2:c.85dupC;p.(Gln29Profs*29)wasfoundinhomo- tion of results in ClinVar has been classiﬁed as benign and zygosis in the patient resulting a truncated apoA-I. In as VUS. It is well known that exon 26 is critical in folding silico analysis showed damaging and conservation for this of APOB protein also, in silico analysis reﬂected impact in variant. Sanger sequencing conﬁrmed the variant found the variant. The functional characterization of variant in in APOA1. APOB has allowed us to classify it as benign avoiding the Conclusions: This variant c.85dupC;p.(Gln29Profs*29) “uncertain signiﬁcance”. has been previously described as a cause of ApoA1 References deﬁciency2. ApoA-I deﬁciency is generally associated with 1-Miserez,A.R.andKeller,U.(1995)Differencesinthe markedly increased risk of atherosclerotic cardiovascular phenotypic characteristics of subjects with familial defec- disease.However,inthisstudyweidentiﬁedahomozygous tive apolipoprotein B-100 and familial-hypercholesterole- frameshift mutation of the APOA1 gene as the molecular mia. Arterioscler. Thromb. Vasc. Biol, basis of apoA-I deﬁciency ina 58-year-old womanwithout C. Rodriguez Jimenez: None. D. Gómez-Coronado: isquemic cardiopathy. A familiar study would be required None. J. Sanguino: None. E. Sevilla: None. A. Carazo: for a better understanding of this rare disease-causing None. N. Gallego-Onís: None. V. Gómez del Pozo: None. mutation. F. Arrieta: None. S. Rodríguez-Nóvoa: None. E. Sevilla: None. C. Rodríguez Jiménez: None. J. Sanguino: None. A. Carazo: None. V. Fernández- E-P05.05 Montaño: None. I. Rueda-Arenas: None. F. Arrieta: None. Phenotype-genotypecorrelationinRussianpatientswith S. Rodríguez-Nóvoa: None. arrhythmogenic right ventricular cardiomyopathy E-P05.04 A. Shestak1, A. Bukaeva1, O. Blagova2, Y. Lutokhina2, Study functional in APOB in HepG2 from patient with M. Polyak1, S. Dzemeshkevich1, E. Zaklyazminskaya1 Familial Hypercholesterolemia. 1Petrovsky National Research Center of Surgery, Moscow, C. Rodriguez Jimenez1, D. Gómez-Coronado2, Russian Federation, 2The Department of Cardiology of the J. Sanguino1, E. Sevilla1, A. Carazo1, N. Gallego-Onís1, V.N. Vinogradov Faculty therapeutic clinic, I.M. Sechenov V. Gómez del Pozo1, F. Arrieta1, S. Rodríguez-Nóvoa1 First Moscow State Medical University, Moscow, Russian Federation 1INGEMM, Madrid, Spain, 2Hospital Ramón y Cajal, Madrid, Spain Arrhythmogenic right ventricular cardiomyopathy (ARVС) is an inherited disease leading to ﬁbro-fatty Introduction: Familial defective apoB100 (FCHL2, # replacement of right ventricle and sudden cardiac death. 144010) is a genetic disorder of LDL metabolism char- Identiﬁcation of mutation(s) in causative genes is one of acterized by hypercholesterolemia and premature athero- themajordiagnosticcriteriaofARVC.Methods:Clinical, sclerosis. FCHL is caused by heterozygous mutation in the instrumental examination, medical and genetic counseling APOB gene. APOB is the ligand for the LDLreceptor and wereperformedfor70ARVCprobands(meanage41,9y. there are some essential residues that are decisive for the o.). Screening of 16 genes was performed by high- APOB-LDL receptor afﬁnity1. throughput semiconductor sequencing combined with Materials and methods: A 56-year-old man with raised Sanger sequencing. Potential role of genetic variants was levels of LDL-c in serum, with family history and evaluated according to ACMG criteria. Mutational spec- premature coronary artery disease. The DNA sample from trumofdesmosomalandnon-desmosomalgenesinARVC patient was analysed by NGS using a customized panel probandswasstudiedincomparisonwithcontrolgroupof846 J.delPicchia 46 DCM probands. Results: Deﬁnite, borderline or pos- respectively.TheACEIDandMTHFRC677Tpolymorph- sibleARVCdiagnosisbasedontheTaskForceCriteriaof isms were genotyped using PCR based methods. Statistical 2010 was established for 70 probands. Some patients in tests were conducted with StatsDirect. The signiﬁcance of our cohort had signs of dilated/restrictive cardiomyopathy the differences in observed frequencies of polymorphisms (N=17), LVNC (N=10), BrS patterns (N=4). Likely was assessed by chi-squared test (p<0.05). The distribution pathogenic genetic variants and VUCSes were identiﬁed of the genotypes in all lots respects Hardy Weinberg in46%ofARVCprobandsindesmosomal(PKP2,DSG2, equilibrium condition. DSP, DSC2, JUP) and non-desmosomal (LMNA, SCN5A, Results: Signiﬁcant associations were detected between MYH7, MYBPC3, TTN, FLNC, LDB3) genes. Mutational HA and the ACE DD (OR=1.44, p=0.0007) and MTHFR spectrum of genes in ARVC probands with a pre- TT (OR=1.46, p=0.0009). The ACE D allele was dominance of variants in desmosomal genes (64%) was associated with earlier onset of AH in patients with AH different from one in the DCM control group. (p=0.00005). ACE DD (OR=1.88, p=0.0006), ACE D Genetic variants in non-desmosomal genes prevailed in (OR=1.92, p<0.0001), and MTHFR TT (OR=2.28, patients with ARVC overlapping phenotypes. Conclu- p<0.0001) were signiﬁcantly associated with AH among sion: Likely pathogenic genetic variants and VUCSes subjects whose parents also have AH. Smoking subjects were identiﬁed in 46% of ARVC probands. Identiﬁcation with MTHFR TT genotype (OR=1.68, p=0.0004) and of mutations in desmosomal and non-desmosomal genes those heterozygous (OR=1.46, p=0.0002) or homozygous in addition to the deep phenotyping results allowed us to (OR=1.62,p=0.0005)forACEDpresentedhigherriskfor study the genetic heterogeneity of ARVC. This work was AH. ACE DD and alcohol consumption predispose to AH supported by Russian Science Foundation grant №16-15- (OR=5.6, p=0.0004). 10421. Conclusions:ThisstudysuggeststhatACEandMTHFR A.Shestak:None.A.Bukaeva:None.O.Blagova:None. genes are associated with AH in the studied population. Y. Lutokhina: None. M. Polyak: None. S. Dzemeshkevich: C. Barbarosie: None. R. Nica: None. O. Aparcioaie: None. E. Zaklyazminskaya: None. None. A. Duca: None. P. Apostol: None. O. Alexiu-Toma: None.I.Radu:None.R.Sionel:None.M.Toma:None.D. E-P05.06 Cimponeriu: None. S. Nica: None. Testing the association between ACE ID and MTHFR C667T gene polymorphisms and arterial hypertension E-P05.08 in the Caucasian population A novel EMD mutation in patient with dilated cardiomyopathy C. Barbarosie1, R. Nica2, O. Aparcioaie1, A. Duca1, P. Apostol3, O. Alexiu-Toma1, I. Radu1, R. Sionel1, L.Piherova1,P.Melenovska1,V.Baresova1,J.Sovova1,D. M. Toma2, D. Cimponeriu1, S. Nica4 Musalkova1, J. Sikora1, H. Hartmannova1, K. Hodanova1, T. Schimerova2, M. Kubanek2, S. Kmoch1 1Faculty of Biology, University of Bucharest, Bucharest, Romania,2CentralMilitaryUniversityEmergencyHospital 1RURD, Prague 2, Czech Republic, 2IKEM, Prague 4, "Dr. Carol Davila", Bucharest, Romania, 3Genetic Expert Czech Republic Center, Sante Clinic, Bucharest, Romania, Bucharest, Romania, 4Bucharest Emergency University Hospital, Emery-Dreifus muscular dystrophy is an inherited degen- Bucharest, Romania erative myopathy. One of the earliest manifestation of this disorders are muscle contractures causing joint deformities. Introduction: Genetic polymorphisms of various genes Almost all patients with Emery-Dreifuss muscular dystro- play a signiﬁcant role in the predisposition for arterial phy develop abnormalities in heart rhythm, such as atrial hypertension(AH).Therelationbetweenseveralgenes and ﬁbrillation, bradycardia, syncope, heart failure or an AH have been investigated in different populations but increased risk of sudden death. Among Emery-Dreifuss X- results were inconsistent and inconclusive. The aim of this linkedmyopathybelongsdegenerativemyopathycausedby study was to evaluate whether polymorphisms in two can- mutation in EMD gene. Emerin is a member of the nuclear didate genes are associated with AH in Romania’s adult lamina-associated protein family and with other proteins Caucasian population. takes part in membrane anchorage to the cytoskeleton. Materials and methods: We analysed data from 1660 Emerin is a serine-rich protein and composed of three unrelated Romanian Caucasian subjects (835 with AH and domains: nucleoplasmic domain, transmembrane domain 825 normotensive). The average age of the hypertensive and short lumenal domain. More than 100 mutations are patients and controls were 54.66±4.30 and 47.73±4.05, known in EMD gene but only one in lumenal domain. WeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 847 present a patient diagnosed with Emery-Dreifuss muscular berelatedtoMI.Polymorphismsinthoseclockgenesmight dystrophyanddilatedcardiomyopathycausedbynewEMD beanadditionalriskfactorformyocardial infarction.Grant gene mutation at the luminal domain and its biological no. FDMZ-2019-IP8 consequences. LM201509 NCLG, AZV 15-27682A, SVV- I. Škrlec: None. J. Milić: None. R. Steiner: None. 260367, NV19-08-00122 L. Piherova: None. P. Melenovska: None. V. Baresova: E-P05.12 None. J. Sovova: None. D. Musalkova: None. J. Sikora: Genetic components of congenital heart defects in None. H. Hartmannova: None. K. Hodanova: None. T. children Schimerova: None. M. Kubanek: None. S. Kmoch: None. V. Galagan1,2, A. Dorokhina2,1, M. Tsyhankova1, E-P05.10 S. Kulbalaieva1, Y. Dudierina2, V. Samilyk2 The inﬂuence of the circadian genes CLOCK and ARNTL on myocardial infarction 1National children’s specialized hospital «OKHMATDYT» of Ministry of Health of Ukraine, The Center of Medical I. Škrlec1, J. Milić2, R. Steiner3,2 Genetics, Kyiv, Ukraine, 2O.O. Bogomolets’ National Medical University, Kyiv, Ukraine 1Hystology, Genetics, Cellular and Molecular Biology Laboratory, Faculty of Dental Medicine and Health, Josip Introduction:Amongcongenitalmalformationsinchildren Juraj Strossmayer University of Osijek, Osijek, Croatia, thegreatestnumberistakenbydefectsofthecardiovascular 2Faculty of Medicine Osijek, Josip Juraj Strossmayer system. According to Ukrainian and foreign researchers, University of Osijek, Osijek, Croatia, 3Clinical Department congenital heart defects (CHD) occur at an average fre- of Cardiovascular Diseases and Intensive Care, Clinic for quency of 59-60 per 10000 newborns. The purpose of this Internal Medicine, University Hospital Osijek, Osijek, study was to determine the frequency ofCHD in newborns Croatia and genetic components of this pathology in Kyiv. Materials and methods: The following methods were Introduction: The circadian rhythm regulates various used in this work: clinical-genealogical, cytogenetic physiological mechanisms, and its disruption can promote including cytomolecular (FISH), biochemical (TMS) and manydisorders.Manycardiovasculareventsshowmorning conventional clinical and instrumental methods. circadian preferences, such as myocardial infarction (MI), Results:ThefrequencyofisolatedCHDinnewbornswas dissection of aortic aneurysms, and stroke. Disturbance of determined based on medical-genetic counseling (MGC) endogenous circadian rhythms enhances the chance of MI, practice at the Specialized Center of Medical Genetics in showing that circadian clock genes could have a crucial Kyiv.In2018thefrequencywas90per10000livebirths,in functionintheonsetofthedisease.Itwashypothesizedthat 2019- 93 per 10000. All cases were conﬁrmed by the polymorphisms of one nucleotide (SNP) in two circa- cardiologist-ultrasound-diagnostics at specialized cardiac dian rhythm genes (CLOCK and ARNTL) could be asso- centers and maternity hospitals. During the study period ciated with MI. (2018-2019) the weighted percentage of an isolated CHD Materials and methods: This case-control study was was 53% among all congenital malformations in live births performed on 1057 participants. The sample included 431 in Kyiv. Analysis of genetic components including patients (243 males, 188 females) of Croatian origin with syndromes of various forms of the CHD (2018-2019), ﬁrst non-fatal acute myocardial infarction and 626 participants discovered during MGC, showed that the causes of the inthecontrolgroupwithoutMI.ThreeSNPswereanalyzed CHD were due to chromosomal pathology- 52%, isolated in CLOCK (rs13124436, rs6811520, and rs11932595), and forms- 24%, genetic pathology- 13%, undifferentiated three in the ARNTL gene (rs12363415, rs4757144, and multiple malformations- 11%. rs3789327). Conclusions: Every child with a validated form of the Results:Statisticallysigniﬁcantdifferences,estimatedby CHD should pass the MGC and screening at a specialized the chi-square test, were found in the distribution of alleles genetic institution to eliminate syndromal forms, calculate and genotypes between MI and no-MI groups of the various genetic risks for the family and prevent them. The CLOCK (rs6811520 and rs13124436) and ARNTL mean frequency of isolated CHD in newborns is 92 per (rs3789327 and rs12363415) genes. Some of the tested 10000 in Kyiv. SNPswereassociatedwithcardiovascularriskfactorsinMI V.Galagan:None.A.Dorokhina:None.M.Tsyhankova: patients. None. S. Kulbalaieva: None. Y. Dudierina: None. V. Conclusion:Accordingtotheresultsofthepresentstudy, Samilyk: None. thepolymorphismsintheCLOCKandARNTLgenescould848 J.delPicchia E-P05.15 Hadjidekova1,S.Mehrabian5,M.Petrova5,L.Traykov5,D. Genomicmarkersinthedeterminationoflong-termrisk Toncheva1,2 in patients with stable angina undergoing coronary bypass surgery 1Department of Medical Genetics, Medical University of Soﬁa, Soﬁa, Bulgaria, 2Gynecology and assisted reproduc- A. Ponasenko, M. Sinitsky, A. Tsepokina, M. Asanov, tion hospital “Malinov”, Soﬁa, Bulgaria, 3Department of O. Barbarash Biology, Medical genetics and Microbiology, Faculty of Medicine, Soﬁa University “St. Kliment Ohridski”, Soﬁa, Research Institute for Complex Issues of Cardiovascular Bulgaria, 4Department of Genetics, Faculty of Biology, Diseases, Kemerovo, Russian Federation Soﬁa University “St. Kliment Ohridski”, Soﬁa, Bulgaria, 5Depatment of Neurology, UH “Alexandrovska”, Medical Introduction: Cardiovascular mortality in Russian Fed- University of Soﬁa, Soﬁa, Bulgaria erationis57%.Itisknownthatgeneticpolymorphismplay the key role in cardiovascular diseases development. The Introduction: Clinical and epidemiological studies have aim of this research was to determine the most important demonstratedalinkbetweenAlzheimer’sdisease(AD)and polymorphicvariantsofgenesinvolvedinﬁvepathogenetic high levels of blood lipids such as cholesterol, a common waysofcoronaryarteryatherosclerosisamongpeople from feature of coronary heart disease (CHD), yet the biological large industrial region. mechanisms remain unknown. Materials and methods: 78 polymorphic variants of 41 Materials & Methods: Whole-exome sequencing was genesinvolvedininﬂammation,lipidmetabolism,endothe- performed on two DNA pools set up of Alzheimer patients lial function, blood coagulation and innate immune (n=70)andhealthyindividuals(n=100),respectively.After response were analyzed in 260 coronary artery disease reads quality ﬁltering, 143,493 genetic variants detected in patientswithstableanginaand300healthydonors(control) bothpoolswereannotated.Alistofvariantsassociatedwith resident in Kemerovo Region using PCR method. CHDwascompiledusingthepubliclyavailableENSEMBL Results: It was discovered that coronary artery disease database(n=1479).Wesurveyedthepooldataforpresence patients from Kemerovo Region are characterized by the of CHD associated variants and selected those present in difference in genotype frequencies compared to overall both pools. European population. Genes of inﬂammation and endothelial Results: Of the 92 CHD associated variants detected in function(NOS3rs1799983,EDNrs5370andCRPrs3093077) our pool data, 24 variants in 22 genes were estimated to more contribute to coronary artery disease in resident of large have signiﬁcantly higher frequency in AD patients industrial region. Polymorphism in genes of innate immune compared to the healthy individuals (FDR<0.05). Func- response (TLR1 rs5743551, IL1F9 rs17659543) and coagula- tional analysis was performed on the 22 genes using tion factor II (rs1799963) can play protective role. APOB, ToppGene platform. Results indicate lipid metabolism and TLR1 and TREM1 associated with increased mortality from lipoprotein transport associated pathways to be most cardiovasculardiseases;andSELPLG–withhighriskofacute signiﬁcantly overrepresented in AD patients compared to cerebrovascular accident development. Genes of lipid and controls. calcium metabolism have no signiﬁcant contribution in Conclusion: The analysis of CHD associated variants in coronary atherosclerosis. This study was supported by basic AD patients and healthy controls suggests shared herit- research project of Research Institute for Complex Issues of abilityingenesinvolvedinoverrepresentedlipidpathways. Cardiovascular Diseases №0546-2015-0012. Acknowledgment: KP-06-N33/5 from 13.12.2019 - National Science Fund A. Ponasenko: None. M. Sinitsky: None. A. Tsepokina: of Bulgaria. None. M. Asanov: None. O. Barbarash: None. DN 03/7 from 18.12.2016 - National Science Fund of Bulgaria. M.B. Ganev: None. D. Serbezov: None. L. Balabanski: E-P05.16 None.R.Vazharova:None.S.Karachanak-Yankova:None. Functional gene analysis indicates shared heritability of O. Antonova: None. D. Nikolova: None. M. Mihaylova: coronary heart disease and Alzheimer’s disease None. R. Staneva: None. V. Spasova: None. V. Damya- nova: None. D. Nesheva: None. Z. Hammoudeh: None. S. M. B. Ganev1, D. Serbezov1, L. Balabanski1,2, R. Hadjidekova: None. S. Mehrabian: None. M. Petrova: Vazharova2,3, S. Karachanak-Yankova1,4, O. Antonova1, D. None. L. Traykov: None. D. Toncheva: None. Nikolova1, M. Mihaylova1, R. Staneva1, V. Spasova1, V. Damyanova1, D. Nesheva1, Z. Hammoudeh1, S.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 849 E-P05.18 Baas7, D. Dooijes8, F. Asselbergs7, D. Barge-Schaapveld9, A DNA repair pathway polymorphism in angiographi- P.Koopman10,A.vandenWijngaard1,S.Heymans1,11,12,I. cally proven coronary artery patients of southern Iran Krapels1, H. Brunner1,5 M. Bijanzadeh, S. Seyedian, F. Ahmadi, S. Hosseini 1MaastrichtUniversityMedicalCenter,Maastricht,Nether- lands, 2Amsterdam University Medical Center, Amsterdam, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Netherlands, 3University Medical Centre Groningen, Gro- Iran, Ahvaz, Iran, Islamic Republic of ningen, Netherlands, 4Antwerp University Hospital, Antwerp, Belgium, 5Radboud University Medical Centre, Introduction:Coronaryarterydisease(CAD)isamongthe Nijmegen, Netherlands, 6Erasmus MC University Medical most common causes of death and is based on the interac- Centre, Rotterdam, Netherlands, 7University Medical Cen- tion between environmental risk factors and predisposing ter Utrecht, Utrecht, Netherlands, 8University Medical genes. X-ray repair cross-complementing group 1 Center Utrecht, Maastricht, Netherlands, 9Leiden Univer- (XRCC1), a DNA repair protein involved in single-strand sity Medical Center, Leiden, Netherlands, 10Heart Center breaks (SSBs) and base excision repair (BER) pathways, Hasselt, Hasselt, Belgium, 11KU Leuven, Leuven, Belgium, was reported to be responsible for the efﬁcient repair of 12The Netherlands Heart Institute, Nl-HI, Utrecht, Nether- single strand breaks and damaged bases in DNA. lands Arg399Gln (rs25487) is one of the common XRCC1 poly- morphisms that might be associated with increased risk Filamin C (FLNC) variants are associated with cardiac and for CAD. muscular phenotypes. Originally, FLNC variants were Materials and methods: A case-control study was described in myoﬁbrillar myopathy (MFM) patients. Later, performed to investigate the relation between this poly- high-throughput screening in cardiomyopathy cohorts morphismandtheCADdevelopment.290patientsand216 determined a prominent role for FLNC in isolated hyper- controls were screened for the mentioned SNP by Restric- trophic and dilated cardiomyopathies (HCM and DCM). tion Fragment Length Polymorphisms (RFLP) method. FLNCvariantsarenowamongthemoreprevalentcausesof Results: The frequency of the GA genotype of XRCC1 genetic DCM. FLNC-associated DCM is associated with a Arg399GlnwassigniﬁcantlyhigherinCADpatientsthanin malignant clinical course and a high risk of sudden cardiac controls(p=0.002,OR:1.21,95%CI(1.06-1.37))andalso death. The clinical spectrum of FLNC suggests different dominant mode (AA + GA) genotype of XRCC1 pathomechanismsrelatedtovarianttypesandtheirlocation Arg399Gln had a 1.851-fold increased risk for CAD in the gene. Proper functioning of FLNC is crucial for (p=0.005). structural integrity and cell signaling of the sarcomere. The Conclusion: Our ﬁndings demonstrated that Arg399Gln secondary protein structure of FLNC is critical to ensure polymorphism of XRCC1 has a signiﬁcant relationship and this function. Truncating variants with subsequent hap- a probable predisposing role in CAD. Our results support loinsufﬁciency are associated with DCM and cardiac the role of DNA damages and the malfunctions of DNA arrhythmias. Interference with the dimerization and folding repairsysteminCADpatients.Introducingofthiscandidate of the protein leads to aggregate formation detrimental for gene along with other related genetic variants can help the muscle function, as found in HCM and MFM. Variants development of early diagnosis and effective interventional associated with HCM are predominantly missense variants strategies that are safe, necessary and individualized for which cluster in the ROD2 domain. This domain is CAD patients. This study (project no. CVRC-9714) was important for binding to the sarcomere and ensure proper grantedbyresearchaffairsofAhvazJundishapurUniversity cell signaling. We here review FLNC genotype-phenotype of medical sciences. correlations based on available evidence. M. Bijanzadeh: None. S. Seyedian: None. F. Ahmadi: E. Vanhoutte: None. J. Verdonschot: None. G. Claes: None. S. Hosseini: None. None.A.Helderman-vandenEnden:None.J.Hoeijmakers: None. D. Hellebrekers: None. A. de Haan: None. I. E-P05.20 The FLNC gene in myopathies and Christiaans: None. R. Lekanne-Deprez: None. E. van cardiomyopathies Craenenbroeck: None. H. Boen: None. B. Loeys: None. Y. Hoedemakers: None. C. Marcelis: None. M. Kempers: E. Vanhoutte1, J. Verdonschot1, G. Claes1, A. Helderman- None. E. Brusse: None. J. van Waning: None. A. Baas: van den Enden1, J. Hoeijmakers1, D. Hellebrekers1, A. de None. D. Dooijes: None. F. Asselbergs: None. D. Barge- Haan1, I. Christiaans2,3, R. Lekanne-Deprez2, E. van Schaapveld: None. P. Koopman: None. A. van den Craenenbroeck4, H. Boen4, B. Loeys4, Y. Hoedemakers3,5, Wijngaard: None. S. Heymans: None. I. Krapels: None. C. Marcelis5, M. Kempers5, E. Brusse6, J. van Waning6, A. H. Brunner: None.850 J.delPicchia E-P05.21 E-P05.23 From genomics data to multiscale simulation - portable A newly detected variant in the MYBPC3 gene in a pipeline for extracting cardiomyophaty speciﬁc patient with hypertrophic cardiomyopathy parameters S. Josifovska1, R. Vazharova2,3, L. Balabanski2, N. Ilic Raicevic, L. Lenhardt Ackovic, V. Kovacevic, M. Malinov2, S. Panov1, M. Ganev4, D. Toncheva4 S. Stojanovic, J. Randjelovic, M. Mattioni, A. S. Yavuz, M. Lazarevic, T. Borovski 1Faculty of Natural Sciences and Mathematics, SS Cyril andMethodiusUniversity,Skopje,Macedonia,TheFormer Seven Bridges Inc, Boston, MA, United States Yugoslav Republic of, 2Genome Centre, GARH Malinov, Soﬁa, Bulgaria, 3Department of Biology, Medical Genetics Introduction: Hypertrophic and dilated cardiomyopathy andMicrobiology,FacultyofMedicine,SoﬁaUniversitySt. are the most common inherited cardiovascular diseases Kliment Ohridski, Soﬁa, Bulgaria, 4Department of Medical which lead to increased mortality and morbidity if not Genetics, Medical University of Soﬁa, Soﬁa, Bulgaria diagnosed in early stages. Design and development of new drugs and therapies which would prevent initiation and Introduction: Hypertrophic cardiomyopathy (HCM) is a progression of familial cardiomyopathies is achievable kind of cardiomyopathy, a cardiac dysfunction due to dis- today due to improved simulation methods and genomic easesofthemyocardium(WHO,1995).HMCcausespartial data availability. The goal of this study was to establish a enlargement of the myocardium. portable pipeline for annotating variants associated with Materials and methods: We report on middle aged familial cardiomyopathy and to determine induced changes patient with familial history and developed HCM. Exome atproteinlevel.Theoutputscombinedwiththeclinicaldata sequencing was performed onthe patient’s extracted DNA, could then be used for simulation of structure and function followed by a targeted analysis of genes from the “Cardio” of the heart. gene panel. Results were validated by Sanger sequencing. Materials and methods: Analyzing steps encompass Results: The analysis resulted in detection of a hetero- variant calling, variant annotation with best ﬁtting tool zygous, probably pathogenic variant in the MYBPC3 gene using apposite databases, and ﬁnal reﬁnement of the (NM_000256.3: c.2965delG; NP_000247.2:p.Glu989- variants. The workﬂow consists of BWA-GATK best Serfs*3). This variant has not been previously reported in practices, Ensembl Variant Effect Predictor and bix2mus individuals with HCM. The MYBPC3 encodes for the (custom-made tool). In this study, 100 samples of Cardiac myosin-binding protein C. The MYBPC3 has a individuals with diagnosed cardiomyopathy are processed structural role as it is located in striated muscle sarcomere giving a statistically powerful dataset. The workﬂow was A-bands and binds myosin heavy chain in thick ﬁlaments written in the CWL. and titin in elastic ﬁlaments causing muscle contraction. Results: The composed workﬂow produced a subset of Pathogenic variants in the MYBPC3 gene account for annotated variants that are cardiomyopathy speciﬁc. approximately15%ofcasesoffamilialHCM.Thedeletion Selected annotated variants were further enriched with that we detected leads toa frameshift resulting in an amino custom parameters which can be used as inputs for the acid substitution of glutamic acid to serine at codon 989. MUSICO heart function simulation. Furthermore, due to the new reading frame, a stop codon Conclusions:Thedevelopedworkﬂowfordiscoveryand can be detected 3 codons downstream, likely affecting the annotation of variants associated with analyzed forms of protein function because of a possible truncated protein inherited cardiomyopathy is operating system-independent, form. The inheritance is autosomal dominant. No other runnable on cloud or locally, ensuring portability, reprodu- known pathological or probably pathological variants cibility and reliability. This workﬂow provides an innova- associated to HCM were found. tive way to infer simulation parameters starting from Conclusions: The genetic causes underlining HMC are genomics data. complex and identifying novel variants may contribute to This research was funded by the EU project better distinction of this dysfunction and assessment of the SILICOFCM. risk of familial predisposition. N. Ilic Raicevic: None. L. Lenhardt Ackovic: None. V. S.Josifovska:None.R.Vazharova:None.L.Balabanski: Kovacevic: None. S. Stojanovic: None. J. Randjelovic: None. M. Malinov: None. S. Panov: None. M. Ganev: None.M.Mattioni:None.A.S.Yavuz:None.M.Lazarevic: None. D. Toncheva: None. None. T. Borovski: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 851 E-P05.25 L. Nuñez1, R. Pan-Lizcano1, P. Piñon2, X. Flores2, Genetic structure of hypertrophic cardiomyopathy G. Aldama2, R. Calviño2, N. Vázquez-González3, in Russia J. M. Vazquez-Rodriguez3, M. Hermida-Prieto1 E. V. Filatova1, N. S. Krylova2, I. N. Vlasov1, 1Cardiology Research Group. Instituto de Investigación M. S. Maslova2, N. Poteshkina2, P. A. Slominsky1, Biomédica de A Coruña (INIBIC)-CHUAC-UDC, A M. I. Shadrina1 Coruna, Spain, 2Department of Cardiology, Complexo Hospitalario Universitario A Coruna (CHUAC)-INIBIC, A 1Institute of Molecular Genetics RAS, Moscow, Russian Coruna, Spain, 3Department of Cardiology, Complexo Federation, 2Pirogov Russian National Research Medical Hospitalario Universitario de A Coruña (CHUAC)- University, Moscow, Russian Federation CIBERCV, Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidad de A Coruña (UDC), A Introduction: Hypertrophic cardiomyopathy (HCM) is the Coruna, Spain most common heritable cardiovascular disease, classically deﬁned as the presence of idiopathic left ventricular Background:Sudden death (SD) due to ventricular hypertrophy. HCM is predominantly a single gene disorder ﬁbrillation(VF)duringacutemyocardialinfarction(AMI) with an autosomal dominant pattern of inheritance. How- is one of the leading causes of death in Western societies. ever,pathogenicallelesarenotidentiﬁedinatleast25%of IthasbeensuggestedthattheriskofSDduetoVFinAMI patientswithHCM.Moreover,thewholespectrumofgenes is the result of the interaction between genetic factors and and mutations that contribute to the development of this environmental factors. Moreover, it has been proposed disorderinRussianpopulationhasnotbeenfullydescribed. that variants in genes related to cardiac excitability, Therefore, the aim of our study was to identify genetic mainly SCN5A, could play an important role in VF variants associated with the HCM in patients from Russia. during AMI. Materials and methods: The study cohort included 99 Methods:Genetic variants in 36 genes encoded proteins unrelated patients with HCM. We performed targeted related to pathways involved in atherothrombosis were exome sequencing and a subsequent bioinformatic analysis analyzedby next generation sequencingin12 patients with using the various algorithms for prediction of the potential FV during AMI. Mutations found were conﬁrmed by pathogenicity of variants, as well as the ClinVar database. Sangersequencing.Visualizationofthemutationusingpdb Results: The frequency of pathogenic and potentially and in silico prediction of the effects produced by the pathogenetically signiﬁcant variants in the main HCM- mutation(MutationTester,SNAP2,SIFT2,Polyphen,PhD- relatedgeneswas18%inourpatientswiththisdisorder.We SNP) were performed. also identiﬁed 22 potentially pathogenetically signiﬁcant Results:In one patient, p.Trp83Ser was identiﬁed in variants, including novel ones,inother HCM genes and52 KCNJ11 gene that encodes a forming KATP channel potentially pathogenetic variants in other 35 genes with subunit, whereas in another patient p.Thr738Pro in known associations to 17 different inherited cardiac SCN10A, encoding the forming subunit of the sodium conditions. channel, were identiﬁed. In both variants, more than four Conclusion: Thereby the prevalence of individual in silico tools suggested deleterious function of the pathogenic variants in HCM-related genes in Russian protein. population is very low. Therefore, it is necessary to Conclusion:Mutationsingeneencodedformingchannels continue the search for new genes and genetic variants subunits,asKCNJ11andSCN10A,couldhavearoleinthe associated with the development of HCM. This work was developmentofFVduringAMI.Thus,itisessentialtouse supported by the Russian Foundation for Basic Research anambitiousstrategy, including allgenes related tocardiac (grants no. 19-015-00343, 18-015-00322) and the Russian excitability, to clarify the pathophysiological basis of Science Foundation (grants no. 20-15-00293). ventricular ﬁbrillation in acute myocardial infarction. E.V. Filatova: None. N.S. Krylova: None. I.N. Vlasov: Funding Acknowledgements:This work was supported None. M.S. Maslova: None. N. Poteshkina: None. P.A. by a grant from Instituto de Salud Carlos III(PI18/01737) Slominsky: None. M.I. Shadrina: None. and a non-conditional-grant from Abbott Vascular. L. Nuñez: None. R. Pan-Lizcano: None. P. Piñon: None. E-P05.27 X. Flores: None. G. Aldama: None. R. Calviño: None. N. Variants in KCNJ11 and SCN10A associated to ven- Vázquez-González: None. J.M. Vazquez-Rodriguez: None. tricular ﬁbrillation during acute myocardial infarction. M. Hermida-Prieto: None.852 J.delPicchia E-P05.28 4National Medical Research Center for Children’s Health, A new case of Fish-eye disease in Spain. Moscow, Russian Federation, 5National Medical Research Center of Cardiology, Moscow, Russian Federation J. Sanguino, C. Rodríguez Jiménez, E. Sevilla, A. Carazo, V. Gómez del Pozo, N. Gallego-Onís, F. Arrieta, Introduction: Left venticular noncompaction cardiomyo- S. Rodríguez-Nóvoa pathy (LVNC) is a genetically determined cardiomyopathy, characterized by the presence of increased trabecularity and INGEMM, Madrid, Spain pronounced intertrabecular spaces extending into the left ventricle chamber. This study was aimed at ﬁnding new key Introduction: Fish-eye disease (FED; MIM#136120) is a links in LVNC development. rare disease with inheritance pattern autosomal recessive Materials and methods: The study included 26 families caused by Lecithin:Cholesterol Acyltransferase Deﬁciency ofLVNCpatients.Forallindividualswasperformedexome 1. This disorder is characterized by raised levels of total sequencing on Illumina Nextseq 550. cholesterol, triglycerides and decreased levels of HDL-c, Results: Clinical and instrumental examination of 102 apoA, and apoB in serum. We report a new case of suspi- people was done: 41 (40.2%) were healthy, in 61 (59.8%) cion of Fish-eye disease send to our laboratory to conﬁrm patients the diagnosis of LVNC was conﬁrmed, 15 (14%) the diagnosis genetic. were children. According to the examination results, the Patient and method: A 42-years-old male, with corneal followingclinicalphenotypesofLVNCcanbedistinguished: opacity, very level low of HDL-c in serum, splenomegaly, LVNC dilatation phenotype,LVNC hypertrophic phenotype, without anemia or kidney disease, and raised levels of LVNC and a combination of hypertrophic with dilatational triglycerides, liver enzymes and homocysteine in serum, was phenotype, isolated LVNC, a combination of LVNC with remitted to our laboratory. The patient´s DNA sample was congenitalheartdefects.Thepathogenicitywasevaluatedfor analyzed by NGS using a customized panel MTB-v2 of 411 the identiﬁed nucleotidevariants in 66 genes associatedwith genes.ThevariantfoundwasconﬁrmedbySangersequencing the developmentofLVNC andin 122 genesassociated with ResultsWefoundanhomozygousmissensevariantin LCAT, thedevelopmentofothercardiomyopathies.Pathogenic(PV) NM_000229.2: c.491G>A p.(Arg164His). In silico analysis or probably pathogenic (PPV) variants were found in 16 showed damaging and conservation for this variant. families: 11 variants in LVNC genes (5 PPV in MYH7, 2 P Conclusion: In this work, we report a new case of Fish variantsinTTN,onePVandonePPVinMYBPC3,onePPV -eye disease. The variant found in LCAT c.491G>A p. in TPM1 and one PPV in SCN5A) and 5 variants in genes (Arg164His) had been previously reported in three siblings associated with other cardiomyopathies (2 PPV in DES, 1 with typical triad: corneal opacity, anemia and kidney PPV in RBM20, 1 PV in VCL, 1 PV in DSG2). dysfunctionandthefunctionalstudyshowedlackofactivity Conclusions: The study of LVNC development on 26 inLCAT2.However,ourpatientexhibitedamildphenotype families revealed mutations in MYH7, TTN, MYBPC3, despite of display of same variant suggesting the existence TPM1, DES, RBM20, VCL and DSG2 genes. of others factors that decreased the clinical manifestations. A. Meshkov: None. O. Kulikova: None. R. Myasnikov: J. Sanguino: None. C. Rodríguez Jiménez: None. E. None. A. Kiseleva: None. M. Divashuk: None. A. Sevilla:None.A.Carazo:None.V.GómezdelPozo:None. Zharikova: None. O. Skirko: None. I. Eﬁmova: None. M. N. Gallego-Onís: None. F. Arrieta: None. S. Rodríguez- Pokrovskaya:None.E.Mershina:None.V.Sinitsyn:None. Nóvoa: None. E.Basargina:None.N.Sdvigova:None.S.Boytsov:None. O. Drapkina: None. E-P05.29 Genetics of familial left venticular noncompaction E-P05.30 cardiomyopathy in Russia Expression of miRNAs as a marker for cardiovascular risk in patients with type 2 diabetes mellitus A. Meshkov1, O. Kulikova1, R. Myasnikov1, A. Kiseleva1, M. Divashuk1,2, A. Zharikova1, O. Skirko1, I. Eﬁmova1, M. P.Gateva1,I.Mihaleva1,K.Kamenova1,S.Giragosyan2,R. Pokrovskaya1,E.Mershina3,V.Sinitsyn3,E.Basargina4,N. Dodova2, R. Kaneva2, I. Dimova3 Sdvigova4, S. Boytsov5, O. Drapkina1 1Department of Pharmacology and Toxicology, Medical 1NationalMedicalResearchCenterforPreventiveMedicine, University-Soﬁa,Soﬁa,Bulgaria,2LaboratoryofGenomic Moscow,RussianFederation,2RSAU–MAAnamedafterK. Diagnostics, Molecular Medicine Center, Medical Univer- A. Timiryazev, Moscow, Russian Federation, 3Lomonosov sity - Soﬁa, Soﬁa, Bulgaria, 3Department of Medical Moscow State University, Moscow, Russian Federation, Genetics, Medical University - Soﬁa, Soﬁa, BulgariaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 853 evidences that somatic mutations can play a role in endo- The use of circulating miRNAs as biomarkers is a potential thelial dysfunction, and atherosclerotic plaques are char- additionaloptioninthediagnosisandprognosisofdiseases, acterized by increased level of DNA adducts. The aim of complementary to established protein-based biomarkers. In this research was to study the level of genotoxic stress our study, we isolated miRNAs from plasma of diabetic markers; secretion and gene expression of proathero- patients with and without cardio-vascular disease (CVD). sclerotic cytokines IL-6 and IL-8 by endothelial cells The analysis included 6 patients with type 2 diabetes mel- exposed to alkylating mutagen mitomycin C (MMC). lituswithoutCVD(controlgroup)and9patientswithtype2 Materials and methods: Primary human coronary- diabetesmellitusandCVD(targetgroup).Followingreverse (HCAEC) and internal thoracic artery endothelial cells transcription and subsequent real-time PCR analysis of an (HITAEC) were used in this research. Cytokinesis-block equal amount of baseline miRNAs, the following miRNAs micronucleusassaywasperformedtoscoregenotoxicstress were successfully analyzed: miR-16-5p, miR-155-3p, miR- markersinexposedandcontrolcellcultures.Concentration 155-5p,miR-210-3p, miR-221-3p miR-424-5p. The com- ofIL-6andIL-8inculturemediumandmRNAlevelofthe parative analysis of expression showed a statistically sig- corresponding genes were measured immediately after niﬁcantincreaseintheexpressionofallthesemiRNAsinthe 6 hours of cell incubation with mutagen and 24 hours after target group compared to the control – see table bellow. elimination of MMC from cell cultures, using ELISA and RT-qPCR. miRNA Relativeexpression(RQ) Results: Exposed cells were characterized by increased miR-16-5p 2.5 level of all studied cytogenetic markers compared to miR-155-3p 2.2 control. After 6 hours of exposure, a signiﬁcant decrease miR-155-5p 7.5 inthesecretionandgeneexpressionofIL-8,anddecreasein miR-210-3p 5.1 the mRNA level of the IL-6 gene in the exposed cultures miR-221-3p 6.2 was discovered. At the second time point (6+24 h), on the miR-424-5p 10.5 contrary,theconcentrationandmRNAlevelofIL-8,aswell as expression of the IL6 gene sharply increased in cultures The highest level of increase was established for miR- exposed to MMC compared to control, and the HCAEC 155-5p (its target is ICAM-1 – with role in inﬂammation were more sensitive to mutagenic effects than HITAEC. and in the regulation of vascular permeability, affected in Thisstudywassupportedbybasicresearchproject№0546- atherosclerosis) and miR-424-5p (its target is HIF1A – the 2015-0012. master transcriptional regulator of the adaptive response to M. Sinitsky: None. A. Kutikhin: None. D. Shishkova: hypoxia). In conclusion, CVD risk assessment, supported None. A. Tsepokina: None. M. Asanov: None. A. by emerging circulating biomarkers, such as miRNAs, is Ponasenko: None. important for stratifying high-risk individuals, optimizing treatment strategies, and enhancing our understanding of E-P05.36 basic biology. Acknowledgment: This study was supported AssociationofgenepolymorphismsMTHFRinKazakh- by Grant NoD-66/2019, Medical University Soﬁa. stani patients with implanted left ventricular assist P. Gateva: None. I. Mihaleva: None. K. Kamenova: devices None. S. Giragosyan: None. R. Dodova: None. R. Kaneva: None. I. Dimova: None. M. Zhalbinova1,2, S. Rakhimova2, M. Bekbosynova3, S. Andosova3, B. Abdirova3, A. Akilzhanova2,1 E-P05.31 InvitroinducedDNAalkylationinendotheliocytesleads 1L.N. Gumilyov Eurasian National University, Nur-Sultan, to genotoxic stress and secretion of proatherosclerotic Kazakhstan, 2National Laboratory Astana, Center for Life cytokines Sciences,Nur-Sultan,Kazakhstan,3JSC“Nationalresearch cardiac surgery center”, National medical holding, Nur- M. Sinitsky, A. Kutikhin, D. Shishkova, A. Tsepokina, Sultan, Kazakhstan M. Asanov, A. Ponasenko Introduction: Chronic heart failure (CHF) is one of the Research Institute for Complex Issues of Cardiovascular main health problems in Kazakhstan, which requires heart Diseases, Kemerovo, Russian Federation transplantation(HT)toextendthepatient’slife.Thepopular treatment of CHF is the implantation of left ventricular Introduction: Atherosclerosis is a leader in morbidity and assist device (LVAD) which extends patient’s life before mortality among all cardiovascular pathologies. There are HT. However, LVAD causes risk of thrombosis and854 J.delPicchia bleeding in cardiac patients. Patients are normally pre- years old, applied with poor weight gain, a slight speech scribed with an antithrombotic therapy to prevent risks of development delay, poor physical exercise tolerance. At an thromboembolism. The purpose of this study is to evaluate earlyage-regurgitation,lackofbodyweight.Thediagnosis patients for genetic variants responsible for risk of throm- has not been established. Examination has revealed diffuse bosis: MTHFR (*1) and MTHFR (*2). hypotension, asthenia, phenotypically signs of connective Materials and methods: Venous blood samples were tissue dysplasia, Laboratory studies: increased transami- recruited from patients (n=100) with implanted LVADs nases, increased lactate level, hepatosplenomegaly. (HW, HM2, HM3) at the National Research Center for According to clinical criteria - mitochondrial Nijmegen Cardiac Surgery. Warfarin was prescribed according to disease. Diagnostic assessment (Wolf NI, Smeitink JA. clinical protocol (min=0.9mg; max=7.2mg; Std.=1.15). Mitochondrialdisorders)inachildconﬁrmedmitochondrial Genotyping was done for MTHFR (*1) rs1801133 and pathology. As the boy grew, there was an increase of MTHFR (*2) rs1801131 by real-time polymerase chain clinical symptoms: increased weakness, fatigue, muscle reaction with TaqMan probes. hypotension, hypomimia. GC-MS in dynamics: titer 3- Results:GenotypingresultswereanalyzedonIBMSPSS metylglutaric and 3- metylglutaconic increase, MRS- con- Statistics 23 for n=98 patients (>18 years old). Results ﬁrmed mitochondrial neurocyte activity. Diagnosed with presented that most of the patients have wild type of atypical forms of 3-methylglutaconic aciduria (3-methyl- genotype which proves absence to the risk of thrombosis: glutaconic deﬁciency — CoA-hydratases) Prescription: MTHFR (*1) (G/G=47%; G/A=41%; A/A=10%, p = mitochondrial therapy during rehabilitation. It led to tem- 0.563); MTHFR (*2) (T/T =54%; T/G=38%; G/G=6%, p porary positive dynamics. Conclusions: timely diagnosis of = 0.288). Results are not statistically signiﬁcant. a rare disease based on biomarkers can improve the con- Conclusions: Research advices to study other SNPs dition of the patient due to pathogenetic therapy. which will allow us to identify the reasons of thrombosis O. Vernigor: None. O. Grechanina: None. M. and bleeding in LVAD patients and also to study more Kanyuka: None. about coagulation factors, aspirin resistance, warfarin metabolism. Study needs to add more samples to be able E-P06.03 to compare results with other samples. X-linked ALG13-CDG resulting from c.320A>G var- M. Zhalbinova: None. S. Rakhimova: None. M. Bekbo- iant - can transferrin proﬁle change and correlate with synova: None. S. Andosova: None. B. Abdirova: None. A. the clinical phenotype? Akilzhanova: None. A. Jezela-Stanek1, A. Bogdańska2, P. Pokora3, E-P06 Metabolic and Mitochondrial Disorders J. Paprocka4, A. Tylki-Szymańska3 1National Institute of Tuberculosis and Lung Disease, E-P06.01 DepartmentofGeneticsandClinicalImmunology,Warsaw, The case of atypical form of 3-methylglutaconic Poland, 2The Children’s Memorial Health Institute, aciduria Department of Biochemistry, Radioimmunology and Experimental Medicine, Warsaw, Poland, 3Children’s O. Vernigor, O. Grechanina, M. Kanyuka Memorial Health Institute, Department of Pediatrics, Nutrition and Metabolic Disorders, Warsaw, Poland, Interregional Specialized Medical Genetic Center - Center 4Medical University of Silesia, Department of Pediatric of Rare (Orphan) Diseases, Kharkiv National Medical Neurology, School of Medicine in Katowice, Katowice, University, Kharkiv, Ukraine Poland Methylglutonicaciduria(MGA)isclinicallyandgenetically Introduction: Congenital Disorders of Glycosylation heterogeneous disease. Genes responsible for development (CDG) are multisystemic metabolic disorders, in general, knowndiseases:OPA3,AUH,TAZ,DNAJC19.Oneofthe caused by defects of N-linked, O-linked oligosaccharides diagnostic methods of MGA is an analysis of the spectrum pathways. Their clinical presentation and aetiology are of organic acids in urine by gas chromatography-mass highly heterogeneous, which may cause a diagnostic spectrometry, as there are biomarkers of the disease - 3- dilemma.Sofar,ALG13c.320A>Gvariantwasreportedin methylglutaric and 3-methylglutaconic acid increase is tenfemalesandonemale.ContrarytootherknownALG13- characteristic.Materialsandmethods:inourcenterthereare CDG, in probands harbouring this mutation normal glyco- 3 children with an atypical form of 3-methylglutaconic sylation andmass spectrometry patternwereobserved (two aciduria, a description of one clinical case. The child is 3 and one individuals, respectively). There is, however, oneAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 855 another report, giving evidence of slightly reduced glyco- Material and Method: Genomic DNAs were extracted sylation with the absence of one glycan in MS. Since these fromthepatientandhisfather,followedbyCYP27A1gene laboratory data are not conclusive, and the number of sequencing. Furthermore, in order to demonstrate the reported patients is still very limited, we like to present deletion, multiplex ligation-dependent probe ampliﬁcatio- novel individuals, pointing out their transferrin IEF results. nof the CYP27A1 gene was performed in the proband. Materials: Three female probands with de novo ALG13 Results:Wefoundanovelheterozygousc.508_509ins16 c.320A>G variant (P3, with the most severe psychomotor (p.E170Vfs*16) mutation in CYP27A1 gene in the pro- impairment, also heterozygous for c.3433C>T in the band’s father. Consequently, a compound heterozygous CACNA1A gene). mutation was detected in the proband. The effect of this Methods: Transferrin isoforms examined by isoelectric novelpointmutationonCYP27A1functionwaspredictedto focusing (IEF) of iron saturated serum in agarose gel in a bedamagingbyinsilicoanalysis.Aftergeneticcounseling, pH gradient 5-7 with immunoﬁxation, demonstrated as the his grandmother who was his legal guardian, consented to percentageofeachisoformfractioninadensitometricscan. kenodeoxycholic acid (CDCA) treatment. Cholestanol Results: Transferrin isoforms showed normal proﬁles in decreased to normal levels and some symptoms improved P1, while in P2 - slight elevation of asialo, monosialo, at the end of two months treatment. disialo fraction; P3 - ﬁrst analysis: normal; second (in Conclusion: Genetic testing for presymptomatic family another sample): slight elevation of only disialo fraction. membersofaffectedpatientsshouldbesuggestedespecially Conclusions: Obtained IEF data delineate the character- to offer an opportunity to prevent or decrease the disease istics of ALG13-CDG caused by c.320A>G variant, manifestations with CDCA therapy. providing evidence of variability or speciﬁcity of glycosy- H.N. Cesur Baltacı: None. B. Sağlam Ada: None. N. lation defect. These may be signiﬁcant for genetic results Yürür Kutlay: None. A. Tükün: None. S. Tıraş Teber: veriﬁcation but also clinical assessment and correlation. None. T. Coşkun: None. A.Jezela-Stanek:None.A.Bogdańska:None.P.Pokora: None. J. Paprocka: None. A. Tylki-Szymańska: None. E-P06.05 A novel CTCF variant in a patient with congenital E-P06.04 anomalies Cerebrotendinous xanthomatosis with novel compound heterozygous mutation ofCYP27A1gene N. Okamoto1, F. Miya2,3,4, T. Tsunoda2,3,4, K. Kosaki5 H.N.CesurBaltacı1,B.SağlamAda2,N.YürürKutlay1,A. 1Department of Medical Genetics, Osaka Women’s and Tükün2, S. Tıraş Teber3, T. Coşkun4 Children’s Hospital, Osaka, Japan, 2Department of Med- ical Science Mathematics, Medical Research Institute, 1MedicalGeneticsDepartment,AnkaraUniversity,Ankara, Tokyo Medical and Dental University, Tokyo, Japan, Turkey, 2Department of Medical Genetics, Düzen Labora- 3Laboratory for Medical Science Mathematics, tories Group, Ankara, Turkey, 3Department of Pediatric RIKENCenterforIntegrativeMedicalSciences,Yokohama, Neurology,AnkaraUniversity School ofMedicine, Ankara, Japan, 4Medical Science Mathematics, Department of Turkey, 4Departments of Pediatric Metabolism, Hacettepe Biological Sciences, Graduate School of Science, The University Faculty of Medicine, Ankara, Turkey University of Tokyo, Tokyo, Japan, 5Center for Medical Genetics, Keio University School of Medicine, Introduction: Cerebrotendinous xanthomatosis (CTX) is a Tokyo, Japan rarelipidstoragediseasecharacterizedbytheaccumulation of cholesterol and cholestanol in various tissues. It is Introduction: The DNA-binding protein CCCTC-binding inherited in an autosomal recessive manner caused by the factor(CTCF)andthecohesincomplexplayimportantroles mutations of CYP27A1 gene localized on 2q35. This gene inchromatinarchitectureinvertebrates.Pathogenicvariants encodes sterol 27-hydroxylase. Here we present a 8-year- inCTCFwerereportedinpatientswithneurodevelopmental old male with attention deﬁcit and hyperactivity disorder. disorderswithdistinctivefacialfeatures.Wereportapatient He was born to non-consanguineous parents. He was con- with a novel variant in CTCF with intellectual disability sulted to us for CYP27A1 gene analysis by the information (ID) and multiple anomalies. of a homozygous deletion in exon 6 of CYP27A1 gene in Clinical Report: The 6-year-old male was the ﬁrst child his mother. Additionally, his 7-dehydrocholesterol and of healthy and non-consanguineous Japanese parents. He plasma cholestanol levelsincreased consistently withCTX. showedcongenitalcardiacanomalies,duodenalatresia,and His father had epilepsy together with limited intellectual atresia ani. His developmental milestones were also capacity. retarded. He also showed characteristic facial features.856 J.delPicchia Conventional cytogenetic studies and microarray analysis c.589G˃A(p.G197R)(p.Gly197Arg)mutationandhisfather gave normal results. is a heterozygote for c.1015G˃A (p.G339R)(p.Gly339Arg) Method: With the approval of our institutional ethics mutation. One of his asymptomatic sister is a heterozygote committee, DNA samples from the patient and her parents forc.1015G˃A(p.G339R)(p.Gly339Arg)mutation.Another were analyzed by WES. sisterwithcornealcystinosisisaheterozygoteforc.589G˃A Results: The patient was heterozygous for CTCF frame- (p.G197R)(p.Gly197Arg) mutation. Overall, we can trace shift variant (NM_006565:exon3:c.723delT:p.N241fs). The the (potential) phenotype of these patients using their variant was de novo. mutation. This study shows us the genetic heterogenity of Discussion: Cornelia de Lange syndrome, a classical cystinosisinTurkishpopulationandhelpsustounderstand cohesinopathy,mayshowmultiplemalformationsincluding the biochemical-genotype-phenotype relationship in this CHD and gastrointestinal malformations. CTCF may disease. regulateorganogenesis.MutationsinCTCFmayalsocause B. Celtikci: None. B. Kazanci: None. a multiple anomaly syndrome with ID. N. Okamoto: None. F. Miya: None. T. Tsunoda: None. E-P06.08 K. Kosaki: None. A unique combination of two lysosomal diseases in a child revealed as a result of a screening E-P06.07 Two forms of a disease in the same family: compound O. Buhaiova, O. Grechanina, Y. Hrechanina, L. Molodan, heterozygosity in the father and heterozygosity in his N. Pokaziy, A. Bulavina, D. Shkolnikova sister both with corneal cystinosis, and heterozygous daughter and his other sister both having risks for Interregional Specialized Medical Genetic Center - Center nephropathic cystinosis of Rare (Orphan) Diseases, Kharkiv National Medical University, Kharkiv, Ukraine B. Celtikci1, B. Kazanci2 Introduction: Lysosomal storage disorders are character- 1Hacettepe University, Ankara, Turkey, 2Ulucanlar Eye ized by comorbidity, polymorphism and genetic hetero- Hospital, Ministry of Health, Ankara, Turkey geneity, which makes their timely diagnosis difﬁcult. Materials and methods: To identify patients with Cystinosis is a rare and autosomal recessive inherited dis- atypical forms of MPS, Pompe, Gaucher, Fabry disease order resulting from the accumulation of intracellular among residents of Kharkov region in 2018. In Kharkiv cystine, due to the mutations of the CTNS gene encoding region, selective screening for accumulation diseases thecystinosinproteinthat carries thelysosomalaminoacid has begun. cystine. Its incidence is high in Turkey, because of the Results: determination of excretion of total glycosami- frequent consanguineous marriage and manifesting hetero- noglycans(GAGs)indailyurine(2733patients);determina- zygotes. The most common clinical diagnosis is kidney tion of the level of fractional blood GAGs-(683patients), involvement. Corneal form occurs later. Some cases are biochemical study of the level of enzymes and molecular diagnosed with photophobia, halo and glare style visual genetic diagnostics (712patients). This revealed: Combina- ﬁndings, depending on the density of corneal crystals. tion of Fabry disease and Pompe disease in 1 patient. In a Spindle- and fusiform-shaped corneal crystals were child with diffuse muscular hypotension, retarded physical detected in our patient and his sister. Sequencing of CTNS and statokinetic development, hepatomegaly, decreased genewasperformedonaMiSeq(Illumina).VCFﬁleswere activity of the lysosomal enzyme acid α-glucosidase, analyzed by Variant studio (Illumina) and Geneticist decreased Lyso-Gb3, the GLA gene (heterozygous variant Assistant (SoftGenetics) Software. Sequence variant clas- c.31G> C p. (Gly11Arg)) was detected. GLA - encodes a siﬁcation was done according to the ACMG Standards and homodimeric glycoprotein. A mutation in the gene affects Guidelines. Detected variants were conﬁrmed by Sanger the synthesis, processing and stability of the enzyme that sequencing. Our patient with corneal cystinosis has the causes Fabry disease, which results from the inability to compound heterozygosity of c.589G˃A (p.G197R)(p. catabolize alpha - D-galactosyl glycolipid moieties. GAA - Gly197Arg) /c.1015G˃A (p.G339R)(p.Gly339Arg) muta- The gene produces an acid alpha glycosidase enzyme. The tions, correlated with cystinosis and his daughter is a het- body uses GAA to break down the glycogen used to erozygote for c.1015G˃A (p.G339R)(p.Gly339Arg) produce energy. mutation, correlated speciﬁcally with nephropathic cysti- Conclusions: The introduction of a selective nosis. As expected, his mother is a heterozygote for screening system for diseases of accumulation made itAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 857 possible to diagnose early and to start adequate pathoge- pathogenic likelypathogenic probably variantofuncertain pathogenic signiﬁcance neticpersonalizedtherapyinatimelymannerforthisgroup of patients. For the ﬁrst time, a combination of Fabry and LDLR c.316_328delCCCAAGAC c.325T>G:p. c.2389+5G>C c.616A>C:p.(S206R); GTGCT:p.(K107Rfs*95); (C109G); Pompe diseases was detected in 1 patient. LDLR c.940+1_c.940+4delGTGA; c.401G>C:p. c.663_683dupCTGCAAGGAC (C134S) AAATCTGACGA; O. Buhaiova: None. O. Grechanina: None. Y. Hrecha- LDLR c.1186+1G>T; c.798T>A:p.(Asp266Glu); nina: None. L. Molodan: None. N. Pokaziy: None. A. LDLR cp..1(P658643_H16fs9*11d4e)lTGGCCCAA: c.1187-7C>G Bulavina: None. D. Shkolnikova: None. LPL c.472T>C:p.(Y158H) APOA2 c.122_123insACCGT:p. (V41=fs*2); APOA2 c.53G>A:p.(G18E) E-P06.10 Spectrum of mutations in Russian patients with hypercholesterolemia O.N. Ivanova: None. T.D. Krylova: None. N.A. Seme- nova:None.P.A.Vasiluev:None.N.V.Milovanova:None. O. N. Ivanova, T. D. Krylova, N. A. Semenova, P. A. E.Z. E.Y. Zakharova: None. Vasiluev, N. V. Milovanova, E. Z. E.Y. Zakharova E-P06.11 Federal State Budgetary Scientiﬁc Institution "Research Pathogenic variant p.E191K in ALPL is common in Centre for Medical Genetics", Moscow, Russian Federa- mild forms of hypophosphatasia in Northwest Russia tion M. Fedyakov1, Y. Eismont1, T. Ivaschenko2, I. Sosnina3, Y. -Introduction: We presented a genetic spectrum of Snegova3, S. Scherbak1, Y. Barbitoff4, A. Shikov1, hypercholesterolemia in a cohort of 72 unrelated O. Glotov1 patients from Moscow region. -Materials. The patients with high level of total cholesterol (>6,7 mmol/l) and/ 1City Hospital 40, Saint-Petersburg, Russian Federation, or low-density lipoprotein cholesterol (>4,9 mmol/l) were 2D.O.Ott Research InstituteofObstetrics,Gynecology and screened on targeted NGS panel on IonS5 (Thermoﬁsher Reproductology, Saint-Petersburg, Russian Federation, Scientiﬁc) for the following genes: LDLR(NM_000527), 3Consultative and diagnostic center for children, Saint- APOB(NM_000384), PCSK9(NM_174936), ABCG5 Petersburg, Russian Federation, 4Bioinformatics institute, (NM_022436), ABCG8(NM_022437), APOA2 Saint-Petersburg, Russian Federation (NM_001643), LIPA(NM_000235), LPL(NM_000237). Informed consents have been obtained from all patients or Introduction: Hypophosphatasia (HPP) is a rare heritable theirlegalrepresentativestoconductthestudy.Theaverage metabolic disorder characterized by defective mineraliza- age of the patients was 12,04+/-1,27 years old. The tionofboneand/orteethinthepresenceofreducedactivity nomenclature of variants and the assessment of their of unfractionated serum alkaline phosphatase (ALP). The pathogenicity has been carried out in accordance with overallprevalenceofsevereHPPisrangefrom1/100000to HGVS, ACMG recommendations. Variant validation has 1/300 000. Mild forms of HPP are more frequent than been performed by Sanger sequencing. severe forms - expected prevalence can reach 1/6000 in -Results:Wefound44variantsamong72ofcases(61%). Westernpopulations.Russianprevalenceofmildandsevere Known pathogenic mutations have been detected in 27 HPP is still unknown. Genetic analysis provides determin- patients, 21 of them were in LDLR gene, and six in the ing of diagnosis in cases with suspected HPP. genes APOB, LIPA, ABCG8. 17 patients harbor new Materials and methods: We analyzed genomic DNA variants with varying degrees of pathogenicity (see table samplesfrom217unrelatedindividualswithsuspectedHPP below). (inclusion criteria: low and/or recurrent low levels of ALP, -Conclusions: Pathogenic LDLR variants have been lowgrowth,recurrentfracturesandothers).Primers’system detected in 47% (34/72) of unrelated patients with for Sanger sequencing was designed and validated for hypercholesterolemia, the same results were shown in the coding 2-12 exons of ALPL gene. Exome data of 353 of literature. The most common variant in this gene is the unrelated individuals(in-house controlgroup) wasusedfor known pathogenic mutation c.1775G>A(p.G592E) (6.9%) genetic variant estimation of prevalence in Northwest and the previously unpublished splicing variant c.940 Russia. +1_c.940+4delGTGA (5,5%). The study has conﬁrmed Results:Detectionratewas11%-21inheterozygousand the genetic heterogeneity of hypercholesterolemia in the 3 in compound-heterozygous. Mild HPP was founded in Russian cohort. 87,5% positive cases (21/24). 5 novel mutations (3 missense, 2 frameshift) were detected. Most frequent pathogenic variant in ALPL gene was p.E191K in exon 6.858 J.delPicchia The prevalence of this mutation was: 2.8% in suspected closetothatinthenearestneighbors-Poland,Hungaryand HPP group (12/434), 0.28% (2/706 chromosome) in home Slovakia, but are lower than European average, and the controls, 0.25% in gnomAD. genetic heterogeneity of these diseases in Ukraine is Conclusions: Mild forms of HPP predominate in North- pronounced. west Russian patients with suspected HPP. Mutation p. Conclusions: Existence of high genetic heterogeneity of E191K in exon 6 is 20 times common in patients with low LSDinUkrainecreatessigniﬁcantproblemsduringmedical levels of ALP compare general population. genetic counseling for families and requires the develop- M. Fedyakov: None. Y. Eismont: None. T. Ivaschenko: ment of speciﬁc diagnostic algorithm that regulates the None. I. Sosnina: None. Y. Snegova: None. S. Scherbak: stages of diagnostic search using DNA analysis. None. Y. Barbitoff: None. A. Shikov: None. O. N. Olkhovych: None. N. Pichkur: None. N. Troﬁmova: Glotov: None. None. S. Kormoz: None. I. Gregul: None. Y. Gyvitsa: None. N. Samonenko: None. Y. Doronina: None. M. E-P06.14 Tcygankova: None. O. Radzihovskaya: None. N. Highgeneticheterogeneityoflysosomalstoragediseases Gorovenko: None. in Ukraine E-P06.15 N. Olkhovych1,2, N. Pichkur1,2, N. Troﬁmova1,2, A novel de novo variant in MT-ATP6 in a patient with S. Kormoz2, I. Gregul2, Y. Gyvitsa2, N. Samonenko2,3, Mitochondrial myopathy, Lactic Acidosis and Side- Y. Doronina2, M. Tcygankova2, O. Radzihovskaya2, roblastic Anemia (MLASA) plus: expanding the clinical N. Gorovenko1,3 phenotype 1Institute of Genetic and Regenerative Medicine, Kyiv, J. Dupont1, P. Janeiro2, M. J. Palaré3, S. Quintas4, Ukraine, 2National Children Hospital Ohmatdyt, Kyiv, A. B. Sousa1 Ukraine, 3National Medical Academy of Postdiploma Education named P.L.Shupika, Kyiv, Ukraine 1Serviço de Genética Médica, Departamento de Pediatria, HospitaldeSantaMaria,CentroHospitalareUniversitário Introduction: Lysosomal storage diseases (LSD) are Lisboa Norte, Centro Académico de Medicina de Lisboa, inherited metabolic diseases that are caused by genetic Lisbon, Portugal, 2Centro de Referência de doenças alterationsinlysosomalenzymesgenes.Mostofthehuman hereditárias do metabolismo, Departamento de Pediatria, disease is characterized by marked genetic heterogeneity, HospitaldeSantaMaria,CentroHospitalareUniversitário far greater than previously appreciated. This degree of Lisboa Norte, Centro Académico de Medicina de Lisboa, allelic, locus, and phenotypic heterogeneity has important Lisbon, Portugal, 3Unidade de Hematologia Pediátrica, implications for gene discovery and has important impli- Departamento de Pediatria, Hospital de Santa Maria, cations for development of molecular treatments for indi- Centro Hospitalar e Universitário Lisboa Norte, Centro vidual patients. Académico de Medicina de Lisboa, Lisbon, Portugal, Aim: Analysis of genetic heterogeneity of the most 4Unidade de Neurologia Pediátrica, Departamento de common lysosomal storage diseases in patients from Pediatria, Hospital de Santa Maria, Centro Hospitalar e Ukraine. UniversitárioLisboaNorte,CentroAcadémicodeMedicina Materials and methods: The frequencies and spectrum de Lisboa, Lisbon, Portugal of causes mutations in patients with Gaucher (n=62), Niemann-PeakA/B(n=16),metachromaticleukodystrophy Introduction: MLASA is a mitochondrial disorder char- (MLD) (n=28), mucopolysaccharidosis type I (MPS I) acterized by myopathy, lactic acidosis, and sideroblastic (n=17), mucopolysaccharidosis type IIIA (MPS III A) anemia, associated with biallelic mutations in PUS1 and (n=21), GM1-gangliosidosis (n=32) were analyzed. Muta- YARS2genes.In2014,Burrageetal.reportedanMLASA- tion analysis was performed using classical PCR analysis like phenotype (OMIM 500011) in a patient harboring a and Sanger sequencing. Comparative analysis of the novel heteroplasmic point mutation in mitochondrial ATP common mutations in different populations was performed synthase 6 (MT-ATP6). Pathogenic variants in MT-ATP6 according to the published data. areacauseofNARP(neurogenicmuscleweakness,ataxia, Results: Our research has shown that the frequencies of and retinitis pigmentosa) and Leigh syndrome. common mutations in patients with Niemann-Peak A/B, Casedescription:Theprobandisan8-year-oldgirlwith MLD and GM1-gangliosidosis in Ukraine is signiﬁcantly an early infantile presentation of failure to thrive, side- different from other European. Frequencies of common roblastic anemia, axial hypotonia, nystagmus and mild mutationsinpatientswithGaucher,MPSIandMPSIIIAis developmental delay. Slow-growing, sparse and brittleAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 859 striking hair was noticed since infancy. She evolved with during pregnancy was more common among GCK-MODY developmental stagnation and severe ID. Recently, clinical patients: most switched from only diet to insulin. Total deterioration occurred during acute illness. On physical insulin per day in the 1st trimester was signiﬁcantly higher examination she has tip-toe ataxic gait, dystonia, bradyki- in GCK-MODY (34.57vs. 30.5units,p<0.005) patients and nesia, rigidity, and muscle weakness with atrophy. thedifference betweenpercentageof basal insulin was also Ophthalmologicassessment showed salt-and-pepper retino- signiﬁcantlyhigher(34.99vs.20.87%,p<0.005),thelatterof pathy. Persistent hyperlacticaemia and respiratory chain which remained signiﬁcant until the end of pregnancy. complex V deﬁciency in muscle were documented. WES There were no macrosomic or low birth weight neonates. and CNV analysis were negative. Mitochondrial genome Conclusions: GCK-MODY pregnant women received a sequencing in blood identiﬁed a novel de novo homo- higher daily dose of insulin, especially in percentage of plasmic variant in MT-ATP6 gene (NC_012920.1: basal insulin, compared to HNF1A-MODY patients. This m.9014A>G), classiﬁed as uncertain according to ACMG could be due to attempts to achieve target fasting glucose guidelines, but considered likely pathogenic applying the levels duringpregnancyestablished forgestational diabetes ClinGenSVIBayesianclassiﬁcationframework.Functional despite different speciﬁcities of GCK-MODY. The higher studies are ongoing. dose of given insulin could be responsible for the greater Conclusions: MLASA plus is a distinctive phenotype weight gain among GCK-MODY patients. associated with MT-ATP6 uncommon variants. MT- M. Szopa: None. K. Zawadzka: None. K. Cyganek: ATP6–related disease is best deﬁned as a mitochondrial None. P. Witek: None. M.T. Malecki: None. diseasespectrum disorder, asdemonstratedbythepresence of NARP and Leigh features in our patient. Hair E-P06.18 abnormalities are distinctive and might lead the clinician to suspect the diagnosis before multi-organ involvement Mucopolysaccharidosis IIIA - a clinical case develops. J.Dupont:None.P.Janeiro:None.M.J. Palaré: None.S. E. S. SHELBY, M. Axente, A. I. Grigoriu, L. Pădure; Quintas: None. A.B. Sousa: None. CNC RNC Dr. Nicolae Robanescu, Bucharest, Romania. E-P06.16 Introduction: We present the case of a 16 year old boy Management and outcomes in pregnant women with admitted in our hospital in May 2019 with no signiﬁcant GCK-MODY and HNF1A-MODY from Poland birth or family history, normal mental and motor develop- mentuntiloneyearandsixmonthsandprogressiveonsetof M. Szopa, K. Zawadzka, K. Cyganek, P. Witek, M. T. symptoms consisting in macrocrania, hepatosplenomegaly, Malecki cognitive and motor retardation, hetero-aggressive beha- viour, insomnia, incontinence, hirsutism, coarse facial JUMC, Krakow, Poland features,muscleatrophies andscoliosis.Testingforseveral storagediseaseswasnormal.MRIshowedcorticalatrophy, Introduction: Mutations in the glucokinase (GCK) and right maxillary mucocele, corpus callosum hypoplasia, hepatocyte nuclear factor1a (HNF1A) gene are the most occipitalcyst.Hehadopticatrophyandaorticinsufﬁciency. common causes of maturity-onset diabetes of the young A diagnosis of mucopolysaccharidosis was suspicioned. (MODY). The management of both MODY types during Objectives: The goal was to establish a diagnosis for pregnancy is challenging and differs from other forms of optimal medical management and for establishing the diabetes. The aim was to assess clinical management and recurrence risk in order to offer genetic counselling to the pregnancyoutcomesamongwomenwithGCK-MODYand family. HNF1A-MODY. Method: Further investigations were performed. CT Material and Methods: We included 13 GCK and 14 showed skull hyperostosis, thickening of left clavicle and HNF1A-MODY patients. vertebrae (dysostosis multiplex) andfemoral head necrosis. Results: There was no signiﬁcant difference in age of EEGwashypovoltatedwithepileptiformdischarge.Genetic pregnancy between GCK-and HNF1A-MODY women; testing (panel for mucopolysaccharidoses) was performed. those with the HNF1A gene mutation were diagnosed with Results:Patientwas homozygousforSGSH c.1297C>T, MODY earlier (28vs.30years). HNF1A-MODY patients p.(Arg433Trp) mutation, classiﬁed as pathogenic. He was preconceptionbodyweightwashigher(67.28kg)compared diagnosed with Sanﬁlippo syndrome (MPZ type IIIA). toGCK-MODY(62.71kg),butthebodyweightgainduring Conclusions: As treatment for several types of mucopo- pregnancy was signiﬁcantly higher among GCK-MODY lysaccharidoses exists, diagnosis must be made as soon as patients(18.5vs.12.78kg,p<0.005).Treatmentmodiﬁcation possible. To our knowledge, cortical atrophy and corpus860 J.delPicchia callosum hypoplasia were described in other Sanﬁlippo N. Semenova: None. M. Kurkina: None. E. Dadaly: subtypes but - except for two Israeli Arab sisters from a None. D. Guseva: None. T. Strokiva: None. N. consanguineousfamily,innoothercasesofSanﬁlippotype Taran: None. A syndrome. This is the third case with these features, indicating they might also be associated with Sanﬁlippo E-P06.21 type A syndrome. BH4-deﬁcient hyperphenylalaninemia in Russia E.S. Shelby: None. M. Axente: None. A.I. Grigoriu: None. L. Pădure: None. P. Gundorova1, I. A. Kuznetsova1, A. A. Stepanova1, A. V. Polyakov1, Y. S. Itkis2 E-P06.20 A novel homozygous pathogenic PEX26 gene’s variant 1Federal State Budgetary Institution "Research Centre for in patients with Zellweger syndrome from Dagestan Medical Genetics", Moscow, Russian Federation, 2Research Centre for Medical Genetics, Moscow, Russian N. Semenova1, M. Kurkina1, E. Dadaly1, D. Guseva1, Federation T. Strokiva2, N. Taran2 Introduction: Tetrahydrobiopterin-deﬁcient hyperphenyla- 1Reseach Center for Medical Genetics, Moscow, Russian laninemia(BH4-HPA)isagroupofheterogeneousdiseases, Federation, 2Federal Research Centre of Nutrition and caused by impaired synthesis or regeneration of tetra- Biotechnology, Moscow, Russian Federation hydrobiopterin (BH4), a cofactor of the phenylalanine, tyrosine and tryptophan hydroxylases. Six different genes Introduction:Peroxisomebiogenesisdisorders(PBD)area are known as responsible for BH4 metabolism. The pro- heterogeneous group of autosomal recessive disorders that portion of BH4-HPA and the mutation spectrum of affect multiple organ systems. Approximately 80% of PBD BH4 synthesis and regeneration genes is unknown in patients are classiﬁed in the Zellweger syndrome spectrum, Russia. which are caused generally by mutations in the PEX1, Materialsandmethods:Duringthe20years,morethan PEX6, PEX10, PEX12, or PEX26 genes. 3,100 patients with PKU and HPA were diagnosed in the Materials and methods: We present two unrelated DNA-diagnostic laboratory of “RCMG”. Among them, 30 families of Dagestan origin with three 1-year-old male patients with BH4-HPA were identiﬁed. Sanger members with cholestasis hepatopathy and development sequencing of PTS and QDPR genes and custom panel delay. Parents of one family were consanguineous. All NGS sequencing of all HPA genes and DNAJC12 were patientswerebornatterm,hadappropriatebirthweightsfor performed. gestational age. From 2 months of age they have had poor Results: In 25 patients “HPA-BH4A” diagnosis was feeding, development delay. Physical examination showed conﬁrmed, 18 different PTS variants were found on 50 jaundiced,hepatosplenomegalyandcoagulopathy.At1year alleles. The most common variant were p.Thr106Met of age, they couldn’t sit and stand on their own. Two sibs (32,0%), p.Asn72Lys (20,0%), p.Arg9His (6,0%). Seven (monozygous twins) had very low cholesterol level and novel variant were found, including the whole PTS gene normal GGT. The concentrations of C26 and phytanic acid deletion. In 4 patients “HPA-BH4C” diagnosis was in plasma were increased and made up respectively conﬁrmed, 5 different QDPR variants were found on 8 13.2mM/ml (normal 0.22-2.2nN/ml) and 59.42mg/ml alleles. Three of them were not previously reported. Three (normal0-3.11mg/dl); ratio of C26/C22 was 0.149 (normal patients were homozygous and one compound-heterozy- 0.009-0.018). Another patient had normal phytanic acid gous. In addition, one patient with DOPA-responsive concentrationinplasma(0.01mg/ml)buthighlevelofC26 dystonia and homozygous variant с.524С>А (p. and C26/C22 (15.4 and 0.312 respectively). All children Ala175Asp) in SPR gene was identiﬁed. had normal bile acid concentration in urine. Conclusions: The proportion of BH4-HPA in Russia is Results: NGS was used to analyze 52 genes responsible about1%ofallHPA.PTSgenemutationsleadtotheBH4- for hereditary diseases with cholestasis. A nucleotide HPA in 86% of cases, QDPR mutations in 14%. The variant in PEX26 gene was identiﬁed: c.347T>A (p. detection of BH4-HPA patients should be performed via Leu116Gln) in homozygous state. This variant was differential diagnostic methods. Nowadays the reported conﬁrmed with Sanger sequencing. Parents are healthy cohort is involved in setting up a pterin method into a and heterozygous for mutant allele. practice. Conclusions: Our clinical cases describe the phenotype P. Gundorova: None. I.A. Kuznetsova: None. A.A. associated with the c.347T>A (p.Leu116Gln) variant in Stepanova: None. A.V. Polyakov: None. Y.S. Itkis: None. PEX26 gen of Dagestan originAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 861 E-P06.26 E-P06.28 Screening for genetic variants associated with cardio- Variant nonketotic hyperglycinemia due to novel vascular diseases in patients with type 2 diabetes compound heterozygous LIAS mutations: a case with a mellitus branchpoint mutation I. Mihaleva1, M. Mincheva2,3, M. Hristova-Savova3, L. Pölsler1, B. Mühlegger1, S. Gang2, P. Traunfellner1, K. Belemezova3, M. Rizov3, S. Yovinska3, R. Dimova4, A. Amberger1, K. Wimmer1, S. Rudnik1, J. Zschocke1 T. Tankova4, P. Andreeva-Gateva1, I. Dimova2,3 1Institute of Human Genetics; Medical University 1Department of Pharmacology and Toxicology, Medical Innsbruck, Innsbruck, Austria, 2Department of Pediatrics University Soﬁa, Soﬁa, Bulgaria, 2Laboratory of Genomic and Adolescent Medicine; Academic Teaching Hospital diagnostics, Molecular Medicine Center, Medical Univer- LKH Feldkirch, Feldkirch, Austria sity Soﬁa, Soﬁa, Bulgaria, 3Genetic Laboratory, SAGBAL “DrShterev”,Soﬁa,Bulgaria,4DepartmentofEndocrinol- Nonketotic hyperglycinemia (NKH) results from defects in ogy, Medical University Soﬁa, Soﬁa, Bulgaria the glycine cleavage system and is characterized by neo- natal seizures, psychomotor delay, and elevated glycine Astrongassociationbetweentype2diabetesmellitus(DM) levels. It is caused by bi-allelic mutations affecting the and cardiovascular diseases (CVD) exists. CVD are the subunits of the mitochondrial glycine cleavage system leading cause of morbidity and mortality among patients (including GLDC). The term “variant NKH” refers to the with diabetes. Our objective was to study the allelic and deﬁciencyofoneoftheglycinecleavagecofactors,suchas genotypicfrequenciesofgeneticvariantsthathaveshowna lipoate. This organosulphur compound is also part of the strong association with CVD in diabetic patients with and oxoacid dehydrogenase complexes such as PDHC and without cardiovascular complications and to assess the requires lipoyl synthase (LIAS gene) for its biosynthesis. additional contribution of genetic variation in determining NKHwassuspectedinaboywhopresentedwithneonatal the risk for such complications. We have used CVD Stri- intractable seizures from day 2 and died at 6 weeks of age. pAssay kit (Vienna Lab) based on polymerase chain reac- Blood and CSF glycine concentrations were elevated, tion (PCR) and reverse hybridization. The following lactate was normal. mutationswerestudied:FVG1691A(Leiden),FVH1299R Massive parallel sequencing showed heterozygosity for (R2), Prothrombin G20210A, Factor XIII V34L, theknownGLDCmutationc.2316-1G>Aandthenonsense β-Fibrinogen-455G-A,PAI-14G/5G,GPIIIaL33P(HPA- mutation c.985A>T, p.(Lys329*) in LIAS. Additionally, a 1), MTHFR C677T, MTHFR A1298C, ACE I/D, Apo B novel intronic variant c.551-24A>T affecting a predicted R3500Q, Apo E2/E3/E4. 36 diabetic patients divided in 2 branch point in LIAS intron 5 was found. Analysis of groupswereanalyzed:1)20diabeticpatientswithCVDand mRNAtranscriptsinlymphocytesoftheheterozygousLIAS 2) 16 diabetic patients without CVD. Results: We found c.551-24A>T carrier father showed retention of the 82-bp higher than population frequency for the following alleles/ intron. Presumably due to nonsense-mediated mRNA genotypes - 5.5% for FV Leiden allele, 9.7% for FVR2 decay, this splice effect, leading to the premature stop allele, 38.9% for β-Fibrinogen genotype -455G/A, 58.9% codon p.(Asp184Glyfs1*), was seen only in a small for PAI-1 4G allele, 36.1% for ACE D/D genotype. Sta- proportion of the father’s transcripts. A minigene experi- tisticallyhigherfrequencywasestablishedforβ-Fibrinogen ment conﬁrmed this effect in the majority of the minigene -455 G-A in the patients with CVD compared to non-CVD transcripts. (55% vs. 18.7%). Conclusion: We detected high frequency This case report represents the 6th patient with variant of β-Fibrinogen - 455 G/A genotype in diabetic patients, NKH due to bi-allelic LIAS mutations. It illustrates the especially in these with CVD. Based on its pro-inﬂamma- difﬁculties encountered by identiﬁcation of single hetero- tory role and its connection to possible thrombotic events, zygous coding or splice donor/acceptor variants in more patients would beneﬁt from anti-inﬂammatory treatment. than one candidate gene for a recessive condition. Acknowledgment:ThisstudywassupportedbyGrantNoD- L.Pölsler:None.B.Mühlegger:None.S.Gang:None.P. 66/2019, Medical University Soﬁa. Traunfellner: None. A. Amberger: None. K. Wimmer: I. Mihaleva: None. M. Mincheva: None. M. Hristova- None. S. Rudnik: None. J. Zschocke: None. Savova: None. K. Belemezova: None. M. Rizov: None. S. Yovinska: None. R. Dimova: None. T. Tankova: None. P. E-P07 Immunology and Hematopoietic System Andreeva-Gateva: None. I. Dimova: None.862 J.delPicchia E-P07.1 D. F. Osorio1, M. L. Agudelo1, O. I. Beltrán1,2 Novel Indel variants in the CALR gene in mieloproli- ferative neoplasm patients 1Facultad de Medicina, Universidad Militar Nueva Gran- ada, Bogotá DC, Colombia, 2Unidad de Genética. L. Gailite1, Z. Dobele1, D. Rots1, J. Isakova1, B. Janicka Organización Colsanitas SA, Bogotá DC, Colombia Kupra2, K. Bernate3, L. Belajeva2, L. Zarina2, S. Lejniece1 Introduction: Patients with rare diseases often go undiag- 1RigaStradinsUniversity,Riga,Latvia,2RigaEastClinical nosed for years while suffering from acute and/or chronic University Hospital, Riga, Latvia, 3Pauls Stradins Uni- symptoms and signs that resulting in numerous health ser- versity Hospital, Riga, Latvia vice use, multiple specialist involvement, and poor-quality life. The case report here describes a female adult with Objectives: Mieloproliferative neoplasm (MPN) subtypes familial articular hyperlaxity due to Loeys-Dietz Syndrome are diagnosed based on clinical and genetical data. JAK2 foundonexomesequencingandprimaryimmunodeﬁciency gene variants serves as diagnostic criteria for polycythemia conﬁrmed by hypogammaglobulinemia vera (PV), essential thrombocythemia (ET) and primary Methods: a retrospective analysis of family history, myeloﬁbrosis (PMF), while CALR gene variants - for ET detailed clinical history since infancy and adulthood, andPMF.Theaimofthestudywastosummarizemolecular physical evaluation by geneticist for contrasting phenotype data and utility of CALR gene indel testing in a clinical combined with immunological tests and trio exome MPN cohort. sequencing Material and methods: In the study 354 patients with Results: a 27-year-old woman of non-consanguineous MPN were included. All patients were tested for JAK2 p. parents; mother and aunts with symptoms of chronic V617F variant by qPCR and CALR gene indels by myalgia, joint hyperlaxity, frequent sprains. Sister presented ﬂuorescent-fragment length analysis (PCR-FFLA). Sanger multiple dislocations that have required surgical interven- sequencing was performed to conﬁrm and identify pre- tions. Father shows a history of asthma, various atopies and viously detected variants. depression. Since childhood, she presents mild hypotonia, Results: JAK2 gene variant p.V617F was identiﬁed in myalgia, recurrent ankle and rotula sprains and chronic 208 (58.8%) patients. Indels in CALR gene were identiﬁed fatigue without an identiﬁed cause. During high school has in 38 (10.7%) patients: 52bp deletion c.1099_1150del52 in suffered asthma, myopia, astigmatism, multiple foods, and 20 cases and 5bp insertion c.1154_1155insTTGTC in 12 medication allergies, inﬂammatory bowel disease, gastritis, cases. The rest six patients were identiﬁed to have rare overweight,depressionanddifﬁcultiesinlearning.Facewith variants: c.1103_1148del (2 patients), c.1111_1141del and downslanting palpebral ﬁssures, cutaneous and joint hyper- novel variants - c.1107_1140del and complex indel - laxity and skin striae. Normal echocardiography. Functional c.1131_1154delinsTTGTC (2 patients), that could be test revealed low serum IgG (5.76 g/L) and IgA (0.16 g/L), identiﬁed only with Sanger sequencing not by PCR-FFLA. normal postvaccinal antibodies production, and a trio-based CALR variant identiﬁcation in two patients with previously exome sequencing reporting a probably pathogenic variant diagnosedPVresultedinre-analysisoftheclinicaldataand (c.980G>A, p. Arg327Gln) in TGFB2 gene. changeofdiagnosistoET.ForonepatientJAK2andCALR Conclusion: Usually, cases with medical complexity can variant co-occurrence was identiﬁed. be explained by an extremely rare disease. However, Conclusions: CALR testing should be performed for all another hypothesis diagnostic maybe that constellation of MPN cases. CALR testing can help to distinguish PV from symptoms is due to the co-occurrence of two or more rare other MPN forms. Validation with Sanger sequencing is disease in an individual necessary to conﬁrm and identify rare CALR variants. D.F. Osorio: None. M.L. Agudelo: None. O.I. L. Gailite: None. Z. Dobele: None. D. Rots: None. J. Beltrán: None. Isakova:None.B.JanickaKupra:None.K.Bernate:None. L. Belajeva: None. L. Zarina: None. S. Lejniece: None. E-P08 Intellectual Disability E-P07.3 E-P08.02 Young adult with co-occurrence of common variable Further clinical and molecular delineation of Alazami immunodeﬁciency and Loeys-Dietz syndrome: near the syndrome associated with variants in LARP7 end of the diagnostic odyssey?Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 863 E.Gumuslu1,K.Karaer2,E.Gumus3,A.Ekici1,C.Kraus1, Genomic Hybridization (aCGH) allows efﬁcient genetic A. Reis1 diagnosisofpathologicalconditionsbeforetheirfullclinical manifestation. Application of novel “genotype-ﬁrst” diag- 1Institute of Human Genetics, Friedrich-Alexander-Univer- nosis is of great importance to the patient’s health and sität Erlangen-Nürnberg, Erlangen, Germany, 2Gaziantep medical outcome due to higher rates of chromosomal GenetikHastaliklarTaniMerkezi,Gaziantep,Turkey,3Sitki abnormalities detection compared to conventional kar- Kocman University School of Medicine, Medical Genetics yotyping and multiple ligation-dependent probe ampliﬁca- Department, Mugla, Turkey tion (MLPA) analysis. Materials and methods: The aCGH technique was used Autosomal recessive neurodevelopmental disorders are to determine the genetic background of developmental extremely heterogeneous and for many only few affected abnormalities in a 8-year-old female Macedonian patient. individuals have been described hampering delineation of The blood-derived DNA sample was analyzed using the thefullspectrumofclinicalpresentation.Inalargestudyof Affymetrix® CytoScanTM 750K Array (Applied Biosys- Turkish consanguineous families we identiﬁed a family tems) that includes 550 k non-polymorphic and 200 k SNP with3affectedsiblings(twomales11and8y.o.andone5 markers. The data were interpreted by using Chromosome y.o.female)allpresentingwithintellectualdisability,severe Analysis Suite (ChAS) Software (v4.0). verbal deﬁciency (2-3 words), short stature (<3p), delayed Results: The patient showed the following clinical walking, seizures and dysmorphic features including malar conditions: motor delay, deafness, lack of concentration hypoplasia,broadnose,shortphiltrum,widemouthandfull and several dysmorhological features (blepharophymosis, lips. After excluding aneuploidies exome sequencing telecanthus, narrow palpebral ﬁssures, wide nose, low set revealed a novel frameshift insertion c.475_478dup, p. ears, small mouth and arched eyebrows). Noteworthy, the (Lys160Ilefs*2) in the LARP7 gene. LARP7 is a negative girl was operated from atrial septal defect and was transcriptional regulator of polymerase II, acting by means previously diagnosed with Ohdo Sy. Karyotyping results of the 7SK RNP system. revealed a normal female 46, XX karyotype, while the Frameshifting variants in LARP7 have been associated MLPAanalysisformicrodeletionswasnegative.TheaCGH with Alazami Syndrome (OMIM 615071) characterized by analysisdetected apathological microduplication occurring ID, severe growth restriction and characteristic facial at the 10q26.3 cytoregion (787 kb, 26 genes included), as dysmorphisms. To date, 15 patients were reported. By well as mosaic presence of 3 copies of the Xq26.3q28 comparing this family with the previously reported cases, cytoregion (15,864 kb, 115 genes included). westrengthenthekeyfeaturesofAS:ID,growthrestriction, Conclusion: The present chromosomal abnormalities andhighlightthefacialfeaturesincludingmalarhypoplasia, detected by aCGH analysis could be responsible for the broad nose, full lips and teeth abnormalities. Interestingly, developmental delay of the patient, considering their patholo- no cases with seizures were described, so far. As we failed gicalexpressionaccordingtoClinVardatabase.Furtherstudies to identify in exome sequencing any variant in seizure are needed to conﬁrm these preliminary ﬁndings. associated genes and all three siblings are concordant we D. Nestoroska: None. V. Anastasovska: None. E. wonderedifthissymptomispartoftheclinicalspectrumof Sukarova-Angelovska: None. M. Pesevska: None. G. AS. Although we cannot exclude an undetected cause Ilieva: None. independentofLARP7,weproposethatseizuresareasofar undescribed symptom associated with Alazami Syndrome. E-P08.05 E.Gumuslu:None.K.Karaer:None.E.Gumus:None.A. BRAT1-related neurodevelopmental disorders: two Ekici: None. C. Kraus: None. A. Reis: None. unrelated patients - one previously undescribed mutation E-P08.03 Genomic and clinical characterisation of microduplica- B. Eichhorn1, S. Weidensee2, H. Reichenbach3, M. Klaus1 tions in a patient with developmental delay 1MVZ Mitteldeutscher Praxisverbund Humangenetik D. Nestoroska, V. Anastasovska, E. Sukarova-Angelovska, GmbH, Dresden, Germany, 2MVZ Mitteldeutscher Prax- M. Pesevska, G. Ilieva isverbund Humangenetik GmbH, Erfurt, Germany, 3MVZ MitteldeutscherPraxisverbundHumangenetikGmbH,Leip- Genetic Laboratory, University Pediatric Clinic, Skopje, zig, Germany Macedonia, The Former Yugoslav Republic of BRAT1 gene mutations cause lethal neonatal rigidity and Introduction: The implementation of array Comparative multifocal seizure syndrome (RMFSL) or864 J.delPicchia neurodevelopmental disorder with cerebellar atrophy with Introduction: Loss-of-function variants in BRSK2 have or without seizures (NEDCAS), inherited in an autosomal- recently been described as causative for a neurodevelop- recessive manner. RMFSL is characterized by lack of mental phenotype in 12 individuals with speech delay and developmental progress, neonatal onset hypertonia, micro- variable additional features including intellectual disability, cephaly,intractableseizuresanddeathbeforetheageoftwo motordelay,behavioralissuesandautism.Hereweprovide years, whereas NEDCAS results in milder clinical course. a detailed clinical description of two further individuals Here, we report a 2 9/ -year-old girl with severe global with variants in BRSK2. 12 developmental delay (absent speech, no sitting), short sta- Materials and methods: We performed phenotype ture, microcephaly, mild facial dysmorphism, brain ven- analysis and exome sequencing on two individuals with tricle enlargement and stereotypic hand movements. The intellectual disability and developmental delay of secondfemalepatientshowedalsoprofounddevelopmental unknown cause. disability (nohead control), lack of eyecontactwith ocular Results: We identiﬁed two previously undescribed motility disturbance, microcephaly, and mild facial dys- heterozygous variants in BRSK2: the frameshift variant morphism. Epileptic seizures occurred at the second day of c.1398del; p.(Ser467Alafs*42) and the de novo missense life. She died at 17 months. A panel diagnostic via variant c.209T>C; p.(Leu70Pro). Both individuals pre- sequencing by synthesis was conducted, including candi- sentedwithdevelopmentaldelay/mildintellectual disability date genes contributing to neurodevelopmental disorders. with pronounced speech delay. One individual had Patient 1 and 2 each carried a well-described mutations unilateral renal agenesis and inguinal hernia, which have causing either RMFSL or milder phenotype (c.638dupA/p. not been described in individuals with BRSK2 variants (Val214Glyfs*189)) and involved in a RMFSL before. (c.2125_2128delTTTG/p.(Phe709Thrfs*17)), respectively. Conclusion: Our data provide further insight into the Additional, both girls harbour the identical previously BRSK2-associated phenotype. So far, no genotype-pheno- undescribed variant c.2164_2165delinsGA/p.(Leu722Asp) type correlation can be determined. resulting in a missense mutation. Generally, amino acid H.Kemmer:None.B.Popp:None.A.Verloes:None.D. substitutions in BRAT1 gene in homozygous or compound Horn: None. M. Holtgrewe: None. C. Zweier: None. N. heterozygous state have been described to be causative for Ehmke: None. neurodevelopmental disorders. Segregation analysis in our families conﬁrmed compound heterozygosity. There is a E-P08.08 strong evidence for the disease causing effect of the New insights into the phenotype of COL4A3BP-related unknownmutationintheBRAT1gene,duetotheevidence intellectual disability: an emerging Golgipathy in two unrelated cases. Although a genotype-phenotype correlation is not noticeable for this variant. J. R. Alves1, J. Dupont1, J. P. Monteiro2, A. B. Sousa1 B. Eichhorn: None. S. Weidensee: None. H. Reich- enbach: None. M. Klaus: None. 1Serviço de Genética Médica, Hospital de Santa Maria, Centro Hospitalar e Universitário Lisboa Norte, Lisboa, E-P08.06 Portugal, 2Serviço de Pediatria, Hospital Garcia de Orta, Phenotypic presentation of two additional individuals Almada, Portugal with heterozygous variants in BRSK2 Introduction: COL4A3BP encodes a protein implicated in H. Kemmer1, B. Popp2,3, A. Verloes4, D. Horn1, intracellular ceramide transport to the Golgi complex. De M. Holtgrewe5, C. Zweier3, N. Ehmke1 novo missense variants in this gene have been linked to developmental disorders (DD) in a large-scale study of 1Institute of Medical Genetics and Human Genetics, patients with severe undiagnosed DD (Fitzgerald et al., Charité-Universitaetsmedizin Berlin, Berlin, Germany, 2015). Only ﬁve patients have been reported to date and 2Institute of Human Genetics, University of Leipzig clinical data remains very scarce. We report a new patient Hospitals and Clinics, Leipzig, Germany, 3Institute of with COL4A3BP-related intellectual disability (ID) aiming Human Genetics, Friedrich-Alexander-Universität Erlan- to contribute to the recognition of this condition. gen-Nürnberg, Erlangen, Germany, 4Department of Genet- Materialsandmethods:Clinicaldatawascollectedfrom ics, APHP-Robert DEBRE University Hospital, Denis the patient’s medical records and compared with previous Diderot School of Medicine, Paris University, Paris, reports from scientiﬁc literature and databases. France, 5Core Unit Bioinformatics - CUBI, Berlin Institute Results: A 5 year-old girl with unremarkable family of Health, Berlin, Germany history, pregnancy and delivery, presented with postnatal microcephaly, axial hypotonia, and severe globalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 865 developmental delay. Short stature and facial dysmorphisms words spoken at 2.5 years with poor vocabulary at the were noted and, at 24 months, she developed generalized moment. Good social skills were present. Karyotype was seizures.Currently,shedoesnotwalkunaided,saysonlyone normal. aCGH analysis showed 1 pathogenic copy of the word, and has poor visual contact and marked stereotypic segment on the chromosome 10q11.22 (437 kb) including behaviorwithbruxism.Wholeexomesequencingidentiﬁeda GPRIN2(611240) gene associated with brain development, de novo pathogenic variant in COL4A3BP (S260L). according to aDGV and ClinVar databases. Conclusions:Thismissensevariantwaspreviouslyfound Conclusions: The application of microarray will expand in 4 out of 5 known patients, suggesting a mutational the spectrum in diagnosing cytogenomic abnormalities by hotspotinthisgene.Formerfunctionalevidenceindicatesit including complex structural variants. resultsinintracellularimbalancesinceramide,pivotaltothe M. Pesevska: None. V. Anastasovska: None. E. Sukar- synthesis of sphingolipids. Our case has signiﬁcant overlap ova-Angelovska: None. D. Nestoroska: None. G. with clinical data from previous patients. This report adds Ilieva: None. evidence to an emerging consistent phenotype associated with COL4A3BP mutations, characterized by severe ID, E-P08.10 postnatal microcephaly, epilepsy, autistic behavior includ- Deletion 7q31.2q31.31 segregating in a family with ing striking bruxism, and unspeciﬁc dysmorphic features. speech and language deﬁciencies J.R.Alves: None.J.Dupont:None.J.P.Monteiro: None. A.B. Sousa: None. M. Rieger1, M. Krumbiegel1, M. Reuter1, A. Schützenberger2, A. Reis1, C. Zweier1 E-P08.09 Paediatric patient with deletion on chromosome 1Institute of Human Genetics, Friedrich-Alexander-Univer- 10q11.22 diagnosed by aCGH sität Erlangen-Nürnberg FAU, Erlangen, Germany, 2Divi- sionofPhoniatricsandPediatricAudiology,Departmentof M.Pesevska,V.Anastasovska,E.Sukarova-Angelovska,D. Otorhinolaryngology, Head and Neck Surgery, Friedrich- Nestoroska, G. Ilieva Alexander-Universität Erlangen-Nürnberg FAU, Erlangen, Germany University Pediatric Clinic, Skopje, Macedonia, The Former Yugoslav Republic of Deletions of chromosome 7q31 have been described in individualswithvariableneurodevelopmentaldisordersand Introduction: The microchip-based diagnostic practices speech impairment. These deletions usually contain become widely introduced in postnatal diagnosis of indi- FOXP2, in which loss-of-function mutations represent a viduals with developmental delay and dysmorphism. Array major cause for speciﬁc language and speech phenotypes. ComparativeGenomicHybridization(aCGH)technologyto Recently,asinglepatientwithdevelopmentaldelayaswell whole human genome screening revealed an unexpectedly as speech and language impairment carrying a 3.2 Mb large number of deletions and duplications. deletion in 7q31.2q31.31 excluding FOXP2 was reported. Materials and methods: aCGH analysis was perform in By chromosomal microarray analysis we now identiﬁed a pediatricpatientwithdysmorphiaandmotordelayusingthe similar microdeletion in three family members presenting CytoScan_750k Array platform (Affymetrix) which com- with variable speech, language and neurodevelopmental prises 550 k non-polymorphic and 200 k SNP markers by phenotypes.Theindexpatientpresentedwithnormalmotor the Chromosome Analysis Suite (ChAS) Software (v4.0). milestones but delayed speech development, reduced com- Results: Our patient was born with small birth weight prehension and an incomplete sentence structure at age 5 with idiopathic thrombocytopenia during the neonatal years.Atage10yearsheattendedaschoolforchildrenwith period. At the age of 4 years, she has short stature and special needs and presented with microcephaly, attention following sings of dysmorphia - sparse hair, baldness in deﬁcits and slurred speech. His sister was referred at age 3 infancy, slow growing hair, wide fontanel, dry skin, no years with normal ﬁrst milestones but a delay in speech sweating,smallteeth,deepseteyes,widenasaltip,smooth development. Linguistic testing revealed impairment of all philtrum, up slanted palpebraes, protruded tongue in language and speech levels with limited vocabulary and infancy, prominent forehead and some missing teeth-upper slurred and imprecise pronunciation. The mother had incisors. Hydronephrosis on the left kidney, reﬂux vesi- attended a school focusing on speech and language deﬁ- caurinaria, atrial septal defect, dilatated pulmonary artery ciencies and now presented with slurred speech. Segrega- and CNS plexus hypertrophy were noticed by ultrasono- tion analysis in the healthy, maternal grandparents did not graphy. Also, subclinical hypothyreosis was present. She detectthemicrodeletion,thusindicatingdenovooccurrence has mild motor delay, started to walk at 20 months, ﬁrst inthemother.Thedeletioncontains17genesandislocated866 J.delPicchia in close proximity to the 3’ end of FOXP2, but not including it. Though positional effects on FOXP2 expres- Clinicalandgeneticsfeaturesofbothpatients sion cannot be excluded, our ﬁndings support a new locus Feature Patient1 Patient2 on 7q31.2q31.31 associated with mild neurodevelopmental Coordinate(GRCh37) 233195538- 233195538- and more prominent speech and language phenotypes. 233318065 233311912 M. Rieger: None. M. Krumbiegel: None. M. Reuter: Length 123kb 116kb None. A. Schützenberger: None. A. Reis: None. C. Overlapped ALPP,ALPPL2, ALPP,ALPPL2, Zweier: None. codinggenes DIS3L2 DIS3L2 Inheritance father unknown E-P08.11 Clinical signiﬁcance of 2q37.1 duplication in patients with intellectual disability and facial dysmorphism Discussion and conclusion: Duplication of 2q37 includ- ing DIS3L2 is assumed as benign (DECIPHER, ISCA, Z. Capkova1,2, P. Capkova1,2, J. Srovnal1,3, K. Staffova1,3, ClinVar). We described two unrelated patients with ASD, K. Adamova1,2, J. Pazderova1, M. Hajduch3, ID and facial dysmorphia who carried the duplication of M. Prochazka1,2 2q37 including DIS3L2. We suggest that this CNV might cause of abnormal phenotype with variable penetrance. Of 1Department of Medical Genetics, University Hospital course,wecannotexcludeanucleotidelevelchangeswhich Olomouc, Olomouc, Czech Republic, 2Department of could explain a variable penetrance of 2q37 duplication. Medical Genetics, Faculty of Medicine and Dentistry, Acknowledgment: Supported by MH_CZ_DRO_F- Palacký University Olomouc, Olomouc, Czech Republic, NOL_00098892, IGA_LF_2020_007 3InstituteofMolecularandTranslationalMedicine,Faculty Z. Capkova: B. Research Grant (principal investigator, of Medicine and Dentistry, Palacký University Olomouc, collaborator or consultant and pending grants as well as Olomouc, Czech Republic grants already received); Modest; University Hospital Olomouc, Palacký University Olomouc. P. Capkova: B. Background: 2q37 duplications including only ALPP, Research Grant (principal investigator, collaborator or ALPPL2, DIS3L2 have been already described in patients consultant and pending grants as well as grants already withIDandfacialdysmorphia.However,theseduplications received); Modest; University Hospital Olomouc, Palacký were concluded as benign variations based on inheritance University Olomouc. J. Srovnal: B. Research Grant from health parents. (principal investigator, collaborator or consultant and Aim:WereporttwounrelatedpatientswithASD,IDand pendinggrantsaswell asgrantsalreadyreceived); Modest; facial dysmorphic features. University Hospital Olomouc, Palacký University Olo- Methods: Karyotyping, exclusion of CGG triplet repeats mouc. K. Staffova: B. Research Grant (principal investi- expansion in FMR1 and chromosomal microarray (CMA) gator,collaboratororconsultantandpendinggrantsaswell were performed in both patients after informed consent as grants already received); Modest; University Hospital collecting from their parents. Olomouc, Palacký University Olomouc. K. Adamova: B. Results: Chromosomal aberration and Fragile-X syn- Research Grant (principal investigator, collaborator or drome were excluded in both. 2q37 duplication including consultant and pending grants as well as grants already ALPP, ALPPL2, DIS3L2 was revealed by CMA. In patient received); Modest; University Hospital Olomouc, Palacký 1theduplicationwasinheritedfromfather.Inheritancewas University Olomouc. J. Pazderova: None. M. Hajduch: unknown in patient 2. No other clinically relevant CNVs None. M. Prochazka: None. were observed. E-P08.14 Early neurodevelopmental milestones acquisition in Clinicalandgeneticsfeaturesofbothpatients fragile X syndrome, a caregivers online report Feature Patient1 Patient2 Height <3thpercentile 40thpercentile C. Azevedo Soares1,2, D. Gonzaga3, I. Vaz Matos3, Headcircumference <3thpercentile 34thpercentile N. Tkachenko1, A. Fortuna1,2, G. Soares1, A. Prior3 Weight <3thpercentile 23thpercentile 1Centro de Genética Médica Jacinto Magalhães, Porto, Bodymass 15.02 15.50 index(BMI) Portugal, 2Unit for Multidisciplinary Research in Biomedi- Addclinicalfeatures microcephaly none cine, Instituto de Ciências Biomédicas Abel Salazar/ Universidade do Porto, Porto, Portugal, 3Unidade deAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 867 Neurodesenvolvimento, Serviço de Pediatria, Centro compound-heterozygous mutations in the GRID2 gene, Materno-InfantildoNorte,CentroHospitalarUniversitário encoding an ionotropic glutamate receptor. So far, seven do Porto, Porto, Portugal affectedindividualsfromthreeunrelatedfamilieshavebeen reported. The disorder is characterized by delayed psycho- Introduction: Fragile X syndrome (FXS) is a genetic dis- motor development, intellectual disability, severely order affecting neurodevelopment caused by FMR1 dys- impaired gait due to progressive cerebellar ataxia, ocular function.Theidentiﬁcationofdevelopmentaldelaypatterns movement abnormalities, and progressive cerebellar atro- could accelerate the diagnostic of FXS in a population of phy in brain imaging. By trio exome sequencing, we now children with development delay. identiﬁed a novel homozygous variant (c.568C>T; p. Methods: We designed an online survey in which FXS Gln190*)inGRID2inafouryearoldfemalepatientfroma patients’ caregivers indicated patients characteristics. We consanguineous Iraqi family. Both parents were conﬁrmed usedtheHaizea-Llevantdevelopmentscaleasareferenceof to be heterozygous carriers. The patient was born after normalcy.Timeofacquisitionwasexpressedasmonthsold uneventful pregnancy and showed early-onset severe (mo) and for each milestone timing it was calculated the delayed psychomotor development. At the age of 4 years, median (M) and P25 and P75 (P25-P75). she does not sit, walk or speak and presents with severe Results:Fifteencaseswereconsideredforanalysis:three muscular hypotonia. Further clinical characteristics are a females and 12 males. The median age for postnatal distinct truncal and appendicular progressive ataxia and diagnosis was 48 mo: 36 mo for males and 72 mo for binocularverticalnystagmuswithahighfrequenthorizontal females.MaleFXSpatientsshowedadelayedacquisitionof component, central hearing loss and incomplete loss of early milestones such as cervical control (M= 6mo, 2-12 sight.Shedoesnotﬁxobjectsorinteracts withpeople.She mo) with normal median time of acquisition of the ﬁrst isdystrophicwithaweightunderthethirdpercentileofthe word (M= 13mo, 11.75-21mo), and delayed acquisition of centralEuropeanstandard.Eatinghairandgnashingofteeth autonomous walking (M= 22mo, 16.5-24 mo). Given the are striking behaviors. In addition, cerebral magnetic reso- small number of female FXS in our study, it was not nance imaging (MRI) showed cerebellar hypoplasia. Our possible to conclude if females had a characteristic pattern ﬁndings further delineate the mutational and clinical spec- of developmental delay. trum of GRID2 associated spinocerebellar ataxia type 18. Conclusions: FXS patients present a biphasic delayed K.L.M.L. Hetzelt: None. C. Kraus: None. S. Kusnik: development intheﬁrst twoyears of lifewithanimportant None.C.Thiel:None.A.B.Ekici:None.A.Reis:None.C. delayontheacquisitionofgrossmotorskills.Nevertheless, Zweier: None. the clinical presentation was highly variable to allow the discrimination these patients with FXS by their pattern of E-P08.17 developmental delay. Notwithstanding, this work bring the A novel patient helps to deﬁne the phenotype, develop- attentiontotheearlygrossmotorskillsimpairmentinFXS, mental trajectory and clustering of de novo missense that can be improved with targeted interventions. mutations in the HECW2 syndrome C. Azevedo Soares: None. D. Gonzaga: None. I. Vaz Matos: None. N. Tkachenko: None. A. Fortuna: None. G. S. Bendova1, M. Vlckova1, M. Hancarova1, D. Prchalova1, Soares: None. A. Prior: None. V. Stranecky2, Z. Sedlacek1 E-P08.16 1Department of Biology and Medical Genetics, Charles A case of autosomal recessive spinocerebellar ataxia University 2nd Faculty of Medicine and University Hospital type 18 with a novel mutation in GRID2 Motol, Prague, Czech Republic, Prague, Czech Republic, 2Department of Pediatrics and Adolescent Medicine, Diag- K. L. M. L. Hetzelt1, C. Kraus1, S. Kusnik2, C. Thiel1, nostic and Research Unit for Rare Diseases, Charles A. B. Ekici1, A. Reis1, C. Zweier1 University 1st Faculty of Medicine and General University Hospital,Prague,CzechRepublic,Prague,CzechRepublic 1Institute of Human Genetics, Friedrich-Alexander-Univer- sität Erlangen-Nürnberg FAU, Erlangen, Germany, De novovariants in HECW2,whichencodes theHECT, C2 2DepartmentofPediatrics,UniversityHospitalforChildren and WW domain containing E3 ubiquitin protein ligase 2, and Adolescents, Friedrich-Alexander-Universität Erlan- were initially identiﬁed in large exome sequencing (ES) gen-Nürnberg FAU, Erlangen, Germany studies.AseriesofsevenpatientsclearlyassociatedHECW2 withaneurodevelopmentaldisorderwithhypotonia,seizures Autosomal-recessivespinocerebellarataxiatype18isarare and absent language (OMIM #617268) in 2017. Since then geneticneurologic disorder. It iscaused by homozygous or onlytwonovelcasereportshavebeenpublished.Wepresent868 J.delPicchia the genotype, phenotype and developmental trajectory of a dysmorphism including upslanting palpebral ﬁssure, bul- new patient, and review all previous cases. The 8-year-old bous nose, cleft lip and palate, pectus excavatum, boy has hypotonia, microcephaly, failure to thrive, severe intellectual disability, developmental delay, hypotonia and intellectual disability, absent speech, and seizures. His facial increased alkaline phosphatase level. One out of three featuresincludeprominentupperlipandstrabismus.TrioES sisters of index patient had similar clinical features. The identiﬁeddenovovariantChr2(GRCh37):g.197106886C>T, other family members were healthy. Whole exome sequen- NM_001348768.1(HECW2):c.3572G>A, p.(Arg1191Gln). cing (WES) was performed to the index patient. Sanger Thevarianthasbeenreportedinthreepreviouspatients,and seguencing analysis was used for family segregation is considered causal for the HECW2 syndrome. The pheno- analysis. type of the patient ﬁts the previous cases; however, he also Results: A novel homozygous mutation (c.715_717del hasaventricularseptumdefect,andheneitherhasabnormal TGG;p.Trp239del)ofPGAP3genewasdetectedwithWES brain MRI ﬁndings nor requires gastrostomy tube feeding. analysis in the index patient (NM_033419.5). Family Long-termfollow-upshowsregressionofmotorskillsaround segregationanalysiswasperformedandbioinformatictools 12 months, abnormal EEG ﬁndings since 14 months wereusedfortheevaluationofthisnovelvariant.Thesame (prompting anti-epileptic therapy), and self-injurious beha- homozygous mutation was noted by sanger seguencing viour and sleep disturbances since 45 months of age. Our analysis in her younger sister, who had similar clinical analysis(includingvariantsfromlargestudiesanddatabases) features. Both parents and the other healthy sisters were indicatesthatdeleteriousmissenseHECW2variantsclusterin heterozygous for this mutation. exons encoding the HECT domain and its adjacent region Conclusions:Wereportenovelhomozygousmutationof (exons20-29,withresiduesArg1191,Arg1330andGlu1445 PGAP3 gene. HPMRS should be kept in mind in patients being the hotspots), and possibly also the WW2 domain with developmental delay, hypotonia, cleft palate and mild (exons 12-13). Concurrently, these regions are deserts for to moderate serum ALP elevation. missense variation in normal individuals. Supported by 17- F.Hazan:None.S.Gürsoy:None.P.Karaoğlu:None.Ü. 29423A, LM2018132 and 00064203. Yılmaz: None. S. Bendova: None. M. Vlckova: None. M. Hancarova: None. D. Prchalova: None. V. Stranecky: None. Z. E-P08.19 Sedlacek: None. A 3-year old girl with Hypotonia, Ataxia, And Delayed- Development Syndrom (HADDS) E-P08.18 AnovelPGAP3mutationintwosiblingswithhyperpho- K. Khuller1, T. Haack2, C. Finetti3, F. J. Kaiser1, sphatasia with mental retardation syndrome A. Kuechler1 F. Hazan1, S. Gürsoy2, P. Karaoğlu3, Ü. Yılmaz3 1Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany, 2Institut für 1DepartmentofMedicalGenetics,Dr.BehcetUzChildren’s MedizinischeGenetikundAngewandteGenomik,Tübingen, Hospital,Izmir,Turkey,2DepartmentofPediatricGenetics, Germany, 3SPZ, Elisabeth-Krankenhaus, Essen, Ger- Dr.BehcetUzChildren’sHospital,Izmir,Turkey,3Depart- many ment of Pediatric Neurology, Dr. Behcet Uz Children’s Hospital, Izmir, Turkey Hypotonia, ataxia, and delayed development syndrome (HADDS, OMIM #617330) is a neurodevelopmental syn- Introduction: Hyperphosphatasia with mental retardation drome characterized by congenital hypotonia, delayed syndrome (HPMRS) OMIM # 239300), is an autosomal psychomotor development, variable intellectual disability recessive disorder characterized facial dysmorphism, intel- with speech delay, variable dysmorphic facial features, and lectual disability, seizures, cardiac abnormalities, develop- ataxia,oftenassociatedwithcerebellarhypoplasia.In2017, mental delay and elevated alkaline phosphatase. Six heterozygous variants in EBF3 are described for the ﬁrst subgroups of HPMRS were ideﬁned in which pathogenic time by three parallel publications in 2017 as causative for mutations affect genes involved in either synthesis (PIGV, HADDS (Chao et al., 2017, Harms et al., 2017, Sleven PIGW, PIGO, PIGY) or remodeling (PGAP2, PGAP3) of et al., 2017). At present, 23 patients with different types of the anchor proteins. mutations including missense, frameshift or nonsense Material and methods: A two year-old girl patient was mutations as well as variants affecting conserved splice referred to our genetic clinic for intellectual disability and elements are reported. All reported cases showed a hetero- hypotonia. There was a ﬁrst-degree consanguinity between genous phenotype. We report on a case of a 3-year old girl the parents. This patient had microcephaly, facial with a class 5-mutation in EBF3, detected by Next-Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 869 Generation-Sequencing. She presented with delayed O. Levchenko: None. N. Demina: None. A. development, microcephaly, ataxia, reﬂux, and feeding Lavrov: None. difﬁculties. She also showed a thermoregulatory dysfunc- tion, which was not observed in other affected individuals E-P08.23 sofar.Wepresentdetailedclinicaldataofourpatientinthe Patient with the Tatton-Brown-Rahman syndrome &lt context of the current literature thus expanding the pheno- de novo constitutive DNMT3A variant typic spectrum of the HAAD syndrome. K.Khuller:None.T. Haack:None. C.Finetti:None.F.J. I. Jaszczuk1,2, I. Winkler3, A. Sobczyńska-Tomaszewska4, Kaiser: None. A. Kuechler: None. M. Lejman5, A. Pietrzyk4, M. Kacprzak4 E-P08.20 1University Children’s Hospital, Department of Pediatric TMEM222 is a new cause of autosomal recessive Hematology, Oncology and Transplantology, Lublin, intellectual developmental disorder Poland, 2Department of Cancer Genetics with Cytogenetic Laboratory, Medical University, Lublin, Poland, 3St’Johns O. Levchenko, N. Demina, A. Lavrov Center Oncology, Lublin, Poland, 4MedGen Medical Centre, Warsaw, Poland, 5Genetic Diagnostics, Depart- Research centre for medical genetics, Moscow, Russian ment of Pediatric Hematology, Oncology and Transplan- Federation tology, Medical University, Lublin, Poland Introduction: The prevalence of autosomal recessive Introduction: Tatton-Brown-Rahman syndrome (TBRS; intellectual developmental disorder (ARIDD) in affected OMIM 615879) isanovergrowthandintellectual disability children of an outbred population is estimated about 10%. syndrome, ﬁrst described in 2014. Additional clinical fea- There are 72 types of ARIDD described in OMIM. tures includedysmorphic features, obesity,musculoskeletal TMEM222 was once described as a candidate gene for disorders (hypotonia, hypermobility, kyphoscoliosis) and ARIDD with moderate intellectual disability, speech delay, behavioural problems (autistic spectrum disorders) and mild hypotonia, aggressiveness and body shivering. afebrile seizures. The underlying cause of the syndrome is Materials and methods: Whole exome sequencing constitutivevariantsintheDNMT3gene.Wepresentan11- (WES) was performed using IlluminaTruSeq® ExomeKit old boy with recognized Tatton-Brown-Rahman syndrome and IDT xGen® Exome Research Panel on Illumina and conﬁrmed variant in the DNMT3 gene. NextSeq 500. Materials and methods: During molecular diagnostic Results: We describe the Caucasian 31-year-old men procedure analysis of FMR1 gene for FRAXA syndrome born from consanguineous parents. Birth weight was 4800 and panel of 264 genes correlated with autism and mental g,conditionsevere.Hehadinfantilespasmswhenwokeup retardation (NGS) were performed. duringﬁrst2-8months.Hewalkssince3yearswithataxia, Results: For FMR1 gene expansion of CGG repeats was speaks few words, understands speech and uses computer. not identiﬁed. NGS analysis allowed identiﬁcation of Phenotype: hypotonia, microcephaly, hypothelorism, big known heterozygotic variant p.Pro904Leu (c.2711C>T) in nose, short philtrum, big mouth, full lips, gingival the DNMT3A. This variant is reported in dbSNP database hyperplasia, small chin, broad and short distal phalanges, (rs149095705) and ClinVar Database as likely pathogenic. narrow feet with valgus deformity, broad big toe. His Molecular analysis of p.Pro904Leu was also performed for brother 11 years old has similar phenotype but with proband’s mother and sister were mutation was not prominentincisorsandseizuressincebirth.Hecannotwalk identiﬁed. Unfortunately the father’s material was not andspeak.Hisbirthweightwas4700g.Theirhealthysister available for genetic analysis. There is high probability of hadbirthweight3500g.WESrevealedhomozygoussplice de novo character of identiﬁed variant. variant c.539+2T>C NM_032125 in TMEM222. Sanger Conclusions: In the case of patients with intellectual sequencing conﬁrmed this variant as heterozygous in disability and obesity, Tatton-Brown-Rahman syndrome parents and sister, and homozygous in affected brother. should be considered in the differential diagnosis. Studies Conclusions: Given the similarity of the phenotype with using theNGStechnique facilitate thediagnosisofpatients thepreviouslydescribed,thecorrespondenceofsegregation with intellectual disabilities. to the autosomal recessive type of inheritance, we suppose I. Jaszczuk: None. I. Winkler: None. A. Sobczyńska- this variant to be causative. We describe new ARIDD with Tomaszewska:None.M.Lejman:None.A.Pietrzyk:None. developmentaldelay,hypotonia,seizures,highbirthweight M. Kacprzak: None. and dimorphisms.870 J.delPicchia E-P08.24 S.Susgun:None.E.Yucesan:None.O.Kocaturk:None. Biallelic NALCN variant detected by homozygosity M. Calik: None. U. Ozbek: None. S. Ugur Iseri: None. mapping and whole exome sequencing in a consangui- neous family from Turkey E-P08.27 Laryngomalacia, recurrent overgrowth of pharyngeal S. Susgun1,2,3, E. Yucesan1, O. Kocaturk4, M. Calik5, lymphoid tissue, mild developmental delay and macro- U. Ozbek2,6, S. Ugur Iseri2 cephaly in a girl with a de novo heterozygous mutation in ZBTB7A 1Department of Medical Biology, Faculty of Medicine, BezmialemVakifUniversity, Istanbul, Turkey, 2Department C.vonderLippe1,K.Tveten1,Ø.L.Holla1,Ø.L.Busk1,M. ofGenetics,AzizSancarInstituteofExperimentalMedicine, G. Haug2, W. Thorstensen3,4, A. K. Aasebøstøl3, Istanbul University, Istanbul, Turkey, 3Graduate School of T. Prescott1 Health Sciences, Istanbul University, Istanbul, Turkey, 4Department of Neurology, Faculty of Medicine, Harran 1DeptofMedicalGenetics,TelemarkHospitalTrust,Skien, University, Sanliurfa, Turkey, 5Department of Pediatric Norway, 2Dept of Medical Genetics, St. Olavs University Neurology, Faculty of Medicine, Harran University, Hospital, Trondheim, Norway, 3Dept of Otolaryngology, Sanliurfa, Turkey, 6Department of Medical Genetics, Head and Neck Surgery, St. Olavs University Hospital, School of Medicine, Mehmet Ali Aydinlar Acibadem Trondheim, Norway, 4Dept of Neuromedicine and Move- University, Istanbul, Turkey ment Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway Neurodevelopmental disorders (NDD) are a large and het- erogeneous group of diseases including intellectual dis- Case:This12-year-oldgirlhadacongenitalumbilicalhernia ability,developmentaldelayandautismspectrumdisorders. and laryngomalacia, as well as frequent upper airway infec- Several ultra rare NDD associated variants in numerous tions, obstructive sleep apnea and serious otitis media from genesspeciﬁcalmosttosinglefamilieshavebeenidentiﬁed infancy. Strikingly, recurrent pharyngeal lymphoid hyper- by unbiased next generation sequencing technologies. To plasiahasnecessitated17surgicalprocedures;startingatage determine the genetic component of NDD in a con- 15monthsold.Herthymusisdescribedaslargeforherage. sanguineousfamilyfromTurkey,wehaveperformedSNP- Generalized lymphadenopathy / hepatosplenomegaly are based homozygosity mapping in the family along with absent. She has mild motor and language delay. Current whole exome sequencing (WES) in the affected sib pair. measurements are height 25%, weight 4 kg > 97,5%, head The SNP genotyping data generated on two different array circumference97,5%.WES-triodetectedadenovononsense chips was combined with PLINK to detect homozygous variant in ZBTB7A, NM_015898.3:c.832G>T p.(Glu278*). stretchescommontotheaffectedsibpair.TheWESdatawas Thevariant isnot presentingnomAD, and the geneisLoF- ﬁltered for rare alleles with predicted pathogenic impact on intolerant(pLI=0.96;O/e=0:07)andispredictedtoresultin proteinfunctioninthehomozygousloci.Thiscollectiveeffort NMD. No other SNVs ofinterestweredetected,and a 180k has led us to identify a loss of function variant in NALCN in array CGH analysis was unremarkable. the homozygous state. Sanger sequencing has conﬁrmed Discussion: ZBTB7A (OMIM #605878) encodes the segregation of this variant with the NDD phenotype in the leukemia/lymphoma related factor, LRF ZBTB7A is a pedigree. NALCN encodes a member of sodium leak channel candidate gene for some phenotypic features reported in complexandisassociatedwitharecessiveOMIMphenotype; individualswithmicrodeletionsofchromosome 19p13.3; Hypotonia, infantile, with psychomotor retardation and notably macrocephaly, obesity, sleep apnea, umbilical characteristic facies 1 (MIM:615419) hernia, learning difﬁculties and developmental delay Our study presents the combined analysis of linkage and (1,2) - all features present in the girl we describe. Ohishi exomeanalysisasapowerfulandprecisetooltodiagnosea et al. (3) recently reported a boy with macrocephaly, clinically rare and recessively inherited condition on intellectual disability and sleep apnea who had a de novo molecular level. We are planning to analyze possible likely pathogenic heterozygous missense variant in functional effects for the variant using in vitro studies to ZBTB7A. enlighten the molecular pathogenesis. Conclusion:WebelievethatthedenovoZBTB7Avariant ThisworkhasbeensupportedbythegrantsofTUBITAK in our patient is the cause of her distinct phenotype -- (113S331) and TUBA GEBIP 2019 program and Bezmia- laryngomalacia, recurrent overgrowth of pharyngeal lym- lem Vakif University Scientiﬁc Research Support Unit phoid tissue, macrocephaly and delayed motor and (Project no:12.2019/9) language development.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 871 C. von der Lippe: None. K. Tveten: None. Ø.L. Holla: E-P08.32 None. Ø.L. Busk: None. M.G. Haug: None. W. Thor- The clinical utility of targeted NGS in neurodevelop- stensen: None. A.K. Aasebøstøl: None. T. Prescott: None. mentaldisorders:acaseofagirlwithpontocerebellar hypoplasia caused by TSEN54 gene pathogenic E-P08.31 variants Study of diagnostic yield of genetic studies in neuronal migration disorders M. Wayhelova1,2, V. Vallova1,2, E. Hladilkova2, H. Filkova2, J. Oppelt3, J. Soukalova2, P. Kuglik1,2 N. Ortiz Cabrera, M. Vilar Egea, B. Fernández Garoz, V. Cantarín Extremera, A. Duat Rodríguez, L. González 1Department of Experimental Biology, Faculty of Science, Gutierrez Solana, M. Jimémez Legido, V. Soto Insuga, MasarykUniversity,Brno,CzechRepublic,2Departmentof M. Ruiz Falcó, J. García Peñas Medical Genetics, University Hospital Brno, Brno, Czech Republic, 3CEITEC-Central European Institute of Technol- HospitalInfantilUniversitarioNiñoJesús,Madrid,Spain ogy, Masaryk University, Brno, Czech Republic Neuronal migration is the key factor in lamination of cer- Next-generation sequencing (NGS) techniques represent ebral cortex. At 12th day stage of development neuronal a widely used, powerful tool for the identiﬁcation of the progenitorsbeginmigration.Excitatoryneuronsarebornin genetic causes of neurodevelopmental disorders and the dorsal ventricular zone and migrate superﬁcially to the congenital abnormalities. We present a case of a girl cortical plate. These neurons migrate along the vertical (*2016) from the 3rd gravidity of healthy non-con- ﬁbers of the radial glia. The layers of the cortex form in an sanguineous couple (mother *1984, father *1978). She “inside-out” sequence with later born neurons migrating was diagnosed a global developmental delay, micro- past their predecessors in the cortical plate so that they are brachycephaly,severedysplasiaofbrainstemandmuscle more superﬁcial in their ﬁnal position than earlier born hypertonia. She has a normal female karyotype 46,XX neurons(1). and normal array-CGH proﬁle arr(1-22,X)x2. She was The neuronal migration disorders (NMD) include: lissen- investigated by targeted NGS by gene panel ClearSeqXT cephaly, periventricular heterotopia, polymicrogyria (PMG) Inherited Disease (Agilent Technologies) containing and cortical dysplasias(2). NMD present with: epilepsy, more than 2700 genes known to cause inherited dis- developmental delay (DD), intellectual disability (ID) and orders. We detected pathogenic variants in the TSEN54 other malformation could be associated. Although the gene in compound heterozygosity, NM_207346.2:c.[56 majority of this disorders have a genetic base, some +2T>G;160C>G];[919G>T]. The parents are healthy environmental causes such as intrauterine infections could heterozygouscarriersofthesevariants,aswasconﬁrmed causethem(3).Todaymorethan100geneshavebeenrelated by Sanger sequencing. Pathogenic variants of the to NMD (3) including genes related to tubulinopathies (2). TSEN54 are causative in extremely rare pontocerebellar WedidanobservationalstudyofNMDpatientsseenatthe hypoplasia (PCH) type 2A, 4 and 5. The combination Clinical Geneticclinic from june2018until december 2019. of splicing and missense variants has been described We analyzed the results of NGS based genetic studies. in only one case of PCH5 so far, resulting in recurrent Results: 29 patients were studied, the global diagnostic fetal lethality. Therefore, we suggest the TSEN54 yieldwas28%.Wewereabletodetectlargedeletionsusing pathogenic variants could have been the cause of pre- NGS. We found pathogenic variants in ARFGEF2, ARX, vious recurrent abortions in the presented family. This DEPDC5, DYNC1H1, NEDD4L, PAFAH1B and TCF20. case showed the usefulness and effectivity of our mole- Pathogenic variants in DEPDC5 were the most frequent cular diagnostics algorithm enhanced by NGS approa- pathogenic ﬁnding 29% of positive results. ches to elucidate the molecular genetic causes in Conclusions: One third of patients with NMD will heterogeneous neurodevelopmental disorders. Supported beneﬁt from a genetic diagnosis. DEPDC5 is a frequently by the project of Faculty of Science of Masaryk Uni- involved in this disorders. versity MUNI/A/1127/2019 and IP UH Brno 2019 N. Ortiz Cabrera: None. M. Vilar Egea: None. B. PIG 5/19. Fernández Garoz: None. V. Cantarín Extremera: None. A. M. Wayhelova: None. V. Vallova: None. E. Hladilkova: Duat Rodríguez: None. L. González Gutierrez Solana: None. H. Filkova: None. J. Oppelt: None. J. Soukalova: None. M. Jimémez Legido: None. V. Soto Insuga: None. None. P. Kuglik: None. M. Ruiz Falcó: None. J. García Peñas: None.872 J.delPicchia E-P08.33 ears.Hehaswidelyspacedteethandelongatedgums.Since Intrafamilial variability of Refsum syndrome the age of 8 months he has fever/infection associated seizures but needs no permanent medication. S. Geuer, I. Schwaab, R. König In this report we present detailed clinical and molecular data of a new patient with SKDEAS to raise awareness of Bioscientia, Ingelheim, Germany this clinically recognizable rare intellectual disability syndrome. A consanguine Pakistani couple with two daughters affec- A. Busche: None. M. Vockel: None. A. Bohring: None. ted by intellectual disability and developmental delay has been investigated by genetic diagnostics. The younger girl E-P08.36 hasmoreseveredevelopmentdelayandshowsincontrastto Two families with inherited protein truncating CHD3 her sister microcephaly, craniosynostosis and autistic variants suggest reduced penetrance in Snijders Blok- behaviour. Whole exome sequencing of the more severe Campeau syndrome affectedsisterrevealedahomozygouspathogenicvariantin PEX5 - a gene known to be causative for autosomal J. van der Spek1, J. den Hoed2, L. Snijders Blok1,2,3, recessive Refsum syndrome. Segregation analysis con- C.W.Ockeloen1,M.E.H.Simon4,L.E.L.M.Vissers1,3,S. ﬁrmed homozygosity of the variant in the other sister and E. Fisher2,3, T. Kleefstra1,3 heterozygosityoftheparents.Wholeexomesequencingdid notdetectanotherpotential pathogenicvariant.Thus,itcan 1Department of Human Genetics, Radboud University be concluded that the detected PEX5 variant causes a Medical Center, Nijmegen, Netherlands, 2Language and Refsum syndrome with uncharacteristic features and ahigh Genetics, Max Planck Institute for Psycholinguistics, intrafamilial variability. Nijmegen, Netherlands, 3Donders Institute for Brain, S. Geuer: A. Employment (full or part-time); Signiﬁcant; CognitionandBehaviour,Nijmegen,Netherlands,4Depart- Bioscientia. I. Schwaab: A. Employment (full or part- ment of Medical Genetics, University Medical Center time); Signiﬁcant; Bioscientia. R. König: A. Employment Utrecht, Utrecht, Netherlands (full or part-time); Signiﬁcant; Bioscientia. Chromodomain Helicase DNA-binding 3 (CHD3) is a E-P08.35 chromatin remodeling ATPase which functions as an A further patient with Skraban-Deardorff syndrome: important subunit of the nucleosome remodeling and dea- Presentation of the clinical and molecular phenotype of cetylase (NuRD) complex. De novo mutations in CHD3 a rare intellectual disability syndrome resultinSnijdersBlok-Campeausyndrome(#MIM618205), characterized by global developmental delays and/or intel- A. Busche, M. Vockel, A. Bohring lectual disability, speech delay, macrocephaly, hypotonia and facial dysmorphism. The vast majority (~95%) of InstitutfürHumangenetik,WestfälischeWilhelms-Universi- pathogenic mutations reported so far are missense muta- tät, Münster, Germany tions. Interestingly, CHD3 is predicted to be extremely intolerantforlossoffunctionvariance.Non-penetranceand/ The Skraban-Deardorff syndrome (SKDEAS, or variable expressivity has not been reported. Here we OMIM#617616)isararegeneticconditioncharacterizedby describe two cases with seemingly pathogenic, but inher- intellectualdisability, ahistoryoffebrileand/or non-febrile ited, protein truncating variants in CHD3. seizures, and a recognizable facial appearance. SKDEASis In a 4-year-old girl with global developmental delay, caused by heterozygeous mutations in WDR26 autism spectrum disorder, severe feeding difﬁculties, and (OMIM*617424)andisinheritedinanautosomaldominant facial dysmorphisms, ﬁtting with the spectrum of Snijders pattern. To our knowledge only 15 patients have been Blok-Campeau syndrome, whole exome sequencing reported so far. revealed a nonsense variant, p.(W1217*), in the CHD3 Here we present a 3 year and 3 months old boy with helicasedomain.Thevariantwasinheritedfromherhealthy SKDEAS due to the heterozygous de novo mutation mother and grandmother. c.508G>T; p.(Gly170*) in WDR26. He has moderate In a 3-year-old boy with developmental delays, pre- intellectual disability and shows the characteristic facial dominated by speech delay, another maternally inherited gestalt comprising prominent forehead, bitemporal narrow- nonsense variant, p.(S1443*), was found. Facially, he ing, large appearing eyes with rounded palpebral ﬁssures, resembled the gestalt previously described for Snijders depressed nasal root, rounded nasal tip, anteverted nares, Blok-Campeausyndrome. Hismother,inwhomthevariant short philtrum, tended upper lips, full checks, and low setAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 873 was de novo, had macrocephaly and was otherwise performed within the TRANSLATE-NAMSE care project. unaffected. Theresultingvariantswereprioritizedusingphenotypeand Thesetwocasesexemplifythatproteintruncatingvariants imagedata(PEDIA/PrioritizationofExomeDatabyImage in CHD3 may result in reduced penetrance and/or variable Analysis). A probably pathogenic hemizygous variant expressivity.Wearecurrentlycollectingmorefamilieswith c.410A>G;p.(Asp137Gly)intheSMSgenewasdetectedin inherited CHD3 variants to enhance our understanding of both brothers and subsequently also in the affected cousin. disease penetrance in Snijders Blok-Campeau syndrome. The mothers are heterozygous carriers of the SMS variant. Additionally, we will perform functional studies of these We emphasize the marked intrafamilial variability of CHD3 variants to increase our insight in the underlying intelligence from low normal to mild / moderate ID of this pathogenic mechanisms. rareandpossiblyrecognizableX-linkedDD/IDsyndrome. J. van der Spek: None. J. den Hoed: None. L. Snijders K.Cremer:None.S.Hoffjan:None.A.Schmidt:None.S. Blok: None. C.W. Ockeloen: None. M.E.H. Simon: Peters: None. M. Kreiß: None. E. Mangold: None. M. None. L.E.L.M. Vissers: None. S.E. Fisher: None. T. Mücke: None. H. Hundertmark: None. F. Brand: None. A. Kleefstra: None. Heimbach: None. A. Knaus: None. A. Buness: None. S. Sivalingam: None. P.M. Krawitz: None. H. Engels: None. E-P08.37 Snyder-Robinson syndrome with notable intrafamilial E-P08.39 clinical variability detected by WES and PEDIA X-linked TAF1 intellectual disability - decoding a new neurodevelopmental entity in the genomic era K.Cremer1,S.Hoffjan2,A.Schmidt1,S.Peters1,M.Kreiß1, E. Mangold1, M. Mücke3, H. Hundertmark1, F. Brand4, A. R. Gouveia, O. Moldovan, A. B. Sousa Heimbach1, A. Knaus4, A. Buness5, S. Sivalingam5, P. M. Krawitz4, H. Engels1 Serviço de Genética, Hospital de Santa Maria, Centro Hospitalar e Universitário Lisboa Norte, Centro Acadé- 1InstituteofHumanGenetics,UniversityofBonn,Schoolof mico de Medicina de Lisboa, Lisboa, Portugal Medicine & University Hospital Bonn, Bonn, Germany, 2Institute of Human Genetics, Ruhr-University Bochum, Introduction: TAF1 is a subunit of the transcription factor Bochum, Germany, 3Center for Rare Diseases Bonn IID complex important in embryogenesis and neuronal (ZSEB), University Hospital Bonn, Bonn, Germany, 4Insti- development. Recently, X-linked mental retardation tute for Genomic Statistics and Bioinformatics, School of 33 syndrome (MRXS33; MIM#300966) caused by patho- Medicine & University Hospital Bonn, Bonn, Germany, genicvariantsinTAF1wasdescribed,featuringintellectual 5Core Unit for Bioinformatics Data Analysis, University of disability (ID), hypotonia, neurological abnormalities, and Bonn, School of Medicine & University Hospital Bonn, dysmorphicfeatures.Toourknowledge,36missenseanda Bonn, Germany splice site pathogenic variants have been reported so far. Case Presentation: A 10-year-old boy with develop- Pathogenic variants in the spermine synthase (SMS) gene mental delay was referred for genetic evaluation. He was cause the X-linked recessive Snyder-Robinson syndrome the only child of non-consanguineous parents with no (SRS, MIM #309583), which is characterized by develop- relevant family history. Atrial septal defect, restrictive mental delay / intellectual disability (DD / ID), speech muscle ventricle septal defect, mild Ebstein malformation, abnormalities, muscle and bone abnormalities, growth and axial hypotonia, were documented in the neonatal retardation,epilepsy,andfacialdysmorphism.Wereporton period. He evolved with moderate to severe ID, limited twobrotherswithnon-speciﬁcDDandmuscularhypotonia. speech (barely 20 words), hypertonic lower limbs, ataxic The older, nine-year-old brother showed motor develop- gait, midline stereotypies, self-injurious behavior, and mental delay, speech abnormalities, intelligence in the severe strabismus (surgically corrected). He had no lower average range (total IQ 89), asthenic build with a autonomy for daily activities. Cerebral MRI was normal. borderlinetallstature,longﬁngersandtoes,hyperextensible On physical examination, he presented slight facial joints, and mild facial dysmorphism. The younger, two- asymmetry, downslanted palpebral ﬁssures, sunken eyes, year-old brother showed motor and speech developmental bulbous nose, downturned corners of the mouth, micro- delay and a similar facial gestalt. Family history comprised gnathia, and deep plantar creases. Karyotype, array-CGH, a cousin (son of the mother’s sister) with global develop- and metabolic investigation were normal. mental delay (total IQ 50), muscular hypotonia and EEG Results: Whole exome sequencing was performed after abnormalities. An X-linked ID syndrome was suspected. extensive investigation, revealing a hemizygous TAF1 Whole exome sequencing (WES) of both brothers was874 J.delPicchia variant: c.412+4A>G, affecting splicing. Maternal testing Conclusions:According totheproposedanalysis results, conﬁrmed it was de novo. splice site variant NC_000003.12(NM_001024847.2): Conclusions: This variant, which had not been pre- c.1600-2A>G in TGFBR2 gene disrupts mRNA splicing viously reported, was classiﬁed as probably pathogenic. leading to a truncated protein and causing LDS2. According to the literature, this is the second pathogenic The work was funded by the Research Council of splice site variant described in TAF1. Our case shares Lithuania (No. S-MIP-17-19/LSS-150000-1179). common features with previously described patients, but Keywords: TGFBR2, Loeys-Dietz syndrome 2, qPCR there is wide clinical variability making WES/WGS best G. Petraitytė;: None. E. Siavrienė: None. V. Mikštienė: suited to reach a diagnosis. None. R. Norvilas: None. B. Burnytė: None. A. Utkus: R. Gouveia: None. O. Moldovan: None. A.B. Sousa: None. E. Preikšaitienė: None. None. E-P08.41 E-P08.40 A novel de novo truncating TRIM8 mutation associated Analysis of the effect of a novel splice site variant in with intellectual disability and renal failure. TGFBR2 on mRNA level M. A. McClatchey1, Z. D. du Toit2, R. Vaughan1, G.Petraitytė;1,E.Siavrienė1,V.Mikštienė1,R.Norvilas2,B. S.D.Whatley3,S.Martins3,S.Hegde4,J.teWaterNaude5, Burnytė1, A. Utkus1, E. Preikšaitienė1 D. H. Thomas6, D. F. Grifﬁths6, Genomics England Research Consortium, A. J. Clarke1,3, A. E. Fry1,3 1Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius Uni- 1Division of Cancer and Genetics, Cardiff University, versity, Vilnius, Lithuania, 2Hematology, Oncology and Cardiff, United Kingdom, 2Department of General Medi- Transfusion Medicine Center, Vilnius University Hospital cine, Glangwili General Hospital, Carmarthen, United Santaros Klinikos, Vilnius, Lithuania Kingdom, 3All Wales Medical Genomics Service, Cardiff, United Kingdom, 4Children’s Kidney Centre, University Introduction: TGF-β signaling pathway is a critical mole- Hospital of Wales, Cardiff, United Kingdom, 5Paediatric cular pathway in a regulation of cell growth, development, Neurology Service, University Hospital of Wales, Cardiff, and differentiation. One of the receptors of this pathway is United Kingdom, 6Department of Cellular Pathology, encoded by TGFBR2 (MIM#190182) gene. Heterozygous University Hospital of Wales, Cardiff, United Kingdom pathogenic variants in TGFBR2 are the cause of Loeys- Dietz syndrome2(LDS2; MIM#610168),adisorderwhich Introduction: Truncating mutations in the C-terminus of mainlyaffectstheconnectivetissue.Herewereportanovel the TRIM8 protein have been reported in patients with splicesitevariantinTGFBR2geneandpresentitseffecton severe developmental delay, intellectual disability and epi- mRNA level. lepsy. Only six previous patients have been reported (see Materials and methods: DNA of the proband was Assoum et al PMID: 30244534). Three of the previous analyzed by next generation sequencing gene panel patients were noted to have proteinuria and one (a patient technology. In order to elucidate the pathogenicity of the with epileptic encephalopathy) was diagnosed with identiﬁed splice site variant in the TGFBR2 gene, total nephrotic syndrome. blood mRNA of the proband was isolated, template cDNA Case Presentation: We describe an 8-year-old boy with was synthesized and quantitative PCR using TaqMan gene mild intellectual disability who was found to have expression assay designed for TGFBR2 gene was proteinuria at 2 years of age. Renal biopsy ﬁndings were performed. suggestive of focal segmental glomerulosclerosis. The Results: TGFBR2 gene acceptor splice site variant proteinuria persisted and the patient’s kidney function NC_000003.12(NM_001024847.2):c.1600-2A>G was declined despite treatment. He had a renal transplant at 7 detected in proband’s DNA. Using different bioinformatics yearsofage.Priortothetransplanthehadthreegeneralized tools, this variant was predicted to be pathogenic and seizureswhichwerecontrolledwithsodiumvalproate.Trio- affecting mRNA splicing. Quantitative expression analysis based whole genome sequencing as part of the 100,000 of several TGFBR2 exons revealed that c.1600-2A>G Genomes Project found a de novo heterozygous frameshift causes loss of 5’ part of exon 8 - the last exon of analyzed mutation in TRIM8 (NM_030912.2) c.1198_1220del, p. transcript, presumably leading to a frameshift and a loss of (Tyr400ArgfsTer2). part of Ser/Thr kinase domain and C-terminus of TGFBR2 Conclusion: The experience of this patient is further protein. evidence that TRIM8 truncating mutations cause both neurological and renal features. This case also suggestsAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 875 the spectrum of disease associated with TRIM8 mutations gene mutation with diverse neurologic features. Our case may be wider than previously thought - with the potential supportstheinterfamiliarvariabilityofthesamemutationin for more severe kidney problems but milder intellectual this gene. disability. We highlight the need for proteinuria screening G. Büki: None. J. Zima: None. B. Galik: None. A. in patients with TRIM8 mutations. Gyenesei: None. K. Hadzsiev: None. B. Melegh: None. J. M.A. McClatchey: None. Z.D. du Toit: None. R. Bene: None. Vaughan: None. S.D. Whatley: None. S. Martins: None. S. Hegde: None. J. te Water Naude: None. D.H. Thomas: E-P09 Neurogenetic and Psychiatric Disorders None. D.F. Grifﬁths: None. A.J. Clarke: None. A.E. Fry: None. E-P09.02 Probably digenic Aicardi-Goutieres syndrome caused E-P08.42 by heterozygousADAR-andRNASEH2B-mutations- an A recurrent ZC4H2gene mutation associated with extended case report diverse neurological symptoms in a patient with Wieacker-Wolff syndrome M. Hempel1, A. Bley1, T. Bierhals1, K. Radig1, M. Lee-Kirsch2, C. Kubisch1 G. Büki1,2, J. Zima1, B. Galik2, A. Gyenesei2, K. Hadzsiev1,2, B. Melegh1,2, J. Bene1,2 1University Medical Center Hamburg-Eppendorf, Ham- burg, Germany, 2Technical University Dresden, Dresden, 1University of Pecs, Medical School, Clinical Center, Germany Department of Medical Genetics, Pecs, Hungary, Pecs, Hungary, 2Szentagothai Research Center, University of Introduction: Aicardi-Goutières syndrome (AGS) is an Pecs, Pecs, Hungary, Pecs, Hungary inﬂammatory disease associated with a broad phenotypic spectrum although an infantile sub-acute encephalopathy Introduction: Wieacker-Wolff syndrome is an X-linked represents the classical manifestation. Mutations in seven recessive neurodevelopmental disorder presenting e.g. genes have been identiﬁed causing monogenic AGS: intellectual disability, developmental delay, characteristic TREX1, ADAR, RNASEH2A, RNASEH2B, RNASEH2C, facial features and contractures of the feet. Relatively few SAMHD1, IF1H1. The majority of patients carry biallelic cases have been reported so far with high clinical hetero- mutations, however for speciﬁc variants in ADAR, TREX1 geneity, especially amongst heterozygous females. The and IF1H1 a dominant effect has been described. diseaseiscaused bymutations inthe ZC4H2gene, altering Casereport:Wereportonaboypresentingwithmuscular a zinc ﬁnger domain-containing protein with four cysteine hypotonia and global developmental delay at the age of and two histidine residues. 6 months, who furtherdeveloped slow regression, secondary Materialsandmethods:Whole-genomesequencingwas microcephaly and movement abnormalities. A brain MRI performed in a 5-year-old male patient to identify the revealed a leukencephalopathy with severe hypomyelination disease-causing mutation. Libraries were prepared using of cerebral white matter. Blood interferon signature showed TruSeqTM DNA PCR-Free HT Library Prep Kit (Illumina) the characteristic pattern of an interferonopathy type 1. and sequenced on NovaSeq 6000 platform (Illumina) with Genetic results: Whole exome sequencing in the index 150bp paired-end chemistry. The detected mutation was and his healthy unrelated parents identiﬁed a maternally validated by Sanger sequencing. inherited recurrent mutation in RNASEH2B (p.Ala177Thr) Results: A recurrent hemizygous missense mutation and a paternally inherited very likely pathogenic variant in (c.593 G>A) in ZC4H2 gene was discovered in our patient ADAR (p.Arg892Cys). Neither a second coding variant in and not in his parents. This mutation leads to an arginine- these two genes nor other variants explaining the phenotype glutamineaminoacidchangeandsofaritwasfoundonlyin couldbedetected.Genome-wideCNVanalysisdidnotshow one large family. However, our patient shares common a relevant CNV, in particular not in AGS-associated genes. hallmarks of the syndrome with the previously reported RNAanalysisfromskinﬁbroblastsveriﬁedbothvariantsina cases, the unique feature is that he does not present seizure heterozygous state but could not detect a second aberration and he has a severe speech delay. affecting the RNASEH2B or ADAR transcripts. Discussion:Intra-andinterfamiliarphenotypicvariability Discussion: The patient reported here is affected by is a well-known phenomenon in several Mendelian classical AGS. Extended genetic analysis revealed com- disorders. Among patients with Wieacker-Wolff syndrome bined heterozygous mutations inRNASEH2B andADAR as only one recurrent mutation was reported in the ZC4H2 the most probably cause of disease strongly suggesting a gene until now. Here we report another recurrent ZC4H2 digenic inheritance of AGS in this pedigree.876 J.delPicchia M. Hempel: None. A. Bley: None. T. Bierhals: None. K. The investigation was ﬁnanced by grant of Poland’s Radig: None. M. Lee-Kirsch: None. C. Kubisch: None. National Health Program for 2016-2020 (no. 74/44/3.4.3/ 18/DEA). E-P09.03 D. Czarnecki: None. M. Ziółkowski: None. A. Długosz: The connection of COMT and receptor DRD2 poly- None. J. Feldheim: None. N. Waszkiewicz: None. A. morphisms with alcohol craving and hunger in people Kułak-Bejda: None. M. Gorzkiewicz: None. J. Budzyński: treated due alcohol dependence None. J. Chodkiewicz: None. A. Junkiert-Czarnecka: None. D. Czarnecki1, M. Ziółkowski1, A. Długosz2, J. Feldheim2, N. Waszkiewicz3, A. Kułak-Bejda3, M. Gorzkiewicz4, E-P09.04 J. Budzyński5, J. Chodkiewicz6, A. Junkiert-Czarnecka7 Case report: Alexander Disease in a 12-month-old male infant with epilepsy and global retardation 1Nicolaus Copernicus University, Department of Psychia- tricNursing,Torun,Poland,2UniversityofTechnologyand N. Baba, K. Burghardt, I. Schreyer, C. A. Hübner Life Sciences, Faculty of Chemical Technology and Engineering, Bydgoszcz, Poland, 3Medical University of Institute of Human Genetics, University Hospital Jena, Białystok, Department of Psychiatry, Choroszcz, Poland, Jena, Germany 4NicolausCopernicusUniversity,DepartmentofMolecular GeneticsandJustice,Torun,Poland,5NicolausCopernicus We report on a 12-month-old male infant of healthy University, Department of Vascular and Internal Diseases, unrelatedGermanparentswhowaspresentedinourgenetic Torun,Poland,6UniversityofLodz,InstituteofPsychology, counseling center in September 2019 with global retarda- DepartmentofHealthPsychology,Łódź,Poland,7Nicolaus tion. One month before, he had two focal clonic seizures Copernicus University, Department of Clinical Genetics, predominantly on the left side of the body, which led to Torun, Poland hospitalization. The family history revealed no epilepsy or other relevant neurological or genetic diseases. An MRI Introduction: In Poland about 25% patients maintains scanofthebrainrevealedaseveremyelinationdefectwith abstinence, after one year from ﬁnished of therapy. So it’s white matter abnormalities. Genetic diagnostic workup important, to identify the predictors of relapse of alcohol included:cytogeneticanalysis, array-CGHand NGS-based drinking. To the predictors belong among others alcohol panel diagnostics for familial focal epilepsies, extended craving, which in some patients is the strongly connected regarding GFAP. NGS identiﬁed a likely pathogenic with hungerbefore meal.It isconsiderthat polymorphisms mutation in GFAP (c.235C>G (p.Arg79Gly) hetero- of COMT and DRD2 genes are associated with increase of zygous).Toourknowledgethisspeciﬁcmutationhasbeen alcohol drinking. Aim of study was evaluation of connec- reported in only one patient suffering from Alexander tion, feeling of alcohol craving and hunger in patients with disease (AxD) (Gorospe et al., 2002). AxD is a very rare alcohol dependence with polymorphism of DRD2 neurodegenerative disease which belongs to the leukody- (c.2137G>A) and COMT (c. 472G>A). strophies. Patients with AxD have unspeciﬁc symptoms Material and Methods: Studied 184 patients during like progressive motor and intellectual retardation, devel- hospitalization due to alcohol dependence and 99 people opmental regression and multiple other neurological with control group. In study, used the scales: PACS, scale symptoms including seizures. In most cases gain-of-func- ofhungerbeforemealsandalsomoleculartestingofCOMT tion mutations in GFAP encoding the glial ﬁbrillary acidic and DRD2 polymorphism. protein underlie this disorder, which result in the accu- Results:PatientswithoutCOMTpolymorphism,butwith mulation of the variant protein in astrocytes, then called polymorphismofDRD2(genotypeG/A)felthighvaluesof Rosenthal ﬁbers. The exact cellular pathogenesis remains alcohol craving, which did not decrease during 4 weeks of unknown. Only about 500 cases of AxD have been therapy (7.18 vs. 7.00; p>0.05). At the same time, patients reported worldwide. Survival time depends on the age at feltstronglyhunger,whichdidnotdecreaseduring4weeks onset of AxD, a median of 14 years was found in a larger of therapy (13 vs. 11; p>0.05). The observation, suggest, cohort (Prust et al., 2011). AxD should be considered dif- that it can be extracted, based on the tested polymorphism, ferential diagnosis of global developmental retardation, group of patients who feel chronic and co-existing alcohol seizures and white matter abnormalities. craving and hunger, and this patients have got risk of N. Baba: None. K. Burghardt: None. I. Schreyer: None. relapse alcohol drinking or nutrition disorders. C.A. Hübner: None. Conclusions: The polymorphism of DRD2 can be connected with the strongly alcohol craving and hunger.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 877 E-P09.07 B. Budisteanu: None. I. Focsa: None. F. Linca: None. Copy number variants in autism spectrum disorders D. Ioana: None. G. Gaina: None. L. Albulescu: None. patients I.Dobrescu:None.M.Budisteanu:None.A.Arghir:None. S. M. Papuc1, A. Erbescu1, C. Iliescu2,3, M. Dobre1, E-P09.09 I. Minciu2,3, F. Rad2,3, I. Mihailescu3, L. Mateescu2,3, A. C. A new case of beta-propeller protein-associated neuro- Tutulan-Cunita1,4, R. Grozavescu2,3, E. Andrei3, degeneration (BPAN) in a 7-year old male with a novel B.Budisteanu3,I.Focsa1,2,F.Linca3,D.Ioana3,G.Gaina1, mosaic WDR45 mutation L.Albulescu1,I.Dobrescu2,3,M.Budisteanu1,3,5,A.Arghir1 H. Wang, G. Fteeh 1Victor Babes National Institute of Pathology, Bucharest, Romania, 2Carol Davila University of Medicine and LomaLindaUniversity,SchoolofMedicine,LOMALINDA, Pharmacy, Bucharest, Romania, 3Prof. Dr. Alex. Obregia CA, United States Clinical Hospital of Psychiatry, Department of Pediatric Neurology, Bucharest, Romania, 4Cytogenomic Medical Introduction: Beta-propeller protein-associated neurode- Laboratory, Bucharest, Romania, 5Titu Maiorescu Uni- generation (BPAN) is a neurodegeneration with brain iron versity, Faculty of Medicine, Bucharest, Romania accumulationdisorder.BPANisveryrare,withfewthan60 casesreportedtodateinwhichthevastmajorityofcasesare Copy-number variants (CNVs) have been shown to be female and sporadic, resulting from a de novo mutation in involved in etiology of neurodevelopmental disorders like theWDR45genelocatedatXp11.23.Herewereportanew autism spectrum disorders (ASDs), intellectual disability case of BPAN in a male. (ID), and other psychiatric disorders. Chromosomal Case Description: This a 7 years old adoptive boy with microarray analyses (CMA) has offered a high detection history of autism, developmental delay, and seizures. He rateofsmallandlargeCNVsassociatedwithASD,andled was not able to walk until age of 4 and nonverbal. He was to discovery of new autism genes. We report on the results diagnosedwithLennoxGastautsyndrome.EEG(duringthe of chromosomal CMA investigation in a group of ASDs sleep) showed frequent to abundant high to very high patients. Eighty patients were referred to our laboratory for voltage sharp, spike and slow wave discharges present in genetic testing with ASDs as part of a broad phenotype right and left hemisphere. The brain MRI indicated including ID or other clinical features. A complete clinical prominent mineralization of the globus pallidi and sub- evaluation was performed with focus on psychiatric exam- stantia nigra considering iron accumulation or mitochon- ination and psychological evaluation with speciﬁc ASDs drial disorder. tests (ADOS, ADI-R). Array-CGH completed with kar- Result: The initial workup of chromosome microarray yotyping, FISH and qPCR tests were performed. A total of was negative, the subsequent brain-iron accumulation gene 21 pathological CNVs (14 deletions and 7 duplications), panel reported as WDR45, X-linked, c.577C>T (p. with a median length of 3.7 Mb were detected in 17 Gln193*), zygosity (indeterminate, 46% allele fraction), patients.Theinvolvedgenomicregionsoverlap550OMIM pathogenic. genes.Besideswell-describedsyndromicregionsassociated Discussion/Conclusion: BPAN is phenotypically similar with ASDs (e.g. deletions of 1q21.1, 22q13.3, 22q11.2, inbothmaleandfemalewhichischaracterizedbyclustered MBD5; Xq28 duplication), other genomic regions, rarely spasm,hypsarrhythmiapatternsonEEGanddevelopmental reported in patients with ASDs were identiﬁed (deletion of delay or regress. The similarity in both genders was 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1, explained by somatic mosaicism in surviving males and CHRNA7); thus having the potential to reveal new ASD germline or somatic mutations in females, as well as genes. Our data illustrates the utility of array-CGH in the skewing of X chromosome inactivation. Only a few male investigation of patients with ASDs, speciﬁcally in the caseswerereportedandthisisanewmalecasewithanovel context of complex phenotypes. Acknowledgment: The mosaic mutation and presenting with characteristic clinical research leading to these results has received funding from features. theEEAGrant2014-2021,undertheprojectcontractNo6/ H. Wang: None. G. Fteeh: None. 2019, and MRI Projects PN 92.033.02.03 and PN 16.22.05.01. E-P09.10 S.M. Papuc: None. A. Erbescu: None. C. Iliescu: None. New mendelian gene for bipolar disorder. M. Dobre: None. I. Minciu: None. F. Rad: None. I. Mihailescu: None. L. Mateescu: None. A.C. Tutulan- Cunita: None. R. Grozavescu: None. E. Andrei: None.878 J.delPicchia M. F. Rossi1,2, D. Lopergolo1,2, M. A. Trusso3, E. Benetti4, E. Dámaso1, A. Culiáñez-Casas2, I. Lara-Espejo2, C. Fallerini1, S. Furini4, A. Goracci3,5, A. Fagiolini3,5, M. Castillejo1, A. Castillejo2, M. García-Escudero2, A. Renieri1,2, F. Mari1,2 J. Soto2 1Medical Genetics, University of Siena, Siena, Italy, 1ElcheUniversityHospital-FISABIO,Elche,Spain,2Elche 2Genetica Medica, Azienda Ospedaliera Universitaria University Hospital, Elche, Spain Senese, Siena, Italy, 3Department of Molecular Medicine and Development, University of Siena, Siena, Italy, Introduction: Bipolar disorder (BD) is a complex psy- 4Department of Medical Biotechnologies, University of chiatric condition with high heritability. Extended families Siena, Siena, Italy, 5Department of Mental Health; with high prevalence of BD provide an opportunity to PsychiatryUnit,AziendaOspedalieraUniversitariaSenese, identify novel risk genes. We present ﬁndings from whole Siena, Italy exome sequencing (WES) obtained from a Spanish family with high density of BD cases and dominant autosomal Introduction: Bipolar Disorder (BP) is a mental health pattern of inheritance. condition characterized by extreme mood ﬂuctuations that Materials and -Methods: Blood DNA was obtained includeemotionalhighsandlows.Itaffectsabout1%ofthe from 8 family members: ﬁve patients diagnosed of BD, world population and its estimated heritability is around another patient with other mental disorder and two healthy 70%, similar to Schizophrenia. individuals. WES was performed using SureSelect-Human- Materialsandmethods:AlargeautosomaldominantBP AllExonV6+UTR (AgilentTechnologies) libraries and family with eleven affected subjects was included in the sequencing on Illumina-NovaSeq6000. Alignment and study. Mental health of seven family members was variant calling was performed by SureCall and variant ascertained by clinical observation and by the use of ﬁltering by a custom pipeline for cohort analyses on Alissa speciﬁc tests. Exome sequencing was performed in all Interpret softwares (AgilentTechnologies). members.Variantsprioritizationwasperformedonthebasis Results:Thetotalsizeofcapturedregionwas90Mb.An of the frequency (<5%), evidence of pathogenicity and average of 87% of the target regions had 30X coverage or association with BP. better. The within-family association of rare coding and Results:Threemembers,thefemaleproband,hermother splice-site variants with predictable loss of function and his maternal uncle, were diagnosed with BP and four present in cases and absent in controls was investigated. members (two proband’s sisters and two proband’s male We found an unreported stopgain candidate variant cousins) were categorized as healthy subjects. Exome (NM_001080521.3:c.161C>A) at RASSF10 gene, co-seg- analysis revealed one single variant that met the above regating with BD (p=0.036). RASSF10 plays an important given criteria present in all three affected members and in roleinregulatingembryonicneurogenesis.Itisexpressedin none of the healthy ones. It is a missense variant, absent in normal brain tissue and epigenetically inactivated in brain controls (Exome Sequencing Project or 1000 Genomes tumors.Theseevidencesmightsuggestanimportantroleof Project).Multiplelinesofcomputationalevidencesupporta RASSF10 in normal brain function. deleterious effect of the variant (CADD 35). The mutated Conclusions: RASSF10 could be a new candidate gene gene encodes for a protein involved in cell motility and associated to BD, although further studies are needed to be extracellular matrix remodeling. A recent study revealed validated. New associated BD genes could shed light on that this protein is downregulated in plasma samples of a understanding the molecular basis of mental disorders and large cohort of patients with mood disorder and its deﬁning possible targets for new treatments. expression was reduced in a C. elegans model of E. Dámaso: None. A. Culiáñez-Casas: None. I. Lara- Alzheimer’s disease. Espejo:None.M.Castillejo: None.A.Castillejo: None.M. Conclusions: We were able to identify a gene that likely García-Escudero: None. J. Soto: None. contributed to BP in our family. M.F. Rossi: None. D. Lopergolo: None. M.A. Trusso: E-P09.12 None.E.Benetti:None.C.Fallerini:None.S.Furini:None. Brainmalformationsdiagnosisandclinicalmanagement A.Goracci:None.A.Fagiolini:None.A.Renieri:None.F. in pediatric patients Mari: None. A. Erbescu1, S. M. Papuc1, C. Iliescu2,3, C. Burloiu2, E-P09.11 O. Tarta- Arsene2,3, D. Barca2,3, C. Motoescu2,3, RASSF10, a new gene associated to hereditary forms of I. Minciu2,3, N. Butoianu2,3, B. Budisteanu2, A. C. Tutulan- Bipolar Disorder?Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 879 Cunita1,4,A.Dica2,C.Anghelescu2,D.Craiu2,3,A.Arghir1, for the differential diagnosis in complex clinical M. Budisteanu1,2,5 phenotypes involving cerebellar ataxia 1Victor Babes National Institute of Pathology, Bucharest, N. Ivanova1, K. Mihova1, K. Kamenarova1, S. Bichev2, Romania, 2Prof. Dr. Alex. Obregia Clinical Hospital of T. Chamova3, S. Cherninkova3, J. Samuel3, Psychiatry,Bucharest,Romania,3CarolDavilaUniversityof V. Guergueltcheva4, D. Avdjieva-Tzavella5, H. Kathom5, MedicineandPharmacy,Bucharest,Romania,4Cytogenomic A. Savov2, I. Kremensky1, V. Bojinova6, V. Mitev1, Medical Laboratory, Bucharest, Romania, 5Titu Maiorescu I. Tournev3,7, A. Jordanova1,8, R. Kaneva1 University, Faculty of Medicine, Bucharest, Romania 1Molecular Medicine Centre, Department of Medical Brain malformations (BMs) encompass a large spectrum of Chemistry and Biochemistry, Medical University – Soﬁa, disorders with various genetic etiologies, anatomic abnorm- Soﬁa, Bulgaria, 2National Genetic Laboratory, University alities, and clinical features. We report on the results of a Hospital of Obstetrics and Gynaecology “Maichin dom”, studyfocusedondiagnosisandclinicalmanagementofBMs Soﬁa, Bulgaria, 3Neurology Clinic, University Hospital inaRomanianpediatricpopulation.Onehundredandtwenty “Aleksandrovska”, Soﬁa, Bulgaria, 4Neurology Clinic, patients with BMs and complex phenotype were selected University Hospital “Soﬁamed”, Soﬁa, Bulgaria, 5Specia- from those referred for developmental delay and/or epilepsy, lized Hospital for Active Treatment Children’s Hospital, between 2010-2019, to our departments. General clinical Prof. Dr. Ivan Mitev“, Soﬁa, Bulgaria, 6Neurological examination, neurologic, dysmorphologic, psychiatric/psy- Clinic for Children, Multiproﬁle hospital for active chologic evaluations and brain imaging studies were per- treatment in neurology and psychiatry “St. Naum”, Soﬁa, formed for all the children. Genetic investigations included Bulgaria, 7Department of Cognitive Science and Psychol- array based comparative genomic hybridization (Agilent ogy,NewBulgarianUniversity,Soﬁa,Bulgaria,8Molecular Technologies), and classical and molecular cytogenetics. Neurogenomics Group, VIB-UAntwerp Center for Molecu- Gyration anomalies, corpus callosum defects, cerebellar lar Neurology, University of Antwerp, Antwerp, Belgium malformations, and heterotopia, isolated or in different com- binations,associatedwithcomplexclinicalpresentationswere Introduction: Cerebellar ataxias are genetically hetero- detected in our patient group. Genomic imbalances, 4 dele- geneousgroupofneurodegenerativedisordersthatcouldbe tions and 3 duplications, were detected in 7 patients. Syn- present with complex and variable clinical phenotypes dromic regions (17p13.3, 1q21.1, 1q43-q44, 22q11.2) were overlapping other neurological disorders. Most of them are prevalentinourstudygroup;however,someoftheseregions extremely rare and therefore, poorly studied, difﬁcult to are known to be clinically heterogeneous, thus our patients diagnoseandsymptomaticallytreated.Introductionofnext- might contribute to further delineation of the phenotypic generation sequencing in clinical practice provides a fast spectrum. In our study group, chromosomal defects were and effective decision for precise genetic diagnosis. detectedwithahighincidenceinpatientswithBMsaspartof Materials and methods: We performed whole exome complexphenotypes.Epilepticseizuresand/ordevelopmental sequence(WES)tosearchfordisease-causingvariantsin13 delaywerethemostcommonclinicalfeatures.Brainimaging patients with complex clinical phenotypes involving and genetic studies were instrumental in the diagnostic algo- cerebellar ataxia and one or more of the following rithm, with impact on prognosis and genetic counselling of symptoms: spasticity, peripheral neuropathy, epilepsy, these cases. Acknowledgment: This work was supported by dysmorphic features, intellectual disability. grants of the Romanian National Authority for Scientiﬁc Results:WES-dataanalysisledtotheidentiﬁcationofthe Research Innovation, CCCDI-UEFISCDI, Projects number potentially disease-causing variants in 10 families. They 87/2019 and 88/2019, COFUND-ERANET E-RARE 3- include ﬁve novel and four already known pathogenic HETER-OMICS-2, within PNCDI III variants in the SACS, PNPLA6, PRNP, SCN8A, SPG7, A. Erbescu: None. S.M. Papuc: None. C. Iliescu: None. CoQ8A and KIF1A genes. After additional genetic analysis C.Burloiu:None.O.Tarta-Arsene:None.D.Barca:None. andthoroughpatients’phenotypingwewereabletoconﬁrm C. Motoescu: None. I. Minciu: None. N. Butoianu: None. genetic diagnosis in 9 families. B. Budisteanu: None.A.C. Tutulan-Cunita:None.A.Dica: Conclusions: Our study enriches genetic and clinical None. C. Anghelescu: None. D. Craiu: None. A. Arghir: databases with novel genetic variants and clinical cases of None. M. Budisteanu: None. severalraregeneticdisordersthatwillhelptodelineatetheir molecular mechanisms. It added a new spot to the E-P09.13 geographic distribution worldwide of the spastic ataxia of Whole exome sequencing greatly increases the chances Charlevoix-Saguenay that has been previously limited to a speciﬁc geographic region. WES provides a fast and880 J.delPicchia effective tool for precise genetic diagnosis that allows to investigation. Asymptomatic parents presented the GDAP1 destinguish among variaty of clinical phenotypes sharing mutation in the heterozygous state. common clinical feature of cerebellar ataxia. Conclusion: The homozygous c.165T>G detected in Acknowledgements:ThisstudywassupportedbyGrants GDAP1 in our patient is likely responsible for her CMT B02/3/2014 and D01-285/17.12.2019 National Science disease. This result is important in terms of diagnosis for Fund/Ministry of Education and Science, Bulgaria. molecular biologists and geneticists. N. Ivanova: None. K. Mihova: None. K. Kamenarova: N. Benslimane: None. F. Miressi: None. C. Magdelaine: None. S. Bichev: None. T. Chamova: None. S. Chernin- None.P.Faye:None.F.Sturtz:None.F.Favreau:None.A. kova:None.J.Samuel:None.V.Guergueltcheva:None.D. Lia: None. Avdjieva-Tzavella: None. H. Kathom: None. A. Savov: None. I. Kremensky: None. V. Bojinova: None. V. Mitev: E-P09.15 None. I. Tournev: None. A. Jordanova: None. R. Another case of Cofﬁn-Siris-Syndrome 10 identiﬁed by Kaneva: None. trio exome sequencing. E-P09.14 L. Mulahasanovic1, H. Gabriel1, S. Biskup1, AnovelmutationofGDAP1associatedwithsevereform C. Schell-Apacik2, C. Bus3 of Charcot-Marie-Tooth disease 1Praxis für Humangenetik, Tuebingen, Germany, 2Medi- N. BENSLIMANE1, F. Miressi1, C. Magdelaine1,2, cover Human Genetics Berlin-Westend MVZ, Berlin, P. Faye1, F. Sturtz1,2, F. Favreau1,2, A. Lia1,2 Germany, 3Humangenetik Tübingen, Tuebingen, Ger- many 1EA6309-Neuropathie périphérique et Maintenance Myéli- nique, Limoges, France, 2Laboratoire de Biochimie et Cofﬁn-Siris syndrome (CSS) is a rare genetic disorder Génétique Moléculaire CHU DUPUYTREN, Limoges, characterized mainly by developmental delay, intellectual France disability and characteristic facial features. Hypoplasia or absence of the ﬁfth ﬁnger and toe nails are most common Introduction: Charcot-Marie-Tooth disease (CMT) is the in affected individuals. Until now, ten responsible genes mostcommonhereditaryneuropathywithaprevalenceof1/ for CSS have been identiﬁed. Recently, de novo variants 2500; also known as sensory-motor neuropathy. There are in the gene SOX4 were identiﬁed in four patients with several forms of CMT which are differentiated by their typical features of CSS, particularly ﬁfth ﬁnger clin- modeoftransmission(recessive,dominant,autosomalorX- odactyly(Zawertonetal.,2019).ThisnewCSStype10is linked), and their electrophysiological aspect (demyelinat- characterized by intellectual disability, microcephaly and ing or axonal forms). Currently, more than 90 genes are facial abnormalities. SOX4 belongs to a family of SRY- involved in CMT. related transcription factors, which are playing a key role MaterialandMethods:A47-year-oldpatientpresenting in multiple developmental pathways. Expression studies CMT disease was sampled with peripheral blood collected showed that SOX4 is highly expressed during neurogen- inEDTAtubesaftergivingherinformedconsent.Genomic esis. All four pathogenic SOX4 variants identiﬁed before DNA was extracted by standard methods. Next Generation were located within the SOX family-speciﬁc HMG Sequencing(NGS)strategywasperformedusinga92genes domain of the protein, which is crucial for DNA-binding. custom panel designed for CMT and associated neuropa- Here we report on a mildly affected female patient car- thies diagnosis. rying the de novo variant c.278T>A; p.Leu93Gln in the Results: The patient was a 47-year-old woman, present- SOX4 gene, which is also located in the HMG domain. ing a severe demyelinating form of CMT disease. The Shecouldsitattheageof4monthsandstartedwalkingon diseaseonsetwasinearlychildhoodwithalossofwalking his own with 15 months. She had delayed speech devel- around the age of 11 and since then a wheelchair opment and learning disability, was restless and agitated, dependence. Molecular biology analysis highlighted the and was diagnosed with ADHD at the age of 8 years. At presence of a new GDAP1 mutation, never described to theageof21,shepresentedwithmilddysmorphicfeatures date. This mutation, c.165T>G, located on exon 2, was (e.g. long face; deep-set, dysmorphic ears; low palpepral presented in the homozygous state and leads to the ﬁssures; diffuse inserted eyebrows; wide mouth; long replacementofanasparticacidinposition55byaglutamic ﬁngers;slight brachydactyly ofthe ﬁfth ﬁngers; broad big acid (p.Asp55Glu) and it is predicted pathogenic by two toes) and displayed anxiety and a lack of motivation. prediction softwares. Splicing involvement is under L. Mulahasanovic: None. H. Gabriel: None. S. Biskup: None. C. Schell-Apacik: None. C. Bus: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 881 E-P09.18 arecausedbysustainedorintermittentmusclecontractions. Clinical features of three familial cases of Neuronal The major feature is over-activity of muscles required for Intranuclear Inclusion Disease (NIID) movement. Dystonias can clinically vary in their manifes- tation and severity affecting all age groups and leading to H. Furuya, Y. Miyamoto, T. Furushima, S. Ohtsuru, considerabledisabilityandimpairedqualityoflife.Withits Y. Morita, Y. Osaki high throughput capacity and proportionally low cost, next generation sequencing is now being extensively used in Kochi Medical School, Kochi, Japan research/diagnostic settings to determine novel genes and mutations associated with dystonias. Background: Neuronal intranuclear inclusion disease Materials and methods: Genomic DNA was isolated (NIID)(MIM 603472) is a neurodegenerative disorder from whole blood. Whole exome sequencing (WES), characterized by eosinophilic intranuclear inclusions in followed by family segregation analysis using Sanger neuronal cells. Such inclusions are also found in non-neu- sequencing, was performed on 21 probands with hetero- ronalcells.Theclinicalfeaturesandpathologicalﬁndingsin genous dystonia phenotypes. The pathogenicity of the patientswithNIIDarehighlyvaried.Here,wepresentthree variant was scored by the prediction tools DANN, GERP, familialNIIDcasesaccompaniedwithparkinsonism,which SIFT and MutationTaster. is not so common in this disorder. Results: WES revealed 10 dystonia genes with varying Objective: Cases: All cases are adult onset NIID with frequenciesand12variants,4ofwhicharenovel(Table1). Parkinsonism with dementia and severe psychosis. The diagnostic rate is 62%. Table1 Genes and variants Results: In MRI imaging, diffuse cerebral atrophy was identiﬁed in Turkish dystonia cohort observed in all cases. High intensity of the cortico- medullary junction in diffusion-weighted imaging (DWI), Genes(#of Mutations Zygosity Novel/ which is characteristic ﬁndings in NIID, was seen in all families) Reported NIID. In neurological examination, all NIID showed laterality or severely increased Pulmomental Reﬂex GCH1(n=3) c.284C>Tp.Pro95Leu het Novel c.631_632delATp. hethet Reported (PMR). Ante-mortem diagnosis was made by identiﬁcation Met211ValfsTer38 Reported of intranuclear inclusions with skin biopsy in all NIID. c.646C>Tp.Arg216Ter Neuroimaging diagnosis for usual Parkinsonism shows PTS(n=2) c.84-3C>G hom Reported normal with DAT scan and MIBG scintigraphy. TOR1A(n=1) c.907_909delGAGp. het Reported Conclusion: Intranuclear accumulation of abnormal Glu303del proteins and/or dysfunction of protein degradation SLC2A1(n=1) c.972G>Ap.Ser324Ser het Reported might underlie in the pathogenesis of NIID. However, DDC(n=1) c.1040G>Ap.Arg347Gln hom Reported NIID is considered as a heterogeneous disease entity and KMT2B(n=1) c.6863delCp. het Novel shows various clinical features. Although dementia is Pro2289ArgfsTer36 common in NIID, Parkinsonism is also often observed in TH(n=1) c.698G>Ap.Arg233His hom Reported this disorder. Achknowledgement: We also thank to Dr. ATP13A2(n=1) c.1551_1556delCCTCAC hom Novel Sone J and Prof. Sobue G (Department of Neurology, p.Leu518_Thr519del Nagoya University, Japan) for immune staining of biopsy ATP1A3(n=1) c.1838C>Tp.Thr613Met het Reported specimen. KIF1C(n=1) c.2005C>Tp.Arg669Ter hom Novel H. Furuya: None. Y. Miyamoto: None. T. Furushima: None.S.Ohtsuru:None.Y.Morita:None.Y.Osaki:None. Conclusions:The10genesidentiﬁedrevealahighlocus E-P09.20 heterogeneity. Further, ATP13A2 and KIF1C which also The Complex Molecular Basis of Dystonias in a give rise to spasticity and ataxias, point to genetic and Turkish Cohort pathophysiological overlaps between neurological conditions. S. Tekgul1, G. Simsir1, Z. Yapici2, A. Basak1 S. Tekgul: None. G. Simsir: None. Z. Yapici: None. A. Basak: None. 1Koç University, Istanbul, Turkey, 2Istanbul University, Istanbul, Turkey E-P09.21 Genetic study of early-onset parkinsonism in Thailand: Introduction: Dystonias are neurological conditions in targeted next-generation sequencing which abnormal movements or postures are observed, that882 J.delPicchia P. Phowthongkum performed comprehensive study of HLA gene variants discovered by NGS after lack of pathogenic mutations in Faculty of Medicine, Bangkok, Thailand patientsaffected by epilepsy with orwithout autism/mental retardation and compared with patients with other pathol- Background: Early-onset Parkinson disease (EOPD) is ogies (referred as controls). We focused on variants anno- deﬁned by PD with the onset age of less than 50 years. tated as Variants of Unknown Signiﬁcance (VUS). We Patients may present predominantly with lower limb dys- determined the frequency of such variants in DRB1 and toniaratherthantypicalrestingtremorinlate-onsetpatients DRB5, in cases and controls, as they were the most com- which is the challenge in making the diagnosis in younger monlyfoundinbothgroups.Thefrequencyvariedbetween patients. Many patients apparently are responded dramati- 11-15% in cases and 11-23% in controls. In addition, we callywithdopaminereplacementbutdevelopedearlymotor reported variants found only in cases(5 variants in DRB5 complications, in contrast, to consistently respond to the and 1 in DRB1), only in controls (7 in DRB5 and 10 in treatmentinDOPAResponsiveDystonia(DSD).Molecular DRB1)andbothincasesandcontrols(5inDRB5and6in diagnosis, therefore, helps in diagnosis EOPD, facilitates DRB1). We found 2 HLA-DMB and 2 HLA-G variants genetic counseling and treatment customization. only in cases. This is a pilot study of the involvement of Methods: A total of 51 patients with early-onset HLA class II gene variants in neurological disorders and it parkinsonism from 49 families referred to Neurogenetics will be followed by the analysis of these individual Center at King Chulalongkorn Memorial Hospital. Genetic variants’ role. test was performed with targeted next-generation sequen- F. Shakola: None. I. Dimova: None. V. Peycheva: None. cing panel containing 34 genes causing PD or dystonia. K. Mihova: None. K. Kamenarova: None. R. Kaneva: Results:ElevenpatientswithEOPD(21.5%)werefound None. tocarrylikelypathogenicorpathogenicvariantsinGBA(5/ 51),PARK2(4/51 from 2 families),PINK1 (2/51 from 2 E-P09.27 families). Familial EOPD (2 families) harbored 3 different Identiﬁcationofthemolecularetiologyinearlyepileptic pathogenic variants in PARK2 (one family with homo- encephalopathy using whole exome sequencing zygous deletion of exon7 and the other family with one heterozygous deletion of exon 5 and one heterozygous E.Isik1,T.Atik1,S.KeskinYilmaz2,G.Aktan2,H.Onay3,S. missensevariant).Theyallhaveonsetoflessthan30years. Gokben2, F. Ozkinay1,3 Conclusions: Our ﬁndings add an understanding of the genetic architecture of EOPD in Southeast Asia. Targeted 1Subdivision of Pediatric Genetics, Department of Pedia- next-generation sequencing is an effective and affordable trics, Faculty of Medicine, Ege University, Izmir, Turkey, methodformakinggeneticdiagnosisforPD.Heterozygous 2Subdivision of Pediatric Neurology, Department of GBA deﬁnitely increases risk of EOPD in the Southeast Pediatrics, Faculty of Medicine, Ege University, Izmir, Asianpopulation.Individualseekingcarriertestingincludes Turkey, 3Department of Medical Genetics, Faculty of GBA should be informed about the risk of parents to Medicine, Ege University, Izmir, Turkey develop neurological disorders. P. Phowthongkum: None. Epilepticencephalopathies(EEs)areagroupofdevastating disorders caused by epileptic activity; resulting in dete- E-P09.23 rioration in developmental, cognitive and motor functions. NGSsurveyinneurologicaldisorders-focusonvariants ThenumberofgenesidentiﬁedasbeingresponsibleforEEs in HLA class II genes has been increasing rapidly. However, despite a compre- hensive molecular analysis, a molecular diagnosis can only F. Shakola, I. Dimova, V. Peycheva, K. Mihova, beestablishedin50%ofcases.Theaimofthisprojectisto K. Kamenarova, R. Kaneva use whole exome sequencing to determine the molecular etiology of EEs inmolecularly undiagnosed patients witha Molecular Medicine Center, MU Soﬁa, Soﬁa, Bulgaria pedigree suggestive of an autosomal recessive single gene disease. Three EEs families, having either consanguineous Neuroinﬂammatory mechanisms may be involved in the parents of an affected individual and/or having more than genesis of epilepsies and autistic spectrum disorders. An one affected offspring were enrolled in the project. Prior to NGS study with TrueSightOne gene panel was performed this project, the families had been evaluated using a next on 30 patients with neurological disorders (including sei- generation sequencing panel which included 16 EE genes; zures as a main component). In 10 patients pathogenic/ however,nomolecular diagnosis could be established.In5 probably pathogenic mutations were discovered. We have cases from the 3 selected EEs families in our study geneticAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 883 etiology was investigated using WES, with segregation These genes have been previously reported in literature analysisthenbeingperformedusingSangersequencing.All associated to MS. patients in the study group had infantile onset epileptic Conclusions: These ﬁndings support the idea that seizures and severe developmental delay. WES revealed familial MS could present a genetic background. The biallelicdiseasecausingmutationsinDENDD5A,GRNand variants found in this research require further study and TBCD genes in Family 1, Family 2 and Family 3, respec- could lead to a better understanding of MS. tively.Ineachfamily,theidentiﬁedvariantsassociatedwith L.TorreFuentes:None.J.Matías-GuiuAntem:None.V. the disease were segregated. Reverse phenotyping sup- Pytel: None. P. Montero Escribano: None. L. Hernández ported the molecular analysis. In conclusion, this study Lorenzo: None. P. Maietta: None. S. Álvarez: None. U. providesavaluablecontributiontothegenotype-phenotype Gómez Pinedo: None. J. Matías-Guiu Guía: None. relationship by determining rare epilepsy syndromes in a previously undiagnosable patient group. WES provides a E-P09.30 usefuldiagnosticalternative;particularlyinconsanguineous Spontaneous rescue of a FMR1 repeat expansion families. E.Isik:None.T.Atik:None.S.KeskinYilmaz:None.G. E. Erbs, M. Rasmussen, D. L. Lildballe Aktan: None. H. Onay: None. S. Gokben: None. F. Ozkinay: None. Department of Clinical Genetics, Lillebælt Hospital, Vejle, Denmark E-P09.28 Whole-exome sequencing in familial multiple sclerosis Introduction:FragileXsyndrome(FXS)isusuallycaused by CGG-repeat expansion in the 5’ UTR region of the L. Torre Fuentes1, J. Matías-Guiu Antem2, V. Pytel1, Fragile X Mental Retardation 1 (FMR1) gene of >200 P. Montero Escribano2, L. Hernández Lorenzo1, repeats causing methylation of the region. Rare cases are P.Maietta3,S.Álvarez3,U.GómezPinedo1,J.Matías-Guiu caused by pathogenic variants within the coding region. Guía1,2 Materials and methods: Genetic testing for FXS was requested in a male infant born to a mother known to 1InstituteofNeuroscience,HealthResearchInstituteofSan harbour a FXS full mutation (>200 CGG-repeats). The Carlos Clinical Hospital, Madrid, Spain, 2Neurology maternal grandmother was a carrier of a FXS premutation. department, San Carlos Clinical Hospital, Madrid, Spain, AnalysisofCGG-repeatsoftheFMR1genewasperformed 3NIMGenetics, Madrid, Spain usingPCR,RP-PCR,andSangersequencing.STRmarkers were used in linkage analysis. Introduction: Multiple sclerosis (MS) is an inﬂammatory Results: An unexpected very short PCR fragment was autoimmune disease of the central nervous system (CNS) detected in the male infant. Subsequent Sanger sequen- which causes demyelination and axonal damage. MS is cing conﬁrmed an 88 bp deletion (c.1-156_1-69del) in considered a polygenic disease where genetic risk factors hemizygous form. The deletion included all CGG- can be more likely detected in familial MS. The aim of the repeats and ﬂanking sequences. However, the deletion studyistoanalysegeneticvariationsofsignallingpathways did not include FMR1 exons. Linkage analysis revealed and genes related to MS. that the allele, which has been expanded in the mother Materials and methods: Whole-exome sequencing andthematernalgrandmother,waspassedontothemale (WES) with Ion Proton technology was performed in 138 infant. individuals from 23 families including at least 2 MS Conclusion: Grønskov et al. previously reported a ~150 patients.WecomparedpatientswithMS,patientswithother bp deletion of all CGG-repeats and ﬂanking sequences in a autoimmune disease and healthy individuals. Signalling normal female patient, who was hemizygous for the FMR1 pathways and genes related to MS were analysed. Variant gene due to a large deletion of the other X chromosome. ﬁltering and prioritization were performed with an own Western blot showed that the FMR1 protein level was pipeline using criteria to include relevant and functional unaffected. This reported deletion comprises the deletion variants associated to MS. detectedinthemaleinfant.Basedonthisreport,weexpect Results: In our cohort, some variants matched criteria to our patient to be unaffected. be considered as a possibly pathogenic variable. The In conclusion, a male infant was rescued from FXS by a associated genes (NOD2, NLRP7, CYP24A1, TNFAIP3, spontaneous deletion. TNFRSF13B, LRP2, CIITA, ACE) were mainly involved in E. Erbs: None. M. Rasmussen: None. D.L. Lildballe: the immune system as well as in vitamin D regulation. None.884 J.delPicchia E-P09.32 D. Nikolova: None. M. Mihaylova: None. R. Staneva: Genes with variants associated with frontotemporal None.V.Damyanova:None.M.Ganev:None.V.Spasova: dementia are enriched in extracellular matrix organiza- None. D. Nesheva: None. Z. Hammoudeh: None. S. tion pathways Hadjidekova: None. S. Mehrabian: None. M. Petrova: None. L. Traykov: None. D. Toncheva: None. S.Karachanak-Yankova1,2,L.Balabanski1,3,D.Serbezov1, R. Vazharova3,4, O. Antonova1, D. Nikolova1, M. E-P09.33 Mihaylova1, R. Staneva1, V. Damyanova1, M. Ganev1, V. Characterization of the PRNP gene mutations and the Spasova1, D. Nesheva1, Z. Hammoudeh1, S. Hadjidekova1, genotype-phenotype correlation in Hungarian patients S. Mehrabian5, M. Petrova5, L. Traykov5, D. Toncheva1,6 with prion disease 1Department of Medical Genetics, Medical Faculty, Med- H.Zeke1,Á.Palásti1,B.A.Fekete1,V.Molnár1,A.Gál1,Z. ical University-Soﬁa, Soﬁa, Bulgaria, 2Department of Grosz1, G. G. Kovács2, M. J. Molnár1 Genetics, Faculty of Biology, Soﬁa University “St. Kliment Ohridski”, Soﬁa, Bulgaria, 3Gynecology and assisted 1Institute of Genomic Medicine and Rare Disorders, reproduction hospital “Malinov”, Soﬁa, Bulgaria, Semmelweis University, Budapest, Hungary, 2Department 4Department of Biology, Medical genetics and Microbiol- of Laboratory Medicine and Pathobiology, University of ogy, Faculty of Medicine, Soﬁa University “St. Kliment Toronto, Toronto, ON, Canada Ohridski”, Soﬁa, Bulgaria, 5Depatment of Neurology, UH “Alexandrovska”, Medical University-Soﬁa, Soﬁa, Bul- Introduction:Abnormalaccumulationofprionproteinsare garia, 6Bulgarian Academy of Sciences, Soﬁa, Bulgaria responsible for several fatal neurodegenerative diseases. PRNP is the only gene in which pathogenic variants are Introduction: Frontotemporal dementia (FTD) is a geneti- known to cause genetic prion disease. However, several cally and pathologically heterogeneous degenerative dis- pathogenicmutationsofPRNPwithheterogeneoustypeand order,secondtoAlzheimer’sdiseaseasacauseofdementia position were published with disease-causing or modifying in patients under 65 years of age. The present case-control effectonotherneurodegenerativedisorders.Inasigniﬁcant study aims to broaden the understanding of the molecular portion, genetic cause can be explained with the most pathogenesisofFTDbywholeexomesequencing(WES)of common pathogenic mutation E200K in the PRNP gene. pooled DNA samples. Materials and methods: Hundred-twenty-six patients Materialsandmethods:Theanalysiswasundertakenon werereferred(ageatreferral:57+13,7years)toourinstitute 140 FTD patients grouped in two DNA pools (original and with clinically suggested prion disease during 2015-2019. replicate) and a control DNA pool of 100 age-matched Sangersequencingwasappliedtoanalyzetheentirecoding healthy subjects. The WES was performed in BGI region of PRNP gene. Genomics at a mean coverage of at least 250 x per sample Results: Altogether 25 unrelated prion-positive cases and the obtained variants were ﬁltered by stringent criteria. were detected during the 4-year observational period. Results: The number of biallelic autosomal variants Heterozygous c.598G>A (E200K) variant was detected in foundinthecontrolDNApoolis180692.Theoriginaland 22/25 cases. Besides this most commonvariantinone case replicate patient DNA pool contain 18 003 and 21 555 the previously described c.350 C>T (A117V) variant was variantsnotfoundinthecontrolpool,respectively.Among found. In one family a rare, 168 bp octapeptid-repeat these variants 2344 are found in both patient pools, as 175 insertion was observed, which is known to be associated have less than 1% frequency in non-Finish Europeans in with a very slow disease progression. In addition, a novel GnomAD. These variants are located in 174 genes and can mutation c. 490 A>G (R164G) has been also identiﬁed be considered as FTD associated. The pathway enrichment which associated to a slow progression as well. analysis of these genes using Reactome software platform Conclusions: In our cohort 88 % of the genetically showed over-represented pathways mainly in extracellular conﬁrmed prion disorders were associated to the most matrix organization. common E200K PRNP mutation. The type and location of Conclusion: The detection of over-represented extracel- thealterationofthePRNPgenemayhaveanimportantrole lular matrix organization pathways in FTD contributes to in the determination of the phenotype, which makes the the understanding of the pathogenetic mechanisms under- genetic counselling challenging. lying neurodegeneration. Acknowledgment: KP-06-N33/5 Funding: This study was supported by the Hungarian from 13.12.2019 - National Science Fund of Bulgaria. Brain Research Program (KTIA_NAP_ 2017-1.2.1-NKP- S. Karachanak-Yankova: None. L. Balabanski: None. D. 2017-00002). Serbezov: None.R.Vazharova:None.O.Antonova:None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 885 H. Zeke: None. Á. Palásti: None. B.A. Fekete: None. V. None. G. Karadima: B. Research Grant (principal investi- Molnár:None.A.Gál:None.Z.Grosz:None.G.G.Kovács: gator,collaboratororconsultantandpendinggrantsaswell None. M.J. Molnár: None. as grants already received); Modest; Pﬁzer. F. Consultant/ Advisory Board; Modest; Roche. G. Koutsis: B. Research E-P09.35 Grant (principal investigator,collaboratororconsultantand Autosomalrecessiveaxonalneuropathywithneuromyo- pending grants as well as grants already received); tonia; mutations in HINT1 are not uncommon in the Signiﬁcant; Teva Pharmaceuticals, Genesis Pharma. Other; Greek population Signiﬁcant; Novartis, Genesis Pharma, Sanoﬁ-Genzyme, Teva. Z. Kontogeorgiou1, D. Pandis2, C. Kartanou1, M. Breza1, T. Zambelis2, M. Panas1, G. Karadima1, G. Koutsis1 E-P09.38 Trio whole-exome sequencing conﬁrms KCND2 de novo 1Neurogenetics Unit, 1st Department of Neurology, School missense mutations as a cause of autosomal dominantly ofMedicine,EginitionHospital,NationalandKapodistrian inherited severe seizures and developmental delay University of Athens, Athens, Greece, 2Clinical Neurophy- siology Unit, 1st Department of Neurology, School of U. Zechner, D. Rosenkranz, H. Bolz Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece Senckenberg Centre of Human Genetics, Frankfurt, Ger- many Autosomal recessive axonal neuropathy with neuromyoto- nia (ARAN-NM) has been recently shown to result from Trio whole-exome sequencing was carried out in a female histidine triad nucleotide-binding protein 1 (HINT1) gene proband with epileptic encephalopathy (delayed myelina- mutations. It accounts for around 10% of recessive axonal tion, hypoplastic corpus callosum, abnormal EEG) and Charcot-Marie-Tooth disease (CMT) in European popula- severe global retardation noticed from the age of 3 months tions. A single case has been reported to date in the Greek (no psychomotor milestones acquired, muscle hypotonia, population. We presently report a case-series of 3 Greek irregular eye movements and lack of ﬁxation, stereotypic patients with ARAN-NM identiﬁed during screening of hyperkinetic arm and leg movements) and her healthy par- undiagnosed recessive axonal CMT cases with a combina- ents. The patient manifested intractable epileptic seizures tion of whole-exome and Sangersequencing.Patient 1 was fromtheageof1year;therewasnosigniﬁcantpsychomotor a 19 year-old female presenting with walking difﬁculty at development. She died at the age of 21 years. A hetero- the age of 8 years. She gradually developed lower limb zygous de novo missense variant, c.1210G>C (p.(Val404- atrophies and at 15 years old was also diagnosed with Leu)),wasdetectedinKCND2,thegeneencodingKv4.2,a myoclonic epilepsy. On EMG she showed motor axonal majorpore-formingsubunitinsomatodendriticsubthreshold neuropathy with neuromyotonia. She was compound het- A-type potassium current (ISA) channels. The variant has erozygous for mutations c.110G>C (p.Arg37Pro) and not been described in the literature or in disease- and c.250T>C(p.Cys84Arg)inHINT1.Patient2wasa20year- population-speciﬁc variant databases. It leads to the oldwomanpresentingwithwalkingdifﬁcultiesattheageof exchange of an evolutionarily highly conserved residue in 14years.Shegraduallydevelopedfootdropandupperlimb the S6 transmembrane segment which is part of the chan- distal weakness. On EMG she showed a motor axonal nel’scentralporeforionpermeation.All11appliedinsilico neuropathy with neuromyotonia. She was homozygous for prediction algorithms categorized the variant as deleterious. the c.110G>C (p.Arg37Pro) mutation in HINT1. Patient 3 In a previous report on KCDN2 as a disease gene, a wasa 49year-oldmalepresentingwith walking difﬁculties monozygotic twin pair with epilepsy and developmental attheageof15years.Hegraduallydevelopedfootdropand delay carried a heterozygous de novo missense variant upper limb distal weakness. On EMG he showed a pre- affecting the same residue (Lee et al., PMID: 24501278). dominantly motor axonal neuropathy with neuromyotonia. This p.(Val404Met) mutation (c.1210G>A) was shown to He was homozygous for the c.110G>C (p.Arg37Pro) lead to enhanced inactivation of closed Kv4.2 channels and mutation in HINT1. We conclude that HINT1-related CMT impaired inactivation of open channels (Lin et al., PMID: may be relatively common in Greece and should be further 29581270). Thus, our ﬁnding supports dominant de novo systematically screened for in appropriately selected KCND2 missense variants as a cause of intractable, early- populations. onset epilepsy with severe global retardation. Z. Kontogeorgiou: None. D. Pandis: None. C. Kartanou: U.Zechner:None.D.Rosenkranz:None.H.Bolz:None. None. M. Breza: None. T. Zambelis: None. M. Panas:886 J.delPicchia E-P09.39 E-P09.42 Correlation of genetic analysis and evolution of MRI Earlyonsetofcomplexseizuresasaﬁrstsignof16p11.2 changes leading to diagnosis of Labrune syndrome deletion syndrome J. Pilch1, M. Machnikowska-Sokołowska2, M. Rydzanicz3, E. Sukarova-Angelovska, V. Anastasovska, F. Duma, A. Pollak3, J. Kosińska3, P. Gasperowicz3, L.Muaremovska,D.Nestoroska,G.Ilieva,M.Pesevska,M. K. Gruszczynska2, E. Emich-Widera1, R. Płoski3 Velkov 1DepartmentofPediatricNeurology,MedicalUniversityof PediatricClinic,Skopje,Macedonia,TheFormerYugoslav Silesia, Katowice, Poland, 2Department of Diagnostic Republic of Imaging and Interventional Radiology, Department of Radiology and Nuclear Medicine, Medical University of Background: Recent technologies enabled clariﬁcation of Silesia, Katowice, Poland, 3Department of Medical Genet- some previously undetected causes of intellectual disability ics, Medical University of Warsaw, Warsaw, Poland andautismspectrumdisorders.Therearereportsof16p11.2 deletion in the literature, describing variable clinical pre- Progressive leukoencephalopathy with calciﬁcation and sentation in patients. Most of them describe developmental cysts wasﬁrst reportedbyLabrune in1996.Thepathology delay, autism and seizures, however phenotypic pattern is underlyingthediseaseisadiffusecerebralmicroangiopathy undistinguishable and variable. There is still no sufﬁcient with development of micro-, macrocysts, tumour-like vas- clinical data of this CNV in babies. cular hyperplasia, calciﬁcation, glial proliferation, demye- Case report: We report on a patient with developmental lination, necrosis, iron deposition and haemorrhage. delay and complex seizures. This is a second child in a Mutations in the SNORD118 gene were associated with family, the pregnancy and delivery was uneventful. Labrune syndrome in 2012. Since then only individual Microcephaly, foramen ovale and generalized hypotonia cases have been presented. were noticed shortly after birth. At the age of 3 months he We report a normally developing 10-years-old girl developed infantile spasms, followed by profound devel- suffering from chronic headaches without neurological opmental delay within the next several months. He has symptoms. Initially, Aicardi-Goutieres syndrome was microcephaly, early closure of the fontanel, high forehead, suspected. We performed retrospective analysis of three bitemporal narrowing, wide nasal root, narrow palpebral annual brain MRI with MR angiography. In all MRI we features, upper lip notch, short neck, cryptorchidism. found diffuse symmetrical white matter areas of increased Karyotype was normal. aCGH analysis (using Affymetrix® signal with U-ﬁbers sparing. Deep nuclei were affected. CytoScanTM 750K Array) showed deletion of 16p11.2 Cystic areas, enlarging in consecutive examinations were (1.430kb),alsodeletiononchromosome14q11.2(433kb), observedinthalami,withmasseffectinlastMRI.Multiple both are considered as pathogenic according aDGV signals with blooming effect were spread both supra- and database. infratentorially. Partial peripheral contrast enhancement Discussion and conclusion: Deletion of the 16p11.2 is wasseeninsupratentorialchanges.AsuspicionofLabrune mostly described in older children that developed autistic syndrome has arose after progression of cysts in degener- spectrum of disorder, ADHD, etc. Wide clinical variability ated white matter and appearance of calciﬁcations. is described between patients, mostly due to the variations Complex heterozygous mutations 17:008173448-G>C onsizeandbreakpointofthedeletedregion.Therearesome and 17:008173570-G>C in the SNORD118 gene encoding inconsistencies in phenotype described in literature, how- small nuclear RNA were found in patient using whole everthiscouldbeapartofachangingphenotypewithage. exome sequencing. Both parents are carriers of identiﬁed Since the baby had two pathogenic microdeletions, it is mutations. difﬁcult to distinguish between two phenotypes. Conclusion: Follow up MRI examinations in normally E. Sukarova-Angelovska: None. V. Anastasovska: None. developing child and correlation with in-depth genetic F. Duma: None. L. Muaremovska: None. D. Nestoroska: analysis led to diagnosis of a rare genetic metabolic None. G. Ilieva: None. M. Pesevska: None. M. syndrome. Collaboration between radiologists, geneticist Velkov: None. and clinicians was crucial for establishing ﬁnal diagnosis. J.Pilch:None.M.Machnikowska-Sokołowska:None.M. E-P09.45 Rydzanicz: None. A. Pollak: None. J. Kosińska: None. P. WholeExomeSequencingofconsanguineousfamiliesof Gasperowicz: None. K. Gruszczynska: None. E. Emich- clinicallydiagnosedwithNeurodevelopmentalDisorders Widera: None. R. Płoski: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 887 B. Turkgenc1, K. Yararbas2,3, H. Keskin Karakoyun1,4, EXOSC3, B4GALNT1, GBA2, WWOX, ERCC6, CHKB, A.Yesilyurt1,A. Gezdirici5,B.Tatlı6,7,N. H.Akcakaya8,N. TBCK, GLDC,TRAPPC9, CYP7B1, MID1 and TTN E. Hacifazlioglu9, O. Coskun7, G. Yesil10, B. Ekici11, genes. CLP1 and GJC2 genes were found mutated twice. C. Yıldırım12, H. Onal13, G. Turanlı14, Y. Alanay15,16 A total of 6 novel variants were identiﬁed. Interestingly, clinicallyrelevantTTNandMID1variantsweredetectedin 1Acibadem Genetic Diagnostic Center, Istanbul, Turkey, thesamepatient,explainingthecombinatorialeffectsofthe 2Acibadem Genetic Diagnosis Center, Istanbul, Turkey, genes may contribute to phenotype complexity and 3Department of Medical Genetics, Faculty of Medicine, variability. Acibadem University, Istanbul, Turkey, Istanbul, Turkey, Conclusions: Identiﬁcation of pathogenic/ potentially 4Department of Biochemistry and Molecular Biology, pathogenic variants and novel variants may lead to the Acibadem University, Istanbul, Turkey, 5Kanuni Sultan design of personalized therapeutic strategies and the Süleyman Training and Research Hospital, University of implementation of genetic counseling of NDD as well as Istanbul Health Sciences, Istanbul, Turkey, 6Pediatric to monitoring and early intervention, even before the onset Extreme NeuroTherapeutics Center, Istanbul, Turkey, of the disorder. 7Department of Pediatric Neurology, Faculty of Medicine, B. Turkgenc: None. K. Yararbas: None. H. Keskin Istanbul University, Istanbul, Turkey, 8Department of Karakoyun: None. A. Yesilyurt: None. A. Gezdirici: None. Genetics, Aziz Sancar Institute of Experimental Medicine, B. Tatlı: None. N.H. Akcakaya: None. N.E. Hacifazlioglu: Istanbul University, Istanbul, Turkey, 9Zeynep Kamil None.O.Coskun:None.G.Yesil:None.B.Ekici:None.C. Women’s and Children’s Disease Training and Research Yıldırım: None. H. Onal: None. G. Turanlı: None. Y. Hospital, Istanbul, Turkey, 10Department of Medical Alanay: None. Genetics, Faculty of Medicine, Bezmialem Foundation University, Istanbul, Turkey, 11Pediatric Neurology, Vital E-P09.50 Fulya, Istanbul, Turkey, 12Department of Pediatric Neurol- Early-onset parkinsonian syndrome and PLA2G6 gene ogy, Acibadem Altunizade Hospital, Istanbul, Turkey, mutation 13Department of Pediatric Endocrine and Metabolism, Istanbul Kanuni Sultan Süleyman Training and Research C. Skrypnyk1, M. B. Falah2 Hospital, Istanbul, Turkey, 14Department of Pediatric Neurology, Faculty of Medicine, Medipol University, 1ArabianGulfUniversity,CollegeofMedicineandMedical Istanbul, Turkey, 15Department of Pediatric Genetics, Sciences, Al Jawhara Center for Molecular Medicine, AcibademMaslakHospital,Istanbul,Turkey,16Department Manama, Bahrain, 2Arabian Gulf University, University of Medical Genetics, Faculty of Medicine, Acibadem Medical Center, King Abdullah Medical City, Manama, University, Istanbul, Turkey Bahrain Introduction: Neurodevelopmental disorders (NDD) are Introduction: The parkinsonian syndromes encompass a heterogeneous conditions in which the development of the numberofentitiesgroupedbasedonsharedclinicalfeatures central nervous system is disturbed. Recent advancements but separated by different pathologies. Non-motor features in genomics have enabled scientists to identify numerous evolvingcoincidentwithprogressivemotordisabilitymake mutations underlying NDD. the diagnosis very challenging. Materials and methods:We usedwhole exome sequen- Material and methods: Clinical assessment, brain cing (WES) to identify the causative genes in 22 patients MRI, EEG, biochemical proﬁle and genetic testing were with NDD. Consanguinity was reported in all families. performed for a 25 years old male patient that Genomic DNA was extracted using the QIAamp DNA presentedwithprogressiveneurologicalsymptoms,general- Blood Mini QIAcube Kit (QIAGEN, Hilden, Germany). ized myoclonic jerks, unilateral left upper body tremor and The DNA libraries were created by the Nextera DNA rigidity, walking difﬁculties, swallowing difﬁculties, poor Exome kit (Illumina) and sequenced on NextSeq concentration and attention, behavioral changes and bouts 500 sequencer using 2x150 bp sequencing kits (Illumina). of anger. Bioinformatic analyses were performed on Seqgenomize Results: The patient is the ﬁrst child of healthy ﬁrst platform including an automated variant classiﬁcation tool. degree cousins parents and has a positive family history of Results:InseriesofpatientswithNDDstudiedbyWES, epilepsy. Behavioral changes were recorded since age 17 we found pathogenic/likely pathogenic variants in 17 years old and neurological symptoms had onset at age 22. different genes, which consist of 2 frameshift duplication, CAG repeats testing was previously reported normal and 4 frameshift deletion, 6 nonsense, 9 missense and a splice ruledoutHuntingtondisease.BrainMRIshowngeneralized site variants in WDR62, CLP1, IGHMBP2, ADSL, GJC2, cerebral and cerebellar atrophy without signs of iron888 J.delPicchia accumulation or T2 lesions in basal ganglia. EEG revealed rs1800629, IL-1β rs16944, and IL-6 rs1800795 was generalized epileptic complexes. Serum ceruroplasmin and performed using TaqMan real-time PCR assays. copper values were normal. Rare forms of Parkinson, Results: IL-1β rs16944 G allele in females has been Multiple system cerebellar atrophy and Spinocerebellar associated with faster PD progression on UPDRS motor ataxia were considered as differential diagnoses. Whole examination (Part III, p=0.014), on motor complications genomesequencingidentiﬁedaPLA2G6genehomozygous (Part IV, p=0.026), and on UPDRS total (p=0.005). IL-6 pathogenicmissensemutationandclariﬁedthediagnosisof rs1800795 GG genotype was statistically signiﬁcant Parkinson Disease type 14 (OMIM#612953, predictor of depression (p=0.047) and anxiety (p=0.004) ORPHA199351). progression on related scales. Conclusions:Wholegenomesequencingisaveryuseful Conclusion: Polymorphic variants in IL-1β, and IL-6 and fast tool in elucidating a complex and heterogeneous genesinﬂuenceParkinson’sdiseasecourseduringﬁve-year phenotype. PLA2G6 mutations should be considered in follow-up. patients with atypical early-onset parkinsonian syndrome. M. Pesic: None. N. Maksimovic: None. A. Aleksic: Genetic testing is required when consanguinity associates None. M. Gulic: None. A. Djuranovic: None. M. Grk: with complex and early neurodegenerative onset. None. M. Dusanovic Pjevic: None. I. Stankovic: None. V. C. Skrypnyk: None. M.B. Falah: None. Markovic: None. A. Marjanovic: None. I. Novakovic: None. N. Dragasevic-Miskovic: None. V.S. Kostic: None. E-P09.52 Polymorphisms in genes for proinﬂammatory cytokines E-P09.53 IL-6, IL-1β, andTNF-α in relation with Parkinson’s Search for molecular genetic factors in Parkinson’s disease progression disease M. Pesic1, N. Maksimovic1, A. Aleksic2, M. Gulic1, M. Shadrina1, S. Pchelina2, S. Illarioshkin3, P. Slominsky1 A. Djuranovic1, M. Grk1, M. Dusanovic Pjevic1, I. Stankovic3, V. Markovic3, A. Marjanovic3, I. Novakovic1, 1Institute of Molecular Genetics, Russian Academy of N. Dragasevic-Miskovic3, V. S. Kostic3 Sciences, Moscow, Russian Federation, 2The Petersburg Nuclear Physics Institute of the National Research Center, 1InstituteofHumanGenetics,Belgrade,Serbia,2Instituteof Kurchatov Institute, Russian Academy of Sciences, Gat- Medical Statistics and Informatics, Belgrade, Serbia, china,RussianFederation,3FederalStateScientiﬁcInstitu- 3Clinic for Neurology, ClinicalCenter ofSerbia, Belgrade, tion, Scientiﬁc Center of Neurology, Russian Academy of Serbia Sciences, Moscow, Russian Federation Introduction: Parkinson’s disease (PD) is a progressive Introduction: At present, there is no doubt about the and complex neurological disorder with heterogeneous complexityofthenatureofthepathogenesisofParkinson’s symptomatology.Chronicneuroinﬂammationcontributesto disease(PD)duetodisruptioninthefunctioningofvarious the pathogenesis of PD. Activation of microglia and metabolic systems, which leads to dopaminergic system increased levels of pro-inﬂammatory mediators such as deﬁciency. At the moment, there is no single picture of the tumor necrosis factor alpha (TNF-α), interleukine-1 beta etiopathogenesis of this disease. (IL-1β), and interleukine-6 (IL-6) have been reported after Materials and methods: Toxic models of PD in rodents post-mortem analysis of the substantia nigra from PD andvarioussamplesofpatientswithPDwerestudiedusing patients. This study aimed to estimate the association of sequencing of full exome, transcriptome, and RT-PCR. TNF-αrs1800629,IL-1βrs16944,andIL-6rs1800795with Results: An analysis of patients with a presumed thedisease progressionintheinitial motorstage,afterﬁve- autosomal dominant form of PD revealed eight new genes, year follow-up. mutations in which can lead to the development of the Material and methods: Our study included 64 con- disease, was carried out. Three different variants were secutivePDoutpatientsatHoehnandYahrdiseasestage1. detected in the SCN3A gene in three patients. Analysis of The severity of PD, depression, anxiety, and cognitive toxic models of PD revealed new ones that can play an impairment were evaluated using rating scales: Uniﬁed important role at different stages of pathogenesis (vesicular ParkinsonDiseaseRatingScale(UPDRS)Part(I-IV),Mini- transport, projection of neurons, RNA splicing and Mental State Examination (MMSE) score, Hamilton myelination processes). A detailed analysis of the mRNA Depression Rating Scale (HAM-D), and Hamilton Anxiety level of individualgenes intheperipheral blood ofpatients Rating Scale (HAM-A). Patients completed the same with PD revealed several genes, the level of which protocol at Years 1, 2, 3, and 5. Genotyping of TNF-α speciﬁcally varied in untreated patients with PD.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 889 Conclusion: Our data indicate a consistent involvement E-P09.55 ofthetranscriptomeinthepathogenesisofPDandhighlight Further evidence of the expanding clinical spectrum of the independent role of various brain structures and PIGT-CDG: from epileptic encephalopathy to intellec- individual parts of nerve cells in the formation of a tual disability with epilepsy. response to the development of neurodegeneration. In addition, we showed the possible involvement of SCN3A I.BenAyed1,2,F.Kamoun3,A.Souissi4,A.Bouzid4,M.Ben in the process of neurodegeneration. This work was Said4, S. Ben Nsir3, W. Bouchaala5, A. Tlili6,7, C. Triki3, S. supported by the Russian Science Foundation (grants 20- Masmoudi4 15-00262). M. Shadrina: None. S. Pchelina: None. S. Illarioshkin: 1Laboratory of Molecular and Cellular Screening Pro- None. P. Slominsky: None. cesses,Center ofBiotechnologyofSfax, UniversityofSfax, Tunisia., SFAX, Tunisia, 2Medical Genetic Department, E-P09.54 University Hedi Chaker hospital of Sfax,, Sfax, Tunisia, Polymorphism of the functional promoter microsatellite 3Child Neurology department, Universitary Hedi Chaker locus of the arginine vasopressin receptor in Yakut men hospitol of Sfax,, SFAX, Tunisia, 4Laboratory of Molecular arelinkedtoextraversion&neuroticismpersonalitytraits and Cellular Screening Processes, SFAX, Tunisia, 5Child Neurology department, Universitary Hedi Chaker hospitol S.S.Nakhodkin1,N.A.Barashkov1,2,V.G.Pshennikova1,2, of Sfax,, SFAX, Tunisia, SFAX, Tunisia, 6Department of S. A. Fedorova1 AppliedBiology,CollegeofSciences,UniversityofSharjah, Sharjah,UnitedArabEmirates,7HumanGeneticsandStem 1M.K. Ammosov North-Eastern Federal University, Cell Laboratory, Research Institute of Sciences and Yakutsk, Russian Federation, 2Laboratory of Molecular Engineering, University of Sharjah, Sharjah, United Arab Genetics, Yakut Scientiﬁc Centre of Complex Medical Emirates Problems, Yakutsk, Russian Federation Introduction: PIGT-CDG is a rare Glycosylpho- Polymorphismofthefunctionalpromotermicrosatellitelocusof sphatidylinositol disorder. The patients show a broad clin- the arginine vasopressin receptor (AVPR1A) can cause the ical spectrum from epileptic encephalopathy to severe formationofpersonalitytraitscharacterizedbyimpulsivity,poor intellectual disability and treatable epilepsy with later age control of one’s impulses, extravagance, anxiety, exaggeration at onset. of the expected danger and an acute reaction to social dis- PatientandMethods:Illumina®TruSight™Oneclinical approval.Inthispaper,weevaluatedtheeffectoftheRS1locus exomewasperformedina4-year-oldgirlwithMiSeqnext- in the AVPR1A gene, in the formation of personal character- generation sequencing platform in order to explore a istics in 121 individuals of Yakut men, and also conducted a profound developmental delay associated with severe comparativeanalysisofthefrequencydistributionofallelesand hypotonia, seizure, and nystagmus. genotypes. The study revealed the involvement of the poly- Results: The analysis revealed a homozygous missense morphicmarkerRS1intheformationofsuchpersonaltraitsas variant in PIGT (NM_015937.6): c.1519C>T (p. "avoidanceofdamage"and"dependenceonreward".Thedata Arg507Trp). Segregation analysis supports the recessive obtainedindicateamodulatingeffectofethnicityonidentifying pattern of inheritance. The pathogenicity of p.Arg507Trp associations of the AVPRA1 gene with personality traits. The wasestimatedasdeleteriousbyweb-basedpredictiontools. frequenciesofRS1allelesdifferedinYakut(Asian)volunteers So far 26 patients with a GPI anchor deﬁciency due to compared to white (Finland, Ireland, Israel), and European recessive PIGT variants have been described. Our patient whitepopulationshadahigherrangeofGATAtrackdiversity. shares the most common features associated with PIGT- WeidentiﬁedsevendifferentallelesoftheRS1marker.Atthe CDG: intellectual disability/development delay, seizures, same time, short and long alleles (R8, R14, R15, R16) were nystagmus, and brain MRI anomalies. Most of the absent in our sample in homozygous form. The Yakut popu- published PIGT deﬁcient patients had evident cortical and lationischaracterizedbyapronounceddeﬁcitofheterozygotes cerebellaratrophy.Ourpatientdemonstratedsevereatrophy and a low level of actual heterozygosity, which can be of the cerebral hemispheres with slight atrophy of the explained by the founder effect in the Yakut population. The cerebellum at the age of 4 years. If the predominant work was supported by the Ministry of science and higher presentation of patients is that of an epileptic encephalo- education of the Russian Federation (the main part of NEFU) pathy including severe drug resistance, only some cases and with the support of RFBR grant (18-05-600035_arctic). (4/26)withsevereIDandtreatableepilepsywithlaterageat S.S. Nakhodkin: None. N.A. Barashkov: None. V.G. onsetwerereported.Ourpatienthadaglobaldevelopmental Pshennikova: None. S.A. Fedorova: None.890 J.delPicchia delay with seizures; she became seizure-free with only one father carried the same heterozygous MYORG variant and antiepileptic drug. showed no brain calciﬁcation. Conclusion: Here, a report a novel pathogenic missense Conclusions: We report a homozygous MYORG change variant in PIGT gene associated with treatable epilepsy asthemostlikelycauseofPFBCpresentingasparoxysmal strengthening the hypothesis that missense variant can lead dyskinesia in our patient and thus expand the known to cause a milder phenotype with treatable seizures phenotypic spectrum of MYORG-associated PFBC. I.BenAyed:None.F.Kamoun:None.A.Souissi:None. A.Westenberger:F.Consultant/AdvisoryBoard;Modest; A. Bouzid: None. M. Ben Said: None. S. Ben Nsir: None. Centogene.G.Saranza:None.K.Grütz:None.C.Klein:F. W. Bouchaala: None. A. Tlili: None. C. Triki: None. S. Consultant/Advisory Board; Modest; Centogene. A.E. Masmoudi: None. Lang: None. E-P09.56 E-P09.57 Primary familial brain calciﬁcation manifesting as A Portuguese family-based exome sequencing in pri- isolatedparoxysmaldyskinesia:Casereportofapatient mary headaches with a homozygous MYORG change A. Dias1,2, M. Alves-Ferreira1,2, J. Sequeiros1,2, J. Pereira A. Westenberger1, G. Saranza2, K. Grütz1, C. Klein1, Monteiro1, A. Sousa1,2, C. Lemos1,2 A. E. Lang2,3 1i3S – Instituto de Investigação e Inovação em Saúde, 1Instituteof Neurogenetics, University of Lübeck, Lübeck, Porto, Portugal, 2ICBAS - Instituto Ciências Biomédicas Germany, 2Edmond J. Safra Program in Parkinson’s Abel Salazar, Porto, Portugal Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, ON, Introduction: Primary headaches comprises migraine with Canada, 3Division of Neurology, Department of Medicine, or without aura (MA/MO) and cluster headache (CH). University of Toronto, Toronto, ON, Canada During the last 17 years, our group has been able to clini- cally characterize more than a thousand patients, relatives Introduction: Primary familial brain calciﬁcation (PFBC) and controls and we performed several candidate-gene isahereditarydisordercharacterizedbycalciumdepositsin association studies in different pathways. Moreover, we the brain and presenting clinically with neuropsychiatric found several variants involved in the vascular component, symptoms,cognitivedysfunction,oravarietyofmovement trigeminal nociceptive plasticity, neurogenic inﬂammation disorders. Currently, changes in six genes are known to and in the release of neurotransmitters. However, these cause PFBC, with SLC20A2, PDGFB, PDGFRB, XPR1 complex diseases are caused by several genetic factors. variants related to autosomal dominant forms and MYORG Whole-exomesequencing(WES)isapowerfulapproachto and JAM2 variants to autosomal recessive ones. explorecodingregions,particularlylow-frequencyvariants. Patients and Methods: We identiﬁed a 26-year-old OuraimwastoperformaWESinthreefamiliestounravel femalepatient,presentingwithperiodicinvoluntarypostur- genetic factors involved in migraine and CH susceptibility. ing of her limbs and symmetrical bilateral brain calciﬁca- Materials and methods: We gathered clinical informa- tions.GenetictestingwasperformedforPRRT2,SLC20A2, tion and DNA samples from 3 families with primary PDGFB, PDGFRB, XPR1, and MYORG. Her parents also headaches and associated phenotypes. Afterwards, a WES underwent targeted MYORG sequencing. was performed. Results:Inourpatient,theparoxismalkinesigenicattacks Results:Weanalysed20patientsfromthe3familiesand ﬁrstappearedateightyearsofage,becamemorefrequentin we found common and rare variants in genes already her teenage years (up to ten attacks per day) and were associated with migraine subtypes as CACNA1A and completely absent during her pregnancies. Neurologic PRRT2 and in new genes that may open new pathways examination was normal between episodes. Neuroimaging of study. revealed symmetrical bilateral calciﬁcations involving the Conclusions:Thesepreliminaryresultsneedtobefurther cerebellum, basal ganglia, thalamus, midbrain, and the explored and interactions among these variants need to be frontal and occipital cortical and subcortical areas. In understood to deepen the pathophysiological pathways of addition, in her pregnancies, the placentae were noted to migraine. In the future, we will also correlate epigenetics have widespread calciﬁcation. Our genetic analyses identi- and brain activity data to assess the risk of chronic and ﬁed a homozygous previously reported and likely patho- episodic migraine in women. Understanding the mechan- genicmissensevariantintheMYORGgene(c.1831C>T;p. isms underlying primary headache pathophysiology could Arg611Trp) and no PRRT2 changes in our patients. Her lead to the development of more effective and better-Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 891 tolerated therapeutic approaches to avoid the overlay of E-P09.60 painful events. Potential genetic modiﬁers of the inherited neurodegen- A. Dias: None. M. Alves-Ferreira: None. J. Sequeiros: erative disorder SCA3 None. J. Pereira Monteiro: None. A. Sousa: None. C. Lemos: None. R. M. Burger1,2,3,4, M. L. Saraiva-Pereira5, M. Franca6, C.Gordon7,L.B.Jardim5,M.Cornejo-Olivas8,O.Rieß1,2,3, E-P09.58 T. Schmidt1,2,3 PrevalenceofPTENmutationsinTurkishchildrenwith autism spectrum disorders and macrocephaly 1University of Tübingen, Medical Genetics and Applied Genomics, Tübingen, Germany, 2University of Tübingen, H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3, Center of Rare Diseases, Tübingen, Germany, 3University B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7, of Tübingen, NGS Competence Center of Tübingen M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 (NCCT), Tübingen, Germany, 4IZKF, Graduate program oftheUniversityofTübingen,Tübingen,Germany,5Labor- 1Demiroglu Bilim University, Istanbul, Turkey, 2Istanbul atório de Identiﬁcação Genética, Hospital de Clínicas de University, Istanbul, Turkey, 3Behcet Uz Hospital, Izmir, Porto Alegre, Porto Alegre, Brazil, 6Department of Turkey, 4Ege University, Izmir, Turkey, 5Katip Celebi Neurology, University of Campinas-UNICAMP, Campinas, University, Izmir, Turkey, 6Okmeydanı Hospital, Istanbul, Brazil, 7Sackler Faculty of Medicine, Tel Aviv University,, Turkey, 7Yeditepe University, Istanbul, Turkey Tel Aviv, Israel, 8Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Background: Spinocerebellar ataxia type 3 (SCA3) is an Recently,peoplewithautismspectrumdisorders(ASD)and autosomal-dominantly inherited neurodegenerative disease macrocephalywerefoundtocarrymutationsinPTENgene. and the most common inherited ataxia worldwide. Its Mutations in this gene cause PTEN Hamartoma Tumour pathogenic mutation is an abnormal expansion of the CAG Syndrome (PHTS). However, PHTS often goes undetected repeatsover55triplet-repeatswithintheATXN3genewhich especiallyinchildrensincethemanifestationsofthedisease encodesforanexcessivelylongpolyglutamine(polyQ)tract are variable and subtle and guidelines for testing are few. in the disease protein ataxin-3. Patients show a widely Studiesshow1to17%prevalenceratesofPTENmutations spread variation in age at onset and clinical variability of inchildrenwithASDandmacrocephaly.Thevaryingresults phenotype. Until today this phenomena is not fully on prevalence suggest the need for further studies. The aim explained. In the past, it was shown that the age at onset ofourstudyistoﬁndPTENprevalenceinTurkishchildren inverselycorrelateswiththeexpandedCAGrepeats.Within withASDandmacrocephalyandincreaseawarenessofthis thewiderange ofageatonsetbetween 5-75yearsonly45- syndromeinTurkey.Tothebestofourknowledgethiswill 60% can be explained by the CAG repeat expansion. be the ﬁrst PTEN prevalence study done in Turkey and Aim:Theaimofourstudyistoidentifygeneticmodiﬁers South Eastern Europe. This is also the largest pediatric whichcanexplainthewiderangeofageatonsetaswellas cohortforPTENprevalencestudyinpatientswithASDand the clinical heterogeneity of SCA3. macrocephaly. Materials and methods: PTEN sequencing Methods: Previously several genes (ATXN3, ATXN2, were done for 128 patients with ASD and head cir- APOE, CACNA1A) were described as candidate genes in cumference size more than 97% on growth charts between literature. We are genotyping two big cohorts EUROSCA the ages of 3 to 18 recruited from ﬁve different child and (Europe)andEUSAge(Israel,Brazil,Peru)intermsofsingle- adolescentpsychiatryclinicsinTurkey.Result:Wefound2 nucleotide polymorphism (SNP) within candidate genes. known pathogenic, 1 new pathogenic and 2 variants of ResultsandConclusion:Avariationinpolymorphismcan insigniﬁcance (VUS) mutations out of 128 patients. The leadtodifferentisoformsofthegenes,functionalchangesof prevalence is 2,3% (VUS mutations are excluded). Con- the encoding proteins and different interactions with mole- clusion:WerecommendPTENtestinginpatientswithASD cules.ASNPinATXN3hasalreadybeenfoundtoinﬂuence and macrocephaly. Grant for this study is awarded by the pathophysiology of SCA3.Therefore,SNPs of candidate ‘PTEN Research’ in London, UK. genes seem to have an inﬂuence on the pathophysiology of H.Kaymakcalan:None.I.Kaya:None.N.CevherBinici: SCA3 and may be promising genetic modiﬁers to observe None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: further in order to learn more about the disease. None. E. Nikerel: None. M. Aksoy: None. D. Celik: None. R.M. Burger: None. M.L. Saraiva-Pereira: None. M. S. Kose: None. N. Majroh: None. S. Duruk: None. Franca: None. C. Gordon: None. L.B. Jardim: None. M. Cornejo-Olivas: None. O. Rieß: None. T. Schmidt: None.892 J.delPicchia E-P09.61 O. Ozgen1, G. Akan2, A. Colak3, S. Acar4, F. Oncu5, Co-ocurrence of two rare genetic diseases in a patient H. Yanbay5, D. Yeşilbursa5, S. Turkcan5, F. Atalar6 with intellectual disability, refractory epilepsy and skeletal abnormalities 1Istanbul University Medical Faculty, Aziz Sancar Experi- mentalResearchInstitute,MolecularMedicineDepartment, M. Rodrigues, M. P. Soares, P. Dias, A. B. Sousa Istanbul, Turkey, 2MUHAS Genetics Laboratory, Biochem- istryDepartment,SchoolofMedicine,MuhimbiliUniversity Serviço de Genética Médica, Hospital de Santa Maria, of Health and Allied Sciences, Dar es Salaam, Tanzania, Centro Hospitalar Universitário de Lisboa Norte EPE, United Republic of, 3Department of Biomedical Engineer- Centro Académico de Medicina de Lisboa, Lisbon, ing, Biomedical Engineering Institute, Bogazici University, Portugal, Lisbon, Portugal Istanbul, Turkey, 4Department of Bioengineering, Yildiz TechnicalUniversity,Istanbul,Turkey,5PsychiatryClinics, Introduction: Whole-exome sequencing (WES) is a pow- TurkishMinistryofHealthBakirkoyResearchandTraining erful tool to identify the genetic causes of rare mendelian Hospital for Psychiatry, Neurology and Neurosurgery, disorders and can be particularly useful in patients with Istanbul, Turkey, 6Istanbul University Medical Faculty, complex and genetically heterogeneous phenotypes. The Medical Genetics Department, Child Health Institute, authorsdescribeapatientwithphenotypicmanifestationsof Istanbul, Turkey two rare genetic diseases: autosomal recessive cerebellar ataxia type 23 (SCAR23, OMIM #616949) and con- Background:Thyroidhormonemodulationofcrucialbrain tractures, pterygia, and variable skeletal fusions syndrome- neurotransmitter systems and the misregulation of these 1A (CPSKF1A, OMIM #178110). pathways are of particular relevance in schizophrenia Methods and results: We report a 21-year-old male (SCH). Type II deiodinase enzyme (DIO2) has a critical patientborntonon-consanguineousparents,withirrelevant potency on thyroid metabolism that converts prohormone family history. He has language delay, mild to moderate thyroxine (T4) to the active hormone triiodothyronine (T3) intellectual disability (ID), refractory epilepsy, ﬁne motor also it seemsthat canparticular relevance inschizophrenia. skill deﬁcits, short neck, narrow shoulders, mild facial The aim of this study was to investigate the genetic con- dysmorphisms, hypoplastic hypothenar eminence and tributionoftheDIO2genetoSCHbythegenotypeanalysis hypoplastic ﬂexion creases. His skeletal survey showed ofDIO2Thr92AlaandORFa-Gly3Asppolymorphismsand C4-C5 fusion. Brain MRI, karyotype, array-CGH and to compare the serum levels of free triiodothyronine (FT3), FMR1 testing were normal. WES revealed two variants in free thyroxine (FT4), and thyroid-stimulating hormone TDP2 gene: c.345_348del, p.(IIe117Profs*7) (likely patho- (TSH) concentrations in 290 unrelated Turkish SCH genic) and c.949C>T, p.(Arg317*) (variant of uncertain patients and 198 healthy controls. signiﬁcance). These variants have not been previously Method and Results: We genotyped two single nucleo- reported and are in a compound heterozygous state. WES tide polymorphisms (SNPs) Thr92Ala and ORFa-Gly3Asp also showed a heterozygous deletion encompassing at least located on DIO2 gene, and performed SNP association exons 4-7 of the MYH3 gene (likely pathogenic). analysis along with the thyroid hormonal status in SCH Discussion and conclusions: The presence of variants patients and healthy controls. The distribution of Thr92Ala c.345_348del and c.949C>T in TDP2 gene may justify the genotypes in SCH was signiﬁcantly different compared to neurological ﬁndings in our patient, namely ID and controls (p=0.045). In men cohort, both allele and epilepsy, establishing the diagnosis of SCAR23. On the genotype frequencies were found signiﬁcantly other hand, the heterozygous deletion of exons 4-7 of the different than controls (p=0.03). However, neither allele MYH3 gene might explain the dysmorphic and skeletal and nor genotype frequencies of ORFa-Gly3Asp poly- ﬁndings of the patient, whose features are more suggestive morphism were statistically signiﬁcant in the study of CPSKF1A. This case illustrates the challenge of group. Decrease of mean FT3 (p<0.001) and TSH diagnosing two genetic disorders co-occurring in the same (p=0.004) concentrations were observed in SCH patients patient. comparedtocontrols.Thr92Alagenotypeswerefoundtobe M. Rodrigues: None. M.P. Soares: None. P. Dias: None. signiﬁcantly associated with FT3 and TSH levels (p<0.05, A.B. Sousa: None. respectively). Conclusion: Our results indicate that DIO2 Thr92Ala E-P09.62 reduces Deiodinase-2 Activity and FT3 Levels in Turkish DIO2Thr92Ala Reduces Deiodinase 2 Activity and SCHpatients.Ourﬁndingsalsoshowthattheimportanceof Serum T3 Levels in Patients with Schizophrenia thyroid hormone metabolism in SCH.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 893 O. Ozgen: None. G. Akan: None. A. Colak: None. S. E-P09.65 Acar: None. F. Oncu: None. H. Yanbay: None. D. SORL1 variant associated with familial Parkinson’s Yeşilbursa: None. S. Turkcan: None. F. Atalar: None. disease and dementia in a large Greek pedigree. E-P09.63 T. Bourinaris1, G. Xiromerisiou2, H. Houlden1, Schizophrenia patients have signiﬁcantly less f-SatIII A. Singleton3, SYNaPS study group, J. Hardy1, and more rDNA repeats compared to healthy donors J. Vandrovcova1 V. Sergeeva1, A. Poletkina1, E. Ershova1, N. Veiko1, 1UCL Institute of Neurology, London, United Kingdom, A. Martynov1, J. Chudakova1, A. Artyushin1, 2UniversityofThessaly,Larissa,Greece,3NationalInstitute E. Malinovskaya1, A. Filev1, M. Konkova1, L. Bravve2, on Aging, Bethesda, MD, United States N.Zakharova2,G.Kostyuk2,O.Agafonova1,G.Shmarina1, S. Kostyuk1 Background: 10% of Parkinson’s disease is caused by certain monogenic forms. Several causal genes have been 1FSBI “Research Centre For Medical Genetics”, Moscow, identiﬁedtodaybuttheunderstandingofunderlyinggenetic Russian Federation, 2N. A. Alexeev Clinical Psychiatric mechanisms has proved challenging. Many of the affected Hospital №1, Moscow Healthcare Department., Moscow, families remain genetically unsolved. Russian Federation Methods: In this study we use molecular techniques to investigate a large pedigree with many affected individuals Introduction: Dysregulation of rRNA biogenesis is impli- fromanisolatedvillageincentralGreeceaffectedbyahigh cated in some human diseases. rDNAcopy number (CN) in incidenceofParkinson’sdisease. Weutilizedwholeexome thegenomeisafactoratplay.F-SatIIIisanАТ-richrepeat sequencing and linkage analysis to identify coding variants ofpericentromeric heterochromatin in the ﬁrst chromosome that are of putative signiﬁcance. We then apply association (1q12). rDNA and 1q12 interact ininterphase cells. rDNA analysis across a wider population to highlight the CN might correlate with f-SatIII. signiﬁcance of these variants in sporadic cases. Materialsandmethods:Weanalyzedleukocytesof469 Results: Linkage to chromosome 11 was found with a healthy donors (HD) and 777 patientswith schizophrenia LODscoreof2.2.Thephenotypicspectrumofourpatients (F20.00, SP). CN was determined using non-radioactive was not uniform: 3 presented with Parkinson’s disease hybridization withbiotin-labelled DNA probes. without dementia, while another2 presented with dementia Results: Genomes of SP contain increased levels of thatwaslaterclassiﬁedasAlzheimer’sdisease.Allpatients rDNACNanddecreasedlevelsoff-SatIIIcomparedtoHD: carried a novel heterozygous variant in SORL1 segregating 532 ± 118 copies with 18,0 ± 5,9 pg/ng of f-SatIII and with disease in the family. 413 ± 105 copies with21,6 ± 6,9 pg/ng of f-SatIII, Conclusions:Thisistheﬁrst reportofthediscovery ofa respectively, p < 10 -80. Amount of f-SatIII depends on likely pathogenic variant in SORL1 in a large family with rDNA CN:DNA of HD and SP containing low (200 - 350) some of the affected individuals presenting with Parkin- or high (>700) CN of rDNA contained 10 - 30pg/ng of f- son’s disease without dementia at disease onset. SatIII. 55% of SP have 500 - 600 CN of rDNA and 15-20 T.Bourinaris:None.G.Xiromerisiou:None.H.Houlden: pg/ngoff-SatIII.Only15%ofHDhavethesamenumbers. None. A. Singleton: None. J. Hardy: None. J. 16% of SP have <20 pg/ng of f-SatIII and rDNA CN > Vandrovcova: None. 500with their ratio > 40, only 1.5% of HD have this ratio. 26% of HD have rDNA CN <400, f-SatIII> 20 pg/ng and E-P09.66 their ratio <20 and only 1, 9% of SP are in this area. Thus, Molecular Complexity of Spastic Ataxias and Heredi- there is acorrelation between rDNA CN and the size if tary Spastic Paraplegias in Turkey heterochromatin regions. Conclusions:SPhavesigniﬁcantlylessf-SatIIIandmore G. Simsir1, S. Tekgul1, H. Apaydin2, S. Ertan1, A. Basak1 rDNA repeats compared to HD. V. Sergeeva: None. A. Poletkina: None. E. Ershova: 1Koç University, Istanbul, Turkey, 2Istanbul University- None.N.Veiko:None.A.Martynov: None.J.Chudakova: Cerrahpasa, Istanbul, Turkey None. A. Artyushin: None. E. Malinovskaya: None. A. Filev: None. M. Konkova: None. L. Bravve: None. N. Introduction: Hereditary spastic paraplegias (HSPs) and Zakharova:None.G.Kostyuk:None.O.Agafonova:None. autosomal recessive cerebellar ataxias (ARCAs) are neu- G. Shmarina: None. S. Kostyuk: None. rological diseases that may overlap genetically and clini- cally. Both can be associated with other neurologic or non-894 J.delPicchia neurologic symptoms and complex phenotypes. Sig- G.Simsir: None.S.Tekgul:None.H.Apaydin:None.S. niﬁcantly,ARCAsfrequentlyshowpyramidalinvolvement, Ertan: None. A. Basak: None. which results in spasticity. Molecular analysis is challen- ging due to complex genetics and rarity of these diseases. E-P09.67 However, recent developments in next generation sequen- A homozygous pathogenic variant in the STAMBPgene cing technologies help to understand complex genetic associated with microcephaly-capillary malformation background of these diseases. syndrome - the ﬁrst case report in a Roma patient Materials and methods: DNA isolated from peripheral bloodwasused.37probandswithspasticityandataxiawere M. Giertlova1, M. Mistrik1, J. Saligova2, E. Zavadilikova2, subjected to whole exome sequencing (WES), followed by A. Baranova2, M. Hyblova3, G. Minarik3 bioinformaticanalysis.Mostfamilieswereconsanguineous. Results: 26 mutations (15 novel) in 10 genes were 1AlphamedicalInc.,Martin,Slovakia,2PediatricUniversity identiﬁed (Table1). Table1 Genes and mutations identiﬁed Hospital and Medical faculty, University of P. J. Safarik, by WES in the Turkish cohort under study Kosice, Slovakia, 3Medirex Inc., Bratislava, Slovakia Introduction: ThegeneSTAMBP(STAM-binding protein) Genes(#of Mutations Novel/Reported families) encoding a deubiquitinating enzyme is associated with microcephaly-capillary malformation syndrome (MIC- SACS(n=7) c.8867T>Cp.Leu2956Ser NovelNovelNovel CAM) (OMIM 614261). We present a case study of the c.12923_12927delAAGAA ReportedReported patient with the MIC-CAM phenotype with a homozygous p.Lys4308SerfsTer21 ReportedNovel- c.4192T>Cp.Cys1398Arg Novel pathogenic variant in the STAMBP gene. c.11374C>Tp.Arg3792Ter Materialandmethods:Thefull-termnewbornpresented c.7205_7206delTTp. with microcephaly (-3.3SD) and small capillary malforma- Leu2402ArgfsTer6 tionsindifferentareasofthebody.Focalmyoclonicspasms c.3484G>Tp.Glu1162Ter c.7732_7734delGATp. developed from the 3rd month of age. At the 6th month, the Asp2578deland focal EEG abnormalities, brain atrophy and profound c.3767A>Gp.Tyr1256Cys developmental delay with hypotonia led to suspicion of SPG7(n=5) c.1861C>Tp.Gln621Ter NovelReported the early infantile myoclonic encephalopathy. Similar c.1715C>Tp.Ala572Val NovelNovel/ clinical ﬁndings were documented in her older sister c.2096T>Cp.Met699Thr Reported c.1861C>Tp.Gln621Ter/ deceased at the 9th month of age. Consanguinity was c.1715C>Tp.Ala572Val* recorded in the family pedigree. The molecular diagnosis CAPN1(n=4) c.759+1G>Ac.397C>Tp. ReportedReported was found by whole-exome sequencing (Illumina NextSeq Arg133Terc.907T>Gp. NovelReported platform)usingHumanCoreExomeKit(TwistBioscience) Trp303Glyc.397C>Tp. andconﬁrmedbySangersequencing.Thedetectedvariants Arg133Ter wereannotatedbyIngenuityVariantAnalysis(Qiagen)and SPG11(n=2) c.7158_7161dupACAAp. NovelReported His2388ThrfsTer6 classiﬁed according to the ACMG criteria. c.3809T>Ap.Val1270Asp Results:Homozygouslikelypathogenicmissensevariant HSD17B4(n=2) c.425A>Gp.Asp142Gly Novel in the STAMBP gene was identiﬁed (hg20: MRE11A(n=1) c.1442C>A,p.Thr481Lys Reported chr2:73831044A>G; ENST00000394070.7; c.188A>G; p. KIF1C(n=1) c.866A>Cp.Gln289Proand Novel-Novel Y63C). This genetic ﬁnding is consistent with the MIC- c.940+1G>A CAM phenotype observed in our patient. VPS13D(n=1) c.12629C>Tp.Ala4210Val Reported Conclusion:Lessthan20casesofMIC-CAMhavebeen PNPLA6(n=1) c.940C>Tp.Arg314Trp Novel reported so far. We present the ﬁrst case of MIC-CAM SYNE1(n=1) c.3371A>Gp.Asp1124Gly Novel syndrome in a Roma origin patient with homozygous c.188A>G; p.Y63C variant in the STAMBP gene. The heterozygous variants occur in gnomAD Exomes exclu- All patients are true homozygotes except one compound sivelyintheEuropeanpopulationwithfrequency0.000014. heterozygote* Thehypothesizedfoundereffectofthevariantremainstobe Conclusions:25/37probandsweresolved,corresponding clariﬁed. to68%diagnosticyield.Thegenesidentiﬁedpointtoahigh M.Giertlova:None.M.Mistrik:None.J.Saligova:None. heterogeneity and complexity of the cohort investigated. E. Zavadilikova: None. A. Baranova: None. M. Hyblova: The results further reveal the well-known genetic overlap None. G. Minarik: None. among HSPs and ARCAs.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 895 E-P09.68 Ankara, Turkey, 3Gazi University Department of Pediatric Expressivity of mutations in TUBB2B is highly variable Neurology, Ankara, Turkey J. Dekker, K. E. M. Diderich, R. Schot, D. J. Smits, Introduction: Inherited Glycosylphosphatidylinositol deﬁ- M. Wilke, M. A. van Slegtenhorst, G. M. S. Mancini ciencies (IGDs) are a subclass of Congenital Defects of glycosylation. Most common ﬁndings of IGDs are devel- Erasmus MC, Rotterdam, Netherlands opmental delay, seizures, andpersistent hyperphosphatasia. Moreover GRIN2B mutations cause another rare neurode- Microtubules play an important role during cortical devel- velopmental disorder which has overlapping ﬁndings with opment by regulating mitosis and neuronal migration. IGDs, e.g. developmental delay, intellectual disability and TUBB2B codes for one the β-isoforms of tubulin and epilepsy. Herein, it is aimed to present a case diagnosed dominant negative mutations in this gene result in mal- withtwodenovovariantsinPIGOandGRIN2Bgenes:one formations of cortical development (MCD) like poly- is causing a dominant and the other is causing a recessive microgyria,pachygyria,dysmorphicbasalganglia,epilepsy disorder. and intellectual disability. However, phenotypic hetero- MaterialMethod:Aseven-month-oldgirlwaspresented geneity has been reported in cases with isolated congenital withhydronephrosis,seizure,microbrachycephaly,bilateral ﬁbrosis of extraocular muscles (CFEOM3A) and myoclo- hypoplastic ﬁfth ﬁngernails, abnormal distal phalanx nus-dystonia.Hereweshowthreeindividualsinonefamily morphology of ﬁngers on radiography and persistent withamissensevariantinTUBB2B,whoexhibitanunusual hyperphosphatasia. There was no consanguinity of her phenotype.At21weekofgestationadvancedUSrevealeda parents. Whole-exome sequencing (WES) analysis was foetus with relative small head, enlarged lateral ventricles, performed to evaluate genetic etiology. borderline hypoplastic cerebellum and a thin corpus callo- Results: Two rare variants in PIGO (NM_032634.4) sum, which were less pronounced at MRI. Given the gene; c.1944C>G (p.Cys648Trp) and c.2708_2710delTCT uncertain prognosis, the couple decided to terminate the (p.Phe903del) were shown by WES analysis. Sanger pregnancy. Exome sequencing on foetal material identiﬁed sequencing performed to the parents, and unveiled that a heterozygous maternally inherited variant in TUBB2B those two variants was maternal and de novo respectively. (c.530A>T, p.Asp177Val), not present in GnomAD and The variants were evaluated as in trans position, by using predicted damaging. The healthy mother had only a lan- a heterozygous polymorphism (rs505297) and NGS read- guagedelayinchildhood.Theoldestsonofthecouplewas ings of WES data. Further, a rare de novo variant was also examined because of mild delay of both motor skills detected in GRIN2B (NM_000834.5) gene: c.1852G>A and speech. He follows regular education programme with (rs1428234478) (p.Val618Ile). extra support. The same variant in TUBB2B was conﬁrmed Conclusion: Some prospective and retrospective studies intheson.HisMRIrevealeddecreasedsupratentorialbrain have been shown the underestimated number of multiple volume, enlarged ventricles, mild cortical dysgyria, thin molecular diagnosis of which results in phenotypes over- corpus callosum and dysmorphic vermis and basal ganglia, lapping or separated. In our case phenotypes of two a pattern typical of tubulinopathies. Although we cannot diagnosis were overlapping. If one of multiple genetic exclude that the mother is a mosaic carrier, these results diagnoses had been overlooked, this would change the illustrate the wide phenotypic heterogeneity of tubulino- present or future management options of disorders and pathies, including reduced penetrance and very mild genetic counseling to families. expressivity. A. Sezer: None. Ö.B. Gündoğdu Öğütlü: None. Z. J. Dekker :None. K.E.M. Diderich: None. R. Schot: Türkyılmaz:None.K.Gücüyener:None.G.Kayhan:None. None. D.J. Smits: None. M. Wilke: None. M.A. van F.E. Perçin: None. Slegtenhorst: None. G.M.S. Mancini: None. E-P10 Neuromuscular Disorders E-P09.69 An infant with two de novo variants causing recessive E-P10.01 and dominant disorders: Diagnostic challenge Aicardi-Goutières Syndrome: unexpected another gene mutation which related epilepsy: a case report A. Sezer1, Ö. B. Gündoğdu Öğütlü1, Z. Türkyılmaz2, K. Gücüyener3, G. Kayhan1, F. E. Perçin1 1Gazi University Department of Medical Genetics, Ankara, Turkey, 2Gazi University Department of Pediatric Surgery,896 J.delPicchia F.Duymus1,B.GokselTulgar1,D.Esin1,G.Turkoglu1,M. progressive,highlydisablingandlife-threateningdiseasein E. Sarı1, T. Cora1, A. Kartal2 shorttermifanearlytreatmentisnotestablished.Itisarare disease, with prevalence less than 1 / 100,000 habitants in 1Selcuk University Faculty of Medicine, Medical Genetics worldwide. Huelva is one of the most important endemic Department, Konya, Turkey, 2Selcuk University Faculty of foci of the disease worldwide and the second in Spain. Medicine, Pediatric Neurology Department, Konya, Tur- Inherited with anautosomaldominant pattern characterized key byareducedpenetrance,whichvariesaccordingtoageand geographic area. This poses big problems and big chal- Aicardi-Goutières syndrome (AGS) is an inherited ence- lenges to monitoring patients and their families. phalopathy that mainly affects the brain, the immune sys- Objectives:Toknowthepenetranceintheendemicfocus tem, and the skin. Several of the genes (TREX1, of Valverde del Camino, Huelva RNASEH2A, RNASEH2B, RNASEH2C, IFIH1, ADAR, Methodology: A retrospective, observational study was SAMHD1)mutationscancauseAGS.Thesyndromecanbe performed. For this work, medical records have been seen as autosomal dominant/recessive. Generally, the onset collected and statistically analyzed. Demographic details ofAGSoccurswithintheﬁrstfewdaysormonthsoflife.In (sex, age at diagnosis of the disease, age at the onset of our case, the most severe neonatal form of AGS1 is typi- symptoms) were obtained callyduetomutationintheTREX1gene.Inadditiontoour Results: Data from 112 patients have been analyzed patient, SPTAN1 gene mutation was detected. This gene Conclusions: The prevalence obtained in our population mutationcancauseEarlyinfantileepilepticencephalopathy is quite different between mens and womens. A higher type 5 which inherited autosomal dominant. We thought proportion of men develop symptoms, most women with thatthecommonpointofthetwomutationsmightbesevere the pathogenic variant are asymptomatic. This could be epilepsyandcerebellaratrophyforourpatient.Herepileptic explained by the presence of polymorphisms in the TTR attacks started at about 4 months of age. On the physical gene that modulate disease expression as well as clinical examination microcephaly, joint stiffness, dystonia, abnor- symptoms. Thisisa very interestingﬁeld ofstudy that will mal eye movements, tetraplegic spasticity, and neuromotor allow us to better understand the disease. developmental retardation were presented. In cranial MR, cerebral atrophy, intracerebral calciﬁcations, and calciﬁca- PopulationPenetrance tions of the periventricular area were observed. Epilepsy Age Overall Mens Womens attacks started at the age of 3 months. We performed (years) penetrance% penetrances% penetrance% RNASEH2B gene sequence analysis in the patient and could not detect a mutation. We detected two mutations 30 3 4 0 with whole-exome sequencing. One of them was homo- 40 10 16 2 zygous c.13_15dupATC mutation in the TREX gene and 50 16 20 9 the other was heterozygous c.2882 C> T in the SPTAN1 60 28 33 21 gene. AGS is a very rare disease of unknown frequency. 70 34 40 25 Ouraiminpresentingthiscaseistoseetworaremutations >70 51 60 37 together and think that the disease can change its severity. F. Duymus: None. B. Goksel Tulgar: None. D. Esin: None.G.Turkoglu:None.M.E.Sarı:None.T.Cora:None. Á.GrageraMartínez:None.L.HerranzArriero:None.C. A. Kartal: None. Borrachero Garro: None. F. Muñoz Beamud: None. E-P10.02 E-P10.04 Penetrance of Familial Amyloid Polyneuropathy in Amyotrophic lateral sclerosis (ALS) in the Faroe Huelva. One of the most important foci in worldwide Islands, a genealogical approach Á.GrageraMartínez1,L.HerranzArriero2,C.Borrachero M. Johansen1,2, K. Svenstrup3, Ó. Mortensen4, Garro1, F. Muñoz Beamud1 G. Andorsdóttir4, M. S. Petersen1,2 1Juan Ramon Jimenez University Hospital, Huelva, Spain, 1Department of Occupational Medicine and Public Health, 2Badajoz University Hospital, Badajoz, Spain The Faroese Hospital System, Tórshavn, Faroe Islands, 2CentreofHealthSciences,UniversityoftheFaroeIslands, Introduction: Hereditary amyloidosis mediated by trans- Tórshavn, Faroe Islands, 3Neurological Department, Uni- thyretin (hATTR) is a hereditary, neurodegenerative, versity Hospital Copenhagen, Rigshospitalet andAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 897 BispebjergHospital,Copenhagen,Denmark,4FarGen,The Materialsandmethods:WehavestudiedtheDNAof43 Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Russian CMT-patients (25 myelinopathy, 18 axonopathy) Islands after excluding the most common cause of CMT – PMP22 duplications. MPS libraries were prepared with the use of ALS is a progressive neurodegenerative disease. In 5-10% Ion AmpliSeq™reagents and sequencing by Ion S5™Sys- of cases, a family history is identiﬁed. Although the inci- tem. Panel includes 15 CMT genes: MFN2, MPZ, EGR2, dence of ALS in the Faroes is similar to other European FGD4, LITAF, PMP22, PRX, MORC2, SH3TC2, HINT1, countries, we have observed an overrepresentation of cases HSPB1, NEFL, NDRG1, GDAP1, GJB1, mutations in originating from the small geographically isolated island of whichwerepreviouslyidentiﬁedasthecauseofthedisease Suðuroy,whichleadtothestudyaim:estimationoffamilial for at least 2 unrelated Russian families. ALS in the Faroese population. All ALS cases have been Results: After the targeted MPS sequencing, a deﬁnite registered since 1987. In this study, 43 patients were molecular diagnosis deﬁned as a pathogenic or a likely included. First, familial ALS was recognized when occur- pathogenic variant, was reached in 16% of cases (n = 7). ringbetweenﬁrst-orsecond-degreerelatives.Secondly,the Variants of unknown signiﬁcance were found in 16% of Faroese Multi Generation Register, which contains infor- cases (n = 7). 68% (n=29) of cases were molecularly mation aboutfamilial relationships since 1650,was usedto undiagnosed. In most cases variants were found in the construct pedigrees amongst patients to identify risk SH3TC2(5) and MFN2(3) genes. 6 patients had variants in families (≥3 cases within 3 generations). Fifteen cases ori- the following genes: MPZ, GDAP1, HINT1, LITAF, PRX, ginated from Suðuroy where the prevalence of ALS was MORC2. more than 3 times higher than the nationwide prevalence. Conclusion: Diagnoses by the MPS panel were con- Six patients had familial ALS (13.9%) of which four ori- ﬁrmedfor16%ofthepatients,whiletheWESisefﬁcientin ginatedfromSuðuroy.Throughpedigrees,weidentiﬁedsix 19-45%ofcases.Thus,smallMPS-panelisausefultoolfor additional patients with possible familial ALS (28%). This highly genetically heterogeneous pathology. It helps to study is suggestive of familial clustering in excess of avoid consequent tests of frequent genes associated with expectedforALSinSuðuroyandtheproportionoffamilial CMT with the Sanger sequencing while having the ALS in the Faroe Islands was high. High levels of efﬁciency comparable to WES. inbreedingandgeneticsubstructurehavebeendemonstrated M.D. Orlova: None. O.A. Schagina: None. O.P. Ryzh- in the Faroese population. Combined with these results, kova:None.G.E.Rudenskaya:None.E.L.Dadali:None.A. there is strong support of a genetic contribution to ALS in V. Polyakov: None. the Faroe Islands and further genetic studies are warranted. Funding: Aage og Johanne Louis-Hansens Fond, Minister E-P10.06 Erna Hamiltons Legat for videnskab og kunst, Sjúkra- Rapid exome sequencing with in silico variant prioritiz- kassagrunnurin, Betri Stuðul, Aase og Ejnar ing and the diagostic odyssey of a child with various Danielsens Fond. neurological symptoms M. Johansen: None. K. Svenstrup: None. Ó. Mortensen: None. G. Andorsdóttir: None. M.S. Petersen: None. A. Illés1, K. Árvai1, B. Kocsis-Deák1, Á. Herczegfalvi2, P. Lakatos3, J. Kósa1,3 E-P10.05 Efﬁciency of the MPS panel of 15 genes associated with 1PentaCore Laboratories, Budapest, Hungary, 22nd genetically heterogeneous hereditary neuropathies Department of Pediatrics, Semmelweis University, Buda- pest, Hungary, 3Department of Internal Medicine and M. D. Orlova, O. A. Schagina, O. P. Ryzhkova, Oncology, Semmelweis University, Budapest, Hungary G. E. Rudenskaya, E. L. Dadali, A. V. Polyakov Introduction: The hereditary motor and sensory neuro- Research Centre for Medical Genetics, Moscow, Russian pathies are a heterogenous disease group which could be Federation caused by several gene mutations, such as deletions, duplications and single nucleotide substitutions. The com- Introduction:Charcot-Marie-Toothdiseaseisagenetically plex genetic etiology could harden the differential diag- heterogeneous pathology related to hereditary peripheral nostics and lengthen the path to identify the genetic neuropathies.Thepurposeoftheresearchistoevaluatethe background. efﬁciency of panel sequencing for a highly genetically Material and methods: In our case, a four-year-old boy heterogeneous pathology. was examined, who born with hypotonia and showed delayed motor development. At the age of three, EMG898 J.delPicchia analysis showed axonal polyneuropathy and motor nerve musclehistologyrevealedpositivesarcoglycanproteinsbut conduction could not be detected in his legs. After the reduceddysferline.Duetothemusclebiopsyresultwehave analysis of copy number variations of PMP22 and SMN planned DYSF gene sequence analysis and a novel genes, further neuropathies associated genes were c.754A>G (p.Thr252Ala) variant was detected in homo- sequenced without any results. Finally, whole exome zygous state. This variant was classiﬁed as likely patho- sequencing was performed, and the results were analysed genic accordingto ACMG criteria andsegregation analysis by focusing on primer neuropathy associated genes. revealedtheparentsoftheprobandascarrier.Accordingto Results: A pathogenic heterozygous S72L mutation her physical examination and the result of the molecular (rs104894621) was identiﬁed in the PMP22 gene, which analysis we have concluded that this novel mutation gen- was previously associated with Charcot-Marie-Tooth dis- erates a phenotype as Limb Girdle Muscular Dystrophy ease. Sanger sequencing also conﬁrmed the result. Type 2b of the dysferlinopathy spectrum. Conclusions: Based on our result the clinical diagnosis S. Kocagil: None. E. Kaplan: None. E. Susam: None. B. was conﬁrmed and the genetic counsellor could provide Durak Aras: None. S. Artan: None. E. Erzurumluoglu adequate information to the parents before the birth of the Gokalp: None. O. Cilingir: None. second child. It is important to highlight that in case of neuropathies, after screening copy number variations, E-P10.12 performing whole exome sequencing could shorten and The retrieval of candidate genes of inverse comorbidity make easier the identiﬁcation of potential pathogenic between cancer and neurodegeneration considering mutations in the background of the symptoms. The fast apoptosis as a key process identiﬁcation of causal variants could contribute to the selection of speciﬁc therapy and family planning. D. Gomboeva1, O. Saik2, E. Bragina1, V. Ivanisenko2, A.Illés:None.K.Árvai:None.B.Kocsis-Deák:None.Á. V. Puzyrev1 Herczegfalvi: None. P. Lakatos: None. J. Kósa: None. 1TomskNationalResearchMedicalCenter,Tomsk,Russian E-P10.10 Federation,2FederalResearchCenterInstituteofCytology A novel mutation of DYSF gene in a patient with Limb and Genetics, Novosibirsk, Russian Federation Girdle Muscular Dystrophy type 2b Introduction: Epidemiological studies have revealed the S. Kocagil1, E. Kaplan2, E. Susam1, B. Durak Aras1, reduced cancer incidence in patients with Huntington dis- S. Artan1, E. Erzurumluoglu Gokalp1, O. Cilingir1 ease (HD), indicating a presence of inverse comorbidity or dystropy of HD and cancer. The one of promising biolo- 1EskisehirOsmangaziUniversityMedicalGeneticsDepart- gical process, which unites these two groups of diseases, is ment, Eskisehir, Turkey, 2Eskisehir Osmangazi University apoptosis. Cancer is characterized by inhibited apoptosis, Pediatric Neurology Department, Eskisehir, Turkey while in HD, on contrary, apoptosis is up-regulated. Thus, identiﬁcation of pro- and anti-apoptotic genes and study of Dysferlinopathy muscular disease spectrum encompasses a their regulation is hopeful for investigation of inverse group of phenotypes; including Limb Girdle Muscular comorbidity mechanisms of HD and cancer. Dystrophy type 2b, Myoshi myopathy, scapuloperoneal Materials and methods: The genetic network was syndrome, distal myopathy with anterior tibial onset, ele- reconstructed using ANDSystem (Ivanisenko, 2015). Net- vated serum CK concentration only, and congenital mus- work included all genes and proteins associated with HD culardystrophy.BiallelicpathogenicvariantsofDYSFgene (n=140). The list of genes of apoptosis was retrieved from is known to be responsible for dysferlinopathies. The pre- KEGG (hsa04210 identiﬁer, n=136). Prioritization was valenceofthediseaseisunknownbutincidenceishigherin carriedusingToppGeneandfunctionsofANDSystem.The the populations that consanguineous marriage is observed special criteria were calculated, including: betweenness frequently.Herewereporta17years-oldfemalepatientthat centrality, stress centrality, closeness centrality, cross-talk was referred to our outpatient clinics for proximal muscle centrality and cross-talk speciﬁcity (Saik et al., 2018). The weakness.Shehaddifﬁcultyinwalkingandclimbingstairs search of miRNA was conducted using MirTarBase forthelast6months.Inherphysicalexamination;herdeep database. tendon reﬂexes of the lower extremities were diminished, Results: 10 genes were identiﬁed: APOE, BDNF, her muscle strength was normal and she could walk on the HSPA4, HTT, IL6, INS, LEP, PSEN1, SP1, SQSTM1. tip of her toes and stand on her heels. Her serum creatine Through the analysis at the miRNA level, we retrieved 5 kinase levels were detected over 20.000 U/L repetitively common miRNA (let-7c-5p; miR-1-3p; miR-149-5p; miR- therefore muscle biopsy was planned. Quadriceps femoris 22-3p; miR-223-3p) regulate of expression of proteinAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 899 coding genes (SP1, HSPA4, BDNF, IL6). All genes are D. Esin: None. F. Duymus: None. B. Goksel tulgar: important for neurodegeneration and associated with None.G.Turkoglu:None.M.E.Sari:None.T.Cora:None. cancer: play different roles in carcinogenesis, cancer A. Kartal: None. progression dependent on type of cancer. Conclusions: The approach uncovered miRNA- apopto- E-P10.15 tic genes regulation might give new insights into the LGMD 2E: using sequence analysis to verify sarco- mechanisms of inverse comorbidity between cancer and glycanopathy neurodegeneration. This work was supported by the RFBR grant No.19-015-00391. L. Khlunovska1, I. Lastivka1, V. Antsupova2, D. Gomboeva: None. O. Saik: None. E. Bragina: None. M. Ryznychuk1, L. Hodovaniuk3 V. Ivanisenko: None. V. Puzyrev: B. Research Grant (principal investigator, collaborator or consultant and 1HSEEofUkraine,“BukovinianStateMedicalUniversity”, pendinggrantsaswell asgrantsalreadyreceived); Modest; Chernivtsi, Ukraine, 2Bohomolets National medical uni- Russian Foundation for Basic Research. versity, Kyiv, Ukraine, 3Bukovynian Center for Rehabilita- tion and Integrated Rehabilitation of Children, Chernivtsi, E-P10.14 Ukraine A novel compound heterozygous MPV17 mutation causing axonal sensorimotor polyneuropathy Introduction: Muscular dystrophy of the lumbar girdle (LGMD)isaheterogeneousgroupofhereditaryprogressive D. ESIN1, F. DUYMUS1, B. GOKSEL TULGAR1, neuromuscular diseases. G. TURKOGLU1, M. E. SARI1, T. CORA1, A. KARTAL2 MaterialandMethods:AclinicalcaseofLGMD2Eina 9 year old child. Clinical, genealogical, laboratory and 1Selcuk University School Of Medicine, Medical Genetics instrumental and molecular-genetic methods were used. Department, Konya, Turkey, 2Selcuk University School Of Results: Girl K., up to 8 years old, developed in Medicine,PediatricNeurologyDepartment,Konya,Turkey accordance with age norms. At age 8, the mother began to notice motor impairment in the child; at age 9, a duck Charcot-Marie-Tooth disease type 2EE is an autosomal walkappeared.Itbecamedifﬁcultforthechildtoclimbthe recessive sensorimotor peripheral axonal neuropathy that is stairs, squat and jump; there was pain in the calf muscles. causedby mutationsin theMPV17 gene.MPV17 encodesa The girl complained of fatigue during normal physical channel-forming protein of the inner mitochondrial mem- activity. Objective data: stimulation neuromyography - a brane.Inthiscase,itisaimedtopresenttheﬁrstclinicalreport decrease in the muscles of the lower extremities (47% on of MPV17-related axonal sensorimotor neuropathy with the right and 61% on the left); a 35-fold increase in compoundheterozygousmutation.Thepatientwasa16-year- creatinekinase levels.Toclarifythediagnosis, amolecular- old male and these second child of healthy, consanguineous genetic examination was assigned: analysis and testing of parents. He had severe distal muscle atrophy, pes cavus the removal/duplication of 123 strength genes (Los deformity, foot drop, hammertoes, atrophy of the intrinsic Angeles, 2019). Two pathogenic variants c.2T>C and hand muscles and bilateral thenar and hypothenar muscles. c.341C>T (p.Ser114Phe) were identiﬁed in the SGCB Hyporeﬂexiaofupperlimbswasobserved.Theﬁrstsymptom gene. The SGCB gene is associated with an autosomal of the patient was the loss of balance and walking difﬁculty recessive LGMD type 2E. Final diagnosis: LGMD 2E starting at the age of six. c.122G> A and c.376-9T> A (sarco-glycanopathy). mutationsintheMPV17genewasdetectedbywhole-exome Conclusions:Signiﬁcantdifﬁcultiesariseinthediagnosis sequencing.TheMPV17:c.122G>Avarianthasalreadybeen of genetic variants of neuromuscular diseases only on the described as a pathogenic variant. The MPV17:c.376-9T> A basis of a clinical study. The use of sequence analysis variantdescribedasavariantofuncertainsigniﬁcance.Tothe makesitpossibletoclarifythetypeofmusculardystrophy. best of our knowledge, the coexistence of these two hetero- Giventhehereditarynatureofthedisease,itisnecessaryto zygous mutations was not found in the literature review. In recommend genetic counseling and molecular genetic this case report, we emphasize that a novel compound het- screening for the purpose of prophylaxis and/or prognosis erozygous MPV17 mutation can cause non-syndromic per- of offspring. ipheral axonal neuropathy and should be considered in the L. Khlunovska: None. I. Lastivka: None. V. Antsupova: differential diagnosis of juvenile-adult onset severe axonal None. M. Ryznychuk: None. L. Hodovaniuk: None. sensorimotor neuropathy.900 J.delPicchia E-P10.18 M. Truglio2, M. Fabbretti2, B. Torres2, T. Mazza2, ScreeningofSMAcarrierstatusinRepublicofMoldova A. De Luca2, M. Roggini1, L. Bernardini2, A. Pizzuti1 I. Coliban1, N. Ușurelu2, V. Sacară1 1Sapienza University of Rome, Rome, Italy, 2Casa Sollievo della Sofferenza IRCCS Foundation, San Giovanni 1Laboratory of Human Molecular Genetics, Institute of Rotondo, Italy Mother and Child,, Chisinau, Moldova, Republic of, 2Laboratory Prophylaxis of Hereditary Pathologies, Insti- Introduction: Spinal muscular atrophy with congenital tute of Mother and Child,, Chisinau, Moldova, Republic bone fractures 2 (SMABF2) is a rare autosomal recessive of neuromuscular disorder characterized by arthrogryposis multiplex congenita and prenatal fractures. Reported Introduction: Spinal muscular atrophy (SMA) is an auto- patients present biallelic loss-of-function single-nucleotide somal-recessivedisease,withafrequencyofcarriersof1:35 variants in ASCC1 gene, encoding a subunit of the tran- upto1:117intheCaucasianpopulation.Theprevalenceof scriptional coactivator ASC-1 complex. We describe the SMA in the Republic of Moldova constitutes 8.43 ﬁrst SMABF2 case with documented prenatal disease evo- ±0,15:100000 population which is signiﬁcantly higher than lution,causedbyanin-framemicrodeletionandanonsense thedatafromOrphanet(2,93)andRussia(0,31-3,91).95% nucleotide variant in a stillbirth. of SMA is caused by deletion of exon 7 of SMN1. If both Materials and methods: The stillbirth, born from non- personsinacouplearecarriers,theyhavea1-in-4chanceof consanguineous parents, presented hydrops, lower limbs having a child with SMA. hyperextension withbendingofthehips,bilateral club-foot Materials and methods: 30 persons that formed 15 and congenital fractures. Prenatal ultrasound had showed couples who addressed for family planning, without a bilateral club-foot, closed ﬁsts and fetal biometric para- family history of SMA were diagnosed for determining the meters at middle-lower limits. Microarray analysis was status of exon 7 SMN1 by qPCR method, melting curve. performed on DNA extracted from umbilical cord. Data The DNA concentration was measured by spectrophoto- wereanalyzedbyCytoGenomicssoftware.NextGeneration metry. For PCR reaction each DNA sample was used as 2 Sequencing analysis was performed using the TruSightOne replicates for SMN1 exon 7 and 1 replicate for the external sequencing panel kit. NGS data were processed and standard (ALB, exon 12). EvaGreen was used as a DNA- analyzed using an in-house implemented pipeline. binding dye. Results: A 64Kb microdeletion, involving four exons of Results:ForallDNAsamples,ampliﬁcationoccurredfor ASCC1,wasdetectedbymicroarrayanalysis.NGSdisclosed both exon 12 ALB and exon 7 SMN1. According to the a single-nucleotide variant of the same gene (c.1027C>T; p. melting curves, for 22 persons the exon7 SMN1 was Arg343*), resulting in a premature termination codon. determined to be present and for 8 persons was determined Conclusions: This is the ﬁrst case of ASCC1 due to an heterozygous status (5 women and 3 men). Among those exonicmicrodeletionandanucleotidevariantincompound who are heterozygous, 2 people form the same couple. heterozygosity, expanding the mutational spectrum of this Conclusions:FollowingtheHardy-Weinbergequilibrium gene. This case provides further evidence that exonic copy (0,23) for 26% of the patients, the status of carriers of the number variants are an underestimated cause of disease- deletion was established. Screening of SMA carriers is an alleles and that the integrated use of the last generation important step in assessing the risk of giving birth to an genetic analysis tools, together with careful clinical affected child. evaluations, are fundamental for the characterization of I. Coliban: None. N. Ușurelu: None. V. Sacară: None. rare diseases even in prenatal setting. G. Mastromoro: None. M. Giuffrida: None. V. Guida: E-P10.19 None. D. Guadagnolo: None. E. Marchionni: None. F. Di A case of Spinal Muscular Atrophy with Congenital Palma: None. M. Truglio: None. M. Fabbretti: None. B. BoneFractures2expandsASCC1prenatalpresentation Torres: None. T. Mazza: None. A. De Luca: None. M. and mutational spectrum Roggini: None. L. Bernardini: None. A. Pizzuti: None. G. Mastromoro1, M. Giuffrida2, V. Guida2, E-P10.20 D. Guadagnolo1, E. Marchionni1, F. Di Palma1, An interesting case: 30-year-old male patient with myotonic dystrophy typeI has got normal CTG repeats sequenceintheDMPKgene,butitdoesnotcomplywith its clinical featuresAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 901 S. Tutgun Onrat1, M. Elmas1, H. Demirbaş2 structural variants. To date, deletions of this region is mostly considered as pathogenic; yet duplications are still 1Afyon Health Science University, Faculty of Medicine, controversial.Hereapatientwith16p13.11duplicationthat Department of Medical Genetics, Afyonkarahisar, Turkey, have ﬁndings concordant with previous reports and two 2Afyon Health Science University, Faculty of Medicine, additional ﬁndings is presented, aiming to further enhance Department of Neurology, Afyonkarahisar, Turkey our understanding of the nature of 16p rearrangements. Materials and methods: After the DNA was isolated Introduction:Myotonicdystrophytype1DM1isinherited from the peripheral blood sample of the patient, the data in an autosomal dominant pattern a multisystem disorder, obtained by microarray using the “afyymetrix cytoscan causedbyexpansionofaCTGtrinucleotiderepeatinthe3′- optima array kit” were analyzed for gain or loss according untranslated region of the DMPK gene, with pathogenic to the GRCh37 (hg19) reference genome using ChAS alleles ranging from around 50 to over 1000 CTG triplets 3.1.1.27 (Chromosome Analysis Suite) software. repeats(1).Somefeaturesincludeskeletalmuscleweakness Case Report: Patient is a 5 years and 2 months old and myotonia. The age at onset is extremely variable in female,admittedtopediatricneurologydepartmentwiththe DM1, and inversely correlates with the expansion size and complaintsofseizuresandspeechdelay.Shewasdiagnosed individual-speciﬁc differences in somatic instability (2-4). with epilepsy and atypic autism. A peripheral blood Materials and methods: We want to present most karyotyping was normal (46,XX). Microarray result of the interestingly our patient-male (30 years) with Myotonic patient revealed a 1833 kbp-long microduplication, invol- Dystrophy Type I disease, the exact number of repeats of ving the 16p13.11 region. (arr[hg19] 16p13.11 the CTG trinucleotide for both alleles of the DMPK1 gene (14,897,804-16,730,375)x3) was detect by PCR-Fragman analysis. Afterwards, the age Discussion: 16p13.11 duplications were previously of the disease, the clinical severity of the disease, described as rare benign variants whereas there are also radiological and laboratory ﬁndings were compared with some reports of pathogenicity; relating it to a phenotypic these patients. In addition, detailed pedigree analysis of the spectrum involving autism, intellectual disability, hypoto- patients was performed and thus anticipation and variable nia, motor and speech delay, seizures, abnormal MRI and expressivity of the disease was determined. cardiac malformations and this spectrum applies for our Results: We ﬁnd a result of the important in terms of patient as well. Additionally, upslanting palpebral ﬁssures myotonic dystrophy; he has got clinically myotonic and preauricular skin tag are important phenotypic ﬁndings discharges in EMG(electromyography) diagnosed as myo- of our patient that were not reported before. tonicdystrophy,butwhenexaminedintermsofthenumber M.S. Yildirim: None. A.B. Arslan: None. A.G. of repeats, the DMKP1 gene was a normal number of Zamani: None. repeats in terms of 8/17 for both alleles. Conclusions: Myotonic dystrophies represent the most E-P11.004 variable clinical phenotypes, so treatment stratiﬁcation is Phenotypic features in a patient with 1p36 deletion key for any modern therapeutic approach. We still need syndrome much more understanding of the signs and symptoms of Myotonic dystrophies patients in correlation to their F. Stipoljev1,2, A. Vicic1,3, R. Gjergja-Juraski4,2 molecular origins. S. Tutgun Onrat: None. M. Elmas: None. H. Demirbaş: 1Clinical Hospital “Sveti Duh”, Zagreb, Croatia, 2Faculty None. of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia, 3Univesity of Applied Health Sciences, E-P11 Multiple Malformation/Anomalies Syndromes Zagreb, Croatia, 4Children’s Hospital Srebrnjak, Zagreb, Croatia E-P11.001 16p13.11 microduplication in a patient with seizures: Monosomy1p36ischaracterizedbyvariablesizedeletions, A case report about an elusive syndrome whilethephenotypicfeaturesincludeintellectualdisability, developmentaldelay,distinctivefacialdysmorphicfeatures, M. S. Yildirim, A. B. Arslan, A. G. Zamani hypotonia, seizures, cardiac defects, hearing impairment and ophthalmologic problems. Herein we present a patient Necmettin Erbakan University, Konya, Turkey with 1p36 deletion syndrome. The girl was born with muscular VSD and the Pierre Robin sequence. She was Background: The short arm of chromosome 16, (16p) and operated due to the Pierre Robin at the early age and got especially the 16p13.11 region is involved in many tracheal canulla up to3 years of age. MRI of the neuroaxis902 J.delPicchia later revealed the syrinx of the spine. She has distinctive in the 22q11.2 DS group versus the group without deletion facialfeaturesincludingmicrobrachycephaly,deep-seteyes (p <0.05). Conotruncal cardiac defects alone were insufﬁ- with straighteyebrows;midface hypoplasiawithbroad,ﬂat cient for 22q11.2 DS prediction but sufﬁcient when nose and philtrum. Ears are low-set, rotated backwards and accompanied with other anomalies. abnormallyshaped.Comparedtootherdescribedcases,her Conclusion: A comprehensive physical examination is chin is rather small. There are no abnormalities of gastro- crucialatidentifyinganysubtle featureswhichmay leadto intestinal system, kidneys, or genitalia. She is hypotonic, testing and a deﬁnite diagnosis. Grant from Thammasat with severe intellectual disability, refractory epilepsy and University (Grant No.2/32/2558) temper tantrums; having vision, hearing and speech pro- K. Rojnueangnit: None. T. Khetkham: None. P. Onsod: blems. Array CGH analysis using SurePrint G3 Human None. T. Chareonsirisuthigul: None. CGH 8x60K microarrayrevealed 4.3Mbloss intheregion 1p36.33-p36.32. Deletion was conﬁrmed with FISH ana- E-P11.006 lysis using subtelomeric 1p probe, and a karyotype was Diverse phenotypes in a family of six all with 22q11.2 designated as 46,XX,del(1)(p36.32)dn. Cytogenetic analy- duplication or double duplication sis of parental peripheral blood revealed normal female karyotype in mother and a 46,XY,inv(10)(p11.2q21.2) A. Zagorac1, A. Golub1, B. Zagradišnik1, A. Erjavec karyotype in father, while FISH analysis showed normal Škerget1, D. Krgović1, Š. Stangler Herodež1, A. Osterc distribution of signals characteristic for subtelomeres 1p in Koprivšek1, N. Kokalj Vokač1,2 both parents. In conclusion, our case emphasizes the sig- niﬁcance of molecular cytogenetic analysis in order of 1University Medical Centre Maribor, Maribor, Slovenia, establishing accurate diagnosis and patient management, as 2Medical Faculty Maribor, University Maribor, Maribor, well as counseling parents regarding future pregnancies. Slovenia F. Stipoljev: None. A. Vicic: None. R. Gjergja- Juraski: None. Introduction: 22q11.2 duplications may be largely unde- tected, as a result of less-distinct, unpredictable, and/or E-P11.005 milder phenotype. Double duplications 22q11.2 are extre- Identiﬁcation of clinical features to predict 22q11.2 mely rare. We describe the family of six, all with 22q11.2 deletion syndrome, proven by multiplex ligation-depen- duplication or double duplication. The boy proband with dent probe ampliﬁcation duplication had a global developmental delay, seizures and dysmorphic features. The girl proband with double dupli- K. Rojnueangnit1, T. Khetkham1, P. Onsod2, T. cation, had sensorineural hearing loss, mild intellectual Chareonsirisuthigul2 disabilities, mild speech delay and minor dismorphic fea- tures. Other relatives were unaffected, except for very mild 1Thammasat University, Klong-Luang, Thailand, 2Mahidol possible manifestations in the mother. University, Bangkok, Thailand Materials and methods: aCGH analysis using 8x60K array, microsatellite segregation analysis and QF-PCR for Introduction: 22q11.2 deletion syndrome (22q11.2 DS) is the informative marker on peripheral blood for all family, the most common microdeletion syndrome with a wide were performed. Clinical exsom analysis by NGS of the variety of clinical features. However, there are no clinical affected boy and the girl, were done. criteriafordiagnosis;conﬁrmationissolelybygenetictests. Results: aCGH revealed 3 copies, approximately 2,8Mb, Normally, these tests are only performed if clinicians of22q11.2inbothparents,affectedboyandoneunaffected recognize signs and symptoms; therefore, we aimed to girland4copiesofthesameregioninoneaffectedgirland identify any clinical features that may help clinicians be another unaffected girl. Segregation microsatellite analysis aware of 22q11.2 DS. and QF-PCR conﬁrmed that both parents carry the Materials and methods: Participants with at least two duplication (2:1), two children inherited duplication from anomalies were enrolled from June 2015 - May 2018 at theirmother,anothertwodaughtersinheritedtwocopiesof Thammasat University Hospital. Complete patient history 22q11.2 (2:2) from each parent, it’s a double duplication. and physical examinations were done; multiplex ligation- NGS analysis didn’t identify any additional mutations that dependent probe ampliﬁcation analysis for 22q11.2 were would be clinically characterized as being pathogenic. performed with blood samples. Conclusions: The family described illustrates the pheno- Results: Out of 48 participants, we identiﬁed 11 (23%) typic variability associated with 22q11.2 duplication or with 22q11.2 DS. Palate anomalies, hypocalcemia, and ≥ 3 doubleduplication.Itprovidessupportfortheviewthatthe affectedbodysystemswerehighlysigniﬁcantpresentations 22q11.2 duplication/double duplication may not beAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 903 pathogenic on its own and require additional genetic, cases thanks to international datasharing would allow us to epigenetic or nongenetic factors, to express the phenotype. concludeontheimplicationofthisgeneinasevereformof A. Zagorac: None. A. Golub: None. B. Zagradišnik: 3C syndrome. None. A. Erjavec Škerget: None. D. Krgović: None. Š. N. Bourgon: None. M. Lefebvre: None. A. Bruel: None. Stangler Herodež: None. A. Osterc Koprivšek: None. N. J. Thevenon: None. J. Riviere: None. C. Poe: None. M. Kokalj Vokač: None. Chevarin: None. T. Jouan: None. Y. Duffour: None. L. Faivre: None. C. Thauvin: None. E-P11.007 A homozygous WDR91 nonsense variant responsible of E-P11.008 severe form of 3C syndrome Allan Herndon Dudley syndrome due to a novel pathogenic variant in the SLC16A2 gene N. BOURGON1,2, M. LEFEBVRE1,2, A. BRUEL1,2, J. THEVENON1,2, J. RIVIERE1,2, C. POE1,2, T. N. Delchev, H. M. Kathom, D. M. Avdjieva-Tzavella M. CHEVARIN1,2, T. JOUAN1,2, Y. DUFFOUR1,2, L. FAIVRE1,2,3,4, C. THAUVIN1,2,3,4 Medical University-Soﬁa, Soﬁa, Bulgaria 1UMR 1231, GAD team, DIJON, France, 2FHU TRANS- Introduction:Allan-Herndon-Dudleysyndrome(AHDS)is LAD, Dijon, France, 3Centre de Génétique, CHU Dijon a rare, X-linked condition caused by various pathogenic Bourgogne,Dijon,France,4CentrederéférenceAnomalies variantsintheSLC16A2gene.InhemizygousmalesAHDS du Développement, Dijon, France is characterized by dysthyroidism, hypotonia and feeding difﬁculties (in infancy), developmental delay and drug- Introduction: 3C syndrome is a rare genetic syndrome resistant seizures. Additional ﬁndings may include pyr- characterized by craniofacial anomalies, cardiac and cere- amidal and extrapyramidal signs as well as intellectual bral related to WSHC5 (MIM # 220210) and CCDC22 disability. Heterozygous females are rarely affected. (MIM # 300963) variants. Molecular bases of some cases Materials and methods: We present a 9 month old boy suspected of 3C syndrome remained identiﬁed. with facial dysmorphism, psychomotor delay and myoclo- Patients and methods: We report 4 fetuses with 3C nus in addition to hypomyelination ﬁndings on brain MRI. syndrome from a unique consanguineous family. Case 1 Dysthyroidism(elevatedT3,lowT4,fT4levelsandnormal had a fetal hydrops with hygroma coli, cerebellar TSH) alongside poor weight gain, irritability and axial hypoplasia, severe tetraventricular hydrocephalus with hypotonia were also found. Based on those ﬁndings a macrocephaly,facialdysmorphiaandinterventricularseptal targeted SLC16A2 gene sequencing was performed. defect. The 3 other cases have been suspected with fetal Results: A novel hemizygous variant, c.695del (p. hydrops during the ﬁrst trimester associated with brain Asn232Metfs*35), was identiﬁed in SLC16A2 conﬁrming abnormalities. the diagnosis - Allan-Herndon-Dudley syndrome (MedGen Results:ESperformedincase1identiﬁedahomozygous UID: 208645). This variant is neither present in population WDR91 nonsense variant (NM_014149.3:c.240C>G, p. databases (ExAC no frequency) nor reported in the Tyr80*) in a homozygous region. Family segregation literature in individuals with SLC16A2-related conditions. conﬁrmed the homozygous status of this variant in all Thissequencechangecreatesaprematuretranslationalstop affected fetuses and in the heterozygous status in both signal and has been classiﬁed as pathogenic. parents, as well as two healthy children and absence in the Conclusions:Allan-Herndon-Dudleysyndrome,however third healthy child. International datasharing and targeted rare, should be considered in children manifesting the sequencingofacohortof3Csyndromepatientshavesofar typical clinical, phenotypic, laboratory and imaging ﬁnd- failed to identify other patients with WDR91 variants. ings. In our case we found a speciﬁc constellation of WDR91 interacts with WDR81 in the endosome-lysosome developmental delay and dysthyroidism which lead to pathway for early-to-late endosome conversion. WDR91 targeted sequencing analysis and the correct diagnosis. We appears to be essential, particularly for neuronal and brain hope that this novel pathogenic variant in SLC16A2 will development. provide additional information about AHDS and its Conclusion: Identiﬁcation of a homozygous WDR91 genotype-phenotype correlations. nonsense variant in several fetuses with 3C syndrome in a T.N. Delchev: None. H.M. Kathom: None. D.M. consanguineousfamilysuggeststhatWDR91isanewgene Avdjieva-Tzavella: None. responsible for this syndrome. Identiﬁcation of new similar904 J.delPicchia E-P11.009 E-P11.010 Clinical characterization of Aicardi-Goutières Syn- The third family with TAF6-related phenotype: Ala- drome 7 in an extreme preterm infant, due to a zami-Yuan syndrome recurrent IFIH1 variant E. Tuc1, F. B. Bengur1, A. Aykut2, O. Sahin2, Y. Alanay3 E. Phillips, M. Kerr, A. Khan 1Acibadem Mehmet Ali Aydinlar University School of DepartmentsofMedicalGeneticsandPediatrics,University Medicine, Istanbul, Turkey, 2Marmara University School of Calgary Cumming School of Medicine, Alberta Chil- of Medicine, Department of Ophthalmology, Istanbul, dren’sHospitalResearchInstitute.,Calgary,AB,Canada Turkey, 3Acibadem Mehmet Ali Aydinlar University School of Medicine, Department of Pediatrics, Pediatric Genetics Introduction: Aicardi-Goutières Syndrome (AGS) is a Unit, Istanbul, Turkey genetically heterogeneous disorder of interferon 1 upregu- lation.Approximately10%ofpatientspresentatbirthwitha Introduction:HomozygousvariantsinTAF6genecausean congenital infection-like syndrome with hepatosplenome- autosomal recessive intellectual disability syndrome with galy, thrombocytopenia, neurologic abnormalities and brain Cornelia de Lange syndrome (CdLS)-like features, namely calciﬁcations.Characterizationof this disorder in premature Alazami-Yuan Syndrome (ALYUS;MIM#617126). We infantsislimited,anddiagnosisinthisgroupischallenging. report the sixth patient from a third family with additional We present a case of AGS type 7 in an extreme preterm ocular and behavioral features. infant, and highlight the role of whole exome sequencing ClinicalReport:Theprobandwasevaluatedafterfamily (WES) in providing a timely diagnosis. memberswithcongenitalnystagmuswerereferred.Heisan Materials and methods: A female infant was delivered 18-years-old male with moderate intellectual disability, at 27+2 for pre-eclampsia, IUGR, and abnormal Dopplers. mild dysmorphic features and stereotypic behaviors. His Frombirth,shehadrefractorythrombocytopenianecessitat- movements stop when verbally distracted and he responds ing almost-daily transfusions, as well as anemia, progres- with single words. Bilateral nystagmus was noticed in sive hepatosplenomegaly, cholestasis, pulmonary childhood. Flash electroretinogram recordings of cone and hypertension, respiratory insufﬁciency, poor feeding, and rod function were normal. Ophthalmological evaluation of punctate brain calciﬁcations. Screening for TORCH infec- other family members with congenital nystagmus demon- tionsandautoimmunethrombocytopeniawasnegative.She strated decreased visual acuity and impaired cone and rod wastreatedtwiceforpresumedculture-negativesepsis,with function. minimal clinical improvement. In the face of worsening Results: Whole exome sequencing (WES) in family multi-organdysfunction,palliativemeasureswereinstituted members revealed two different causative genetic condi- and she died at 54 days. tions. Homozygous missense pathogenic variant, Results: Singleton WES identiﬁed a likely pathogenic c.323T>C;p.(Ile108Thr) in TAF6 (NM_001190415.1) and variant in IFIH1: c.2159G>A, p.(Arg720Gln). This mis- heterozygous missense variant of uncertain signiﬁcance, sense variant has been reported twice in ClinVar, and c.1708G>A;p.(Val570Met) in PDE6C (NM_006204.3) published in 6 individuals with variable AGS. Pathogenic were identiﬁed in the proband. His sister and her son were variants in IFIH1 cause autosomal dominant AGS7, and both homozygous for the variant in PDE6C gene. account for 3-5% of cases. Conclusion: The proband shares the same homozygous Conclusion: AGS7 presents with a variable phenotype, missense variant, c.212T>C;p.(Ile71Thr) in TAF6, pre- including a neonatal-onset form. Phenotypic overlap with viously reported in a Saudi family by Alazami et al. Three common disorders of prematurity complicates diagnosis in siblings from the same Saudi family and a Turkish patient critically ill, extreme preterm infants. Rapid WES in such were simultaneously published by Yuan et al. Comparison cases can provide a timely diagnosis, and inform counsel- of WES data from the proband and the published Saudi ling on prognosis, recurrence, and end-of-life decision family revealed a shared haplotype of 3Mb in the region making. Grant: MITO-FIND, funding from including TAF6 gene. This ﬁnding supports pathogenicity MITOCANADA ofthishomozygousvariantandsuggestsanancientfounder E. Phillips: None. M. Kerr: None. A. Khan: B. Research effect. Grant (principal investigator,collaboratororconsultantand E. Tuc: None. F.B. Bengur: None. A. Aykut: None. O. pendinggrantsaswell asgrantsalreadyreceived); Modest; Sahin: None. Y. Alanay: None. MITO-FIND. F. Consultant/Advisory Board; Modest; MITOCANADA.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 905 E-P11.014 Introduction: Haploinsufﬁciency of HNRNPK, which The First Case Report Coexistence of Asymmetric encodestheheterogeneousnuclearribonucleoproteinK,has Crying Face, Congenital Ptosis And Isotretinoin recently been identiﬁed as cause of Au-Kline syndrome Embryopathy (MIM #616580). Major ﬁndings include muscular hypoto- nia, developmental delay, intellectual disability, cardiac, M. Seven1, A. Kalayci Yigin1, M. T. Alay1, S. Sozer urogenital and skeletal abnormalities, and a characteristic Tokdemir2 facial gestalt. With one exception, all patients with Au- Kline syndrome published so far have loss-of-function 1Department of Medical Genetics, Cerrahpasa Medical mutations. There is only a single patient with a de novo Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, missense variant (p.L155P) which is located in KH2, the 2Department of Genetics, Aziz Sancar Research Institute of second of three K-homology RNA-binding (KH) domains Experimental Medicine, Istanbul, Turkey of HNRNPK which ensure sequence-speciﬁc RNA and DNA binding. Due to the limited number of patients, the Introduction:IsotretinoiniscategorizedasXgroupofdrug phenotypicconsequences ofmissensevariantsinHNRNPK by Food and Drug Administration (FDA). Teratogenic remain to be deﬁned. effects are well deﬁned and mainly includes: craniofacial Methods and results: We report a second patient abnormalities,cardiovascular,centralnervesystem,thymic/ with a de novo missense variant in HNRNPK and typical parathyroid anomalies and ear abnormalities [1]. Asym- features of Au-Kline syndrome. The 10 year-old girl metric crying face (ACF) is very rare ﬁnding of 0.2-0.6% hassevereglobaldevelopmentaldelay,muscularhypotonia, and mimics the sign of peripheral facial paralyses. Gen- cleft palate, a branchial cyst, hydronephrosis, vertebral erally, associated with left-sided predominance. segmentation anomalies and facial dysmorphism. Based Clinical Findings and method: 28-day baby referred to on the clinical phenotype Au-Kline syndrome was our clinic for dysmorphological examination. Her mother suspected and conﬁrmed by Sanger sequencing was followed-up in our teratology clinic for isotretinoin which revealed a de novo missense variant c.146C>T, p. usage during the pregnancy. On baby’s physical examina- L49P in HNRNPK [NM_0021404]. This variant affects a tion; congenital ptosis in the right eye, ACF, nevus moderately conserved amino acid, locates to KH1, ﬂammeus in the glabella, cleft in the right earlobe, retro- the ﬁrst K-homology RNA-binding domain of HNRNPK, micrognathia, bilateral sandal gap, radial deviation in wrist is not listed in GnomAD and is predicted to be pathogenic and metatarsus adductus were detected. The right lower lip by in silico tools. Together with the typical clinical of the patient was observed to be moving down, when phenotype this strongly suggests that the variant is crying.ACFwasidentiﬁed.Inordertoexcludefacialnerve disease-causing. paralysis, electromyelography (EMG) was performed. His Conclusion: Our observation conﬁrms that HNRNPK karyotype was normal. missense variants affecting KH domains can lead to the Conclusion:Intheliterature,thereisonlyonecasereport characteristic clinical phenotype of Au-Kline syndrome. about isotretinoin embryopathy with ACF which was not C. Fauth: None. U. Albrecht: None. E. Maurer: None. J. conﬁrmed by EMG. Congenital ptosis is a common sign Zschocke: None. andmaybeassociatedwithmanyabnormalities,however,to the best of our knowledge coexistence of congenital ptosis E-P11.016 andACFwithisotretinoinembryopathyistheﬁrstreported Clinical and molecular characterization of a rare case case in here. diagnosed with Bardet Biedl Syndrome M. Seven: None. A. Kalayci Yigin: None. M.T. Alay: None. S. Sozer Tokdemir: None. I. O. Focsa1, M. Budisteanu2,3,4, C. Burloiu2, L. C. Bohiltea1, M. Balgradean5,6 E-P11.015 Au-Klinesyndromeduetoadenovomissensevariantin 1"C.Davila"UniversityofMedicineandPharmacy,Buchar- HNRNPK est, Bucharest, Romania, 2Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Bucharest, Romania, 3Victor Babes C. Fauth1, U. Albrecht2, E. Maurer1, J. Zschocke1 National Institute of Pathology, Bucharest, Romania, 4Titu Maiorescu University, Bucharest, Romania, 5Marie Curie 1Institute of Human Genetics, Medical University Children’s Clinical Hospital, Bucharest, Romania, 6Carol Innsbruck, Innsbruck, Austria, 2Department of Pediatrics Davila University of Medicine and Pharmacy, Bucharest, I, Medical University Innsbruck, Innsbruck, Austria Romania906 J.delPicchia Bardet Biedl syndrome (BBS) is a rare, pleiotropic cilio- Department of Molecular Medicine, University of Pavia, pathy caused by mutations in 21 genes. BBS 12 gene Pavia, Italy mutations are responsible for 5-6% from molecular diag- nosed cases. Clinical spectrum is highly variable in- and Introduction: Basel-Vanagaite-Smirin-Yosef syndrome between families. The main features are: rod cone dystro- (BVSYS) is an extremely rare autosomal recessive genetic phy, polydactyly, obesity, cognitive impairment, renal disorder characterized by severe developmental delay and anomalies and urogenital malformations. We report on a variable congenital anomalies, caused by variants in the new case of BBS caused by BBS12 mutation. The 7 years MED25 gene. Since 2015, 17 patients have been described old girl is the ﬁrst child, born at 42 weeks from healthy, with common clinical features and homozygous variants in unrelated, gypsy parents. Physical parameters at birth were the MED25 gene, leading to a better deﬁnition of the phe- normal. Post axial polydactyly in all four members, bra- notype associated with BVSYS. chydactyly and 2-3 ﬁngers syndactyly, were noted. Last Materials and methods: Here we report two young physical exam reveals macrocephaly (OFC >2SD), obesity sisters, of consanguineous parents, presenting typical (weight >6SD), dysmorphyc features, rod cone dystrophy, dysmorphicfeaturesandneuroimagingﬁndingsofBVSYS, genital malformations, severe intellectual disability, and plus polymicrogyria. behavior abnormalities (self aggressive behavior, hyperki- Patient 1 showed features of BVSYS at physical nesia, food intake abnormalities). Over the last year, renal examination (strabismus, large and overhanging nasal tip, dysfunction and hypertension have occurred. Clinical short philtrum, down-turned corners of the mouth, micro- diagnosiswasestablishedduetopresenceofmorethanfour gnathia, bilateral 2nd-3rd toe syndactyly Y-shaped) and a primary features included in consensus criteria. Molecular delayed psychomotor development. Brain MRI showed genetic tests conﬁrmed the diagnosis, identifying an bilateral perisilvian polymicrogyria, thin corpus callosum, homozygous nonsense mutation in BBS12 gene temporal and parietal atrophy, cyst of the cavum septum (c.1063C>T;p.Arg355*).Themutationwasreportedﬁrstin pellucidumandcavumvergae,enlargementofthethirdand 2007intwoFrenchgypsyfamilies.Later,othertwopatients lateral ventricles. were reported. Our patient brings new evidence in the Patient2(patient1’ssister)showsimilarclinical features phenotype caused by this rare mutation. Further studies are at physical examination and brain MRI; she died at 1 year needed for a better understanding of genotype-phenotype of age and authoptic investigations were not performed. relation. Albeit there is a little experience in predicting the Results (patient 1): Karyotype and array-CGH were phenotypeseveritytaking into account themutational load, normal; WES identiﬁed an homozygous frameshift variant anearlyclinicalandmoleculardiagnosismaybehelpfulfor c.1778_1779delAG in MED25. The variant leads to a good management of these patients. stop coding formation and results in a loss of function I.O. Focsa: None. M. Budisteanu: None. C. Burloiu: protein. None. L.C. Bohiltea: None. M. Balgradean: None. Conclusions: Our cases showed among neuroimaging ﬁndings also perisilvian polymicrogyria. which has never E-P11.017 been described before in BVSYS. We suggest including it Improving the phenotype description of Basel-Vana- among the possible cerebral anomalies of BVSYS and gaite-Smirin-Yosef syndrome, MED25-related: the rele- emphasize the importance of a detailed clinical and vance of neuroimaging ﬁndings. neuroradiological evaluation of these patients. I. Maini: None. E. Errichiello: None. S. Carafﬁ: I. Maini1, E. Errichiello2, S. Carafﬁ1, S. Rosato1, None. S. Rosato: None. V. Bizzarri: None. M. Pollazzon: V. Bizzarri1, M. Pollazzon1, G. Trimarchi1, G. Contrò1, None. G. Trimarchi: None. G. Contrò: None. C. Gelmini: C. Gelmini1, M. Napoli3, R. Pascarella3, S. Rizzi4, None. M. Napoli: None. R. Pascarella: None. S. Rizzi: C. Fusco5, O. Zuffardi6, L. Garavelli1 None. C. Fusco: None. O. Zuffardi: None. L. Garavelli: None. 1MedicalGeneticsUnit,DepartmentofMaternalandChild HealthDepartment,AUSL-IRCCSofReggioEmilia,Reggio E-P11.018 Emilia, Italy, 2Unit of Medical Genetics, Department of Concurrent hypomethylation in both IC loci found in a Molecular Medicine, University of Pavia,, Pavia, Italy, Beckwith-Wiedemann syndrome case 3Neuroradiology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 45. Child Neuropsychiatry Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 5Child Neuropsychiatry Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 6Unit of Medical Genetics,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 907 V. Anastasiadou1, I. Kyprianou2, A. Miltiadous2, A.Mroczkowska5,P.Skowera5,B.Styka5,D.Winnicka5,M. P. Gerasimou2, J. Chi3,2, I. Savvidou1, P. Costeas2,3 Lejman5, J. Kowalczyk1 1DepartmentofClinicalGenetics, ArchbishopMakariosIII 1Department of Pediatric Hematology, Oncology and Medical Centre, Nicosia, Cyprus, 2Molecular Hematology- Transplantology, Children’s University Hospital, Lublin, oncology, Karaiskakio Foundation, Nicosia, Cyprus, 3The Poland, 2Department of Neonate and Infant Pathology, Center for the Study of Haematological Malignancies, Children’s University Hospital, Lublin, Poland, 3MedGen Nicosia, Cyprus MedicalCentre,,Warsaw,Poland,4DepartmentofClinical GeneticsandPatomorphology,UniversityofZielonaGora, Introduction: Beckwith-Wiedemann syndrome (BWS) is Zielona Gora, Poland, 5Laboratory of Genetic Diagnostic, a clinically heterogeneous overgrowth syndrome asso- Children’s University Hospital, Lublin, Poland ciated with an increased risk of embryonal tumour development. BWS incidence ranges from 1 in Introduction: Cantu syndrome is characterized by con- 10,000-15,000 newborns with 85% of the cases sporadic. genital hypertrichosis, characteristic craniofacial dys- Genetic or epigenetic alteration within two domains of morphicfeatures,cardiomegalyandosteochondrodysplasia. imprintedgrowthregulatorygenesonchromosome11p15, It is caused by mutations in ABCC9 or KCNJ8 genes. We IC1 (H19DMR) or IC2 (KvDMR), lead to deregulation wouldliketoreporttwonewcasesofCantusyndrome:33- and BWS phenotype. Other known causes of BWS are year-old patient and her 3-month-old daughter. Mother uniparental disomy (UPD), trisomy 11p15, mutations in during adolescence was diagnosed with hypogonadotropic the CDKN1C gene, as well as small deletions and hypogonadism. She had distinctive facial features, hyper- translocations. trichosisonthefaceandpolycysticovaries.Neithersignsof Materials and methods: We describe a 2-year-old girl, cardiomegaly nor osteochondrodysplasia were observed. referred because of global developmental delay. On Her daughter had similar coarse facial features, generalized examination we noted macrosomia, midface and scalp hypertrichosis and enlarged tongue. She was born on time hemangiomas and a protruding tongue. She suffers of with normal length and weight parameters. After genetic choking episodes. Speech is limited. She is the ﬁrst child consultation Whole Exome Sequencing was performed. andaproductofspermdonation.Macrosomiawasnotedon Materials and methods: The sequencing of isolated, prenatal ultrasound. Neonatal hypoglycemia was not enriched genomic DNA was performed on NovaSeq 6000. reported. MS-MLPA analysis (MRC Holland) was per- Raw sequences in fastq format were mapped to hs37d5 formed to look for epimutations in the imprinted 11p15 reference. The following in silico prediction software regionassociatedwithBWS(IC2lossofmethylationorIC1 programs were used to assist with interpretation of gain of methylation). The results were conﬁrmed with a pathogenicity of detected variant: SIFT, MutationTaster, second sample from the proband. PolyPhen-2 as embedded in Alamut visual v 2.9.0. The Results:Concurrenthypomethylationonboth imprinting presence of the variant in control populations was checked loci,IC1andIC2,wasobservedonchromosome11p15.No in 1000Genomes, the ExomeVariantServer, and the Exome copy number chromosomal abnormalities were detected. Aggregation Consortium and gnomAD. Sanger sequencing Conclusions: We discuss the clinical and molecular was also performed. ﬁndings of this case because of the rarity of simultaneous Results: A new missense variant Arg1116Pro was found loss of methylation pattern in both IC1 and IC2 loci. in one allele of ABCC9 gene. Considering the symptoms Relevant literature is currently limited. andthedetectedvariantpatientswerediagnosedwithCantu V. Anastasiadou: None. I. Kyprianou: None. A. Miltia- syndrome. dous:None.P.Gerasimou:None.J.Chi:None.I.Savvidou: Conclusion: We would like to present two patients- None. P. Costeas: None. mother and her daughter with some distinctive clinical featuresforCantusyndromeandnewpathogenicvariantin E-P11.020 ABCC9 gene. Our report is a valuable contribution in New heterozygous pathogenic variant in ABCC9 gene expanding molecular and clinical spectrum of Cantu identiﬁed in two patients diagnosed with Cantu syndrome. syndrome K. Wojciechowska: None. A. Tarkowska: None. M. Kacprzak: None. D. Loska: None. A. Pietrzyk: None. M. K. Wojciechowska1, A. Tarkowska2, M. Kacprzak3, Babicz: None. M. Holweg: None. A. Mroczkowska: None. D. Loska3, A. Pietrzyk4, M. Babicz5, M. Holweg5, P.Skowera:None.B.Styka:None.D.Winnicka:None.M. Lejman: None. J. Kowalczyk: None.908 J.delPicchia E-P11.022 T. Atik, S. Simsir, E. Isik, F. Ozkinay Further delineation of putative CDK10 loss-of-function variants: a new form of ciliopathy phenotype Ege University Faculty of Medicine, Department of Pediatrics, Izmir, Turkey G. Forzano1, R. Artuso2, E. Andreucci2, V. Palazzo2, A.Pagliazzi1,F.Vanderwert1,G.Gori1,F.DiGiovanni1,E. Developments in the genomic era and large-scale exome/ Fiorentini1, S. Giglio3 genome sequencing studies have identiﬁed mutations in several members of the CHD (Chromodomain Helicase 1Medical Genetics Unit, University of Florence, Florence, DNA-binding protein) gene family in neurodevelopmental Italy, 2Medical Genetics Unit, Meyer Children’s University disorders.EspeciallythegroupIIICHDfamilyconsistingof Hospital, Florence, Italy, 3Medical Genetics Unit, Uni- CHD6, CHD7, CHD8 and CHD9 has well-documented versity of Florence, Meyer Children’s University Hospital, rolesintranscriptionregulation,impactinginorganogenesis. Florence, Italy Thesefourenzymesaresimilarintheirconstituentdomains. While mutations in the CHD2 and CHD8 have been linked CDK10encodesaproteinkinasewhichinteractswithcyclin toautismandintellectualdisability.Additionally,CHD7has to form a heterodimeric protein kinase that plays a central beenfoundtobeassociatedwithCHARGEsyndromewhich role in the regulation of cellular growth, ciliogenesis and isawell-knowncongenitalmalformationsyndrome.Herein primary cilium elongation. Bi-allelic loss-of-function this report, we present a case having intellectual dysability, CDK10 mutations have been recently reported associated autism and several congenital anomalies and a de-novo with a distinct disorder, named Al-Kaissi syndrome, nonsensemutationinCHD8geneasapossiblecauseofthe describedsofarinonly10patientsfrom6distinctfamilies. clinical phenotype. A 5,5 year-old boy with macrocephaly, We report the case of a 5-year-old boy with a complex autism, intellectual disability and congenital anomalies phenotype: growth retardation, global developmental delay including severe hypospadias, ventricular septal defect, with absent speech, thin corpus callosum and paucity of inguinal hernia, cryptorchidism, anal atresia and hemi- white matter visible at the brain MRI, vertebral anomalies vertebrae(T12) was referred to our department. He has also and a typical facial appearance (triangular face, bilateral been treating for hypothyroidism. Trio whole exome epicanthic folds, hypertelorism, depressed nasal bridge, sequencing(WES) was performed, and a de-novo hetero- low-set and posteriorly rotated ears, small chin); besides zygousnonsensec.727C>T(p.Arg243*)mutationintheﬁrst these features, our patient was born with ostium secundum exon of CHD8 was detected and it was found to be likely atrial septal defect and pulmonary valve stenosis. Array- pathogenic according to ACMG 2015 criteria. We consider CGH and CHD7 molecular analysis were normal. Trio that the mutation found in the patient could be responsible whole exome sequencing (WES) disclosed a homozygous for a congenital malformation syndrome similar to splice site variant in the CDK10 gene. Our patient’s phe- CHARGE syndrome, causing a disruption in CHD7-CHD8 notype resembles the clinical features described in patients complex. Further functional analysis is planned. As a con- affected by Al Kaissi syndrome, except for the congenital clusion, mutations in CHD8 gene, especially disrupting heart defect (CHD): none of the patients with the same CHD7-CHD8 complex, could be responsible for a con- mutation as our case were reported to have any heart genital malformation syndrome similar to CHARGE. anomalies; to date, only one patient with Al-Kaissi syn- T. Atik: None. S. Simsir: None. E. Isik: None. F. drome showed patent ductus arteriosus. The WES analysis Ozkinay: None. excluded further variants of the genes described in asso- ciation with heart malformations and therefore our case is E-P11.025 likely to allow us to expand the clinical phenotype of a Chromoanasynthesis with involvement of chromosome syndrome which is not yet fully characterised. 21: rare cause for dysmorphic features and develop- G.Forzano:None.R.Artuso:None.E.Andreucci:None. mental disorder V. Palazzo: None. A. Pagliazzi: None. F. Vanderwert: None. G. Gori: None. F. Di Giovanni: None. E. Fiorentini: J. Lisfeld1, M. Pettersson2, S. Rudolph3, S. Fuchs1, None. S. Giglio: None. J. Eisfeldt2, M. Hempel1, A. Lindstrand2 E-P11.024 1Institute of Human Genetics, University Medical Center AnonsensemutationintheﬁrstexonofCHD8causesa Hamburg-Eppendorf, Hamburg, Germany, 2Department of multi-organ disease phenotype: Is it a novel syndrome Molecular Medicine and Surgery, Karolinska Institutet and or a detection of an additional gene resulting in Department of Clinical Genetics, Karolinska University CHARGE syndromeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 909 Hospital, Stockholm, Sweden, 3Gemeinschaftspraxis für Chromosome 15 spans more than 102 million DNA base HumangenetikundGenetischeLabore,Hamburg,Germany pairsandrepresentsmorethan3percentofthetotalDNAin cells.Chromosome15likelycontains600to700genesthat Background: Although various complex chromosomal provide instructions for making proteins. These proteins rearrangements have been described, the underlying performavarietyofdifferentroles inthebody.Changesin pathomechanisms are still not fully understood. One of the the number or structure of chromosome 15 can cause models discussed is chromoanasynthesis, a replication- intellectual disability, delayed growth and development, based process that forms complex rearrangements during hypotonia, and characteristic facial features. These changes numerous cycles of fork stalling and template switching include an extra copy of part of chromosome 15 in each (FoSTeS) and microhomology-mediated break-induced cell,amissingsegmentofthechromosomeineachcell,and replication (MMBIR). A commonly acknowledged a circular structure called ring chromosome 15. Sixteen mechanism for catalyzing these events is DNA polymerase patients who have a CNV on 15th chromosome as a result slippage, which could lead to both inter- and intrachromo- of the arrayCGH analysis made using 180K CGH + SNP somal rearrangements. oligoarrayaftertheyhadbeendirectedtoTrakyaUniversity Case report: We report on a 22-year-old man with Hospital,GeneticDiseasesDiagnosisCenterbetween2016- moderate global developmental delay, short stature, micro- 2019, were included in our study. The indications of the cephaly, severe hearing impairment and dysmorphic patients were intellectual disability, hypotonia, micro- features resembling patients with Down syndrome. Brain cephaly, developmental delay, increased nuchal translu- MRI and echocardiography results were normal. cency,intrauterinegrowthretardationetc.Ninepatientshad Methods and results: Chromosome analysis revealed a 15q partial deletion and 7 patients had 15q partial dupli- derivative chromosome 21. CGH array analysis could cation. As a result of the segregation analysis, 3 patients delineate one duplication on 21p and ﬁve duplications on werediagnosedwithAngelmanSyndrome,onepatientwas 21q.Follow-upanalysisusingshort-readpaired-endwhole- diagnosed with Ring15. It was determined that 4 patients genome sequencing (WGS) revealed a complex rearrange- (del. in 2 patients, dup. in 2 patients) with CNV on chro- ment consisting of a total of seven duplications on mosome 15q had inherited the CNV from a parent. As a chromosome 21. Four out of the total seven breakpoint result of segregation analysis, the diagnoses of the 8 junctions could be delineated on the nucleotide level and patients, 4 having a deletion and the other 4 having a provided evidence of DNA polymerase slippage and errors duplication, will be conﬁrmed. during DNA replication as the underlying mechanism of H.Gurkan: None. E. Atlı:None. S. Yalcıntepe: None. E. formation. Chromosome analyses and WGS data for both &. Atlı: None. S. Demir: None. Y. Özen: None. H. parents were unremarkable, thereby indicating a de novo Tozkır: None. rearrangement. Discussion: The patient described here is affected by a E-P11.027 complexchromosomalrearrangementconsistingofmultiple Distal 18q deletion syndrome in girl partial duplications within chromosome 21. Duplications were mostly rearranged and one was inverted. O.Gumeniuk,Y. Chernenkov, S.Sanaeva, P.Golobokova, J.Lisfeld:None.M.Pettersson:None.S.Rudolph:None. T. Ilysova S. Fuchs: None. J. Eisfeldt: None. M. Hempel: None. A. Lindstrand: None. Saratov State Medical University, Saratov, Russian Fed- eration E-P11.026 Clinical results of chromosome 15 copy number Distal18qdeletionsyndromeisararehereditarywithpiece variations distal section of the long (q) arm of chromosome 18 is missing. Syndrome can lead to a wide variety of signs and H.Gurkan1,E.Atlı1,S.Yalcıntepe1,E.&.Atlı1,S.Demir1, symptoms. Purpose. To study the features distal 18q dele- Y. Özen1, H. Tozkır2 tionsyndromeingirl.Patientandmethods.14-year-oldgirl with physical and sexual delayed development, language 1Trakya University, Medical Faculty, Department of delay, learning difﬁculties, muscle weakness, deformation MedicalGenetics,Edirne,Turkey,2Tekirdag,NamıkKemal ofthefoot,frequentnon-diabeticketoacidosis.Physicaland University, Medical Faculty, Department of Medical instrumental examination, conventional chromosomal ana- Genetics, Tekirdag, Turkey lysis was carried out. Results. Girl was born full term with normal birth weight, following a pathological pregnancy.910 J.delPicchia Tetralogy of Fallot was diagnosed in neonatal period. region:threecopiesof400Kbp(withoutgenes),fourcopies FamilyHistory:congenitalcataractinthemotherandinthe of 406Kbp (involving CDH4 gene), three copies of grandfather on the mother’s side. She attends a special 543Kbp (containing three genes: CDH4, MIR125, TAF4) needs school and has poor school performance, with difﬁ- and four copies of 2.304Mbp, comprising TAF4 and 86 culty in attention, concentration, comprehension and obey- more genes. ing orders. She had delayed physical and sexual Discussion: In the present case conventional and development, microcephaly, poor subcutaneous fat, asym- molecular cytogenetics detected a marker chromosome metric wide chest, long arms, short shoulders, gait dis- derived from chromosome 20. The array clariﬁed the turbance,deformityofthefootontheright(Friedreichfoot) amount and the segment involved. The extra chromosome and speciﬁc facial dysmorphies: wide nose bridge, hyper- comprisedacomplexduplication/triplicationinthe20q13.3 telorism, epicantum, thin upper lip, "carp mouth". Her IQ region. The girl has some dysmorphic features and global (intelligence quotient) was 53, and he showed mild mental developmental delay consistent with 20q duplication retardation. Laboratory examination: increased level of syndrome. Nevertheless, to our knowledge this is the ﬁrst TSH,adecreaseinT4(primarycongenitalhypothyroidism, case involving only this region. Every new case of a rare late form). Abdominal ultrasound: echo-signs gallbladder chromosomal alteration should be reported in order to agenesischaracteristic.Conventionalchromosomalanalysis obtain a more precise genotype/ phenotype correlation, on 30 metaphases from peripheral blood lymphocyte cul- improving risk evaluation and genetic counselling. tures showed two cell lines: 46, XX, del(18)(q21q21). M.Souto:None.P.Botelho:None.M.Martins:None.O. Conclusions.Theclinicalfeaturesofthecasewerefrequent Moutinho: None. R. Pinto Leite: None. non-diabeticketoacidosis,gallbladderagenesis,severeheart disease and late genetic diagnosis. E-P11.030 O. Gumeniuk: None. Y. Chernenkov: None. S. Sanaeva: A Rare Case Report: Cloves Syndrome None. P. Golobokova: None. T. Ilysova: None. M. T. Alay1, A. Kalayci Yigin1, B. Uyanik2, M. Seven1 E-P11.028 A complex duplication/triplication of 20q 1Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, M. Souto1, P. Botelho1, M. Martins2, O. Moutinho3, 2Department of Medical Genetics, University of Health R. Pinto Leite1 Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey 1Laboratório de Genética, Centro Hospitalar Trás-os- Montes e Alto Douro, Vila Real, Portugal, 2Consulta de Introduction: Clove(s) syndrome (CS) is one of the rare Genética,CentroHospitalar Trás-os-MonteseAltoDouro, syndromes characterized with congenital adipose tissue Vila Real,Portugal,3ServiçodeGinecologia eObstetrícia, excessivesize,vascularmalformation,epidermalnevusand CentroHospitalarTrás-os-MonteseAltoDouro,VilaReal, scoliosis/spinalmalformation.Althoughtheetiologyofthe Portugal disease is not fully understood, it usually occurs as a result ofpost-zygoticmutationsthatfunctioninthePIK3CAgene. Introdution: Partial duplication of the long arm (q) of CSsyndromecanaffectsofttissue,bloodvessels,bone,and chromosome 20 occur very rarely. The phenotype usually internalorgans.Itssymptomsvarywidelybetweenmildand consists of brachycephaly, epicanthus, anteverted nostrils, severe anomalies. shortneck,verticalchindimple,andcongenitalheartdefect Clinical Findings: A 3-year-old girl was referred to our or murmur. Some cases have development growth, speech, outpatient clinic with a preliminary diagnosis of vascular motor, and social interactions delay. The authors present a malformation. In her physical examination, there was case of partial trisomy 20q. progressivegrowthintheabdomen,pigmentedskinlesions ClinicalReport:8-year-oldgirlwithshortstature,minor in the left half of the body from birth, and capillary dysmorphic features and global developmental delay. malformation(nevusﬂammeus)intherightlowerlimband Blood culture and cytogenetic analysis were performed perivulvar region. Scoliosis, left hemihypertrophy, sandal according standards protocols. Cytogenetics analysis gap and macrodactyly were detected in the toes. revealedachromosomemarkerinallmetaphasesanalyzed. Results: In the Clinical Exom DNA sequence analysis Parents karyotype were normal. Fluorescence in situ from the blood sample taken from the patient, a Hetero- hybridization(FISH)techniqueidentiﬁedtheextramaterial zygous c.436G˃A p.(Val146Ile) mutation was detected and as chromosome 20. Array Comparative Genomic Hybridi- conﬁrmedbySangersequence.ThePIK3CAgeneisnamed zation (aCGH) technique revealed a gain in the 20q13.33Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 911 as an oncogene encoding 23 exons, located on the PI3K/ severe arthrogryposis and intrauterine growth restriction. AKT signal pathway. Thehomozygousstateinourpatientcanbethecauseofthe Conclusion: As a result of changes in the PIK3CA gene, severe phenotype that was not described before. congenitallipamatosishasbeenreportedtocauseanomalies M. Marques: None. P.M. Almeida: None. S.M. Ribeiro: and syndromes such as overgrowth, vascular malforma- None. F. Ramos: None. L. Ramos: None. tions, epidermal nevus. Applying the diagnostic criteria of Keppler-Noreuiletal.,ourcasewasfoundtobecompatible E-P11.032 withthediagnosisofCS.CSistheﬁrstcasereportedinour TwoTwinSisterWithCohenSyndromeAndHirsutism: country supported by molecular analysis. A Case Report Keywords: Cloves Syndrome, PIK3CA gene, Clinical Exome. F. Ozdemir1, A. Kalayci Yigin1, Z. Ocak2, M. Seven1 M.T. Alay: None. A. Kalayci Yigin: None. B. Uyanik: None. M. Seven: None. 1Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, E-P11.031 2Department of Medical Genetics, Medical Faculty, Uni- CockayneSyndrome:apreviousdescribedheterozygous versity of Istinye, Istanbul, Turkey variant in homozygosity Introduction: Cohen syndrome is a genetic disease char- M.Marques1,P.M.Almeida1,2,S.M.Ribeiro1,F.Ramos1, acterizedbyarareneurodevelopmentaldelay,microcephaly L. Ramos1,2 and hypotonia. While phenotypic ﬁndings may differ among patients, it may appear normal in the neonatal per- 1Hospital Pediátrico, Centro Hospitalar e Universitário de iod,asfacialfeaturesarenotevident.Theﬁrstclinicalsigns Coimbra, Coimbra, Portugal, 2Faculty of Health Sciences, include nutritional difﬁculties, hypotonia, microcephaly, University of Beira Interior, Covilhã, Portugal neuromotor developmental retardation and joint hypermo- bility. Due to neutropenia, upper respiratory infections and Cockayne syndrome (CS), is a rare autosomal recessive oral aphthae could be observed. The disease has an auto- multisystem disorder, mainly characterised by postnatal somal recessive inheritance pattern and is caused by growth failure, progressive neurological dysfunction, mutations in the VPS13B gene. microcephaly, impaired vision and hearing, skeletal ClinicalFindingsandMethod:Inthisstudy,wepresent abnormalities and premature ageing. CS is caused by two twin sister cases with hirsutism ﬁndings and neuro- mutations in ERCC6 and in ERCC8 gene. Studies per- motor developmental retardation, microcephaly, mega formed thus far have failed to delineate clear genotype- sisterna magna in cranial MR and prominent antihelix, phenotype relationships. low hairline, camptodactyly and dysmorphic ﬁndings such We present a one-year-old girl, from consanguineous as narrow forehead. DNA were isolated from peripheral parents, referred due to congenital cataracts, microcephaly, blood samples taken from two siblings. The mutation was shortstatureandarthrogryposis.Shehadahistoryofreduced detectedasaresultofclinicalexomanalysisandconﬁrmed fetalmovements,intrauterinegrowthrestrictionandhydram- by Sanger sequence. The results were evaluated with nios. At 6 months of life she had microcephaly (-3,0SD), American College of Medical Genetics (ACMG) criterias growth failure and severe developmental delay. Brain MRI and compared with genetic databases. showeddiffusehypomyelinationofthecerebralwhitematter, Result: As a result of the analysis, c.412+1G> T hypoplasticcorpuscallosumandsmalllens.Weperformeda pathogenic variant was detected homozygous in the broad gene panel analysis that identiﬁed a probably VPS13B gene in both sisters. Conclusion: This mutation pathogenic missense variant [c.611C>T (p.Thr204Lys)] in supports Cohen’s syndrome with clinical ﬁndings. homozygous form, on ERCC8 gene. Parental study con- Keywords: Cohen Syndrome, Hirsutism, Clinical Exome ﬁrmed that they are heterozygous for this variant. Sequencing. CS belongs to the family of NER (nucleotide excision F. Ozdemir: None. A. Kalayci Yigin: None. Z. Ocak: repair)-related disorders existing a large variation in None. M. Seven: None. severity. Our patient has CS type 2, which is a neonatal severe form, typically lethal in the ﬁrst decade of life. Our E-P11.036 patient has a homozygous probably pathogenic missense A large homozygous deletion in two sibs suffering from variant in the ERCC8 gene that was already described in a multiple congenital disorders compound heterozygous state (c.611C>A; c.1122+1delG) whohasCStypeI,withoutcongenitalcataracts,smalllens,912 J.delPicchia S. Seyedhassani1, M. Ebrahimi1, M. Tavakoli1, L. Najaﬁ2, Universitaire de Rennes, ERN-ITHACA, Rennes, France, M. Neshan1,3 2Rennes University, Institute of Genetics and Development of Rennes (IGDR) UMR6290 CNRS, Rennes, France, 1Dr. Seyedhassani medical genetic center, Yazd, Iran, 3Service de Génétique Moléculaire et Génomique, Centre IslamicRepublicof,2Islamicazaduniversity,Tehran,Iran, Hospitalier Universitaire de Rennes, Rennes, France, Islamic Republic of, 3National institute for genetic engi- 4APHP, GH Pitié Salpêtrière, Department of Genetics, neering and biotechnology, Tehran, Iran, Islamic Republic Unit of Development Genomics, Paris, France, Paris, of France,5UnitéFonctionnelledegénétiqueclinique,Hôpital ArmandTrousseau,Assistancepublique-HôpitauxdeParis, One family was referred to genetic counseling center Centre de Référence Maladies Rares des anomalies du because of multiple disabilities. They had three involved développement et syndromes malformatifs, Paris, France, children resulting from consanguineous marriage with 6Department of Clinical Genetics, Amsterdam UMC - inbreedingcoefﬁcientabout6.25%.A10monthsboyanda Locatie VUMC, Amsterdam, Netherlands 8 years old girl suffering from delayed development, high crying, irritability, decreased head circumference, visual Holoprosencephaly (HPE; MIM# 236100) is the most and hearing impairment and ﬁnally quadriplegic mental frequent congenital brain malformation (1 in 10,000 live retardation. Another girl was dead in 11 years old with births, 1 in 250 conceptuses). It results from incomplete similar manifestations. This family had three normal chil- midline division of the prosencephalon between 18th and dren and was pregnant too. 28th day of gestation, affecting both the forebrain and the Chromosomal study and CGH array were normal. Whole face. The clinical spectrum is very wide, ranging from Exome Sequencing were used to enrich all exons of protein- severe HPE with a single cerebral ventricle and cyclopia codinggenesaswellassomeimportantothergenomicregions. to clinically unaffected carriers in familial HPE. The full Next generation sequencing was performed to sequence close spectrum of HPE includes also microforms characterized to 100 million reads on Illumina Sequencer. In this test, point by midline defects, with cleft lip/palate, hypotelorism, mutations and micro-insertion/deletions and duplication coloboma and/or single maxillary median incisor (<20bp)can be simultaneouslydetected.Alarge homozygous (SMMI). HPE is phenotypically and genetically hetero- deletionaroundfollowingregionwaspredicted:chr11:653904- genous and was previously considered as a dominant 710516,about56600bp,includinggenes:TMEM80,EPS8L2, disease with variable expression and incomplete pene- DEAF1. DEAF1 gene acts as a regulator of transcription. trance. From the use of High Throughput Sequencing Activity of this protein is important in the regulation of Technologies, it emerges that the penetrance and the embryonic development. Mutations in this gene have been phenotypic variability have digenic or oligogenic origin. found in individuals with cognitive disability. EPS8L2 is a To date, at least 18 genes are implicated in HPE and are ProteinCodinggene.DiseasesassociatedwithEPS8L2include all associated with key pathways of forebrain develop- Deafness. TMEM80 is target gene of DEAF1 and decreased ment including sonic hedgehog (SHH) pathway. Inter- mRNAlevelswereobservedforTmem80throughoutthebrain estingly, among these genes, DISP1 appears to have a ofDEAF1knockoutmice.Clinicalmanifestationswereseenin speciﬁc mode of inheritance. DISP1 is a positive factor involved sibs appeared as a result of dysfunction of deleted necessary for efﬁcient secretion of the SHH morphogen genes individually and interaction with other related genes. and thus the establishment of its concentration gradient Prenatal diagnosis was done and fetus born in normal along the midline of the neural tube. We describe the condition. clinical characteristics of three families with severe HPE S.Seyedhassani:None.M.Ebrahimi:None.M.Tavakoli: or microform associated to compound heterozygous var- None. L. Najaﬁ: None. M. Neshan: None. iants in DISP1. We will review the literature and discuss the genotype-phenotype correlations. E-P11.037 A. Lavillaureix: None. C. Dubourg: None. C. Quelin: Recessive inheritance of DISP1 variants in holoprosen- None. B. Keren: None. S. Whalen: None. Y. Hendriks: cephaly spectrum patients None. J. Bos: None. V. David: None. V. Dupe: None. S. Odent: None. A. Lavillaureix1,2, C. Dubourg3,2, C. Quelin1, B. Keren4, S.Whalen5,Y.Hendriks6,J.Bos6,V.David3,2,V.Dupe2,S. E-P11.038 Odent1,2 Detection of the pathogenic CNVs in the Macedonian patient with profound developmental delay 1Service de génétique clinique, Centre de Référence Maladies Rares, CLAD-Ouest, Centre HospitalierAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 913 V. Anastasovska1, E. Sukarova-Angelovska1, D. Nestoroska1, N. Zdraveska2, G. Ilieva1, M. Pesevska1 EBF3-relateddisorderswereﬁrstdescribedin2017(Sleven etal,Harmsetal,Chaoetal,Tanakaetal,Blackburnetal). 1Genetic Laboratory, Skopje, Macedonia, The Former Commonly reported features include global delays, mild- YugoslavRepublicof,2DepartmentofNeonatology,Skopje, severe intellectual disability, ataxia, hypotonia, and mild Macedonia, The Former Yugoslav Republic of facialdysmorphisms.Additional ﬁndings include high pain tolerance, febrile seizures, brain malformations, strabismus, Introduction: The array Comparative Genomic Hybridi- feedingdifﬁculties,scoliosis,genitourinaryanomalies,short zation (aCGH) is now recognised as a ﬁrst tier diagnostic stature, perseverative social behaviours and motor testforpatientswithwiderangingphenotypesandhasledto stereotypies. greater sensitivity in the detection of sub-microscopic Herein, we report on a 19-year old female patient with a genomic changes and pathogenic copy number variants de novo likely pathogenic heterozygous variant in EBF3, (CNVs). c.487C>T, p.(Arg163Trp). Our patient shows many symp- Materials and methods: aCGH was performed in the toms of EBF3-related disorders, including cognitive delay, Macedonian patient with clinical signs of dysmorphia and mental health concerns, hypotonia, strabismus, autonomic developmental delay using the Affymetrix® CytoScanTM dysfunction, poor feeding, complex renal anomaly, neuro- 750K Array (Applied Biosystems), that comprises 550 k genicbladder,febrileseizures,unstablegait,andanunusual non-polymorphic and 200 k SNP markers. The data was coronal pattern of sulcation in the cerebellar tonsils. analysed using Chromosome Analysis Suite (ChAS) Soft- Additionally, she had two unexplained episodes of ware (v4.0). signiﬁcant elevation in AST and ALT (4000-6000 U/L), Results:Wedescribea2.5-year-oldgirlwithdysmorphia not previously reported. and developmental delay. She has midfacial hypoplasia, Our report provides further expansion of the phenotypic facial asymmetry, prominent cheeks, deep set eyes, narrow spectrum of EBF3- related disorders. Long term outcomes rima oculi, short bulbous nose, simple and lop ears, round arenotwelldescribed;ourpatientrepresentsthethirdoldest face and brachydactyly. Congenital hypothyroidism was individualintheliterature.Theelevatedlivertransaminases detected at newborn screening, therefore she was on remain unexplained and could be related to her EBF3- continuous l-thyroxine therapy. At the age of 2 weeks the related disorder, but the possible underlying mechanism is baby developed hemolytic crises, followed by apnoic unknown. EBF3 encodes a member of the early B-cell episodes. Developmental delay was noticed at 6 months factor transcription factor family. Haploinsufﬁciency has of age, both for global and ﬁne motor skills. She started to been proposed as a mechanism of EBF3-related disease walk at 2 years of age, and no speech development so far. (Lopes et al. 2017). This report contributes to the under- Her height and weight are below 3 percentile. Karyotype standing of the long-term outcomes and health surveillance was 46,XX, del18p- (11.1-pter). aCGH analysis was for affected individuals, and further supports the ﬁnding of showed pathogenic 3 copies of the chromosomes multiple pleiotropic effects seen in EBF3-related disorders. 6q13q14.1 (4.081 kb) and 19p13.3 (650 kb) and one copy C.A. Chang: None. W. Al-Hertani: None. M. of chromosome 18p11.32p11.21 (14.919 kb), according to Innes: None. aDGV and ClinVar databases. Conclusions: The array CGH analysis has become a E-P11.040 widely accepted tool that supplements conventional kar- Expansion of phenotypic spectrum of EP300 mutations yotyping in patients with an unexplained phenotype. V. Anastasovska: None. E. Sukarova-Angelovska: None. R. Kosaki1, K. Kosaki2 D.Nestoroska:None.N.Zdraveska:None.G.Ilieva:None. M. Pesevska: None. 1Division of Medical Genetics, National Center for Child HealthandDevelopmentHospital,Setagaya,Tokyo,Japan, E-P11.039 2Center for Medical Genetics, Keio University School of EBF3-related neurodevelopmental disorder - case Medicine, Tokyo, Japan report of female with phenotypic expansion and review of the literature Rubinstein-Taybi syndrome (RSTS) is a congenital mal- formation syndrome characterized by typical facial C. A. Chang1, W. Al-Hertani2, M. Innes1 appearance, broad thumbs and halluces, and intellectual disability.HeterozygousmutationsinCREBBP(50-60%)or 1Alberta Children’s Hospital, Calgary, AB, Canada, 2Bos- EP300 (8-10%) have been detected. Recently, a hetero- ton Children’s Hospital, Boston, MA, United States geneous group of patients with CREBBP or EP300914 J.delPicchia mutations who have clinical features atypical for RSTS duodenal stenosis was treated surgically. Ultrasound have been reported though exome analysis. We here report revealed an agenesis of the left kidney, and a pancreas four unrelated patients with EP300 mutations to expand anulare. At the age of 9 months, he presented with phenotypicspectrum.[Methods]Informedconsentfromthe microbrachycephaly, triangular facies, iris coloboma on parents and approval from the local institutional review botheyes,low-setears,andpartialcutaneoussyndactylyof board were obtained. Medical exome analysis was per- the 4th and 5the toes on the left foot, consistent with formed. [Results] All the four patients had heterozygous previous reports of patients with FS1. mutationofEP300.Patient1)5-month-oldmalewithsome Methods: Conventional chromosomal analysis (CA), ofRSTSincludingintellectualdisability(ID),broadthumbs, array-CGH, quantitative PCR (qPCR) and Whole Trio andventricularseptaldefect.Nonsensemutationp.Gln965* Exome Sequencing (Trio-WES) were performed. was detected. Patient 2) 2-year-old female with atypical Results: GTG karyotyping showed a normal male result. features of RSTS including ID and normal thumbs. Mis- Array CGH detected a 4.9 Mb microdeletion of chromo- sense mutation p.Val1656Ala was detected. Patient 3) 11- some region 2p24.3 to 2p24.1, resulting in haploinsufﬁ- month-old female with double outlet right ventricle, mye- ciency of MYCN. qPCR segregation analyses of the index lomenigocele, hydrocephalus, imperforate anus, coloboma, patientandhisparentsdemonstratedadenovodeletion.No and hearing impairment. Dual mutations were detected: pathogenic variants beside the 2p24 microdeletion were EP300 frameshift mutation p.Gln2048Thrfs*24 and SOS1 revealed by Trio-WES of the patient and his parents. Thr778Pro mutation. Patient 4) 6-year-old female with Conclusion: Our results conﬁrm that FS1 can be caused PDA, PS, coloboma, and hearing impairment.: EP300 fra- by microdeletions of the chromosomal region 2q24 as meshift mutation p.Gln2048Thrfs*24 was detected.[Dis- single abnormality. cussion]Wedemonstratedtheclinicalvariabilityofpatients C. Schell-Apacik: None. S. Rauschke: None. A. Weber: with EP300 mutations. The combination of coloboma and None.M.Blankenburg:None.L.Mulahasanovic:None.H. imperforate anus has been reported in a patient with a fra- Gabriel: None. S. Biskup: None. M. Stumm: None. meshiftmutation(p.H815Tfs*128)inEP300(Masudaetal. 2015).Recurrenceofsuchaspeciﬁccombinationofdefects E-P11.044 suggestscausalrelationship.PhenotypicspectrumofEP300 Ocular phenotype inpatients withGNB5variantsandim- mutations may be much broader than has been previously pact of variants onGbeta5 expressionand function appreciated. R. Kosaki: None. K. Kosaki: None. Z. Shao1,2, A. Tumber3, J. Maynes4, E. Tavares3, S. Hewson2, A. Schulze2, P. Kannu2, A. Vincent3 E-P11.042 Deletion 2p24 and Feingold Syndrome Type 1 1Post-Graduate Medical Education, University of Toronto, Toronto, ON, Canada, 2Division of Clinical and Metabolic C. Schell-Apacik1, S. Rauschke2, A. Weber2, Genetics,HospitalforSickChildren,Toronto,ON,Canada, M. Blankenburg2, L. Mulahasanovic3, H. Gabriel3, 3Department of Ophthalmology and Vision Sciences, S. Biskup3, M. Stumm2 Hospital for Sick Children, Toronto, ON, Canada, 4Divi- sionofMolecularMedicine,TheHospitalforSickChildren 1Medicover Human Genetics Berlin-Westend MVZ, Berlin, Faculty of Medicine, University of Toronto, Toronto, ON, Germany, 2Medicover Genetics GmbH, Berlin, Germany, Canada 3Praxis für Humangenetik Tuebingen, Tuebingen, Ger- many BiallelicmutationsinGproteinsubunitbeta5(GNB5)gene were ﬁrst reported to cause a multi-system disorder with Introduction: Feingold Syndrome Type 1 (FS1 - OMIM cardinal characteristics that include global developmental #164280) is a very rare syndromic microcephaly entity for delay, seizures, generalized hypotonia, early-onset sinus which MYCN is the major disease-causing gene. The inci- node dysfunction and eye disease. We have previously dence of FS1 is currently unknown. About 10% of FS1 reported the unique electroretinal signal of a 3-year-old patients have deletions encompassing all or part of the femalewithahomozygousnullvariantinGNB5(GNB5-L; MYCN gene. We report an additional FS1 case, carrying a NM_016194.3:c.1032C>A/p.Y344* and GNB5-S; 4.9 Mb de novo microdeletion of the chromosomal NM_006578.3:c.906C>A/ p.Y302*) representing dual ret- region 2p24. inalsignallingdefectsthatconstitutesfeaturesofbradyopsia Clinical data: The boy is the only child of unrelated and rod ON-bipolar dysfunction. Subsequently, another parents. He was born in the 32th (31+5) gestational week female patient was identiﬁed with a homozygous missense by Caesarean after preeclampsia. At the age of two days, a variant in GNB5 (NM_016194.3:c.920T>G/p.L370R)Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 915 throughwholeexomesequencing(WES).Furthermore,this identiﬁed in introns: deletions c.76+36delAC in intron 1 patientalsohasahomozygousmissensevariantinMCCC1 SALL1 gene, c.120+42G>T in intron 1 of TCL1 and (c.1394C>Tp.T465I)thatrepresents3-methylcrotonyl-CoA c.298_34C>T in intron 2 of TCL1 gene and substitution of carboxylase deﬁciency. The 3-MCC deﬁciency was con- c.393+36T>A in intron 3 of TCL1B gene. ﬁrmedenzymatically.AnotherheterozygousHemoglobinE Conclusions: Molecular evaluation is of extreme impor- variant of codon 26 (GAG>AAG) [HBB c.79G>A] that tance for families with a history of GHS. Diagnosis, early represents HbE trait was also identiﬁed, consistent with detection of the syndrome and good management make patient’s clinical presentation of splenomegaly. We there- possible of normal life of the patient. fore conducted a deep phenotypic analysis to segregate the B.A. Marszalek-Kruk: None. contribution of each genetic variant with a focus on her ocular phenotype whichinvolveshigh myopia. Wealso set E-P11.046 out to study the impact of the GNB5 variants on gene 45,X/46,XY gonosomal mosaicism as an unexpected expression,translationandprotein-proteininteractionusing ﬁnding in a patient with lymphoproliferative disease primary ﬁbroblast culture from the patient. With increased useofWESingeneticdiagnosis,morepatientsarefoundto J. Stellmachova1, V. Curtisova1, P. Rohon2, R. Vrtel1, have multiple molecular variants in syndromes with over- P. Vrtel1, K. Adamova1, D. Vrbicka1, M. Prochazka1, lappingphenotypes.Thisstudyhighlightstheimportanceof M. Palova3 detailed phenotyping and need of functional assays to aid variant classiﬁcation. This work is supported by the Rare 1Department of Medical Genetics University Hospital and Disease Foundation and the BC Children’s Hospital Foun- Palacky University, Olomouc, Czech Republic, 2Palacky dation Microgrant. University, Olomouc, Czech Republic, 3Department of Z. Shao: None. A. Tumber: None. J. Maynes: None. E. Hematooncology University Hospital and Palacky Univer- Tavares: None. S. Hewson: None. A. Schulze: None. P. sity, Olomouc, Czech Republic Kannu: None. A. Vincent: None. Introduction: We present a case of delayed diagnosis of a E-P11.045 mixed gonadal dysgenesis in a 53 old woman. Mutations in SALL1, TCL1 and TCL1B genes in Case presentation: The patient had short stature patients with Goldenhar syndrome (150cm), obesity, coarse facial features, mild male pattern hair loss, primary amenorrhea and borderline intellect. Her B. A. Marszalek-Kruk short stature and primary amenorrhea were never investi- gated. She was ascertained following a diagnosis of Department of Genetics, Wroclaw University of Environ- follicular lymphoma during a preventive mammography. mental and Life Sciences, Wroclaw, Poland Cytogenetic examination of the bone marrow detected complex changes including 46,XY clones prompting a Introduction: Goldenhar syndrome (GHS) is a rare inher- request for genetic examination with following results: ited syndrome. The incidence of this disease is between Karyotype from peripheral blood:45,X [12]/46,XY[38] 1:5600 to 1:25000. Syndrome is a multiple congenital dis- (24% monosomy X), FISH native peripheral blood: ish order characterized by malformed ears, micrognathia, oral (DXZ1x1)[40]/(DXZ1x DYZ3x1)[160] (20% monosomy cavity malformations and dermal cysts. Due to malforma- X), FISH buccal smear: ish (DXZ1x1)[68]/(DXZ1x tion patients usually have problem with airway. DYZ3x1)[132] (34% monosomy X). Her gonads were Materials and methods: DNA was isolated from removed,andpresenceofboth45,Xand46,XYcloneswas peripheral blood leukocytes from the patients. Exons of detected by FISH. Patients with "45,X/46,XY mixed genes SALL1 TCL1 and TCL1B were ampliﬁed by gonadal dysgenesis" syndrome can present with small polymerasechain reaction(PCR)under optimal conditions, stature have an increased risk of gonadoblastoma and usingspeciﬁcprimers.ThePCRproductsweresubjectedto congenital abnormalities of heart and kidneys (similar like RFLP analysis and were puriﬁed on the DNA Gel Out Turner syndrome). columns followed by direct sequencing method. Conclusion: Early diagnosis of gonosomal mosaicism Results: During examination were detected 3 substitu- 45,X/46,XY enables multidisciplinary cooperation and tions. The c.3720G>A mutation in exon 3 of the gene treatment. Although the Czech Republic has a very good SALL1 which is a silent mutation (A1240A). Another of and longstanding tradition of primary care which enables the described mutation is c.166G>A in exon 2 of TCL1 the diagnosis in most cases to be reached by puberty there causingtheconversionofV56Iandc.277G>Ainexon2of are still some adult patients who remain undiagnosed. This TCL1BcausingG93R.Additionally4polymorphismswere case highlights the usefulness of karyotype examination in916 J.delPicchia women with unexplained primary amenorrhea and/or short E-P11.049 stature. New case of Bardet Bield Syndrome caused by novel Supported by MH CZ - DRO (FNOl, 00098892) biallelic mutations in IFT172 gene J. Stellmachova: None. V. Curtisova: None. P. Rohon: None. R. Vrtel: None. P. Vrtel: None. K. Adamova: None. M. Sánchez Soler1, M. Ballesta-Martínez2, A. Serrano- D. Vrbicka: None. M. Prochazka: None. M. Palova: None. Antón1, V. López-González2, L. Rodríguez-Peña1, E. Guillén-Navarro2 E-P11.048 HDAC2 as a potential ‘second hit’ to KIAA0586. Novel 1Medical Genetic Sección, H. Clinic Universitary V. ‘two hit hypothesis’ vs Digenic inheritance (DI) ? Arrixaca, IMIB-Arrixaca, El Palmar, Spain, 2Medical Genetic Sección, H. Clinic Universitary V. Arrixaca, S. Kupchik1, S. Lau1, O. Beckett1, K. McWalter2, IMIB-Arrixaca. CIBERER, El Palmar, Spain E. Normand3, Y. Kogelman1, P. Campeau4 Introduction: IFT172 is part of the intraﬂagellar transport 1MaimonidesMedicalCenter,Brooklyn,NY,UnitedStates, (IFT), a bidirectional mechanism allowing the protein 2Gene Dx, Gaithersburg, MD, United States, 3Gene Dx, motility within the cilia and biallelic mutations inthis gene Gaithesburg, MD, United States, 4University of Montreal, have been described in patients with isolated retinosis pig- Montreal, QC, Canada mentosa, short-rib thoracic displasia 10 with or without polydactyly, joubert syndrome, recently with oro-fagio- An11yearoldfemalewithshortstature,repairedopenneural digital syndrome and only in three cases of Bardet Bield tubedefect(NTD)andpostaxialpolydactyly(PAP)wasfound syndrome (BBS). on trio exome sequencing to have two frameshift variants, a Material and methods: Description of a new case of paternally inherited pathogenic AR variant in KIAA0586: BBS caused by two novel mutations in IFT172 gene. c.428delG:p.Arg143LysfsX4 and a de novo variant of Results5 years-old boy, ﬁrst child of healthy non con- unknown signiﬁcance in HDAC2: c.1359_1362delAACA: p. sanguineous parents. He had retinosis pigmentosa, myopia, Thr454ArgfsX51.KIAA0586encodesaconservedcentrosomal languagedelay,obesity(weightp>99+4.8SD),OFCp>99 proteinessentialforciliogenesis. Bi-allelicpathogenic variants (2.7SD), generalized brachydactyly, abnormal palmar inKIAA0586resultinaspectrumofautosomalrecessive(AR) creases, round face, short palpebral ﬁssures, small teeth ciliopathy disorders ranging from short rib thoracic dysplasia andonecafeaulaitspot.Cardiacandrenalanomalieswere with polydactyly-14 to Joubert syndrome. HDAC2, not cur- ruled out and the hearing was normal. ArrayCGH and rentlyknowncausativeofdisease,isamammalianzincﬁnger molecular study of Prader-Willi were normal. Firstly, transcriptionfactorhistonedeacetylase2proteinthatactsboth commom mutations associated with BBS were studied as positive and negative regulator of transcription. HDAC2 without positive result. NGS of genes associated with found expressed in mouse brain may play a role in normal retinosis pigmentosa detected two variants probably dama- proliferationanddifferentiationofneuralprecursorcells.There ging in IFT172 gene: c.2635G>A and c.4540-6C>G. The are reports of a de novo HDAC2 missense variant in an indi- ﬁrstwaspresentinthemother andthesecond inthefather, vidual with a Cornelia de Langue syndrome like phenotype, supporting their pathogenity. NTDandPAPwhoalsoexhibiteda15q11.2-q11.3duplication Conclusions: We report on a new case of BBS due to and in an individual with intellectual disability (ID). We biallelic mutations in IFT172 gene supporting its implica- hypothesize our patient’s phenotypic manifestations could be tion in this syndrome. We describe two new mutations in explainedbyeitherdigenicinheritance(DI)orbyanovel‘two thisgene.AchievingmoleculardiagnosiswithNGSpermits hithypothesis’inwhichasingleARpathogenicallelereaches adequate genetic counseling in families. thresholdofclinicalexpressionduetopresenceofanadditional M.SánchezSoler:None.M.Ballesta-Martínez:None.A. de novo variant in a signiﬁcant regulatory transcript namely Serrano-Antón: None. V. López-González: None. L. HDAC2. If conﬁrmed, it could have signiﬁcant genetic coun- Rodríguez-Peña: None. E. Guillén-Navarro: None. seling and genetic mechanisms of disease causation implica- tions.Acollaborationisunderwaytocharacterizephenotypic E-P11.050 and biochemical consequences of HDAC2 mutations. Father-daughterincest:30-year-oldwomanwithSeckel- S. Kupchik: None. S. Lau: None. O. Beckett: None. K. like microcephaly and homozygous STIL pathogenic McWalter: A. Employment (full or part-time); Signiﬁcant; variant Gene Dx. E. Normand: A. Employment (full or part-time); Signiﬁcant;GeneDx.Y.Kogelman:None.P.Campeau:None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 917 C. Ding1, J. Spranger2, S. Diederich1, D. Galetzka1, Diagnosis and veriﬁcation of multiple congenital dys- S. Schweiger1, O. Bartsch1 morphism (MCD) syndromes is often difﬁcult due to the varietyofclinicalforms andinter-andintrafamilialclinical 1Institut Institute of Human Genetics, University Medical polymorphism. It is known that in sporadic cases, the Centre of the Johannes Gutenberg University, Mainz, diagnosis will be most reliable with the full range of phe- Germany, 2Children’s Hospital, University Medical Centre notypic sings. Differential diagnosis of MCD syndromes of the Johannes Gutenberg, Mainz, Germany can also be difﬁcult due to the similarity of phenotypic features in different syndromic forms. In such cases, the Among children resulting from incestuous matings, mental problem of clarifying the diagnosis and resolving the issue retardation and congenital malformations are known to be of the possibility of conducting a prenatal diagnosis of the very common (PMID: 6779972, 5127404), but molecular disease in the fetus in the family during subsequent preg- studies to identify the underlying defects in these children nancy can be solved by the use of high-throughput DNA are still scarce or lacking (PMID: 26320005, 20509080). sequencingmethods.Proband,aboybornin2013,wasﬁrst Wereporthereawomanresultingfromaforcedincestuous consultedwiththeaimofdiagnosisattheageof2yearsold conception (father-daughter incest). For many years, her regarding complaints of short stature, congenital ptosis, diagnosis had been Seckel syndrome due to extreme pri- nystagmus,severehypotrichosis,renalhypoplasia,violation mary microcephaly (-10 SD), pre- and postnatal growth of pronation-supination (radio-lunar synostosis?), lobar retardation (-5 SD), prominent nose, and severe develop- holoprosencephaly, delayed development. Cartilage-hair mental retardation. Upon re-examination at age 30 years, hypoplasiaandNoonansyndromewereexcludedclinically. she also displayed profound intellectual disability, absent CMA was negative. The NGS revealed a small deletion in speech, most severe behavioral abnormalities resulting in KIAA0556 gene (c.2373delC) in a homo- or hemizygous blindness (due to head banging and eye scratching) as well state. Thus,thediagnosis ofJoubertsyndrome(JS) type 26 as tetraplegia. Microarray analysis revealed a highly was established. JS is a heterogeneous disease - 36 genetic increased loss of heterozygosity (LOH 25.3%), consistent forms are presented in the OMIM, all with AR type of with incest. Of note, LOH >50% was detected for eight inheritance which have far from classical phenotypic man- chromosomes. Whole exome sequencing revealed a ifestations of this syndrome. A stricter approach to the homozygous variant c.3377A>G p.Tyr1126Cys in the description of phenotypes will probably solve the problem STIL gene. of such a high genetic heterogeneity. Supported by RFBR Pathogenic STIL variants result in non-syndromic auto- grant 18-015-00090. somal recessive primary microvephaly type 7 (MCPH7, V.A. Galkina: None. A.V. Marakhonov: None. R.A. OMIM #612703). The degree of intellectual disability Zinchenko: None. amongreportedpatientsisveryvariable,rangingfrommild to severe, and seems not to be genotype speciﬁc. Several E-P11.055 features observed in the proband (including stereotypic Co-occurrence of mutations in KIF7 and KIAA0556 in behavior, tetraplegia, and profound global retardation) are Joubert syndrome with ocular coloboma, pituitary not typical ﬁndings in MCPH7, suggesting that additional malformation and growth hormone deﬁciency unrecognized recessive variants could possibly have con- tributed to the more complex phenotype in the patient, M. Niceta1, M. L. Dentici1, A. Ciolﬁ1, R. Marini2, adding to the classic form of MCPH7. S. Barresi1, F. R. Lepri1, A. Novelli1, E. S. Bertini1, C.Ding:None.J.Spranger:None.S.Diederich:None.D. M.Cappa2,M.C.Digilio1,B.Dallapiccola1,M.Tartaglia1 Galetzka: None. S. Schweiger: None. O. Bartsch: None. 1Genetics and Rare Diseases Research Division, Ospedale E-P11.054 Pediatrico Bambino Gesù, Rome, Italy, 2Unit of Endocri- The problem of identifying syndromes with a high nology, Academic Department of Pediatrics, Ospedale degree of genetic heterogeneity and clinical Pediatrico Bambino Gesù, Rome, Italy polymorphism Introduction: Joubert syndrome is a recessive neurodeve- V. A. Galkina, A. V. Marakhonov, R. A. Zinchenko lopmental disorder characterized by clinical and genetic heterogeneity.Clinicalhallmarksincludehypotonia,ataxia, Research Center for Medical Genetics, Moscow, Russian facial dysmorphism, abnormal eye movement, irregular Federation breathingpatterncognitiveimpairmentand,themolartooth sign is the pathognomonic midbrain-hindbrain918 J.delPicchia malformationonmagneticresonanceimaging.Thedisorder patients with KS distinct face, neurodevelopmental deﬁcit, ispredominantlycausedbybiallelicmutationsinmorethan congenital heart disease, and skeletal/dental malformations. 30 genes encoding proteins with a pivotal role in mor- Our patients have respectively partial atrio-ventricular phology and function of the primary cilium. Oligogenic septal defect, double outlet right ventricle, left ventricular inheritance or occurrence of genetic modiﬁers has been hypertrophy and atrio-ventricular septal defect with atrial suggested to contribute to the variability of the clinical isomerism. Neurodevelopmental deﬁcits were constant but phenotype. We report on a family with peculiar clinical variablewithrespectivelydevelopmentaldelay,behavioural spectrum Joubert syndrome molecularly and clinically dis- troubles with autistic traits, perceptive sensory deafness, secting a complex phenotype, in which hypogonadism, mentalretardationanddelayedspeechwithabnormalvoice; pituitary malformation and growth hormone deﬁciency learning disabilities and behavioural troubles; developmen- occur as major features. tal delay, psycho-motor retardation, delayed speech, and Case Description and Methods: A 7 year-old male was mental retardation; and ﬁnally learning disabilities and enrolledinadedicated“UndiagnosedPatientsProgram”for hypernasal speech. apeculiarformofJoubertsyndromecomplicatedbyirisand Conclusion: KS is a clinically recognizable syndrome retinochoroidal coloboma, hypogonadism pituitary malfor- andmostpatientshaveapathogenicvariantintheKMT2D mation, and growth hormone deﬁciency. The molecular or KDM6A genes. The ﬁve cardinal manifestations of KB basis of the complex phenotype was investigated by whole deﬁned in 1988 have been revisited recently (2018). The exome sequencing. new consensus diagnostic criteria propose that a deﬁnitive Results: The concomitant occurrence of homozygosity diagnosis can be made in an individual of any age with a formutationsinKIF7andKIAA0556wasidentiﬁed,andthe history of infantile hypotonia, developmental delay and/or assessment of major clinical features associated with intellectualdisability,andoneorbothofothermajorcriteria mutations in these two genes provided evidence that these like pathogenic molecular variant. In fact, either with or two independent events represent the cause underlying the without molecular genetic conﬁrmation, it seems to be complexity of the present clinical phenotype. possible to go on toward a correct clinical diagnosis. The Conclusion: Beside the clinical variability of Joubert phenotypicvariabilityislinkedtothenatureoftheinvolved syndrome, co-occurrence of mutations in ciliopathy-asso- protein in the epigenetic machinery (readers, writers, ciated genes may contribute to increase the clinical erasers, or chromatin remodelers). complexity of the trait. N.B. Abdelmoula: B. Research Grant (principal inves- M.Niceta:None.M.L.Dentici:None.A.Ciolﬁ:None.R. tigator, collaborator or consultant and pending grants as Marini: None. S. Barresi: None. F.R. Lepri: None. A. well as grants already received); Modest; Research Unit Novelli: None. E.S. Bertini: None. M. Cappa: None. M.C. UR17ES36. B. Abdelmoula: B. Research Grant (principal Digilio: None. B. Dallapiccola: None. M. Tartaglia: None. investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit E-P11.056 UR17ES36. R. Louati: B. Research Grant (principal Neurodevelopmental disorders and chromatin remodel- investigator, collaborator or consultant and pending grants ing dysregulation: the lessons from Kabuki syndrome as well as grants already received); Modest; Research Unit spectrum and clinical presentation of Tunisian cases UR17ES36. F. Abid: B. Research Grant (principal investigator, collaborator or consultant and pending grants N.B.ABDELMOULA,B.Abdelmoula,R.Louati,F.Abid, as well as grants already received); Modest; Research Unit T. Sammouda, W. Smaoui, N. Abdellaoui, K. Trigui, O. UR17ES36. T. Sammouda: B. Research Grant (principal Kaabi, W. Ltaif, S. Aloulou, S. Mallek, S. Kammoun, investigator, collaborator or consultant and pending grants UR17ES36 members as well as grants already received); Modest; Research Unit UR17ES36. W. Smaoui: B. Research Grant (principal Medical University, Sfax, Tunisia investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit Objective: Kabuki syndrome (KS) [MIM: 147920] is UR17ES36. N. Abdellaoui: B. Research Grant (principal linked to dysregulated lysine degradation and chromatin investigator, collaborator or consultant and pending grants organization pathways. Here, we report four Tunisian as well as grants already received); Modest; Research Unit patients, who fulﬁlled clinical criteria of KS, including UR17ES36. K. Trigui: B. Research Grant (principal neurodevelopmental deﬁcits. investigator, collaborator or consultant and pending grants Clinical Presentation: During our genetic couselling at as well as grants already received); Modest; Research Unit the medical university of Sfax (Tunisia), we recorded four UR17ES36. O. Kaabi: B. Research Grant (principalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 919 investigator, collaborator or consultant and pending grants Discussion:Thisistheﬁrstgeneticallyconﬁrmedcaseof as well as grants already received); Modest; Research Unit LADD syndrome in Georgia, presenting with epilepsy as a UR17ES36. W. Ltaif: B. Research Grant (principal new feature. Genetic testing lead to more accurate genetic investigator, collaborator or consultant and pending grants and recurrence risk counseling. Our case expands the as well as grants already received); Modest; Research Unit phenotypic and mutational spectrum of FGFR2 and UR17ES36. S. Aloulou: B. Research Grant (principal conﬁrms application of WES as a ﬁrst-line diagnostic test investigator, collaborator or consultant and pending grants in individuals with multiple congenital anomalies. More as well as grants already received); Modest; Research Unit studies are needed to deﬁne whether genotype-phenotype UR17ES36. S. Mallek: B. Research Grant (principal correlations exist. investigator, collaborator or consultant and pending grants T. Tkemaladze: None. E. Abzianidze: None. E. Kvar- as well as grants already received); Modest; Research Unit atskhelia: None. M. Ghughunishvili: None. V. Skrahina: UR17ES36. S. Kammoun: B. Research Grant (principal None. A. Rolfs: None. investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit E-P11.060 UR17ES36. TGM1 mutation spectrum in patients with lamellar ichthyosis E-P11.059 Lacrimo-auriculo-dento-digital LADD syndrome: ﬁrst F. Ozkinay1, H. Onay1, G. OZTURK1, E. ISIK1, case report of a Georgian patient D. AYYILDIZ EMECEN1, E. ARSLAN1, F. HAZAN2, T. Atik1 T. Tkemaladze1,2, E. Abzianidze1, E. Kvaratskhelia1, M. Ghughunishvili2,1, V. Skrahina3, A. Rolfs3 1EgeUniversityFacultyofMedicine,Izmir,Turkey,2S.B.U. DR.BEHCET UZ CHILDREN’S EDUCATION AND 1Tbilisi State Medical University, Tbilisi, Georgia, 2Givi RESEARCH HOSPITAL, Izmir, Turkey Zhvania Pediatric Academic Clinic, Tbilisi, Georgia, 3CENTOGENE AG, Rostock, Germany Aim: Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of keratinization disorders, caused Background: Lacrimo-auriculo-dento-digital (LADD) by mutations in at least 13 different genes. Lamellar syndromeisextremelyraregeneticdisorderwithonlyabout icthyosis (LI) which is one of the phenotypic features of 100casesreportedworldwide.LADDsyndromeoccursdue ARCI presents with dark brown, plate-like scale with no to pathogenic changes FGFR2, FGFR3 or FGF10 genes. erythroderma. TGM1 mutations is the most common cause Clinical signs and severity may vary, but almost uniformly of the classic LI phenotype. In this study, we investigated there is involvement of the lacrimal systems, cup-shaped the clinical and molecular ﬁndings of eleven LI patients ears, dental and digital abnormalities. who had mutations in TGM1 gene. Case Report: Here we report of a 9 years old girl with Method: Ten patients clinically diagnosed asLI and two LADDsyndromefromGeorgia.Atbirthshepresentedwith consangineouscarrierparents (theirchildwithLIhaddied) malformed left hand, ventricular-septal defect, congenital havingmutationsinTGM1genewereincludedinthestudy. inguinal hernia and kidney aplasia. Dysmorphic features All patients (including death child) were examined by an include lacrimal duct obstruction, low-set and cup-shaped experienced dermatologist and clinical geneticist. Patient ears, dental aplasia and salivary gland malformation. Her histories; including demographic, clinical and laboratory hearing loss started from 2,5 years and is slowly ﬁndings, were obtained from hospital records. TGM1 gene progressive. Interestingly she developed generalized sei- analysiswasperformed usinganext generationsequencing zures from 2,5 years which is not a common feature of platform (Illumina MiSeq). LADD syndrome. Patient was on anti-epileptic treatment Results: Six patients were female, ﬁve male. Plate-like for3yearsandisnowseizure-freeanddrug-freeforalready scale with no eritroderma, the typical features of LI, was 4 years. deﬁned in all patients. Eleven different mutations were Methods: Whole exome sequencing (WES) was per- identiﬁed; eight were missense, two frameshift and one formed and c.1547C>T p.(Ala516Val) variant was identi- nonsense. While ten patients carried the same mutations in ﬁed in FGFR2 gene. In silico tools predict the change both alleles, one was compound heterozygous (c.160C>T; disrupts normal function of the FGFR2 protein. Addition- c.1469A>G). Three of the eleven mutations (c.1148T>G, ally, parental testing conﬁrmed de novo status of the c.889G>A. C.2189delG) in the TGM1 gene had not variant. previously been reported in the literature.920 J.delPicchia Conclusion: By deﬁning three novel mutations, this with LIG4 syndrome diagnosis. Parental testing conﬁrmed study enriched the molecular spectrum of ichthyosis, and compound heterozygosity. also provided a further insight for genetic counselling. J. Chi: None. P. Gerasimou: None. A. Miltiadous: None. F. Ozkinay: None. H. Onay: None. G. Ozturk: None. E. I.Kyprianou:None.L.Koumas:None.L.Loizou:None.E. Isik:None.D.Ayyildizemecen:None.E.Arslan:None.F. Papachristodoulou: None. E. Karaoli: None. A. Loizou: Hazan: None. T. Atik: None. None. P. Costeas: None. E-P11.061 E-P11.062 The Rare LIG4 Syndrome: A case report A case ofantenatal Bartter’s Syndrome with a novel MAGED2 variant manifesting with severe polyhydram- J. Chi1, P. Gerasimou1, A. Miltiadous1, I. Kyprianou1, L. nios and intrauterine fetal death Koumas1, L. Loizou2, E. Papachristodoulou2, E. Karaoli2, A. Loizou2, P. Costeas1 M.Nagasaka1,2,S.Nakago1,C.Nagano2,N.Morisada2,K. Nozu2, K. Iijima2 1Molecular Hematology-oncology, Karaiskakio Founda- tion, Nicosia, Cyprus, 2Pediatric Oncology-Hematology, 1Takatsuki General Hospital, Takatsuki, Japan, 2Kobe Archbishop Makarios III Hospital, Nicosia, Cyprus University Graduate School of Medicine, Kobe, Japan Introduction: The LIG4 syndrome is a rare hereditary Introduction:Polyhydramniosiscausedbyvariousfactors. disorderassociatedwithimpairedDNAdouble-strandbreak Recently,theMAGED2genelocatedontheXchromosome repair mechanisms. Patients show unusual facial features, has been reported to be responsible for antenatal Bartter microcephaly, growth and/or developmental delay, various syndrome with most severe polyhydramnios. skin abnormalities and pancytopenia, which is associated Case: The patient wasagirl diedinutero at31weeksof with combined immunodeﬁciency. gestation.Themotherwasa29-year-oldwoman(gravida3, Case Description: 12-year old patient with obvious para2).Theﬁrstchilddiedinuteroat37weeksofgestation syndromic features with severe microcephaly, very short without polyhydramnios. The second child was normally stature and a very low body weight. Bird-like facial features, delivered at 36 weeks of gestation. She presented with resemblingSeckel’ssyndromeorFanconianemiapatients.He severe polyhydramnios during the third pregnancy. Fetal hadnosignsofacuteillnessnormalignancy.Thepatientisof development was good and no cardiac or morphological Syriandescentandisthesecondchildofasix-memberfamily. abnormalities werenotedbyfetal ultrasound.Onfetal MRI Parents are ﬁrst-degree relatives, both reported healthy. at 27 weeks of gestation, no brain malformation or Methodology: A custom HaloPlexHS (Agilent) NGS gastrointestinal obstruction was noted, but the bladder was panelwasusedtoinvestigatemutationsingenesinvolvedin large.Shehadbeentreatedwithamnioreductionsixtimesin Bone Marrow Failure/Severe Combined Neutropenia, total, but the fetus died suddenly in utero at 31 weeks of Anemias and Chromosome Breakage Syndrome. Sanger gestation. The child was a girl weighing 1980 g, and she sequencing performed parental carrier status. had no apparent morphological abnormalities. Interpretation: Two variants in the LIG4 gene were Genetic testing: Sequencing of DNA from the frozen identiﬁed, c.2440C>T p.(Arg814Ter) and umbilical cord of the third child revealed a de novo c.1273_1278delAGAGAA p.(Arg425_Glu426del). LIG4 nonsenseMAGED2variantwithheterozygosity.SkewedX- c.2440C>T is a nonsense heterozygous variant which chromosome inactivation was observed via prematurely terminates the protein and is classiﬁed as HUMARA assay. pathogenic and LIG4 c.1273_1278del is an in-frame Conclusion: We believe that our case showed a severe deletionclassiﬁedaslikelypathogenicaccordingtoACMG phenotypeofantenatalBartter’ssyndromeduetoMAGED2 recommendations. Compound heterozygous mutations in truncating variant and skewed X-chromosome inactivation. the LIG4 gene have been associated to LIG4 syndrome, an M.Nagasaka:None.S.Nakago:None.C.Nagano:None. autosomal recessive disorder caused by homozygous or N. Morisada: None. K. Nozu: None. K. Iijima: None. compound heterozygous mutations. Parental testing revealed that LIG4 c.2440C>T variant was maternally E-P11.066 inherited and the LIG4 c.1273_1278delAGAGAA variant Intra-uterinefetaldeathinMeier-GorlinSyndromedue was paternally inherited. to compound heterozygous variants of ORC6 gene with Conclusion: The patient is compound heterozygous for a novel mutation: a case report the pathogenic (c.2440C>T) and likely pathogenic (c.1273_1278del) variants in the LIG4 gene, consistentAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 921 H. Thorn1, S. Drunat2, C. Fleury3, E. Alanio4, J. Bory5, Fenzy: None. M. Blocquaux: None. C. Jacquin: None. C. S.Bonneau5,M.Doco-Fenzy6,M.Blocquaux7,C.Jacquin6, Poirsier: None. M. Mozelle-Nivoix: None. C. Poirsier8, M. Mozelle-Nivoix1 E-P11.068 1Medical Genetic Service, CH Simone VEIL, Troyes, A novel GTPBP2 splicing mutation in two siblings France, 2LaboratoryofMoleculargenetics,HôpitalRobert affected with microcephaly, generalized muscular atro- Debré,PARIS,France,3AnatomicalPathologyLaboratory, phy, and hypotrichosis CHU de Reims, Reims, France, 4Anatomical Pathology laboratory,CHUdeReims,Reims,France,5Obstetricsand E. Akbariazar, I. Abdi Rad, A. Vahabi GynaecologyDepartments, CHUdeReims,Reims,France, 6Medical Genetic Service, CHU de Reims, Reims, France, UrmiaUniversityofMedicalSciences,Urmia,Iran,Islamic 7Cytogenetics Laboratory and Laboratory of Molecular Republic of Genetics,CHUdeReims,Reims,France,8MedicalGenetic Service, CHU de Reims, Troyes, France Background: One of the challenging pitfalls in the genetic counseling of patients with syndromic microcephaly is a The Meier-Gorlin Syndrome (MGS) is a rare autosomal deﬁnite clinical diagnosis to determine its etiology. Any recessive disorder with characterized malformatives fea- unknownsyndromicmicrocephalynecessitates piling upof tures. Among mutations of the pre-replication complex clinicalandmoleculargeneticsdatainthehopeofgettinga (ORC1, ORC4, ORC6, CDT1, CDC6), ORC1 and ORC4 genotype-phenotype correlation. mutations appear to be responsible of the most severe Materials and methods: In this study, we identiﬁed a phenotypes.However,ORC6mutationscanleadtoasevere novel splice site mutation in the GTPBP2 gene by Whole abnormal embryological development. Exome Sequencing in two siblings with microcephaly and We present the case of an intrauterine fetal death at progressive generalized muscular atrophy associated with 32 weeks during dichorionic diamniotic twin pregnancy. hypotrichosis. The fetus had a compound heterozygous ORC6 mutation, Results:ThissplicesitemutationintheGTPBP2geneis inherited from both parent. predictedtodisruptthehighlyconservedacceptorsplicesite At 16 weeks, a severe inadequate intra-uterine growth of exon 4 in the GTPBP2 gene. associated with a genu recurvatum and oligohydramnios Conclusion: We describe syndromic microcephaly wereobservedforoneofthetwins(ultrasoundidentiﬁcation related to GTPBP2 gene in two siblings with an autosomal of the fetal sex: female). There was no family background recessive pattern of inheritance, and to the best of our aside the mother which presented neuroﬁbromatosis type I. knowledge, is the ﬁrst report of the GTPBP2 related The parents were unrelated. hypotrichosis microcephaly with generalized muscular Fetal karyotype by amniocentesis on the pathological dystrophy. fetuswas46,XY.Thegeneticexplorationwascompletedby Grant references: This research received no speciﬁc MLPA. No quantitative chromosomal abnormalities were grantfromanyfundingagencyinthepublic,commercial,or detected. not-for-proﬁt sectors. After caesarean delivery at 37 weeks, the fetal anatomo- E. Akbariazar: None. I. Abdi Rad: None. A. pathological examination observed a male fetus with major Vahabi: None. inadequate intra-uterine growth, bilateral microtia, external genital hypoplasia and probable hypospadias, associated E-P11.071 withabnormaljointmorphologyandskeletalmalformations Genotypes and phenotypes in 6p25 deletion syndrome evoking a MGS. His twin brother was healthy. A panel of genes responsible for primary microcephaly I. Bader1, I. Reindl2, G. Sander1, G. Kronberger1, wasperformedandhighlighted2ORC6heterozygousVUS: A.Pleyers1,H.Mayr2,J.Koch2,J.Atzwanger2,C.Frenzel2, c.449+5G>A variant, previously described in patients with E. Haschke-Becher3, D. Kotzot1, W. Sperl2 Meier-Gorlin syndrome, and a new c.360-1G>T variant, never described before and that could also be responsible 1Unit for Clinical Genetics, Paracelsus Medical University forMeier-Gorlinsyndromeaccordingtosplicingprediction Salzburg, Salzburg, Austria, 2Department of Pediatrics; software. Study of alternative splicing conﬁrmed the ParacelsusMedicalUniversity,Salzburg,Austria,3Depart- pathogenicity of the two variants. ment of Medical and Chemical Laboratory Diagnostics, H. Thorn: None. S. Drunat: None. C. Fleury: None. E. Paracelsus Medical University Salzburg, Salzburg, Aus- Alanio:None.J.Bory:None.S.Bonneau:None.M.Doco- tria922 J.delPicchia Wereportthephenotypeandgenotypeoftwochildrenwith gene. We encountered a 3-year-old female patient with a microdeletion in 6p25: distinctive facial appearance (narrow bifrontal diameter, frontal bossing, telecanthus, epicanthal folds, prominent 1. A 4 years and 11 months old boy with a cMRI antihelices, prominent ears, uplifted earlobes, prominent showing large bifronto-temporal arachnoidal cysts nasal bridge), intellectual disability, delayed motor devel- and multifocal white-matter-lesions involving the opment, hypotonia and short stature. She was clinically periventricular, deep, and subcortical cerebral white diagnosed with MOWS. However, since direct sequencing matter. The phenotype of the boy included mild for ZEB2coding exons displayed nopathogenic variantsin developmental delay, strabism, slightly dysmorphic the patient, we performed whole exome analysis for trio in features and mild hearing impairment. the family. No pathogenic SNVs in ZEB2 but biallelic fra- Molecular karyotyping detected a ~ 3,9 Mb meshift variants (p.Thr282fs from mother and p.Ala503fs heterozygous microdeletion in 6p25.3 - 6p25.2 from father) in CNKSR1 were identiﬁed in the patient. deleting34genes,18ofwhichwereOMIMannotated There are two reports that a recognizable autosomal reces- including the transcription factor FOXC1. sive intellectual disability was caused by disruption of 2. A13yearoldgirlwithAxenfeld-Riegeranomalywho CNKSR1.Thep.Thr282fswasrecurrentandthep.Ala503fs developed glaucoma at the age of 12 years and had was novel. However, clinical manifestations of the patient surgery for ASD II in the ﬁrst year of life. The didnotmatchthephenotypesofCNKSR1mutations,which phenotype of the girl included typical dysmorphic were previously reported. In addition, a homozygous var- features. She performs extremely well at high school iantofp.Pro284HisfsTer74inCNKSR1wasregistered224/ (Gymnasium) and in sports. Molecular karyotyping 273,674 in the gnomAD. Thus, copy number analysis was detected a ~ 2,35 Mb heterozygous Deletion in performed using whole exome data. We found an 6p25.3-6p25.2 deleting 17 genes, 8 of which are approximately 360kb deletion around intron 7 of ZEB2 in annotated in OMIM, including FOXC1. thepatient,whichwasdenovo.Thedeletionwasconﬁrmed by the brakepoint analysis using PCR and direct Sanger- From our cases and from review of the literature we sequencing.Basedontheseﬁndings,weconcludedthatthe concludethatamicrodeletionin6p25shouldbeconsidered patient was clinically and genetically diagnosed with as the cause in patients with unclear multifocal cerebral MOWS caused by the novel deletion in ZEB2.<!--End- white matter abnormalities or Axenfeld-Rieger syndrome Fragment--> when additional dysmorphic features and congenital T.Kaname:None.K.Yanagi:None.M.Takeshita:None. anomalies are present, even when intellectual abilities are M. Omata: None. N. Kobayashi: None. Y. Abe: None. K. within the normal range (Vernon et al. 2013). Naritomi: None. Y. Matsubara: None. I. Bader: None. I. Reindl: None. G. Sander: None. G. Kronberger: None. A. Pleyers: None. H. Mayr: None. J. E-P11.075 Koch: None. J. Atzwanger: None. C. Frenzel: None. E. 7q11.23 duplication in a Mayer-Rokitansky-Kuster- Haschke-Becher: None. D. Kotzot: None. W. Sperl: None. Hauser syndrome patient E-P11.074 G. C. R. Cunha1, M. V. Zuben1, A. Lofrano-Porto1, A novel deletion in ZEB2 and biallelic frameshift M.Soares2,P.Moretti1,R.S.Bonadio1,S.F.DeOliveira1, variants in CNKSR1 identiﬁed in a patient dysmorpho- J. Mazzeu1, A. Pic-Taylor1 logically diagnosed with Mowat-Wilson syndrome 1University of Brasilia, Brasilia, Brazil, 2Hospital Uni- T. Kaname1, K. Yanagi1, M. Takeshita1, M. Omata1, versitario de Brasilia, Brasilia, Brazil N. Kobayashi1, Y. Abe1, K. Naritomi2, Y. Matsubara1 Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) is a 1National Center for Child Health and Development, rare congenital disorderaffecting approximately 1:4000- Tokyo,Japan,2OkinawaNanbuRehabilitationandMedical 5000 women. This condition is the second most common Center, Naha, Japan cause of primary amenorrhea and is characterized by absence or hypoplasic uterus, absence of the upper part of Mowat-Wilson syndrome (MOWS) is an autosomal domi- vagina and normal or hypoplasic fallopian tubes. A sex- nantdisordercharacterizedbydistinctivefacialappearance, limited (female) dominant autosomal inheritance with intellectual disability, delayed motor development, micro- incompletepenetranceandvariableexpressivenesshasbeen cephaly and short stature. It is known that most patients suggested. A range of gene and genomic alterations have with MOWS have heterozygous mutations in the ZEB2 been described and contributed to the identiﬁcation ofAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 923 possible causative genes. For example, mutations in WNT4 unknown clinical signiﬁcance (VUS, class 3 variant) in the and LHX1 and CNV regions, especially 1q21.1, 16p11.2, PUF60 gene (Poly-U-Binding Splicing Factor, OMIM 17q12, 22q11.21 and Xp22, were described in affected #604819)onchromosome8q24.3.Thevariantisamissense patients. Here we described a patient with MRKH pre- substitution and has never been described in literature senting a single CNV known to cause the 7q11.23 micro- before. Pathogenic variants in the PUF60 gene are docu- duplication syndrome. The 29 year old patient, born from mentedtocause theautosomal dominant Verheijsyndrome unrelated parents, present primary amenorrhea, absence of (OMIM #615583), disorder with a complex but highly uterus and a short vagina, characteristics of the MRKH variablesymptomatologywithonsetatbirthwhichincludes syndrome,butalsogradeIIhepaticsteatosis,dorsalconvex growth retardation, global developmental delay, eye sinus scoliosis, anterolateral marginal osteophytes, ocular abnormalities, renal agenesis. Considering the patient`s problems (myopia, astigmatism and strabismus), obesity phenotype and the clinical symptomatology of the syn- and facial dysmorphisms, features that ﬁt to 7q11.23 drome produced by pathogenic mutations in the PUF60 microduplicationsyndrome.TheCMA(CytoScanTM750k gene, the identiﬁed c.1640A>G variant may be reclassiﬁed platform, Thermo Fisher Scientiﬁc, Affymetrix) revealed a as a class 4 (Likely Pathogenic) mutation. Parental testing 1,404 Kb duplication of 7q11.23 including 24 genes, the fortheidentiﬁedmutationhasbeenrecommended,butalso same recurrent duplication described in the 7q11.23 dupli- genetic testing of the brother with polydactyly might pos- cationsyndrome.AsthepatienthasMRKHandsomeofthe sibly be adviced. features of 7q11.23 duplication syndrome, we propose that V. Radoi: None. L. Pop: None. L. Bohiltea: None. N. duplication of genes in this region might also be involved Suciu: None. R. Ursu: None. the etiology of MRKH in our patient G.C.R. Cunha: None. M.V. Zuben: None. A. Lofrano- E-P11.080 Porto: None. M. Soares: None. P. Moretti: None. R.S. A novel splice-variant in NONO in a boy with non- Bonadio: None. S.F. De Oliveira: None. J. Mazzeu: None. compaction cardiomyopathy and corpus callosum A. Pic-Taylor: None. aplasia E-P11.079 V. Strehlow1, T. Bartolomaeus1, F. Cavallo2, Variant of unknown clinical signiﬁcance in the Verheij M. Karnstedt1, S. Schubert1, M. Weidenbach2 syndrome gene (PUF60) in a 5 months old boy with multiple neonatal anomalies 1InstituteofHumanGenetics,UniversityofLeipzigMedical Center, Leipzig, Germany, 2Department of Pediatric V. Radoi1,2,3, L. Pop3, L. Bohiltea1, N. Suciu3, R. Ursu1,2,3 Cardiology, Heart Centre Leipzig, University of Leipzig, Leipzig, Germany 1”Carol Davila” University of Medicine and Pharmacy, Department of Medical Genetics, Bucharest, Romania, We describe a 6 month old boy with non-compaction car- 2Synevo Romania, Central Reference Laboratory, Depart- diomyopathy (NCC), multiple VSDs, Ebstein’s anomaly ment of Medical Genetics, Bucharest, Romania, 3National and aplasia of the corpus callosum. Prenatal examination Institute for Mother and Child Health "Alessandrescu- revealed a VSD and corpus callosum aplasia. The boy was Rusescu”, Bucharest, Romania born at 38 weeks of gestation with low birth weight (-1.64 SD) and normal length and head circumference. The new- Reclassifying variants of unknown signiﬁcance (VUS) born needed respiratory support postnatally but could be coming from NGS sequencing is in many cases extremely dischargedhomeattheageof2weeks.Hewasadmittedto challenging, needing a series of supporting criteria. We HeartCentreLeipzigattheageof2.5monthsduetofailure present the case of a 5 months old boy with a complex to thrive and congestive heart failure. Echocardiography neonatal symptomatology including generalized hypotonia, showed NCC of both ventricles, multiple ventricular septal global developmental delay, growth delay, hearing impair- defects and mild Ebstein’s anomaly resulting in severe tri- ment, eye abnormalities, renal agenesis, a.o. The family cuspid regurgitation. Pulmonary artery banding was per- history of the patient revealed a brother with polydactyly. formed at the age of 4 months. Postsurgical course was The clinical suspicion at referral was CHARGE syndrome, prolonged but ﬁnally the child could be transferred to a with recommendations for genetic testing. Whole Exome specializedrehabilitationhospitalattheageof5months.In Sequencing was performed on an Illumina platform. The thecourseoftimethechildshowedadevelopmentaldelay, results of the genetic analysis invalidated the CHARGE reduced spontaneous body movements and central hearing syndrome clinical suspicion, but revealed the presence of impairment. Exome sequencing revealed the hemizygous the heterozygous c.1604G>C / p.Arg535Pro variant of splice-variant c.651-1G>C, p.? in the NONO-gene. In the924 J.delPicchia segregation analysis, a carriership for the NONO-variant of management and to deﬁne follow-up examinations based theasymptomaticmothercouldbeproven.RNAanalysisof on the clinical spectrum of the HPS subtype. the NONO-gene revealed a splice effect on exon 7 and M.M. Golas: None. S. von Hardenberg: None. T. proved the pathogenic effect of the splice-variant. In sum- Ripperger:None.J.Lentes:None.B.Schlegelberger:None. mary, we report a case with a novel NONO variant (16 D. Steinemann: None. S. Morlot: None. B. Auber: None. variants reported so far) and extend the phenotypic spec- trum by NCC of both ventricles and corpus callosum E-P11.084 aplasia. Unusual clinical ﬁndings in a case with PACS2-related V. Strehlow: None. T. Bartolomaeus: None. F. Cavallo: syndrome None. M. Karnstedt: None. S. Schubert: None. M. Weidenbach: None. D. Avdjieva-Tzavella1, S. Atemin2,3, T. Todorov4, H.Kathom1,X.Cao5,S.Wadhwa6,Y.Lei5,V.Mitev3,R.H. E-P11.081 Finnell6,7, A. Todorova4,3 Expanding the clinical and genetic spectrum of the Hermansky Pudlak syndrome type 9 1Department of Clinical Genetics, University Pediatric Hospital, Medical University, Soﬁa, Bulgaria, 2Genetic M. M. Golas, S. von Hardenberg, T. Ripperger, J. Lentes, Medico-Diagnostic Laboratory “Genica", Soﬁa, Bulgaria, B. Schlegelberger, D. Steinemann, S. Morlot, B. Auber 3Department of Medical Chemistry and Biochemistry, Medical University, Soﬁa, Bulgaria, 4Genetic Medico- DepartmentofHumanGenetics,HannoverMedicalSchool, Diagnostic Laboratory “Genica”, Soﬁa, Bulgaria, 5Center Hannover, Germany for Precision Environmental Health, Department of Mole- cular and Cellular Biology, Baylor College of Medicine, Introduction:TheHermanskyPudlaksyndrome(HPS)isa Houston, TX, 77030,, TX, United States, 6Center for multisystemautosomal-recessivediseasethatresultsfroma Precision Environmental Health, Department of Molecular dysfunction of lysosome-related organelles. HPS manifests and Cellular Biology, Baylor College of Medicine, asoculocutaneousalbinism,bleedingdiathesisandvariable Houston, TX, 77030, TX, United States, 7Departments of additionalsymptoms.Basedonthecausativegene,tenHPS Molecular and Human Genetics and Medicine, Baylor subtypes have been described. HPS type 9 (HPS9) being College of Medicine, Houston, TX, United States caused by loss-of-function variants in BLOC1S6 is an exceedingly rare HPS subtype, and up to now, only three Introduction: Developmental and epileptic encephalo- patients have been reported to be affected by HPS9. pathies (DEE) are a heterogeneous clinical and genetic Materials and methods: A DNA sample of the index group of neurodevelopmental diseases. Recently, PACS2 patientwasanalyzedbywholeexomesequencingandarray gene mutations have been implicated in DEE with cere- comparative genomic hybridization (array-CGH). bellar dysgenesis and facial dysmorphism. Almost all Results: The 19-year-old female patient presented with described patients presented with a recurrent de novo mis- oculocutaneous albinism, a bleeding disorder, and suscept- sensemutation,c.625G>A(p.Glu209Lys).Theirphenotype ibility to infections; however, the patient was neither was characterized by early-onset epilepsy, cerebellar dys- affected by gastrointestinal nor pulmonary symptoms. On genesis, dysmorphic facial features, moderate to severe clinical examination, the patient presented with pale skin, developmental delay, and autism. We report the ﬁrst Bul- blond hair as well as fair eyebrows and eyelashes. garian case of this rare syndrome. Nystagmus and photophobia were noted. Genetic analyses CaseReport:Thepatient,a17-month-oldboy,wasreferred usingwholeexomesequencingidentiﬁedanovelsplice-site to geneticevaluationbecause ofthe developmentaldelayand variantofBLOC1S6,c.83-2A>Gp.?(ENST00000220531), neonatal convulsions started during the ﬁrst week of life. He in combination with a deletion of the second BLOC1S6 was born at term after complicated pregnancy. Birth weight allele, which was conﬁrmed as novel interstitial microdele- was 3920 g and length was 51 cm. Physical examination tion using array-CGH (arr[GRCh37] 15q21.1 showed facial dysmorphism including hypertelorism, down- (45821145_46319127)x1). Based on the genetic analyses, slanted palpebral ﬁssures, broad nasal root, broad ﬂat nasal the patient was diagnosed with HPS9 (MIM#614171). bridge, broad nasal tip, posteriorly rotated ears, downturned Conclusions: Our case suggests that immune deﬁciency cornersofthemouthandthinlips.Additionalfeaturesinclude maybeassociatedwithHPS9andthusexpandstheclinical micropenis,invertedwidelyspacednipples,onehypopigmen- spectrum of HPS9. Rigorous genetic testing, including ted skin spot, one café au lait spot, nevus ﬂammeus on the analyses for copy number alterations, is recommended for neck and coloboma of the iris. patients suspected for HPS to guide the clinicalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 925 Results: The molecular genetic analysis was performed defects, because through adequate iodine supplementation, by whole exome sequencing (WES) of trio. The data the development of goiter can be prevented or regress. interpretation revealed a pathogenic variant c.625G>A;p. P.M.Pachniak:None.M.Malarska:None.H.Moczulska: Glu209Lys in the PACS2 gene. The variant was conﬁrmed None.A.Lewandowska-Polak:None.J.Makowska:None. by Sanger sequencing. M. Borowiec: None. Conclusions:Ourstudy expandstheclinicalspectrumof PACS2 mutations. The coloboma of the iris is an unusual E-P11.087 feature and it is difﬁcult to determine whether it is Familial pericentric inversion of chromosome 3 predis- etiologically related to this newly recognized syndrome or posing to de novo interstitial microdeletion 3p14.3- represents a coincidental ﬁnding. p21.31 D. Avdjieva-Tzavella: None. S. Atemin: None. T. Todorov: None. H. Kathom: None. X. Cao: None. S. R.V.Vazharova1,I.Bradinova2,S.Andonova2,S.Bichev2, Wadhwa: None. Y. Lei: None. V. Mitev: None. R.H. A. Savov2 Finnell: None. A. Todorova: None. 1SoﬁaUniversitySt.KlimentOhridski,FacultyofMedicine, E-P11.086 DepartmentofBiology,MedicalgeneticsandMicrobiology, Pendredsyndromeina32-year-old woman- casereport Soﬁa, Bulgaria, 2Medical University Soﬁa, UHOG “Mai- chin dom”, National genetic laboratory, Soﬁa, Bulgaria P. M. Pachniak, M. Malarska, H. Moczulska, A. Lewandowska- Polak, J. Makowska, M. Borowiec Introduction: Pericentric chromosome inversions are rare (except the polymorphic inv(9)(p11;q12)) and are a known Medical University of Lodz, Lodz, Poland cause of reproductive failure or birth of individuals with chromosome imbalance. Here we report clinical and mole- Background: Pendred syndrome is an autosomal recessive cularﬁndingsofindividualsfromafamilywithapericentric inherited disease characterized by by congenital sensor- inversion of chromosome 3. ineural hearing loss, hypothyroidism and Hashimoto’s dis- Materialsandmethods:Thefamilywasrevealedaspart ease. There are signiﬁcant problems with maintaining of a study of CNVs in a cohort of patients with intellectual balance due to disturbances in the vestibular system of the disability and/or multiple congenital anomalies. According internal ear. to the study protocol genetic tests included karyotyping, Case: The patient is a32-year-old woman with rheuma- MLPAandarrayCGH.ArrayCGHanalysiswasperformed toid arthritis, rheumatoid factor, ANA and anti CCP using custom designed whole-genome oligonucleotide antibodiespresentinhightiters,HLA-B27negative.Patient arrays (OGT, UK) with a median probe spacing of about has Hashimoto’s disease, hyperinsulinemia with insulin 2.5 kb and median resolution of about 10 kb. CytoSure resistance, problems with balance and permanent ear Interpret(OGT,UK)softwarewasusedforCNVdetection. implants due to congenital hearing loss of unexplained Results: In the reported family several relatives in four cause. The 35delG heterozygote status was detected at the generations were found to carry an apparently balanced age of 18. Diagnostics was expanded adding exclusion of pericentric inversion of chromosome 3 - inv(3)(p21;q21). other deletions and insertions in the 12-72bp region of the Four inversion carriers presented complex clinical features 2nd exon of the GJB2 gene, with a particular indication of including mild/moderate intellectual disability, epilepsy, theexclusionofthe167Tdeletion,the314deletionandthe occult spina biﬁda and facial dismorphism. By arrayCGH 333 deletion. The 1555A> G mitochondrial mutation was the affected family members were found to carry a not found. The patient at the time was in good condition, heterozygous 4.35 Mb interstitial microdeletion with full verbal contact, actively working professionally. (arr3p21.31p14.3(50,963,804-55,318,121)x1) encompass- Due to presence of goiter, Hashimoto’s disease, hyperinsu- ing a total of 79 genes and disrupting the DOCK3 gene. linemia and vestibular dysfunction, periodic dizziness Conclusions: Unusual ﬁndings in this family are that no Pendred’s syndrome was clinically suspected. Genetic carrier reported reproductive problems like infertility or testing to conﬁrm the syndrome is ongoing. miscarriages, all affected family members share the same Conclusions:Thepedrinaproteinmutationsoccursinthe interstitial microdeletion which occurred as de novo event thyroid follicles, internal ear, kidneys, brain, liver, as well in progenies of four different inversion carriers. This work as in semen. The disease picture can be very diverse. One was supported by funding from the Bulgarian Ministry of should always remember to think about Pendred syndrome Education and Science / FNI, Grant: DTK02-51/2009. afterexcludingthemostcommongeneticcausesofhearing R.V. Vazharova: None. I. Bradinova: None. S. Ando- nova: None. S. Bichev: None. A. Savov: None.926 J.delPicchia E-P11.088 G. Van Winckel1, A. El Mouatani2, T. Attie-Bitach2, A Japanese girl with a novel variant of PIK3R1 showed K. Zaafrane-Khachnaoui3, A. Superti-Furga1, H. Fodstad1, deterioration of insulin resistance to biguanide F. Giuliano1 treatment 1Division of Genetic Medicine, Lausanne University Hospi- K.Yanagi1,S.Toguchi2,K.Satou1,M.Inoue2,K.Nritomi3, tal (CHUV), Lausanne, Switzerland, 2Division of Genetics, Y. Matsubara4, T. Kaname1 Necker Hospital for Sick Children, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France, 3Medical 1Genome Medicine, National Center for Child Health and Genetics Unit 2, L’Archet Hospital, Nice, France Development, Tokyo, Japan, 2Department of Pediatrics, Naha City Hospital, Okinawa, Japan, 3Okinawa Nanbu Heterozygous variants in GLI3 are involved in a clinical Habilitation and Medical Center, Okinawa, Japan, spectrum of polydactyly. Greig cephalopolysyndactyly and 4National Center for Child Health and Development, Pallister-Hallsyndromesarethetwomainsyndromicforms. Setagaya, Japan Several isolated forms of postaxial or preaxial polydactyly are also recognized. SHORT syndrome (MIM#269880) is deﬁned by its acro- We report three unrelated individuals, all from consan- nym; short stature, hyperextensibility of joints or inguinal guineous parents. An Afghan 10-year-old girl, presented hernia or both, ocular depression, Rieger anomaly, and bilateral postaxial polydactyly of the hands associated with teethingdelay.SincethenamewasgivenbyGorlin(1975), developmental delay and multiple malformations. NGS fewer than 50 cases have been reported in the literature. disclosedahomozygousvariant,c.668G>A(p.Ser223Asn), About 10 heterozygous pathogenic variants of the PIK3R1 in GLI3. A newborn boy of Tunisian origin presented with geneinpatientswithSHORTsyndromehavebeenreported an apparently isolated bilateral hand and feet postaxial to date. Here we report a Japanese girl with clinically and polysyndactyly. He was found to have a homozygous genetically diagnosed as SHORT syndrome. A patient is variantc.1673C>T(p.Ser558Leu)inGLI3.Finally,anadult 17-year-old girl born to non-consanguineous parents at malewasdiagnosedwithbilateralmesoaxialpolydactylyof 40weeksand6dayswithbirthweightof1,484g,heightof thehandsassociatedwithintellectualdisabilityandmultiple 37.5 cm and head circumstance of 34 cm. She had most of malformations. NGS disclosed an homozygous variant in the clinically typical features of SHORT syndrome. GLI3, c.565_567delinsTCT (p.Pro189Ser). Extensibility of joints were mild. Her face was triangular To the best of our knowledge, only GLI3 monoallelic with telecanthus, deep-set eyes, wide nasal bridge, down- variants have been implicated in “GLI3 morphopathies” so turned corners of the mouth and large ears. Speech delay far.Given(1)thesimilarityofthepolydactylyphenotypesin and hearing loss were also observed. Her bone age was ourpatientstothoseofclassicGLI3morphopathies,(2)the equivalent to her age. Partial lipodystrophy of the face and rarity of the variants observed, and (3) the absence of other upper limbs were recognizable. She had insulin-resistant pathogenic variants, we suggest that these homozygous diabetes whose blood glucose was difﬁcult to control by variants in GLI3 could be causative. Of note is that the biguanidetreatment.Anovelheterozygousmissensevariant parents of these children, who are heterozygous for these in the PIK3R1 gene (NM_181523) was identiﬁed in the GLI3 variants, are clinically unremarkable. This would patient by whole exome analysis. It was de novo. The indicate when monoallelic, these variants do not reach a variant was located in PI3K regulatory subunit P85 inter- pathogenic threshold necessary for clinical expression. SH2 domain. A recent report shows that biguanide worsen G. Van Winckel: None. A. El Mouatani: None. T. Attie- insulin resistance in SHORT syndrome with a PIK3R1 Bitach: None. K. Zaafrane-Khachnaoui: None. A. Superti- mutation. Her blood glucose became well controlled after Furga: None. H. Fodstad: None. F. Giuliano: None. changing medication of biguanide to mecarmin. K.Yanagi: None.S. Toguchi:None.K.Satou:None.M. E-P11.091 Inoue: None. K. Nritomi: None. Y. Matsubara: None. T. Prader-Willi syndrome caused by novel 3-7 exons Kaname: None. deletion of SNRPN gene E-P11.090 R. Traberg, I. Nasvytiene, M. Sukys, V. Asmoniene New polydactyly phenotypes apparently associated with homozygous GLI3 variants Lithuanian University of Health Sciences, Medical Acad- emy, Department of Genetics and Molecular Medicine, Kaunas, LithuaniaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 927 We report a 6 month old boy who was referred to clinical genome may be due to uniparental disomy or identity-by- genetics consultation because of global development delay descent and may be clinically relevant. The aim of this and failure to thrive. He was 4th child of non-consanguine studywastoreportthefrequencyofROH≥10Mbor>1%in Lithuanian couple. Older brother died due to sudden infant the autosomal genome of individuals with intellectual dis- death syndrome at 12 months of age. The pregnancy was ability (ID) and (or) multiple congenital anomalies (MCA), non complicated, full term and ﬁnished with caesarean and compare these data with a control group from the section duetoplacental abruption.Muscular hypotoniaand Brazilian population, including individuals from the feeding difﬁculties noticed soon after birth. Basic bio- BIPMed repository (www.bipmed.org). chemical blood tests, abdomen ultrasound scan, brain Materials and methods: Calls of homozygosity from ultrasound scan were normal. Neurologic examination 265patientsand289controlstestedwithCytoScan™750K, showednormaltendonreﬂexesbutmuscularhypotonia.On CytoScan™ HD or SNP 6.0™ arrays (Thermo Fisher physical examination (6 months old): height 67 cm (25‰), Scientiﬁc Inc., Life Technologies, Carlsbad, CA, USA) weight 6400 g (<3‰), head circumference 42 cm (10‰). were analyzed using the Chromosome Analysis Suite - The patient was dysmorphic: almond-shaped eyes, narrow ChAS (version 4.0.0.385 (r28959) - Affymetrix®) (hg19) bifrontal diameter, narrow nasal bridge and thin vermilion with ﬁlters set as a minimum of 500 markers and size of of the upper lip, small hands and feet, unilateral cryp- 1,500kb. For complementary investigation, to date, whole torchidism. We performed methylation speciﬁc multiplex exome sequencing (WES) was performed for 4 individuals ligation-dependent probe ampliﬁcation (MS-MLPA) with increased ROH in the genome. (SALSA MLPA Probemix ME028 Prader Willi/Angelman Results:SinglelargeROH≥10Mbweredetectedin1.9% kit, MRC Holland) of 15q11-q13 region. The analysis of patients compared to 0.3% in the control group. ROH showed 3-7 exons deletion of SNRPN gene with maternal >1% in the autosomal genome was detected in 7.2% of methylation proﬁle. Based on symptoms, clinical exam- patients compared to 1.4% in the control group. WES ination and molecular testing results the diagnosis of Pra- revealed three pathogenic homozygous variants (ASPM, der-Willi syndrome was conﬁrmed. The patient died at CTNS and DHCR7) in one patient with 5.56% of ROH. 8monthsofageduetoinfectioncomplicationsandthereis Conclusion: We found a higher proportion of ROHs in no further data about clinical course of that case. There are individuals with ID and (or) MCA. These results highlight onlyfewreportsaboutintragenicSNRPNgenevariantsthat the importance of investigating ROHs in this group of cause Prader-Willi syndrome. We present 3-7 exons dele- patientswhichwithcomplementarytests,suchasWES,can tion of SNRPN gene as novel, not reported in scientiﬁc improve diagnostic yield. Financial support: CNPq, literature, possible cause of Prader-Willi syndrome. FAPESP(#2018/08890-9), CAPES, FAEPEX-Unicamp. R.Traberg:None.I.Nasvytiene:None.M.Sukys:None. G.R. Correia-Costa: None. S. Spineli-Silva: None. I.C. V. Asmoniene: None. Sgardioli: None. A.P. dos-Santos: None. J.R. Marques- Prota: None. R. Secolin: None. N. Leijsten: None. M.H.A. E-P11.092 Ruiterkamp-Versteeg: None.N.deLeeuw: None.I.Lopes- Report and investigation of regions of homozygosity in Cendes: None. V.L. Gil-da-Silva-Lopes: None. T.P. the autosomal genome of Brazilian individuals with Vieira: None. intellectual disability and (or) multiple congenital anomalies previously investigated by chromosomal E-P11.093 microarray analysis A case with novel missense c.425T>C mutation in RIPK4 Gene: Bartsocas Papas Syndrome G. R. Correia-Costa1, S. Spineli-Silva1, I. C. Sgardioli1, A. P. dos-Santos1, J. R. Marques-Prota1, R. Secolin1, A. Yılmaz1, F. I. Karan2, U. Abur3, H. C. Aygün2 N.Leijsten2,M.H.A.Ruiterkamp-Versteeg2,N.deLeeuw2, I. Lopes-Cendes1, 1OndokuzMayısUniversityMedicalFaculty,Departmentof V. L. Gil-da-Silva-Lopes1, T. P. Vieira1 Pediatric Genetics, Samsun, Turkey, 2Ondokuz Mayıs University Medical Faculty, Department of Neonatology, 1Department of Medical Genetics and Genomic Medicine, Samsun, Turkey, 3Ondokuz Mayıs University Medical School of Medical Sciences, State University of Campinas, Faculty, Department of Medical Genetics, Samsun, Tur- Campinas, Brazil, 2Department of Human Genetics, key Radboud University Medical Center, Nijmegen, Nether- lands Backgound:BartsocasPapasSyndrome(BPS)isaformof lethal popliteal pterygium syndrome, caused by homo- Introduction: Regions of homozygosity (ROH) in the zygous mutation in the RIPK4 gene. Although BPS is928 J.delPicchia described lethal, review of the literature reveals individuals presence of a novel likely pathogenic variant, c.1784A>G, who survive into childhood with this condition. p.Tyr595Cys in exon 19. This variant is located in the Case presentation: The patient was born after induction catalyticandribosomaldomainoftheproteinwithahighly due to preeclampsia at 36 weeks gastation. The patient had conserved amino acid. The physico-chemical difference cleftlimb,smallnose,cloudycornea,poplitealandinguinal between Tyrosine and cysteine are very signiﬁcant. The pterygia, complet syndactyly of all ﬁngers and toes, absent variant was identiﬁed in all affected males and carrier of nails, pes equinovarus and ambigious genitale. Abdom- females all displaying clinical features of variable severity, inalandtransfontanelleultrasonographywasnormalandno consistent with CLS. It is noteworthy that most of the congenital heart malformation was detected on echocardio- affected or carrier individuals in the family developed dia- graphic examination. Percutaneous gastrostomy tube was betes type 2; further studies are required for a better deli- placed due to feding difﬁculty and tracheostomy was neation of the disorder and in order to investigate the performed for apropriate follow up. BPS was considered correlation between type 2 diabetes and CLS. with clinical ﬁndings. Next generation sequencing of T. Yammine: None. RIBK4 revealed a novel homozygous missense mutation in exon 2 (c.425T>C; p.Leu142Pro). E-P11.095 Conclusions: BPS is rare and lethal form of popliteal A novel PIK3R1 mutation in a Chinese female with pterygium sendrome, characterized by cutaneous webbing SHORT syndrome and literature review acrossoneormoremajorjoints,cleftlip/palate,syndactyly, genital hypoplasia, ankyloblepharon, and ectodermal Q. Zhang1, X. Wang1, L. Sun2, Q.Li1, Y. Tang1, Y. Wang1, defects, absent eyelashes and eyebrows, and brittle nails. X. Li1, N. Li3, J. Wang3 Our patient had a novel missense c.425T>C mutation in RIBK4 gene. This mutation is predicted as pathological by 1Department of Endocrinology and Metabolism, Shanghai insilico programs. Missense and nonsense mutationscause Children’s Medical Center, Shanghai Jiaotong University both the lethal and nonlethal recessive forms of multiple School of Medicine, Shanghai, China, 2Department of pterygiumsyndrome,characterizedbysevereorgananoma- Pediatric and Adolescent Gynecology, The Children’s lies of ectodermal origin. Although supportive treatments Hospital of Zhejiang University School of Medicine, can be done life span is short so detection of mutation in Hangzhou, China, Hangzhou, China, 3Department of lethal genetic diseases is very important for prenatal Medical Genetics and Molecular Diagnostic Laboratory, diagnosis and patient management in subsequent Shanghai Children’s Medical Center, Shanghai Jiao Tong pregnancies. University School of Medicine, Shanghai, China A.Yılmaz:None.F.I.Karan:None.U.Abur:None.H.C. Aygün: None. Introduction: SHORT syndrome is a rare genetic disease named with the acronyms of short stature, hyper-extensi- E-P11.094 bility of joints, ocular depression, Rieger anomaly and Novel missense mutation c.1784A>G, p.Tyr595Cys in teething delay. It is inherited in an autosomal dominant RPS6KA3 gene responsible for Cofﬁn Lowry Syndrome manner conﬁrmed by the identiﬁcation of heterozygous in a family with variable features and diabetes 2. mutations in PIK3R1. Only 43 cases have been conﬁrmed with gene sequencing in the worldwide. T. YAMMINE1,2 Materials and methods: Whole exome sequencing was performed on the patient and sanger sequencing conﬁrmed 1Medical Genetics Unit, Beirut, Lebanon, 2Saint Joseph the variant comparing to her parents. We made a literature University, Beirut, Lebanon review of all reported SHORT syndrome cases online before February 2020, trying to illustrate the genotype- CofﬁnLowrysyndrome(CLS)isanX-linkedraredisorder, phenotype correlations. characterized by cognitive impairment, craniofacial dys- Results: The patient was a 15-year-old female with morphism, digit abnormalities, skeletal malformations, intrauterine growth restriction, short stature, teething delay, paroxysmal movement disorders and cardiac abnormalities. characteristic facial gestalts, hirsutism and thyroid disease. The gene altered in this disease is RPS6KA3 (ribosomal Sequencing result indicated c.1960C>T, a novel de novo protein S6 kinase), located on Xp22.12. Previously identi- nonsense mutation, leading to the termination of protein ﬁedmutationsaredistributedthroughoutthe22exonsofthe translation (p. Gln654*). We also thoroughly reviewed and gene. A large Lebanese family with several affected mem- presented the clinical manifestations of SHORT syndrome bers, was referred to our Medical Genetics Unit for genetic in43patientsaccordingtothemutationsindifferentexons/ evaluation. Analysis of RPS6KA3gene revealed the introns and in different domains of PIK3R1.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 929 Conclusions: We reported the ﬁrst patient with SHORT genetic counseling and the risk of recurrence, also for syndrome in China, who was also the ﬁrst patient with establishing the optimal prenatal diagnosis methods thyroid disease. Features described in the acronym of depending on the mechanism of disease. SHORTsyndromearenotuniversallyseen.Thyroiddisease L.Caba:None.R.Popescu:None.N.Gorduza:None.M. may be a new clinical symptom of patient with SHORT Gramescu: None. M. Panzaru: None. M. Vicol: None. C. syndrome although it need more evidence to support. Rusu: None. E. Gorduza: None. Q. Zhang: None. X. Wang: None. L. Sun: None. Q. Li: None.Y.Tang:None.Y.Wang:None.X.Li:None.N.Li: E-P11.100 None. J. Wang: None. RBM10 (likely) pathogenic variants are associated with a broad phenotypic spectrum, beyond the classic TARP E-P11.096 syndrome features. The importance of moleculardiagnosisinSilverRussell syndrome for the management of an adult patient C. Kumps1, E. D’Haenens1, S. Vergult1, B. Menten1, J. Leus2, R. Van Coster3, A. Jansen4, K. Devriendt5, L. Caba1, R. Popescu1, N. Gorduza2, M. Gramescu1, A. Oostra6, O. Vanakker1 M. Panzaru1, M. Vicol3, C. Rusu1, E. Gorduza1 1Center for Medical Genetics, Ghent University Hospital, 1UniversityofMedicineandPharmacy“GrigoreT.Popa”, 9000 Ghent, Belgium, 2Medisch Centrum Maria Midde- Medical Genetics Department, Iasi, Romania, 2“St. Spir- lares, 9050 Gentbrugge, Belgium, 3Department of Pedia- idon”Hospital,EndocrinologyDepartment,Iasi,Romania, trics, Division of Pediatric Neurology and Metabolism, 3University of Medicine and Pharmacy "Grigore T. Popa", GhentUniversity,9000Ghent,Belgium,4PediatricNeurol- Bioethics Department, Iasi, Romania ogy Unit, Department of Pediatrics, UZ Brussel, 1090 Brussels, Belgium, 5Center for Medical Genetics, Katho- Introduction: Silver–Russell syndrome (SRS) is a rare lieke Universiteit Leuven, 3000 Leuven, Belgium, 6Depart- disease associated with prenatal and postnatal growth ment of Pediatrics, Division of Pediatric Neurology and retardation, characteristic craniofacial dysmorphic features Metabolism, University Hospital Ghent, 9000 Ghent, (relative macrocephaly, prominent forehead), body asym- Belgium metry and feeding difﬁculties (Netchine-Harbison Clinical Scoring System). SRS is characterized by genetic hetero- Introduction: TARP syndrome (Talipes equinovarus, geneitybecauseitcouldbedeterminedby:hypomethylation Atrial septal defect, Robin sequence and Persistent left of the imprinted control region 1 (ICR1) at 11p15.5, superior vena cava) is a rare X-linked disorder caused by maternal uniparental disomy of chromosome 7 (mUPD7), mutationsintheRBM10gene.Sofar,22patientshavebeen duplications, deletions or translocations involving the reported. We present two novel patients with likely patho- imprintedregionofchromosome7.Wepresentacase with genic RBM10 variants. molecularly conﬁrmed diagnosis of SRS at the age of Case reports: The ﬁrst male proband was born preterm 23 years. with average low birth parameters. Postnatally, a VSD, Materials and methods: The patient was clinically aspeciﬁc brain abnormalities and optical nerve hypoplasia diagnosed at 3 years of age with SRS based on delayed was noted. He displayed facial dysmorphism with tele- prenatal and postnatal growth, relative macrocephaly, canthus, upslanting palpebral ﬁssures, a large mouth with triangular face, prominent forehead, dental malposition, downturned mouth corners and retrognathia. There was a facial and limb asymmetry, bilateral ﬁnger V clinodactyly. growth and development delay. An RBM10 frameshift Thekaryotypewasnormal46,XX.Intime,bonechangesof variant (c.413_416del, p.Ser138Trpfs*60) was identiﬁed, osteoarthritis of the elbow joint, osteopenia, and hypothyr- which was inherited from a mosaic (13%) mother. The oidism were added. At age of 23 years, the patient was second male proband was born preterm with average birth molecularly tested by MLPA technique. We used SALSA measurements. After birth, limb contractures, a pectus MLPA kit ME030 BWS/RSS (MRC Holland, Amsterdam, carinatum, scoliosis and arachnodactyly were noted. Facial The Netherlands). The MLPA result conﬁrmed the features included frontal bossing, crumpled ears and hypomethylation of H19/IGF2 IG-DMR at 11p15.5. In this microretrognathia. A diagnosis of congenital contractural situation, the recurrence risks in sibs of the proband and in arachnodactyly (CCA) was made based on a FBN2 offspring of the proband are low. missense mutation. Upon follow-up, he displayed severe Conclusions: Although the Netchine-Harbison Clinical growth and developmental delay and brain abnormalities, Scoring System is a sensitive diagnostic scoring system, atypical for CCA. Further investigations revealed a molecular testing is especially important in adulthood for930 J.delPicchia maternallyinheritedc.1888+4A>Csplicesitevariantinthe exome sequencing revealed a de novo heterozygous RBM10 gene, that caused exon 15 skipping. missense variant c.734A>G; p.Tyr245Cys in Conclusion: Initially RBM10 mutations were described TBL1XR1 gene. inpatientswhofeaturedthefourcardinalfeaturesofTARP Conclusions: We report on a new case characterized by syndrome. However, recurrent clinical characteristics clinical phenotype of PS and de novo missense variant appear to include severe developmental delay, growth c.734A>G in TBL1XR1 gene. This variant has been prior deﬁciency, heart defects, central nervous system, vision, reported in patient given with developmental delay, short skeletal and facial abnormalities. These 2 additional cases ﬁngers and toes but who does not share distinctive facial illustratethehighlypleiotropicnatureofRBM10mutations, featuresofPS.Hitherto,onlytenpatientswithPShavebeen beyond the classic TARP syndrome features. published. So, our report provided additional clinical and C.Kumps:None.E.D’Haenens:None.S.Vergult:None. molecular data. B. Menten: None. J. Leus: None. R. Van Coster: None. A. A. Serrano Antón: None. M. Sánchez Soler: None. M. Jansen: None. K. Devriendt: None. A. Oostra: None. O. Ballesta Martínez: None. V. López González: None. L. Vanakker: None. RodríguezPeña:None.L.Rausell:None.M.GarcíaHoyos: None. E. Guillén Navarro: None. E-P11.101 TBL1XR1gene(#608628)¿Differentphenotypesrelated E-P11.103 to same variant? Multi-country teamwork to investigate an infant with 45,X/46,X der(Y)t(Y;14), whirl-pooledtype pigmentary A. Serrano Antón1,2, M. Sánchez Soler1,2, M. Ballesta mosaicism, and ambiguous genitalia Martínez1,2, V. López González1,2, L. Rodríguez Peña1,2, L. Rausell3, M. García Hoyos3, E. Guillén Navarro1,2 V.I.RomeroAguilar1,J.Pozo1,A.Llanos2,C.Hubner3,K. Hosomichi4, A. Tajima4 1Sección Genética Médica. Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain, 1Universidad San Francisco de Quito, Cumbaya, Ecuador, 2Grupo Clínico Vinculado al Centro de Investigación 2Department of Genetics, Hospital General de las Fuerzas Biomédica en Red de Enfermedades Raras (CIBERER), Armadas, Quito, Ecuador, 3Institut für humangenetik, Instituto de Salud Carlos III (ISCIII), Madrid, Spain, Universitätsklinikum Jena, Jena, Germany, 4Department 3Departamento de Genética Médica. Instituto de Medicina of Bioinformatics and Genomics, Kanazawa University, Genómica (IMEGEN), Valencia, Spain Kanazawa, Japan Introduction: Pierpont syndrome (PS) is a syndromic Introduction:AnewbornbabywasborninEcuadorfroma intellectual disability that comprises developmental delay, young non-consanguineous couple, with pigmentary shortstature,dysmorphicfeaturesanddistallimbanomalies mosaicism in whirl-pooled hyperpigmentation along the with deep palmar and plantar creases. Recurrent de novo body, ambiguous genitalia with no visible testicles and a missense variant (p.Tyr446Cys) in TBL1XR1 gene was positive screening for suprarenal hyperplasia. A karyotype identiﬁed as disease-causing. Recently, two patients with showedatrisomy14withanadditionalsectionontheextra Pierpont-like syndrome and different de novo missense chromosome. Trisomy 14 is one of the aneuploidies com- variants in TBL1XR1 have been reported. patible with live in a mosaic state and many cases of rear- Materials and methods: We describe the case of a 14- rangementswithchromosome14hadbeendescribedinthe year-old girl, born to healthy non-consanguineous parents. literature. The predominant phenotype of trisomy 14 Pregnancy and neonatal period were uneventful. Postnatal mosaicism includes prenatal and postnatal growth failure, growthwithheightateighthcentileandnormalweight.She ear abnormalities, congenital heart disease, developmental presented mild truncal hypotonia with psychomotor and delay and genitourinary abnormalities. Our patient only expressive language delay. She attends to special school shared some of phenotypic characteristics making addi- with major support and speech therapy. Clinical phenotype tional genetic tests compulsory. with narrow palpebral ﬁssures, depressed nasal bridge, Materials and methods: We performed a multi-country broadnose,longupperlipwithﬂatphiltrum,evertedlower teamwork investigation including karyotype in Ecuador, lipandprominentchin.Shortandbroadhandsandfeetwith FISH in Germany and WES in Japan deep-set grooves in his palms and soles. Results:KaryotypeandFISHresultsconcluded45,X/46, Results:BrainMRI,ophthalmologicalexamination,renal X der(Y)t(Y;14). WES identiﬁed no pathogenic nor likely ultrasound, metabolic analysis, Array-CGH, Fragile-X and pathogenic variants in the genes associated to suprarenal targeted exome sequencing yielded normal results. Whole hyperplasiaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 931 Conclusions:Ourcaseistheﬁrstreportofaninfantwith E-P11.107 a45,X/46,Xder(Y)t(Y;14). Thepigmentarymosaicism isa Possible effect of the imprinting on the Turner´s common feature on trisomy 14. The ambiguous genitalia phenotype were the result of the mosaicism which included Turner syndrome and an abnormal male cell-line. Finally, even P. Vrtel1, R. Vrtel1, K. Adamova1, D. Vrbicka1, though there was a positive test for suprarenal hyperplasia, M. Prochazka1, J. Stellmachova1, E. Klaskova2, WESanalysisreportedtherewerenodamagingvariantsand J. Zapletalova2, J. Pavlicek3, V. Hana4, V. Stara5, steroids were suspended. O. Soucek5, J. Lebl5 V.I. Romero Aguilar: None. J. Pozo: None. A. Llanos: None. C. Hubner: None. K. Hosomichi: None. A. 1Department of Medical Genetics, University Hospital and Tajima: None. Palacky University, Olomouc, Czech Republic, 2Clinic of Paediatrics, University Hospital and Palacky University, E-P11.104 Olomouc, Czech Republic, 3Clinic of Paediatrics, Univer- Partial trisomy 1q42.11-q44 clinical and molecular sityHospital,Ostrava,CzechRepublic,43rdDepartmentof cytogenetic characterization. Case presentation Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and E. Braha1, F. Nedelea2, I. Nedelcu1, O. Popa1 General University Hospital, Prague, Czech Republic, 5Department of Pediatrics 2nd Faculty of Medicine, 1National Institute of Endocrinology "CI Parhon", Bucur- Charles UniversityandUniversity HospitalMotol,Prague, esti, Romania, 2Clinical Hospital Filantropia, Bucuresti, Czech Republic Romania Monosomy of chromosome X - Turner syndrome (TS) is Partial 1q trisomy syndrome is an extremely rare chromo- the only monosomy postnatally compatible with life. The somalabnormality,withonlyafewcasesreported.Frequent incidence of this chromosomal abnormality is 1:2500 live features were short stature, multiple minor anomalies, female births. Their phenotype can be very variable. congenital heart defects especially for terminal duplication, Common is low stature, congenital heart defects, renal learning difﬁculty, speech and developmental delay. Our abnormalities etc. Some of these defects correlate with goal is to contribute to clinical observation of 1q terminal karyotype - karyotype 45,X is the most severe. duplication. We report a male infant (4 months old) with Other hypothesis is focused on parental origin of negative family history. Clinical features include intrauter- chromosomeX.Speciﬁcdefectscancorrelatewithpaternal ine growth retardation with short stature at the time of ormaternaloriginofgonosome.Weusedmoleculargenetic clinical evaluation (-2.04 SD), mild facial dysmorphia analysis for detection microsatellite DNA markers on (microretrognathia, thick eyebrows, hypertelorism, short chromosome X to reveal the origin of these gonosome in nose, long smooth philtrum, thin upper lip vermillion, ten- TS patients. tedupper lip,dysplasticearswithsmalltriangularearlobe), We selected cohort of 50 TS patients (plus their parents) atrial septal defect ostium secundum, patent ductus arter- with 45,X karyotype conﬁrmed by karyotype and native iosus, partial 2-3 toe cutaneous syndactyly, little develop- FISH. We also tested patients with 46,XX karyotype (but mental progress (without head control at 4 months). G- Turner phenotype), for hypothesis of maternal X chromo- banded karyotype did not reveal any chromosomal some homology. abnormalities. The breakpoints were characterised by array DNA was isolated from peripheral blood of the patients CGH using the oligoarray platform CytoScan 750K Array, and the cells of the buccal mucosa of the parents. We used Gene Scan 3000 (Affymetrix). Our patient has a partial the Argus X-12QS forensic kit for the X-chromosome duplication of chromosome 1 between 1q42.11-q44 of analysis, which was optimized for our genetic testing. The 24.72 Mb in lenght (nucleotides 224,499,474 - method is based on detection of 12 STR markers from 249,224,684) according to NCBI 37/hg19. The parents chromosome X. karyotype was normal and FISH tests (for breakpoint) is to Results suggest that 70 % of X chromosomes are of beperformed.Inconclusionwereporta4months-oldmale maternal origin and 30 % cases of paternal origin. The with the distinctive clinical features and probably de novo origin of X chromosome in 46,XX cohort was biparental. 1q42.11q44 duplication without parental chromosomal The next part of our project will be a correlation speciﬁc abnormalities. The case requiers long-term medical follow- heart defects and renal abnormalities with the origin of up for other clinical particulaties highlighted with aging. gonosome. Supported by MH CZ - DRO (FNOl, E. Braha: None. F. Nedelea: None. I. Nedelcu: None. O. 00098892) and grant nr. 17-29111A Popa: None.932 J.delPicchia P. Vrtel: None. R. Vrtel: None. K. Adamova: None. D. presence of a residual mosaic trisomy 16 was excluded by Vrbicka: None. M. Prochazka: None. J. Stellmachova: karyotype analysis and FISH. None.E.Klaskova:None.J.Zapletalova:None.J.Pavlicek: Conclusions:Thisisanadditionalcaseofthephenotypic None.V.Hana:None.V.Stara:None.O.Soucek:None.J. characterization of UPD(16)mat. To date, it isthe ﬁrst time Lebl: None. that an unroofed coronary sinus is described within cardiac malformations associated with UPD(16)mat. Moreover, E-P11.110 according to literature data, it conﬁrms the need to extend Uniparental disomy of chromosome 16: a case report follow-up. with a new cardiac malformation F. Di Palma: None. M. Goldoni: None. E. Marchionni: None. B. Caravale: None. M. Mondovì: None. G. F. Di Palma1, M. Goldoni2, E. Marchionni1, B. Caravale3, Mastromoro: None. D. Guadagnolo: None. P. Versacci: M. Mondovì3, G. Mastromoro1, D. Guadagnolo1, None. V. D’Ambrosio: None. A. Giancotti: None. L. P.Versacci4,V.D’Ambrosio5,A.Giancotti5,L.Bernardini6, Bernardini: None. A. Pizzuti: None. A. Pizzuti1 E-P11.111 1Department of Experimental Medicine, Sapienza Univer- ClinicalanalysisVACTERL/VACTERcasesatchildren sity, Rome, Italy, 2Medical Genetics Unit, Casa Sollievo hospital in Bogotá, Colombia della Sofferenza IRCCS Foundation, San Giovanni Rotondo, Italy, 3Department of Developmental and Social J. S. Rincon Redondo1, I. Rueda1, Y. Ladino2,3, Psychology,SapienzaUniversity,Rome,Italy,4Department M. C. Cuellar1, L. A. Gonzalez1, C. M. Restrepo4, of Pediatrics, Sapienza University, Rome, Italy, 5Depart- O. I. Beltran1,2 ment of Maternal and Child Health and Urologic Science, Sapienza University, Rome, Italy, 6Medical Genetics Unit, 1Facultad de Medicina, Universidad Militar Nueva Gran- Casa Sollievo della Sofferenza IRCCS Foundation, San ada, Bogotá DC, Colombia, 2Grupo GenHOMI, Hospital Giovanni Rotondo, San Giovanni Rotondo, Italy Pediátrico de la Misericordia, Bogotá DC, Colombia, 3Maestría en Genética Humana, Universidad Nacional de Introduction:Maternaluniparentaldisomyofchromosome Colombia, Bogotá DC, Colombia, 4Unidad de Genética y 16[UPD(16)mat]isthemostoftenreportedUPDotherthan Genómica,CIGGUR,EscueladeMedicinayCienciasdela UPD(15). In literature there is not a speciﬁc phenotype Salud, Universidad del Rosario, Bogotá DC, Colombia associated with upd(16)mat and few follow-up data are reported. Introduction: The VACTER-L/VATER association has Materials and methods: We present the case of a 1-y.o. been divided on three subtypes to improve clinical classi- male of a healthy non-consanguineous parents. In prenatal ﬁcation and epidemiologic analysis. It is an acronym that diagnosis IUGR, polydramnios and single umbilical artery corresponds to a group of diverse and complex malforma- was reported. He born late preterm, small for gestational tions that was initially described as the non-random age, and showed facial dysmorphisms and congenital occurrence of ﬁve anomalies together. malformations (esophageal atresia, cardiac defects, mild Methods: Descriptive study of case series of children bone alterations, hypospadias). Transesophageal echocar- with VACTER-L/VACTER diagnosis (using the criteria diography detected persistency of left superior vena cava and classiﬁcation of the EUROCAT) at Hospital Pediátrico draining into the left atrium through an unroofed coronary de la Misericordia (April 2009-December 2016) approved sinus. Brain ultrasound showed dilated and asymmetric by institutional ethical committee. Statistical analysis done lateral ventricles. At present, cognitive and language SPSS program. abilities are adequate for age but he has mild gross motor Results: Preliminary selection of 13 patients, one was delay. Genomic DNA was extracted from peripheral blood excluded. The male: female ratio was 1,4, age range and analyzed by SNP-array (Cytoscan HD; Thermo Fisher (3 months - 9 years old), 1 case had family history of ﬁrst- Scientiﬁc). degreeconsanguinity,1casehadseconddegreeconsangui- Results: SNP-array analysis showed a 147 Kb homo- nity,andotherhadboth.FourpatientshadVACTER-LIKE, zygous 16p13.3 microdeletion and a 114 kb 16q24.3 three patients presented VACTER-STRICT, and ﬁve microtriplication, both segregated from the mother. Region showed VACTER-PLUS diagnosis. Phenotypes were: VC, of Homozigosity (ROH) analysis showed two ROH of 7 ATE, VR, VAT, VTL, ACR, VCR, VAC, VACR (X2), and 13 Mb on chromosome 16 compatible with the VCTRL, and VACRL. Additional anomalies in patients presence of UPD(16) of maternal origin. The possible withVACTER-PLUSincluded:microtia,hemifacialmicro- somia, myelomeningocele, structural SNC malformation,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 933 these four had more than one anomaly. Eight patients had of the proband (Lennox et al., bioRxiv, 2018). F2: two cytogenetic analysis (all normal) and only one case had siblings were suspected to have Ochoa Syndrome (AR), normal sequencing exome. characterized by congenital urinary bladder dysfunction. In Conclusions: VACTERL/VACTER association has a both sibs, the analysis revealed the novel homozygous typical wide clinical variability, which was evident in our splicing variant c.1478-2A>G in the LRIG2 gene (OMIM series. Consanguinity was a relevant factor, as forth part of #608869), associated with Ochoa Syndrome. This variant the patients had it. VACTERL/VACTER has been probablyaltersthepropersplicingmechanism,leadingtoan extensively characterized by the 6 deﬁned anomalies; aberrant mRNA maturation and unfunctional protein nevertheless, diagnosis is not simple in VACTER-PLUS (ongoing experiments). Our report expands the genotypic phenotype,asthesecasesmightpresentwithco-occurrence spectrumofthepathogeneticvariantsofDDX3XandLRIG2 of multiple pathologies, atypical presentation of relatively disease-genes. In these cases, WES approach allowed us to common diseases or misdiagnosis. get closer to the end of these diagnostic odysseys. J.S. Rincon Redondo: None. I. Rueda: None. Y. Ladino: G. Moresco: None. O. Rondinone: None. A. Mauri: None. M.C. Cuellar: None. L.A. Gonzalez: None. C.M. None.C. Santaniello:None.J.Costanza:None.B.Rinaldi: Restrepo: None. O.I. Beltran: None. None. E. Rosina: None. P. Colapietro: None. S. Tabano: None. L. Fontana: None. D. Milani: None. M. E-P11.113 Miozzo: None. Whole Exome Sequencing in unsolved pediatric cases E-P11.115 G.Moresco1,O.Rondinone1,A.Mauri1,C.Santaniello1,J. A novel de novo frameshift mutation in SMC1A gene Costanza1, B. Rinaldi2, E. Rosina2, P. Colapietro3, responsible for Cornelia de Lange syndrome 2 S. Tabano3,4, L. Fontana1, D. Milani2, M. Miozzo1,3 R. Szalai1,2, J. Bene1,2, L. Magyari1,2, A. Maasz1,2, 1Coordination Research Laboratories Unit, Fondazione A. Düh1,2, A. Till1,2, K. Hadzsiev1,2, B. Melegh1,2 IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milano, Italy, 2Highly Intensive Pediatric Care Unit, 1University of Pecs, Clinical Center, Department of Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Medical Genetics, Pecs, Hungary, 2Szentagothai Research Policlinico, Milano, Italy, 3Department of Pathophysiology Center, University of Pecs, Pecs, Hungary and Transplantation, Università degli Studi di Milano, Milano, Italy, 4Laboratory of Medical Genetics, Fonda- Introduction: Cornelia de Lange syndrome (CdLS) is a zione IRCCS Ca Granda Ospedale Maggiore Policlinico, clinically heterogeneous developmental disorder character- Milano, Italy ized by malformations affecting multiple systems. CdLS have been reported in children with mutations of NIPBL, Children suffering from undiagnosed diseases with a pos- SMC1A, SMC3A, RAD21, and HDAC8 genes. Although, sible genetic origin underwent Whole-Exome Sequencing the appearance of classic CdLS is well-characterised, the (WES) to disclose the causative variant. We evaluated phenotypic traits of individuals with various SMC1A twenty-two cases resulted negative to aCGH and kar- mutations have some similarities, but have other features yotyping and found the causative lesion in four of them. that make them different from classic CdLS (e.g., small Herein, we describe two paradigmatic solved cases: one hands but no limb reductions or oligodactyly, prominent withoutanydeﬁniteclinicalsuspicion(F1),andtheotherin intellectual disability and seizures despite milder structural which the diagnosis was suggested (F2). Libraries were malformations, and a high rate of isolated cleft palate). prepared using the SureSelectQXTClinical Research Exome Materials and methods: We present a patient with V2 kit (Agilent) on blood samples collected from patients CdLS2features,includingprogressivemicrocephaly,severe and family members, and were run on NextSeq550 instru- psychomotor retardation, feeding difﬁculties, therapy resis- ment (Illumina). F1: the female proband presents delayed tant epilepsy, lack of expressive speech, nearsightedness, psychomotor development, polymicrogyria, gastro- high arched palate and abnormal palmar creases. Whole esophageal reﬂux and facial dysmorphisms. The analysis Exome Sequencing (WES) analysis was performed using identiﬁed the novel de novo missense variant c.C625G:p. Agilent SureSelectXT library kit and Illumina sequencing H209D in the DDX3X gene, an ATP-dependent RNA technology. Sanger sequencing conﬁrmed the presence of helicase involved in neurogenesis. Mutations in DDX3X the pathogenic variant. were described as causative of X-Linked Dominant Mental Results: WES analysis identiﬁed a c.3237_3238insT (p. Retardation (OMIM #300958) and variants mapping in the Asn1080*) pathogenic variant in SMC1A gene in a samedomainareassociatedtothespeciﬁcphenotypictraits heterozygous state. This alteration is a frameshift variant934 J.delPicchia with a resulting stop codon leading to nonsense-mediated (exones 18, 19, 20, 21) and PIK3CA (A3140T, A3140G, mRNAdecayandlossoffunction,hasneverbeenreported. C3139T)SensiScreen®aswellasSNaPshotmultiplexassay Conclusions: The features of Cornelia de Lange for activating FGFR3 mutations and MLPA for CDKN2A syndrome vary widely, there are 5 distinct subgroups CNVs were performed. (CdLS1-5) according to the phenotype and affected genes. Resultsanddiscussion:FortheEGFRandPIK3CAonly HerewereportapathogenicframeshiftSMC1Amutationin wild type of the tested genetic variants were detected. a Hungarian patient with ﬁtting but unique phenotype Mutations in FGFR3 were found in 50 % from the tested characteristics of Cornelia de Lange syndrome 2, still tumors: 65% - S249C, 30% Y375C and 5% G372C. representing a novel phenotypic variant, as well. Mutations in CDKN2A were detected in 37,5 % from the R. Szalai: None. J. Bene: None. L. Magyari: None. A. tested tumors: 53,3% - homozygous deletions, 40% Maasz: None. A. Düh: None. A. Till: None. K. Hadzsiev: heterozygous deletions and 6,7% duplications. None. B. Melegh: None. Conclusion: The overexpression of the EGFR and PIK3CA was not found to be related to tested mutations E-P12 Cancer Genetics and so far these two molecules are not convenient for bladder cancer targeted therapy. On the other hand the E-P12.07 overexpression of FGFR3 and CDKN2A could be due to Genotyping of urinary bladder carcinomas for up- detected mutations. regulated EGFR, PIK3CA, FGFR3 and CDKN2A to Acknowledgements:BGNSFGrantsNoKP-06-OPR01/ determine the potential for targeted therapy 3-2018, MANU-BAN. O.S. Antonova: None. S. Rangelov: None. B. Mladenov: O. S. Antonova1, S. Rangelov2, B. Mladenov3, None. Z. Hammoudeh: None. D. Nesheva: None. O. Z. Hammoudeh1, D. Nesheva1, O. Ivanovski4, S. Saidi4, Ivanovski: None. S. Saidi: None. G. Petrusevska: None. G. Petrusevska5, C. Slavov6, A. Dimovski7, Z. Yordanova8, C.Slavov:None.A.Dimovski:None.Z.Yordanova:None. D. Plaseska-Karanﬁlska7, Z. Popov4, A. Galabov9, D. Plaseska-Karanﬁlska: None. Z. Popov: None. A. D. Toncheva1 Galabov: None. D. Toncheva: None. 1Department of Medical Genetics, Medical University of E-P12.08 Soﬁa, Soﬁa, Bulgaria, 2Department of Urology, University Germline variants in cancer-associated genes in pedia- Hospital ISUL-Tsaritsa Yoanna, Soﬁa, Bulgaria, 3Depart- tric and young adult patients with brain tumors ment of Urology, UMBALSM “N. I. Pirogov”, Soﬁa, Bulgaria, 4University Clinic of Urology University of St. T. S. Lisitsa1,2, V. V. Semenova1, A. A. Mitrofanov3, Cyrilius and Methodius, Skopje, Macedonia, The Former E. V. Zhukovskaya1, A. F. Karelin1, V. N. Kasatkin1, Yugoslav Republic of, 5Institute of pathology, Medical T. V. Nasedkina1,2 faculty,Skopje,Macedonia,TheFormerYugoslavRepublic of, 6Department of Urology, University Hospital ISUL- 1Dmitry Rogachev National Medical Research Center Of Tsaritsa Yoannaf Soﬁa, Soﬁa, Bulgaria, 7Research Center Pediatric Hematology-Oncology and Immunology, Mos- for Genetic Engineering and Biotechnology “Georgi D. cow, Russian Federation, 2Engelhardt Institute of Molecu- Efremov”, Macedonian Academy of Sciences and Arts, lar Biology, Russian Academy of Sciences, Moscow, Skopje, Macedonia, The Former Yugoslav Republic of, Russian Federation, 3N.N. Blokhin National Medical 8University of National and World Economy, Soﬁa, Research Center of Oncology, Moscow, Russian Federa- Bulgaria, 9The Stephan Angeloff Institute of Microbiology, tion Bulgarian Academy of Sciences, Soﬁa, Bulgaria Introduction: Pediatric and young adult brain tumors are Background:The aim of our study was to identify muta- oftenassociatedwithcancerpredispositionsyndromes.The tional status of the uroepithelial bladder cancer samples for knowledgeofspeciﬁcmutationsincancer-associatedgenes previously detected by us overexpression of EGFR, may alter the management of the cancer, offer novel tar- PIK3CA,FGFR3andCDKN2Agenesinordertodetermine geted therapies and enable early detection of other the potential for targeted therapy. malignancies. Materials & Methods: Tumour samples from 66 Patients and Мethods: Twenty-four patients with brain patients, staged pTa - T4 were collected. The epidemiolo- tumorsaged5-22yearswereenrolledinthestudy,15boys gicaldatarelatedtoage,gender,recurrence,smokinghabits and9girls.Astrocytomawasthemostcommonhistological and occupational exposure were taken from patients’ type (n=10), followed by medulloblastoma (n=6), low- questionarie. RT-PCR for mutation detection in EGFR grade glioma (n=3), ependymoma (n=2),Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 935 craniopharyngioma (n=1), ganglioglioma (n=1), pine- gene mutations. The most common pathogenic mutations oblastoma (n=1). Genomic DNA was isolated from were c.5266dupC, c.3624dupA and c.5444G>A in BRCA1 peripheralbloodleukocytesandnext-generationsequencing and c.67+1G>A in BRCA2. Sixty-one variants with on the NextSeq500 Illumina platform was performed. A unknown signiﬁcance(VUS),mostlymissensevariants,were multigene panel included coding sequences of 132 cancer- identiﬁed and the vast majority of them were in BRCA2 associated genes. The library was prepared using enrich- gene. In MLPA analyses seven gross deletions in BRCA1 mentbyhybridizationwithNimbleGenprobes(Roche).For were detected. The most common gross deletion in BRCA1 theanalysis ofNF1 large rearrangements MLPA assay was gene was exon 18-19 deletion. No gross deletion was performed. detected in BRCA2 gene. Four novel mutations in BRCA1 Results: In total, six patients carried NF1 mutations: andﬁvenovelmutationsinBRCA2 genewereidentiﬁed.In frameshift deletions (n=3), nonsynonymous missence two of 5 patients with both breast and ovarian cancer, (n=2) or nonsense (n=1) mutations. Patients with NF1 BRCA1 pathogenic mutation was detected and this was the mutations had optic pathway glioma (n=3), pylocytic highest mutation rate group. Among ten postmenopausal astrocytoma (n=2) and brain stem tumor (n=1). sporadic breast cancer patients, one had BRCA1 pathogenic Three patients also had clinical features of neuroﬁbroma- mutation. This rate was higher than premenopausal breast tosis type 1, but no NF1 variants were revealed. Other cancer patients’ rate with family history. This study deter- ﬁndings included likely pathogenic variants in APC and minesthevariantsofBRCAgenes,theirfrequenciesandtheir CHEK2 genes. The results were validated by Sanger clinicalsigniﬁcanceinTurkishpopulation.Also,theseresults sequencing. showed that screening indications for BRCA should be Conclusion: Germline variants associated with cancer reviewed. were found in one-third of our patients, one-fourth had the E.A.Ateş:None.C.Alavanda: None.H.Polat: None.A. mutations in NF1 gene. Thus, molecular analysis is Turkyilmaz: None. M.A. Soylemez: None. B.B. Geckinli: important to reveal NF1-associated brain tumors for None. A.I. Guney: None. accuratediagnosisofthediseaseandpersonalizedapproach to treatment including targeted therapies. E-P12.11 T.S. Lisitsa: None. V.V. Semenova: None. A.A. Mitro- The potential of Dendrosomal curcumin (DNC) as a fanov:None.E.V.Zhukovskaya:None.A.F.Karelin:None. therapeutic agent for modulating the expression of p53 V.N. Kasatkin: None. T.V. Nasedkina: None. in both wild type and mutant type cancer cells E-P12.09 m. montazeri1, Y. Pilehvar Soltanahmadi2, N. Zarghami3, Characterization of BRCA Genes’ Variants in Turkish M. Sadeghizadeh4 HereditaryBreastandOvarianCancer(HBOC)Patients 1Department of Medical Biotechnology, Faculty of E.A.Ateş1,C.Alavanda2,H.Polat2,A.Turkyilmaz3,M.A. Advanced Science and Technology, Tehran Medical Soylemez2, B. B. Geckinli2, A. I. Guney2 Sciences, Islamic Azad University, Tehran, Iran, Tehran, Iran, Islamic Republic of, 2Cellular and Molecular 1Marmara University Pendik and Research Hospital, Research Center, Research Institute for Cellular and MedicalGenetics Department, Istanbul, Turkey, 2Marmara MolecularMedicine,UrmiaUniversityofMedicalSciences, University School of Medicine, Medical Genetics Depart- Urmia,Iran,Urmia,Iran,IslamicRepublicof,3Department ment, Istanbul, Turkey, 3Erzurum Region Training and of Medical Biotechnology, Faculty of Advanced Medical Research Hospital, Medical Genetics Department, Sciences, Tabriz University of Medical Sciences, Tabriz, Erzurum, Turkey Iran, Tabriz, Iran, Islamic Republic of, 4Department of Genetics, School of Biological Sciences, Tarbiat Modares Breast cancer is the most common cancer among women. University, Tehran, Iran, Tehran, Iran, Islamic Republic BRCA genes are associated with %10-15 of all breast can- of cers.Sixhundred-fourpatientswhich169ofthemhadfamily history and 435 had breast and/or ovarian cancer, applied to The effect of Dendrosomal curcumin (DNC) on the our clinic. After anamnesis, pedigree analyses and physical expression of p53 in both p53 mutant cell lines SKBR3 examinations, BRCA genes were sequenced via Next-Gen- andp53wild-typeMCF7inboth RNAandproteinlevels, eration Sequencing(NGS) for all patients. Except from 67 and also cell cycle distribution and apoptosis. Curcumin patients with pathogenic mutations in BRCA genes, MLPA derived from rhizome of Curcumin longa modulates key analysiswasplannedforallpatients.Amongpatientsthathad signaling pathways in cellular processes, therefore, it is pathogenic mutation, 36 had BRCA1 and 31 had BRCA2 recentlyconsideredincancerrelatedresearchesforitscell936 J.delPicchia growth inhibition properties against human tumors. It is percentofaffectedindividualswereER/PR[1]positive,and evidenced that p53 is the most common tumor-suppressor theother30%ER/PRnegative. Quantitativeanalysisofthe gene involved in human cancers. Its mutation not only EAF1 & EAF2 gene expression in two sample groups inhibits tumor suppressor activity but also promotes (tumor&normal)wasperformedbyReal-time-PCR(cyber- oncogenic activity. Toxicity of DNC was studied using green method). The expression of the EAF1 & the EAF2 MTT assay and cell cycle distribution, apoptosis study. genes was in tumor tissue compared to normal samples Real-time PCR and Western blot analysis were used to signiﬁcantly decreased (fold change= -5.7 for the EAF1 analyze the expression of p53, and other apoptosis related gene [p=0.000] & -4.4 for the EAF2 gene [0.034]). Lower proteins. DNC treatment during the time increased the expression of the both mentioned genes is apparently cells in the SubG1 and gradually decreases them in the associated with negative prognosis of breast cancer. G1, S and G2/M phases, the percentages of early [1] ER: estrogen receptor & PR: progesterone receptor apoptosis also indicated the inhibition of cell growth S. Heydaran: None. M. Moghanibashi Mansurieh: None. in early phase. Real-Time PCR showed an increased S. Naeemi: None. mRNA expression of BAX, Noxa and p21 during the time with decreased expression of Bcl-2. The expression E-P12.15 of p53 mutant decreased in SKBR3, and the expression Age depending prevalence of RUNX3, BRCA1 genes of p53 wild-type increased in MCF7 cells. Consequently, comethylation among female breast cancer case DNC can drive the tumor cell lines toward the apoptosis by modulating the expression of genes involved in N. Medvedieva1, O. Lobanova2, Z. Rossokha1, apoptosis and proliferation, furthermore, this study sug- V. Vershyhora1, V. Cheshuk2, R. Vereshchako2, gest p53 plays an important role in mediating the survival N. Gorovenko3 by DNC. M.montazeri:None.Y.PilehvarSoltanahmadi:None.N. 1SI Reference Centere For Molecular Diagnostic of Public Zarghami: None. M. Sadeghizadeh: None. Health Ministry of Ukraine, Kyiv, Ukraine, 2Bogomolets National Medical University, Kyiv, Ukraine, 3P.L. Shupyk E-P12.13 National Academy of Postgraduate Education, Kyiv, The expression level of the EAF1 & the EAF2 genes is Ukraine signiﬁcantlydecreasedinIranianbreastcancerpatients Introduction: Genes comethylation is important pathways S. Heydaran, M. Moghanibashi Mansurieh, S. Naeemi of epigenetic mechanisms in the risk of breast cancer development. Hypermethylation of RUNX3 and BRCA1 department of Genetics, Islamic Azad university, Kazerun, genes is involved in disrupted oncosuppression process Iran, Islamic Republic of among breast cancer cases. But no so much known about their co-inﬂuences on breast cancer (BC) risk in different Breast cancer death rate is increasing annually in Iran, and age. Aim of the study was to evaluate RUNX3, BRCA1 early diagnosis is important to reduce the mortality rate. genes age depending comethylation status. Besidegeneticpredisposition,environmentalfactorsarethe Materials and methods: Tumor tissue of 52 BC female most known risk factors. The EAF1 & the EAF2 tumor patients was obtained during surgery. Patients (mean age suppressor genes belong to the ELL family, locating on 53.05±1.86)subdivideddependingofage:Group1(25-44 chromosome3inthehumangenome,whichantagonizethe years), Group 2 (45-60 years), Group 3 (61-85 years). Wnt/β-catenin signaling pathway in different cell lines by Obtained tumor was tested for BRCA1 and RUNX3 gene suppressing the tumorigenic activity. The change of the methylation status.Tumor samples saved using DNA/RNA expressionleveloftheEAF1&theEAF2genesisreported Shield.DNAextractedwithQuick-DNAMiniprepPlusKit. inothercancertypessuchasintestinalandblood.Here,we Bisulﬁde conversion was done by dint of EZ DNA investigated the fold change of these mentioned genes in Methylation-Gold Kit. Converted DNA with methyl- breast cancer (invasive ductal carcinoma: IDC) in Iranian speciﬁc primers was used for PCR analysis. patients. Forty Tumor and marginal normal tissues from Results: No signiﬁcant differences were found for breastcancerpatients(gradeI16%,gradeII58%,andgrade RUNX3 gene methylation. Patients of Group 1 had III 25%) were collected during surgery with immediately signiﬁcantly higher methylation status (41.2%) in BRCA1 treatment of RNA later. All selected patients were HER2 gene compared to patients of Group 2 (25%) and Group 3 positive, with an average age of 56 years old. Seventy (26.6%), respectively. Comethylation of hypermethylatedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 937 BRCA1/RUNX3 was signiﬁcantly prevalence also among and CCa among women from Republic of North Group 1 compared to others (Table). Macedonia. Conclusions: Higher hypermethylated BRCA1/RUNX3 Methods: Using amultiplexPCR SNaPShotanalysiswe genes status was found among young patients (aged 25-44 genotyped rs1042522 and rs2279744 in 131 women with years). Further careful studies are needed to understand CIN or CCa and 110 cytologicaly negative women. cometylation effect of investigated genes on early breast Results: No signiﬁcant difference in either genotype or cancer development. allelic frequencies for rs1042522 and rs2279744 between cases and control was found. Stratiﬁcation of the cases based on grade of the lesion, revealed lower frequency of Methylationstatus RUNX3hypermethylation RUNX3unmethylation CCgenotypeandCalleleofrs1042522inCIN2+andCCa Group1(25-44years)17patients compared to CIN1 [GG vs CC; p=0.001, OR=0.4; CG vs BRCA1 41.2% 5.9% CC; p=0.04, OR=0.03 and CG+ GG vs CC; p=0.004, hypermethylation OR=0.2]. Furthermore, GG genotype and G allele of BRCA1 41.2% 11.7% rs2279744showedsigniﬁcantlylowerfrequencyinCIN2+ unmethylation and CCa cases then in CIN1 [G vs T p=0.02, OR=0.52; Group2(45-60years)20patients GG vs TT; p=0.04, OR=0.29; ТТ vs ТG+GG; p=0.007, BRCA1 25% 0 OR=0.34]. hypermethylation Conclusion: The Arg variant of rs1042522 and T allele/ BRCA1 60% 15% TT genotype of rs2279744 are associated with progression unmethylation of CIN1 to CIN2+ or CCa and may be used as prediction Group3(61-85years)15patients markers in CCa management. Still, clinical importance of BRCA1 26.6% 6.7% hypermethylation these variants warrants further validation in more compre- BRCA1 60% 6.7% hensive studies. unmethylation S. Duvlis: None. D. Dabeski: None. D. Plaseska- Karanﬁlska: None. N.Medvedieva:None.O.Lobanova:None.Z.Rossokha: E-P12.21 None. V. Vershyhora: None. V. Cheshuk: None. R. Monitoring circulating tumor DNA in a breast cancer Vereshchako: None. N. Gorovenko: None. patient to provide real-time cancer progression information E-P12.19 Impact of TP53 (rs1042522) and MDM2 (rs2279744) L. C. Liu1, C. C. Hung2, T. K. Lin2,3, C. W. Yeh4, polymorphisms on cervical intraepithelial lesions and C. W. Huang4, Y. N. Su2,5 cervical cancer in North Macedonian women 1DepartmentofMedicine,CollegeofMedicine,ChinaMedical S. Duvlis1, D. Dabeski2, D. Plaseska-Karanﬁlska3 University, Taichung, Taiwan, 2Soﬁva Genomics Co., Ltd., Taipei, Taiwan, 3Graduate Institute of Clinical Medicine, 1Institute of public health of Republic of North Macedonia, College of Medicine, National Taiwan University, Taipei, Skopje, Macedonia, The Former Yugoslav Republic of, Taiwan, 4National Center for High Performance Computing, 2Clinic for gynecology and obstetrics, Clinical center National Applied Research Laboratories, Hsinchu, Taiwan, "Majka Tereza", Skopje,Macedonia,TheFormerYugoslav 5Dianthus Maternal Fetal Medicine Clinic, Taipei, Taiwan Republicof,3ResearchCenterforGeneticEngineeringand Biotechnology "Georgi D. Efremov", Skopje, Macedonia, Background:Liquidbiopsyisamini-invasivetestandeasyto The Former Yugoslav Republic of get specimen for cancer progression information based on circulating tumor DNA (ctDNA). In this study, we analyzed Introduction: Variant in cell cycle regulation genes may ctDNA dynamics and aim to push liquid biopsy toward clin- inﬂuenced cervical intraepithelial lesions (CIN) and malig- ical practice. nantprogressiontocervicalcancer(CCa).Singlenucleotide Method: We used next-generation sequencing (NGS)- polymorphisms (SNPs) rs1042522 within the codon 72 of based panel assay and molecular barcoding technology to TP53 and rs2279744 within MDM2 promoter genes are analyzevariantsin197genes.Weexaminedabreastcancer plausible factors that could have impact on cervical carci- patient after surgery and frequently monitoring of ctDNA. nogenesisconferringincreasedattenuationofp53pathway. Results:InApril2017,ERBB2c.2264T>C(2.00%)was WeinvestigatedtheassociationoftheseSNPswiththeCIN detectedinctDNAaswellasERBB2c.2664T>C(70.56%)938 J.delPicchia andPIK3CAc.1634A>C (22.93%)weredetected intissue and poorly differentiated tumor cells more frequently than of the patient. After seven months, ERBB2 c.2264 T>C patientswith Pro/Ala genotype(p=0.01). Ouranalysisalso (9.00%)andPIK3CAc.1634A>C(0.76%)weredetectedin revealed that colon cancer was more frequent than rectal in ctDNA, and it seems the therapy did not work. The patient carriers of UCP2 +3474 ins allele (p=0.02). Also, carriers was suggested to change other chemotherapy and targeted of ins allele had distant metastases more frequently than therapy. Three months later, ERBB2 c.2264 T>C (0.59%), patients with del/del genotype (p=0.024). PIK3CA c.1625 A>C (0.04%) and PIK3CA c.1634 A>C Conclusion: Our ﬁndings indicate that there is an (0.07%) were detected in February 2018. Then we follow association between PPARG gene Pro/Ala polymorphism the cancer genetic status every 1-2 months for the patient and tumor cells differentiation and UCP2 gene +3474 ins/ with given the same treatment. For ERBB2 c.2264T>C in del polymorphism with tumor location and the presence of particular, the mutation rates were shown 0.56%, 0.68%, distant metastases in CRC patients. 1.96% and 3.48%, respectively. Key words: Colorectal cancer, PPARɣ, UCP2 Conclusion: Using liquid biopsy to monitor ctDNA E.M.N.D. Ajaj: None. dynamicsaftersurgerymaybehelpfulforpatienttoestimate prognosis. The liquid biopsy can be used to monitor E-P12.31 treatment effect in patient who receive cancer therapies. MGMT methylation status in glioblastomas multiforme L.C.Liu:None.C.C.Hung:A.Employment(fullorpart- time); Signiﬁcant; Soﬁva Genomics, Co., Ltd. T.K. Lin: A. A. V. Antonets, Y. G. Yakovlenko, S. V. Mordanov, Employment (full or part-time); Signiﬁcant; Soﬁva Geno- A. A. Tushev, V. A. Moldovanov, V. Y. Deribas, micsCo.,Ltd..C.W.Yeh:None.C.W.Huang: None.Y.N. S. S. Todorov Su: A. Employment (full or part-time); Signiﬁcant; Soﬁva Genomics Co., Ltd.. Rostov Medical State University, Rostov-on-Don, Russian Federation E-P12.24 Analysis of PPARG and UCP2 gene polymorphisms in Introduction: Epigenetic silencing of the methyl-guanine colorectal cancer patients methyl transferase (MGMT) gene promoter by gene pro- motermethylationsuggestsapartialinabilityofthetumour E. M. N. D. Ajaj to repair the chemotherapyinduced DNA damage. In ret- rospective analyses, MGMT methylation has been corre- Institute Of Human Genetics, Belgrade, Serbia lated with a response to or beneﬁt predictive value of a methylated MGMT status for response to or beneﬁt from Introduction: Altered lipids metabolism is a hallmark alkylatingagentchemotherapyandthusimprovedoutcome characteristic of colorectal cancer (CRC). Peroxisome pro- has been demonstrated repeatedly in glioblastomas. liferator - activated receptor gamma (PPARG) and uncou- Moreover, MGMT methylation identiﬁes a sub-population pling protein 2 (UCP2) act as transcriptional regulators of with a better prognosis irrespective of the applied lipid metabolism. Recent studies have shown that PPARG treatment. and UCP-2 could represent biomarkers for prognosis in Materials and methods: We examined 10 patients with CRC and possible target for cancer therapy. We aimed to the diagnosis of glioblastoma multiforme treated in the investigate the association between PPARG Pro12Ala neurosurgical department and have observed them within (rs1801282) and UCP2 45 bp +3474 ins/del polymorph- 12 months by present. DNA was extracted from freshly isms with clinicopathological factors of tumor progression frozen tumor tissue. Detection of the MGMT gene in CRC patients. hypermethylation was carried out with methyl-speciﬁc real Material and methods: Our study included 160 CRC time PCR. pateints, mean age 65,39±8.55 years. Among them, there Results: Hypermethylation of the MGMT gene was were 98 men (61.3%) and 62 (38.8%) women. PPARG detected in 4 patients. We have not observed relapse in Pro12Ala genotypes were detected by PCR-RFLPs while patientswithhypermethylationby12monthsfromsurgery. UCP2+3474 ins/del polymorphism was detected by PCR. One patient with unmethylated secondary glioblastoma all patients, data about tumor location, histologic differ- multiforme after anaplastic astrocytoma had died. entiation, preoperative serum carcinoembryonic antigen Conclusion: In light of emerging human genetic and level, the presence of lymph node metastases, distant molecular knowledge, molecular diagnosis of oncological metastases and stage of the disease were recorded. diseases might help in the establishment of prognosis Results: Analysis of PPARG Pro12Ala polymorphism and personalized treatment for patients and improve life hasshownthatcarriersofPro/Progenotypehadmoderately quality.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 939 A.V. Antonets: None. Y.G. Yakovlenko: None. S.V. Y. Hrechanina, L. Molodan Mordanov: None. A.A. Tushev: None. V.A. Moldovanov: None. V.Y. Deribas: None. S.S. Todorov: None. Interregional Specialized Medical Genetic Center - Center of Rare (Orphan) Diseases, Kharkiv National Medical E-P12.35 University, Kharkiv, Ukraine BRCA1 and BRCA2 pathogenic variants spectrum in patients with hereditary breast and ovarian cancer Introduction: Hutchinson-Gildford Syndrome (HGS) is an syndrome orphandiseasefromthegrouponcogeneticsyndromes.The disease is based on a point mutation in Lamin A LMNA M.Šukys,V.Ašmonienė,D.Čereškevičius,I.Nasvytienė,I. (1q21 / 2) gene, which leads to splicing disorder. Valančiūtė Materials and methods: HGS was diagnosed in 3 patients aged 4.5 to 8 years. Classic and modern DepartmentOf Genetics AndMolecularMedicine, Medical technologies were used. Academy, Lithuanian University of Health Sciences, Results: Patient I., 4.5 years old with physical develop- Kaunas, Lithuania, Kaunas, Lithuania mentdelay,progericskinandhairchanges,prominentbrain skull over facial, pronounced expanded venous network, Introduction: Hereditary breast and ovarian cancer syn- microangiopathy. Progeric changes increase, the subcuta- drome is one of the most common cancer susceptibility neous fat layer disappears, the skin becomes thin, dry syndromes, affecting 1 of 1600 women. Affected patients patches of stretched skin alternate with patches sclerotic harbor pathogenic variant in BRCA1 or BRCA2 genes, changes, alopecia develops, expansion of superﬁcially which increases lifetime risk for women of developing located vessels. Molecular genetic analysis: a mutation in breast or ovarian cancer to nearly 80%, for men breast the LMNA gene (G608G). Pathology had a progressive cancer - 8%. Detection of such variant allows early courseandmanifestedagainstofmethylenetetrahydrofolate screening and monitoring for better cancer management. reductase deﬁciency. Biomarkers: glucose - ↓, lactate - ↑, Methods: We report BRCA1 and BRCA2 analysis results cholesterol - ↑↑, LDL cholesterol - ↑, VLDL cholesterol - oftheHospitalofLithuanianUniversityofHealthSciences ↑↑, atherogenic coefﬁcient - ↑↑↑, homocysteine - ↑↑ The Kauno Klinikos from year 2015 till 2019. Analysis was comorbidpathologywasdiagnosed:acombinationofHGS performedforpatientswhowereatincreasedriskofhaving associated with mutation in the LMNA gene (G608G), BRCA1/2 genes pathogenic variants according to the local methylenetetrahydrofolate reductase deﬁciency, hyperho- laws. Analysis was performed in two steps: ﬁrstly, it was mocysteinemia, lipid metabolism disorder. Therapy: posi- analyzed with pyrosequencing kit for 6 common variants. tive dynamics was noted - skin condition improved, Later, If needed, analysis on Sanger sequencing or Next decreased dryness, skin became more elastic, hair growth generation sequencing for coding genes regions was appeared. continued. Conclusions:Searchformetabolicdisorders,clariﬁcation Results: BRCA1 and BRCA2 analysis for 6 common of their nature in the case of a combination of HGS with pathogenic variants was performed for 1737 patients methylenetetrahydrofolate reductase deﬁciency have (including familial BRCA1 and BRCA2 variant cases). allowedtodevelopindividualtacticsofpatientmanagement Pathogenicvariantwas found for 12,95%patients. Coding taking into account revealed disorders, the correction has region sequencing was performed for 647 cases, as other reduced clinical disease manifestations, improved the patients testing is still ongoing, 10 % pathogenic variants quality of life of the patient and family. were found. From all pathogenic variants, most frequent Y. Hrechanina: None. L. Molodan: None. were BRCA1: c.4035delA 43,4 %; c.5266dupC - 23,1%; c.181T>G - 10%; BRCA2: c.657_658delTG 4,8%. E-P12.40 Conclusion: The c.4035delAmightbe the most frequent KRAS, NRAS, BRAF mutation spectrum in Georgian variant in Lithuania, whereas in neighboring countries patients with metastatic colorectal cancer c.5266dupC is more common M.Šukys:None.V.Ašmonienė:None.D.Čereškevičius: D. Agladze1,2,3, S. Iordanishvili4, L. Margvelashvili4,3, None. I. Nasvytienė: None. I. Valančiūtė: None. E. Kldiashvili4, O. Kvlividze1,5 E-P12.37 1School of Medicine, New Vision University, Tbilisi, The case of Hutchinson-Gildford Syndrome associated Georgia, 2Research Institute of Clinical Medicine, Tbilisi, with G608G mutation in LMNA gene and Methylenete- Georgia, 3Pediatric Surgery Center (KidCo), Tbilisi, trahydrofolate reductase deﬁciency Georgia,4Petre Shotadze Tbilisi MedicalAcademy, Tbilisi,940 J.delPicchia Georgia, 5Georgian Foundation for Genetic and Rare CpG islands has been recognized as a potential early bio- Diseases (GeRaD), Tbilisi, Georgia markerofcarcinogenesis.Additionally,thesechangesaffect tumor stage and grade, which may have an impact on the Introduction: According to the NCDC data Colorectal choice of the right treatment method. Cancer(CRC)istheﬁfthamongmostcommonmalignancy Materials and methods: We aimed to investigate the in Georgian population. In 2019 326 new cases of CRC methylation proﬁles of selected tumor suppressor genes to havebeenregistered.TestingCRCformutationsinKRAS, ﬁnd out whether aberrant methylation can be signiﬁcantly NRAS, BRAF genes are common in most countries to correlatedwithtumorstageand/orgrade.TumorDNAfrom determine resistance to anti-EGFR therapy. carefully selected 44 patients diagnosed with NMIBC and Aim of the study: To detect most common mutations in MIBC was analyzed. Methylation proﬁles were examined KRAS, NRAS, BRAF genes of metastatic CRC cells in by MS-MLPA technique. The capillary electrophoresis Georgian patients affected with mCRC and to compare the method provided data for calculating the percentage of data with the results of similar studies in other countries. methylation of particular genes. A value above 15% was Materials and methods: Study was made in Georgian considered as a positive result. population. Inclusion criteria was the morphologically Results: Among the analyzed genes, the most frequently diagnosed mCRC. DNA was extracted from 111 patients hypermethylated genes were CDH13, APC and RARβ. FFPE Tissue. KRAS (exon 2,3,4), NRAS (exon 2,3,4) and RASSF1 methylation showed a signiﬁcant correlation with BRAF (exon15) were ampliﬁed. For mutations detection the invasive stage. Hypermethylation of CDH13 (AUC = Sanger Sequencing method has been used. 0,75) and RASSF1 (AUC = 0,67) has been statistically Results: Analyzing data showed that in 111 tested signiﬁcantly associated with the histological high-grade patients mutation was detected in 21.6% cases. KRAS bladder cancer and both genes are good classiﬁers for this exon2 mutation was detected in 18.9% cases, NRAS ex4 condition. mutationin0.9%,BRAFex15mutationin1.8%.Therewas Conclusions:ThisstudyconﬁrmstheassociationofCpG no mutation detected in KRAS ex 3 and 4 and NRAS ex2 island methylation of CDH13 and RASSF1 with bladder and 3. From overall 24 detected mutations most common cancer and suggests its potential role in the assessment of mutations are KRAS ex2 G12D 37.5%, G12V 25%, G12C bladder cancer aggressiveness. Medical University of Lodz 20.8%, G13D 4.1% and BRAF Ex15 V600E 8.3%. Grant No. 502-03/2-159-02/502-24-305. Conclusions: The study of 111 Georgian patients M. Pietrusinski: None. E. Borkowska: None. M. Con- affected with mCRC showed that the most common stantinou: None. Z. Jablonowski: None. J. Salamunia: mutations in KRAS gene is G12D, followed by the same None. M. Borowiec: None. codon mutations G12V and G12C. Similar studies already conducted in different countries in patients affected with E-P12.44 mCRC showed the similar results. AretrospectivestudyofpatientswithMultipleMyeloma D. Agladze: None. S. Iordanishvili: None. L. Margve- tested in Laboratory of Medical genetics, Varna, lashvili: None. E. Kldiashvili: None. O. Kvlividze: None. Bulgaria E-P12.41 V. Miteva, T. Ruseva, M. Hachmeriyan, M. Levkova, Aberrant methylation of CDH13 and RASSF1 as L. Angelova classiﬁersofmuscle-invasive,highgradebladdercancer. Medical University Varna, Varna, Bulgaria M. Pietrusinski1, E. Borkowska1, M. Constantinou1, Z. Jablonowski2, J. Salamunia1, M. Borowiec1 Introduction: Multiple myeloma (MM) is a clonal bone marrowdiseaseofB-cells,atthelaststageofdifferentiation 1Medical University of Lodz, Department of Clinical and is the second most common hematologic neoplasia. Genetics, Lodz, Poland, 2Medical University of Lodz, 1st MМ is a heterogeneous disease characterized by very Clinic of Urology, Lodz, Poland complex cytogenetic and molecular genetic aberrations. Materials and methods: We performed a retrospective Introduction: The mortality among men due to bladder review of patients with MM referred to Laboratory of cancer is approximately twice as high in Poland as in other MedicalGenetics,Varna,Bulgariabetween2017and2019. European countries. Bladder cancer is a result of multistep Bone marrow (BM) samples of 65 patients with MM at accumulation of genetic and epigenetic alterations and different stages of the disease were evaluated for cytoge- exposureto environmental factors.Aberrant methylationof netic analyses and 19 of them for interphase ﬂuorescentAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 941 insituhybridization(iFISH).Chromosomeswereclassiﬁed of patient was 65.5±7.7 years diagnosed with ESCC stages according to the International System for Human Cytoge- T1-T4. Expression level of 24 genes, targets of the main netic Nomenclature 2016 (ISCN 2016). FISH was antitumor drugs was investigated in our research. Over- performed on BM samples and 200 interphase nuclei were expression of metalloproteinase genes MMP1, MMP9, evaluated per sample. The iFISH was performed using MMP10 during cancer progression (stages 2-4) was commercially available probes (Kreatech TM FISH probes) signiﬁcantly found among patients with T2, T3 stages of for the detection of two oncohaematological markers: ESCC (p-value<0.05). MMP1, MMP9 and MMP13 genes deletions of 17p13 (TP53) and rearrangements involving identiﬁed as up-regulated in patients with T4 stage (p- immunoglobulin heavy chain (IGH) region on 14q32 value<0.05). According recent publications matrix metallo- chromosome. proteinases is frequently up-regulated and correlates with Results:Cytogeneticanalysiswassuccessfulin57ofthe vascular invasion, metastasis and poor outcomes among 65 patients (87.7%). Six patients out of these 57 (9.23%) patients with ESCC. had different abnormal karyotypes sustainable with the Conclusion: Our research study showed that metallopro- diagnosis MM.iFISH analysis was successful in all 19 teinase genes (MMP1,MMP9, MMP10 andMMP13)were patients. Deletion del17p13 was detected in seven patients overexpressedamongpatientswithESCC.Furtherresearch (36.84%) and rearrangements involving 14q32 in one will be continued and additional validation of ﬁndings will (5.26%). be performed. Conclusion:The detection ofchromosomalabnormalities Grant reference: #AP05134722, #AP05135430 and in MM by conventional cytogenetics is limited due to the #AP05136106 MES low mitotic index of malignant plasma cells. This S.Rakhimova:None.U.Kozhamkulov:None.A.Sharip: disadvantagecanbeovercomewiththeuseofFISH,which None.A.Molkenov:None.Y.Zhukov:None.M.Omarov: can detect speciﬁc target arrangements and chromosomal None. M. Tuleutaev: None. U. Kairov: None. A. copy number changes. Akilzhanova: None. V. Miteva: None. T. Ruseva: None. M. Hachmeriyan: None. M. Levkova: None. L. Angelova: None. E-P12.56 Resveratrolcanmisslaryngealsquamouscellcarcinoma E-P12.45 cells from immune response Matrix metalloproteinases expression level in patients with oesophageal squamous cell carcinoma B.GokselTulgar1,M.E.Sarı1,G.Turkoglu1,F.Duymus1, D. Esin1, E. Marzioglu Ozdemir2, T. Cora1 S. Rakhimova1, U. Kozhamkulov1, A. Sharip1, A. Molkenov1, Y. Zhukov2, M. Omarov2, M. Tuleutaev2, 1Selcuk University Faculty of Medicine, Medical Genetics U. Kairov1, A. Akilzhanova1 Department, Konya, Turkey, 2Konya Education and Research Hospital, Genetic Diseases Diagnosis Unit, 1National LaboratoryAstana, Nazarbayev University, Nur- Konya, Turkey Sultan,Kazakhstan,2Oncologycenter,Nur-Sultan,Kazakh- stan The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that mediates intracellular signals in Introduction: More than 80%of oesophageal cancer cases response to various extracellular stimuli. Previous studies occur in developing countries, Central and East Asia havebeenshownthatEGFRisactivatedandoverexpressed countries and the prevalent type is oesophageal squamous inmanytypesofhumanepithelialcancer.Inalimitedstudy cellcarcinoma(ESCC).Theaimofourstudywastoanalyse on epithelial cancer cells, resveratrol has been shown to of major genes, anticancer drug targets based on whole have an inhibitory effect on EGFR tyrosine kinase activity transcriptome sequencing data for Kazakhstani patients. in vitro. Programmed death-ligand 1(PD-L1) is normally Materials and methods: Tissue samples were collected expressed in healthy cells, is also expressed in cancer cells from 25 ESCC-affected patients immediately after Ivor- during cancer development and leads to the concealing of Lewis esophagectomy in Oncology Center. Whole tran- cancer cells from the immune system. In this study, we scriptome sequencing was performed regarding the TruSeq aimed to investigate the effect of resveratrol on EGFR and RNA Protocol. STAR software and DESeq2 package have PDL-1 inLaryngeal squamous cell carcinoma cells(HEP2), been used for mapping and deﬁning differentially which is epithelial cancer. We cultivated HEP2 and expressed genes. HEK293 (human embryonic kidney cell) cell lines as a Results: 25 male and female (14 and 11 respectively) controlcellline.WedeterminedtheIC50valueas100uM. patients with ESCC were recruited for study. Average age EGFR, MYC, and PD-L1 gene expression levels were942 J.delPicchia evaluated by gene expression studies. GAPDH and ACTB Conclusion: We designed a sensitive method and geneswereidentiﬁedashousekeepinggenes.Asaresultof sophisticated pipeline for tumor-speciﬁc RE insertion thestudy,geneexpressionrelativechangelevelsforEGFR, detection in as little as 1% of cells. The developed method MYC, and PD-L1 were determined as 1.145, 0.475, 2.695, wastheﬁrst toevaluateREactivityinchildhoodleukemia. respectively. According to these results, resveratrol did not Funding: This work was supported by RSF18-14- cause a signiﬁcant change in EGFR and MYC expression 00244 grant. levelsintheLSCCcellline,whileitsigniﬁcantlyincreased S.Z. Urazbakhtin: None. M.V. Saliutina: None. G.A. PD-L1 levels. It has been found interesting because the Nugmanov: None. Y.B. Lebedev: None. A.Y. Komkov: resveratrol, which is normally included in the literature as None. Y.V. Olshanskaya: None. E.A. Zerkalenkova: None. ananticancer,increaseslevelsofPD-L1becauseitislikely I.Z. Mamedov: None. to support escape from the immune response. B. Goksel Tulgar: None. M.E. Sarı: None. G. Turkoglu: E-P12.58 None. F. Duymus: None. D. Esin: None. E. Marzioglu Somatic Variant Interpretation in TET2 using two Ozdemir: None. T. Cora: None. distinct next generation sequencing platforms E-P12.57 H. Saat1, M. Say2, T. Bahsi3,4, S. Sevinc5 Investigation of retroelement activity in childhood leukemia 1Ankara Dıskapı Yıldırım Beyazıt Training and Research Hospital,DepartmentofMedicalGenetics,Ankara,Turkey, S. Z. Urazbakhtin1, M. V. Saliutina1, G. A. Nugmanov1, 2Gen Era Diagnostics, Bioinformatics Department, Istan- Y. B. Lebedev1, A. Y. Komkov1, Y. V. Olshanskaya2, bul, Turkey, 3Dr. Abdurrahman Yurtaslan Ankara Oncol- E. A. Zerkalenkova2, I. Z. Mamedov1 ogy Training and Research Hospital, Department of Medical Genetics, Ankara, Turkey, 4Ankara Provincial 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Health Directorate, Central Genetic Laboratory, Ankara, of Russian Academy of Science, Moscow, Russian Federa- Turkey, 5Gen Era Diagnostics, Application Department, tion, 2Dmitry Rogachev National Medical Research Center Istanbul, Turkey Of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation EvansSyndromeisarareautoimmunedisorderinwhichthe immune system produces antibodies that destroy ery- Introduction: Retroelements (RE) are interspersed repeats throcytes, platelets and/or certain leukocytes. The patients that comprise a sufﬁcient part of the human genome. The mayhavedifferentsymptomsrelatedtothetypeandextend majorityofthemarecurrentlyinactivebutfunctionalcopies of blood cells affected. The most common symptoms can be a source of genetic instability associated with some includehemolyticanemiaandthrombocytopenia.Similarly, types of cancer. Currently, there is very limited data about some database is included same phenotype knowledge for retrotranspositions in hematological malignancies. In this Myelodysplastic Syndrome. Herein, we have analyzed the studyweperformanalysisofREactivityinchildhoodacute DNA sample extracted from whole blood of a 19-year-old lymphoblastic and acute myeloblastic leukemia. male with an initial diagnosis of Evans Syndrome starting Materials and methods: Digested DNA obtained from fromtheageof10.Nextgenerationsequencing(NGS)was paired tumor/normal samples was ligated to adapters with performed using Clinical Exome Solution (CES) of Sophia UniqueMolecularIdentiﬁers.PrimersspeciﬁctoyoungRE GeneticsontheontheIlluminaNextSeq550®platform.has were used to selectively amplify sequences ﬂanking RE been analyzed for using. Through analysis of the CES data insertions in the genome. These sequences were used to for single nucleotide and copy number variations has identify new insertions by custom pipeline. To test method revealed a frameshift variant at TET2 gene with a variant sensitivity, we prepared a mixture of cells from 4 healthy fractionofonly6%in120reads.Wehavethereforedecided donors, with different cell concentrations. to validate this result using the same biospecimen in an Results: Polymorphic RE insertions, distinguishing alternative platform, namely Archer®Myeloid dedicated for donors from each other, were used to determine method’s somatic variant analysis. Accordingly, the identical variant sensitivity. We were able to detect 95% of insertions of a was conﬁrmed using the Archer platform with 13% variant person, whose cells comprised 1% of the mixture at fraction in 744 reads. Somatic mutations in TET2 encoding sequencing depth of 2,000,000 reads per Alu library and Tet methylcytosine dioxygenase 2 has been reported to be 300,000 per for L1 library. Using our method and pipeline associated with myelodysplastic syndrome (MDS). MDS we analyzed 14 T-ALL, 34 B-ALL and 18 AML paired refers to a heterogeneous group of closely related clonal tumor/normal samples. hematopoietic disorders characterized by ineffectiveAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 943 hematopoiesisresultinginlowbloodcountsandpossibility P. Gerasimou: None. A. Miltiadou: None. I. Kyprianou: of developing acute myeloid leukemia. The variant identi- None. J. Chi: None. V. Anastasiadou: None. P. ﬁed in TET2 can be considered as somatic and may aid Costeas: None. correct diagnosis and treatment for the patient. H.Saat:None.M.Say:None.T.Bahsi:None.S.Sevinc: E-P13 Genome Variation and Architecture None. E-P12.60 E-P13.3 A novel de novo splicing mutation in the TSC2 gene Copy number losses of 11p14.3-p13 and 11p13-p12 causes exon in a patient with tuberous sclerosis detected by CGH array revealed to be heterozygous syndrome deletion of 11p14.3-p12 on one chromosome 11 and heterozygous duplication within 11p13 on the other P. Gerasimou1, A. Miltiadou1, I. Kyprianou1, J. Chi1, chromosome 11 by metaphase FISH analysis V. Anastasiadou2, P. Costeas1 K. Wakui1,2, T. Kosho1,2, Y. Fukushima1,2 1Molecular Hematology-oncology, Karaiskakio Founda- tion, Nicosia, Cyprus, 2Department of Clinical Genetics, 1Department of Medical Genetics, Shinshu University Archbishop Makarios III Medical Centre, Nicosia, School of Medicine, Matsumoto, Japan, 2Center for Cyprus MedicalGenetics,ShinshuUniversityHospital,Matsumoto, Japan Introduction: Tuberous sclerosis complex is an autosomal dominantdisordercharacterizedbyhamartomasinmultiple Introduction: Wilms tumor-Aniridia-Genitourinary organ including the brain, skin, heart and kidneys among abnormalities-growth and mental Retardation (WAGR) othercomplications.Approximately10to30%ofcasesare syndrome/11p13 deletion syndrome is a rare genetic con- due to mutations in the TSC1 gene. TSC2 gene mutations dition associated with contiguous-gene deletions including frequency is consistently higher and are associated with PAX6 and WT1. An 8-month-old boy with aniridia and his more severe phenotype. parents were analyzed for possible genomic variations. Case Description: Newborn with prenatal diagnosis of Methods: Cytogenomic microarray testing using a CGH heart tumor. Suspected Tuberous Sclerosis. array (135K [hg18], Roche NimbleGen) was performed to Methodology: A custom HaloPlexHS (Agilent) NGS evaluate copy number variations (CNVs). We employed panel was used to investigate mutations in Syndromic metaphase FISH analyses using selected BAC clones to associated genes as per manufacturer’s instructions. Sanger identifythechromosomalrearrangementsrelatedtotheCNVs. sequencing performed for parental carrier status and RNA Results: Copy number losses of 11p14.3-p13 investigation for exon skipping. (chr11:25,784,386-32,872,519; 7.1 Mb) including the Interpretation: A heterozygous novel splice-site muta- PAX6andWT1genesandof11p13-p12(chr11:33,555,357- tion in the TSC2 gene was detected in the patient sample. 42,819,900;9.3Mb)weredetectedbytheCGHarrayinthe The c.139-2A>T (NM_000548.5) mutation is located two patient. And the FISH signals of the probes mapping the nucleotides from the splice acceptor site between exons 2 normal copy number region between the two copy number and 3 of the TSC2 gene. It is classiﬁed as pathogenic loss regions were absent in the abnormal chromosome 11, according to ACMG recommendations and Bioinformatics as were the probes mapping the distal and proximal copy tools predicted that this novel mutation have pathogenic number loss regions. Additional microarray analyses of the effects on splicing machinery. RNA investigation revealed parents uncovered a copy number gain of 11p13 thatthis variation leadsinexon3skipping.Parental testing (chr11:32,910,676-33,522,409; 0.6 Mb) in the mother. showed that this is a de novo mutation in the patient as Conclusion: Comprehensive genomic evaluation of a neither of the parents were carriers. case of WAGR syndrome ultimately revealed a hetero- Conclusion: More than 1,100 mutations in the TSC2 zygous deletion of 11p14.3-p12 (chr11:25,784,386- gene have been identiﬁed in individuals with tuberous 42,819,900; 17.0 Mb) on one chromosome 11 and a sclerosis complex. This study highlighted the presence of a heterozygous duplication of a part of 11p13 (chr11:32,910, noveldenovosplicingmutationintheTSC2genethatleads 676-33,522,409; 0.6 Mb) on the other chromosome 11. in exon 3 skipping and is responsible for the loss of 29 Metaphase FISH analysis is indispensable in clarifying amino acids, which causes the production of an aberrant exact chromosomal rearrangements while distinguishing protein isoform. between homologous chromosomes. K. Wakui: None. T. Kosho: None. Y. Fukushima: None.944 J.delPicchia E-P13.4 F. K. Colak1, M. Say2, M. A. Dülger3, B. B. Turan3 Identiﬁcation of unsolved rare genetic cases of North Cyprus 1Dr. Sami Ulus Obstetrics and Gynecology, Children Health and Disease Training and Research Hospital, M. C. Ergoren1, E. Manara2, S. Paolacci2, G. Tuncel3, Department of Medical Genetics, Ankara, Turkey, 2Gen S. G. Temel4, G. Mocan1, M. Dundar5, M. Bertelli6 Era Diagnostics, Bioinformatics Department, Istanbul, Turkey, 3Gen Era Diagnostics, Application Department, 1Near East University, Faculty of Medicine, Nicosia, Istanbul, Turkey Cyprus, 2MAGI Euregio, Bolzano, Italy, 3Near East University, DESAM Institute, Nicosia, Cyprus, 4Bursa Next-generation sequencing (NGS) platforms with dedicated Uludag University, Faculty of Medicine, Bursa, Turkey, softwareareincreasinglybeingusedtoidentifycopynumber 5Erciyes University, Faculty of Medicine, Kayseri, Turkey, variations (CNVs) along with single nucleotide variants 68MAGI’s LAB S.r.l., Roverato, Italy (SNVs) simultaneously. Array-based technologies including SNPgenotypinghasbeenbeemployedinparalleltoNGSfor Cyprus, which is the third largest island in the Mediterranean further characterization of the CNV event. Such combined Sea, has been at the crossroads of multiple civilizations approachesmayresolvechallengingcasesinmedicalgenetics throughouthumanhistory.Today,theTurkishCypriotsandthe especiallyforrecessiveconditionswhenonecopyofthegene Greek Cypriots constitute two major ethnic groups in Cyprus, is deleted while the other copy carries a pathogenic CNV. along with some minor groups. Even though Turkish-Cypriot Herein, we have adopted Clinical Exome Solution (CES) of paternallineageshaveanautochthonousquality,someY-DNA SophiaGeneticsinapatientwithaninitialdiagnosisofPierre haplotypes are shared between the Turkish Cypriots and the Robinsyndrome.Thecapture-basedtargetenrichmentkithas Greek Cypriots. It should be no surprise that the genetic char- enabled us to cover approximately 4490 genes. Sequencing acteristicsofthecurrentTurkish-Cypriotpopulationhavebeen was performed on the Illumina Next Seq 550® platform. determined by the interactive forces of migrations, admixture, Sophia DDM platform was used as a interface to evaluate genetic drift, etc. We aimed at elucidating the path from the SNVsandCNVs.HumanCytoSNP-12v2.1BeadChipKitat interesting or unusual clinical phenotypes of rare diseases to IlluminaSNParrayplatformwasusedforfollow-updetection potentially novel gene variants. In the present study, the most of CNV events. Analysis of NGS data for CNV events has recenthigh-throughputgenomictechnologieswereemployedto revealed one copy loss at chromosome 22q11 including the studythegeneticetiologyofsuchdiseases.Accordingly,WES gene TBX1. The loss had exactly the same boundaries as wasusedtosequencetrios.Asaresult,weidentiﬁedanumber deducedfromSNPgenotyping.Although,haploinsufﬁciency of novel population-speciﬁc gene variants, each of which cau- of TBX1 is associated with DiGeorge syndrome, we have ses rhizomelic chondrodysplasia punctate type 5, Wiedeman- interestingly identiﬁed a novel missense pathogenic SNV in Rautenstrauch Syndrome, tricho-rhino-phalangeal syndrome TBX1intheNGSdata.CombinedanalysisofCNVeventsin type1,Joubertsyndrome,etc.Lackofgeneticdatabasesinthe NGS and SNP array platforms has enabled us to identify a region of middle eastern, the laboratory set up the capacity to deletion involving the TBX1 gene in a patient. We propose produce DNA sequence data expands the number of con- that the SNV identiﬁed in the nondeleted copy may explain tributors to DNA sequence databases, which is beneﬁcial for the phenotypic variability associated with TBX1 deletions. science and may be helpful for any number of bioinformatic F.K.Colak:None.M.Say:None.M.A.Dülger:None.B. analyses. Overall, this study emphasizes the importance of B. Turan: None. revealingrare-disease-causingvariantsinaparticularpopulation for immediate use in accurate diagnosis, for improved under- E-P14 Cytogenetics standing of the underlying molecular mechanisms and for developing effective preventive medicine strategies. E-P14.01 M.C. Ergoren: None. E. Manara: None. S. Paolacci: Both 17q12 duplication and deletion detected in the None. G. Tuncel: None. S.G. Temel: None. G. Mocan: patient with normal phenotype and their segregation in None. M. Dundar: None. M. Bertelli: None. family with variably affected members E-P13.5 H. Zunova, M. Stolfa, T. Rasplickova, D. Novotna, Parallel analysis of next generation sequencing data for M. Vlckova small nucleotide and copy number variations and a follow-up approach using SNP array genotyping detect DBMG, 2nd Faculty of Medicine Charles University and a biallelic variant in TBX1 gene University Hospital Motol, Prague, Czech RepublicAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 945 Chromosomal band 17q12 is a gene rich region ﬂanked by analysedandinterpretedusingChromosomeAnalysisSuite segmental duplications which make the region prone to (ChAS) Software (v4.0). deletionsandduplicationbyNAHRmechanism(non-allelic Results:7-month-oldchildhadhypotonia,wasunableto homologousrecombination).Whilethedeletionscausewell hold his head, to sit and did not develop ﬁne motor skills. described clinical unit with speciﬁc phenotype called The clinical conditions included asthenia, frequent respira- RCAD (renal cyst and diabetes mellitus), the phenotype tory infections and atypical convulsion. Dysmorphological caused by reciprocal duplications of the same region still features followed wide forehead, protruded eyes, long remains unclear especially due to variable expressivity and eyelashes, triangular face, slender extremities and dimin- incompletepenetranceandfact,thattheyareoftendetected ishedfattissue.Karyotyperesultsweretypicalforanormal in healthy patients. Here we present unusual case of family male (46, XY). The array CGH analysis revealed a where the mother is carrier of duplication (paternally pathological microduplication of a 10q segment - arr inherited) and also deletion (inherited from mother with 10q22.2q23.1(75,709,593-80,912,470)x3 that was 5230 kb RCAD) of the identical 17q12 region. All of her children long and includes 44 genes. were diagnosed with 17q12 microduplication syndrome. Conclusion: Application of array Comparative Genomic Except of the mother and grandfather, all her children car- Hybridization (aCGH) in patient with severe hypotonia, rying duplication express variable degree of neurodeve- dysmorphia and neurological disability represents a great lopmental problems, such as epilepsy, mild intellectual diagnostic marker compared to conventional karyotyping. disability, delayed speech development or attention deﬁcit The results suggest that the main reason for the various disorder, that correlate with the hypothesis of incomplete clinical and dysmorphological features of the child has penetrance and variable phenotype published by many genetic background. Keywords: array Comparative Geno- studies.AsapotentialcausativegenesareconsideredLHX1 mic Hybridization, karyotype, dysmorphia, hypotonia for neurodevelopmental problems and gene ACACA for G. Ilieva: None. E. Sukarova-Angelovska: None. D. epilepsy. The simultaneous occurrence of deletion and Nestoroska: None. S. Naunova-Timovska: None. M. duplication of the same chromosomal region in one family Pesevska: None. V. Anastasovska: None. is very rare. This case supports hypothesis that 17q12 duplications are stable and may segregate in a family for E-P14.07 several generations. Supported by: 00064203, NF-CZ11- Chromosome instability index: a potential human PDP-3-003-2014, AZV17-29423A cancer biomarker? H. Zunova: None. M. Stolfa: None. T. Rasplickova: None. D. Novotna: None. M. Vlckova: None. T. Sylaidy1, E. Lialiaris2, T. S. Lialiaris3 E-P14.05 1Demokritus University of Thrace, Dept of Mol. Biology Duplication of 10q22.2q23.1 as a cause for severe and Genetics, Alexandroupolis, Greece, 2Aristotle Univer- hypotonia in a child sityofThessaloniki,DeptofBiology,Thessaloniki,Greece, 3DemokritusUniversityofThrace,MedicalSchool,Deptof G. Ilieva, E. Sukarova-Angelovska, D. Nestoroska, Genetics, Alexandroupolis, Greece S. Naunova-Timovska, M. Pesevska, V. Anastasovska Introduction: Chromosome Instability Index (CII) is a University Pediatric Clinic, Skopje, Macedonia, The biomarker that has been remarkably increased in cancer Former Yugoslav Republic of patients and it consists of three parameters: Sister Chro- matid Exchange (SCE) frequencies, Proliferating Rate Introduction: Array comparative genomic hybridization Index(PRI)andMitoticIndex(MI).Themostimportantof (aCGH) technique enables high-resolution screening of the theaboveisSCEsbecausetheyshowedthemostsigniﬁcant genome for segmental genomic copy number variations difference between patients and controls. The aim of the (CNVs). The technique today represents an unsurpassed study was to investigate the CII as possible biomarker in tool for detecting minor chromosomal aberrations in chil- different types of cancer. dren with expressed pathological clinical features, such as Material and Method: We used our data of the SCE hypotonia, dysmorphia, motor and mental delay. methodology as it isa simple, sensitive and rapid detection Materials and methods: aCGH analysis was performed techniqueusedtoevaluatechromosomalfragility.Increased in a child with clinical signs of dysmorphia and severe SCEs mean increased unspeciﬁc damage to the DNA hypotonia using the Affymetrix® CytoScanTM 750K Array molecule, which was caused by various mutants in (Applied Biosystems). Each array was consisted of 200 k lymphocyte cultures. SNP and 550 k non-polymorphic markers. The data was946 J.delPicchia Discussion: A signiﬁcant alteration in both SCE Conclusion: It is shown induction of chromosomal frequency and PRI was observed in patients with different structural aberation as sign of genotoxicity for examined types of cancer, such as breast and stomach cancer or concentration of thimerosal and paracetamol and their leukemia.Speciﬁcally,SCEsincancerpatientswerealmost common treatment of lymphocites cultures. Suppresing twicethanincontrols.Additionally,asfarasPRIisconcert, effect of paracetamol on thimerosal genotoxicity in there was a signiﬁcant reduction in cancer patients lymphocytes culture treated with 1 µg/ml of thimerosal compared to normals. We believe that, the co-calculation was shown as indicative for furter examination of of SCEs, PRIs and MIs in an index, can predict the paracetamol use in prevention of genotoxicity. chromosomalinstabilityinhumancancer.So,CIIndexwas M. Mackic-Djurovic: None. D. Klepo: None. H. Neﬁć: createdasCI=20*SCEs+10*(3-PRI)+2/10*(60-MI).From None. D. Rukavina: None. the results it is revealed that CII (cancer)>>CII (control). Conclusions: The results of the present study demon- E-P14.09 strate that SCEs can offer reliable results for the studies of Genetic diagnosis of true hermaphroditism; case report chromosome instability and so CII could be used as in an Angolan patient biomarker for cancer and this is of great importance in premature diagnosis. N. Calumbuana1, C. Correia2, I. C. Capuepue1, T.Sylaidy:None.E.Lialiaris:None.T.S.Lialiaris:None. J. C. V. D. Van-Dúnem1, M. M. P. Chimpolo1 E-P14.08 1Faculdade de Medicina da UAN, Luanda, Angola, 2Syn- Genotoxicity of thimerosal and paracetamol in human labHealth Medical Genetics, Porto, Portugal lymphocyte culture Genotoxicity of thimerosal and paracetamol in human lymphocyte culture Introduction: The present work reports a case of marked gynecomastia, ambiguous genitalia and female body fat M. Mackic-Djurovic1, D. Klepo2, H. Neﬁć2, D. Rukavina3 distribution in a young boy of 14 years of age with no family history of hermaphroditism. Scan tests have shown 1Center for Genetics, Sarajevo, Bosnia and Herzegovina, thepresenceofauterusandarightovary.Laboratoryexams 2Faculty of Natural Science and Mathematics, Sarajevo, (FSH, LH and Testosterone levels) were also added to the Bosnia and Herzegovina, 3Veterinary Faculty, Sarajevo, clinical investigation. Bosnia and Herzegovina Objectives: To report the case of a genetic diagnosis of an individual with sex differentiation disorder, seen by a Introdaction: Although its use has been reduced, thimer- urology consultant in Luanda. osalisstillpresentasconservansinmultidosecontainersof Materials and methods: Initially, sexual markers were some vaccines or as a trace from pathogen inactivation analysed by capillary electrophoresis followed by conven- processinvaccinesproduction.Paracetamol,aswidelyused tional cytogenetic analysis. 200 nuclei were analysed by analgoantipyretic, is most often used for treatment of FISH with a probe for the SRY gene and another for the X postimunisationpirexy.Proﬁlacticuseofparacetamolupon chromosomecentromereforexactdeterminationofthe%of vaccinationisstillpresent,despitethefactthatinthiscases each line. paracetamol decrease immune response on some vaccines. Results: The results of the molecular examination by Materials and methods: Blood samples of three healthy capillaryelectrophoresisshowedanatypicalgenotype,with donors were included in the study. Tested substances were tri-allelic markers, similar to those of mixtures. The added 24 hours after culture were started and following cytogenetic analysis of 50 metaphases indicated 35 concentration were examined: thimerosal (1 µg/ml and metaphases 46,XX and 15 metaphases 46,XY. The 0.5 µg/ml), paracetamol 20 µg/ml, thimerosal with para- examination of FISH conﬁrmed the presence of 70% of cetamol (0,5 µg/ml/20 µg/ml and 0.5 µg/ml/ 20 µg/ml). the nuclei showed two signals for the X chromosome Cultivations were lasted for 72 hours, and analysys of centromere and none of the SRY and 30% showed one structural chromosomes aberations was performed. signal for the X chromosome and one SRY centromere. Results: Results shown that frequency of chromosomal Conclusion: We present a true chimera hermaphroditism structural aberation was signiﬁcantly incresed in all tretaed with a 46XX/46XY karyotype and hypothesize that the cultures in comparission with negative control. Number of patient is a tetra-gamete or chimera due to early post- chromosomal structural aberations was highest in culture zygotic error and fusion of two distinct zygotes that gave treated with 1 µg/ml of tiomersal. In cells treated with rise to only one embryo. The results obtained will be used thiomersal1µg/mlwithpresenceof20µg/mlofparacetamol, for clinical decision-making. the number of aberation was signiﬁcatly decreased.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 947 N.Calumbuana:None.C.Correia:None.I.C.Capuepue: D. Sabau1,2, F. Nițu2, S. Grigore2, C. Tatai2, D. Guzun3,2, None. J.C.V.D. Van-Dúnem: None. M.M.P. P. Apostol2 Chimpolo: None. 1Emergency Hospital “Sfantul Ioan” Bucharest/ Clinica E-P14.10 Sante Bucharest, Bucharest, Romania, 2Clinica Sante, A Rare Immune Deﬁciency Case With Dysmorphic Bucharest, Romania, 3Fundeni Clinical Institute, Buchar- Findings: ICF Syndrome est, Romania A. Kalayci Yigin, F. Ozdemir, A. Ozaydin, M. Seven Introduction:Miscarriageisacommoneventinawoman’s life. Most occur before 12 weeks and it has been estimated Department of Medical Genetics, Cerrahpasa Medical only 2-3% of pregnancies end spontaneously in the second Faculty,IstanbulUniversity-Cerrahpasa,Istanbul,Turkey trimester.Second-trimesterpregnancylosshasbeendeﬁned as miscarriage diagnosed between the duration of gestation Introduction: ICF (immune deﬁciency, centromeric region 12-24 weeks. instability, facial anomalies) syndrome is a rare autosomal Materialandmethods:Wereportthecaseofateenager recessive inherited chromosomal breakage syndrome. In who suffered a miscarriage in the second trimester mitogen-induced lymphocytes, it is characterized by aga- (19 weeks). She was referred to our medical genetics maglobulinemia or hypogammaglobulinemia, as well as department for further testing due to fetal malformation of rearrangements of chromosomes 1, 9, 16, adjacent to the the central nervous system, meningocele diagnosed by centromere, in the heterochromatin regions. ultrasound.Weperformedkaryotypeanalysisoftheproduct Clinical Findings: A 16-year-old male patient was of conception and analysed 70 cells. referred to our outpatient clinic for genetic analysis with a Results: The ﬁnal cytogenetic result according to ISCN preliminary diagnosis of ICF syndrome, due to recurrent 2016 was: mos 46,XYqh-,inv(7)(p12q21)[61]/46,XX[9]. lower and upper respiratory tract infections from a young The structural modiﬁcation identiﬁed in the majority of age.Thepatientistheonlysurvivingchildofthefamilyand celllines(themaleline),theinversion,hasthebreakpoints no feature has been deﬁned in his own and family history. mostlikelyintheregions7p12and7q21anditcouldbethe In the physical examination; hypertelorism, nasal root cause of the malformation discovered by ultrasound. The ﬂatness, deeply located eyes, ﬂat and wide forehead, normal cell line (the female line), might be the result of frequent hard and black hair were present. The ear was vanishing twin syndrome, possible sexual ambiguity of the located downward and the bucket was facing forward. fetus or maternal contamination. Results: Immunoglobulin (Ig) levels: A, G and M were Conclusions: Considering even the possibility of mater- lower than normal. IgE levels were normal. In Ig G nal contamination, the diagnostic value for this case is of subtyping, IgG1, G2 and G4 levels are higher than normal. great importance,since it stillofferstheexplanationfor the + + + CD3 , CD4 , CD8 were detected. Chromosomal analysis pregnancy loss. To conclude, we consider karyotyping revealed 46 XY. Chromosomal instability in the perisen- analysis of the product of conception to be of a great value tromeric heterochromatin region of chromosomes 1, 9 and when diagnosing the causes of miscarriages. 16, decondensation of chromosome 9 and speciﬁc multi- D. Sabau: None. F. Nițu: None. S. Grigore: None. C. branch chromosome structure was detected. Tatai: None. D. Guzun: None. P. Apostol: None. Conclusion: According to our karyotype analysis of the patient decondensation of chromosome 9, multi-branch E-P14.12 chromosome structure, low levels of immunglobulins and ADAMTS1, THBS1, RBFOX2 and WHSC1 gene accompaning dysmorphic face was considered as a ICF expression as a biomarker of individual radiosensitivity syndrome. in human lymphocytes A. KalayciYigin:None.F.Ozdemir:None.A.Ozaydin: R. Savchenko1, S. Vasilyev1, V. Fishman2, E. Sukhikh3, None. M. Seven: None. O.Gribova4,Z.Startseva4,A.Murashkina5,A.Dorofeeva6, D. Shunkova6, I. Lebedev1 E-P14.11 A case of mosaicism with two different sex cell lines 1Research Institute of Medical Genetics, Tomsk National detected by chromosome analysis in a second trimester Research Medical Center of RAS, Tomsk, Russian Federa- spontaneous miscarriage tion, 2Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russian Federation, 3Tomsk Regional Oncol- ogy Center, Tomsk, Russian Federation, 4Cancer Research948 J.delPicchia Institute,TomskNationalResearchMedicalCenterofRAS, Genetics Service, Cambridge, United Kingdom, 3Adden- Tomsk, Russian Federation, 5National Research Tomsk brookes Hospital, Cambridge University NHS Foundation State University, Tomsk, Russian Federation, 6Siberian Trust, Cambridge, United Kingdom, 4Department of State Medical University, Tomsk, Russian Federation Paediatrics, University of Cambridge, Cambridge, United Kingdom The search for genetic markers of human individual radio- sensitivity is important. The microarray analysis of gene Introduction: Microarrays are increasingly requested as a expression in human lymphocytes revealed the correlation ﬁrst-linegeneticinvestigationforchromosomeanomaliesin of ADAMTS1, RBFOX2, THBS1 and WHSC1 gene the neonatal population. Paediatricians, frequently trainees, expression with the spontaneous γH2AX foci level and the usuallychoosetheindicationandtakeconsent.Thisisoften radiation-induced micronuclei frequency. The aim of this withoutspeciﬁctraininginhowtoconsentforgenetictests. study was to assess the possibility of predicting individual Materials and methods: We conducted a retrospective radiosensitivity using analysis of ADAMTS1, RBFOX2, study over one year on our tertiary neonatal unit to assess THBS1 and WHSC1 gene expression and methylation level theindications,consentprocess,diagnosticyieldandresults of their promoters. We analyzed the blood lymphocytes delivery for microarray testing. obtained from 47 individuals, included 20 male and 27 Results:Of98neonatalmicroarraystherewasdocumen- female after exposure to 2 Gy of γ-rays in vitro. The tedevidenceofconsentin62%ofcasesandinonly2%was micronucleus frequency was assessed using FISH-based consent informed with documented discussion about micronucleus test with pancentromeric probes. The gene prognostic information, variants of uncertain signiﬁcance expression level was analyzed by real-time PCR. Targeted (VUS), incidental ﬁndings and possible implications for bisulﬁte analysis by NGS was used to estimate the methy- family members. Nearly a quarter of microarrays were lationlevelofgenepromoters.Themicronucleusfrequency requested for intra-uterine growth restriction without was correlated with expression of ADAMTS1 (R=-0.52, congenitalanomalies,andinthisgroupnolikelypathogenic p=0.033), THBS1 (R=-0.52, p=0.03) and WHSC1 (R=- variants were identiﬁed. Four times more VUS were 0.37, p=0.032) in non-irradiated cells and with expression identiﬁed than likely pathogenic copy number variants. In of THBS1 (R=-0.53, p=0.033) and RBFOX2 (R=-0.30, 41% of cases, there was no documentation that the results p=0.027) after irradiation. Simultaneous use of expression had been communicated to the parents. However, all cases levels of all analyzed genes allowed to identify individuals with clinically actionable ﬁndings were referred to clinical withincreasedradiation-inducedmicronucleusfrequencyin genetics. groups of male (p=0.00026), female (p=0.048) and all Conclusions: There is a need to build greater consensus individuals (p=0.0009). DNA methylation level was cor- on the indications for microarray testing in neonates, and related with expression of RBFOX2 only (R=-0.58; trainingforpaediatriciansregardinghowtotakeadequately p=0.009). It is possible to identify individuals with informed consent for genetic testing. Citation:Andrews K, increased radiation-induced micronucleus frequency using Prapa M, Radford E, et al Taking consent for neonatal gene expression level of analyzed genes, but not the microarrayanalysisasascreenforgenomicrearrangements: methylation level of gene promoters. This study was sup- arepaediatriciansequippedforthegenomicera?Archivesof portedbyGrantofthePresidentofRussianFederationMK- DiseaseinChildhoodPublishedOnlineFirst:28September 5944.2018.4 and RFBR grant №19-34-90143. 2019. doi: 10.1136/archdischild-2019-317966 R. Savchenko: None. S. Vasilyev: None. V. Fishman: K.A. Andrews*: None. M. Prapa*: None. E.J. Radford*: None. E. Sukhikh: None. O. Gribova: None. Z. Startseva: None. I. Simonic: None. S. Holden: None. G. None. A. Murashkina: None. A. Dorofeeva: None. D. Belteki: None. Shunkova: None. I. Lebedev: None. E-P14.20 E-P14.14 Could be a supernumerary marker chromosome in Aretrospectivestudyofindicationsandconsentprocess mosaic associated with pregnancy loss? A case report forneonatalmicroarrayanalysisasascreenforgenomic rearrangements P. APOSTOL, M. Cristea K. A. Andrews*1,2, M. Prapa*1,2, E. J. Radford*3,4, Clinica Sante – Genetic Expert Center, Bucharest, I. Simonic1, S. Holden1,2, G. Belteki3, * equally shared Romania 1DepartmentofMedicalGenetics,UniversityofCambridge, Fertility problems are became common disorder in the last Cambridge, United Kingdom, 2East Anglian Medical time.Althoughcytogeneticabnormalities(e.g.thepresenceAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 949 of a supernumerary marker chromosomes) represent an automatically identify facial phenotypes of patients with important cause of abortions, for some of couples the small supernumerary marker chromosomes we already etiology remains unexplained. established successfully Emanuel (ES) and Pallister-Killian A couple, both partners of 38 years old, was refereed to Syndrome (PKS) identiﬁcation from 2D facial photos. The our center for genetic investigations. In their history a comparison between ES or PKS and normal individuals pregnancy loss in the ﬁrst trimester due to foetal cardiac expressed a full separation between the cohorts. These defects (ultrasonographically detected) is described. A resultsshowthatNPGisabletohelpintheclinic,andcould peripheral blood sample was collected and karyotype was reduce the time patients spend in diagnostic odyssey. The performed from two independent cultures. Chromosome same development is currently undertaken for cat-eye syn- analysis was performed using the classical G-banding drome. It became possible thanks to a grant from NORD. method (650 bands resolution). Thelinkforthepresentprojecttouploadpicturesofcat-eye Cytogenetic analysis, done by two observers, shown a syndromewillbeprovidedontheposter.NPGalsohelpsto normal karyotype for the wife (46,XX), while the husband differentiate ES or PKS from each other and other patients was found to have a mosaic karyotype: mos 46,XY,22pstk with small supernumerary marker chromosomes and most +[78]/47,XY,22pstk+,+mar[8](accordingtoISCN2016). likely also from patients with cat-eye syndrome. Thus, Forthiscase86metaphaseswereanalysed–78metaphases especiallyincountrieswithnoaccesstomoresophisticated with a normal polymorphism 22pstk+ and 8 metaphases geneticapproachesapartfrombandingcytogeneticsNPGis with a supernumerary marker chromosome with unknown averytimelyapproach.Inclusionofmorefacialpicturesof chromosome origin. Further studies, including molecular patient with sSMC, like cat-eye-, isochromosome-18p- analyses to highlight the breakpoint, are necessary in order syndromeorothersmaycontributetohigherdetectionrates toidentifytheoriginofthismarkerchromosome.Fewcases in future. Supported by NORD Research Program grant of supernumerary marker chromosome are described in the number 18002. literature, most of them of small size and associated with T. Liehr: None. A. Al-Rikabi: None. different phenotypes, including infertility. In conclusion, although only 9.3% of the investigated E-P15.05 metaphases had the chromosome marker, proper genetic Performance evaluation study of INNO-LiPA® counseling is recommended for the couple. Although the CFTRiage potential risk of this supernumerary marker chromosomes for pregnancy loss cannot be deﬁned, it should be C. Dobbels1, L. Tremmerie1, M. Seia2, M. D’Apice3, considered for further pregnancies and prenatal genetic M. Lucarelli4, K. Stouffs5, S. Seneca5, A. Gheldof5, tests should be done. C. Orsini6, G. Mersch1, V. Kostanjevecki1 P. Apostol: None. M. Cristea: None. 1Fujirebio, Gent, Belgium, 2Medical Genetics Lab, Milan, E-P15 New Technologies and Approaches Italy, 3PTV Foundation, Rome, Italy, 4Dipartimento di Medicina Sperimentale, Rome, Italy, 5Center for Medical E-P15.04 Genetics, Brussels, Belgium, 6Fujirebio Italia S.r.l., Rome, Towards Next-Generation Phenotyping (NPG) for cat- Italy eye syndrome Objectives: The INNO-LiPA® CFTRiage assay based on T. Liehr, A. Al-Rikabi reverse-hybridization is a simple method allowing simulta- neous analysis of 88 CFTR mutations with automatic Jena University Hospital, Institute of Human Genetics, interpretation using LiRASTM for LiPA Cystic Fibrosis Jena, Germany v.5 software. By performing just one ampliﬁcation and hybridizationwiththeINNO-LiPACFTRiage>95%ofthe We presently work together with the company FACE2- samples can already be characterized. Worst case 2 addi- Gene, (https://www.face2gene.com/) to establish the possi- tional conﬁrmation strips, using the same amplicon, are bilitytorecognizecat-eyesyndromejustbyanalyzingfacial requiredtoobtaincompletecharacterization.Theaimofthe pictures of an individual patient. Forms of next generation study was to assess the success rate, agreement with a phenotyping(NPG)areneededtoincreasefurtherthevalue reference result and reproducibility of the INNO-LiPA® of any kind of genetic approaches, including timely con- CFTRiage assay. siderationof(molecular)cytogeneticsduringthediagnostic Methods: To assess the success rate and agreement, quest. As NGP we used in this study the facial dysmor- 324 stored DNA samples from (suspected) CF patients, phology novel analysis (FDNA) technology. To heterozygous carriers and healthy subjects were tested at 3950 J.delPicchia external sites. The DNA was ampliﬁed with the OneAmp rareassociationofcitrindeﬁciencyandprogressivefamilial kit and consecutively tested with the INNO-LiPA® intrahepatic deﬁciency (PFIC 2). CFTRiage strips and, where applicable with the INNO- Material and methods: The proband is a 3-month-old LiPA® CFTR conﬁrmatory strips. For reproducibility boy, born from consanguineous union. He presented with testing, a panel of 6 DNA samples was tested at three sites intermittentjaundicefrom15daysafterbirth,withelevated (2 external, and 1 in-house), by different persons, on transaminase and alpha-fetoprotein serum levels, very high different days, on different instruments, and in-house on 3 serum bile acid concentration, and normal serum gamma- different lots of the INNO-LiPA CFTRiage. glutamyltransferase (GGT) activity. An expanded panel- Results: The success rate was 100.0% (95% CI based NGS was performed on genomic DNA from the [99.2%;100.0%]). An agreement of 99.7% (95% CI proband, including 29 genes implicated in PFIC, and [98.6%;99.7%]) between INNO-LiPA CFTRiage assay additional 224 other genes for cholestasis. and the reference result was obtained. The reproducibility Results: Two different homozygous variants were of the INNO-LiPA CFTRiage was 100.0% (95% CI of identiﬁed in the child: A c.1062T>A in ABCB11 gene [98.6%; 100.0%]). responsible for PFIC2, and a novel probably pathogenic Conclusion: The study proved that the INNO-LiPA® variantinSLC25A13gene responsible for citrindeﬁciency. CFTRiage assay has an excellent performance and is an Both parents were heterozygous for both variants. easy to use assay to detect 88 CFTR mutations Conclusions: Using large panel-based NGS allowed the simultaneously. identiﬁcation of a combination of two rare intricate C.Dobbels:None.L.Tremmerie:A.Employment(fullor inherited causes of neonatal cholestasis, needing an part-time); Modest; Fujirebio. M. Seia: None. M. D’Apice: appropriate treatment and dietary management to avoid None. M. Lucarelli: None. K. Stouffs: None. S. Seneca: complications. None.A.Gheldof:None.C.Orsini:A.Employment(fullor H. Fredj: None. S. Hizem: None. Y. Elaribi: None. I. part-time); Modest; Fujirebio. G. Mersch: A. Employment Rejeb: None. H. Jilani: None. M. Sebai: None. M. (full or part-time); Modest; Fujirebio. V. Kostanjevecki: A. Chaabouni: None. F. Broly: None. L. Ben Jemaa: None. Employment (full or part-time); Modest; Fujirebio. E-P15.08 E-P15.06 Sequencing Illumina DNA libraries on BGISEQ-500 Association of two rare inherited causes of neonatal sequencing platform using custom protocol intrahepatic cholestasis revealed by next generation sequencing J. A. Vnuchkova, P. A. Koshkin, D. V. Pyankov, S. A. Korostelev H. Fredj1, S. Hizem1, Y. Elaribi1, I. Rejeb1, H. Jilani1, M. Sebai1, M. Chaabouni2, F. Broly3, L. Ben Jemaa1 Genomed Ltd, Moscow, Russian Federation 1Department of Congenital and Hereditary Diseases, Introduction: Convertion of Illumina DNA libraries to Mongi Slim Hospital, La Marsa, Tunis, Tunisia, 2pediatric DNA nanoballs and subsequent sequencing on BGI/MGI clinic, Sfax, Tunisia, 3Service Toxicologie et Génopathies. sequencing platforms could resolve potential problem of InstitutdeBiochimieetBiologieMoléculaireCHUdeLille, obtaining optimal cluster density on Illumina platforms. In Lille, France this study we describe a custom protocol for sequencing Illumina DNA libraries on BGISEQ-500 sequencer and Introduction: Neonatal cholestasis is a heterogeneous presentcomparativeanalysisofdataobtainedfromNextSeq groupofraredisordersofimpairedbileﬂowinthenewborn 500 and BGISEQ-500 sequencers. and young infant, some of which might be fatal if not Materials and methods: Set of 48 DNA libraries was identiﬁed and treated rapidly. More than 100 inherited prepared using Swift 2S Turbo DNA Library Kit (Swift etiologies were identiﬁed to cause cholestatic liver diseases Bioscience)andNimbleGenSeqCapHybridizationreagents with the initial presentation of jaundice. Clinical diagnosis and probes (Roche). Sequencing was performed on of neonatal cholestasis is considered to be an extremely NextSeq500andBGISEQ-500platforms.Oligonucleotides challenging process. With the advent of next generation for library convertion and BGISEQ-500 sequencing were sequencing (NGS), it becomes possible to rapidly identify ordered from Microsynth (Switzerland). Demultiplexing of the genetic cause of such disorders in a high-throughput BGISEQ-500 data was performed using custom tool. manner. We report on a case of neonatal cholestasis FastQC, aligning and coverage analysis were performed investigated by an expanded panel-based NGS, revealing a using FASTQC, BWA MEM and Mosdepth tools. VariantAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 951 calling was performed using in-house pipeline for clinical Results: We included 53 patients. Twenty-three children variant interpretation based on ACMG criteria. (43.4%) presented emergence delirium. Eight children with Results: Custom protocol for sequencing Illumina DNA emergencedeliriumandeightcontrols(afterageandgender libraries on BGISEQ-500 was developed. Comparative matching) were selected for methylation proﬁle evaluation. analysis of Illumina and BGI data was performed. We Copy number variation analysis demonstrated no presence observed comparably good quality in both datasets accord- of pathogenic deletions or duplications. Analysis of ing to various quality control metrics, even having a better methylation raw data showed a difference in the average qualityforBGISEQ-500data.Variantcallingshowedsome beta value between cases and controls in selected diversity in general amount of obtained variants between chromosomes. two platforms, however all clinically signiﬁcant variants Conclusions: Our results suggest that DNA methylation were similar in both datasets. proﬁles may present signiﬁcant differences between chil- Conclusions:Ourstudysuggeststhatdevelopedprotocol dren with emergence delirium and controls, including is acceptable for sequencing hybridization-based DNA speciﬁc genomic regions. Therefore, we emphasize the libraries. The limitation of the method is a necessity to importance of investigating and identifying epigenetic use unique single indexes. The development of library alterationstounderstandthisrelevantclinicaladverseevent. convertion kit based on this study is potential. V. Quintao: None. Y. Gasparini: None. V. Almeida: J.A. Vnuchkova: None. P.A. Koshkin: None. D.V. None.A.Dias:None.M.Montenegro:None.M.Carmona: Pyankov: None. S.A. Korostelev: None. None. L. Kulikowski: None. E-P15.09 E-P15.10 InvestigationoftheDNAmethylationproﬁleinchildren Gene expression proﬁling of RNA samples from frozen presenting emergence delirium blood and optimization of sample storage conditions V. Quintao1,2, Y. Gasparini2, V. Almeida2, A. Dias2, E. Koh, S. Yu, S. Hwang M. Montenegro2, M. Carmona1, L. Kulikowski2 Hanyang University, Ansan, Korea, Republic of 1Hospital das Clinicas HCFMUSP, Faculdade de Medi- cina, Universidade de Sao Paulo, Sao Paulo, Brazil, Gene expression proﬁling is one of the most powerful 2Laboratorio de Citogenomica, Hospital das Clinicas technologies to understand bio-molecular alterations which HCFMUSP, Faculdade de Medicina, Universidade de Sao are affected by external stimulus such as environmental Paulo, Sao Paulo, Brazil toxicants. In order to obtain reliable interpretation of these data,integrityofRNAshouldbeprimarilyqualiﬁed,which Introduction: Among cognitive changes related to anes- is determined from the very moment of sample collection thesia,emergencedeliriumisfrequentinchildrenandcould and storage conditions. In the meantime, whole blood can be observed in up to 30% of cases. The occurrence of beobtainedwithless-invasivewaycomparedtootherssuch delirium may be related to postoperative cognitive and as tissues. However, blood is vulnerable to freezing and behavioral changes. Recent studies demonstrated the often loses its availability for RNA downstream applica- involvement of epigenetic processes in the behavioral tions. In this study, we compared changes of RNA quality changes related to anesthesia. Thus, performing the DNA accordingtotheseveralsamplestorageconditionsincluding methylation proﬁles is an important tool for studying the temperature and duration of incubation before freezing, role of epigenetic factors in these events. long-term freezing and types of collection tubes. After Materials and methods: After IRB approval, children simple QC steps, we performed mRNA-seq to compare between1and12yearsold,submittedtogeneralanesthesia gene expression patterns of RNAs from various storage for endoscopic procedures, were recruited. Emergence conditions. We found that quality of RNA samples is deliriumwasconsideredasPediatricAnesthesiaEmergence obviouslyaffectedbystorageconditionsleadingtochanges Delirium Scale score ≥ 10. DNA from blood lymphocytes in gene expression patterns compared to control (Fold were extracted by QIAamp DNA BloodMidi Kit (QIA- changes>|2|). Differentially expressed genes in this study GEN®). The genomic array was performed using iScan are grouped as snoRNA family, which is involved in (Illumina®) with HumanCytoSNP850K and Inﬁnium structureofrRNA,tRNAandsoon.Asaresults,wesetthe MethylationEPIC BeadChips. Arrays data were treated guideline for optimal blood sample storage. By proceeding and analyzed using Bluefuse®, GenomeStudio®, and to further study, it is expected to set the markers for RNA speciﬁc packages in R environment. samplequalitybyinducingwhetherthesegenestakecharge in RNA degradation in some ways. This study was952 J.delPicchia supported by Korea Environment Industry & Technology F. Zimmer1, N. Pluta1, B. Wolf2, D. Atlan3, A. Zaum1, Institute(KEITI)through"the Environmental Health Action S. Rost1 Program", funded by Korea Ministry of Environment (MOE) (2017001360005). 1Institute of Human Genetics, Wuerzburg, Germany, E. Koh: None. S. Yu: None. S. Hwang: None. 2iCoSys, Fribourg, Switzerland, 3Phenosystems SA, Braine le Chateau, Belgium E-P15.12 Quick assessment of antioxidant effects in combined Introduction: Whole genome sequencing (WGS) is treatments measuring catalase gene activity in vitro becoming more and more meaningful not only in human genetic research but also for future molecular genetic N.Tomic,M.Hadzic, N. Lojo-Kadric, J.Ramic,L.Pojskic diagnostics. The main challenges in WGS lie in data ana- lysisandvariantinterpretationratherthaninthesequencing University of Sarajevo, Institute for Genetic Engineering technology itself. The detection of disease-causing variants and Biotechnology, Sarajevo, Bosnia and Herzegovina in those extensive genome data requires the application of appropriate software tools. Luteolin isthe bioﬂavonoidwith known protective roles. It Materials and methods: Here we present the data inhibited genotoxicity experimentally induced by haloge- analyses of four genomes from patients with muscular natedboroxine(HB).Statisticallysigniﬁcantdecreaseinthe dystrophies (without mutations using gene panel or exome frequency of micronuclei and nuclear buds was observed sequencing) by applying the software GensearchNGS before, but mechanism of its anti-genotoxic activity is not (PhenoSystems). We used integrated variant calling, CNV clear. Since HB is recognized as inhibitor of catalase tools and anomaly scans together with external tools (e.g. activity as a major antioxidant enzyme, we designed cnMops, Alamut, CADD) to analyze and validate the experiment to assess antioxidative effects of luteolin on patient’s data (see table). level of relative expression of catalase (CAT) gene. Cell cultures from peripheral blood lymphocytes of ﬁve healthy Results: donors were established and treated with luteolin, HB, and patient 1 2 3 4 luteolinand HBcombined. After 72hours incubation,total sex F M F M RNA was isolated from harvested cells and reverse-tran- geneof SGCG DMD DMD DMD scribed.SYBRbasedReal-TimePCRampliﬁcationmethod interest (goi) for analysis of relative gene expression in treated cultures aligned 1.262.574.555 1.072.189.661 666.864.288 680.631.017 was used. Analysis of results included normalization of sequences ratiooftarget(CAT)andhousekeeping(GAPDH)geneand fastq(Gb) 90,9 77,9 48,1 48,9 statistical analysis (REST®). Signiﬁcant up-regulation of mean 64 29 34 18 coverage CAT expression on transcriptional level was found in (goi) simultaneously treated cultures when compared with cul- variants 5.706.907 5.679.385 5.635.599 5.709.193 (total)* tures treated with each substance individually. In luteolin- variants 453 2.321 3.151 2.003 treatedcultureswhencomparedtoHB-treatedculturesCAT (goi)* candidate homozygousSNV pending heterozygous hemizygous expression was down regulated but not statistically sig- variant intron1 SNV deletion niﬁcant.Incomparisontocontrol(DMSO),CATexpression intron63 intron2 splice crypticacceptor pending cryptic unknown was up regulated in simultaneously treated cultures but in effects(in activated acceptor individuallytreatedculturesitwasdownregulated,withno silico activated prediction) statistical signiﬁcance. Obtained results may indicate that comments musclebiopsy: RNA-analysisof skewedX- heterozygous new approaches to the treatment of skin changes with HB reducedgamma- DMDwithout inactivation intronic sarcoglycan pathological deletion should include luteolin and monitoring corresponding expression ﬁndings (SGCG) antioxidant system. For more precise determination of *variantcallingoptions:frequency>20%,coverage>5 luteolin effects and potential, more treatments and genes should be explored. N. Tomic: None. M. Hadzic: None. N. Lojo-Kadric: Conclusion:Inatleastthreeoutoffourpatients,deﬁnitely None. J. Ramic: None. L. Pojskic: None. suffering from muscular dystrophies, we could detect promising structural variants and/or SNVs in the non- E-P15.13 coding regions of known genes (DMD, SGCG). The most Closing the diagnostic gap on muscular dystrophies promising candidate variants are now under considerationAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 953 forfurtherfunctionalstudiesinordertoconﬁrm/excludethe Employment (full or part-time); Signiﬁcant; Fluidigm. T. deleteriousness of those variants. Goralski: A. Employment (full or part-time); Signiﬁcant; F. Zimmer: None. N. Pluta: None. B. Wolf: None. D. Fluidigm. C. Kubu: A. Employment (full or part-time); Atlan: A. Employment (full or part-time); Signiﬁcant; Signiﬁcant; Fluidigm. R. Kung: A. Employment (full or Phenosystems SA. A. Zaum: None. S. Rost: None. part-time); Signiﬁcant; Fluidigm. B. Lacar: A. Employ- ment (full orpart-time); Signiﬁcant;Fluidigm.C.Park:A. E-P15.17 Employment (full or part-time); Signiﬁcant; Fluidigm. M. Nanoscale automation of RNA sequencing library Phelan: A. Employment (full or part-time); Signiﬁcant; preparation on a microﬂuidic platform Fluidigm. G. Sun: A. Employment (full or part-time); Signiﬁcant; Fluidigm. D.A. King: A. Employment (full or A. Hamilton1, S. Chamnongpol2, J. Alipaz2, J. Brockman2, part-time); Signiﬁcant; Fluidigm. B. Fowler2, J. A. Geis2, T. Goralski2, C. Kubu2, R. Kung2, B. Lacar2, C. Park2, M. Phelan2, G. Sun2, D. A. King2 E-P15.18 Using RNA-Seq as complementary diagnostic tool in 1Fluidigm GmBH, Munich, Germany, 2Fluidigm Corpora- congenital heart defects: pilot study in a group of tion, South San Francisco, CA, United States transplanted children Insights from the analysis of expressed gene products by A. del Pozo1, C. Rodríguez-Antolín2, R. Martín-Arenas3, Á. RNA sequencing enables human disease researchers to González-Rocafort4,M.Solís1,B.Ruz2,L.GarcíaGuereta4, better understand the underlying structure and function of L. Fernández García-Moya2, E. Vallespín1 genes of interest. We developed a microﬂuidics-based solution that automates many tedious hands-on steps of the 1INGEMM - Hospital Universitario La Paz - CIBERER, RNA-seq library prep workﬂow including poly(A) RNA Madrid,Spain,2INGEMM-HospitalUniversitarioLaPaz, selection. The method generates up to 48 random-primed Madrid, Spain, 3Genycell Biotech España, Madrid, Spain, stranded RNA-seq libraries from as little as 10 ng of total 4Cirugía Cardiaca Infantil. Hospital Universitario La Paz, RNA. Nanoliter reaction volumes signiﬁcantly reduce Madrid, Spain reagent consumption tolower overall costs persample.We aredevelopinganoptionforuseofuniquedualindex(UDI) TheimplantationofNGSinclinicalroutinehassupposeda tags to improve proper assignment of reads reported for great advance in the diagnostic of mendelian diseases pro- sequencers with patterned ﬂow cells, such as the Illumina® viding very valuable information for disease management. NovaSeq™. In this poster, results from an internal analy- Still there are cases where NGS testing does not provide a tical study of the Advanta™ RNA-Seq NGS Library Prep conclusive diagnosis due to the limits that present studies Kit and a comparison to results obtained from the Illumina based exclusively on DNA analysis specially in the inter- TruSeq® Stranded mRNA Kit are presented. Our study pretation of challenging variants as those within intronic, included >900 samples at 10 and 100 ng of input that regulatory or splicing regions. generated genome mapping rates >80%, with rRNA reads Recent works endorse RNA-Seq as a complementary <10%. Technicalreplicatecorrelations wereobservedtobe technique that would provide more evidences to lead to a >98% inall conditions. Acomparable numberof genes are diagnostic.Althoughpromisingresults,methodologicaland detectedinlibrariespreparedwitheitherAdvantaorTruSeq qualityissuesmustbedeterminedtoensureclinicalvalidity/ kits. The Advanta RNA-Seq Kit provides an RNA-seq utility of the study. library prep solution offering walkaway automation that In this work, it had been selected a group of 9 pediatric substantially minimizes manual pipetting steps and hands- patients who had undergone a heart transplant surgery on time. The inclusion of UDIs further improves the during the period 2018-2019 due to a congenital heart workﬂow with high-data-output sequencers such as the defect with negative or inconclusive result for gene- NovaSeq.ForResearchUseOnly.Notforuseindiagnostic panel study. procedures. Ithasbeendesignedapilotdiagnosticschemetoachieve A. Hamilton: A. Employment (full or part-time); arobustdiagnosisthatincludestheDNAinformationofthe Signiﬁcant; Fluidigm. S. Chamnongpol: A. Employment patients together with RNA-Seq data from their cardiac (full or part-time); Signiﬁcant; Fluidigm Corporation. J. tissue from the discarded heart. Alipaz: A. Employment (full or part-time); Signiﬁcant; The RNA-Seq pipeline integrates several tools that Fluidigm. J. Brockman: A. Employment (full or part- compares a target sample against a control cohort selected time); Signiﬁcant; Fluidigm. B. Fowler: A. Employment from the GTEx project. It includes tools for: 1) aberrant (full or part-time); Signiﬁcant; Fluidigm. J.A. Geis: A. splicing events identiﬁcation, 2) aberrant expression954 J.delPicchia quantiﬁcationand3)identiﬁcationofallele-speciﬁcexpres- E-P15.21 sion of variants determined both by DNA-Seq and RNA- The use of artiﬁcial intelligence to assess factors of Seq. genetic predisposition to cancer of the uterine body This study has enabled the characterization of a new candidate and the study of previous VUS variants what I. Ugarov1, V. Chernyh1,2, I. Sharkova1,2, N. Ivanov1, shows the potential of such approaches to be adopted in V. Maslennikov1, D. Ostapenko1, V. Solovey1 routine diagnosis. A. del Pozo: None. C. Rodríguez-Antolín: None. R. 1xGen Cybernetics, Moscow, Russian Federation, 2Federal Martín-Arenas: A. Employment (full or part-time); Sig- state scientiﬁc budgetary Institution «Research Centre for niﬁcant; Genycell Biotech España. Á. González-Rocafort: Medical Genetics», Moscow, Russian Federation None. M. Solís: None. B. Ruz: None. L. García Guereta: None. L. Fernández García-Moya: None. E. Vallespín: UterineCorpusEndometrialCarcinoma(UCEC)isamalignant None. multifactorial neoplasm which is characterized by high pre- valence. Currently, there are no screening methods for asses- E-P15.20 singgeneticpredispositiontoUCEC,sothedevelopmentofan Try to ﬁnd the somatic mutation in the brain! approach to analyzing the results of genetic testing, devoid of the previously described shortcomings and providing identiﬁ- J. Kárteszi cation of variants characteristic of multifactorial pathology, is an actual problem. Objective: to develop an approach to Genetic Laboratory, Zalaegerszeg, Hungary identifypatternsintheresultsofgenetictestingthataretypical forpatientswithmultifactorialcancerandtodevelopagenetic It was demonstrated in recent years that somatic mutations panelforscreeningforpredispositiontoUCEC.Materialsand happen in neuronal stem cells. However, the effect of methods: For a set of genes, the analysis of refereed scientiﬁc somatic mutations during tumorigenesis had been proven articles on the following keywords was performed:" Uterine long time ago. We also know that some clue oncogenes Corpus Endometrial Carcinoma"," predisposition"," muta- have important role in neurodevelopment and maintenance tion","SNP".DatafromTumorPortalwasusedtoevaluatethe ofbrainintegrity.Basedoncommonregulatorypathwaysin model’s performance (http://www.tumorportal.org/) and the both tumorigenesis and neurodegeneration I discuss the CancerGenomeAtlas(TCGA).Basedonthedata,twogroups possible use of oncogenetic research evidences in the were formed: patients with UCEC (n=248) and a control explanation of devastating neurogenic diseases. “Loss of cohort of patients with other nosologies (n=6498). Results: a heterozygosity” is widely used in tumour genetics. On the methodhasbeendevelopedthatallowsustoidentifyscreening other hand, plenty of neurogenic disorders were described patterns of multifactorial conditions. Patterns and a mathema- with “dominant negative effect” which meant loss of tical model based on the method takes into account genetic functionoftheeffectedgenes.Datawerecollectedthatuntil variants in 229 genes related to UCEC, showing 79% sensi- the normal allele functioned well this effect didn’t work. tivity and 85% speciﬁcity. Screening patterns cover all highly Somatic mutation in neuronal stem cells containing a signiﬁcant mutated genes according to Tumorportal data, germline mutation may destroy the function of the normal excluding CCND1, ERBB3, ZNF471, and ING1. The use of allele. I propose that neurodegeneration can be clonal dis- artiﬁcialintelligence to assess factorsof genetic predisposition order in some instances. The complicated pathogenesis of to cancer of the uterine body and preclinical prevention. Parkinson disease is highly studied and GBA (beta-gluco- I. Ugarov: None. V. Chernyh: None. I. Sharkova: None. cerebrosidase) gene heterozygous mutations were found N. Ivanov: None. V. Maslennikov: None. D. Ostapenko: morefrequentlyinthefamilialformofthedisease.Gaucher None. V. Solovey: None. disease is an autosomal recessive lysosomal storage dis- order caused by glucocerebrosidase deﬁciency. It was E-P15.22 detectedthatParkinsondiseaseismorefrequentinGaucher The ﬁrst Albanian case of Waardenburg syndrome type Ipatientsbutalso inthecarrier parents.Liquidbiopsy type 4A iswellknownintumour research.Let’strytouseittoﬁnd the somatic mutation in the brain! The ﬁrst successful step A. Laku - Babameto in this direction may also lead to the understanding of a subset of autosomal dominant neuronal diseases with Service of Genetic Laboratory, University of Medicine, incomplete penetrance. University Hospital Cenetr “Mother Teresa”, Tirana, J. Kárteszi: None. AlbaniaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 955 Waardenburg syndrome type 4 (WS4), is a very rare con- standardDNAsize.Inthisstudywetestedthepossibilityto genital disorder with variable clinical expression, char- modulate fragment length in exome-libraries using the acterisedbyHirschsprungdisease,andabnormalmelanocyte standard or a modiﬁed version of the Nextera Flex for migration, resulting in pigmentary abnormalities and sen- Enrichment bead-linked transposome (Illumina), extending sorineural deafness. Three disease-causing genes have been fragment length up to 550bp. identiﬁed:mutationsintheSOX10,END3,orEDNRBgenes M&M:Genomiclibrarieswereobtainedwiththestandard areknowntocauseWStypeIV.Variantsintheendothelin- Nextera Flex for Enrichment Library Prep kit or its new Breceptor(EDNRB)geneon13q22regionhavebeenfound modiﬁed version (not commercially available yet), and to cause the Waardenburg syndrome type IVA (WS 4A), subsequently enriched in exonic portions with the Illumina that combines clinical features of pigmentary abnormalities Exome Panel. Libraries have been sequenced in 150PE to of the skin, hair and irides, sensorineural hearing loss, and 80X mapped coverage. Hirschprung disease. We report a 15 months - old albanian Results: Genomic libraries with different fragment boy who was diagnosed as WS IVA. He presented clinical lengths (200, 300, 400, 500bp) have been successfully manifestations as skin and hair hypopigmentation, hyperte- generatedbyadjustingsimpleexperimentalconditionssuch lorism, broad nasal bridge, epicanthal folds, bilateral blue as bead-based size-selection and PCR extension time. homochromatic irides, mild developmental delay, muscular Exome enrichment did not change the different fragment hypotonia, short stature and constipation. The entire exome sizes, that were subsequently conﬁrmed by sequencing. has been evaluated for variants clinically relevant to the Targetcoverageandnumberofvariantsacrossthemultiple describedphenotypebythewholeexomesequencing,butit fragment sizes are being evaluated. was not detected any variant indicative of the genetic diag- Conclusions: The availability of two distinct bead-based nosis of the patient. The diagnosis was conﬁrmed by chro- transposomelibraryprepkitswillallowtogeneratelibraries mosomal microarray analysis. It was detected a 23153 kb with a wide range of fragment size, thus permitting to one copy loss on the long arm of chromosome 13. A modulate/improve genotypability in targeted resequencing. pathogenic CNV has been detected in the 13q21.1q31.1 B. Iadarola: None. M.Rossato: None. M.Paterno:None. region, totally encompassing the EDNRB gene. The D.Lavezzari:None.C.DegliEsposti:None.C.DeQuattro: EDNRB gene has been found totally deleted in our patient. None.B.Giovannone:None.G.Bhattacharjee:A.Employ- It is observed a variable phenotype in patients with hetero- ment (full or part-time); Signiﬁcant; Illumina. R. Tim: A. zygous loss of function of EDNRB gene. This is the ﬁrst Employment (full or part-time); Signiﬁcant; Illumina. M. case of WS 4A to be reported from Albania. You: A. Employment (full or part-time); Signiﬁcant; A. Laku - Babameto: None. Illumina. M. Delledonne: C. Other Research Support (supplies, equipment, receipt of drugs or other in-kind E-P15.23 support); Modest; Illumina. Generation of whole-exome-libraries with a wide-range of fragment length with the Nextera Flex bead-linked E-P16 Diagnostic Improvements and Quality Control transposome approach to improve genotypability B. Iadarola1, M. Rossato1, M. Paterno1, D. Lavezzari1, E-P16.01 C. Degli Esposti1, C. De Quattro1, B. Giovannone1, Validation of a Next Generation Sequencing BRCA G. Bhattacharjee2, R. Tim2, M. You2, M. Delledonne1 assay using buccal DNA swabs to meet current and future demands in diagnostic ﬁeld 1UniversityofVerona,Verona,Italy, 2Illumina,San Diego, CA, United States E. De Paolis1, M. De Bonis1, E. Ferri2, C. Marchetti2,3, A. Pietragalla2, G. Scambia2,3, A. Urbani1,3, A. Fagotti2,3, Introduction: Short-read sequencing in targeted resequen- A. Minucci1 cingpreventstheidentiﬁcationofclinically-relevantgenetic variants within or in close proximity to duplicate genomic 1Molecular Diagnostic and Genomics Laboratory, Fonda- regions. We recently found that the analysis of fragments zione Policlinico Universitario A. Gemelli IRCCS, Rome, longer than standard-size improves mapping quality and 00168,Italy,2DivisionofOncologicalGynecology,Depart- thus genotypability of many clinically relevant genomic ment of Women’s and Children’s Health, Fondazione regions. However, modulating fragment length in enzy- Policlinico Universitario A. Gemelli IRCCS, Rome, matic-based library preparation is challenging, as optimal 00168, Italy, 3Catholic University of the Sacred Heart, ratio between DNA/enzymes is not easily identiﬁable or Rome, Italy because bead-linked transposome chemistry is setup for a956 J.delPicchia Introduction:Mostofthecommercialsequencingmethods autosomal recessive alleles has not been established for the use blood as primary sample source of genomic DNA Brazilianpopulation.Therefore,clinicalutilityofthesetests (gDNA). Buccal swab is an emerging sample collection is not determined for this speciﬁc population. device due to convenient and non-invasive characteristics. Methods:Weactivelysearchedforpathogenicvariantsin ThisstudyassessesthesuitabilityofbuccalswabasgDNA autosomalrecessiveconditions,nottheprimaryobjectiveof source and evaluates the performance of Next Generation analysis, in 100 whole exomes performed for diagnostic Sequencing (NGS) Devyser kit for detecting BRCA patho- purposesinaprivatelaboratoryinBrazil.Commonvariants genic variants (PVs). (e.g., frequency >1%) in common recessive conditions Materialsandmethods:Swabsandbloodsampleswere (HFE, SERPINE1, BTD) were excluded from our analysis. collected from 5 healthy and 3 BRCA PVs carriers. Buccal Wereviewedthemethodologyofthreecommercialtestsfor swabswereobtainedusingFLOQSwab(COPAN,Brescia, carrier status and assessed whether variants found in our Italy) placed with NAO basket. Both sample types were cohort were covered by these commercial kits. extractedusingtheQIAmpDNAMinikit(Qiagen,Hilden, Results: Rare pathogenic variants in genes associated Germany). NGS Devyser BRCA kit (Devyser, Hägersten, with autosomal recessive conditions were found in 37% of Sweden)was usedfor theBRCA ampliﬁcation. Sequencing patients.Amongthese patients, 40,5% presentedmore than was performed on MiSeq platform (Illumina, CA, US). onevariant.Averagenumberofgenestestedbycommercial Quality parameters were evaluated from sequencing data. kits was 433. More than half (54%) of variants found were NGS data were analyzed by Amplicon Suite (SmartSeq, notuniversallycoveredbyallcommercialkitsassessed.As Novara, Italy). for individual laboratories, coverage of recessive variants Results: Concentration and quality of DNA extracted varied from 45% to 66,5%. from buccal swab samples were adequate for library Conclusion: Information about limited sensitivity for preparationandsequencing.Comparablequalityparameters carrier status panels for pathogenic variants in Brazilian result from the evaluation of NGS data across samples patientsshouldbeaddressedingeneticcounsellingtoavoid types.BRCAgeneticalterations(SNPs,PVs,CNV)detected false reassurance and adjusting expectations from couples. in buccal DNA swabs were concordant with those from The usage of larger target gene panels, or even whole matched blood samples. exome sequencing, might overcome this limitation. Conclusions: Devyser BRCA NGS kit performs as well W.A.R. Baratela: None. C.M. Moreira: None. P.R. withbuccalswabscollectedusingCopanFLOQSwabasit Sacramento-Bobotis: None. G.M.N. Filho: None. M.G. doeswithsamplescollectedfromblood.Similargenotyping Penna:None.R.R.F.Souza:None.A.C.C.Trindade:None. performances between the two DNA sources were C.R.Furuzawa:None.D.P.Pereira:None.C.Olivati:None. observed, supporting the use of buccal swabs as alternative G.M. Spolador: None. V.C. Pereira: None. R.A. da Silva: sampletypeinNGS.Largerstudyhasbeenplannedinorder None. M.N.P. Santos: None. C.R.D.C. Quaio: None. to perform the validation assay. E. De Paolis: None. M. De Bonis: None. E. Ferri: None. E-P16.03 C. Marchetti: None. A. Pietragalla: None. G. Scambia: Allele dropout caused by an AT-repeat in MME None. A. Urbani: None. A. Fagotti: None. A. Minucci: None. H.T.Hilmarsen1,P.F.Rosenegger2,Ø.L.Holla1,S.B.C. F. Reiter3, L. Strand1, G. J. Braathen1, J. Senderek4, H. E-P16.02 Høyer1, M. Auer-Grumbach4 Clinical utility of carrier status for autosomal recessive conditions in the Brazilian population 1Telemark Hospital Trust, Skien, Norway, 2Medical Uni- versity of Vienna, Vienna, Austria, 3Haukeland University W. A. R. Baratela, C. M. Moreira, P. R. Sacramento- Hospital, Bergen, Norway, 4LMU Munich University Bobotis,G.M.N.Filho,M.G.Penna,R.R.F.Souza,A.C. Hospital, Munich, Germany C. Trindade, C. R. Furuzawa, D.P. Pereira, C. Olivati,G. M.Spolador,V.C.Pereira,R.A.daSilva,M.N.P.Santos, Introduction: The MME-gene encodes a widely expressed C. R. D. C. Quaio zinc-dependentmetalloendopeptidase(Neprilysin).Biallelic sequence variants in MME cause axonal Charcot-Marie- Fleury Medicina e Saúde, São Paulo, Brazil Tooth disease and fetomaternal alloimmune membranous glomerulopathy, while heterozygous variants are suscept- Introduction: Commercial tests for carrier status determi- ibility factors for axonal Charcot-Marie-Tooth disease. The nation of common autosomal recessive conditions are cur- frameshift deletion NM_007289.3(MME):c.467delC rently offered in Brazil. Nevertheless, frequency of rareAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 957 (p.Pro156Leufs*14) has been reported as a dominant sus- molecules and diagnostic testing for hereditary cancer ceptibility factor and as a cause of recessive neuropathy. predispositionsyndromewasperformedtoidentifyinherited Materials and methods: We present three axonal risk and consider use of PARPinhibitor therapy. Treatment neuropathy families and three simplex individuals carrying with ﬁrst-line adjuvant chemotherapy concluded in October the MME c.467delC variant. Probands underwent Next- 2018. The patient relapsed (Jan 2019) and was enrolled in Generation-Sequencing (NGS); most relatives were Sanger clinical trial GYO16, receiving pembrolizumab infusions sequenced. with oral epacadostat. In Feb 2019, ctDNA was monitored Results: NGS identiﬁed heterozygous c.467delC in the usingabespokeassaydesignedfrommatched-normalwhole probands with familial disease and in two simplex cases. exome sequencing. ctDNA was initially detected (4.61 Thelastsimplexcasewashomozygous.SubsequentSanger MTM/mL) and continued to increase across multiple analysis conﬁrmed these results in all cases. Six additional timepoints (15.33 MTM/mL), consistent with the patient’s relatives appeared to be homozygotes by Sanger sequen- reported progressive disease andexitfrom GYO16 studyin cing. However, NGS showed these six individuals to be Nov. 2019. Positive ctDNA results allow opportunity to heterozygotes. Further investigation revealed a highly monitor treatment response and trending disease burden polymorphic AT-repeat in close proximity to the variant. through longitudinal screening of ctDNA levels. All heterozygous individuals who appeared homozygous Conclusion: This case study utilized three different for c.467delC were heterozygous for the AT-repeat (8AT/ molecular tests to inform and monitor cancer treatment. 13AT).Theheterozygousindividualswerehomozygousfor There arean increasing number ofmolecular genomictests the AT-repeat. incorporatedintopractice,eachwithauniquepurposeinthe Conclusions:AheterozygousAT-repeatsituatedinclose patientcontinuumofcarethatgeneticprofessionalsneedto proximity to MME c.467delC causes allele dropout on be aware of. Sanger sequencing; heterozygotes appear to be homozy- N.Hook:A.Employment(fullorpart-time); Signiﬁcant; gotes.Anincorrectdiagnosisandcascadetestingmayhave Natera,Inc.J.Wallace:A.Employment(fullorpart-time); a large clinical impact. This highlights that even a small Signiﬁcant;Natera,Inc.B.Zimmermann:A.Employment difference in nucleotides outside the primer binding sites (full or part-time); Signiﬁcant; Natera, Inc. N. Liang: A. may cause allele dropout. Employment (fullor part-time); Signiﬁcant; Natera, Inc.R. H.T. Hilmarsen: None. P.F. Rosenegger: None. Ø.L. Swenerton:A.Employment(fullorpart-time);Signiﬁcant; Holla: None. S.B.C.F. Reiter: None. L. Strand: None. G.J. Natera, Inc. U. Do: Other; Signiﬁcant; Natera, Inc (past Braathen: None. J. Senderek: None. H. Høyer: None. M. employee). S. Sawyer: A. Employment (full or part-time); Auer-Grumbach: None. Signiﬁcant;Natera,Inc.J.Saucier:A.Employment(fullor part-time);Signiﬁcant;Natera,Inc.S.Parmar:A.Employ- E-P16.04 ment (full or part-time); Signiﬁcant; Natera, Inc. A. Cancer care and a tale of three molecular Aleshin: A. Employment (full or part-time); Signiﬁcant; “genomic” tests Natera, Inc. N. Hook, J. Wallace, B. Zimmermann, N. Liang, E-P16.06 R. Swenerton, U. Do, S. Sawyer, J. Saucier, S. Parmar, Decade-long progress of molecular genetics diagnostics A. Aleshin of cystic ﬁbrosis in Khanty-Mansi region (Russia) Natera, Inc, San Carlos, CA, United States M. Donnikov1, V. Mescheryakov1, N. Satsuk2, A. Vorobyov1, L. Kolbasin3, I. Urvantseva4, O. Glotov5, Introduction: Patient-speciﬁc, bespoke assays detect cir- A. Glotov6, L. Kovalenko1 culating tumor DNA (ctDNA) by analyzing cell free DNA to monitor molecular residual disease, recurrence, and 1Medical Institute of Surgut State University, Surgut, treatment response in cancer patients. We present a case Russian Federation, 2Regional Children Clinical Hospital, study of a patient diagnosed with cancer where three indi- Nizhnevartovsk, Russian Federation, 3Medical Genetics vidual molecular tests were utilized in the care continuum. Counseling Service of Diagnostics and Cardiovascular CasePresentation:A56yoCaucasianfemalediagnosed Surgery Center (Cardiology Clinic) of KHMAO-Ugra, withstageIIIcovarianclearcellcarcinomawastreatedwith Surgut, Russian Federation, 4Diagnostics and Cardiovas- totalabdominalhysterectomywithbilateralsalpingooophor- cular Surgery Center (Cardiology Clinic) of KHMAO- ectomy, omentectomy, appendectomy, lymph node sam- Ugra, Surgut, Russian Federation, 5Department of Geno- pling,peritonectomy, and optimal tumor debulking in June, mic Medicine, D. O. Ott Research Institute of Obstetrics, 2018. Comprehensive genomic proﬁling for tumor Gynecology and Reproduction, Saint Petersburg, Russian958 J.delPicchia Federation, Saint Petersburg, Russian Federation, 6Department of Genomic Medicine, D. O. Ott Research Mutantalleleslist InstituteofObstetrics,GynecologyandReproduction,Saint № CFTRalleles(HGVS;legacy) Number Frequency Petersburg, Russian Federation (n=110) 10- rare(publishedelsewhere) 25 0.229(sum) Introduction:Cysticﬁbrosis(CF)newbornscreeningsince 36 2006 year provided patients surge requiring elucidation of genetic diagnosis but scarce molecular tools allowed detection of only major mutations speciﬁc for mixed Rus- M.Donnikov:None.V.Mescheryakov:None.N.Satsuk: sian population. Introduction of high-resolution melting None. A. Vorobyov: None. L. Kolbasin: None. I. analysis (HRMA), MLPA, NGS techniques at regional Urvantseva: None. O. Glotov: None. A. Glotov: None. L. genetics laboratory allowed to perform extensive genetic Kovalenko: None. analysis of CFTR gene. Materialsandmethods:gDNA was obtained bywhole- E-P16.07 blood column extraction; HRMA performed by “Precision- Comparison of DNA extraction methods for samples Melt Software” (Bio-Rad). MLPA performed with SALSA from old blood collections Probemix P091-D2_CFTR (MRC-Holland). NGS per- formed on MiSeq (Illumina) using NimbleGen SeqCap S. Samut Tagliaferro, A. Zejnelagic, R. Farrugia, EZ_CysFib kit, mean coverage 70x. Raw data processed S. Bezzina Wettinger with bwa, GenomeAnalysisToolKit, annotated by dbNSFP (SnpEff, SnpSift), variants ﬁltered by SNVViewer. University of Malta, Msida, Malta Results: During 2009-2019 regional genetics laboratory studied1,095gDNAsamplesfromnewbornssuspiciousfor Introduction: Limited information is available on which CF.FirstthreeyearsonlyeightCFTRmutationsweretested methods are suitable to extract DNA from 20-year-old by allele-speciﬁc PCR. Successive introduction of HRMA, blood samples and samples kept in non-ideal storage con- MLPA, Sanger sequencing and NGS allowed to perform ditions.TheaimsofthisstudyweretoassessifDNAcanbe comprehensivegeneticanalysissince2014.Werevealed36 extracted from whole blood collected and stored at -20 °C mutations (25 found once) in 110 alleles of 55 CF patients for 7-20 years, and to identify which commercial DNA (with 2 CFTR mutations), including conﬁrmed CF cases in extraction kit is most suitable for this purpose, yielding 10 adult patients. Interestingly to note year-to-year good quality DNA. increased proportion of North Caucasus mutations within Materials and methods: Nine whole blood samples regional mutation spectrum. collected in 1999, 2001 and 2012, all having low (between Conclusions: Introduction of state-of-the-art techniques 100 μL to 200 μL) blood volumes, were used in this study. in regional genetics laboratory allowed to perform timely DNA extraction was performed using three different DNA comprehensive genetic analysis of CFTR gene and deduce extraction kits, according to their respective instructions. changes in regional mutations structure related to high Results:TheQuick-DNAMiniprepPluskitproducedthe migration rate of North Caucasians to Siberia. highest DNA yield ranging from 0.51 – 20.2 µg, followed by the DNeasy Blood and Tissue kit which gave DNA Mutantalleleslist yieldsrangingbetween0.30µgand2.92µg.Incontrast,the № CFTRalleles(HGVS;legacy) Number Frequency MagAttract HMW DNA kit was less efﬁcient at extracting (n=110) DNA from these samples, with DNA yields ranging 1 c.1521_1523delCTT(p.Phe508del) 58 0.527 between 0.16 and 0.80 µg. The average yield was not 2 c.1545_1546delTA(p.Tyr515X; 6 0.055 affected by the age of the sample. 1677delTA) Conclusion: From the results obtained, it can be 3 c.274G>A(p.Glu92Lys;E92K) 5 0.046 concluded that good quality DNA can be extracted from 4 c.54-5940_273+10250del21kb(p. 4 0.036 whole blood samples biobanked for 18 to 20 years at Ser18ArgfsX16;dele2,3) -20 °C. This study was limited by the small number of 5 c.3196C>T(p.Arg1066Cys;R1066C) 4 0.036 samples. DNA concentrations were not affected by the 6 c.413_415dupTAC(p.Leu138dup) 2 0.018 number of years the blood sample was stored, but were 7 c.1397C>G(p.Ser466X;S466X 2 0.018 affected by the type of kit used to extract the DNA. (TAG)) S. Samut Tagliaferro: None. A. Zejnelagic: None. R. 8 c.1399C>T(p.Leu467Phe;L467F) 2 0.018 Farrugia: None. S. Bezzina Wettinger: None. 9 c.3209G>A(p.Arg1070Gln;R1070Q) 2 0.018Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 959 E-P16.08 de Génétique,CHU laTimone, Marseille, France, 4Service Low density oligonucleotide microarray for the detec- d’hématologie, CHU-Toulouse, Toulouse, France, 5Service tion of ethnospeciﬁc mutations causing ﬁve genetic de Génétique, CHU-Versailles, Versailles, France, disorders prevalent among the Yakut population 6Génétique, IGH, Montpellier, Montpellier, France, 7Ser- vice de Génétique, chu Cochin, Paris, France M. Savvina, N. Maksimova, A. Sukhomyasova The ACLF provides laboratories since 2005 with external North-Eastern federaluniversity, Yakutsk, Russian Federa- quality assessmentsfor thecaryotype(including FISH) and tion array-CGH. More than 70 laboratories in constitutional cytogenetics, hematology and array-CGH participate each In yakut population of republic of Sakha (Yakutia) serious year. The evolution of our practices requires continuously genetic disorders occur with relatively high frequency. There adaptation but these EQAs and their European equivalents is a pressing need for comprehensive carrier screening and have made us aware of the state of knowledge and certain moleculardiagnostic,butmethodsofgeneticdiagnosticsthat limitations reveal the loss of competence in classical cyto- commonlyusedtodayarenotabletoafforditduetothehigh genetic analysis as well as of molecular pangenomic tech- cost and time consumption for a single test. For such pur- niques. Indeed we have identiﬁed technical gaps or pitfalls poses, we developed an ethnicity-speciﬁc assay based on that we will illustrate with 2 examples. Postnatal Cytoge- DNA microarray. Microarray is designed to address most netics: We proposed a pericentric chromosome 5 inversion prevalentmutationsamongyakutpopulation:4582_4583insT inv(5)(p13q13)consideredavariantintheliterature.Alarge inCUL7gene,с.5741G>AinNBASgene,с.806С>ТinDIA1 discrepancy was observed between laboratories reporting gene, c.1090G>C in FAH gene, c.-23+1G>A in GBJ2 gene thischromosomeapolymorphismandothersreasoningasa causing 3-M syndrome, SOPH-syndrome, Tyrosinemia type classicpericentricinversion.The"youngest"cytogeneticists 1,Methaemoglobinaemiatype1,Nonsyndromichearingloss have lost experience regarding a variant not recently anddeafness(DFNB1)type1Arespectively.Oligonucleotide reportedintheliterature.PostnatalArray-CGH:Thesecond probesprinted onto aldehydegroup-coatedglass slides using proposedcaseinvolvedacaryotype-validatedpentasomyX. non-contact microarrayer. The assay based on reverse hybri- Surprisingy some laboratories missed the pentasomy. They dization, which include two-step multiplex PCR reactions concluded a trisomy or tetrasomy mosaicism. The expla- with production of one-stranded Cy5 labeled-PCR products nation may lie in the limitations of the assessment of the followingitshybridizationwitholigonucleotideprobes.Using copynumberbyalgorithmsusedinthepresenceofunusual this microarray, we estimated heterozygose carrier frequency ratios especially at the level of gonosomes, a too fast ana- in120healthypeopleofyakutethnicityandvalidateddataby lysis or a technique that did not allow to evaluate a large real-time PCR and PCR-RLFP methods. The evaluation of numberofchromosomeXcopies.Thisexerciseallowed us thismicroarraydemonstratesthatitiscomprehensive,robust, to observe the limitations of certain computational algo- sensitive,speciﬁc,andeasilymodiﬁable.Thedevelopedassay rithms and remind us of the importance of maintaining a can be considered as an alternative cost-effective tool for solid formation in classical cytogenetic analysis to best genetic screening purposes and it is suitable for both carrier interpret theresultsfrom pangenomicmolecular techniques screening and disease diagnostics in yakut population in the (array-CGH, WGS/WES). republicofSakha(Yakutia).Theresearchisconductedunder M.Doco-Fenzy:None.D.Sanlaville:None.C.Missirian: thestatetargetprogram:projectFSRG-2020-0014“Genomic None. I. Luquet: None. C. Terre: None. C. Schluth-Bolard: of Arctic: epidemiology, hereditary and pathology” None. M. Till: None. C. Sarrauste de Menthières: None. J. M. Savvina: None. N. Maksimova: None. A. Sukhomya- Dupont: None. sova: None. E-P16.10 E-P16.09 Next-generationsequencingforthediagnosisofSpanish Lessons from 14 years of french cytogenetic EQA patients affected by congenital ﬁbrinogen defects concerning clinical genetics I. Tirado, L. Romero, N. Vilalta, M. Carrasco, J. Souto, M. Doco-Fenzy1, D. Sanlaville2, C. Missirian3, I. Luquet4, E. Martínez-Sánchez, V. Criado, M. Simón, L. Alías, c. Terre5, C. Schluth-Bolard2, M. Till2, C. Sarrauste de S. Quero, J. Mateo Menthières6, J. Dupont7 Unitat d’Hemostàsia i Trombosi, Servei d’Hematologia. 1Service de Génétique, CHU-Reims, Reims, France, 2Ser- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain vicedeGénétique,CHU-LyonBron,Lyon,France,3Service960 J.delPicchia Introduction: The aim of our study was to characterize doesnotrequiretrainedprofessionalsordedicatedfacilities. patients with ﬁbrinogen (Fbg) deﬁciencies by analyzing The preanalytical workﬂow should minimize DNA degra- FGA, FGB and FGG genes using next generation dation and fragmentation. This study demonstrates the sequencing (NGS). compatibility of QIAGEN gDNA sample preparation kits Methods: Functional and immunologic Fbg levels were with different saliva collection devices, as part of a work- determined with Clauss FibR (Stago) and NOR-Partigen ﬂow for extraction of high-quality, intact salivary gDNA. Fibrinogen (Siemens), respectively. A custom Nonacus Methods: Saliva was collected from 10 healthy indivi- v1.2.1 Cell 3TM Target that includes the FGA, FGB and duals using six different collection devices, according to FGG genes was performed on a MiSeq instrument manufacturer’scollectioninstructions.gDNAwasextracted (Ilumina). All variants were conﬁrmed by Sanger sequen- using either QIAamp technology (manual) or the QIA- cing using an Applied Biosystems 3500. symphony instrument (automated) and quality and quantity Results:Geneticandphenotypicﬁndingsaresummarized were spectrophotometrically assessed. A qPCR assay in Table 1. targeting human β-Actin and the QIAGEN Investigator QuantiplexProRGQKit,amultiplexgeneassay,wereused toevaluatecompatibilitywith qPCR.TheAgilentTapeSta- Patient/Fbg Clinical Functional/ NGS/Sanger deﬁciency antigen tion 4200 was used for fragmentation analysis. Fbgg/L Results: High donor-to-donor variability was observed, 1Aﬁbrinogenemia Intracerebral <0.0/0.0 HomozygousFGA buttherewasnosigniﬁcantdifferenceintotalyieldbetween haemorrhageMesenteric c.532C>Tp.R178*New thrombosis stopcodon thesalivacollectiondevicesused.DNApuritywasassessed Sonofthe Asymptomatic 2.4/2.6 HeterozygousFGA by A /A ratio, showing good sample quality with both patient1 c.532C>Tp.R178* 260 280 Newstopcodon extraction methods. Intact gDNA was recovered and 2 Asymptomatic 1.8/4.8 HeterozygousFGA showed low fragmentation of high-molecular-weight Dysﬁbrinogenemia c.112A>Gp.R38G (FibrinogenAarhus. gDNA. Samples analyzed demonstrated consistent and Ref.1) stable performance in qPCR applications, showing no 3 Postpartumhemorrhagic <0.1/7.2 HomozygousFGA Dysﬁbrinogenemia diathesis.Femoral c.112A>Gp.R38G inhibition. thrombosis (FibrinogenAarhus) Conclusions: QIAGEN gDNA sample preparation kits are compatible with various saliva collection devices. The recovered gDNA is intact high-molecular-weight DNA and Table 1. Summary of patient data. FGA reference is can be used in ampliﬁcation-based qPCR assays. NM_000508.3. C. Lowe: A. Employment (full or part-time); Modest; Conclusions: Two different variants have been found in QIAGEN GmbH. L. Erkelenz: A. Employment (full or theFGAgene.NGShasbeenproventobeausefultoolfor part-time); Modest; QIAGEN GmbH. M. Schmitz: A. simultaneously sequencing all the genes involved in the Employment (full or part-time); Modest; QIAGEN GmbH. ﬁbrinogen deﬁciencies. Reference 1. Blomback, B et al. Biochemistry, Biological Functions, Gene Regulation and E-P16.12 Expression.Amsterdam:Elsevier(pub.)1988.Pp.263-266. Approbation of the molecular genetic method for the Funding: FIS PI18/01492. diagnosis of Helicobacter pylori infection isolated from I. Tirado: None. L. Romero: None. N. Vilalta: None. M. feces of patients with gastroduodenal diseases from Carrasco: None. J. Souto: None. E. Martínez-Sánchez: individuals of Sakha Republic None. V. Criado: None. M. Simón: None. L. Alías: None. S. Quero: None. J. Mateo: None. N. Gotovtsev1,2, N. Barashkov1,2, T. Borisova1, M. Pak1,3, M. Alekseeva3, N. Innokentieva1,3, K. Loskutova1,3, E-P16.11 V. Pshennikova1,2, S. Lekhanova1, S. Fedorova1 ExtractionofgenomicDNA from stabilized salivausing selected QIAGEN puriﬁcation systems 1M.K. Ammosov North-Eastern Federal University, Yakutsk, Russian Federation, 2Yakut Science Center of C. Lowe, L. Erkelenz, M. Schmitz Complex Medical Problems, Yakutsk, Russian Federation, 3Republican hospital №1 – National Center of Medicine, QIAGEN GmbH, Hilden, Germany Yakutsk, Russian Federation Introduction: Saliva is increasingly used as a noninvasive TheInternationalAgencyforResearchonCancerin1994 alternative to blood for the examination of human DNA in classiﬁedHelicobacterpylori(Hp)infectiontotheIgroup ancestry testing or disease monitoring. Sample collection of carcinogen, along with some of the radionuclides andAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 961 radiation. The diagnosis of Hp infection includes mole- hansi-font-family:Calibri; mso-hansi-theme-font:minor- cular genetic research methods by PCR, based on ampli- latin;mso-bidi-font-family:"TimesNewRoman";mso-bidi- ﬁcation of 16S rRNA because it’s a quite speciﬁc and theme-font:minor-bidi; mso-ansi-language:DE;} Hetero- excludesthepossibilityofampliﬁcationofrelatedspecies zygous single-nucleotide variants and large deletions dis- and strains closest to Hp (Campylobacter, Helicobacter ruptingtheKANSL1genecauseKoolen-DeVriessyndrome cinaedi, Helicobacter mustelae and Wolinella succino- (OMIM® 610443). The KANSL1 gene is located on the genes). Detection of Hp infection by PCR methods was 17q21.31 locus, which has been subjected to structural notperformedearlierintheSakhaRepublic.Ouraimwas divergence in humans. The common structural 17q21.31 approbation of the molecular genetic method for the haplotypes diverge mainly in the direction of the inversion diagnosis of Hp infection isolated from feces of patients andthecopy-numberstateofKANSL1,affectingexons1to with gastroduodenal diseases from individuals of Sakha 3 of the gene. The architecture of this genomic region sig- Republic. We studied 92 Yakut patients with gastro- niﬁes a challenge for the clinical interpretation of KANSL1 duodenal diseases conﬁrmed by endoscopic and histolo- variants as reported by Koolen et al in 2016. We present gical study. Two patients had Hp with high degree of several cases illustrating strategies to ascertain the putative dissemination. The urea breath test was positive because clinical signiﬁcance of single-nucleotide variants located the results of determining the presence of Hp and showed within exons 1-3 of KANSL1 (NM_001193466.1). These high concentration of ammonia (high degree of dis- cases corroborate that partial polymorphic duplications of semination). Subsequently, samples of evacuated feces the 17q21.31 region confound the clinical relevance of the were obtained from these two patients. Positive ampliﬁ- KANSL1 variants. Consequently, the same pathogenic var- cation of the 16S rRNA marker gene was obtained from iant can be causative in some individuals, while clinically one of two examined patients. We were able to show that irrelevant in others. Hence, parental testing demonstrating using the proposed method it is possible to determine the the de novo state of the variant in index patients is critical presence of Hp DNA in feces, which allows to pass evidencesupportingitspathogenicity.Importantly,incases endoscopic examination, in cases where there are con- where parental testing is not performed, the variant allele traindications to invasive research methods. This study frequencies combined with copy number analysis can be was supported by Ministry of Science and Higher Edu- used to disentangle the genomic architecture at the locus cation of Russian Federation (basic part to NEFU) and andconsolidate(orexclude)thediagnosisofthesyndrome. RFBR-grant #18-05-600035_Arctika. N. Ordonez-Herrera: None. J. Numrich: None. D. Diego N. Gotovtsev: None. N. Barashkov: None. T. Borisova: Alvarez: None. L. Ramirez: None. K. Kandaswamy: None. None. M. Pak: None. M. Alekseeva: None. N. Innoken- N. Ameziane: None. B. Peter: None. A.M. Bertoli- tieva:None.K.Loskutova:None.V.Pshennikova:None.S. Avella: None. Lekhanova: None. S. Fedorova: None. E-P16.15 E-P16.14 Incidental ﬁndings of Klinefelter’s and Turner syn- Overcoming pitfalls in the genetic diagnosis of the dromes by cancer predisposition gene panel analysis Koolen-De Vries syndrome. L. Golmard1, M. Schwartz1, M. Blanluet1, J. Le Gall1, N. Ordonez-Herrera, J. Numrich, D. Diego Alvarez, V. Moncoutier1, C. Carrière1, J. Carrière1, N. Auger2, L. Ramirez, K. Kandaswamy, N. Ameziane, B. Peter, A. M. D. Stoppa-Lyonnet1,3, C. Colas4, M. Bahuau5, Bertoli-Avella E. Mouret-Fourme4 Centogene AG, Rostock, Germany 1Institut Curie, PSL Research University, Service de Génétique, Paris, France, 2Gustave Roussy, Service de Normal 0 false false false DE X-NONE X-NONE /* Style Pathologie moléculaire, Villejuif, France, 3Université de Deﬁnitions */ table.MsoNormalTable {mso-style-name:"- Paris, Paris, France, 4Institut Curie, PSL Research Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-col- University, Service de Génétique, St Cloud, France, band-size:0; mso-style-noshow:yes; mso-style-priority:99; 5Hôpital Henri Mondor, Service de Génétique médicale, mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; Créteil, France mso-para-margin-top:0in; mso-para-margin-right:0in; mso- para-margin-bottom:10.0pt; mso-para-margin-left:0in; line- Klinefelter’ssyndrome(KS)andTurnersyndrome(TS)are height:115%; mso-pagination:widow-orphan; font- chromosome X aneuploidies, with an additional chromo- size:11.0pt; font-family:"Calibri", sans-serif; mso-ascii- some X in men affected with KS (47,XXY) and a missing font-family:Calibri; mso-ascii-theme-font:minor-latin; mso- chromosomeXinwomen affected withTS(45,X). KSand962 J.delPicchia TS prevalence is estimated to be 1/600 and 1/2500, plussyndromeintheYakutiausingreal-timePCRhasbeen respectively, but their diagnosis often remains unknown. developed. Molecular genetic analysis mutations in the Here we report two incidental ﬁndings of KS and TS by VPS33A gene meets the following parameters: analysis cancerpredispositiongenepanelanalysison3,460patients. timewiththeuseofthedevelopedmethodmakesnotmore KScasewasamandiagnosedwithbreastcancerat67years than 3 hours, including sample preparation and evaluation of age. TS case was a woman with personal (age 54) and oftheresearchresults;Thereliabilityoftheanalysisresults familyhistoryofbreastcancer.Forbothcases,breastcancer by means of the developed method in the study of the gene panel analysis did not detect any pathogenic variant sample n = 100 makes not less than 90%. Molecular butchromosomeXcontrolprobesshowedabnormalresults: genetic analysis of the carriage of a mutation in the presence of two chromosomes X for the man and one VPS33A gene among the Yakuts has proven its effective- chromosomeXforthewoman.SubsequentMLPAanalysis ness and the quickness of execution among the targeted suggested the presence of two chromosomes X and one patients. 6 heterozygous carriers and 1 homozygous car- chromosomeYfortheman,andonechromosomeXandno riage in the VPS33A gene have been revealed. This diag- chromosomeYforthewoman.Karyotypeanalysiscouldbe nosticmethodonMPSPSallowstoreducetheanalysistime performedonlyforthewomanandconﬁrmedthediagnosis and is promising for patients. of TS, with 45,X chromosomal content. Chromosome X S. Novgorodova: None. control probes are used to detect errors of patient identity during sampling or experiment. Our report shows that they E-P16.18 also allow the identiﬁcation of sex chromosome aneu- ExceptionallylatediagnosisofpatientwithPrader-Willi ploidiesforgenetictestingperformedforotherdisorders.It Syndrome is important to inform biological and clinical geneticists about these incidental ﬁndings to perform additional ana- K. A. Zapart, M. Malarska lysis after detection of abnormal chromosome X number and to better anticipate patient speciﬁc follow-up. Medical University of Lodz, Łódź, Poland L. Golmard: None. M. Schwartz: None. M. Blanluet: None. J. Le Gall: None. V. Moncoutier: None. C. Carrière: Prader-Willi Syndrome is an uncommon imprinting dis- None. J. Carrière: None. N. Auger: None. D. Stoppa- order,causedusuallybythedeletionofthepaternalcopyin Lyonnet: None. C. Colas: None. M. Bahuau: None. E. 15q11-q13region.Averageageofpatientsdiagnosedisnot Mouret-Fourme: None. older than 3 years of age when syndromes like hipotonia, feeding difﬁculties and delayed development, including E-P16.16 hypogonadismarise.Distinctivefacialfeaturesinparticular Genetic analysis of mucopolysaccharidosis-plus syn- almond-shapedeyes,anarrowingoftheheadatthetemples, drome (MPSPS) in the Republic of Sakha (Yakutia) a turned-down mouth and a thin upper lip are noticed. Nevertheless, the main complications come from sequelae S. Novgorodova of hyperfagia, thus obesity and intellectual impairment. Still, early diagnosis can prevent most of them. Genomic medicine, Yakutsk, Russian Federation This study presents a case of 27-year-old man, who was admitted to general practitioner because of memory Mucopolysaccharidosis is a group of hereditary metabolic problems. He had never been to genetics clinic before. diseases connected with the disturbance of glycosami- Obesepatient(BMI:47),withdistinctivefacialtraits,reports noglycan metabolism. The Yakut population according to learning difﬁculties and poor short term memory. One-to- thedatagivenbyanumberofresearchers isahomogenous one tuition during his schoolingage was necessary. During population, and it has accumulation of about a dozen dis- his childhood, a psychologist diagnosed him with person- easesofmonogenousnature.Anewhereditarydiseasewith ality disorders. Although he likes playing video games, he anautosomalrecessivetypeofinheritance,belongingtothe ﬁnds it difﬁcult to focus on things. He also reports group of lysosomal diseases, with a mutation in the photophobiaandconstanthunger.Sinceallthosesymptoms VPS33A gene called MPS plus (OMIM # 617303), which wereunusualforPWShewasﬁnallyreferredtoaspecialist. occurs in children of Yakut nationality, leading to early Becauseof nonspeciﬁcsymptomsand low incidence,the infant mortality [Kondo et al., 2017]. We carried out a diagnosis presents a challenge to pediatricians and requires molecular genetic analysis for the carriage of mutations in skilled eye and experience. Such cases show us that the VPS33A gene among the Yakuts (94 cases). The increasing awareness among doctors about genetic condi- method of express-diagnostics – mucopolysaccharidosis- tions is still certainly needed.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 963 K.A. Zapart: None. M. Malarska: None. R. Tripathy, Z. Yüksel, M. Drasdo E-P16.20 Bioscientia, Ingelheim, Germany Rare no longer means unavailable - new concept of routine genetic diagnostics Introduction: Whole exome sequencing (WES) has become an indispensable tool in the ﬁeld of genetic diag- K. Hirschfeldova, L. Obeidova, J. Stekrova, M. Urbanova, nostics. While we have observed an enormous rise in B. Janosikova, I. Zednikova, V. Elisakova, F. Liska, technicalandmedicalstandardsofWESdataanalysis,there B. Chylikova, A. Horinek, A. Panczak, O. Seda remain many limitations in the interpretation of the identi- ﬁed variants. Currently applied analytical strategies rely First Faculty of Medicine Charles University, Prague 2, heavily on assumptions of variant ﬁltering such as the Czech Republic commonly used parameter of variant type (e.g. missense, frameshift,canonicalsplice-site).Thevariantsthenundergo We would like to introduce the new concept of molecular a subjective classiﬁcation of the severity of consequence diagnosticsofgeneticdisordersintendedforroutineclinical based on SNPEff: HIGH, MODERATE, LOW and laboratoriesintheCzechRepublic.Theconceptisbasedon MODIFIER. In this study, we concentrated on the patho- three levels of genetic analysis using the method of next genicity of variants that are often declared to have low generation sequencing. The ﬁrst level is represented by a deleterious effects and hence overlooked during patient panel of genes called OIDIP (Open Interdisciplinary Diag- WES data analysis: synonymous (LOW), splice region nostic Panel) designed for routine differential diagnosis of (LOW)andintron(MODIFIER)variantsaccordingtoVEP both selected common and rare diseases. However, the annotation in order to understand the pathogenicity of such provided genetic analysis is much more complex and, if variants. relevant,thePolygenicRiskScore(PRS)calculationcanbe Materials and methods: We determined only very rare doneonbasisofco-analysedSNPs.Moreover,thedetection synonymous,spliceregionandintronvariantsinpatientsin of diverse clinically signiﬁcant common variants (trombo- which WES was performed. We concentrated on those philic mutations, lactose intolerance, warfarin drug variants which showed signiﬁcant overlap with the given response, etc.) is performed at the background. From the patient phenotype. We studied the predicted effect of such epidemiologic point of view, two genes are included to variants on splicing using reverse transcriptase PCR (RT- detect carriers of pathogenic alleles for cystic ﬁbrosis and PCR). phenylketonuria to spread knowledge of associated risks Results:Weidentiﬁedseveralsynonymous,spliceregion within Czech population. The second level of genetic test- and intron variants that are usually underestimated by ing is represented by “clinical exome” suited for diagnosis conventional ﬁltering and/or annotation methods. ofrareandgeneticallyheterogenousdiseases.Thelastlevel Conclusion:ItisimportanttobuildWESvariantﬁltering of genetic testing is featured by whole exome sequencing strategies based on the phenotypic overlap before concen- and is still intended for special cases. Appropriate clinical trating on the uncovered regions or other genetic mechan- questionnaires arean integral part ofthe concept aswellas isms. The diagnostic yield is increased with such ﬁltering website (www.oidip.cz), which should serve to connect and conformational strategies such as RT-PCR. clinical specialists and share the information. The aim is to R. Tripathy: A. Employment (full or part-time); provide rapid genetic diagnostics of a wide spectrum of Signiﬁcant;BioscientiaGmbH.Z.Yüksel:A.Employment evenrarepathologiestogeneralpublic.Supp.bytheESIF- (full or part-time); Signiﬁcant; Bioscientia GmbH. M. Operational programme Prague - Growth Pole of the Drasdo: A. Employment (full or part-time); Signiﬁcant; Czech Rep. Reg. No. CZ.07.1.02/0.0/0.0/17_049/0000828 Bioscientia GmbH. K.Hirschfeldova:None.L.Obeidova:None.J.Stekrova: None. M. Urbanova: None. B. Janosikova: None. I. E-P17 Bioinformatics and Statistical Methods Zednikova: None. V. Elisakova: None. F. Liska: A. Employment (full or part-time); Modest; GENvia, s.r.o.. B.Chylikova:None.A.Horinek:None.A.Panczak:None. E-P17.04 O. Seda: None. AGWAS ofListeriamonocytogenes strainsoffood and clinical origins E-P16.22 Importance of Low and Moderate impact variants in whole exome sequencing (WES) analysis964 J.delPicchia F. Laporte1, M. Maury2, E. Patin3, A. Leclercq2, A. Díaz-de Usera1, R. González-Montelongo1, L. Quintana-Murci3, R. Chikhi1, M. Lecuit2, H. Aschard1 J. M. Lorenzo-Salazar1, C. Flores1,2,3 1Department of Computational Biology-USR 3756 CNRS, 1Genomics Division, Instituto Tecnológico y de Energías Institut Pasteur, Paris, France, 2Biology of Infection Unit, Renovables (ITER), Santa Cruz de Tenerife, Spain, NationalReferenceCenterandWHOCollaboratingCenter 2ResearchUnit,HospitalUniversitarioN.S.deCandelaria, Listeria, Institut Pasteur, Paris, France, 3Human Evolu- Universidad de La Laguna, Santa Cruz de Tenerife, Spain, tionary Genetics, Institut Pasteur, Paris, France 3CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain Introduction: Genome-wide Association Studies (GWAS) have been central to identify genetic variations associated Introduction: Bioinformatics benchmarking is essential to withcomplexhumanphenotypes.Thereisnowtremendous provide guidance for improving the variant calling process interest for implementing GWAS-like approaches to gen- and deﬁne standards and performance metrics. Following omes of pathogenic bacteria in order to advance our the GA4GH recommendations and the PrecisionFDA understanding of infectious disease risk and underlying challenges, we aimed to assess the performance of our bacterial virulence factors. However, bacterial genomes current whole-genome (WGS) and whole-exome (WES) harbour complex structure and long-range linkage dis- sequencing and bioinformatic workﬂows for detecting sin- equilibrium (LD), making such analyses extremely chal- gle nucleotide variants (SNVs) and small insertion and lenging. We aim at identifying genetic variation in Listeria deletion (indels) in human samples. monocytogenesassociatedwithfoodversusclinicalsources Materials and methods: We used the NIST-GIAB pilot usingwholegenomesequencingof3718strainsoffoodand sample NA12878/HG001 WGS provided by the Preci- clinical origins collected in the context of Listeria surveil- sionFDA,andWESsequenceswithPE75at>50Xobtained lance in France. on a HiSeq4000 (Illumina) in our laboratory, both used as Materials and methods: We used both real and internal references. Variants were called with the Haploty- simulated data to assess the performances of various peCaller following the Genome Analysis Toolkit Best GWAS approaches. First, we considered SNPs derived Practices workﬂow recommendations (GATK v3.8 and from the core genome, and unitigs obtained by compacting v4.1.4). A high conﬁdence set of variants accounting for the de Bruijn graph. Second, we compared alternative ad read depth, and variant calling and mapping quality was hoc algorithms for deriving pairwise genetic relatedness compared against the GIAB gold standard. between strains. Third, we assessed a range of logistic and Results: A relatively high accuracy was observed linear mixed models (LMM) with various random effect. according to recall, precision and F-score metrics from the And fourth, we assessed solutions to account for the benchmark of WGS (>97.9%) and WES (>87.5%), with observed extensive LD. minor differences among SNVs and indels. The lower Results and conclusion: We identiﬁed multiple critical observed WES accuracy might be related to the non- issues in existing approaches, resulting in invalid GWAS uniform coverage found in WES enrichment when resultsinourdata.Wedevelopedsolutionsforeachofthose comparing to synthetic-WES reads from HG001. issues, implementing an adaptive inference of relatedness Conclusions: We have developed and tested a custom between strains, a stepwise LMM model selection, and a pipelinetoconductWGSandWES-basedbenchmarkingto genome LD correction inspired from human GWAS. The ensurereproducibility.Theseresultssupportthatourcurrent developed and validated approach shows promising results procedures and workﬂows are reliable albeit a ﬁne-grained intheactualsetofListeriacollectedprospectively,pointing study of inaccuracies is needed. multiple variations associated with food versus clinic Funding: Ministerio de Ciencia e Innovación (RTC- origins. 2017-6471-1; MINECO/AEI/FEDER, UE); ITER agree- F. Laporte: None. M. Maury: None. E. Patin: None. A. ment OA17/008. Ministerio de Educación y Formación Leclercq: None. L. Quintana-Murci: None. R. Chikhi: Profesional (A.D.U.; FPU16/01435). None. M. Lecuit: None. H. Aschard: None. D. Jáspez: None. A. Muñoz-Barrera: None. L.A. Rubio- Rodríguez: None. A. Ínigo-Campos: None. V. Garcia- E-P17.05 Olivares: None. A. Díaz-de Usera: None. R. González- A benchmarking of germline small-variant calling from Montelongo: None. J.M. Lorenzo-Salazar: None. C. whole human genome and exome sequencing data Flores: None. D.Jáspez1,A.Muñoz-Barrera1,L.A.Rubio-Rodríguez1,A. Ínigo-Campos1, V. Garcia-Olivares1,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 965 E-P17.06 Y. Einhorn Mining the MGI resource to unravel genes and molecular mechanisms driving ciliary dysfunction: Genoox, Tel-Aviv, Israel lessons from ciliopathy mouse models Introduction: TheACMG andClinGen recentlypublished A. V. Anagnostopoulos, M. Tomczuk, J. E. Richardson, new technical standards for CNV classiﬁcation in order to C. L. Smith, C. J. Bult, The Mouse Genome Informatics replace the old guidelines. These new standards are highly Staff and Software Team detailed and structured compared with the previous guide- lines. Thus, while the detailed evaluation criteria will TheJackson Laboratory,BarHarbor,ME,United States increaseclassiﬁcationconsistencybetween different labs, it can be time consuming and hold some computational Ciliopathies comprise a broad spectrum of genetically and challenges. Here, we present a novel AI-based variant phenotypically heterogeneous disorders arising from muta- classiﬁcation engine (aiVCE) for CNV classiﬁcation based tions that disrupt ciliary structure or function, and ranging on the new ACMG/ClinGen framework. from mild single-organ pathologiestolethal multi-systemic Methods: An aiVCE was developed for implementing syndromes. Phenotypic manifestations can include respira- the new recommendations and removing their computa- tory dysfunction, infertility, brain malformations, hydro- tionalandtechnicalchallenges.Asnogoldstandarddataset cephalus, heterotaxia, polydactyly, renal anomalies, with category level evidence exists for classiﬁed CNVs, to neurosensorydeﬁcits,andcognitiveimpairment.Moreover, evaluatetheaiVCEwebenchmarkagainstthedatasetwhich the clinical features of syndromic ciliopathies are often was used for the recommendations creation where each variable and overlapping, depending on the causal gene, CNV was evaluated by two different clinical labs. mutation type or site, and/or other genetic modiﬁers of Results: Comparing the results. shows high concordance penetranceorexpressivity,renderingdiagnosischallenging. without any strong conﬂict. Looking on the variants that Mice present a premier model system to dissect the both reviewer classiﬁed the same, 100% of the P variants functional roles of motile and non-motile cilia in diverse were classiﬁed as P or VUS-Leaning-Pathogenic (VUS-P), tissue/cell types and developmental stages, discover new 100% of the VUS variants were classiﬁed as VUS,VUS-P ciliopathy clinical entities and/or contributing loci, and or VUS-Leaning-Benign (VUS-B)and 71% of the B evaluate therapeutic strategies. Mouse Genome Informatics variants were classiﬁed as B/VUS-B and the remaining (MGI, http://www.informatics.jax.org) integrates data from (29%) as VUS. multiple sources to correlate mouse phenotypes and human Conclusions: Herein we demonstrated how an AI-based disease symptoms and inform disease pathogenesis and algorithm can aid in following the new CNV classiﬁcation treatment. Here, we employ MGI data mining tools to: recommendations, a task which is challenging, time exploreanarrayofmousemutations,allelesandphenotypes consuming and error prone. associated with ciliary dysfunction; assess phenotypic outcome in different genetic backgrounds; ﬁnd experimen- Table.BenchmarkinganaiVCEforCNVclassiﬁcation tal mouse models of known ciliopathies (e.g., Joubert against labs’ classiﬁcation syndrome); and delineate candidate genes or pathways associated with core ciliopathy features. We present labs\aiVCE B VUS-B VUS VUS-P P enrichment analysis of 239 candidate ciliopathy genes and, as hydrocephalus (DOID:10908) emerges as the only B 1 4 2 0 0 enriched human condition exclusively associated with 5 B/VUS 0 0 5 0 0 genes (Dpcd, Kif27, Nme5, Stk36 and Ulk4), we prioritize VUS 0 2 39 6 0 Ulk4 for further characterization and corroborate its VUS/P 0 0 8 9 4 candidacy based on genomic, homology, expression, P 0 0 0 6 17 functional, pathway, phenotype and disease model data B/P 0 0 1 1 0 available at MGI. Supported by NIH grant HG000330. A.V. Anagnostopoulos: None. M. Tomczuk: None. J.E. Richardson: None. C.L. Smith: None. C.J. Bult: None. Y. Einhorn: A. Employment (full or part-time); Sig- niﬁcant; Genoox. E-P17.07 UsingAIforanautomatedCNVClassiﬁcationbasedon the new ACMG/ClinGen recommendations966 J.delPicchia E-P17.08 gene associated with Laurin-Sandrow syndrome in CNVariome digitalized: a new approach towards CNV Colombia. prioritization (CNV laundering) for uncovering mechanisms of brain disorders L. J. Moreno-Giraldo1,2,3,4, M. Escobar -Muñoz1,4, D. Arturo-Terranova1,4, J. M. Satizábal Soto1,4 M. A. Zelenova1,2, Y. B. Yurov1,2, S. G. Vorsanova1,2, I. Y. Iourov1,2,3 1Universidad del Valle, Cali, Colombia, 2Universidad Santiago de Cali, Santiago de Cali, Colombia, 3Universi- 1Mental Health Research Center, Moscow, Russian Fed- dad Libre, Santiago de Cali, Colombia, 4Congenital eration, 2Academician Yu.E. Veltishchev Research Clinical diseases metabolism research group -Category A Colcien- Institute of Pediatrics, N.I. Pirogov Russian National cias 2019, Santiago de Cali, Colombia Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russian Federation, 3Rus- Laurin-SandrowSyndrome(LSS)isanautosomaldominant sian Medical Academy of Continuous Professional Educa- inheriteddiseaseofamalformitiesnature,itsincidencedoes tion of the Ministry of Health of the Russian Federation, not exceed 16 cases worldwide. It is characterized by a Moscow, Russian Federation complete polysyndactyly in hands, feet in the form of a mirror image and malformations at the level of the nose Introduction: Brain disorders are constantly associated suchashypoplasiaofthenasalalaeandtheshortcolumella. with copy number variations (CNVs). Increase in CNV To inform a new intronic variant associated with LSS in a burden is common in psychiatric disorders, leading to dis- Colombian female patient of 2 years and 11 months of age ruptionsofsharedbiologicalprocesses.However,thereisa with multiple malformations associated with agenesis of lack of approaches used for uncovering pathogenic path- bony parts, a molecular study was conducted using com- ways/CNVs in brain diseases using genomic data. plete exome sequencing and afterward a bioinformatic Materials and methods: Here, we propose an algorithm predictionanalysisofthesplicingeffectthroughtheHuman —“CNVlaundering”—forCNV/pathwayprioritizationin Splicing Finder prediction software. As a result, a variant brain disorders. Algorithm’s stages are (1) CNV data is was found in the LMBR1 gene c.1282-14G>A, Intron 16 obtained and checked for recurrence (recurrent CNVs Splicing, heterozygosis (69%); associated with LSS. The excluded); (2) ontology and expression of CNV genes bioinformatic study demonstrated the pathogenicity of the obtained (genes not expressed in the brain excluded); (3) variant, which allows a phenotype-genotype association. gene-geneinteractionsareretrieved;(4)candidatepathways Ourﬁndingsinformtheﬁrstcasereportedintheliteratureof obtained by analyzing the set of interacting genes; (5) a patient with LSS in Colombia. Besides, they suggest that pathway prioritization and clusterization using a novel this intronic variantplaysa pathogenic role associated with prioritizationcriterion(numberofCNVgenesinapathway/ the phenotype of the patient and allows us to conclude that total number of pathway genes). Using the algorithm and theuseofbioinformaticssoftwareforthepredictionintronic Affymetrix CytoScan HD microarray, we analyzed 191 variants are a useful tool to evaluate the clinical sig- genomes of children with neurodevelopmental disorders niﬁcance, promoting its use to provide directed clinical and congenital abnormalities (patient inclusion criteria: approaches. absence of CNVs larger than 500 kbp). L.J. Moreno-Giraldo: None. M. Escobar -Muñoz: None. Results: The most signiﬁcant pathway clusters were D. Arturo-Terranova: None. J.M. Satizábal Soto: None. determined as “proteasome”, “neurodegenerative diseases”, “regulation of TP53”, “vesicles functioning”, “signaling by E-P17.11 NOTCH”, “actin functioning”. Cross platform bio-informatics data analysis Conclusions:“CNVdatalaundering”allowsforpathway using docker and CNV prioritization. The application of the algorithm providesforaccumulationofknowledgeaboutthemechan- B. Wolf1, P. Kuonen1, D. Atlan2 ismsofbraindiseasebothinindividualcasesandincertain disorders.SupportedbyRFFIandCITMA(projectNo.18- 1University of applied sciences and arts western switzer- 515-34005). land, Fribourg, Switzerland, 2Phenosystems SA, Wallonia, M.A. Zelenova: None. Y.B. Yurov: None. S.G. Vorsa- Belgium nova: None. I.Y. Iourov: None. Introduction:Theﬁeldofbio-informaticshasabigvariety E-P17.10 of tools to perform all sorts of data analysis. New and New intronic variant at the Splicing site of the LMBR1 excitingtoolsarereleasedconstantly,relyingonavarietyofAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 967 underlyingtechnologies.Whilethosedifferenttoolshelpto explain this accuracy. We then tested the effect of improvenotonlythequalityofthedataanalysisbuthelpto hypothesis-driven data manipulation on the classiﬁcation perform new types of analyses, they are often complicated accuracy. 1) To highlight possible morphological features to install and only run on Linux. Although bigger labora- we created occlusion-sensitivity maps. 2) To assess the tories often run their analyses on clusters using pre-con- relevanceofconedistributionwesplitthecolorchannelsof ﬁgured pipelines, this is often not the case in smaller the fundus images. 3) We compared the distance between laboratorieswhichrelyonwindowsmachineswithalimited the fovea and the optic disc. informatics support. Color channel separation didn’t improve the basal Methods: We propose to use docker for Windows with performance, discarding the cone distribution hypothesis. WSL 2 to integrate bio-informatics tools into existing Distancesbetweenthefoveaandtheopticdiscweresimilar analysistoolslikeGensearchNGSwithaminimaloverhead. acrossgender,basedonat-test(p-value>0.05).Finally,we WSL 2 greatly reduces the I/O overhead previous versions comparedtheperformanceofdifferentocclusion-sensitivity of Docker or approaches likes emulation. We show maps.Thisallowedustoidentifyadistinctiveveinstructure Results: We released a new version of GensearchNGS close to the ocular disc in the nasal side of the eye, which allows users that have Docker installed to use a providing a differential feature to label images. varietyofbio-informaticstools(suchasBWAorBismark), Image manipulation is a viable method to help interpret previously only available to linux users. DCNN models and extract clinically relevant knowledge. Conclusions: We show that by using Docker combined Thus,ourstudyshowsthatclinicalexpertisecannarrowthe with WSL 2, Linux only bio-informatics tools can be run feature space and help guide model training. http://www. with a minimal overhead on windows and integrated into eye2sex.com/ http://www.fundus2gender.org/ existing data analysis tools. We demonstrate this by M.A. Ibarra-Arellano: None. S. Dieck: None. M.W. integrating NGS aligners into GensearchNGS, an existing Yeung:None.S.Thiele:None.T.Pantel:None.I.Moghul: cross-platform NGS data analysis tool. This new approach None. N. Pontikos: None. P. Krawitz: None. gives users a big ﬂexibility and greatly reduces the complexity to run some of those tools. E-P17.15 B. Wolf: None. P. Kuonen: None. D. Atlan: A. Employ- Deciphering the epidemiological, molecular and func- ment (full or part-time); Signiﬁcant; Phenosystems SA. tional features of Variants of Uncertain Signiﬁcance in Inherited Retinal dystrophies E-P17.13 Insightinto an artiﬁcial neural network, that learned to I. Iancu, A. Arteche, A. Avila-Fernandez, infer gender from funduscopies M. Del Pozo-Valero, R. Riveiro-Alvarez, M. Trujillo-Tiebas, I. Perea, M. Corton, P. Minguez, M. A. Ibarra-Arellano1, S. Dieck1, M. W. Yeung2, C. Ayuso S.Thiele3,T.Pantel4,I.Moghul5,N.Pontikos5,P.Krawitz1 DepartmentofGenetics,InstitutodeInvestigaciónSanitaria- 1Universitätsklinikum Bonn, Bonn, Germany, 2UMCG - Fundación Jiménez Díaz University Hospital-Universidad UniversityGroningen,Groningen,Netherlands,3University Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain HospitalBonn,Bonn,Germany,4Charité-Universitätsme- dizinBerlin,Berlin,Germany,5UniversityCollegeLondon, Introduction: Inherited retinal dystrophies (IRD) are a London, United Kingdom highlyheterogeneousgroupofrarediseaseswithamolecular diagnosis ratio >50%. Reclassiﬁcation of Variants of Deep convolutional neural networks (DCNN) outperform UncertainSigniﬁcance (VUS) represents a challengeintheir human experts in many medical classiﬁcation tasks. Yet, diagnosis. We aimed to study VUS epidemiological, mole- due to the “black-box” nature DCNNs remain dismissed in cular and functional features that can provide rules to the clinic. Thus, extracting knowledge from artiﬁcial intel- improve VUS clinical management. ligence(AI)becomesanimportantbioinformatic’sresearch Methods: In a two years period, we collected 669 IRD topic.WeanalyzedaDCNNthatlearnedtoinferthegender casesstudiedbyclinicalexomesequencinganddetermined from fundus images with high accuracy. This puzzled their diagnostic status. We identiﬁed 152 VUS in 129 ophthalmologists since they haven’t found any differential unsolved cases, and studied their features in the context of features. the same cohort causal variants (N=379 cases). We trained an inceptionv3 DCNN to classify gender in Results:Whilethetypeofcommercialclinicalexomeused fundusimagesfromUKBiobank.WithanAUCof0.82,we didnotshowanydifference,theanalystinchargeseemstobe asked ophthalmologists for possible features that could asourceofdiscrepancy,asoneofthemostIRDexperienced968 J.delPicchia clinician showed greater VUS reporting (p=1.52e-04). We variants where called by DeepVariant, one common with found signiﬁcantly differential patterns for VUS frequency, HC, both not in the high conﬁdence set. according to inheritance classiﬁcation and involved gene, Conclusions: DeepVariant seems to adapt to targeted being recessive cases signiﬁcantly less frequent (p=0.01), gene panel data, suggesting the possible implementation of andABCA4andIMPG2showingthelowestandhighestVUS thealgorithmtoaccuratedetectgermlinevariantsinhuman frequency ratio, respectively (p=1.05-e08;p<0.001). More- samples. We currently investigate the efﬁciency of over,frameshiftandstop-gainvariantsarebarelyreportedas DeepVariant, on a range of gene panels and genomic VUS (p=6.3e-07). Last, we applied ﬁve pathogenicity regions of different features, to accurately detect germline predictors to VUS and causal variants respectively and variantsinanysetofgenomicintervalssmallerthanaWES. extractedthebestcombinationtoannotatepathogenicityfrom T. Loupis: None. D. Vrachnos: None. K. Zoi: None. D. the former to be applied to the VUS. Thanos: None. P. Makrythanasis: None. Conclusions: We identiﬁed patterns in IRD cases molecularanalysesandinterpretationrelatedwithincreased E-P17.19 probability to inform them with a VUS. Considering the INTERACTIONANALYSISofSMAD4COMPLEXES biases found we have deﬁned a rules-based algorithm to select VUS for further studies. N. Kawashita, A. Itagaki, K. Tamura I. Iancu: None. A. Arteche: None. A. Avila-Fernandez: None. M. Del Pozo-Valero: None. R. Riveiro-Alvarez: Kindai University, HigashiOsaka, Japan None.M.Trujillo-Tiebas:None.I.Perea:None.M.Corton: None. P. Minguez: None. C. Ayuso: None. SMAD4 mediates this TGF-β signaling, is frequently mutated in pancreatic cancer. In addition, SMAD4 muta- E-P17.16 tions have been identiﬁed not only in pancreatic cancer but Validating DeepVariant: Assessment of a deep learning also in other cancers such ascolorectal and gastriccancers. variant caller in Targeted Next Generation The analysis method used the fragment molecular orbital Sequencing data (FMO)method,whichcancalculatethemolecularstructure and the interaction between molecules. In this study, we T. Loupis, D. Vrachnos, K. Zoi, D. Thanos, investigated whether the effects of genetic mutations on P. Makrythanasis pathogenicity could be estimated using the FMO method. The structure (1dd1.pdb) of the wild type SMAD4 trimer Greek Genome Center, Biomedical Research Foundation was obtained from the protein structure data bank (PDB), Academy of Athens (BRFAA), Athens, Greece and the structure was corrected by MOE Structure Pre- paration. Pathogenic mutations were obtained from Clin- Introduction:In2018,DeepVariantwasintroduced,adeep Var,andthestructureofmutantswereconstructedbyMOE convolutional neural network tool which is reported to Homology modeling and wild type structure as a template. outperform other variant callers. The algorithm can be The computer used supercomputer K (AICS, RIKEN) and implemented in three different type of datasets: 1) Short FX100 (Nagoya Univ). The calculation was performed at read Whole Genome Sequencing 2) Short read Whole the calculation level of MP2/6-31G* using ABINIT-MP as Exome Sequencing (WES) and 3) PacBio reads, excluding thesoftware.Thesumofinterfragmentinteractionenergies the commonly used Targeted Next Generation Sequencing (IFIE-sum) was compared between the wild type and the (TNGS) panels or at least without validating the perfor- mutant. Comparing the calculated results of the wild type mance of DeepVariant in such data. and the mutant, the interaction energy was destabilized in Materials and methods: We created artiﬁcial TNGS data, themutantsuchasR361C.R361Cmutationdestabilizedthe bydownscalingWESdatafromthereferencesampleNA12878 interactionbetweenD537andD351.R361,D537andD351 to simulate an in-house TNGS custom designed gene panel form a hydrogen bond network during SMAD4 trimer (containing less than 100 genes), targeting clinical signiﬁcant formation. After R361C mutation, this hydrogen bond germline variants. Performed variant calling using DeepVar- network could not be formed, and the results of computa- iant’sWESmodelandGATK’sBestPracticesgermlinevariant tional analysis showed that this trimer formation was callingpipeline(HaplotypeCaller,HC),comparingbothresults destabilized. It is thought that a similar analysis could to the high conﬁdence calls of the NA12878. predict a pathogenic mutation. Results: DeepVariant achieved 100% accuracy with the N.Kawashita:None.A.Itagaki:None.K.Tamura:None. artiﬁcial TNGS data calling all 51 of the high conﬁdence variantsoftheNA12878sameasHC.Furthermore,2extraAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 969 E-P17.20 C. Ledeuil: None. M. Lodin: None. V. Allamand: None. Evaluation of 4splicingprediction algorithms in a NGS M. Eyries: None. V. Jobic: None. B. Keren: None. A. De clinical diagnosis context. becdelievre: None. C. Bellanne-chantelot: None. J. BURATTI1, E. LEJEUNE1, P. RICHARD2, C. METAY2, E-P17.21 F. ADER2, C. SAINT-MARTIN1, C. LEDEUIL2, M. Detectionofnon-referencesequencesinpopulation-scale LODIN2, V. ALLAMAND3, M. EYRIES1, V. JOBIC2, B. WGS data KEREN1, A. DE BECDELIEVRE2, C. BELLANNE- CHANTELOT1 T. Krannich, B. Kehr 1Département de Génétique, Hôpital Pitié-Salpêtrière, AP- Berlin Institute of Health, Berlin, Germany HP. Sorbonne Université, PARIS, France, 2Service de Biochimie Métabolique, Hôpital Pitié-Salpêtrière, AP-HP. Non-reference sequence insertions are a less frequently Sorbonne Université, PARIS, France, 3Inserm UMRS 974, investigated class of genomic structural variation. Here, Institut de Myologie, PARIS, France DNA sequences are found within an individual that are novel with respect to a given reference. These sequences Inmoleculargenetics,variantinterpretationisacriticalstep occurprimarilyduetothefactthatareferencegenomelacks in order to make a diagnosis. Presumed splice variants some ancestral sequence since it is mostly derived from a present speciﬁc analytical difﬁculties in clinical practice few or a single individual. Therefore, newly sequenced outside the natural splicing sites (GT and AG individuals can yield genomic sequences which are absent dinucleotides). from a reference genome. To ﬁnd such insertions in short- Laboratory tests to study splicing on RNA are expensive read sequencing data, it is necessary to perform a de novo and time consuming, thus it is unrealistic to perform them assembly of the non-reference sequence, an algorithmically onthelargeamountofvariantsidentiﬁedbyNGS.Theuse challenging and computationally expensive task. In recent ofinsilicopredictiontoolsisthereforenecessarytoquickly years,onlyafewmethodsandtoolshavebeendevelopedto select the most convincing splicing variants before sending detect these non-reference sequence insertions and even them to experimental validation. Many tools are available fewer to perform the detection on large cohorts. One inser- but often based on a web interface and limited to only one tioncallerthatexploitsthesimultaneousanalysisofmultiple request at a time. samplesisPopIns.PopInsextractsunmappedreadsfromall Consequently,wehaveselected4algorithmswhichallow individuals, assembles a non-redundant set of contig automaticannotationofvariantsandsimpleintegrationinto sequencesacrossallindividuals,anchorsthesesequencesto bioinformatics pipelines: MaxEntScan (2004), the reference and ﬁnally genotypes each individual. We dbscSNV_ada (2014), SpliceAI (2019) and SPiP (2019). entirely redesigned the assembly module, a key step to To assess the performance of these tools, we collected 47 combinesamples.Thenovelassemblymoduleusesahighly variants suspected of altering splicing which were tested specialized data structure called compacted colored de experimentally at the Pitié-Salpêtrière Hospital, Paris. 33 Bruijn Graph. By applying this new approach to simulated variants out of 47 have a demonstrated effect on RNA, 14 data, the detected sequences are more precise while their have not. We compared the 4 scores (percentage) with the computation requires less memory. Subsequently, this will real known effects, considering a predicted effect threshold considerably improve the detection of non-reference at 15%. sequence insertions and, therefore, offer more comprehen- sive variant call sets for population and disease studies. /47variants MaxEntScan dbscSNV SpliceAI SPiP T. Krannich: None. B. Kehr: None. Noannotation 13 19 2 1 Consitstentprediction 28 23 40 35 E-P17.23 Unconsistentprediction 6 5 5 11 re-Searcher:auser-friendlyGUI-basedbioinformaticstool for simpliﬁed genomics data mining from big VCF ﬁles In conclusion, there is no perfect prediction tool. D. Karabayev1, A. Molkenov1, K. Yerulanuly1,2, However,wehaveshownthatthe2mostrecentalgorithms A.Daniyarov1,A.Sharip1,A.Seisenova1,Z.Zhumadilov1,3, offerbetterannotationandbetterperformanceonpredicting U. Kairov1 the variant’s impact on splicing. J. Buratti: None. E. Lejeune: None. P. Richard: None. 1Nazarbayev University, NationalLaboratoryAstana, Nur- C. Metay: None. F. Ader: None. C. Saint-martin: None. Sultan, Kazakhstan, 2L.N. Gumilyov Eurasian National970 J.delPicchia University,Nur-Sultan,Kazakhstan,3Corporatefund“Uni- Results:Resultsshowedhighervariantallelefrequencies versity Medical Center”, Nazarbayev University, Nur- in the Croatian population at six loci (rs1045642, Sultan, Kazakhstan rs2279343, rs1799853, rs1057910, rs28371725, rs9923231) and lower at two loci (rs1695, rs1801272). High-throughput sequencing platforms generate a massive The most signiﬁcant differences were: 0.4608 vs 0.4880 in amount of high-dimensional genomic datasets available for ABCB1, 0.0932 vs 0.2430 inCYP2B6*4, 0.1228 vs 0.1470 analysis. The availability of modern and user- friendly in CYP2C9*2, 0.3325 vs 0.2980 in GSTP1 and 0.3488 vs bioinformatics tools for analysis and interpretation of 0.4030 in VKORC1 genes, in Europeans and Croatians genomicsdatabecomesanessentialpartduringtheanalysis respectively. of sequencing data. The Variant Call Format (VCF) is a Conclusions: Croatian population shows higher variant standard format that contains genomic information and allele frequencies in several genes responsible for metabo- variants of sequenced samples. Existent tools that process lism of anticoagulation drugs (warfarin, acenocumarol and VCF ﬁles usually have command-line as their interface phenprocoumon). This ﬁnding indicates higher bleeding without an intuitive graphical interface that may be chal- and over-anticoagulation risk in Croatians, demanding lenging for a broad biomedical community interested in lower drugs` prescription doses. Also, lower doses of genomics data analysis. We present re-Searcher, a new phenytoin and celecoxib, while higher doses of digoxin, bioinformatics application tool with user-friendly GUI, fentanyl, bupoprion and efavirenz are more frequently developedtosimplifygenomicdataminingfromVCFﬁles. required in Croatians compared with European average. D. Karabayev: None. A. Molkenov: None. K. Yerula- Acknowledgement: Croatian Science Foundation (HRZZ nuly: None. A. Daniyarov: None. A. Sharip: None. A. IP-01-2018-2497 and HRZZ-IP-2014-09-4454). Seisenova: None. Z. Zhumadilov: None. U. Kairov: None. Z. Celinscak: None. M. Zajc Petranovic: None. A. Stojanovic Markovic: None. M. Pericic Salihovic: None. E-P18 Personalized Medicine and Pharmacogenomics N.SmolejNarancic: None.B.Janicijevic:None.T.Skaric- Juric: None. E-P18.01 E-P18.04 Comparison of genetic variation in ADME genes Construction of mental support system in cancer between the Croatian population and Europeans (gno- genomic medicine mAD database) H. Fukushima1, M. Ishida2, T. Takahashi3, H. Onishi2, Z. Celinscak, M. Zajc Petranovic, A. Stojanovic Markovic, T. Hamaguchi1 M.PericicSalihovic,N.SmolejNarancic,B.Janicijevic,T. Skaric-Juric 1Department of Clinical Cancer genomics, Saitama Med- ical University International Medical Center, Hidaka, InstituteforAnthropologicalReasearch,Zagreb,Croatia Japan, 2Departmentof Psycho-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan, Introduction:Thepharmacogeneticdatahavebeenstudied 3Department of Supportive Oncology and Palliative Med- extensively due to their clinical importance in the appro- icine, Saitama Medical University International Medical priate drug prescription. Center, Hidaka, Japan Aim:todetermineallelefrequenciesof27mostimportant ADME polymorphisms (20 of them 1A, 1B or 2A clinical Introduction: The genomic medicine of cancer imple- annotation levels of evidence) in the Croatian population mented in Japan, since two multigene-panel tests, Onco- and to compare them with the European population. guide NCC Oncopanel system and FoundationOne cancer Materials and methods: The 27 loci from 20 ADME genomic proﬁle were covered by the national healthcare genes were genotyped in the Croatian study sample insurancesysteminSeptember2019.Thereimbursementis consisted of 429 participants. Allele frequencies were restricted to solid tumor patients with no standard therapy, combined with published data on the Croatian population or completed or expected to complete it. According to the (weighted frequencies according to sample sizes). The fact that only about 10 to 20 percent of the patients taking Croatian allele frequencies were compared with the genomic proﬁling test will be able to ﬁnd novel candidate European population average data taken from the gnomAD drugs and therapies, most of the patients do not see them. database (selection criteria: control cases only and non- Under the situation patients forced to remind the end of Finnish). their anticancer therapy in time and may face the fear of their death caused by disease. The aim of this study is toAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 971 identify the needs and ﬁnd effective way for mental pro- Conclusions: Individuals with divergent patterns of blem of the patients undergoing genomic proﬁling test. mitochondrial and nuclear ancestry are at increased risk Method: Current status and a series of procedures for for preterm birth. These ﬁndings may in part explain the genomic proﬁling test were reviewed by specialists of higher rates of preterm birth in African Americans and in Psyco-oncology and supportive care division. And Inves- individuals with a matrilineal family history of tigate an interview with medical stuff involved in genomic preterm birth. proﬁling test to clarify individual problem. Funded by The March of Dimes Prematurity Research Results: Consulting to supportive care specialist is Center at the University of Pennsylvania (22-FY17-890). recommended and description about availability of the N. Crawford: None. D.B. Prendergast: None. J.W. team is added to the explanatory leaﬂet on genomic Oehlert: None. G.M. Shaw: None. D.K. Stevenson: None. proﬁling.Psyco-oncologistsandsupportivecaredoctorjoin N.Rappaport:None.M.Sirota:None.S.A.Tishkoff:None. theexpert-panelinordertoadviceineachcase.Ourgoalis N. Sondheimer: None. toconstructsupportsystemofthepatientreceivinggenomic medicine including sufﬁcient mental care. E-P19.02 H. Fukushima: None. M. Ishida: None. T. Takahashi: The incidence of the commonest alpha-1-antitrypsin None. H. Onishi: None. T. Hamaguchi: None. deﬁciency (AATD) alleles (PI*Z and PI*S) in the population of Polish newborns E-P19 Genetic Epidemiology, Population Genetics and Evolutionary Genetics J. Chorostowska-Wynimko1, R. Struniawski1, M. Borszewska-Kornacka2, A. Jezela-Stanek1 E-P19.01 Divergent patterns of mitochondrial and nuclear 1National Institute of Tuberculosis and Lung Diseases, ancestry are associated with the risk for preterm birth DepartmentofGeneticsandClinicalImmunology,Warsaw, Poland, 2Medical University of Warsaw, Neonatal and N. Crawford1, D. B. Prendergast2, J. W. Oehlert3, Intensive Care Department, Warsaw, Poland G. M. Shaw3, D. K. Stevenson3, N. Rappaport4, M. Sirota4, S. A. Tishkoff1, N. Sondheimer5,1 Introduction: Alpha-1 antitrypsin deﬁciency (AATD, MIM613490) is listed among the most common genetic 1The University of Pennsylvania, Philadelphia, PA, United disordersinCaucasians.Itconsiderablyincreasestheriskof States, 2The Hospital for Sick Children, Toronto, ON, progressive obstructive lung diseases, as well as hepatic Canada,3StanfordUniversity,PaloAlto,CA,UnitedStates, dysfunction, especially in early childhood. The protein is 4The University of California San Francisco, San Fran- encoded by the SERPINA1 gene, harbouring numerous cisco, CA, United States, 5The University of Toronto, polymorphisms. Among them, Z (PI*Z) and S (PI*S), Toronto, ON, Canada resulted from mutation at Glu342Lys and Glu264Val position, respectively, are most commonly occurring deﬁ- Objective: To examine linkages between mitochondrial ciency alleles. They lead to the synthesis of structurally geneticsandpreterm birth byassessingtherisk for preterm abnormal AAT protein, enable to succeed a physiological birth associated with the inheritance of nuclear haplotypes conformation, and thus accumulating in hepatocytes (Z thatareancestrallydistinctfrommitochondrialhaplogroup. protein)ordegrading(Sprotein).Dataontheprevalenceof Study design: Genome-wide genotyping studies of AATD and frequency of mentioned deﬁciency alleles in cohorts of preterm and term individuals were evaluated. Poland are scarce, with only one published preliminary We determined the mitochondrial haplogroup and nuclear result and no studies with large enough group to be repre- ancestry for individuals and developed a scoring for the sentativefortheentirepopulation.Ourpresentationaimsto degree to which mitochondrial ancestry is divergent from show the results of a study which investigates the pre- nuclear ancestry. valence of deﬁciency alleles Z and S in Poland. Results: Infants with higher degrees of divergent Materialsandmethods:Real-timePCR genotypingand mitochondrial ancestry were at increased risk for preterm AAT blood concentration measurement by nephelometry birth (0.124 for preterm vs 0.105 for term infants; P<.05). wereperformedfromthedrybloodspots(DBS)samplesof Thisﬁndingwasvalidatedin1of2replicationcohorts.We approx. 5000 newborns. also observed that greater degrees of divergent ancestry Results: Among 4948 newborns (preliminary data) both correlated with earlier delivery within the primary study variants were identiﬁed in 221 children, including PI*Z population,butthisﬁnding wasnotreplicatedinsecondary allelein115(2.3%)andPI*Sallelein106neonates(2.1%). cohorts born preterm.972 J.delPicchia Blood A1AT concentration was signiﬁcantly lower in both higher incidence of anencephaly in elder mothers (42 years groups. and over). Conclusions: The estimated prevalence of AAT deﬁ- Discussion: Gradual implementation of ultrasound pre- ciency alleles per 1.000 persons were 11,5 (9,4-13,6) for natal diagnostics started in the 80s of the last century and PI*Z and 10,6 (8,6-12,6) for PI*S. It indicates more lead to a very signiﬁcant decrease in the incidence of frequentoccurrenceoftheZallele inPoland than inearlier anencephaly cases in births. Additionally, the total inci- reports. dence of anencephaly decreased signiﬁcantly as well. We J.Chorostowska-Wynimko:None.R.Struniawski:None. foundsigniﬁcantlyhigherincidenceofanencephalyinelder M. Borszewska-Kornacka: None. A. Jezela-Stanek: None. mothers (42 years and over). Supported by the Ministry of Health of the Czech E-P19.03 Republic, grant nr. AZV 17-29622A Incidence of anencephaly in the Czech Republic: Long- A. Sipek Sr: B. Research Grant (principal investigator, term population based study collaborator or consultant and pending grants as well as grants already received); Signiﬁcant; Research grant A.SipekSr1,2,3,V.Gregor1,2,A.SipekJr1,4,5,J.Klaschka6,7, provided by Ministry of Health of the Czech Republic, M. Maly6,8, J. Jirova9 grant nr. AZV 17-29622A. V. Gregor: B. Research Grant (principal investigator, collaborator or consultant and 1Department of Medical Genetics, Thomayer Hospital, pending grants as well as grants already received); Prague,CzechRepublic,2DepartmentofMedicalGenetics, Signiﬁcant; Research grant provided by Ministry of Health Pronatal Sanatorium, Prague, Czech Republic, 3GENNET, oftheCzechRepublic,grantnr.AZV17-29622A.A.Sipek Prague, Czech Republic, 4Institute of Biology and Medical Jr: B. Research Grant (principal investigator, collaborator Genetics, First Faculty of Medicine, Charles University, or consultant and pending grants as well as grants already Prague, Czech Republic, 5Institute of Medical Genetics, received);Signiﬁcant;Research grantprovidedbyMinistry Third Faculty of Medicicne, Charles University, Prague, ofHealthoftheCzechRepublic,grantnr.AZV17-29622A. CzechRepublic,6InstituteofComputerScienceoftheCzech J. Klaschka: B. Research Grant (principal investigator, AcademyofSciences,Prague,CzechRepublic,7Instituteof collaborator or consultant and pending grants as well as Biophysics and Informatics, First Faculty of Medicine, grants already received); Signiﬁcant; Research grant Charles University, Prague, Czech Republic, 8National provided by Ministry of Health of the Czech Republic, Institute of Public Health, Prague, Czech Republic, 9Insti- grant nr. AZV 17-29622A. M. Maly: B. Research Grant tute of Health Information and Statistics of the Czech (principal investigator, collaborator or consultant and Republic, Prague, Czech Republic pending grants as well as grants already received); Signiﬁcant; Research grant provided by Ministry of Health Introduction: Anencephaly is a lethal anomaly of the of the Czech Republic, grant nr. AZV 17-29622A. J. central nervous system from the group of neural tube Jirova: B. Research Grant (principal investigator, colla- defects. The main goal of our study was to evaluate the borator or consultant and pending grants as well as grants incidence of anencephaly (and its possible trends) during already received); Signiﬁcant; Research grant provided by the long-term period. Ministry of Health of the Czech Republic, grant nr. AZV Methods: For this study, we have used data from the 17-29622A. National Registry of Congenital Anomalies of the Czech Republic. We analyzed the incidence of anencephaly in E-P19.04 births and in prenatally diagnosed cases in the 1964-2016 Assessmentofknowledgeandattitudetowardsbiobanks period. We also evaluated maternal age in these cases. The among healthcare students and their willingness to statisticalanalysiswasperformedbyPoissonregressionand donate biospecimens in Libya Fisher’s exact test. Results: During the study period there were 6 891 062 A. Elhadi1, I. Alhudiri2, A. Elmarghani3, M. Elhadi1, children born in the Czech Republic. Among those, 1232 A. Msherghi1, A. Buhmeida4, N. Enattah2,5, A. Elzagheid2 childrenwerebornwithanencephaly.Another966casesof anencephaly were diagnosed during prenatal diagnosis and 1Faculty of Medicine, University of Tripoli, Tripoli, Libyan these pregnancies were electively terminated, the total Arab Jamahiriya, 2Genetic Engineering Department, Bio- numberofanencephalycaseswas2198.Thetotalincidence technology Research Center, Tripoli, Libyan Arab Jama- of anencephaly signiﬁcantly decreased during the study hiriya, 3Cell Biology Department, Biotechnology Research period (p = 0.0136). The incidence in births decreased Center, Tripoli, Libyan Arab Jamahiriya, 4Center of signiﬁcantly as well (p <0.001). We found statistically ExcellenceinGenomicMedicineResearch,KingAbdulaziz,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 973 Jeddah,SaudiArabia,5UniversityofTripoli,Libya,Tripoli, BRCA1 exon 11 in 48 Libyan breast cancer patients with Libyan Arab Jamahiriya family history of cancer. Materials and methods: All patients had family history Introduction: Globally, many studies have assessed of cancer and were included in the study only if they have knowledge and attitude about biobanks and the willingness family history of breast or ovarian cancer, male breast todonatespecimensinhealthworkersandmedicalstudents. cancer or triple negative tumours. PCR was performed The study aims to evaluate the knowledge and attitude of using speciﬁc primer pairs spanning BRCA1 exon 11 medicalandbiomedicalstudentsinLibyatowardsbiobanks followed by Sanger sequencing. Genetic analysis was done and their willingness to donate biological samples. using Sequencher®5.1. Materials and methods: A cross-sectional study was Results: We identiﬁed 12 genetic variants in BRCA1 conducted among senior healthcare students at the main exon 11. Three variants were novel (c.1019T>C Libyan Universities. Students from faculties of Medical, c.2363T>G, c.3192T>C); c.2363T>G is predicted by SIFT Dental,PharmacyandMedicalTechnologywhowereabout as damaging. Six variants were of unknown signiﬁcance to graduate at the end of the 2020/2021 academic year (c.918T>C, c.1853G>C, c.1886G>A, c.2215A>G, completed a structured and self-administered online ques- c.2612C>T,c.3113A>C,c.3784T>C),and3wereclassiﬁed tionnaire distributed in social media University pages and as benign in ClinVar database (c.918T>C, c.2082C>T, via emails. The questionnaire included information about c.2311T>C). personal and general health, attitudes towards biomedical Conclusions: Scanning of the entire BRCA1 is needed research and donation and awareness of biobanks. to identify any associated deleterious mutations. Although Results: A total of 324 students successfully completed the clinical importance of unclassiﬁed variants is and submitted the questionnaire. The majority of students unknown, the association of certain variants with deleter- approved medical research (96%, 311/324) and 75% (244/ ious mutations and contralateral breast cancer warrants 324) were willing to participate in genetic research. Less genetic testing and counseling in Libyan population. than5%ofstudentswereunwillingtoparticipateingenetic Keywords: Genetic variants, Breast cancer, research. Approximately 48% (155/324) were aware of the BRCA1, Libya term biobank and 74% (240/324) were willing to donate H. Elshwekh: None. I. Alhudiri: None. H. Abdul Jalil: their specimens to a biobank. None. A. Mohamed: None. A. Elkikli: None. N. Jornaz: Conclusions: This study provides novel information on None. N. Enattah: None. the likelihood of donating biospecimens and although students were largely willing to donate biological samples, E-P19.07 they were not aware of biobanking. It is therefore highly PenetranceoftheCFTR5Talleleincongenitalbilateral recommendedtoreinforcemedicalandbiomedicalcurricula absence of the vas deferens to educate students about biobanking, medical and genetic research. D. Seidl1,2, Á. Mikó1,2, A. Kaposi2, K. Tory1,2 A.Elhadi:None.I.Alhudiri:None.A.Elmarghani:None. M.Elhadi:None.A.Msherghi:None.A.Buhmeida:None. 1Semmelweis Univesity, 1st Department of Paediatrics, N. Enattah: None. A. Elzagheid: None. Budapest, Hungary, 2MTA-SE Lendület Nephrogenetic Laboratory, Budapest, Hungary E-P19.06 Genetic variants of BRCA1 exon 11 in Libyan breast Introduction: Congenital bilateral absence of the vas cancer patients deferens(CBAVD)isresponsiblefor2%ofmaleinfertility. Onethird(25-40%)ofpatientswithCBAVDarecompound H. Elshwekh, I. Alhudiri, H. Abdul Jalil, A. Mohamed, heterozygous for the CFTR 5T (c.1210-7_1210-6delTT) A. Elkikli, N. Jornaz, N. Enattah variant and another variant in trans. The 5T allele, with a MAFof3%inthegeneralEuropeanpopulation,causesthe Biotechnology Research Centre, Tripoli, Libyan Arab loss of exon 10 in 95% of mRNA. Using a formerly Jamahiriya developedpopulation-geneticalgorithmweaimedtoassign the penetrance of the 5T variant. Introduction:Themajorityofhereditarybreastandovarian Materials and methods: We collected phenotype and cancers are associated with mutations in two genes, breast genotype data from 3279 patients with biallelic CFTR cancer type 1 and 2 susceptibility genes (BRCA1 and mutations from PubMed. The penetrance (P) of the 5T BRCA2). Here we describe for the ﬁrst time analysis of variantwascalculatedbycomparingitsallelecount(AC)to the AC of the loss-of-function (LOF) variants in the974 J.delPicchia European non-Finnish patient population and in the common among women with a high concentration of HPV gnomAD as P=(AC /AC ) /(AC /AC ) , (5.9% and 15.2 % p = 0.002). 5T LOF patient 5T LOF gnomAD tested by Fisher’s exact test. Conclusions: in Russian women, IL1B -511 T/T Results: We found the 5T allele in 339/3279 (10.34%) genotypes signiﬁcantly associated with an increased risk patients, trans-associated to LOF mutations in 187/635 of HPV infection and -511C/-31T haplotype, it considered (29.3%) of the patients with CBAVD. None of the as a preventive factor against the risk of HPV infection. compoundheterozygouspatientswiththe5Tallele(without A. Al bosale: None. E.V. Mashkina: None. othervariantincis)developedCF.Wefoundthepenetrance of the 5T variant to be 4.3% (p=5x10-389). E-P19.09 Conclusions:Accordingtoourpenetranceestimation,for COMT Micro-haplotypes distribution in North African a couple with heterozygous CFTR 5T allele in one parent populations: Usefulness in population evolutionary and a LOF variant in another, the risk of a son being studies affected by CBAVD is 1% (25% x 4.3%). Supported by the ÚNKP-19-3-II New National Excel- S.Boussetta1,L.Cherni1,2,A.J.Pakstis3,N.BenSalem1,S. lence Program of the Ministry for Innovation and Elkamel1, H. Khodjet-el-khil4, K. K. Kidd3, A. Benammar- Technology. Elgaaied1 D. Seidl: None. Á. Mikó: None. A. Kaposi: None. K. Tory: None. 1Laboratory of Genetics, Immunology and Human Pathol- ogy, Faculty of Sciences of Tunis, University of Tunis El E-P19.08 Manar, Tunis, Tunisia, 2High Institute of Biotechnology, analysis the interactions of IL1Β, IL4, IL6 genes University of Monastir, Monastir, Tunisia, 3Department of polymorphism in infected women with human Genetics, Yale University School of Medicine, New Haven, papillomavirus CT,UnitedStates,4CollegeofHealthSciences.QUHealth, Doha, Qatar a. Al bosale, e. v. Mashkina Introduction: The COMT gene encodes for catechol-O- southern Federal University, Rostov-on-don, Russian methyl-transferase enzyme that has the major role in the Federation regulation of synaptic catecholamine neurotransmitters. Many variants oftheCOMT genehavebeendescribed and Introduction: The presence of functional SNPs in the pro- some of them are in strong linkage disequilibrium deﬁning moter regions can be considered as one reason for the imbal- haplotypes associated with the enzyme activity level. Our ance in cytokines levels during HPV infection which leads to aim is to investigate the haplotypic distribution of the an imbalance of pro- and anti-inﬂammatory cytokines. COMT gene markers in North African population in order Materials and methods: In our work, we assessed the to assess their usefulness in investigating North African association of polymorphic variants of the IL1β-31T>C, population genetic structure. -511C>T,IL4-589C>TandIL6-174G>Cgeneswithhigh- Materials and methods: Four markers (rs2020917, riskHPVinfectioninwomen,ages30yearsandolder(101 rs4818, rs4680, rs9332377) have been typed in 275 North women infected with HPV with viral load more than 4lg African populations using TaqMan technology. Haplotypes and 93 women without HPV). Polymorphic variants have been phased. Linkage disequilibrium (LD), Fst detected by allele-speciﬁc PCR. distance matrix and Principal Component Analysis (PCA), Results: The individual SNP genes IL1β -31T>C, IL4 wereperformed.Forcomparativeanalyses,datafromthe59 -589C>T and IL6 -174G>C did not reveal signiﬁcant Kidd Lab populations and the 1000 Genome Project, differences in all frequencies of genotypes and alleles. At were used. the same time, the difference in frequency of the -511T Results: Our main ﬁndings show that COMT activity allele and TT genotype of the IL1β gene between two prediction, according to LD performance, could be limited groups was statistically signiﬁcant (OR = 1.71, 2.02 to rs4818-rs4680 micro-haplotypes. North Africans and respectively). Analysis of intergenic interactions for all SouthAsiansshowintermediatefrequencyvalues(20%and contribution allelic variants revealed the signiﬁcant inter- 25%respectively)ofthelowactivity(CG)haplotypewhen action for polymorphic variants IL1β, IL4 and IL6 genes compared to those of African populations and East Asians (OR for the combination of loci was 4,70 CI 95 % (2,55 - thatshowfrequenciesof55%and40%respectively,andto 8,67) (P = 0,0001). Haplotypes analysis revealed that the European populations frequency of 10%. Fst genetic -511C / -31T haplotype is statistically signiﬁcantly less distance and PCA analysis showed genetic differentiation between Africans, North African, Europeans, East andAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 975 South Asians according to their signiﬁcant haplotype The research was partially supported by grants RFFR frequency differences. №20-015-00061andwithinthestatetaskoftheMinistryof Conclusion:ThehighlevelofgeneticdiversityofCOMT education and science of Russia. haplotypesalongwithdifferentLDlevelscanbeusefultool N. Kashirskaya: None. N. Petrova: None. E. Kondra- for population genetic studies and included in ancestry tyeva: None. A. Voronkova: None. Y. Melyanovskaya: informative panels. Grants: MHESR. LGIPH-E05. 15-20 None.A.Zodbinova:None.E.Zhekaite:None.E.Amelina: S.Boussetta:None.L.Cherni: None.A.J.Pakstis:None. None. S. Krasovskiy: None. M. Starinova: None. A. N.BenSalem:None.S.Elkamel:None.H.Khodjet-el-khil: Marakhonov: None. T. Vasilyeva: None. A. Polyakov: None. K.K. Kidd: None. A. Benammar-Elgaaied: None. None. T. Adyan: None. E. Ginter: None. S. Kutsev: None. R. Zinchenko: None. E-P19.10 ThecoverageofRussianCFpatientswithgenetictesting E-P19.11 in 2011-2018. Association of polymorphism of the DRD2 / ANKK1 Taq1Agenewithdepressioninopenmalepopulationof N. Kashirskaya1, N. Petrova1, E. Kondratyeva1, 45-64 years (epidemiological study) A. Voronkova1, Y. Melyanovskaya1, A. Zodbinova1, E.Zhekaite1,E.Amelina2,S.Krasovskiy2,M.Starinova1,A. V.Gafarov,E.Gromova,D.Panov,E.Krymov,I.Gagulin, Marakhonov1, T. Vasilyeva1, A. Polyakov1, T. Adyan1, E. A. Gafarova Ginter1, S. Kutsev1, R. Zinchenko1 Institute of Internal and Preventive Medicine – branch of 1Federal State Scientiﬁc Budgetary Institution «Research Institute of Cytology and Genetics SB RAS, Novosibirsk, Centre for Medical Genetics», Moscow, Russian Federa- Russian Federation tion, 2Pulmonology Research Institute under FMBA of Russia, Moscow, Russian Federation Purpose: To study the association of the DRD2/ANKK1 Taq1A gene polymorphism with depression in open male Cystic Fibrosis Patient Registry of Russian Federation population aged 45-64 years. (CFPR-RF) 2011-2018 collects demographic and clinical Methods: Under the IV screening of the international data in accordance with the agreed European program "HAPIEE" and the WHO program "MONICA- inclusion criteria and deﬁnitions. psychosocial" in 2003-2005 a representative sample of the Aim: To compare the coverage of CF patients with populationaged45-64years(n=781ofmen)wassurveyed. genetic testing in 2011 and 2018. All study participants ﬁlled out the depression scale Materials and methods: CFPR-RF 2018 included data proposed by WHO MONICA-psychosocial program. The of 3142 CF patients while 2011 - 1015 patients. genotyping oftheDRD2/ANKK1Taq1A genepolymorph- Results: In 2018 molecular-genetic testing was per- ism was done in frame of the budgetary issue # АААА- formed in 94.3% (2011 -91.8%) of CF patients (children- А17-117112850280-2. 94.6%, adults -93.6%). Two mutations were identiﬁed in Results: The prevalence of depression in the open 82.4%,one-in14.0%,none-in3.7%ofpatients.Thetotal population of men 45-64 was 36.3% (13.5% with a high frequency of identiﬁed alleles was 89.3% (80.0% in 2011). level and 22.8% with middle level). A comparative The worst situation is in the Volga region - only 87.9% of intergroup analysis showed that odds ratio (OR) of a high CFpatientsaregeneticallytested.ThebestisintheCentral level of depression was 3.86-fold higher in personswith T/ - 97.6% and the Ural - 97.3% RF regions (St. Petersburg - C genotype than those with C/C genotype without 100.0%, Moscow - 98.2%). The allele frequency of the depression. OR of a high level of depression was in 3.28 mostcommonmutationsinRFin2018:F508del-53.05%, times higher in persons with T/C genotype compared to CFTRdele2,3-6.09%,E92K-3.04%,3849+10kbC->T- persons with middle level of depression and with homo- 2.38%, 2143delT - 2.11%. In total 223 pathogenic variants zygous C/C genotype. Males with T allele of the DRD2 were identiﬁed and 100 of them repeatedly. gene more likely to be at high level of depression in 2.63 Conclusion: The number of CF centers and patients times than persons with C allele who had more often no participating in CFPR-RF 2018 has tripled since 2011. depression. CFTRgeneticvariantsidentiﬁcationhasbeenimprovedbut Conclusions: Reliable associations were found between there are still CF patients that are either not tested at all the presence of Taq1A (T allele) and depression in males (5.7%) or have unidentiﬁed one or two CFTR mutations. aged 45-64 years. V. Gafarov: None. E. Gromova: None. D. Panov: None. E. Krymov: None. I. Gagulin: None. A. Gafarova: None.976 J.delPicchia E-P19.12 AppliedScience,UCSIUniversity,Kualalumpur,Malaysia, Pertinence of genetic testing ordered by different 3SchoolofBiosciences,FacultyofScienceandEngineering, medicalspecialties.Experiencefromareferencelabora- University of Nottingham, Semenyih, Malaysia, 4Malaysia tory in Colombia Genome Institute, National Institutes of Biotechnology, Bandar Baru Bangi, Malaysia, 5Centre of Healthy Ageing I. T. Bernal, S. J. Maradei, A. J. Muñoz, Y. M. Gómez and Wellness, Faculty of Health Sciences, Universiti Kebangsaan Malaysia,, Kuala Lumpur, Malaysia, 6Faculty Biotecgen S.A., Bogota, Colombia of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia Introduction: In the last decade, there has been a rapid increaseinthetechnicalcapacityofmultiplegeneticteststo Introduction: DNA damage due to toxic heavy metals detect DNA variants that can be used to diagnose different (HMs)isaglobalpublichealthconcern.UnregulatedDNA pathologies and to guide speciﬁc diagnostic strategies. In damage leads to aberrant gene expression and may initiate Colombia,therehasbeenadramaticincreaseintherequest diseaseprocesses.Thisstudyaimedtoinvestigateimpactof for all types of genetic studies by the vast majority of dietarynutrientsinmodulatingDNAdamageduetoHMsin medical specialties, without adequate guidance by clinical non-occupationally exposed Malaysian women. geneticists, regarding to the choice of molecular study and Methods: A cross-sectional study was conducted invol- interpretation of results. ving 134 Malay women aged between 20 to 50 years. Hair Materials and methods: We reviewed all the molecular samples were collected from occipital region of the scalp. studies received in our laboratory during the year 2019, Concentrations of four HMs were quantiﬁed using Induc- grouping them by requesting specialty, type of study and tively Coupled Plasma Mass Spectrometry (ICP-MS). result, determining the index of relevance and/or accuracy, Degree of DNA damage was detected using Alkaline- and the diagnostic yield of each one. Comet assay. Hundred cells were randomly selected and Results: We received 834 orders for genetic studies, scored using online software for evaluating four comet requested by 25 different medical specialties, with a total of assay parameters. Participant’s daily energy, macro and 248 positive results (29,7%), 119 VOUS (14,2%) and 467 micro nutrient intake wereextracted from afood frequency negative results (55,9%), mainly corresponding to NGS questionnaire. panels. The two specialties with the highest number of Results: The basal level of DNA strand breaks was requests for molecular studies were Clinical Genetics and 11.49 ±5.67 (%DNA in comet tail mean ± SD). Mean Oncohematology, the former having the highest diagnostic concentrationsofarsenic,mercury,chromiumandcadmium yield,the40%ofmedicalspecialtieshadonlynegativeresults. were 0.1318 ± 0.329, 0.984 ± 4.107, 6.151 ± 4.3487, and Conclusion: We strongly recommend that genetic tests 0.201 ± 0.868 mg/kg respectively. After adjustment for prescribedbyuntrainedmedicalstaffshouldbereservedfor covariates, signiﬁcantly lower cadmium levels were found caseswithhighclinicalsuspiciononly,otherwiseitleadsto forhighvitaminDintake(p=0.043)andsigniﬁcantlylower increased time for diagnosis and treatment, and economic chromium levels were found for high calcium intake detriment to the health system. Moreover, medical special- (p=0.043). High intake of manganese had positive impact ties should be instructed on the impact of VOUs and the (p=0.031) on comet tail DNA in individuals with high importance of their reclassiﬁcation. concentrations of hair arsenic.Conclusion: Speciﬁc dietary I.T. Bernal: None. S.J. Maradei: None. A.J. Muñoz: nutrients maymodulate heavymetalinducedDNAdamage None. Y.M. Gómez: None. in non-occupationally exposed individuals. The project was funded by UCSI Universities (Proj-In- E-P19.14 FMHS-029 and Proj-In-FMHS-019) and FRGS/1/2014/ Effectofdietarynutrientsonmodulationofheavymetal SKK10/UCSI/03/1. induced DNA damage in community dwelling C.Y. Ng: None. A.B. Normina: None. E.S.S. Tan: None. Malaysian women M.S.Seghayat:None.P.Y.Tan:None.S.R.Mitra:None.E. S.C. Ng: None. A. Muhamad: None. R. Sharif: None. A. C.Y.Ng1,2,A.B.Normina1,E.S.S.Tan1,M.S.Seghayat1, Razak: None. F. Amini: None. P. Y. Tan3, S. R. Mitra3, E. S. C. Ng1, A. Muhamad4, R. Sharif5, A. Razak6, F. Amini1 E-P19.16 Origin and migration path of Val30Met in Familial 1School of Healthy Aging, Medical Aesthetics & Regen- Amyloid Polyneuropathy (TTR-FAP) in Portugal erativeMedicine,FacultyofMedicineandHealthSciences, UCSI University, Kuala Lumpur, Malaysia, 2Faculty ofAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 977 C. Leal1, T. Coelho2, M. Alves_Ferreira3, D. Santos3, M. K. Aktas1, C. Mujde2, A. Rencuzogullari3, A. Bisgin2,4 I. Alonso3, J. Sequeiros3, C. Lemos1,3, A. Sousa1,3 1Cukurova University Faculty of Medicine, Adana, Turkey, 1ICBAS, Porto, Portugal, 2CHUP, Porto, Portugal, 3i3s, 2CukurovaUniversityAGENTEM(AdanaGeneticDiseases Porto, Portugal Diagnosis and Treatment Center), Adana, Turkey, 3Cukur- ova University Faculty of Medicine, Surgical Oncology Introduction: Variability in age-at-onset (AO) of Familial DepartmentofBalcaliHospitalandClinics,Adana,Turkey, Amyloid Polyneuropathy (TTR-FAP Val30Met) is well 4Cukurova University Faculty of Medicine, Medical Genet- known. Three independent Val30Met mutational events ics Department of Balcali Hospital and Clinics, Adana, have been hypothesized by different authors, suggesting an Turkey association with AO differences among the main clusters. Whether there is a common origin for Val30Met mutation Introduction: It has been reported that patients with ade- in the Portuguese cluster remains an open question. nomas or polyps in the colon or rectum may have an Objectives: To distinguish between one or multiple increased risk of developing colorectal cancer. However, it mutational events among the Portuguese Val30Met TTR- is still unclear in different populations that the APC and FAP kindreds, through characterization of the genetic MUTYHgenetic proﬁling might haveeffect.Thus,instudy background surrounding Val30Met locus and to estimate we determined the incidence of APC and MUTYH muta- the age of ancestral mutational event(s). tionsinpatientswithtubularadenomaandadenocarcinoma. Methods:FromthelargestVal30MetTTR-FAPdatabase Material and Methods Peripheral blood samples of 18 worldwide we carried out an extensive family-based patients were sequenced for APC and MUTYH genes via haplotype study, in 45 families from two disease clusters MiSeqNGSSystem(Illumina).DatawasanalyzedbyQCI- (Northern Coast and Inland). Analyze and QCI-Interpret bioinformatics tools. Results: Mean AO was signiﬁcantly higher in patients Results: 11 clinically signiﬁcant variants in APC and from Inland than from Northern Coast (p <0.001). A MUTYH genes were detected in 55.5% (n=10) of 18 common haplotype of different lengths was shared by patients whom 50% of tubular adenoma, 44% adenocarci- almost all carriers, providing strong evidence of a major noma and only one of hyperplastic polyp. In tubular single-founder effect for Val30Met in these two disease adenomagroup,77.7%ofthemhadatleastonemutation,6 clusters.Weestimatedthatthemutationaleventoccurredin variants in APC gene and 2 variants in MUTYH gene themid-VI century (AD) (1450-1475years ago), spreading retrospectively. Interestingly, while 1 of APC variants is a from Póvoa de Varzim/Vila doCondeto theInlandregion. novel, two of them are variants classiﬁed as uncertain Although AO variability in Val30Met Portuguese kindreds signiﬁcant.Ontheotherhand,only25%ofadenocarcinoma does not seem associated to different mutational origins, patients had mutations on APC and MUTYH genes (1 in striking differences in the extended haplotype downstream APC and 1 in MUTYH). STR D18S1133 were found between Northern Coast vs. Conclusions: Our data suggested that patients with both Inland. premalignant and malignant tumors of colorectum should Conclusions: 1) We were able to clarify Val30Met undergo genetic screening for the beneﬁt of patients and ancestral origins and its migration path between these two their families. Portuguese cluster, 2) Exploring this genomic region may M.K. Aktas: None. C. Mujde: None. A. Rencuzogullari: providenew insights onAO variability, withtheidentiﬁca- None. A. Bisgin: None. tion of genetic modiﬁers. C.Leal:None.T.Coelho:F.Consultant/AdvisoryBoard; E-P19.19 Modest;Pﬁzer.M.Alves_Ferreira:None.D.Santos:None. Association between Interleukin 17A and Interleukin I. Alonso: None. J. Sequeiros: None. C. Lemos: None. A. 17FGenePolymorphismsandPeriodontalPathogensin Sousa: None. Chronic Periodontitis among Libyans. E-P19.18 E. Alsherif1, I. Alhudiri2, M. ElJilani2, P. Rutland3, Incidence of APC and MUTYH mutation carriers of N. Enattah1,2 premalignant (tubular adenoma) versus malignant (adenocarcinoma) tumors of colon and rectum in 1University of Tripoli, Tripoli, Libyan Arab Jamahiriya, Southern Turkey 2Biotechnology Research Centre, Tripoli, Libyan Arab Jamahiriya, 3University College London, London, United Kingdom978 J.delPicchia Background: Chronic periodontitis (CP) is triggered by may have a signiﬁcant role in the IS therapy outcome. periodontal pathogens and inﬂuenced by genetic and Polymorphisms (rs243866, rs243865, rs243864, environmental factors. Recent studies suggest that anti- rs2285053)withintheMMP-2genecouldpotentiallyaffect inﬂammatory cytokines such as interleukin 17 (IL-17) MMP-2 gene expression and consequently IS patients’ plays a prominent role in the pathogenesis of CP. This recovery and the occurrence of HT. study aims to investigate the association between CP and Aim: To analyze the correlation between genotypes and interleukinIL-17(AandF)genepolymorphisms.Wealso haplotypes of the selected MMP-2 gene polymorphisms on aim to evaluate the association between eight subgingival IS patients’ recovery, along with testing the occurrence of pathogens (Porphyromonas gingivalis, Treponema denti- HT after thrombolytic therapy. cola, Tannerella forsythia, Prevotella intermedia, Pre- Methods:Thestudyincluded170patientswithIStreated votella nigrescns, Campylobacter rectus, Aggregatibacter with thrombolytic therapy. Patients’ convalescence was actinomycetemcomitans, Eikenella corrodens) and CP in determined using the Modiﬁed Rankin Scale (mRS) after Libyans. 3 months from IS onset, where the good outcome has been Materials and methods: The study consisted of 100 deﬁned with scores 0-1 and unfavorable with scores 2-6. Libyan individuals between the ages of 25 and 65 years Genotypisation was performed using Real-Time PCR including 50 cases and 50 controls. DNA was extracted (rs243866, rs243865, rs243864) and PCR-RFLP from buccal swabs and paper points for subgingival (rs2285053) methods. Haplotype analysis was performed pathogensamples.IL17(A&F)genotypingwasperformed by Haploview software. by PCR followed by Sanger sequencing. Speciﬁc 16S Results: Obtained frequencies of genotypes and alleles rRNA primers for each pathogen were applied in a were in accordance with Caucasian population results. We multiplex PCR reaction and visualized by agarose gel have observed no association between any genotypes or electrophoresis for detection of subgingival pathogens. haplotypes with thrombolytic therapy outcome and HT Results: IL17A AA, GG and AG (rs2275913) genotypes occurrence. Haplotypes GCTC, ATGC, GCTT and GCGC were detected in patients with CP. IL-17F CT (rs763780) (rs243866, rs243865, rs243864, rs2285053) were the most genotype was seen in CP group only. A novel variant c. frequent among our patients (73.2%, 17.0%, 5.6%, 1.5%, *34G>AinIL17Fwasfoundin14%ofpatients.Signiﬁcant respectively). Using Solid spine of LD method, haplotype association between the subgingival pathogens and CP (p- block was deﬁned among all investigated polymorphisms value =0.0001) and high prevalence of subgingival withintheMMP-2gene.PatientswithGCTChaplotypehad pathogens in CP group. less frequently repeated IS (60% Vs. 75.5%, p=0.021). Conclusion: IL-17 gene polymorphisms are associated Conclusion: MMP-2 promotor haplotype GCTC may be with CP, and strong association between subgingival protective against recurrent IS. pathogens and CP exist. Further large scale studies are M.G. Dusanovic Pjevic: None. L. Vojvodic: None. M.B. needed to elucidate the association. Grk: None. N. Maksimovic: None. T. Damnjanovic: None. E. Alsherif: None. I. Alhudiri: None. M. ElJilani: None. M.M. Pesic: None. M. Gulic: None. K. Kacar: None. B. P. Rutland: None. N. Enattah: None. Jekic: None. E-P19.25 E-P19.29 Analysis of the association withinMMP-2gene poly- Populationgeneticstudyfromfourpolymorphismofthe morphisms and ischemic stroke outcome after throm- ADRB3, APOA5, ADIPOQ and PPARG genes asso- bolytic therapy ciated with metabolic syndrome in Bucaramanga, Santander-Colombia M. G. Dusanovic Pjevic1, L. Vojvodic2, M. B. Grk1, N.Maksimovic1,T.Damnjanovic1,M.M.Pesic1,M.Gulic1, V. Hernández Espinosa1, A. Castillo Pico1, G. Mantilla K. Kacar3, B. Jekic1 Mora1,C.I.Vargas Castellanos1,F.RondonGonzalez2,L. Vera Cala3, V. L. Perez Romero4 1Institute of Human Genetics, Faculty of Medicine, Belgrade, Serbia, 2Euromedik Hospital, Belgrade, Serbia, 1Human Genetics Research Group. Universidad Industrial 3St. Sava Hospital, Belgrade, Serbia deSantander,Bucaramanga,Colombia,2Microbiologyand Genetics Research Group. Universidad Industrial de Introduction: Thrombolytic therapy has signiﬁcantly Santander, Bucaramanga, Colombia, 3GUINDESS improvedrecoveryinischemicstroke(IS)patients,reduced Research Group. Universidad Industrial de Santander, mortality, but is followed by the risk of hemorrhagic Bucaramanga, Colombia, 4Basic Sciences Applied to transformation(HT).Matrixmetalloproteinases2(MMP-2) Sustainability Research Group. Universidad de Santander,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 979 Bucaramanga, Colombia synovial pannus overproduces matrix metalloproteinase (MMP)andleadstosynovialjointsimpairment.Expression Introduction: Metabolic Syndrome (MetS) is a cluster of of MMP is controlled by cytokines at the transcriptional alterationsincludingincreasedfastingbloodglucoselevels, level. Methotrexate (MTX), as anchor treatment in RA, high triglycerides levels and blood pressure, abdominal could indirectly inﬂuence MMP production through cyto- obesity and lower HDL cholesterol levels. MetS is a mul- kine expression modulation. Hence, MMP-2 promoter tifactorial disorder and includes genetic-environmental haplotype could affect its expression, and as a result inﬂu- interactions. ADRB3, APOA5, ADIPOQ and PPARG are ence disease activity and MTX response. We investigated among the most studied genes having roles in several the association of MMP-2 promoter haplotype with MTX metabolic pathways. A differential distribution of these monotherapy efﬁcacy/toxicity. polymorphicgenesindifferenthumanpopulationshasbeen Material and methods: We included 109 RA patients. reported by numerous studies worldwide. We aim to MTX efﬁcacy was estimated using the changes in Disease determine the genetic composition of Single Nucleotide activity score (DAS28) after 6 months of MTX mono- Polymorphisms (SNPs) rs2075291 (G / C), rs2241766 (G / therapy, according to EULAR response criteria. Adverse T),rs1800571(G/T)andrs4998(C/A/G)inapopulation effects (AE) were collected during the follow-up period. sample of Bucaramanga, Colombia. Bone erosion appearance was estimated after 6 months of Materials and methods: A blood sample was collected treatment. Genotyping for MMP-2 gene polymorphisms from1057healthysubjects.DNAextractionwasperformed (rs243866, rs243865, rs2285053) was performed using the using the PrepFilerTM kit. Polymorphisms were ampliﬁed Real Time orPCR-RFLPmethods.Haplotypeanalysiswas in a multiplex PCR, and a SNaPshot minisequencing performed using the Haploview software. reaction followed by analysis on an ABI PRISM 310. Results: Investigated MMP-2 haplotypes were not Allelic frequencies and Hardy-Weinberg test (EHW) were associated with MTX response or overall AE. Haplotypes obtained by Arlequin v 3.5. GCC, ATC, GCT and GTC were most frequent among our Results: The most frequent genotype and allele for each patients (64.3%, 19.2%, 11.8%, 3.6%, respectively). Using of the polymorphisms were: ADRB3 GG gene (0.738), G Conﬁdence intervals LD method, haplotype block was (0.859); APOA5 GG (0.766), G (0.875); ADIPOQ TT deﬁned between rs243866 and rs243865 MMP-2 gene (0.561), T (0.749); and PPARG CC (0.861), C (0.928). polymorphisms (r2=0.74, D’=0.94). ATC haplotype was These results agree with previous studies (Ziki 2016; Kim not observed among patients with nausea (n=9) while it 2018). No deviations from EHW were found after was present in 21% of patients without this AE (p=0.03). performing Bonferroni correction. Conclusion: According to our study MMP-2 promoter Conclusions:Thefrequenciesobtaineddonotdifferfrom haplotype does not inﬂuence MTX therapy outcome in RA those previously reported. Finding SNPs under EHW patients. contribute to determine the possible association of these M.B. Grk: None. V. Milic: None. M.G. Dusanovic polymorphisms with MetS Pjevic: None. N. Maksimovic: None. T. Damnjanovic: V.HernándezEspinosa:None.A.CastilloPico:None.G. None. M.M. Pesic: None. M. Gulic: None. B. Jekic: None. Mantilla Mora: None. C.I. Vargas Castellanos: None. F. Rondon Gonzalez: None. L. Vera Cala: None. V.L. Perez E-P19.31 Romero: None. MITF variation sites associated with intermediate pigmentation phenotypes in a Brazilian population E-P19.30 sample Analysis of association of MMP-2 gene promoter haplotype with efﬁcacy and toxicity of methotrexate in L. Marcorin1, A. L. E. Pereira1, G. Debortoli2, patients with Rheumatoid arthritis M. L. G. Oliveira1, T. M. T. Carratto3, N. C. A. Fracasso1, G. Valle-Silva3, A. B. C. Silva3, E. A. Donadi4, M. B. Grk1, V. Milic2, M. G. Dusanovic Pjevic1, A. L. Simões1, E. C. Castelli5, H. L. Norton6, E. J. Parra2, N.Maksimovic1,T.Damnjanovic1,M.M.Pesic1,M.Gulic1, C. T. Mendes-Junior3 B. Jekic1 1Departamento de Genética / FMRP-USP, Ribeirão Preto, 1InstituteofHumanGenetics,Belgrade,Serbia,2Instituteof Brazil, 2Department of Anthropology / University of Rheumatology, Belgrade, Serbia Toronto, Mississauga, ON, Canada, 3Departamento de Química / FFCLRP-USP, Ribeirão Preto, Brazil, 4Depar- Introduction:Rheumatoidarthritis(RA)isanautoimmune tamento de Clínica Médica / FMRP-USP, Ribeirão Preto, disease characterised by chronic synovitis. Invasive Brazil,5DepartmentofPathology/FMB-UNESP,Botucatu,980 J.delPicchia Brazil, 6Department of Anthropology / University of N. V. Ekomasova1,2, M. A. Dzhaubarmezov1,2, Cincinnati, Cincinnati, OH, United States S. S. Litvinov1, L. R. Gabidullina2, K. Tambets3, E. K. Khusnutdinova1,2 Introduction: DNA Phenotyping is of large interest in the forensic ﬁeld since it gives an alternative for identifying 1Institute ofBiochemistry andGenetics -Subdivision ofthe physical characteristics in cases that lack suspects. Unfor- Ufa Federal Research Centre of Russian Academy of tunately, the tools developed so far do not perform well Sciences (IBG UFRC RAS), UFA, Russian Federation, whenpredictingphenotypesinadmixedpopulations.MITF 2Bashkir State University, Ufa, Russian Federation, 3Uni- (Melanocyte Inducing Transcription Factor) is an essential versity of Tartu, Tartu, Estonia transcription factor in melanin biosynthesis, regulating the transcriptionofTYR,TYRP1,DCTandSLC24A5genes,and Scythians of the Iron Age were previously described by couldbeagoodtargetforﬁndingnewvariantsforForensic historians and geneticists as a confederation of tribes of DNA Phenotyping. Here we report associations found differentorigins.Nevertheless,todateitremainscompletely between variation sites at the MITF gene and pigmentation unclear whether there is a genetic continuity between the phenotypes in a Brazilian population sample. Scythian-Sarmatian archaeological culture of the Iron Age Materials and methods: Samples were collected from andmodernpopulationofNorthernEurasia.Theaimofour 498 volunteers in Ribeirão Preto, SP. Pigmentation study was to analyze mitochondrial DNA in 9 samples of phenotypes and melanin index measurements (spectro- the Scythian-Sarmatian historical and archaeological cul- photometry) were also collected. Genotype data was ture,followedbycomparingtheresultswithdatafrommore obtained using a) Inﬁnium Multi-Ethnic Global-8 (MEGA) than 1,000 individuals from modern Northern Eurasian Kit Array (Illumina) and b) target sequencing (HaloPlex populations. DNA samples from the Scythian and Sarma- Target Enrichment System For Illumina Sequencing, tiancultureswereshowntobelongtomtDNAhaplogroups: Agilent Technologies), followed by alignment to hg19/ W, W3a, T1a1, U5a2+16294, U5b2a1a2, U5b2a1a1, GRCh37 reference genome and genotyping by Genome U5b2c, T1a1d, C1e. Screening using 1042 samples from Analysis Tool Kit (GATK) HaplotypeCaller. Association modern populations of Northern Eurasia showed that hap- analysis were performed using logistic regression adjusting logroup W was found in almost all analyzed samples and to ancestry composition and Fisher Exact test. reached maximum in Balkar population (15.7%) and was Results: Two variants in linkage disequilibrium in the absent only in some ethno-territorial groups ofBashkirs.In promoter region (rs6761994*A and rs62250968*T, r2 = turn, haplogroup W3 was detected only in populations of 0.698954)wereassociatedwithdarkblondhair,greeneyes the Volga-Ural region, where it reaches its maximum and fair skin. Melanin index is signiﬁcantly lower for among Udmurts (6.8%) and Besermyans (5.1%). The individuals carrying these variants. Previous studies mtDNAhaplogroupT1a1wasdetectedwithafrequencyof reported rs62250968 effects on regulatory motifs and on 1.7% in the Balkar population and a single variant in the MITF expression. group of Burzyansky Bashkirs (1.7%). Haplogroup U5a2 Conclusions: Results showed that rs6761994 and +16294 was identiﬁed in single cases in Mordvins and rs62250968 are associated with intermediate phenotypes Karachays, Haplogroup U5b2a1a was detected in Russians and could be good markers for DNA phenotyping in (3.8%), and in single cases in Besermyans and Arkhan- admixed populations. gelsky Bashkirs. Haplogroups U5b2c, T1a1d, C1e were L. Marcorin: None. A.L.E. Pereira: None. G. Debortoli: unobserved in modern populations studied. The reported None.M.L.G.Oliveira:None.T.M.T.Carratto:None.N.C. study was funded by RFBR according to the research pro- A. Fracasso: None. G. Valle-Silva: None. A.B.C. Silva: ject №19-04-01195. None. E.A. Donadi: None. A.L. Simões: None. E.C. N.V.Ekomasova:None.M.A.Dzhaubarmezov:None.S. Castelli: None. H.L. Norton: None. E.J. Parra: None. C.T. S. Litvinov: None. L.R. Gabidullina: None. K. Tambets: Mendes-Junior: None. None. E.K. Khusnutdinova: None. E-P19.33 E-P19.34 Scythian cultures genetic traces in the mitochondrial Mitochondrial DNA in peripheralblood as a prognostic gene pool of modern Northern Eurasian populations biomarker of acute respiratory distress syndrome T.Hernandez-Beeftink1,2,B.Guillen-Guio1,H.Rodríguez- Pérez1, I. Marcelino-Rodríguez1, J. Lorenzo-Salazar3, A. Corrales1,4, N. Casanova5, M. González-Garay5, E. Espinosa6, A. Muriel7, D. Domínguez6, A. García deAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 981 Lorenzo8, J. Añón8, J. Belda9, J. Garcia5, J. Villar2,4, C. None. M. González-Garay: None. E. Espinosa: None. A. Flores1,3,4 Muriel:None.D.Domínguez:None.A.GarcíadeLorenzo: None. J. Añón: None. J. Belda: None. J. Garcia: None. J. 1ResearchUnit,HospitalUniversitarioN.S.deCandelaria, Villar: None. C. Flores: None. Universidad de La Laguna, Santa Cruz de Tenerife, Spain, 2Research Unit, Hospital Universitario Dr. Negrin, Las E-P19.36 Palmas de Gran Canaria, Spain, 3Instituto Tecnológico de Age structure of neurodegeneration onset is consistent Energías Renovables, Granadilla, Santa Cruz de Tenerife, with multistep aetiology Spain,4CIBERdeEnfermedadesRespiratorias,Institutode Salud Carlos III, Madrid, Spain, 5Department of Medicine, R. L. McLaughlin The University of Arizona, Tucson, AZ, United States, 6DepartmentofAnesthesiology,HospitalUniversitarioN.S. Smurﬁt Institute of Genetics, Dublin, Ireland de Candelaria, Santa Cruz de Tenerife, Spain, 7Intensive CareUnit,HospitalUniversitarioRioHortega,Valladolid, Introduction: Most neurodegenerative diseases are highly Spain,8IntensiveCareUnit,HospitalUniversitarioLaPaz, heritable, implying genetically determined disease risk and Madrid, Spain, 9Anesthesiology and Critical Care Depart- onset. Despite this, neurodegeneration does not typically ment,HospitalClinicoUniversitarioofValencia,Valencia, begin until later in life, with peak incidence between the Spain sixthandeighthdecades.Usinganepidemiologicalmethod classically applied to cancer, a linear relationship between Introduction: Quantitative PCR measures of circulating log-scaled incidence and log-scaled age was recently cell-free mitochondrial DNA (mtDNA) have been asso- demonstratedforamyotrophiclateralsclerosis,supportinga ciated with overall patient mortality in the Intensive Care multistep model of disease onset due to six discreet time- Units (ICUs). Using an orthogonal approach to infer associatedsteps(orexposures)onaverage.Inthisstudy,we mtDNAlevelsinperipheralblood,weaimedtoanalyzethe sought to determine whether other ICD-10 classiﬁed dis- associationwith ICUmortality byacuterespiratorydistress easesofthenervoussystemappeartobemultistepinnature. syndrome (ARDS). Materials and methods: We used least squares regres- Material and Methods: We analyzed Axiom Genome- sion to ﬁt the model log(incidence) ~ (n-1)log(age) in Wide CEU1andAxiomGenome-Wide PanAFR array data published estimates of age-speciﬁc incidence of neurologi- from patients with sepsis-associated ARDS: 269 Spanish cal diseases to estimate n, the average number of steps from GEN-SEP study and 137 African Americans. required for disease onset. Estimates of the mtDNA levels were obtained from the Results: Onset of age-related neurodegeneration is intensities of selected probes, with 100% identity with consistent with multistep aetiology. For Parkinson’s mtDNAandwiththelargestnumberofmismatcheswiththe disease, the average number of steps required across both nuclear sequences. Values were normalized across the sexes in a catchment population of 2 million white individual-probe intensities. Logistic regression was used Americans was 8.4 (r2=1; p=6.1×10-5; 474 cases). For for association with 28-day mortality and ICU mortality in Alzheimer’s disease, 13.0 steps were required on average Spanish and African Americans, respectively. (r2=0.98; p=8.6×10-4; 114 cases). This contrasts with Results and conclusions: A signiﬁcant association was epilepsy, which showed no evidence of a multistep obtained in the Spanish study (OR=1.47; 95%CI=1.11- aetiology (r2=0.01; p=0.76; 501 cases from 0.9 million 1.93; p=6.98e-3). The result was not signiﬁcant in African Icelanders). Americans (OR=0.98; 95%CI=0.72-1.32; p=0.88). Our Conclusions: This model supports the conclusion that results support that circulating mtDNA levels could be a neurodegenerativediseasesbeginlaterinlifebecauseofthe prognostic biomarker among sepsis-associated ARDS. accumulation of multiple time-dependent steps or expo- Funding:InstitutodeSaludCarlosIII(PI14/00844;PI16/ sures. These could be environmental risk factors or age- 00049; PI17/00610; FI17/00177; FI18/00230), co-ﬁnanced associated biological changes in (eg) gene expression or by the European Regional Development Funds, “A way of brain cell type composition, potentially interacting with making Europe” from the EU; ITER agreement OA17/008 genetic risk. to strengthen scientiﬁc and technological education, train- R.L. McLaughlin: None. ing, research, development and innovation in Genomics, Personalized Medicine and Biotechnology. E-P19.37 T.Hernandez-Beeftink:None.B.Guillen-Guio:None.H. Epigenetic variability in Neuromedin U gene and Rodríguez-Pérez: None. I. Marcelino-Rodríguez: None. J. metabolic parameters in a cohort of Italian adults Lorenzo-Salazar: None. A. Corrales: None. N. Casanova:982 J.delPicchia A. Marotta1, F. Noro1, A. Gialluisi1, R. Parisi1, A. Kotsifaki1, S. Nasis1, K. Agiannitopoulos1, A. De Curtis1, S. Costanzo1, A. Di Castelnuovo1,2, D. Mavrogianni2, P. Drakakis2, K. Lamnissou1 C. Cerletti1, M. B. Donati1, G. de Gaetano1, B. Izzi1, L. Iacoviello1,3, F. Gianfagna3,2, on behalf of Moli-sani 1Department of Biology, National & Kapodistrian Uni- Study Investigators versity of Athens, Athens, Greece, 21st Department of Obstetrics and Gynecology, Alexandra Hospital, School of 1IRCCS Neuromed, Pozzilli, Italy, 2Mediterranea Cardio- Medicine, National & Kapodistrian University of Athens, centro,Napoli,Italy,3UniversityofInsubria,Varese,Italy Athens, Greece Background: Neuromedin U (NmU) is a multifunctional Background: Paraoxonase-1 (PON-1) is a calcium depen- neuropeptide involved in adiposity regulation. We aimed to dedantioxidantglycoproteinandoneoftheHDLstructures. analyse the association between epigenetic variants in gene The PON-1 coding region has the two polymorphisms encoding for NmU and metabolic phenotypes, and the L55M(163T>C)andQ192R(575A>G).Thepurposeofthe potential mediating role of low-grade inﬂammation. present study was to investigate the possible association Methods: A subcohort of 1,160 subjects were randomly between these PON-1 polymorphisms with the risk of selected from the Italian Moli-sani cohort (2005-2010, recurrentspontaneousabortion(RSA)inaCaucasianGreek ≥35years). Methylation levels at 17 CpG sites of NMU population. regions76(promoter)and32(intronic)wereanalysedusing Materials and methods: A total of 280 women were pyrosequencing. Principal factor analysis (PFA) was enrolled in this case-control study. The patient group performed to identify the main methylation patterns. consistedof150womenidentiﬁedasRSApatients,andthe Multivariable regressions (age, sex, smoking, alcohol and controls were 130 women with at least two successful vegetables consumption as covariates) were performed to pregnancies and without history of abortions. All indivi- estimate the associations between resulting factors and duals were genotyped for the PON-1 polymorphisms by metabolicphenotypes(BMI,waist,bloodpressure,glucose, PCR-RFLP method. lipids and apolipoproteins A and B). False discovery rate Results: Statistical analysis of the results indicated that (FDR) was used to correct for multiple comparisons. for PON-1 L55M variant the differences of genotype or Mediation analyses were performed using a composite allele frequencies between RSA patient and control groups index of circulating inﬂammation based on hsCRP, were statistically signiﬁcant. In contrary, no signiﬁcant granuocyte-to-lymphocyte ratio, platelet and white blood differences have been observed in genotype or allele cell count (INFLA-score). frequencies among the patient and the control groups for Results:PFAonCpGsitesidentiﬁedtwofactorsforeach the PON-1 Q192R variant. region. F1 of region 76 was signiﬁcantly associated with Conclusion: Our results indicated that the PON-1 lipid-related parameters (total cholesterol, 4.5±1.4 mg/dL, polymorphism L55M (163T>C) may represent a useful 10.8%ofvarianceexplained,p=0.001;ApoB,0.03±0.01g/ biomarker of RSA susceptibility in the Greek Caucasian L, 12.2% of variance explained, p=0.0004). F1 was also population and with combined effects of environmental signiﬁcantly associated with granulocyte-to-lymphcyte factors might contribute to RSA prevalence. ratio, in turn associated with total cholesterol and ApoB References: (allp<0.0001)andmediatedpartofthetotaleffectofF1on Machness M and Machness B (2015) Human paraox- the lipid-related phenotypes (24.1%, p=0.012, and 25.4%, onase-1 (PON1): gene structure and expression, promiscu- p=0.003). ousactivities and multiplephysiological roles. Gene, 2015, Conclusion: Methylation patterns in the promoter region 567:12-21. Shunmoogam N, Naidoo P, Chilton R (2018) of the NMU gene could jointly modulate lipid-related Paraoxonase (PON)-1: a brief overview on genetics, parameters and low-grade-inﬂammation. Funded by Italian structure, polymorphisms and clinical relevance. Vasc Ministry of Health GR2011-02351736 Health Risk Manag 18;14:137-143. A. Marotta: None. F. Noro: None. A. Gialluisi: None. R. A. Kotsifaki: None. S. Nasis: None. K. Agiannitopoulos: Parisi:None.A.DeCurtis:None.S.Costanzo:None.A.Di None. D. Mavrogianni: None. P. Drakakis: None. K. Castelnuovo: None. C. Cerletti: None. M.B. Donati: None. Lamnissou: None. G.deGaetano:None.B.Izzi:None.L.Iacoviello:None.F. Gianfagna: None. E-P19.42 InﬂuenceofeNOSgenehaplotypesandiNOS rs2297518 E-P19.41 gene variant on severe complications and mortality in Paraoxonase -1 polymorphisms L55M and Q192R in surgical patients with secondary peritonitis patients with recurrent spontaneous abortionAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 983 M. Gulic1, N. Maksimovic1, K. Doklestic2,3, M. Grk1, M. Kafyra1,2, M. Stathopoulou1, S. Siest1, G. Dedoussis1,2 M.Svircev3,M.DusanovicPjevic1,M.Kulic3,I.Novakovic1 1University of Lorraine, Nancy, France, 2Harokopio 1Institute of Human Genetics, Belgrade, Serbia, 2Clinic for University of Athens, Athens, Greece Emergency Surgery, Clinical Center of Serbia, Belgrade, Serbia, 3Faculty of Medicine, Belgrade, Serbia Introduction:Researchontheeffectofgeneticbackground on Body Mass Index (BMI) in teenagers and its potential Introduction: Secondary peritonitis is a peritoneal inﬂam- inﬂuence on adult BMI values, has unveiled the effect of mation caused byperforation,necrosisorpenetrant injuries varioussinglenucleotidepolymorphisms(SNPs),including of gastrointestinal tract. Sepsis susceptibility and poor out- the rs13107325, in the SLC39A8 gene. The present analy- comehavebeenobserved,independentlyfrompatientsage, sis,focusesontheroleofthers13107325SNPontheBMI genderandcomorbidities.Nitricoxide(NO)synthesizedby of two teenage, European populations. endothelial NO (eNOS) or inducible NO (iNOS) synthase, Materials and methods: We used data from two plays signiﬁcant role in pathogenesis of sepsis. INOS has European cohorts; the Greek TEENAGE study (data used been associated with NO overload and hypotension in forn=654)andtheFrenchSTANISLASFamilyStudy-SFS sepsis. ENOS-derived NO is linked to the upregulation of (datausedforn=509).Weexaminedthepotentialeffect of proinﬂammatory cytokines and production of superoxides. the rs13107325 polymorphism on the z-scores (zBMI) and This study aimed to assess the inﬂuence of eNOS haplo- logBMI of the teenagers. Analyses adjusted for age and types (T786C, 4b/4a, G894T polymorphisms) and iNOS gender, were conducted via linear regression modelling in rs2297518 gene variant on severe complications and mor- SPSS, for the TEENAGE cohort. Given that some of the tality in surgical patients with secondary peritonitis. teenagers of the STANISLAS cohort could belong to the Material and methods: Study included 149 surgical samefamily,wetestedforpotentialassociationusingtheR patients with secondary peritonitis who underwent emer- statistical software, the GWAF and kinship2 packages, to gency laparotomy, surgical source control, antibiotic correct for familial resemblance. therapy and intensive care support. We evaluated the Results:Thers13107325polymorphismwasrelatedboth following outcomes: septic shock, multiple organ dysfunc- to zBMI (β=0.23, p=0.006) and logBMI (β=0.01, tion syndrome (MODS), mechanical ventilation and p=0.005) of the Greek teenagers. The polymorphism did mortality. Genotyping was performed using Real-time not display any signiﬁcant associations, neither with zBMI PCR (rs2297518) or PCR-RFLP method (T786C, 4b/4a, (p=0,63),norwithlogBMI(p=0.48),whenreferringtothe G894T). ENOS gene haplotypes were evaluated using the French teenagers. Haploview 4.2 software. Conclusion: Genetic background plays a major part in Results: Patients with TbG eNOS haplotype were more obesity development, even from adolescence. Variations in frequently in ICU (p=0.045) and required mechanical the effect of loci display great interest and lay the ventilationsupport(p=0.003)moreoftenthanpatientswith foundation for the creation of genetic scores, for the other haplotypes. Analysis of rs2297518 using multiple prediction of the genetically-associated obesity develop- logistic regression adjusted for confounding factors (age, ment risk. APACHE II score and comorbidities) showed that MODS Funding: Région Grand Est, France - GUTENBERG wasmorefrequentinpatientswithGGgenotype(p=0.017). chair Conclusion: Our ﬁndings suggest that eNOS and iNOS M.Kafyra:None.M.Stathopoulou:None.S.Siest:None. polymorphisms may play a role in development of severe G. Dedoussis: None. complications in surgical patients with secondary peritonitis. E-P19.46 M. Gulic: None. N. Maksimovic: None. K. Doklestic: Genetic Variations Associated with Smoking Relapse in None. M. Grk: None. M. Svircev: None. M. Dusanovic a Chinese population of Taiwan: a 2-year Follow- Pjevic: None. M. Kulic: None. I. Novakovic: None. up Study E-P19.45 G. Li1, P. Weng1, C. Li1, W. Wu1, C. Lai2, K. Hsueh3, The rs13107325 polymorphism of the SLC39A8 gene H. Leu4, L. Chen5, I. Tsai6, K. Liang1, M. Lin1 and body mass index in two teenage, European populations. 1InstituteofPublicHealth,NationalYang-MingUniversity, Taipei, Taiwan, 2Department of Family Medicine, Taipei VeteransGeneralHospital,Taipei,Taiwan,3Departmentof Family Medicine, Kaohsiung Veterans General Hospital,984 J.delPicchia Kaohsiung, Taiwan, 4Healthcare Center, Taipei Veterans Platform,NIHRBiomedicalResearchCentre,Guy’sandSt General Hospital, Taipei, Taiwan, 5Department of Psy- Thomas’ NHS Foundation Trust and King’s College chiatry, Washington University, St. Louis, MO, United London, London, United Kingdom, 3NIHR Maudsley States, 6Institute of Health Policy and Welfare, National Biomedical Research Centre, King’s College London, Yang-Ming University, Taipei, Taiwan London, United Kingdom, 4NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre, Introduction:Manysmokershavesuccessfulquitattempts, King’s College London, London, United Kingdom, 5Imper- but it is easy to end up with smoking relapse. So far, few ial College, London, United Kingdom, 6Biomedical Ima- studies identiﬁed the susceptibility genes of smoking geAnalysis Group, Department of Computing, Imperial relapse around the world. The study was aimed to investi- College London, London, United Kingdom, 7Oxford Uni- gatethegeneticvariantsassociatedwithsmokingrelapsein versity Centre for Functional MRI of the Brain, Oxford, Taiwan. United Kingdom Materials and methods: A total of 600 current smokers having at least one quitting attempt during the 2-year Introduction: We look at whether associations between follow-up were recruited. Fifteen SNPs in seven candidate single nucleotide polymorphisms (SNPs) and subcortical genes (CHRNA3, CHRNA5, CYP2A6, CYP2B6, 5HT , brain volumes, established in adult cohorts, are present at 2A 5HT , 5HT ) were genotyped. Logistic regression and birth. We examine four SNP-volume associations for the 3A 3B Cox proportional hazard models were used to explore the putamen,pallidum, caudateand hippocampus in aneonatal association between the genetic variants and smoking cohort. relapse as well as their association over time. Methods: Data was obtained as part of the Developing Results: After adjusted for gender, age, smoking Human Connectome Project. Our full, mixed-ancestral durations and cigarettes per day, we found that the TC cohortcomprised411term-borninfantswithaccompanying genotypeofrs578776inCHRNA3genecomparedwithTT MRI and genetic data (European subsample 202). Infant genotype (OR=0.68, 95%C.I.=0.47-0.97) and the CT DNA was genotyped for SNPs genome-wide and standard genotype of rs518425 in CHRNA5 gene compared with quality control and imputation were performed. MRI CC genotype (OR=0.68, 95%C.I.=0.48-0.98) would images were acquired at term equivalent age. Volume decrease the risk of smoking relapse. Moreover, the TT estimates for the caudate, putamen, pallidum and hippo- genotypeofrs33940208in5HT genecomparedwithCC campus were extracted using a neonatal atlas. We used a 3A genotype would increase the risk of smoking relapse linear regression model with an additive model of (OR=2.80, 95%C.I.=1.19-6.60). Smokers carrying an association for each genetic variant, including gestational additional T allele of rs33940208 would relapse more ageatbirth,postmenstrualageatscan,intracranialvolume, easily (OR=1.40, 95%C.I.=1.05-1.86). However, we did gender and ancestry principal components as covariates. not ﬁnd any associations between other four genes and The main analysis was with a European cohort (four smoking relapse. imaging phenotypes, corrected p-value, p < 0.0125). Conclusions: Our ﬁndings suggested that the genetic Signiﬁcant results were replicated in the full mixed- variations in CHRNA3, CHRNA5 and 5HT genes were ancestral cohort. 3A associated with the risk of smoking relapse in a Chinese Results: In the European cohort there was a signiﬁcant population of Taiwan. association between SNP rs945270 and putamen volume G.Li:None.P.Weng:None.C.Li:None.W.Wu:None. (p=0.0027,β=0.14,SE=0.04)andaborderlineassociation C. Lai: None. K. Hsueh: None. H. Leu: None. L. Chen: between SNP rs61921502 and hippocampal volume None. I. Tsai: None. K. Liang: None. M. Lin: None. (p=0.012, β=-0.12, SE=0.046). The putamen result replicated in the full mixed-ancestral cohort (p = 3.81x10- E-P19.48 4, β= 0.12, SE=0.03) suggesting this relationship is robust Cangeneticdeterminantsofbrainstructurebedetected across different ancestries at birth. soon after birth? Conclusions: SNP rs945270 was signiﬁcantly associated with putamen volume in a European and mixed-ancestral H. Cullen1, K. Dimitrakopoulou2, D. Batalle1, neonatal cohort showing the relationship previously O. Gale-Grant1, H. Patel3, C. Curtis4, R. Chung4, described in adults, is present at birth. A. Schuh5, L. Cordero-Grande1, E. Hughes1, A. Price1, H. Cullen: None. K. Dimitrakopoulou: None. D. Batalle: D. Rueckert6, J. Hajnal1, S. Smith7, A. Edwards1 None. O. Gale-Grant: None. H. Patel: None. C. Curtis: None. R. Chung: None. A. Schuh: None. L. Cordero- 1Centre for the Developing Brain, King’s College London, Grande: None. E. Hughes: None. A. Price: None. D. London, United Kingdom, 2Translational BioinformaticsAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 985 Rueckert: None. J. Hajnal: None. S. Smith: None. A. U. Kozhamkulov1, M. Sadykov2, A. Azizan2, Edwards: None. A. Akilzhanova1, D. Yerezhepov1, U. Kairov1, C. Chan2 E-P19.49 1National LaboratoryAstana, Nazarbayev University, Nur- Evaluation of tagged single nucleotide polymorphisms Sultan, Kazakhstan, 2Department of Biomedical Sciences, (SNPs)inidentifyingtype1diabetesassociatedhigh-risk School of Medicine, Nazarbayev University, Nur-Sultan, HLA-DRB1 and -DQB1 alleles in North India Kazakhstan N. Chuzho1,2, N. Kumar1, N. Mishra2, G. Mishra1 Introduction: Variation of a number of genes in humans hasbeenfoundtoplayaroleinTBsusceptibility.Anumber 1IndianCouncilofMedicalResearch-NationalInstituteof of genes related to vitamin D metabolism were also impli- Pathology, New Delhi, India, 2Symbiosis School of cated to contribute to the susceptibility to persistent TB Biological Sciences, Symbiosis International (Deemed infectionamongwhichvitaminDreceptor(VDR)hasbeen University), Pune, India well studied. Aim of the study is to evaluate the possible role oftheVDR polymorphismsandpolymorphisms ofthe The human leukocyte antigen (HLA) region with its mul- other genes involved in vitamin D pathway on TB sus- tiple genes and extreme polymorphism is known to be the ceptibility in Kazakhstani population. greatest contributor to the genetic susceptibility to type 1 Materials and methods: DNA samples from 84 diabetes (T1D). To evaluate the risk of developing T1D, it participants were included to the current study. SNPs were is important to deﬁne the individual’s HLA type, particu- genotyped on a SNP array using qualitative real-time PCR larly HLA-DRB1 and -DQB1 allele. Individuals who are on a Life Technologies Quantstudio 12K Real Time PCR positive for HLA-DQA1*05:01-DQB1*02:01 (DQ2) on system using the cycle relative threshold (Crt) method. 11 HLA-DRB1*03 (DR3) and DQA1*03:01-DQB1*03:02 SNPs from 8 genes of the vitamin D metabolic pathway (DQ8) on HLA-DRB1*04 (DR4) have the highest risk of were subsequently analyzed. developing T1D. For determining HLA-DR/ DQ types Results: We speciﬁcally analyzed 11 SNPs belonging to relevanttoT1D,therearevariousHLAtypingmethodsbut the following genes: DHCR7, CYP2R1, GC-1, CYP24A1, mostofthesearetimeconsumingandexpensiveHence,we CYP27A1,CYP27B1,VDRandTNFα.Thesegenesplaya used four SNPs, namely, rs3104413, rs285427, rs9273363 number of different roles including synthesis, activation, and rs2187668 to identify the HLA-DR/DQ types relevant delivery and binding of the activated vitamin D. Our to T1D, viz., DR3/4, DR3/3, DR3/X, DR4/4, DR4/X, and preliminary results indicate signiﬁcant association of VDR DRX/X (where X ≠ DR3 nor DR4). We genotyped (Vitamin D receptor) SNPs (rs1544410, BsmI, with 135 samples of (80 T1D and 55 healthy controls) for the OR=0.425, CI= 0.221-0.816, p= 0.009 and rs731236, SNPs using ARMS-PCR. The PCR parameters were stan- Taq I with OR=0.443, CI=0.228-0.859, p=0.015) and dardized and performed using in-house standardised pro- CYP24A1 (rs6013897 with OR=0.436, CI=0.191-0.996, tocol. Further, we validated our SNP-based HLA-DR/DQ P=0.045) with TB. screeningusing HLA-DRB1/DQB1combi-genotypingSSP Conclusion: Interaction of genetic variation of VDR and kits (BAG Healthcare, Germany). Out of the 80 T1D CYP24A1 may impact susceptibility to TB. The ﬁndings patients, 63 patients (78.6%) and 10 out of 55 healthy provided initial clues to understand individual genetic individuals(18.18%)werefoundtobepositiveforhigh-risk differences in relation to susceptibility and protection to HLA-DRB1*03-DQB1*02 haplotype(p<0.01). For HLA- TB. Grant references: AP05134737; MES RK. DRB1*04-DQB1*03 haplotype, 17 out of 80 T1D U. Kozhamkulov: None. M. Sadykov: None. A. Azizan: (23.75%)and8outof55healthyindividuals(14.55%)were None. A. Akilzhanova: None. D. Yerezhepov: None. U. positive(p<0.01).OurSNP-basedscreeningmethodshowed Kairov: None. C. Chan: None. 100% concordance with the kit-based method. Using our SNP-basedHLAtyping,we wereable topredict HLA-DR/ E-P20 Functional Genomics and Epigenomics DQ types relevant to T1D accurately in a rapid and cost- effective manner. E-P20.1 N.Chuzho:None.N.Kumar:None.N.Mishra:None.G. Borderline Personality Disorder - BION Study: Epige- Mishra: None. netic changes observed after clinical intervention E-P19.50 Geneticvariation ofVDR,CYP24A1 genesandrelation to susceptibility to tuberculosis in Kazakhstan986 J.delPicchia S. Herms1,2,3, I. Bölükbas4, M. Busmann5, U. Lang5, E-P20.3 M. Walter5, J. Wrege5, P. Hoffmann1,2,3, S. Cichon2,6, Liquid biopsy for human cutaneous melanoma staging. S. Euler5 New circulating miRNAs as potential prognostic bio- markers in melanoma 1Human Genomics Research Group, Department of Bio- medicine,Basel,Switzerland,2InstituteofMedicalGenetics B.Sánchez-Sendra1,2,J.F.González-Muñoz1,J.L.García- and Pathology, University Hospital Basel, Basel, Switzer- Giménez1,3,4, L. Navarro5, A. Murgui6, L. Terrádez7, I. land, 3Institute of Human Genetics, University of Bonn, Pinazo8, J. M. Martín8, C. Monteagudo1,2,7 School of Medicine & University Hospital Bonn, Bonn, Germany,4DepartmentofPsychosomaticsandPsychother- 1Biomedical Research Institute INCLIVA, Valencia, Spain, apy, Psychiatric University Hospital Basel, University 2Pathology Department, University of Valencia, Valencia, Basel, Basel, Switzerland, 5Department of Psychosomatics Spain, 3Centro de Investigación Biomédica en Red de and Psychotherapy, Psychiatric University Hospital Basel, Enfermedades Raras (CIBERER), Valencia, Spain, 4Phy- Basel, Switzerland, 6Human Genomics Research Group, siology Department, University of Valencia, Valencia, Department of Biomedicine, University of Basel, Basel, Spain, 5Consortium Hospital General Universitario de Switzerland Valencia, Valencia, Spain, 6Biochemistry and Molecular Biology Department, University of Valencia, Valencia, Introduction: Borderline personality disorder (BPD) is a Spain, 7Pathology Department, Hospital Clínico Universi- common psychiatric condition which is characterized by tario de Valencia, Valencia, Spain, 8Dermatology Depart- impaired social behavior and dysregulated affect and ment,HospitalClínicoUniversitariodeValencia,Valencia, impulse control. To elucidate the genetic predictors of Spain treatment outcome as well as to investigate epigenetic alterationsinthecontextoftreatment,weperformedastudy Introduction: Circulating miRNAs are emerging as a new with about 300 patients. During 80 inpatient days, the class of non-invasive biomarkers of cancer. This study treatment consisted of two weekly 45 min sessions of aimedtoidentifycirculatingprognosticbiomarkersinorder individual short- term psychodynamic psychotherapy to select melanoma patients at high risk of tumor progres- (Leichsenring et al., 2004) and three weekly 75 min ses- sion at the time of diagnosis. We hypothesized that circu- sions of Mentalization-Based Group Therapy lating miRNAs could provide information about melanoma (Karterud, 2015). progression at the time of primary tumor excision. Material/Methods:79sampleshadacompletedataset Materialsandmethods:WeperformedRNA-Seqon25 ofallquestionnaires, twobloodsamplingsatentry andexit plasma samples from patients with primary cutaneous ofthestudy,andinformedconsent.DNAwasextractedand melanoma. We investigated the differential expression of processedonIllumina´s GlobalScreeningArray 24v2-0-MD miRNAs in stages I-III at the time of diagnosis. Functional and HumanMethylationEPIC array. analysis of the involved molecular pathways was also Analysis: Genotype data: All samples achieved high call performed. ratesanddidnotshowlargerstructuralaberrations.Samples Results:miR-182-5pwasdownregulated,andmiR-199a- were checked for ethnicity, gender and hidden relatedness. 5p, miR-877-3p, miR-1228-3p and miR-3613-5p upregu- Methylation data: Samples were checked for detection p- lated in stage III in comparison with stage IA melanoma value and identity using ﬁngerprinting markers. First line patients. Functional analysis of this set of circulating methylation analysis focused on methylation beta values at miRNAsrevealedtheirinvolvementinmolecularpathways entry versus exit. A more detailed analysis focused on the related to cancer. differences in methylation changes within a given sample. Conclusions: Low circulating levels of miR-182-5p, and Results: We present preliminary data on the group high miR-199a-5p, miR-877-3p, miR-1228-3p and miR- comparison and the more detailed per individual analysis. 3613-5p levels, are associated with advanced melanoma Themostsigniﬁcantresultinthegroupdifferentialanalysis stage at the time of primary tumor excision, and may is cg23577102 which is located in the gene LAYN. The therefore serve to recommend sentinel lymph node biopsy individualbasedanalysisrevealedaregiononchromosome and to guide surveillance follow-up and imaging studies 15 having several consecutive markers with identical schedule for tumor staging. Our ﬁndings may serve to changes around the gene DYX1C1. anticipate the stage at the moment of the initial diagnosis S.Herms:None.I.Bölükbas:None.M.Busmann:None. and, therefore, to avoid a delay in the initiation of the U. Lang: None. M. Walter: None. J. Wrege: None. P. adjuvant therapy. Hoffmann: None. S. Cichon: None. S. Euler: None. Work supported by PROMETEO II/2015/009 from Generalitat Valenciana, Spain; PI17/02019 from ISCIII,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 987 Spain; FEDER European funds, and Reto Everest from in the context of the presence or absence of miR-210 AECC. We want to acknowledge the INCLIVA BioBank differential expression, but additional experimental studies (PT17/0015/0049 B.0000768) for its collaboration. are required to evaluate the ﬁndings. This study was B.Sánchez-Sendra:None.J.F.González-Muñoz:None.J. ﬁnancially supported by Russian Scientiﬁc Foundation, L. García-Giménez: None. L. Navarro: None. A. Murgui: grant № 19-75-20033. None. L. Terrádez: None. I. Pinazo: None. J.M. Martín: A.S.Glotov:None.A.Tkachenko:None.R.A.Illarionov: None. C. Monteagudo: None. None. E. Vashukova: None. E-P20.4 E-P20.7 Publication-Based Analysis of miR-210-Dependent bio- C-leptin type receptor 5 and IFN-gamma gene expres- markers of Pre-Eclampsia sion and polymorphisms as markers for 17DD Yellow Fever vaccine immune response A. S. Glotov1,2, A. Tkachenko3,1, R. A. Illarionov4,1, E. Vashukova1 T. Azamor1, A. M. V. Silva1, C. X. Carvalho1, L. Alvarado-Arnez2,J. G.Melgaço1, C. Bayma1,A. D. Ano 1D.O.Ott Research InstituteofObstetrics,Gynecology and Bom1, M. O. Moraes1, P. C. C. Neves1 Reproductology,Saint-Petersburg,RussianFederation,2St. Petersburg State University, Saint-Petersburg, Russian 1Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Federation, 3ITMO University, Saint-Petersburg, Russian Brazil,2UniversidadPrivadaFranzTamayo–UNIFRANZ, Federation, 4Saint Petersburg State Technological Institute Bolivia, Cochabamba, Bolivia, Plurinational State of (Technical University), Saint-Petersburg, Russian Federa- tion Introduction:TheYellowFever(YF)vaccineisoneofthe most effective ever made, although some rare serious Introduction: MicroRNAs are potential biomarkers of adverse events may occur after vaccination due to genetic most pregnancy complications. In recent years, miR-210 innate deﬁciency. YF primary immunization resulted in has been shown as one of the main biomarkers, associated early synthesis of IFN-γ and C-leptin type receptor 5 with various diseases, including pre-eclampsia (PE). (CLEC-5A) is associated with severity in other ﬂaviviral Materials and methods: We obtained miRNAs linked infections. Herein, we have investigated association of with preeclampsia from the manually curated pregnancy single nucleotide polimorphisms (SNP) in IFNG and pathology database PregMiR was developed us early CLEC5A and vaccine efﬁcacy, looking for elucidate the (https://pregmir.ott.ru/). miRNA were included in the genotypic and phenotypic mechanisms that may also be analysis only if their differential expression between correlated to post-vaccination adverse events. samples with PE and normal samples was signiﬁcant Material and Methods: Blood samples from thirty (adjusted p< 0.05). volunteers vaccinated with YF17DD were collected 0, 4, Results: We observed that miR-152, miR-1 and miR- 7 and 10 after immunization (DAI). RT-qPCR assay was 193bwereonlydetectedinstudieswithachangedmiR-210 carried out to quantify expression of CLEC5A, IFNG, IL6, level,whereasmiR-27a,miR-29a,miR-130aandmiR-519b RNASEL, IRF7, IRF9, STAT2 and OAS1. SNP Allelic were detected in studies without miRNA-210 differential discriminations was carried using TaqMan assays. Blood expression. It can be assumed that the most likely cell were stimulated with the envelope viral protein and mechanisms of PE development in the early pregnancy phenotyped by ﬂow cytometry. stage are either upregulation of miR-210, miR-152, miR- Results: We observed an association between CLEC5A 518b and downregulation of miR-126; or upregulation of rs13237944 (AC/CC, p=0.04), and IFNG rs2069718 (AA/ miR-126 and downregulation of miR-182 and miR-518b. TT, p=0.01) and rs2430561 (AG/AA, p=0.04) and high Late stages of PE are determined by miR-210, miR-152, antibody levels, also presenting high expression levels of miR-518b, miR-21, miR-155, miR-181a, miR-182, miR- CLEC5A and IFNG mRNA respectively. Additionally we 193b-3p,miR-517c,miR-518e(upregulation)andmiR-126, observed a phenotype polarization of CLEC5A at 4DAI miR-18a, miR-195, miR-223, let-7f (downregulation); or both in gene expression and ﬂow cytometry. miR-27a, miR-29a, miR-130a and miR-519d, miR-517c, Conclusion: These results indicated that genetically miR-518e miR-155, miR-126, miR-181a, miR-195 (upre- regulated early expression of CLEC5A and IFNG after YF gulation) and miR-223, miR-18a, miR-182 immunization is related to 17DD immunogenicity. The (downregulation). polarized proﬁle of CLEC5A gene expression and abun- Conclusions: The presented results allow speculation dance in cell surface after 17DD immunization could be about the inﬂuence of certain miRNAs on PE development988 J.delPicchia dependent of rs13237944 genotype, indicating CLEC5A as M. Senkal: None. I. Akalin: None. a novel role in the response against YF vaccine. T. Azamor: None. A.M.V. Silva: None. C.X. Carvalho: E-P21.4 None. L. Alvarado-Arnez: None. J.G. Melgaço: None. C. The usefulness of high throughput sequencing for the Bayma:None.A.D.Ano Bom:None.M.O.Moraes:None. diagnosis of hereditary diseases of neuromuscular P.C.C. Neves: None. system E-P21 New Treatments for Genetic Disorders S. A. Garifullina,A. Marakhonov, S. Kutsev, R. Zinchenko E-P21.2 Research Center for Medical Genetics, Moscow, Russian Amazing matching sequences of olive genome with Federation human genome; results of multiple alignments Hereditarydiseasesoftheneuromuscularsystemrepresenta M. Senkal1, I. Akalin2 large group of genetically heterogeneous hereditary dis- eases, which are characterized by marked clinical poly- 1IstanbulMedeniyetUniversity,FacultyofMedicine,Phase morphism. High-throughput sequencing (HTS) methods IV medical student, istanbul, Turkey, 2Istanbul Medeniyet allow an advanced search of genetic causes to make the University, Department of Medical Genetics, Istanbul, most accurate diagnosis. Turkey A family with two affected brothers was referred to the Research Center for Medical Genetics with a primary Introduction: Both cardiovascular and carcinogenic bene- diagnosis of spinal muscular atrophy. Kids from a normal ﬁts of olive and its products (olive oil) have been demon- pregnancy. One of the affected children had moved with strated especially as dietary intake. Here, we were curious support, at the moment of examination moves with the aboutwhetherornotthereispossibleforthcominggenomic wheelchair,mentaldevelopmentwithoutabnormalities.The beneﬁts on the molecular basis. chest is ﬂattened, stiffened spine with curvature, hypermo- Materials and methods: The olive (Olea europae, bility of upper limbs, diffuse muscle atrophy, areﬂexia. Genome ID:10724) genome sequence in the Pubmed Parents are healthy, the family has a third healthy child. genome database was aligned with the human genome Whole exome sequencing was performed for one of the using website NucleotidBlast. The variations of the probands and revealed two novel small frame-shifting matching sequences with nearest restriction sites were deletions of 28 and 2 nucleotides affecting COL6A2 gene investigatedinonlinedatabasessuchasPubmed,PolyPhen- encoding the α2-chain of type VI collagen. The pathogenic 2, Exac.browser. variants in the COL6A2 gene are associated with Bethlem Results:Multiplematchedoligo-sequences(atleast28to myopathy 1 and Ullrich congenital muscular dystrophy 1. more than 500 bpinlength)werefound in67genes with a Segregationanalysisinthefamilyconﬁrmedthecompound similarityrateof73-100%.Amongthesegenes,remarkable heterozygous state in probands. Thus, Ullrich congenital sequence matches were found in cancer related genes muscular dystrophy was diagnosed. The marked clinical (BRAF, BRMS1L, SDHA) and calmodulin (CALM1, polymorphism and the presence of a signiﬁcant number of CALM3) genes. There are many pathological (Egs; genes involved in neuromuscular pathology make accurate rs267607276, rs1060602608, rs1064796271, rs155814427 diagnosedifﬁcult andlead tothe needfor a comprehensive on CALM1 gene leading to Long QT syndrome) and non- search for the causes using HTS methods. pathologicalvariationsdeﬁnedonthehumangenomeatthe S.A. Garifullina: None. A. Marakhonov: None. S. matchedsequences,butinterestinglythewild-typesofthem Kutsev: None. R. Zinchenko: None. were present in the olive genome. Another notable ﬁnding was the presence of diverse restriction enzyme sites within E-P22 Genetic Counselling / Services / Education the matching sequences. Conclusions: Presence of wild type DNA sequences at the plant genome while the disease causing mutations E-P22.01 reported in the similar human genome sequences give the Role of Genetic Nurse in the Gastrointestinal Cancers clues of possible genomic based therapies could emerge as Clinic at Sultan Qaboos University Hospital in Oman the phytotherapy protocols. Moreover, we wondered if oral consumption of genome carrying seeds might give rise to therapy regimens as the DNA pills. Those questions would need more detailed investigations to elucidate them.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 989 I. Alhaddabi, A. AlSayegh, Z. Bruwer, K. Al-Kharusi theveryconceptofaDNAmutation)canbechallengingin medical genetics. What is obvious to us medical profes- SQUH, Muscat, Oman sionals in genetics, may not be obvious to anyone else. Having realised that words might not be the ultimate form Introduction: The cancer genetics service was introduced ofcommunication,wehavestartedanexperimentalmethod at Sultan Qaboos University Hospital in 2011 run by a of creating individualised, caricature-esk diagrams some- cancer geneticist and genetic nurse. The principle goal of times assembled into comic strips to explain difﬁcult con- the clinic is to provide genetic counselling and testing to cepts to patients and their primary health care providers. individualsaffectedwithoratincreasedriskofaninherited Mental pictures rendered into actual images with the com- cancer. pleteavoidanceofjargonandconfusingexpressionsarenot Aim: This study aimed to look into the number of onlyaneffectivemethodofcommunicatingcomplexissues, familiesthatwereseenforgastrointestinalcancerGIduring butitmight beasuccessfulwayofreachingouttodifﬁcult the last ﬁve years and to describe the role of the genetic populations, such as parents with anti-vaccine beliefs. nurse within the clinic. H.E. Magrath: None. E. Kohn: None. B. Csendes: None. Method: The database was reviewed to identify all GI K.F. Hadzsiev: None. cancer cases thatweretestedfrom2015till 2019seen. The role of the genetic nurse was explored over the ﬁve year E-P22.04 periodandtheinvolvementinclinicrelatedprocedureswas Universal, centralized, equal and fully comprehensive documented. geneticserviceswithinaninsularregionofEurope:The Results:Twohundredandtwentypatientswereidentiﬁed Balearic experience with a pathogenic variant. Predictive testing was offered to 136familymembers(greatestnumberseenin2018-2019). D.HeineSuñer1,N.Voloj Soffer2,V.J.AsensioLanda1,A. Initially the role of the genetic nurse was limited to admin Obrador-Hevia1, C. Vidal Lampurdanes2, J. Rosell2, related tasks like arranging follow-up appointments and N. Govea2, A. Perez-Granero2, M. Bernues2, R. Martorell- referrals to gastroenterologist. This developed to include Riera2, A. de Juan Socias2, M. Rosado-Muñoz2, M. Prado- educating affected individuals about the importance of Farnos2, M. Santos-Pons2, M. Montaño Mera2, M. Coll family screening and surveillance, facilitating group Ferrer2, O. Exposito Perez2, C. Salleras Gelabert2, B. sessions for family support and promoting a multidisci- Ortega Vila2, R. Rodriguez Zafra2, I. Martinez-Lopez1 plinary approach with greater involvement of the GI team. Conclusion: A large number of cases are being seen in 1Hospital Universitari Son Espases/Institut d’Investigació Oman in our tertiary hospital. Predictive testing has Sanitaria de Palma (IDISBA), Palma, Spain, 2Hospital increased exponentially over the last two years. This is Universitari Son Espases, Palma, Spain likely related to the improvements that have been put in place by the cancer genetics team and genetic nurse. Healthcare in the Balearic Islands, with a population of I. Alhaddabi: None. A. AlSayegh: None. Z. Bruwer: 1.150.000, is provided by a combination of public and None. K. Al-Kharusi: None. private hospitals and medical centers. Furthermore, last year, the islands received more than 16 million tourists E-P22.03 and many of them used the public health system during Communicating complex diagnoses with the help of their stay, genetic tests included. The Balearic Islands caricatures Department of Health oversees and regulates the public health facilities through the Health Service (IB-Salut). In H. E. Magrath1, E. Kohn2, B. Csendes1, K. F. Hadzsiev1 2017, IB-Salut created the Genetics and Genomics Unit (GENIB). Its objective is to elaborate a plan of dynamic 1DepartmentofMedicalGenetics,UniversityofPecs,Pecs, and transversal Community action and guarantee that any Hungary, 2Faculty of Cultural Sciences, Education and person affected by a genetic-based disease, at risk of Regional Development, University of Pecs, Pecs, Hun- sufferingitinthefuture,atriskoftransmittingitorwhose gary health problem requires genetic or genomic analysis techniques, have equal access to clinical evaluation, Effective patient-doctor communication is not only a fun- geneticcounselingandrelevanttests.Thisisimplemented damental part of patient satisfaction, but also contributes to through a centralized core Clinical Genetics and Diag- bettermedicinaloutcomesbybuildingacaringrelationship nostic Department. Diagnostic tests are designed, inter- with patients. Communicating complex diagnoses to preted and implemented through Molecular Committees patients, explaining the effects of rare mutations (or even organized by specialty where clinical cases are presented990 J.delPicchia and the protocol to be followed is decided. The battery of Pathogenic variants in RYR1 gene were associated with tests to request follows an economy of scale and includes high clinical variability and multiple phenotypes: Suscept- from traditional cytogenetics to NGS techniques such as ibility to Malignant Hyperthermia (OMIM 145600), AD; clinical exome and complete exome. The number of Central core disease, OMIM 117000, AD, AR; King- applications made in 2019 for the entire Balearic com- Denborough Syndrome (OMIM 145600), AD; Minicore munity has been 7,750. Their distribution has been 61% myopathywithexternalophthalmoplegia,(OMIM255320), molecularstudies;31%cytogeneticstudiesand7%family AR; Congenital neuromuscular disease with uniform ﬁber studies. The origin of the tests has been mostly Clinical type 1 (OMIM 117000) AD, AR. Attributing clinical Genetics (1,046) and Pediatrics (1,044), Obstetrics and signiﬁcanceforthevariantswasverydifﬁcultduetolackof Reproduction (912) and Cardiology (149). phenotypedetailsandageofpatient.Thus,susceptibilityfor D. Heine Suñer: None. N. Voloj Soffer: None. V.J. Malign Hyperthermia, was reported as main possible Asensio Landa: None. A. Obrador-Hevia: None. C. Vidal association. Lampurdanes: None. J. Rosell: None. N. Govea: None. A. Conclusions: Without a clear indication and a speciﬁc Perez-Granero: None. M. Bernues: None. R. Martorell- phenotype,genetictestingcancreatedistressforthefamily. Riera: None. A. de Juan Socias: None. M. Rosado-Muñoz: D.M. Serban: None. C.L. Șerban: None. A. Dobrescu: None. M. Prado-Farnos: None. M. Santos-Pons: None. M. None. N. Andreescu: None. A. Chiriță Emandi: None. M. Montaño Mera: None. M. Coll Ferrer: None. O. Exposito Puiu: None. Perez: None. C. Salleras Gelabert: None. B. Ortega Vila: None. R. Rodriguez Zafra: None. I. Martinez- E-P22.08 Lopez: None. Noonan syndrome-molecular spectrum and genotype- phenotype correlation E-P22.07 The thin line between the need for early diagnostic and L. C. Popa, N. Andreescu, S. Farcas, P. Tutac, dealing with unexpected ﬁndings A. Chirita-Emandi, M. Puiu D.M.Serban1,C.L.Șerban1,A.Dobrescu2,N.Andreescu1, Genetics Discipline, Center of Genomic Medicine, “Victor A. Chiriță Emandi1, M. Puiu1 Babes,” University of Medicine and Pharmacy, Timisoara, Romania 1Victor Babes University of Medicine and Pharmacy, Timisoara, Romania, 2University of Medicine and Phar- Background: Noonan syndromeisan autosomal dominant macy Craiova, Craiova, Romania genetic disorder, characterized by a wide spectrum of symptomsandclinicalfeatures,beingcharacterizedbyshort Background: NGS testing has become widely available. stature, skeletalmalformations,hypertelorism,low-setears, Clinicians are recommending testing, hoping for an early pulmonary stenosis, congenital heart defect and thorax diagnosis. This may lead to early treatment; however, in deformations. The most frequent involved genes are some situations testing results are unexpected. We report a PTPN11 (50%), SOS1 (10-13%), RAF1 (5%), RIT1 (5%), newborn with long QT syndrome. KRAS (less than 5%). Methods: Targeted NGS, with a panel of 174 gene Aim: This study aims to correlate the genotype with the related to cardiologic phenotype (TruSightCardio Illumina) phenotype in NS patients in order to identify the wasused.ThepanelincludestheKCNQ1,KCNH2,SCN5A, characteristic features for each gene involved. ANK2, KCNE1, KCNE2, KCNJ2, CACNA1C, CAV3, Materials and method: 12 patients, aged 0 to 17 years SCN4B, AKAP9, SNTA1, KCNJ5, CALM1 genes. Results. old,withNoonansyndromewerediagnosedattheTimisoara Aneutrophicnewbornmale,witha41-42weeksgestational Centre for Genomic Medicine. The molecular testing was period, with normal evolution of neonatal jaundice, with a performed on MiSeq platform (Illumina) using TruSight normal level of creatine kinase, without hypotonia was Cardio Sequencing Panel. As expected, the most commonly examined.Duringlabor,afractureofclaviculaandlesionof involved genes we found were: PTPN11 (c.1504T>G, the eye have been reported. While being monitored, a c.923A>G, c.922A>G, c.236A>G, c.188A>G, c.767A>G) unique episode of bradycardia was observed and ECG was and SOS1 (c.512T>C, c.1322G>A, c.1277A>G, c.842G>T). suggestive for long-QT syndrome. The NGS result did not Results: The main facial features characteristic for NS, indicate any genetic cause to explain patient’s phenotype, mentioned above, were present in all cases, but we also but did report, as incidental ﬁnding in RYR1, with a found signiﬁcant clinical differences between the patient’s heterozygote, probably pathogenic, NM_000540.2: phenotype. The patients with PTPN11 pathogenic variants c.2390G>A, and VUS NM_000540.2:c.10648C>T. showed higher prevalence in developing aorticAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 991 regurgitation, atrial septal defect, “café au lait” spots, a grant from the Russian Science Foundation (project No. exophthalmia, umbilical hernia and thrombocytopenia 19-18-00422) while the patients with SOS1 were presenting hypertrophic G.Zobkova:None.E.Baranova:None.V.Izhevskaya:None. cardiomyopathy, spastic tetra paresis, coarctation of the aorta, lymphedemas and joint laxity. E-P22.10 Conclusion: The variety of phenotypes in NS represent Students’achievementsinmedicalgeneticsarelinkedto different genes with diverse mutations. The genetic their state of happiness variability of NS makes the establishment of a reliable genotype-phenotype correlation essential for the manage- R. M. Dragotoiu, T. S. Grozescu ment of these patients. L.C. Popa: None. N. Andreescu: None. S. Farcas: None. MedicalandPharmacyUniversityCarolDavila,Bucuresti, P. Tutac: None. A. Chirita-Emandi: None. M. Puiu: None. Romania E-P22.09 Viewingtheworldashavingpositiveornegativeeffectson Opinion on genetic testing in relation to reproductive life depends on previously constructed neuronal connec- choice among Russian geneticists. tions, that are constantly stimulated by the memory of speciﬁc events, that generated feelings either of joy, hap- G. Zobkova1, E. Baranova2, V. Izhevskaya3 piness, satisfaction, love or anger, hurt, grief, guilt, etc. Medicalstudentswillhavetofacemanyexamsduringtheir 1City Clinical Hospital № 67 of Moscow Health Depart- training. Teaching them to leave behind all educated ment,Moscow,RussianFederation,2FederalStateBudget- negativefeelingsaboutanexam,andshowingthemhowto ary Educational Institution of Further Professional participate with open minds and hearts instead of fear and Education Russian Medical Academy of Continuous frustration in an examination, can make a difference in the Professional Education of the Ministry of Healthcare of way they perceive this examination and future ones. This the Russian Federation, Moscow, Russian Federation, papershowsapossibleconnectionbetweenfeelingpeaceful 3Research Centre for Medical Genetics, Moscow, Russian and fearless during an examination in medical genetics and Federation respectively the better marks obtained by the participating students. At the end of the ﬁrst term, in January 2019, 105 Introduction: Respect for the autonomy of the individual ﬁrst yearmedical students wereasked totrytorelaxbefore and independent decision-making based on patient’s an open book examination. The 2 - 4 minutes long relaxa- informed choice is the basis of genetic counseling, espe- tion technique began with deep breathing, followed by cially when counseling concerns the patient’s reproductive directing the mind to a place of peace, safety, support and choice. The aim of this study was to elicit the opinion of love,anditendedwithsuggestingfeelingsofhappinessand Russian geneticists on genetic testing in relation to repro- joy,whenseeingthehighgradeeachoneofthemobtained. ductive choice. Not all students were compliant. Students’ papers were Materials and methods: For the pilot study, a ques- evaluatedandrankedtoseeiftheusualnormal distribution tionnairewasdevelopedcontainingquestionsforevaluating of the marks was still present. The results showed marks the main approach to patient counseling. The survey was extremely skewed to the right, letting us conclude that by attended by 30 geneticists. attentively and gradually learning to manage stress levels Results:All30geneticistsansweredthatthepreventionof students could improve their academic performance. the birth of children with a genetic disease is extremely R.M. Dragotoiu: None. T.S. Grozescu: None. important for them. 27/30 specialists agreed with the statement “Before marriage, people should know if they or E-P22.11 their partners are carriers of genetic diseases”. The majority Diagnosis and management of Turner syndrome at one ofrespondents (23/30) agreed that "The governmentshould tertiary medical center in Japan makeitmandatorytotestforcarriageofmutationsingenes for common hereditary diseases. Less than half of the A. Kondo1, A. Hayashi1, M. Yamasaki1, M. Morine1, doctors (11/30) expressed their disagreement with the K. Nii1, T. Iwai1, K. Hinokio1, N. Okamoto2, K. Maeda1 patient’s right not to know the results of their study. Conclusions: Results indicate some ethical issues 1ShikokuMedicalCenterforChildrenandAdults,Zentsuji, associated with genetic counseling for patient’s reproduc- Japan, 2Osaka Women’s and Children’s Hospital, Izumi, tivechoices.Theseissueswillbediscussedinmoredetailin Japan thefollowingbroadstudies.Thestudywascarriedoutwith992 J.delPicchia Background: Turner syndrome occurs in one 1,000 live MaterialandMethods:Retrospectivedatafrommedical female births. Generally, this condition is characterized by recordsandclinicalquestionnaireswithpatientsfollowedin the partial or complete absence of one X chromosome. a reference center in Brazil Results 24 patients (20 females Majority of girls with Turner syndrome can be diagnosed and four males) were enrolled. Media age of symptoms within childhood, but about 20% might be diagnosed at onset was 22 years (range: 12-47 years). All patients adolescence period. Short stature is the most common reported recurrent porphyria related symptoms, such as trigger to have evaluation for those girls. pain,neurologicaland/orpsychiatricdisorders,nevertheless Material and Method: We looked at the patient visited other systemic complications as hypertension and chronic tooutpatientwithshortstatueasmaincomplaintfrom2013 kidney disease were seen in 10 patients. The median to 2019. Retrospective data on age at diagnosis, reason for frequency of attacks in the last year was 3 times, and the karyotype analysis and presenting clinical features was durationofevery attackwas8days.Analgesicdependency collected from the medical records. to opioid was seen in 12 patients. Heme therapy was Result: We have seen 53 girls with short statue. All the initiated in all patients with remission of the symptoms in patientshadbeenthroughkaryotypingasprimaryscreening most of the patients for more than 6 months in its ﬁrst use. of short statue. Of those, 5 were diagnosed as Turner Conclusion: Our cohort of patients showed frequent syndrome. 2 had other genetic condition and 10 was recurrent attacks of acute porphyria requiring in most of diagnosed as persistent short statue related small for them intravenous heme therapy. Although for patients with gestationalage.Mostofthemwerediagnosedasidiopathic. recurrent attacks prophylactic heme infusions may be All the girls with Turner syndrome have been on regular beneﬁc in remitting the symptoms, a subset of patients check-up with pediatrician and/or gynecologist. showed less response to this therapy overtime. Acute Conclusion:GirlswithTurnersyndromewerediagnosed porphyria patients who suffer from recurrent attacks also at early childhood. Once they are referred to large medical report a low quality of life (QoL) and a negative impact on center, it is not difﬁcult to ﬁnd a diagnosis and also several aspects of everyday life, such as unemployment, continuous treatment and check-up are feasible. Next step personal relationships and long-term disability. might be promoting height-screening for early diagnosis C.M. Lourenco: None. M. Carinhani de Cico: None. A. and education for girls with Turner syndrome for contin- Sanches Mateus: None. B. Forte Giacheto: None. Z. uous medical support. Carneiro: None. L. Vagnini: None. I. Bussman: None. A.Kondo:None.A.Hayashi:None.M.Yamasaki:None. M.Morine:None.K.Nii:None.T.Iwai:None.K.Hinokio: E-P23.2 None. N. Okamoto: None. K. Maeda: None. Formalapproachtobiosociality:autonomyandbiobank informed consent E-P23 Ethical, Legal and Psychosocial Aspects in Genetics R. Belyaletdinov E-P23.1 Institute of Philosophy RAS; Institute of Scientiﬁc Informa- A “Sisyphus burden”: Recurrent acute porphyrias tion for Social Sciences, Moscow, Russian Federation attacks in a cohort of Brazilian patients Introduction: The expansion of the role of genes in the C. M. Lourenco1, M. Carinhani de Cico1, A. Sanches treatment and diagnosis develops biosociality and requires Mateus1, B. Forte Giacheto1, Z. Carneiro1, L. Vagnini2, personal reﬂection in case of taking decision on informed I. Bussman3 consentasfarasthemoreitbecomesknownabouthowgenes affect human health and life trajectories, the more responsible 1Faculdade de Medicina - Centro Universitario Estacio de are those, who share genetic information with biobanks. RibeiraoPreto,RibeiraoPreto,Brazil,2CentroPaulistade Materials and methods: Methodologically different DiagnosticoePesquisa,RibeiraoPreto,Brazil,3ABRAPO- approaches to structure of beneﬁcence and autonomy are Associacao Brasileira de Porﬁria, Ribeirao Preto, Brazil compared to describe model of current approaches to biobank science among professionals in Russia. Due to Introduction: Acute porphyrias are mostly autosomal different research situations there are at least several types dominant inborn metabolic errors of the heme biosynthetic of informed consent: broad informed consent, dynamic pathway. Clinical manifestations involve central and per- informedconsentandprojectspeciﬁedinformedconsentas ipheral nervous system. Patients can experience recurrent models for patient reﬂective approaches to biobank acute attacks that can be not only life-threating, but also biomedical researches. The results of study of informed chronically debilitating. consentforbiobanksamongRussianresearchesisanalyzedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 993 in theperspective of connection between science value and Conclusions:Identiﬁedvaluesandprinciplescanprovide solidarity as social beneﬁcence (understood as biological the fundaments for developing and evaluating ethical information), which must dominates over autonomy. clinicalconductinexpandedgeneticdiagnostics,butfurther Results:Thearticleproposeviewhowlocaldevelopment explication is required for convergence between experts. of biobanks are related to process of development of B.Vijlbrief:None.D.Houtman:None.S.Riedijk:None. technoscientiﬁc biosociality and what impact it may have R. Hofstra: None. onideasaboutinteractionofbeneﬁtsandautonomyinlocal context of fast growing biobank system. E-P23.4 Conclusion: The key conclusion of the paper - Legal and ethical issues of genetic passportization paradoxically informed consent (and autonomy) is formal though still important working procedure for biobanks, V. D. Ruzanova, A. A. Inyushkin, E. S. Kryukova, possibly because of biosocial value of biobanks. The study I. S. Povarov, V. I. Belyakov was supported by the Russian Science Foundation (project №19-18-00422). Samara National Reaserch University, Samara, Russian R. Belyaletdinov: None. Federation E-P23.3 In the legislation of Russia, the implementation of genetic Development of ethical clinical conduct for expanded passportizationandtheformationofageneticproﬁleofthe use of genetic diagnostic data: semi-structured expert population is considered as one of the main tasks of che- interviews mical andbiological safety.Itisdeterminedthatsuchwork shouldbecarriedoutconsideringtheneedtoprotectdataon B. Vijlbrief, D. Houtman, S. Riedijk, R. Hofstra the genome. There are legal provisions related to both human rights andfundamentalfreedoms, andthe regime of Erasmus MC, Rotterdam, Netherlands genetic information as a type of personal data. This means thatthelegalcomponentofthegeneticpassportizationgoes Introduction: The amount of data per patient that clinical far beyond addressing the issue of creating genetic pass- geneticsdepartmentsproduceisincreasing,inlargepartdue ports. According to the International Declarations on to innovations in sequencing and array technologies. In Human Rights research in this area should not prevail over light of trends such as big data analysis and value-based respect for fundamental freedoms and dignity of people. healthcare, which respectively emphasize efﬁcient data Scientists warn against possible abuses in this area talking utilization and positive patient outcomes, extended use of about the creation of two types of passports: a forensic genetic data to provide care is being discussed. This care passport and a passport that reﬂects risks to human health may or may not be relevant to an initial indication. Exam- andotherfeaturesofhisbody.Weproceedfromtheneedto ples include providing polygenic risk scores, certain inci- develop specialized genetic passports. The main use of dental ﬁndings or pharmacogenetic passports. This study genetic information today is limited to medicine and for- aims to explicate the values and principles of involved ensics. Meanwhile, the possibilities in this area are experts that underlie expanded use of genetic data to immeasurably wider as soon as the use of human genetic establisha starting point for ethical clinical conduct, andto data for non-medical purposes is also allowed by the clarify how experts think patients might beneﬁt. International Declaration on Human Genetic Data. The Methods:Semi-structuredinterviews,basedonprevalent study was funded by RFBR according to the research pro- principles in medical ethics, have been conducted among 8 ject № 18-29-14073. expertsinvolvedinexpandingthescopeofclinicalgenetics V.D. Ruzanova: None. A.A. Inyushkin: None. E.S. at the Erasmus Medical Center, including clinical geneti- Kryukova:None.I.S.Povarov:None.V.I.Belyakov:None. cists, lab technicians, and bio-informaticians. Results: Common principles in medical ethics (most E-P23.5 notably autonomy, beneﬁcence, non-maleﬁcence and jus- The principle of conﬁdentiality in genomic research tice) prove useful in describing ethical conditions for clinical conduct, but were speciﬁed and supplemented in I. S. Povarov, E. S. Kryukova, V. D. Ruzanova, waysthatdepartfromcurrentclinical practice,anddiffered A. A. Inyushkin among experts. Motivation for expanded use of genetic data, expected patient beneﬁt, and expectations concerning Samara National Research University, SAMARA, Russian departmental responsibility showed only moderate overlap Federation between experts.994 J.delPicchia The principle of conﬁdentiality is one of the key legal and baby”, the emergence of new forms of social inequality, ethicalprinciplesforbuildingrelationshipsbetweenpartiesin interference with the evolution of humankind, etc.); and many areas of public life. Its essence is that the information research ethics (reputation of a scientist in the scientiﬁc obtainedinthecourseofworkisnotsubjectto deliberateor world, biotechnological race, IRB). accidentaldisclosure,andinasituationwhereitisnecessary Conclusion:aconsensusofthescientiﬁccommunityhas to transfer it to third parties, it must be presented in a form been reached in Russia, there are positive steps to interact that excludes its use against the interests of its owner. The with society, a law is being developed. The research was principle of conﬁdentiality accompanies the entire set of supportedbythegrantoftheRussianScientiﬁcFoundation, actionscarriedoutwithgeneticinformation.Itisinextricably project № 19-18-00422. linked to such legal institutions as “medical secrecy”, “per- E. Grebenshchikova: None. sonaldata”,principleofinformedconsent,“autonomyofthe patient’s will” etc. Within the genetic research, the content E-P23.7 and forms of manifestation of this principle have a certain Human germline gene editing: A comparison of reports speciﬁcity, which requires special attention in the legal reg- and recommendations by two leading European ulation of the relevant provisions. Thus, the information national ethics advisory bodies (Nufﬁeld Council and obtained during genetic research is not strictly individual, German Ethics Council) sinceitmayrelatetofamilymembersoftheownerofgenetic information. In this regard, in many cases there is a need in R. Denkhaus makingacompromisedecision.Thisaspectleadstocasesof deviation from the strict rules of conﬁdentiality. Russian Zentrum für Gesundheitsethik, Hannover, Germany legislationrequiresthedevelopmentofaclearandconsistent algorithm for performing appropriate actions by a specialist. Introduction: Human germline gene editing (HGGE) has The study was funded by RFBR according to the research been the subject of numerous position papers by profes- project № 18-29-14073. sional organisations and ethics advisory bodies. On a I.S. Povarov: None. E.S. Kryukova: None. V.D. Ruza- national level, both the British Nufﬁeld Council and the nova: None. A.A. Inyushkin: None. German Ethics Council have published comprehensive reports on ethical aspects of HGGE. Analysis of the two E-P23.6 documents may provide valuable insight into the current Human embryo genome editing in Russia: bioethical stateofopinion-formation inEuropeandhelp toclarifythe analysis of one case prospect for developing a common European policy on HGGE. E. Grebenshchikova Materialsandmethods:Analysisandcomparisonofthe Nufﬁeld Council’s report, Genome Editing and Human INION RAS, Moscow, Russian Federation Reproduction“ (2018) and the German Ethics Council’s opinion, Intervening in the Human Germline“ (2019). Introduction: The statement of the Russian researcher Results: Even though public attitudes towards genetic Denis Rebrikov about his readiness to edit the embryo andreproductivetechnologieshavetraditionallybeenmuch genome aroused wide interest of the international scientiﬁc more sceptical in Germany than in the UK, conclusions on community. Initially, Rebrikov’s research team worked HGGE reached by the Nufﬁeld Council and (the majority with the CCR5 gene related to HIV resistance. But their of) the German Ethics Council are rather similar. Both methodology was different from that used by He. They committees are open towards further exploration of the tested it on abnormalembryos that could notbe transferred potentialofHGGE.Differencesappearwhenitcomestothe to the uterus due to genetic defects. Then he changed his way ethical questions on HGGE are framed, but also with goal and decided to edit the GJB2 gene, causing hereditary regard to a number of substantial issues (e.g. embryo deafness. He said in the media that already has several research or the relevance of the therapy/enhancement families that could take part in an experiment on editing distinction). embryos. Conclusion: Despite remaining differences, the two Materials and methods: the content analysis method councils’ reports reﬂect tendencies towards convergence was used to analyze publications in the Russian media. of opinion between the UK and Germany (and maybe Results: this problem should be considered from three within Europe more generally) on genetic and reproductive perspectives: clinical ethics (normative regulation of technologies. Agreement on basic standards governing the research, ethical aspects of safety and reliability of useofHGGEdoesnotseemoutofreach.Amoratoriumon technologies); ethical and philosophical issues (“designedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 995 clinicalusesofHGGEcouldprovidetimeforfurtherpublic of high quality, international, and open-source PEM for debate. gene therapy is needed. R. Denkhaus: None. C.A. Stewart:None.K.M. Lippold,Ph.D., M.P.H: None. V.L. Bonham: None. E-P23.8 Evaluating the quality, readability, and scientiﬁc accu- E-P24 Late (breaking) e-Posters racy of sickle cell disease gene therapy online patient education materials E-P24.01 RLIM is a candidate dosage sensitive gene for indivi- C. A. Stewart1,2, K. M. Lippold, Ph.D., M.P.H3,4, duals with varying duplications of Xq13, intellectual V. L. Bonham1 disability and recognizable facial features. 1National Human Genome Research Institute, National E. E. Palmer1,2, R. Caroll3, M. Shaw4, R. Kumar3, InstitutesofHealth,Bethesda,MD,UnitedStates,2National U. Nawaz3, A. Minoche5, M. Lefﬂer1, L. Murray1, InstitutesofHealth,Bethesda,MD,UnitedStates,3Ofﬁceof R. Macintosh6, D. Wright7, C. Troedson7, F. McKenzie8, S. the Chief Medical Ofﬁcer, Ofﬁce of the Assistant Secretary Townshend8, M. Ward8, A. Ravine9, C. K. Runke10, E. C. forHealth(OASH),U.S.DepartmentofHealthandHuman Thorland10, M. Hummel11, N. Foulds12, O. Pichon13, B. Services(DHHS),WashingtonDC,DC,UnitedStates,4Oak Isidor13, C. Le Caignec14, A. Bye15, R. Sachdev6, Ridge Institute for Science and Education (ORISE) Fellow, E. P. Kirk6, M. J. Cowley16, M. Field17, J. Gecz3 Oak Ridge Associated Universities, Rockville, MD, United States 1GeneticsofLearningDisability(GoLD)Service,Waratah, Australia, 2University of New South Wales, Sydney, Introduction: A growing number of gene therapy clinical Australia, 3Adelaide Medical School and the Robinson trials for sickle cell disease (SCD) are open in Europe and Research Institute, Adelaide, Australia, 4Adelaide Medical NorthAmerica.TheSCDcommunitiesrequirehighquality, School and the Robinson Research Institute, Waratah, accurate, and accessible information about novel curative Australia,5KinghornCentreforClinicalGenomics,Sydney, genetic therapies. Australia, 6Sydney Children’s Hospital, Randwick, Austra- Methods: Searched the world wide web (WWW) for lia, 7Children’s Hospital at Westmead, Sydney, Australia, patient education materials (PEM) on gene therapy, gene 8School of Paediatrics and Child Health, University of editingandcurativegenetictherapiesforSCD.Newsmedia Western Australia, Perth, Australia, 9Pathwest Laboratory articles, magazines, personal stories and scientiﬁc publica- Medicine WA, Perth, Australia, 10Genomics Laboratory, tionswereexcluded.Asecondarysearchwasconductedby Department of Laboratory Medicine and Pathology, Mayo a medical librarian to identify additional educational Clinic, Scottsdale, AZ, United States, 11West Virginia materials. PEM quality was evaluated using the United University School of Medicine, Morganville, WV, United States Agency for Healthcare Research and Quality States, 12Wessex Clinical Genetics Services,, Southampton, (AHRQ) Patient Education Materials Assessment Tool for United Kingdom, 13CHU de Nantes, Nantes, France, Print or Audiovisual materials (PEMAT-P; PEMAT-AV). 14Hopital Purpan, Toulouse, France, 15Sydney Children’s The readability of PEM was assessed utilizing the Flesch- Hospital, Sydney, Australia, 16Children’s Cancer Institute, Kincaid Grade Level (FKGL) and the Simple Measure of Sydney, Australia, 17Genetics of Learning Disability Gobbledygook (SMOG). Scientiﬁc Accuracy Score (SAS) Service, WARATAH, Australia was assessed by two reviewers and a gene therapy clinical expert. The assessment of the scientiﬁc accuracy included Interpretation of the signiﬁcance of maternally inherited X- an evaluation of the risks and beneﬁts. chromosome variants in males with neurocognitive pheno- Results: Authors identiﬁed on the WWW twelve patient typescontinuestopresentachallengetoclinicalgeneticists education materials: 8 webpages, 1 infographic and 3 and diagnostic laboratories. Here we report eleven males educational videos. Findings include FKGL, SMOG and from eight families with copy-number gains at the Xq13.2- SAS scores. PEMAT understandability scores ranged from q13.3 locus with a common facial phenotype, intellectual 60 - 93% (± 9.78), average 77%, and the actionability disability(ID),distinctivebehavioralfeatures,andaseizure scores ranged from 0 - 70% (±33.8), average 40%. disorderintwocases.Alltestedcarriermothershadnormal Conclusion:AccesstoqualityPEMaboutnovelcurative intelligence.Theduplicationarosedenovointhreemothers genetic therapies for SCD is a requirement for disease wheregrandparentaltestingwaspossible.Inonefamilythe advocacy community engagement and study participant duplication segregated with ID across three generations. recruitmentfor ongoingclinicaltrials.Furtherdevelopment RLIM is the only gene common to all duplications996 J.delPicchia investigated. It encodes a RING (Really Interesting New effort in an in vitro model of hypothalamic neurons using Gene) domain-containing zinc-ﬁnger protein with diverse human ESCs at 3 stages of differentiation: ESCs, hypo- cellular roles including in transcriptional regulation and thalamic progenitors (HPs) and hypothalamic-like neurons ubiquitination-mediated protein degradation. Missense var- (HNs). We identiﬁed 87,170 open chromatin regions iants in RLIM have recently been identiﬁed to cause X (OCRs) contacting promoters in at least 1 stage of HN linked ID in males, with heterozygous females typically differentiation.Interestingly,weobservedthatregardlessof having normal intelligence and highly skewed X-chromo- gene expression pattern during differentiation, overall some inactivation. We detected consistent and signiﬁcant accessibility of interacting OCRs ﬁrst increased during the increase of RLIM mRNA and RLIM protein levels in cells transitiontoHP,thendecreasedfollowingdifferentiationto derived from eight affected males from ﬁve families with HN. In order to relate these ﬁndings to GWAS data, we the duplication. Subsequent analysis of MDM2, as one of tested for enrichment of SNPs within promoter-interacting the targets of the RLIM E3 ligase activity, showed its OCRs. We found signiﬁcant associations with BMI, sleep consistent downregulation in cells from the affected males. traits, age at menarche (AAM) and major depressive dis- However, all the carrier mothers displayed normal RLIM order (MDD). We mapped these trait-associated variants to mRNA levels and had highly skewed X inactivation. We their physically interacting genes. We identiﬁed 2 putative propose duplications at Xq13.2-13.3 including RLIM cause effectorgenesforAAM(RPS26andSUOX)and1forBMI a recognizable, but mild neurocognitive phenotype in (DHRS11), which were also supported by colocalized hemizygous males. hypothalamus eQTLs in GTEx. Additionally, HyPrColoc E.E. Palmer: None. R. Caroll: None. M. Shaw: None. R. analysesrevealed severalputative effector genes associated Kumar: None. U. Nawaz: None. A. Minoche: None. M. with>1trait,includingZRANB2forAAM,BMIandMDD, Lefﬂer: None. L. Murray: None. R. Macintosh: None. D. and FEZF1 for AAM and BMI. Taken together, our ana- Wright: None. C. Troedson: None. F. McKenzie: None. S. lyses provide insight into cis-regulatory architecture during Townshend:None.M.Ward:None.A.Ravine:None.C.K. hypothalamic development and how it may contribute to Runke:None.E.C.Thorland:None.M.Hummel:None.N. hypothalamus-associated phenotypes. Foulds: None. O. Pichon: None. B. Isidor: None. C. Le Funding:R01HG010067,R01HD056465,NIH/NICHD Caignec: None. A. Bye: None. R. Sachdev: None. E.P. 1K99HD099330-01 Kirk: None. M.J. Cowley: None. M. Field: None. J. S.H. Littleton: None. M.C. Pahl: None. C.A. Doege: Gecz: None. None. K.M. Hodge: None. M.E. Leonard: None. S. Lu: None. J.A. Pippin: None. J.P. Bradﬁeld: None. R.K. E-P24.02 Hammond: None. K. Boehm: None. R.I. Berkowitz: None. Cis-regulatory architecture of human ESC-derived C. Lasconi: None. C. Su: None. A. Chesi: None. M.E. hypothalamic neuron differentiation aids in variant-to- Johnson:None.A.D.Wells:None.B.F.Voight:None.R.L. gene mapping of relevant common complex traits Leibel: None. D.L. Cousminer: None. S.F.A. Grant: None. S. H. Littleton1, M.C. Pahl1, C. A. Doege2,K. M. Hodge1, E-P24.03 M.E.Leonard1,S.Lu1,J.A.Pippin1,J.P.Bradﬁeld1,R.K. Developmental consequences of defective ATG7- Hammond1, K. Boehm1, R. I. Berkowitz3, C. Lasconi1, C. mediated autophagy in humans Su1,A.Chesi1,M.E.Johnson1,A.D.Wells1,3,B.F.Voight3, R. L. Leibel2, D. L. Cousminer1,3, S. F. A. Grant1,3 J. J. Collier1, C. Guissart2, M. Olahova1, S. Sasorith2, F. Suomi3, F. Piron-Prunier4, D. Zhang5, N. Martinez- 1Children’s Hospital of Philadelphia, Philadelphia, PA, Lopez6, N. Leboucq7, A. Bahr8, S. Azzarello-Burri8, UnitedStates,2ColumbiaUniversity,NewYork,NY,United S. Reich9, L. Schols9, T. M. Polvikoski10, P. Meyer11, States, 3University of Pennsylvania, Philadelphia, PA, L.Larrieu2,A.M.Schaefer1, S.Zuchner12,I.A. Barbosa13, United States C. Deshpande14, A. Pyle1, A. Rauch8, M. Synofzik9, M. Ryten5, A. Delahodde4, F. Rivier11, R. McFarland1, T. G. Dysregulation of hypothalamus-mediated metabolic home- McWilliams3, M. Koenig2, R. W. Taylor1 ostasisinﬂuencesBMI,pubertaltimingandsleep.However, thegeneregulatory landscape ofthehypothalamusremains 1Wellcome Centre for Mitochondrial Research, Newcastle unclear. We characterized thephysical relationships among University, Newcastle, United Kingdom, 2EA7402 Institut gene promoters and their corresponding cis-regulatory ele- Universitaire de Recherche Clinique, and Laboratoire de ments in human embryonic stem cell (ESC)-derived hypo- Génétique Moléculaire, University of Montpellier and thalamic cells by integrating RNA-seq, ATAC-seq and University Hospital, Montpellier, France, 3Translational promoter-focused Capture C proﬁles. We conducted this Stem Cell Biology & Metabolism Program, ResearchAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 997 ProgramsUnit,FacultyofMedicine,UniversityofHelsinki, Conclusion: Our study providestheﬁrst clinical,genetic Helsinki, Finland, 4Institut de Biologie Intégrative de la and mechanistic demonstration that mutated ATG7 leads to Cellule,Gif-sur-Yvette,France,5RetaLilaWestonResearch profound neurological disease in humans who are able to Laboratories, Department of Molecular Neuroscience, survive for decades in the absence of canonical autophagy, University College London (UCL) Institute of Neurology, deﬁning the importance of this pivotal pathway in human London, United Kingdom, 6Radiation oncology, Albert health. Einstein College of Medicine, Bronx, NY, United States, J.J.Collier:None.C.Guissart:None.M.Olahova:None. 7Neuroradiologie, CHU de Montpellier, Montpellier, S.Sasorith:None.F.Suomi:None.F.Piron-Prunier:None. France,8InstituteofMedicalGenetics,UniversityofZurich, D. Zhang: None. N. Martinez-Lopez: None. N. Leboucq: Zurich, Switzerland, 9Hertie-Institute for Clinical Brain None. A. Bahr: None. S. Azzarello-Burri: None. S. Reich: Research (HIH) and Center of Neurology, University of None. L. Schols: None. T.M. Polvikoski: None. P. Meyer: Tubingen, Tubingen, Germany, 10Translational and Clin- None. L. Larrieu: None. A.M. Schaefer: None. S. Zuchner: ical Research Institute, Faculty of Medical Sciences, None. I.A. Barbosa: None. C. Deshpande: None. A. Pyle: Newcastle University, Newcastle, United Kingdom, None. A. Rauch: None. M. Synofzik: None. M. Ryten: 11Department of Neuropédiatrie and CR Maladies Neuro- None.A.Delahodde:None.F.Rivier:None.R.McFarland: musculaires, CHU de Montpellier, Montpellier, France, None. T.G. McWilliams: None. M. Koenig: None. R.W. 12Dr. John T. Macdonald Foundation, Department of Taylor: None. Human Genetics, Miami, FL, United States, 13Division of Genetics and Molecular Medicine, King’s College London E-P24.04 School of Medicine, Guy’s Hospital, London, United A transcriptome-wide Mendelian randomization study Kingdom, 14Clinical Genetics Unit, Guys and St. Thomas’ todissectthemolecularaetiologyofautoimmunedisease NHS Foundation Trust, London, United Kingdom and cancer outcomes Background: Autophagy is the major intracellular degra- C. Prince, T. G. Richardson dationrouteinmammaliancells,drivingtheendolysosomal removal of toxic protein aggregates, damaged organelles MRC Integrative Epidemiology Unit, Population Health and pathogens. Impaired autophagy has been associated Sciences, University of Bristol, Bristol, United Kingdom with a range of complex human diseases, yet congenital core autophagy disorders are exceedingly rare. Developing functional understanding into the causal mole- Patients:Wholeexomesequencingidentiﬁedpathogenic culardriversofimmunologicaldiseaseisacriticalchallenge bi-allelicvariantsinthenoveldiseasegeneATG7,encoding in genomic medicine. Here we use Mendelian randomiza- a core autophagy protein, in seven individuals from four tion (MR) methods to investigate the effect of genetically families who display complex neurodevelopmental dis- predicted gene expression on 12 autoimmune and 4 cancer orders distinguished by selective neurological, neuromus- outcomes. Gene expression data from the eQTLGen con- cular and endocrine dysfunction. Contrasting Atg7-null sortium (n=31,684) was leveraged to construct weakly mice that demonstrate perinatal lethality, all patients correlated genetic instruments (r2<0.1) for 15,392 investigated are now adults. genes.Applyingtheinverse-varianceweightedMRmethod Results: ATG7 variants lead to diminished levels or loss transcriptome-wide whilst accounting for linkage dis- of ATG7 protein, causing severe attenuation or complete equilibrium structure identiﬁed 773 unique genes with absenceofautophagicreactionsincludingLC3lipidationin evidence of a genetically predicted effect on at least one patient-derived ﬁbroblasts and a marked reduction in disease outcome. We next applied genetic colocalization to starvation-induced long-lived protein degradation. Expres- investigatewhethertheseeffectsmaybeconﬁnedtospeciﬁc sion of mutant atg7 failed to rescue the autophagic defect cell-typesusingdataderivedfrom18typesofimmunecells. displayed by Δatg7 yeast. Skeletal muscle biopsy with no This highlighted various cell-type speciﬁc relationships, detectable ATG7 protein demonstrated myopathic changes including PRKCQ and asthma which appeared to be T-cell including accumulation of p62 and focal mitochondrial speciﬁc,aswellasPTK2Bandinﬂammatoryboweldisease, dysfunction. Despite the loss of ATG7, we detected which was restricted to monocytes and neutrophils. Fur- autophagosomes and autolysosomes in patient ﬁbroblasts thermore, as the use of human genetics can help improve andmuscle,insupportofanalternativeautophagypathway theefﬁcacyandsafetyratesofdrugtargets,weundertooka driving their biogenesis. Moreover, RNA-sequencing of phenome-wide MRanalysisforeachofthese773genes on patientﬁbroblastshighlighteddysfunctionalspinocerebellar 335 health-related outcomes. This atlas of results can be ataxia-associated ITPR1-signalling. usedtoprioritisewhichofthesepotentialtherapeutictargets is least likely to cause unanticipated adverse effects. Our998 J.delPicchia ﬁndingsprovideinsightintothemechanismsandbiological pro-inﬂammatory STAT1 pathway, correlating with pathways which predispose individuals to autoimmune increased production of chemokines. In contrast, Lnc13 disease and cancer. As future work we intend to apply this disruption partially counteracted PIC-induced STAT1 and framework to COVID19 data to improve our capability to pro-inﬂammatorychemokineexpression.Inthepresenceof prevent and treat the cause of the current global pandemic. PIC, Lnc13 translocated from the nucleus to the cytoplasm C. Prince: None. T.G. Richardson: None. acting as a linker between the 3’-UTR of STAT1 and the protein PCBP2, allowing the formation of a complex that E-P24.08 stabilizes STAT1 mRNA and sustains β-cell inﬂammation. The T1D-associated lncRNA Lnc13 modulates human Conclusions: Our results demonstrate that Lnc13 reg- pancreatic β-cell inﬂammation by allele-speciﬁc stabili- ulates virus-induced inﬂammation in pancreatic β-cells zation of STAT1 mRNA. throughamolecularmechanismthatinvolvesallele-speciﬁc activation of the STAT1 signaling pathway. I. Gonzalez-Moro1,2, A. Olazagoitia-Garmendia1,2, I. Gonzalez-Moro: None. A. Olazagoitia-Garmendia: M. L. Colli3, N. Cobo-Vuilleumier4, T. S. Postler5, None. M.L. Colli: None. N. Cobo-Vuilleumier: None. T. L.Marselli6,P.Marchetti6,S.Ghosh5,B.R.Gauthier4,7,D. S. Postler: None. L. Marselli: None. P. Marchetti: None. S. L. Eizirik3,8, A. Castellanos-Rubio1,2,9, I. Santin1,2,7 Ghosh: None. B.R. Gauthier: None. D.L. Eizirik: None. A. Castellanos-Rubio: None. I. Santin: None. 1University of the Basque Country, Leioa, Spain, 2Bio- cruces Bizkaia Research Institute, Barakaldo, Spain, 3ULB E-P24.09 Center for Diabetes Research, Brussels, Belgium, 4Andalu- A transcriptome-wide Mendelian randomisation study sian Center for Molecular Biology and Regenerative ofcardiovasculardiseasetoprioritisegenetictargetsfor Medicine, Sevilla, Spain, 5Columbia university, New York, therapeutic intervention NY, United States, 6Cisanello University Hospital, Pisa, Italy, 7CIBER de Diabetes y Enfermedades Metabólicas G. M. Leyden, T. R. Gaunt, T. G. Richardson Asociadas (CIBERDEM, Madrid, Spain, 8Indiana Bios- ciences Research Institute, Indianapolis, IN, United States, University of Bristol, Bristol, United Kingdom 9Ikerbasque, Basque Foundation for Science, Bilbao, Spain Cardiovasculardisease(CVD)istheleadingcauseofdeath worldwide, however its complex etiology presents a chal- Introduction: Type 1 diabetes (T1D) is an autoimmune lenge for clinical intervention. Here we have applied a disease in which insulin-producing β-cells are speciﬁcally Mendelian randomization (MR) framework using geneti- destroyed by the immune system. The majority of T1D- cally predicted variation in gene expression to prioritize associated polymorphisms lie in noncoding regions of the candidate drug targets for the treatment of CVD. genome and many are predicted to alter the secondary We systematically evaluated the association between structure and expression of long noncoding RNAs 8,851 genes each had ≥ 2 cis-eQTLs based on results from (lncRNAs). We performed a complete functional char- theeQTLGenConsortium)and5CVDrisk-factorsfromthe acterization of a lncRNA that harbors a T1D-associated UK Biobank (UKB) (body-mass index, systolic and SNP, namely Lnc13. diastolicbloodpressure,low-densitylipoproteincholesterol Materials and methods: Overexpression and disruption and triglycerides). Associated genes were then analyzed of Lnc13 were performed in the human pancreatic β-cell usingfactorialMRtoevaluateevidenceofanadditiveCVD line EndoC-βH1 using allele-speciﬁc overexpression vec- lowering effect compared to an HMGCR score acting as a tors and CRISPR-Cas9 mediated deletion. Polyinosinic: proxy for statin inhibition. Phenome-wide analyses were polycytidylic acid (PIC) was used to mimic a virus-related conducted to evaluate the associations with between 569 inﬂammatory response. RNA antisense puriﬁcation (RAP) traits to elucidate potential adverse effects. and RNA immunoprecipitation (RIP) assays were imple- We identiﬁed 377 genetic associations with CVD risk mented to characterize the binding partners of Lnc13. In factors (P<1.13x10-6) with factorial MR analyses high- vitroexperimentswerefurthercorroboratedwithexpression lighting 20 genetically predicted targets with evidence of a analysis of human pancreatic islets. CVD lowering effect in combination with statin treatment Results: Human pancreatic islets harboring the T1D- (P<7.36x10-4). Genes such as FDFT1 were predicted to associated Lnc13 risk allele (rs917997*CC) showed higher have added beneﬁt with statin therapy (OR=0.93; 95% STAT1 expression than islets harboring the heterozygous CI=0.91-0.95; P=2.21x10-10) but are unlikely to make a genotype (rs917997*CT). Upregulation of Lnc13 in pan- safe target based on associations with potential adverse creatic β-cells allele-speciﬁcally increased activation of the side-effects detected in our phenome-wide analysis. InAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 999 contrast, targets such as PRKCE provided evidence of an in a β-catenin- and TCF/LEF-dependent manner. Finally, additive CVD lowering effect (OR=0.94; CI=0.91-0.96; TBX3 overexpression exacerbates the metastatic potential P=1.72x10-9) without predicted adverse effects. of Wnt-dependent human CRC cells. Through the application of a systematic factorial MR Conclusion: Our work implicates TBX3 as a new, analysis, we have prioritized (and deprioritized) potential context-dependent component of the Wnt/β-catenin-depen- drug targets predicted to reduce CVD risk in addition to dent enhanceosome. Our study suggestsanew paradigmin statin therapy. which tissue-speciﬁc co-factors might be the key to G.M.Leyden:None.T.R.Gaunt:None.T.G.Richardson: understand the spectrum of possible transcriptional outputs None. observed downstream of Wnt/β-catenin signaling. Grants: Knut and Alice Wallenberg Foundation, Cancerfonden E-P24.10 (CAN 2018/542), the Swiss National Science Foundation TBX3actsastissue-speciﬁccomponentoftheWnt/beta- and the Canton of Zurich, and the Swiss National Science catenin enhanceosome Foundation (grant PCEPP3_181249). D. Zimmerli*: None. C. Borrelli*: None. A. Jauregi- D. Zimmerli*1,2, C. Borrelli*3, A. Jauregi-Miguel*4,5, Miguel*: None. S. Söderholm: None. S. Brütsch: None. N. S. Söderholm4,5, S. Brütsch1, N. Doumpas1, J. Reichmuth1, Doumpas: None. J. Reichmuth: None. F. Murphy-Seiler: F. Murphy-Seiler6, M. Aguet6, K. Basler1, A. Moor3, C. None. M. Aguet: None. K. Basler: None. A. Moor: None. Cantù4,5 C. Cantù: None. 1Department of Molecular Life Sciences, University of E-P24.11 Zurich,Zurich,Switzerland,2DivisionofMolecularPathol- Complex genomic rearrangements in MECP2duplica- ogy,TheNetherlandsCancerInstitute,Amsterdam,Nether- tion syndrome lands, 3Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland, 4Wallenberg Centre for M.Gandhi1,D.Pehlivan1,C.M.Grochowski1,B.Suter2,J. Molecular Medicine, Linköping University, Linköping, M. Fatih1, H. Y. Zoghbi1, J. R. Lupski1, Sweden, 5Department of Biomedical and Clinical Sciences, C. M. B. Carvalho1 Faculty of Health Science, Linköping, Sweden, 6Swiss InstituteforExperimentalCancerResearch(ISREC),Ecole 1Baylor College of Medicine, Houston, TX, United States, Polytechnique Fédérale de Lausanne (EPFL), School of 2Texas Children’s Hospital, Houston, TX, United States Life Sciences, Lausanne, Switzerland MECP2 Duplication Syndrome (MDS) is a neurodevelop- Introduction: Aberrant regulation of the Wnt/β-catenin mental disorder caused by copy-number gains of the signaling pathway is a prevalent theme in cancer biology. MECP2geneattheXq28locus.Theclinicalpresentationis BCL9andPYGO,thewell-knownβ-catenintranscriptional variable, but there are several predominant features, cofactors, have been proposed as therapeutic targets to including infantile hypotonia, severe developmental delay/ diminish Wnt signaling output in patients with colorectal intellectual disability, recurrent respiratory infections, and cancer (CRC). epilepsy.Onepossibleexplanationforthisvariabilityisthe Material and methods: We combined mouse genetics distinct structural variants (SVs) among MDS patients at with molecular high-throughput genomic technologies on this locus, 26% of which were previously reported as ex vivo and in vitro human cells to discover the molecular complex genomic rearrangements (CGRs). To pursue a nature of CRC-causing Wnt signaling machinery. robust genotype-phenotype correlation, a combination of Results: Here we ﬁnd that, in CRC cells and in custom high-resolution array comparative genomic hybri- developing mouse forelimbs, BCL9 proteins sustain the dization (aCGH), droplet digital PCR (ddPCR), whole- actionofβ-catenininalargelyPYGO-independentmanner. genome sequencing (WGS), and genomic optical mapping Our genetic analyses implied that BCL9 necessitates other were used to resolve MECP2 SVs in 89 MDS probands. interaction partners in mediating its transcriptional output. This analysis revealed CGRs constitute 46.1% (41/89) of We identiﬁed the transcription factor TBX3 as a candidate our cohort, including 15.7% (14/89) triplications (5/14 tissue-speciﬁc member of the β-catenin transcriptional involving triplicated MECP2), 5.6% (5/89) DUP-NML- complex. In developing forelimbs, TBX3 and BCL9 co- DUP(twoduplicationsseparatedbyacopy-numberneutral occupy a large number of Wnt-responsive regulatory segment), and 10.1% (9/89) involving a translocation. De elements,genome-wide.Moreover,mutationsinBcl9affect novo SVs were observed in 18.1% (12/66) of probands: 4 the expression of TBX3 targets in vivo, and modulation of translocations, 4 terminal duplications, 3 single duplica- TBX3abundanceimpactsonWnttargetgenestranscription tions, and 1 DUP-NML-DUP rearrangement. Interestingly,1000 J.delPicchia ourdatademonstratethatCGRsareobservedinalmosthalf Medicine, Salt Lake City, UT, United States ofMDSpatients,withtriplicationsbeing amongstthemost common copy-number ﬁnding. In 9/14 cases with triplica- Introduction:Azoospermiaaffects1%ofmenanditcanbe tions, MECP2 did not map within the triplicated interval. the consequence of spermatogenic maturation arrest (MA). Probands who carry a de novo MECP2 duplication have a Although the etiology of MA is likely to be of genetic higher likelihood of carrying a translocation (4) or large origin, only 13 genes have been reported as recurrent terminal duplication (4), which may contribute to a more potential causes of MA. severe phenotype. Further studies are in progress to inves- Material and Methods: Exome sequencing in tigate genotype-phenotype correlations with molecular 147 selected MA patients (discovery cohort and two characterization of CGRs at this locus. validation cohorts). NHGRI:UM1HG006542 Results:Weidentiﬁed5novelgenesresponsibleforMA M.Gandhi:None.D.Pehlivan:None.C.M.Grochowski: (ADAD2, TERB1, SHOC1, MSH4, and RAD21L1), for None. B. Suter: None. J.M. Fatih: None. H.Y. Zoghbi: which mouse knockout (KO) models are concordant with None. J.R. Lupski: E. Ownership Interest (stock, stock the human phenotype. Four of them were validated in the options, patent or other intellectual property); Modest; twoindependentMAcohorts.Inaddition,9patientscarried 23andme. F. Consultant/Advisory Board; Modest; Regen- pathogenicvariantsin7previouslyreportedgenes-TEX14, eron Pharmaceuticals, Novartis. C.M.B. Carvalho: None. DMRT1, TEX11, SYCE1, MEIOB, MEI1 and STAG3 - allowing to upgrade the clinical signiﬁcance of these genes E-P24.12 for diagnostic purposes. Our meiotic studies provide novel Genetic dissection of spermatogenic arrest through insight into the functional consequences of the variants, exome analysis. Clinical implications for the manage- supporting their pathogenic role. ment of azoospermic men Conclusions: Diagnosing complete MA based on a genetic test is clinically relevant because affected patients A. Riera-Escamilla1, D. Moreno-Mendoza1, K. Holleman2, should not undergo invasive testis surgery (TESE). Our F. Cioppi3, F. Algaba4, M. Pybus5, C. Friedrich6, ﬁndings contribute substantially to the development of a M. J. Wyrwoll6, E. Casamonti3, S. Pietroforte3, pre-TESE prognostic gene panel. Wider implications L. Nagirnaja7, A. M. Lopes8, S. Kliesch9, A. Pilatz10, includetheunderstandingofpotentialgeneticlinksbetween D. T. Carrell11, D. F. Conrad7, E. Ars5, E. Ruiz-Castañé1, NOA and cancer predisposition, and between NOA and K.I.Aston11,W.M.Baarends2,F.Tüttelmann6,C.Krausz3 premature ovarian failure. GrantReferences:InstitutoCarlosIII-FIS(FIS/FEDER- 1Andrology Department, Fundació Puigvert, Universitat PI14/01250;PI17/01822),EuropeanCommission(REPRO- Autònoma de Barcelona, IIB-Sant Pau, Barcelona, Spain, TRAIN, project number: 289880), German Research 2Department of Developmental Biology, Erasmus MC FoundationClinicalResearchUnit‘MaleGermCells:from University Medical Centre, Rotterdam, Netherlands, GenestoFunction’(DFG CRU326),theNational Institutes 3Department of Biomedical, Experimental and Clinical of Health (R01HD078641) Sciences "Mario Serio", University of Florence, Florence, A. Riera-Escamilla: None. D. Moreno-Mendoza: None. Italy, 4Pathology Section, Fundació Puigvert, Universitat K.Holleman:None.F.Cioppi:None.F.Algaba:None.M. Autonoma de Barcelona, Barcelona, Spain, 5Molecular Pybus: None. C. Friedrich: None. M.J. Wyrwoll: None. E. Biology Laboratory, Fundació Puigvert, Instituto de Casamonti:None.S.Pietroforte:None.L.Nagirnaja:None. Investigaciones Biomédicas Sant Pau (IIB Sant Pau), A.M.Lopes:None.S.Kliesch:None.A.Pilatz:None.D.T. Universitat Autònoma de Barcelona, Barcelona, Spain, Carrell: None. D.F. Conrad: None. E. Ars: None. E. Ruiz- 6Institute of Human Genetics, University of Münster, Castañé:None.K.I.Aston:None.W.M.Baarends:None.F. Münster,Germany,7DivisionofGenetics,OregonNational Tüttelmann: None. C. Krausz: None. Primate Research Center, Oregon Health & Science University, Portland, OR, United States, 8Instituto de E-P24.13 Patologia e Imunologia Molecular da Universidade do Diagnostic experience of whole-genome sequencing in a Porto, Porto, Portugal, 9Centre of Reproductive Medicine series of ophthalmic cases from The 100,000 Genomes and Andrology, Department of Clinical and Surgical Project Andrology, University Hospital Münster, Münster, Ger- many, 10Clinic for Urology, Pediatric Urology and S. Nutan1, G. Arno1,2,3, E. Clement4, A. Buckton1, Andrology, Justus Liebig University, Giessen, Germany, A. Lemaigre1, E. Schiff2, H. Knight2, A. Gimenez2, 11Andrology and IVF Laboratories, Division of Urology, S. Malka2, G. Wright2, N. Jurkute2,3, R. Ba-Abbad2,3, Department of Surgery, University of Utah School ofAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1001 O. Mahroo2,3,5, M. Moosajee2,3,6, M. Michaelides2,3, S. Nutan: None. G. Arno: None. E. Clement: None. A. P. Yu-Wai-Man2,3,7, A. Webster2,3 Buckton: None. A. Lemaigre: None. E. Schiff: None. H. Knight: None. A. Gimenez: None. S. Malka: None. G. 1North Thames Genomic Laboratory Hub, Great Ormond Wright: None. N. Jurkute: None. R. Ba-Abbad: None. O. Street NHS Foundation Trust, London, United Kingdom, Mahroo:None.M.Moosajee:None.M.Michaelides:None. 2Moorﬁelds Eye Hospital NHS Foundation Trust, London, P. Yu-Wai-Man: None. A. Webster: None. United Kingdom, 3UCL Institute of Ophthalmology, Lon- don, United Kingdom, 4Dept of Clinical Genetics, Great E-P24.15 Ormond Street Hospital, London, United Kingdom, 5Sec- HDAC8: a newly identiﬁed role on mitotic ﬁdelity and tion of Ophthalmology, King’s College London, London, euploidy safeguard United Kingdom, 6Ophthalmology Dept, Great Ormond StreetHospital,London,UnitedKingdom,7JohnvanGeest N. Maia#1,2, F. Santos1,2,3, C. Oliveira4, R. Santos1,2, Centre for Brain Repair and MRC Mitochondrial Biology B. Porto4, A. P. M. de Brouwer5, P. Jorge#1,2, Unit, Department of Clinical Neurosciences, University of A. Jacome#3 Cambridge, Cambridge, United Kingdom 1Unidade de Genética Molecular, Centro de Genética Introduction: Current molecular diagnostic testing for Médica Doutor Jacinto de Magalhães (CGMJM), Centro inherited eye diseases (IED) is focused on targeted gene Hospitalar Universitário do Porto, Porto, Portugal, 2Uni- panel analysis with variable diagnostic rates. The recent dade Multidisciplinar de Investigação Biomédica (UMIB), completionofreturnofresultsfrom The100,000Genomes Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Project for Moorﬁelds Eye hospital NHS Foundation Trust Universidade do Porto, Porto, Portugal, 3Chromosome highlighted the vast potential of Whole-Genome Sequen- InstabilityandDynamicsLab.(CID),InstitutodeInovação cing (WGS) to maximise diagnosis in IED. e Investigação (i3S), Universidade do Porto, Porto, Methods and Results: As part of the 100,000 Genomes Portugal, 4Laboratório Citogenética, Instituto de Ciências project (pilot and main study), 1673 recruited cases were Biomédicas Abel Salazar (ICBAS), Universidade do Porto, analysed. WGS analysis consisted of evaluation of Porto,Portugal,5DepartmentofHumanGenetics,Donders potentially disease-causing variation, based on the ACMG Institute for Brain, Cognition and Behaviour, Radboud evidence framework and application of suitable curated University Nijmegen, Nijmegen, Netherlands virtual panel(s) from PanelApp (https://panelapp. genomicsengland.co.uk/), resolving 54% (903/1673) of HDAC8,aclassIhistonedeacetylaseisalsoresponsiblefor cases. In an additional 17% (291/1673) of cases, variants the deacetylation of non-histone substrates, such as SMC3 identiﬁed outside of this ﬁltering strategy included non- located at the cohesin complex. The mechanism by which coding,structuralandthose thatwereotherwiseﬁlteredout post-transductional modiﬁcations inﬂuence the mitotic or outside the gene panel. apparatus and the mitotic ﬁdelity remains poorly under- Examples included: 1) Strength of genetic evidence: e.g. stood. Recent studies in mouse oocytes showed that Hdac8 curation and identiﬁcation of known disease alleles in controls meiotic spindle assembly. Using time-lapse ima- ABCA4 (high frequency in control populations and those ging, we have found that HDAC8 co-localizes on spindle escaping standard in silico assessment) encompassed an microtubules and the midbody, and therefore appears to be additional 5% of total diagnoses. 2) Strength of phenotypic involved in chromosome alignment and accurate spindle evidence: e.g. NR2E3 biallelic variants and pathognomonic assembly. We used HeLA cells and human-derived lym- clinicalpresentationofEnhancedS-conesyndromeenabled phoblastoidcelllinesexpressing amutantHDAC8alleleas identiﬁcation of poorly annotated pathogenic variants in in vitro culture systems, both capable of recapitulating the this gene. invivoevents.Thesemodelsprovedtobevaluabletoolsto Conclusion: Crucial to improving diagnostic services understandhowHDAC8depletionaffectsgenomicstability will be the widespread implementation of WGS and duringmitosis.WeobservedthatmutantHDAC8ledtothe incorporating multidisciplinary team meetings. In order to formation of anaphase bridges and lagging chromosomes, maximise WGS effectiveness, expanding the analysis tripolar cells and inefﬁcient chromosome congression. We outside of the coding regions of the targeted gene panel found strong evidence that HDAC8 acts as genome and evaluating the pathogenicity of different classes of euploidy guardian, and understanding the underlying variants will be an important step forward in the post- mechanism in mitosis raised new questions. Overall, our genome age. ﬁndings indicate that HDAC8 deﬁciency promotes1002 J.delPicchia aneuploidy in human cells, providing some insight into the Medicina da Universidade do Porto, Porto, Portugal, mechanisms behind HDAC8-related disorders, such as 12Departamento de Genética Humana, Instituto Nacional Cornelia de Lange Syndrome 5 (OMIM #300882). Fur- deSaúdeDr.RicardoJorge,Lisboa,Portugal,13ToxOmics- thermore, the existence of a therapeutic HDAC8-targeted Centro deToxicogenómicae Saúde Humana, Nova Medical molecule paves the way for new tailored treatments. School, Lisboa, Portugal, 14Institute of Veterinary Anatomy, Funding: Unit for Multidisciplinary Research in Biomedi- HistologyandEmbryology,JustusLiebigUniversity,Gießen, cine is supported by National Funds through the Fundação Germany, 15University of Acibadem, Acibadem Genetic para a Ciência e Tecnologia in the frameworks of the UID/ DiagnosticCentre,Istanbul,Turkey,16NearEast University, Multi/0215/2016 project -UMIB/ICBAS/UP. Nuno Maia Faculty of Medicine, Department of Medical Biology, receivedaresearchgrant2015DEFI-CHUP,E.P.E.#Equal Nicosia, Cyprus, 17Istanbul Memorial Hospital, Assisted contributors Reproductive Technologies and Reproductive Genetics N. Maia#: None. F. Santos: None. C. Oliveira: None. R. Centre, Istanbul, Turkey, 18Istanbul Memorial Hospital, Santos: None. B. Porto: None. A.P.M. de Brouwer: None. Department of Urology & Andrology, Istanbul, Turkey, P. Jorge#: None. A. Jacome#: None. 19Istanbul Memorial Hospital, Assisted Reproductive Tech- nologies and Reproductive Genetics, Istanbul, Turkey, E-P24.16 20Newcastle Fertility Centre, The Newcastle upon Tyne Biallelic mutations in M1AP are associated with meiotic Hospitals NHS Trust, Newcastle upon Tyne, United King- arrest, severely impaired spermatogenesis and male dom, 21Newcastle upon Tyne Hospitals NHS Foundation infertility Trust, Newcastle upon Tyne, United Kingdom, 22Clinic for Urology, Pediatric Urology and Andrology, Justus Liebig C. Friedrich*1, S. G. Temel*2, L. Nagirnaja3, M. S. Oud4, University,Gießen,Germany,23AndrologyandIVFLabora- A. M. Lopes5,6, G. W. van der Heijden4,7, J. Heald8, tories, Department of Surgery, University of Utah School of N. Rotte1,9, J. Wistuba9, M. Wöste10, S. Ledig1, H. Krenz10, Medicine, Salt Lake City, UT, United States R. M. Smits7, F. Carvalho11,6, J. Gonçalves12,13, D. Fietz14, B. Türkgenç15, M. C. Ergören16, M. Çetinkaya17, Male infertility affects ~7% of men, but its causes remain M.Başar18,S.Kahraman19,K.McEleny20,M.J.Xavier8,H. poorly understood. The most severe form is non-obstructive Turner21,A.Pilatz22,A.Röpke1,M.Dugas10,S.Kliesch9,N. azoospermia(NOA),whichis,inpart,causedbyanarrestat Neuhaus9, GEMINI Consortium, K. I. Aston23, D. F. meiosis,butsofaronlyfewvalidatedcausalgeneshavebeen Conrad3, J. A. Veltman4,8, M. J. Wyrwoll*1, F. reported. To address this gap, we performed whole exome Tüttelmann*1 sequencing in 58 men with unexplained meiotic arrest and identiﬁed in three unrelated men the same homozygous fra- 1Institute of Human Genetics, University of Münster, meshift variant c.676dup (p.Trp226LeufsTer4) in M1AP, Münster, Germany, 2Bursa Uludag University, Faculty of encodingmeiosis1arrestingprotein.Thisvariantresultsina Medicine,DepartmentofMedicalGenetics&Departmentof truncated protein lacking 57% of its full-length as shown Histology & Embryology & Health Sciences Institute, invitrobyheterologousexpressionofmutatedM1AP.Next, DepartmentofTranslationalMedicine,Bursa,Turkey,3Divi- wescreenedfourlargecohortsof1904infertilemenfromthe sionofGenetics,OregonNationalPrimateResearchCenter, InternationalMaleInfertilityGenomicsConsortium(IMIGC) Oregon Health & Science University, Portland, OR, United and identiﬁed three additional cases carrying homozygous States, 4Department of Human Genetics, Donders Institute c.676dup and three carrying combinations of this and other for Brain, Cognition and Behavior, Radboud University likely causal variants in M1AP. Moreover, a homozygous Medical Center, Nijmegen, Netherlands, 5Instituto de missense variant p.(Pro389Leu) segregatedwithinfertility in Patologia e Imunologia Molecular da Universidade do ﬁvemenfromaconsanguineousTurkishfamily(LODscore Porto,Porto,Portugal,6InstitutodeInvestigaçãoeInovação = 3.28). The common phenotype between all affected men em Saúde (i3s), Universidade do Porto, Porto, Portugal, was NOA, but occasionally spermatids and rarely a few 7Department of Obstetrics and Gynecology, Radboud Uni- spermatozoa in the semen were observed. A similar pheno- versityMedicalCenter,Nijmegen,Netherlands,8Biosciences type was described for mice with disruption of M1ap. Col- Institute,Faculty ofMedical Sciences,NewcastleUniversity, lectively,theseﬁndingsdemonstratethatmutationsinM1AP Newcastle upon Tyne, United Kingdom, 9Centre of Repro- cause autosomal recessive severe spermatogenic failure and ductiveMedicineandAndrology(CeRA),UniversityHospital male infertility. In view of the evidences from several inde- Münster, Münster, Germany, 10Institute of Medical Infor- pendentgroupsandpopulations,M1APshouldbeincludedin matics, University of Münster, Münster, Germany, 11Serviço the growing list of validated male infertility genes. de Genética, Departamento de Patologia, Faculdade deAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1003 ThisworkwassupportedbyDFGClinicalResearchUnit tothepreviouslyreportedtools.WemadetheInMeRFweb “Male Germ Cells: from Genes to Function” (CRU326). service program, and also made genome-wide InMeRF C. Friedrich*: None. S.G. Temel*: None. L. Nagirnaja: scores available online at https://www.med.nagoya-u.ac.jp/ None. M.S. Oud: None. A.M. Lopes: None. G.W. van der neurogenetics/InMeRF/. Heijden:None.J.Heald:None.N.Rotte:None.J.Wistuba: Grant references None.M.Wöste:None.S.Ledig:None.H.Krenz:None.R. JSPS, MHLW, AMED, and NCNP. M.Smits:None.F.Carvalho:None.J.Gonçalves:None.D. J. Takeda: None. K. Nanatsue: None. R. Yamagishi: Fietz: None. B. Türkgenç: None. M.C. Ergören: None. M. None. M. Ito: None. K. Ohno: None. Çetinkaya: None. M. Başar: None. S. Kahraman: None. K. McEleny: None. M.J. Xavier: None. H. Turner: None. A. E-P24.21 Pilatz:None.A.Röpke:None.M.Dugas:None.S.Kliesch: Genetic basis of inherited retinal disease in a molecu- None. N. Neuhaus: None. K.I. Aston: None. D.F. Conrad: larlycharacterisedcohortofover3000familiesfromthe None. J.A. Veltman: None. M.J. Wyrwoll*: None. F. United Kingdom Tüttelmann*: None. D. A. Jaramillo-Calle1, N. Pontikos1,2, G. Arno1, E-P24.18 N. Jurkute1, E. Schiff1, R. Ba-Abbad1, S. Malka1, A set of random forest models for each amino acid A.Gimenez1,M.Georgiou1,A.T.Moore1,M.Michaelides1, substitution to predict pathogenicity of missense var- A. R. Webster1, O. Mahroo1 iants in the human genome 1UCL Institute of Ophthalmology, London, United King- J. Takeda, K. Nanatsue, R. Yamagishi, M. Ito, K. Ohno dom,2MoorﬁeldsEyeHospital,London,UnitedKingdom Division of Neurogenetics, Center for Neurological Dis- Introduction: In our cohort of >3000 molecularly char- eases and Cancer, Nagoya University Graduate School of acterisedinheritedretinaldisease(IRD)familiesmanagedat Medicine, Nagoya, Japan the Genetics Service of Moorﬁelds Eye Hospital (UK), we investigated proportions with disease attributable to causa- Introduction: When we predict the pathogenicity of a tive variants in each gene. nonsynonymous single nucleotide variant (nsSNV), a radi- Methods: We calculated proportions of families with cal change in amino acid (AA) properties is prone to be IRD attributable to variants in each gene in the whole classiﬁed as being pathogenic. However, not all such cohort, a cohort <18 years, and a “current” cohort (patients nsSNVs are associated with human diseases. seen in last two years). Additionally, we explored correla- Materials and methods: We generated random forest tion between numbers of families and gene transcript (RF) models individually for each AA substitution to length. differentiate pathogenic nsSNVs in the Human Gene Results: We identiﬁed 3195 families with a molecular Mutation Database (HGMD) and common nsSNVs in diagnosis (variants in 135 genes), including 4236 affected dbSNP.Wenamedasetofourmodels“IndividualMetaRF individuals.Thepaediatriccohortcomprised452individuals (InMeRF)”. from 411 families (66 genes). The current cohort comprised Results: Ten-fold cross-validation of InMeRF showed 2614 families (131 genes; 3130 affected individuals). The thattheareaunderthecurves(AUCs)ofreceiveroperating paediatriccohortshowedahigherproportionoffamilieswith characteristic (ROC) and precision-recall (PR) curves were X-linked disease. The 20 most frequently implicated genes on average 0.941 and 0.957, respectively. Variants of accounted for 71.8% of all families (Table 1). Spearman InMeRF and seven recently reported tools were generated coefﬁcients for correlation between numbers of families and by the same training dataset, and were compared using the transcript length were 0.20 (p=0.025) overall, and 0.27 sametrifectaofbenchmarkdatasets.Amongtheeighttools, (p=0.017), -0.17 (p=0.46) and 0.71 (p=0.047) for genes in ROC-AUC and PR-AUC of InMeRF were ranked ﬁrst on which variants exclusively cause recessive, dominant or X- average. Application of InMeRF to nsSNVs in the MUSK linked disease respectively. gene causing congenital myasthenic syndromes (CMS) Conclusions: Our ﬁndings quantify the burden of showed the sensitivity and speciﬁcity of 1.000 (7/7) and inherited retinal disease attributable to each gene. Over 0.857 (12/14), respectively. With regard to the VANGL1 70%offamilieshadpathogenicvariantsinoneof20genes. gene causing spina biﬁda, the sensitivity and speciﬁcity Transcript length (relevant to gene delivery strategies) showed 0.933 (14/15) and 1.000 (8/8), respectively. correlated signiﬁcantly with numbers of affected families Conclusions: We showed that individual modeling each (but not for dominant disease). AAsubstitutionmadetheperformanceofInMeRFsuperior Table 1: Gene prevalence in IRD cohort.1004 J.delPicchia Brompton and Hareﬁeld NHS Foundation Trust, London, Gene Pctoffamilies United Kingdom, 9University of Florence, Florence, Italy, ABCA4 20.8 10National Heart Centre Singapore, Singapore, Singapore, USH2A 9.1 11Harvard Medical School/Massachusetts General Hospi- RPGR 5.1 tal, Boston, MA, United States PRPH2 4.6 BEST1 3.9 Background: Left ventricular non-compaction (LVNC) is RS1 3.5 characterised by myocardial hypertrabeculation and is RP1 3.3 subject to considerable conjecture in the extent to which it RHO 3.3 represents a distinct pathology, a secondary phenotype CHM 2.7 associated with other cardiac diseases (particularly cardio- myopathies), or physiological adaptation. CRB1 2.1 Methods:Weperformedrarevariantassociationanalysis PRPF31 1.8 of 840 LVNC cases and 125,748 gnomAD population MYO7A 1.7 controls,andcomparedresultstosimilaranalysesondilated OPA1 1.6 cardiomyopathy (DCM) and hypertrophic CNGB3 1.4 cardiomyopathy (HCM). RPE65 1.2 Results: We observed substantial overlap in genes and EYS 1.2 variant classes associated with LVNC and with DCM/ GUCY2D 1.2 HCM, indicating that LVNC often represent a secondary PROM1 1.2 phenotypeoccurringincertainpatientswithDCMorHCM. CNGA3 1.1 In contrast, truncating variants (TV) in MYH7, ACTN2 and RDH12 1.1 PRDM16 were uniquely associated with LVNC and may reﬂect a distinct LVNC aetiology. MYH7 TV, generally considered non-pathogenic for cardiomyopathies, were 20- D.A.Jaramillo-Calle:None.N.Pontikos:B.ResearchGrant fold enriched in LVNC cases over controls. Carriers of (principal investigator, collaborator or consultant and pending MYH7 TV in the UK Biobank and healthy volunteers also grants as well as grants already received); Signiﬁcant; displayedsigniﬁcantlygreaternon-compactioncomparedto Moorﬁelds Eye Charity. G. Arno: None. N. Jurkute: None. matched controls, with 50% meeting the diagnostic criteria E. Schiff: None. R. Ba-Abbad: None. S. Malka: None. A. for LVNC. Large deletions in RYR2 and missense variants Gimenez: None. M. Georgiou: None. A.T. Moore: None. M. inthetransmembraneregionofHCN4werealsoenrichedin Michaelides: None. A.R. Webster: None. O. Mahroo: None. LVNC, supporting prior reports of association with arrhythmogenic LVNC phenotypes. E-P24.22 Conclusions: While LVNC is characterised by substan- Thegeneticarchitectureofleftventricularnon-compac- tialgeneticoverlapwithDCMandHCM,itcanalsopresent tion reveals both substantial overlap with other cardi- with a distinct genetic proﬁle involving TV in MYH7, omyopathiesandadistinctaetiologyinasubsetofcases ACTN2 and PRDM16 and with variants associated with joint LVNC/arrhythmia phenotypes. These results will F.Mazzarotto1,M.H.Hawley2,M.Beltrami3,L.Beekman4, enhance the application of LVNC genetic testing and help A. de Marvao5, K. A. McGurk5, B. Statton5, B. Boschi3, F. to distinguish pathological from physiological non- Girolami6, A. M. Roberts5, E. M. Lodder4, M. Allouba7, S. compaction. Romeih7, Y. Aguib7, A. Baksi5, A. Pantazis8, S. K. Prasad5, F. Mazzarotto: None. M.H. Hawley: None. M. Beltrami: E.Cerbai9,M.H.Yacoub7,D.P.O’Regan5,S.A.Cook10,J. None. L. Beekman: None. A. de Marvao: None. K.A. S. Ware5, B. Funke11, I. Olivotto9, C. R. Bezzina4, P. J. R. McGurk: None. B. Statton: None. B. Boschi: None. F. Barton5, R. Walsh4 Girolami: None. A.M. Roberts: None. E.M. Lodder: None. M. Allouba: None. S. Romeih: None. Y. Aguib: None. A. 1University of Florence - Department of Experimental and Baksi: None. A. Pantazis: None. S.K. Prasad: None. E. Clinical Medicine, Florence, Italy, 2Laboratory for Mole- Cerbai: None. M.H. Yacoub: None. D.P. O’Regan: None. cular Medicine, Cambridge, MA, United States, 3Careggi S.A. Cook: Other; Signiﬁcant; Enleofen Bio PTE Ltd. J.S. University Hospital, Florence, Italy, 4Amsterdam UMC, Ware: D. Speakers Bureau/Honoraria (speakers bureau, Amsterdam, Netherlands, 5Imperial College London, Lon- symposia, and expert witness); Modest; MyoKardia. B. don, United Kingdom, 6Meyer University Hospital, Flor- Funke: None. I. Olivotto: B. Research Grant (principal ence, Italy, 7Aswan Heart Centre, Aswan, Egypt, 8RoyalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1005 investigator, collaborator or consultant and pending grants S. Banerjee: None. F.L. Simonetti: None. K.E. Detrois: aswellasgrantsalreadyreceived);Signiﬁcant;MyoKardia. None. A. Kaphle: None. R. Mitra: None. R. Nagial: None. D.Speakers Bureau/Honoraria(speakers bureau, symposia, J. Söding: None. and expert witness); Modest; MyoKardia. C.R. Bezzina: None. P.J.R. Barton: None. R. Walsh: None. E-P24.24 TERT Hypermethylated Oncogenic Region, A new E-P24.23 playerintheactivationofthehTERTgeneincutaneous Reverse regression increases power for detecting trans- T-cell lymphomas. eQTLs A. Chebly1,2, J. Ropio1,3, J. Peloponese4, S. Poglio1, S. Banerjee1, F. L. Simonetti1, K. E. Detrois2, A. Kaphle1, M. Prochazkova-Carlotti1, F. Cherrier1, J. Ferrer1, R. Mitra3, R. Nagial3, J. Söding1 Y.Idrissi1,E.Segal-Bendirdjian5,E.Chouery2,C.Farra2,6, A. Pham-Ledard1,7, M. Beylot-Barry1,7, J. Merlio1,8, R. 1Max Planck Institute for Biophysical Chemistry, Gottin- Tomb2,9, E. Chevret1 gen, Germany, 2George August University, Gottingen, Germany, 3Indian Institute of Technology, Kanpur, India 1Bordeaux University, INSERMU1053Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lym- Trans-actingexpressionquantitativetraitloci(trans-eQTLs) phoma Oncogenesis Team, Bordeaux, France, 2Saint are SNPs regulating the expression of distant target genes Joseph University, Faculty of Medicine, Medical Genetics (>1Mb). Trans-eQTLs account for ≥70% heritability of Unit (UGM), Beirut, Lebanon, 3Porto University, Institute gene expression levels and have great potential to uncover of Biomedical Sciences of Abel Salazar, Instituto de theunderlying biological mechanisms ofcomplexdiseases. Investigação e Inovação em Saúde, Institute of Molecular However, trans-eQTLs are more challenging to identify Pathology and Immunology (Ipatimup), Cancer Biology than locally-acting cis-eQTLs because of their small effect group, Porto, Portugal, 4University of Montpellier, CNRS sizes and the severe multiple-testing burden. Furthermore, IRIM-UMR 9004, Research Institute in Infectiology of strong gene expression correlations entails strong correla- Montpellier, Montpellier, France, 5INSERM UMR-S 1124, tions among SNP-gene association P-values. Our method Team: Cellular Homeostasis Cancer and Therapies, Tejaas can discover trans-eQTLs by performing L2-reg- Université de Paris, Paris, France, 6Saint Joseph Uni- ularized ‘reverse’ multiple regression of each SNP on all versity, Faculty of Medicine, Genetics Department, Beirut, gene expression levels, aggregating evidence from many Lebanon, 7Bordeaux University Hospital Center, Derma- small trans-effects while being unaffected by the strong tology Department, Bordeaux, France, 8Bordeaux Univer- expression correlations. Tejaas, coupled with a novel k- sity Hospital Center, Tumor Bank and Tumor Biology nearest neighbors confounder correction, discovers 18851 Laboratory, Pessac, France, 9Saint Joseph University, unique trans-eQTLs across 49 tissues from the GTEx(v8) Faculty of Medicine, Dermatology Department, Beirut, data. They are enriched to occur in various functional Lebanon regions of the genome, including DHS sites (1.32x enrichment), open chromatin (1.19x), enhancer (1.31x) and Cutaneous T-cell lymphomas (CTCL) encompass a het- promoter (1.10x) regions. They overlap with known cis- erogeneous group of T lymphoproliferative disorders. We eQTLs (1.24x enrichment) from theGTEx analysis andare have previously shown that CTCL are telomerase positive 1.09x enriched to be located within 100kb of known tran- tumors expressing hTERT in which neither ampliﬁcation scription factors. They are also enriched in reporter assay nor promoter hotspot mutations could explain the hTERT QTL regions of K562 (1.79x) and HepG2 (3.29x) cells re-expression. Since the hTERT promoter region is rich in indicating regulatory activity. Many trans-eQTLs overlap CpG islands, we investigated the contribution of DNA with disease-associated SNPs from GWAS, revealing tis- methylation in hTERT expression. We compared hTERT sue-speciﬁc transcriptional regulation mechanisms that promoter methylation status in CTCL cell lines, Sézary drive disease etiology. For example, trans-eQTLs dis- syndrome (SS) patient-derived cells, fresh SS patient cells, covered in whole blood show enrichment in GWAS for and in normal CD4+ and CD34+ cells from healthy blood traits, while heart and aorta have enrichment in car- donors.BisulﬁteSanger sequencingrevealedintumorcells diometabolic traits. Thyroid and pancreas trans-eQTLs a common methylation pattern encompassing a hyper- show enrichments for endocrine system diseases. Tejaas is methylated distal region from -650bp to -150bp and a open-source and available online (https://github.com/ hypomethylated proximal region from -150bp to +150bp soedinglab/tejaas). (relatively to the transcription start site). Interestingly, the identiﬁed hypermethylated region in CTCL cells matches1006 J.delPicchia with the recently described TERT Hypermethylated Onco- integratedgenome-widedatafromUKBiobank(UKB)and genic Region (THOR) reported to be associated with telo- 1,000 Genomes Project (1KG) data representative of the merase reactivation in many cancers, but so far not studied genetic diversity among worldwide populations. inlymphomas.Moreover,we assessedthe effect onTHOR Materials and methods: We investigated genome-wide methylationoftwohistonedeacetylaseinhibitors(HDACi), data of 4,359 traits of 361,194 UKB participants. Using romidepsin and vorinostat, both approved for the treatment 1KGdata,weexploredtheallelefrequencydifferencesand ofCTCLpatients.Overall,ourresultsshowthecontribution linkage disequilibrium (LD) structure across worldwide of THOR hypermethylation in hTERT re-expression in populations.ENCODEdatawereusedtoidentifyregulatory neoplastic CTCL cells and provide new insights into the elements and evaluate the tagging properties of signiﬁcant effectsofepigeneticdrugs(HDACi)onTHORmethylation variants. for the ﬁrst time in lymphomas. Results: No signiﬁcant difference was observed in allele A. Chebly: A. Employment (full or part-time); Signiﬁ- frequencybetweenUKBand1KGGBR.Consideringother cant; Saint Joseph University of Beirut, Faculty of ancestries, we identiﬁed genome-wide signiﬁcant alleles Medecine,MedicalGeneticsLaboratory.B.ResearchGrant with frequencies different from what expected by chance: (principal investigator, collaborator or consultant and UKB vs. 1KG EUR without GBR (rs74945666; allele=T pendinggrantsaswell asgrantsalreadyreceived); Modest; [0.908 vs. 0.03], standing height p=1.48×10-17), UKB vs. Hubert Curien Partnership (PHC-CEDRE), ERASMUS 1KG AFR (rs556562; allele=A [0.942 vs. 0.083], platelet plus scholarships. J. Ropio: B. Research Grant (principal count p=4.84×10-15), UKB vs. 1KG AMR (rs1812378; investigator, collaborator or consultant and pending grants allele=T [0.931 vs. 0.089], standing height p=4.23×10-12), as well as grants already received); Modest; Hubert Curien UKB vs. 1KG EAS (rs55881864; allele=T [0.911 vs. Partnership (PHC-PESSOA, PAUILF), ERASMUS plus 0.001], monocyte count p=7.29×10-13), and UKB vs. SAS scholarships. J. Peloponese: None. S. Poglio: None. M. (rs74945666; allele=T [0.908 vs. 0.061], standing height Prochazkova-Carlotti: None. F. Cherrier: None. J. Ferrer: p=1.48×10-17). LD-structure analysis and computational None. Y. Idrissi: None. E. Segal-Bendirdjian: B. Research prediction showed differences in how some of these alleles Grant (principal investigator,collaboratororconsultantand tag functional elements across human populations. pending grants as well as grants already received); Conclusions: We provide novel evidence regarding how Signiﬁcant; Ligue Nationale contre le Cancer, National the human genetic diversity affects GWAS results where Center for Scientiﬁc Research (CNRS). E. Chouery: None. certain loci appear to be affected by local adaptation while C. Farra: None. A. Pham-Ledard: None. M. Beylot-Barry: others may be biased by population stratiﬁcation. None. J. Merlio: None. R. Tomb: None. E. Chevret: B. A. De Lillo: None. S. D’Antona: None. M. Fuciarelli: Research Grant (principal investigator, collaborator or None. R. Polimanti: None. consultant and pending grants as well as grants already received); Signiﬁcant; National Institute of Health and E-P24.30 Medical Research (INSERM), French Society of 22q11 microdeletions and -duplications: How are they Dermatology (SFD). detected prenatally? E-P24.26 K. Gadsbøll1, I. Vogel2,3, L. Pedersen4,2, O. Petersen1,5 Cross-population genetic variation of loci identiﬁed by Genome-Wide Association Studies conducted in British 1Center for Fetal medicine, Pregnancy and Ultrasound, participants ofEuropean-descent from the UK Biobank CopenhagenUniversity Hospital,Rigshospitalet, Copenha- gen, Denmark, 2Department of Clinical Genetics, Aarhus A. De Lillo1, S. D’Antona1, M. Fuciarelli1, R. Polimanti2,3 University/Aarhus University Hospital, Aarhus, Denmark, 3Center for Fetal Diagnostics, Aarhus University/Aarhus 1Department of Biology, University of Rome Tor Vergata, University Hospital,, Aarhus, Denmark, 4Department of Rome, Italy, 2Department of Psychiatry, Yale University Obstetrics and Gynecology, Aarhus University Hospital, SchoolofMedicine,WestHaven,CT,UnitedStates,3VACT Aarhus, Denmark, 5Department of Clinical Medicine, Healthcare Center, West Haven, CT, United States University of Copenhagen, Copenhagen, Denmark Introduction: There is a well-known European-ancestry Objectives: With chromosomal microarray prevailing in bias in genome-wide association studies, where only a many countries, smaller but disease-causing, chromosomal minority of them are conducted in non-European popula- aberrations are detected. 22q11 aberrations are the most tions. To provide novel insight regarding the inter-popula- commonly occurring microdeletions and -duplications tion diversity of loci associated with complex traits, we causing a spectrum of features. We aim to assess whetherAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1007 fetuses with 22q11 aberrations have common features Methods: We interviewed 77 traditional and unconven- enabling us to detect them from ﬁrst trimester combined tional actors in human genetics - of which 28 during screening (cFTS) parameters. lockdown - to unravel, characterise and structure the Methods: From regional databases, all pregnancies in emerging transition. We applied iterative coding to the Central Denmark Region were identiﬁed between January interviewtranscripts.Inductivereasoning(groundedtheory) 1st, 2008, and December 31, 2018. Pregnancy data was revealed transition points, elements of culture, and emer- linked to genetic outcome data and fetuses with 22q11.2 ging (adjacent) regime changes as major drivers for the aberrations (hg19 chr22:18.8mio-23.7mio) were identiﬁed (future) human genetics regime. and compared to a reference group. Results:Actorsunanimouslyconsiderclinicalgeneticsas Results: We included 200,991 pregnancies and 12,616 dominant for the structure, culture and practice in today’s prenatalgenetictests.42fetuseswerediagnosedwith22q11 human genetics. They point out three historic transition aberrations (23 with microdeletions and 19 with -duplica- points that have shaped this evolution; WWII and its post- tions). One fetus was also diagnosed with Trisomy 21 and war anti-eugenic sentiments, legitimisation of clinical excluded from the analysis. Prenatal detection was based genetics as a medical specialty, and the introduction of on: An elevated risk estimate (n=20), malformations next-generation sequencing. The interviews initiate a (n=14), familial predisposition (n=5), and test after reﬂection on how we do research, who we should care stillbirth (n=2). Compared to the reference group, fetuses for, and where our money comes from. The latest data - with 22q11 aberrations had a signiﬁcantly larger nuchal generated during lockdown - particularly indicate a strong translucency (NT), and lower PAPP-A and β-hCG MoM urgetoanticipateanemergingtransitioninhumangenetics, (p<0.05) but with substantial overlap in the distributions moving beyond The Diseases Formerly Known As Mono- (Figure 1). Risk estimates for Trisomy 13, 18, and 21 were genic (TDFKAM). signiﬁcantly higher for 22q11. Conclusions: Based on the results we present scenario Conclusion: Of 41 prenatally identiﬁed cases with prototypes for the role of human genetics in the context of isolated 22q11 microdeletions and -duplications, 20 (49%) glocal societies, data-driven governance, hybrid healthcare, wereidentiﬁedbycFTS intheﬁrsttrimester.Theydiffered and participatory research signiﬁcantly from the reference group on all cFTS T. Vrijenhoek: None. T. Rigter: None. parameters except age but with substantial overlap in the distributions, supporting the need for more complex E-P24.32 prediction models. Duplex sequencing uncovers age-related increase in the K. Gadsbøll: None. I. Vogel: None. L. Pedersen: None. frequency of de novo indels in mouse mitochondrial O. Petersen: None. DNA E-P24.31 E. Torres-Gonzalez1, B. Arbeithuber1, J. Hester1, The new normal for human genetics - scenario proto- M. A. Cremona2, N. Stoler1, B. Higgins1, K. Anthony1, types from inductive evidence F. Chiaromonte1,3, F. J. Diaz1, K. D. Makova1 T. Vrijenhoek1, T. Rigter2,3 1Pennsylvania State University, University Park, PA, United States, 2Laval University, Quebec City, QC, 1Department of Genetics, University Medical Center Canada, 3Sant’Anna School of Advanced Studies, Pisa, Utrecht, Utrecht, Netherlands, 2Department of Clinical Italy Genetics, Section Community Genetics and Amsterdam Public Health Research Institute, Amsterdam University TostudytheevolutionofmitochondrialDNA(mtDNA),an Medical Center, Vrije Universiteit, Amsterdam, Nether- understanding of the frequency and pattern of mutations, lands, 3Centre for Health Protection, National Institute for and the potential effect of age on these mutations, are Public Health and the Environment, Bilthoven, Nether- essential. This is especially true for de novo mutations lands which can be difﬁcult to detect with conventional sequen- cing techniques due to their high error rates. Duplex Introduction: As many from our genetics community put sequencing permits the detection of mutations at very low great effort in combatting COVID-19, society as a whole frequencies. Our study examined the frequency of mtDNA prepares for the ‘new normal’. We present qualitative pre- de novo insertions and deletions (indels) in mouse germ andperi-lockdown dataindicatingthatnowisalsothetime cells(singleandpooled oocytes) andsomatictissues (brain toredeﬁnethecontributionofhumangeneticstoareformed and skeletal muscle). Two groups of mice were included: society. eight 10-month-old mothers and 28 1-month-old pups. The1008 J.delPicchia denovoindelfrequencyinmousemtDNAwasmeasuredto MDD-drug naïve subjects. Using 212 Italian families with be 1.16e-7 indels per site, 4-fold lower than for de novo T2D, enriched T2D-familial history, and MDD, we ampli- substitutions. Most de novo indels were small (1- to 3-bp ﬁed and tested 163 CRHR1 SNPs by two-point parametric- long), but we also detected events as long as 58 bp. Dele- linkage and linkage-disequilibrium (LD) with the models: tions were more common than insertions. We observed a dominant (D) complete-penetrance (1), D incomplete- higher indel frequency at homopolymeric tracts (≥5 bp in penetrance(2),recessive(R)1andR2(Pseudomarker).We length) than in the rest of the mitochondrial genome. We detected linkage and/or LD to MDD for 98 SNPs/D1, 59 also found a signiﬁcantly higher frequency of de novo SNPs/D2,95SNPs/R1,and14SNPs/R2,andtoT2Dfor15 deletions in skeletal muscle of mothers vs. pups, who were SNPs/D1, 19 SNPs/D2, 12 SNPs/R1 and 10 SNPs/R2. separated by only nine months inage from each other. Our Three independent SNPs are comorbid. We found LD- results demonstrate the power of duplex sequencing in blocks’ implications in the comorbidity. In-silico analysis studying de novo mtDNA mutations, which has allowed us detectedfunctionalgeneandtridimensionalproteinchanges to study their frequency and pattern, as dependent on age, inarisk-SNP.OursistheﬁrstreportofCRHR1-linkage/LD despite such a small difference in age between the studied in MDD and T2D in T2D-families. CRHR1 contribution to animals. MDD appears stronger than and antecedes T2D. Geneti- E. Torres-Gonzalez: None. B. Arbeithuber: None. J. cally-impaired stress/cortisol response may lead to comor- Hester: None. M.A. Cremona: None. N. Stoler: None. B. bid MDD-T2D, likely a molecular-clinical entity in a Higgins: None. K. Anthony: None. F. Chiaromonte: None. families’ subset. Findings should be replicated in other F.J. Diaz: None. K.D. Makova: None. ethnicities. L.DelBosque-Plata:None.R.Gonzalez-Ramirez:None. E-P24.34 D. Gordon: None. T. Postolache: None. R. Wu: None. J. TheneuroendocrineCRHR1genecontributestodepres- Ott: None. C. Gragnoli: None. sion and type 2 diabetes comorbidity in Italian families E-P24.36 L. Del Bosque-Plata1, R. Gonzalez-Ramirez2, D. Gordon3, Role of Speciﬁc micro-RNAs, Cellular Retinol Binding T. Postolache4, R. Wu5, J. Ott6, C. Gragnoli7,5,8 Protein-I (CRBPI) and Retinoic Acid Receptor (RARα) in Lung Adenocarcinoma 1National Institute of Genomic Medicine, Mexico City, Mexico, 2"Dr. Manuel Gea González" General Hospital, F. Centofanti, E. Doldo, S. Agostinelli, G. Costanza, Mexico City, Mexico, 3Rutgers University, Piscataway, NJ, M. Pocci, A. Ferlosio, A. Orlandi United States, 4University of Maryland, Baltimore, MD, United States, 5Penn State College of Medicine, Hershey, Dep. of Biomedicine and Prevention, Anatomic Pathology PA, United States, 6Rockefeller University, New York City, Section, Rome, Italy NY, United States, 7Thomas Jefferson, Philadelphia, PA, UnitedStates,8MolecularBiologyLaboratory,BiosBiotech Lung adenocarcinoma (AC) is one of the most common Multi-Diagnostic Health Center, Rome, Italy histologicalsubtypesintheword.Epidermalgrowthfactor receptor (EGFR) is the most common oncogene mutated MDD increases T2D risk by 60%, independently from in lung AC. Cellular Retinol Binding Protein-1 (CRBP1) antidepressants.ThegeneticsoftheMDD-T2Dcomorbidity is a small cytoplasmatic protein regulating retinol bioa- isstillunderstudied.HypercortisolismoccursinMDDanda vailability and transcriptional activities and it is linked to T2D-patients’ subgroup. Given their hypercortisolism, EGFR signalling. Micro-RNAs (miRNAs) are major epi- MDD-patients have inappropriately normal cerebrospinal- genetic factor that play a key role in the pathogenesis of ﬂuid-CRH and plasma-ACTH levels, indicating impaired lung cancer, in the regulation of retinoic acid and are also negative-feedback. The CRH receptor-1 (CRHR1) may implicated in Copy Number Variation (CNV). In order to explain the MDD- and T2D-hypercortisolism. CRHR1- ﬁnd a possible regulatory mechanism in the pathology of variants predisposing to impaired CRHR1-dosage/function lungAC,weinvestigatedtherelationshipbetweenCRBP1 may lead to hypercortisolism (substrate for serotonin dys- and EGFR through the analysis of miRNAs expression. function and MDD), and hyperglycemia, insulin resistance, miRNAs,CNVanalysis,geneandproteinexpressionwere and increased visceral fat, all T2D-traits. CRHR1-variants performed in lung AC patients with high (CRBP1HIGH) contribute to MDD. CRHR1 mediates glucose-stimulated and low (CRBP1LOW) CRBP1 expression, and in adeno- insulin-secretion and, if impaired, may lead to T2D. We carcinoma cells transfected with CRBP1 (CRBP1+ A549 hypothesizethatCRHR1-variantsmayimpairthestressand cells). Twenty-three miRNAs were found deregulated in cortisolresponse,conferringMDD-T2Dcomorbidity-riskin CRBP1+ A549 cells and eight in patients withAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1009 CRBPIHIGH.Amongthem,has-miR-148a-3pandhas-miR- atypical RTT syndrome. Our ﬁndings further support the 30e-5p bind Tumour Suppressor Gene p53 (TP53) gene; involvement of PDE2A in the regulation of physiological has-miR-4286islocatedinchromosome8regionsanditis neurological mechanisms. implicated in microdeletion; has-miR-1915 regulates dif- Z. Haidar: None. N. Jalkh: None. S. Corbani: None. J. ferent cellular pathways and interacts with Retinoic Acid Abou-Ghoch: None. A. Fawaz: None. C. Mehawej: None. Receptor (RARα). Gene expression analysis discloses 21 E. Chouery: None. genesderegulatedinCRBP1+A549cells,withTP53gene downregulated;whileCNVanalysisidentiﬁedsinglecopy E-P24.39 deletions and ampliﬁcations in 15 chromosomes in lung Views of adults with 22q11 deletion syndrome on AC CRBPIHIGH patients, with TP53 genes showing 3 reproductive medicine options copies. Our ﬁndings provide new insights concerning a new regulatory mechanism of gene expression in A. Mcneill, M. Freeth Lung AC. F. Centofanti: None. E. Doldo: None. S. Agostinelli: University of Shefﬁeld, Shefﬁeld, United Kingdom None. G. Costanza: None. M. Pocci: None. A. Ferlosio: None. A. Orlandi: None. The22q11deletionsyndrome(22q11DS)isoneofthemost common genomic disorders. 10% of cases 22q11DS fol- E-P24.38 lowsanautosomaldominantpatternofinheritance. Several AHomozygousSplicingMutationinPDE2AinaFamily reproductive medicine options are available for adults with with Atypical Rett Syndrome. 22q11DS who wish to have an unaffected child, chieﬂy prenatal testing with termination of affected pregnancies or Z. Haidar1, N. Jalkh1, S. Corbani1, J. Abou-Ghoch1, preimplantation genetic diagnosis (PGD). The views of A. Fawaz2, C. Mehawej1, E. CHOUERY1 people with22q11DSon these options havenotpreviously been studied. An inductive qualitative design using semi- 1Saint-Joseph University, Beirut, Lebanon, 2Lebanese structured interviews was used, to explore the views of University, Beirut, Lebanon adults with 22q11DS on reproductive medicine options. Three overarching themes emerged: 1. Personal and family Rett syndrome (RTT) is an X-linked dominant neurodeve- impact of 22q11DS, 2. Attitudes towards reproductive lopmentaldiseasecharacterizedbyanormalearlypostnatal medicine, and 3. Lack of accessible information. The developmentfollowedbyanarrestofgrowth.Therearetwo interviews revealed that 22q11DS has an impact on family main types of RTT: typical and atypical delineated on the life in ways which could inﬂuence reproductive decision bases of clinical and genetic criteria. In the atypical form, making. Despite the concerns about the implications of patients present with many of the clinical criteria of RTT having a child with 22q11DS, there was reluctance to ter- butdonotessentiallyhaveallofthefeaturesofthedisorder. minate a 22q11DS pregnancy. PGD was viewed more DysmorphicfeatureswereobservedinfewRTTcases.Rett- positively,becauseitdidnotinvolvetermination.Currently like syndrome is a recently introduced term, used when a available information resources on reproductive medicine patientpresentswithanoverlapoffeaturesbetween typical options are not designed for people with intellectual dis- and atypical RTT. While MECP2 mutations are linked to ability, participants identiﬁed that current information themajorityoftypicalRTTcasesandsomeatypicalforms, resourceswerenotaccessibletothem.Ourstudyhighlights the molecular etiology of many entities remains uneluci- the need for health services to have strategies to offer dated. Two affected individuals from a consanguineous patients with genetic conditions such as 22q11DS infor- family presenting with atypical Rett phenotype were stu- mation on reproductive medicine options. For example, by died.MECP2sequencingfollowedbyastrategycombining designing accessible co-produced information resources, whole-exome sequencing and chromosomal microarray offering access to genetic counselling and developing an analysis were performed. MECP2 gene sequencing ruled informatics infrastructure for identiﬁcation of individuals outtheimplicationofthisgeneinthediseaseofthisfamily. with 22q11DS who may beneﬁt from discussion of repro- A strategy combining WES data and CMA allowed the ductive options identiﬁcation of a homozygous splice-site mutation (c.323 A. mcneill: None. M. Freeth: None. +1G>A) in PDE2A in both patients. The mutation segre- gates with the disease in the family and is predicted to E-P24.40 disrupt the 5’-splice site of exon 4 of PDE2A, which was Outcome of cochlear implantation in NLRP3-related conﬁrmed byRNAstudies.Herewereportthesecond case autoinﬂammatory inner ear disorders ofPDE2Amutationsinhumansandtheﬁrstinpatientswith1010 J.delPicchia B. Kim1, Y. Kim2, J. Han3, S. Lee4, M. Carandang5, S. Raza B. Kim1, D. Lee3, D. Oh3, S. Lee2, B. Choi3 PHG Foundation, Cambridge, United Kingdom 1ChungnamNationalUniversity,Daejeon,Korea,Republic of, 2Seoul National University Hospital, Seoul, Korea, Introduction: The AI techniques, machine learning and Republic of, 3Seoul National University Bundang Hospital, deep learning, offer great potential for advancing genomic Seongnam, Korea, Republic of, 4Seoul National University medicine. However, their application has yet to generate BundangHospital,Seoul,Korea,Republicof,5EastAvenue clearly improved outcomes in clinical genomics, and the Medical Center, Manila, Philippines discoverypotentialwithingenomicdatasetsremainslargely untapped. Introduction:Hearinglossisahighlypenetrantphenotype Objectives and methods: Our analysis sets out in NLRP3-related autoinﬂammatory disorders. A recent to determine the early stage practical policy actions study revealed potential medical treatment of hearing loss forcapitalisingontheopportunitiesAIpresentsforgenomic with anakinra (anti-interleukin 1 receptor antagonist) in medicine, minimising harms and expediting its selected cases. However, for severely aggravated hearing effective delivery into healthcare. Informed by a combina- loss not responsive to anakinra, cochlear implantation (CI) tion of literature review and expert interviews, we wouldbethelastresort forhearingrehabilitation. Outcome examine the state of AI applications for genomic medicine of CI is not clearly elucidated yet in this emerging type of and determine the major challenges to realising its full hearing loss related to NLRP3-related autoinﬂammatory potential. disorders, which has a systemic nature and ubiquitous dis- Results: We identify a number of interconnected issues tribution of resident macrophages involving the spiral and barriers to progress, including: the quality and ganglionneuronandthecochlearnerve.Here,wereportthe accessibility of AI training data; ethnic bias in genomic successful outcome of CI in NLRP3-related autoin- datasets; challenges in replicating AI methods and ﬂammatory disorder. results; fragmentation of skills and infrastructure; Materials and methods: Three subjects representing data security and privacy concerns; and regulatory uncer- each type of NLRP3-related autoinﬂammatory disorder: tainty around requirements and the status of AI algorithms CINCA (chronic infantile, neurological, cutaneous, and within clinical genomics. The imperative to address these articular) syndrome; MWS (Muckle-Wells syndrome); and issues is heightened given the fast pace of AI activity in DFNA34, who underwent CI for auditory rehabilitation, genomics. were recruited. Phenotypes as well as genotypes were Wesetoutsevenurgentpolicyprioritiestomeetingthese reviewed in the subjects and audiologic performances challenges.Theyincludetakingactiontoestablishtheright before/after CI over time were evaluated. skills, digital infrastructure, and cross-discipline collabora- Results:Allthreesubjectsshowedexcellentaudiological tions; mitigate against algorithmic bias; prioritise AI outcomeswithrapidimprovementofspeechperceptiontest development for the most pressing and clinically relevant result reaching plateau at 3 months after CI, although problems; support community driven efforts to benchmark distributionofthediseasepredictedpooroutcomebasedon and review new algorithms; and establish the clinical theoretical analysis. governance arrangements for AI applications in clinical Conclusions:Thisistheﬁrstreporttopresentoutcomeof genomics. Action to achieve these priorities is key to CI among subjects with a conﬁrmed NLRP3 genetic harnessing AI. etiology and resultant systemic inﬂammation, and suggests S. Raza: None. that CI is a viable treatment option in this disease entity. Grant references: Ministry of Education E-P24.42 (2018R1A2B2001054BYC) Ministry of Health & Welfare Supporting reproductive decision making for adoles- (HI17C0952BYC) SNUBH Research Fund (13-2020- cents and young adults with Li-Fraumeni Syndrome: 013BYC) CNUH Research Fund, 2019 (BJK) Interprofessional perspectives from a U.S. National B. Kim: None. Y. Kim: None. J. Han: None. S. Lee: Cancer Institute study None. M. Carandang: None. B. Kim: None. D. Lee: None. D. Oh: None. S. Lee: None. B. Choi: None. A. Werner-Lin1, C. Rising2, P. Boyd2, C. Wilsnack2, A. Sleight2, S. P. Hutson3, S. A. Savage2, P. P. Khincha2 E-P24.41 Artiﬁcial intelligence for genomic medicine - a policy 1University of Pennsylvania, Philadelphia, PA, United analysis States, 2National Cancer Institute, Rockville, MD, UnitedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1011 States, 3University of Tennessee, Knoxville, TN, United M. C. A. Nascimento, M. M. U. Castanhole-Nunes, States É. C. Pavarino, J. V. Maniglia, E. M. Goloni-Bertollo Introduction: Li-Fraumeni Syndrome (LFS) is a rare São José do Rio Preto Medical School, São José do Rio genetic condition characterized by lifetime cancer risk Preto, Brazil approaching 100%, common pediatric onset, and limited data to support a clear management strategy beyond inten- Introduction: Hypoxia is one of the essential biological sive cancer screening. For adolescents and young adults phenomena inherent in aggressiveness of a diversity solid (15-39years)withLFS,theinabilitytopredictwhencancer tumors. Reduction of O can modify tumor microenviron- 2 may develop or determine prognoses contribute to sub- ment inﬂuencing the tumor development and progression stantial uncertainty regarding how or whether to pursue and maintenance of cancer stem cells (CSC). Thus, our family formation. aimed was induce CSC accumulation in head and neck Materials and methods: An interdisciplinary team, squamous cell carcinoma (HNSCC) through hypoxia. including medicine, social work, health communication, Materialsandmethods:ThreesamplesofHNSCCwere psychology, occupational science, and nursing developed obtained after surgical resection. They were cultured in and conducted IRB-approved, in-depth interviews with 38 DMEM with 10% FBS and 1% AB/AM, at 37°C and 5% AYA individuals with LFS. Most participants were female CO .Approximately 2x106cellsweresubjected tohypoxia 2 (n=26) and white (n=31). Interviews were recorded, (2%O )for12hoursat37°Cusinghypoxiachamber.Cells 2 transcribed, and analyzed using modiﬁed grounded theory were immunophenotyped by ﬂow cytometry using CD44/ analysis. CD133/ALDH1 markers immediately after hypoxia and Results: Reproductive concerns evolved based on age, after 45 days of cultivation. The presence of CSC was cancer diagnostic and treatment history, relationship status, conﬁrmed by invasion, migration and tumor sphere andcaregivingresponsibilities,andcontributedprominently formation assays. ALDH1, CD44 and CD133 gene expres- to LFS-related distress. Participants balanced developmen- sions were determined by qRT-PCR. Normoxic cells were tal readiness with pressured timelines to achieve family used as control. formation goals and survivorship concerns. Decisions Results: Immunophenotyping showed that 45 days after regarding fertility preservation, pre-implantation genetic hypoxiawas1.5timesmoreeffectiveinCSCaccumulation. diagnosis, or adoption were intertwined with identity, The presence of CSCs was conﬁrmed by migration, divergent spiritual or family beliefs, ﬁnancial resources, invasion (p<0.0001; p<0.0001, respectively) and tumor and ongoing cancer worry. Limited provider guidance or sphere formation assays (hypoxic cells formed more referrals for reproductive or mental health consultation spheroids).GeneexpressiondataaresummarizeinTable1. caused frustration and dissatisfaction with care. Conclusions: We demonstrate hypoxia-induced CSC Conclusions: Optimal LFS care for AYAs must include accumulation. This procedure will help the study of these providers trained to support developmental transitions over rare cells of great importance in oncogenesis process time,speciﬁcallyregardingfamilyformationcontextualized in lifelong cancer risk and survivorship. Established Table 1 - ALDH1, CD44 and CD133 gene expressions interprofessional partnerships can streamline referrals and Sample RQ enable holistic, collaborative care. Mental health providers ALDH1 CD44 CD133 with expertise in rare disease can treat distress and support decision-making that pairs medical recommendations with 1 36.6 22.8 5.3 developmental readiness. 2 13.9 24.3 167.2 A. Werner-Lin: None. C. Rising: None. P. Boyd: None. 3 1.6 2.0 0.7 C.Wilsnack:None.A.Sleight:None.S.P.Hutson:None.S. A. Savage: None. P.P. Khincha: None. Grants: FAPESP (2016/20087-1 and 2018/26166-6). E-P24.43 M.A.S. Bezerra: None. L.A.M. Ferreira: None. R.S. Hypoxia-induced câncer stem cell accumulation in Kawasaki-Oyama: None. C.I. Cuzziol: None. M.C.A. primary cell culture of head and neck squamous cell Nascimento: None. M.M.U. Castanhole-Nunes: None. É. carcinoma C. Pavarino: None. J.V. Maniglia: B. Research Grant (principal investigator, collaborator or consultant and M. A. S. Bezerra, L. A. M. Ferreira, pending grants as well as grants already received); R. S. Kawasaki-Oyama, C. I. Cuzziol, Signiﬁcant; Fundação de Amparo à Pesquisa do Estado de1012 J.delPicchia São Paulo (FAPESP). E.M. Goloni-Bertollo: B. Research B. B. Geckinli1, A. Turkyilmaz2, C. Alavanda1, Grant (principal investigator,collaboratororconsultantand H. Taslidere3, G. Sager4, E. Arslan Ates5, pending grants as well as grants already received); M. A. Soylemez1, A. Arman1 Signiﬁcant; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). 1Marmara University School of Medicine, Department of E-P24.44 Medical Genetics, Istanbul, Turkey, 2S.B.U Erzurum Breast cancer subtypes and predictive factors from a Regional Training and Research Hospital, Department of NorthCyprus Cohort Analysis MedicalGenetics,Erzurum,Turkey,3S.B.UIstanbulHaseki Training and Research Hospital, Genetic Diseases Diag- A. Ulgen nostic Center, Istanbul, Turkey, 4Marmara University School of Medicine, Department of Pediatrics, Istanbul, Department of Epidemiology, Mailman School of Public Turkey, 5Marmara University Pendik Training and Health,ColumbiaUniversity,NewYork,NY,UnitedStates Research Hospital, Department of Medical Genetics, Istanbul, Turkey WepresentaﬁrstepidemiologicalsurveyfromNorthCyprus to determine predictive factors for breast cancer subtypes. Introduction: Warburg Micro syndrome type1 More than 300 breast cancer patients with subtype informa- (WARBM1)isarareautosomalrecessivesyndromecaused tionaresurveyedfromtheStateHospitalinNicosiabetween by homozygous mutation in the RAB3GAP1 gene. It is 2006-2015 for their demographic, reproductive, genetic, epi- characterized by microcephaly, microphthalmia, congenital demiological factors. The breast cancer subtypes, Estrogen cataracts, optic atrophy, cortical dysplasia, mental retarda- receptor (ER) +/-, Progesterone receptor (PR) +/-, and tion and hypogonadism. We are reporting three cases with human epidermal growth factor 2 (HER2) +/- status, are two novel splicing mutations and one including micro- determined. Single and multiple variable, regularized regres- duplication of 3q29. sions,withpredictivefactorsasindependentvariables,breast Materials:Case1isa8-year-oldfemalewithneuromotor cancer subtypes as dependent variables are conducted. Our retardation and spasticity. Parents were consanguineous cohort differs signiﬁcantly from larger cohorts (eg Breast having 3 affected children. She had microphthalmia, Cancer Family Registry), in age, menopause status, age of nystagmus, bilateral optic atrophy, operated congenital menarche, parity, education, oral contraceptive use, breast cataracts and corpus callosum hypoplasia. Case 2 is a six- feeding but the distribution of breast subtypes is not sig- month old male with microcephaly, microphthalmia, niﬁcantly different. Subtypedistribution in our cohort is also congenitalcataracts,diffusecerebralatrophyandcryptorch- not different from another Turkish cohort. We show that the idism. Case 3 is a 21-month-old female having neuromotor ER+ subtype is positively related to post-menopause and retardation, hypotonia and epilepsy. She had microphthal- negatively associated with hormone therapy; ER+/PR+ is mia, congenital cataracts, cerebral atrophy and corpus positively associated with age and breast feeding, and nega- callosum hypoplasia. tively associated with cancer grade and having ﬁrst-degree- Methods: RAB3GAP1 gene was analyzed by DNA relative with cancer. HER2+, which is negatively correlated sequencing. In Case2 mRNA was isolated to generate to withER+andER+/PR+,ispositivelyrelatedtohavingﬁrst- cDNA by reverse transcription, and exon 7-9 were degree-relative with cancer, and negatively associated with analyzed. post-menopause. Regressions identify older age to be posi- Results: In case 1 homozygous c.974-2A>G novel tively correlated to ER+ and ER+/PR+, negatively corre- splicing mutation was detected in two sisters tested. In lated to HER2+. Assuming ER+ and ER+/PR+ to have case 2 homozygous c.748+1G>A mutation was identiﬁed. better prognostic, post-menopause and breast-feeding are cDNA analysis of exon 7-9 showed exon 8 skipping. In beneﬁcial, hormone therapy treatment is detrimental. Next case3homozygousc.2606+1G>Anovelsplicingmutation stepsincludebiomarkersandcuremodelstodeterminelong- was detected. A-CGH analysis revealed 1.7 Mb micro- term survivors duplication of 3q29. Funding:Fulbright Visiting Research Scholarship Grant Conclusions: Novel splicing mutations in case1 at 11. by the US Department of State intronic splice site and in case 3 at 22. intronic splice site A. Ulgen: None. probably affects splicing where functional studies are planned.Functionalstudyincase2showedexon8skipping. E-P24.45 Case 3 is the ﬁrst reported case with WARBM1 and Revealing novel splicing mutations in RAB3GAP1 gene microduplication of 3q29. causing WarburgMicro syndromeanda caseincluding microduplication of 3q29Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1013 B.B.Geckinli:None.A.Turkyilmaz:None.C.Alavanda: E-P24.47 None.H.Taslidere: None.G.Sager: None.E. Arslan Ates: Differences in the frequency of CRC-associated patho- None. M.A. Soylemez: None. A. Arman: None. gen variants in colorectal adenomas and cancers from the Hungarian population E-P24.46 Haplotype landscapes of genes associated with gallstone A. Kalmar1, O. Galamb1, G. Szabo2, B. Bartak3, Z. Nagy3, formation S. Zsigrai3, K. Szigeti3, O. Pipek4, A. Medgyes-Horváth4, I. Csabai4, Z. Tulassay1, P. Igaz1, B. Molnar1 O. K. Clay, S. A. Dingsdag, G. A. Quintero 1Semmelweis University, 2nd Department of Internal Translational Microbiology and Emerging Diseases Medicine; Hungarian Academy of Sciences, Molecular (MICROS), School of Medicine and Health Sciences, Medicine Research Unit, Budapest, Hungary, 2Hungarian Universidad del Rosario, Bogotá, Colombia Academy of Sciences, Molecular Medicine Research Unit, Budapest, Hungary, 3Semmelweis University, 2nd Depart- Introduction: Gallstone disease or cholelithiasis, resulting ment of Internal Medicine, Budapest, Hungary, 4Depart- from gallstone formation/growth, is a costly and common ment of Physics of Complex Systems, Eötvös Loránd health problem. Large prevalence differences exist among University, Budapest, Hungary, Budapest, Hungary age groups, geographic locations or ethnic backgrounds including between men and women. Thus, in Native Colorectal cancer (CRC) has high incidence in Eastern- Americans from North America, 64.1% of women and Europe,especiallyinHungary.Inadditiontoenvironmental 29.5% of men were reported to have gallstones. A genetic factors, the genetic and epigenetic background of this component is established, although individual common phenomenon still remains unknown. We aimed to perform variants(includingavariantoftheABCG8generesponsible whole exome sequencing along the colorectal adenoma- forhepaticcholesterolsecretion)appeartohaveattributable carcinoma sequence on tissue samples in order to identify risks less than 10%. Environment, including diet, and characteristicgermlineandsomaticvariants.GenomicDNA microbiota are also relevant factors. In parallel to pheno- was isolated from 27 adenomas (AD), 52 CRC, 18 healthy typic studies, corresponding genes and possible effects of patients (N) and from 2 colorectal cancer cell lines. Exome their common variation have been identiﬁed (e.g., Weber enrichmentwasdonewiththeNexteraDNAExomeKitand et al., 2019, Curr. Opin. Gastroenterol. 35:82-87; Bustos sequencing was performed using the NextSeq 500 Instru- et al., 2019, Sci. Rep. 9:772). ment (Illumina). Germline and somatic variants were Materials and methods: Using data from the 1000 determined by Genome Analysis Toolkit (GATK) and GenomesProjectspanningpopulationsofallcontinents,we MuTect2 algorithms and were conﬁrmed by ddPCR and performed a global analysis of haplotypes and haplotype in situ hybridization. Certain CRC-associated pathogenic blocks containing genes that are associated with increased variants could be detected in a relatively lower [e.g. APC cholelithiasis risk. Restriction of attention to biallelic SNPs 63.46%)], or with relatively higher frequency compared to with MAFsabove3-5% facilitatestherecognition,analysis the European statistics [e.g. KRAS 40.38%]. Among the and interpretation of haplotype blocks and haplotype germline variants of the one-carbon metabolism, MTHFR classes. A1298C, MTR A2756G and MTRR A66G variants were Results: Full analysis, across world populations, of the detectedwitharelativelyhigherfrequencyintheHungarian haplotype landscapes in which gallstone loci are embedded population compared to the European average. Alterations allows association ﬁndings to be integrated with results for in the frequencies of CRC-associated somatic variants thegenes/proteins,andfacilitatesinterpretationatbothSNP compared tothe European averages might contribute tothe and haplotype-block resolutions. highCRCincidence observedintheHungarianpopulation. Conclusions: The analyses presented represent a step The germline variants of one-carbon metabolism were toward assembling a concerted, haplotype-based view of observed with a relatively higher frequency in our cohort how common variation in human genes may promote or havinganeffectontheDNAmethylationregulationsystem prevent gallstone formation and disease. that might be a link between the genetic and epigenetic Funding: Universidad del Rosario, intramural grant alterations of the CRC development. (2019-2022). A.Kalmar:None.O.Galamb:None.G.Szabo: None.B. O.K. Clay: None. S.A. Dingsdag: None. G.A. Bartak: None.Z.Nagy:None.S.Zsigrai:None.K.Szigeti: Quintero: None. None. O. Pipek: None. A. Medgyes-Horváth: None. I. Csabai: None. Z. Tulassay: None. P. Igaz: None. B. Molnar: None.1014 J.delPicchia E-P24.48 refractory epilepsy, hypotonia and bilateral cataracts. Longitudinal follow up on individuals with SNORD118 Metabolicstudiesshowednormalornon-conclusiveresults. related Leukoencephalopathy with Calciﬁcation and Bythetimewhenthemetabolomictestwasconsidered,the Cysts illustrates a complex structure function clinical condition was critical, with severe hypotonia, interaction. refractory seizures, and sepsis, and ﬁnally, the patient dies. Analysis by non-targeted metabolomics in plasma was A. Ng1, D. Jurado1, Y. Crow2, F. Bolduc1 performed (Metabolon Inc.) This test identiﬁes molecules between 50-1,500 Daltons (Da). The identiﬁcation is 1University of Alberta, Edmonton, AB, Canada, 2MRC performed using four different types of high-performance Institute of Genetics and Molecular Medicine, Edinburgh, Ultra Performance Liquid Chromatography (UPLC) instru- United Kingdom ments paired with Mass Spectrometry (UPLC/MS). The identiﬁcation of each molecule is conﬁrmed against a Mutations in SNORD118 have recently been linked to proprietary chemical library consisting of accurate mole- leukoencephalopathy with calciﬁcations and cysts. Our cular weight/mass plus information on any adductation, in longitudinal follow up of 2 individuals with SNORD118 sourcefragmentation,and/orpolymerization,retentiontime/ pathogenic variants illustrates the complexity of the dis- index on the chromatography columns, and mass spectral order,suggestingseizuresmaybeobservedatdifferenttime fragmentation patterns. point in relation to calciﬁcation and that clinical presenta- Results: Metabolomic analysis demonstrated low levels tionmaybenotbedirectlycorrelatedwithlesionburdenon of glycine, lactate, and serine. Phosphoglycerate dehydro- MRI. Indeed, we observed that before MRIlesionsbecame genase deﬁciency was considered, because all the biomar- visible, the 2 sibliings had transient clinical seizure which kersassociatedwiththemetabolomicbiochemicalsignature resolved until recently and now became co-localized with of this disorder were outside the expected range. MRI changes. In addition, we observed signiﬁcant intra- Conclusion: Metabolomic analysis is useful for the familial variability in clinical and MRI changes. Despite diagnosis of Phosphoglycerate Dehydrogenase Deﬁciency, having the same mutation, the younger sibling had a more and it is also a valuable tool for the study of patients with severe phenotype. Nonetheless, both siblings had similar suspected metabolic disease. EEG ﬁndings of left focal epileptiform abnormalities, with L.A. Lizcano-Gil: None. M.A. Luna-Luna: None. focal clinical seizures. MRI brain showed coarse calciﬁca- tion in basal ganglia, thalami, white matter and dentate E-P24.50 nuclei. Our ﬁndings raise the importance of considering Genetic study on the patients with refractory rickets SNORD118inpatientswithcalciﬁcationbutalsowithearly onset seizure. B. Marik, A. Bagga, A. Sinha, P. Khandelwal, P. Hari, A. Ng: None. D. Jurado: None. Y. Crow: None. F. A. Sharma Bolduc: None. AllIndiaInstituteofMedicalSciences(AIIMS),NewDelhi, E-P24.49 New Delhi, India diagnosisofphosphoglyceratedehydrogenasedeﬁciency by untargeted metabolomic analysis in plasma Introduction: Refractory rickets (RR) is a heterogenous genetic disorder caused by mutations in genes encoding L. A. Lizcano-Gil1, M. A. Luna-Luna2 proteins involved in renal phosphate reabsorption process and vitamin D metabolism. 1Genetica Humana, Bogotá, Colombia, 2Virrey Solis, Methods:Clinical,radiologicalandpedigreeinformation Bogotá, Colombia was noted from 84 patients with RR. Whole exome sequencing was performed with application of Ingenuity Introduction: Phosphoglycerate dehydrogenase deﬁciency Variant Analysis tool and ACMG 2015 criteria for the isarareinbornerrorofserinemetabolismthatcausessevere identiﬁcation of causal variants. neurological abnormalities. Results: Eighty-four patients (45 females; 39 males) Objective: We describe the usefulness of metabolomic belongedto66familieswithdiseaseonsetat2.8+1.3years. analysis patients with the severe form of this condition, Sixty-six different genetic variations in 84 patients have whom usually present symptoms during the ﬁrst weeks beenidentiﬁed,ofwhich,24werePHEX,twoENPP1,three of life. CLCN5, three CTNS, six SLC2A2, seven SLC4A1, four Methods: We present the case of a ﬁve months ATP6V1B1, ﬁve CYP27B1, four VDR and one FGF23, Colombian patient, who presented focal symptomatic DMP1, SLC34A1, EHHADH, GATM, HRAS and FGFR1Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 1015 each. Among them, 30 were novel and 36 were previously RDD. The analysis of the haplotype of patients originated reported. On the basis of the genetic variations identiﬁed, from the center and south of Tunisia is considered to the patients of RR were classiﬁed as- Hypophosphatemic determine if it is a founding haplotype. We carried out a rickets (PHEX, FGF23, DMP1 and ENPP1; n=40; 48%); haplotype-based analysis by way of genotyping 5 micro- Dent disease (CLCN5; n=3, 4%); Cystinosis (CTNS; n=4; satellite markers ﬂanking the SLC29A3 gene spanning a 5%); Fanconi-Bickel syndrome (SLC2A2; n=5, 6%); region of 2 Mb. Microsatellite markers analysis in all Fanconi renotubular syndrome (SLC34A1 n=1, 1%; affected sibling indicates that all c.1088G>A mutation EHHADH; n=2, 2%;); Renal Fanconi syndrome GATM- carriers harbored the same haplotype, indicating common related (GATM; n=1, 1%); Distal renal tubular acidosis ancestor. (SLC4A1, ATP6V1B1 and ATP6V0A4; n=15; 18%); Conclusions:Thisﬁndingcouldbeexplainedbythehigh Vitamin D dependent rickets type 1A (VDDR1A) rateofconsanguinityinourcountry.Otherfactors,genetic, (CYP27B1; n=3, 4%); VDDR2A (VDR; n=7, 8%); epigenetic and/or environmental may have a role in Parathyroid adenoma (HRAS; n=1; 1%) and Osteoglopho- determining intra and interfamilial variation in tissue nic dysplasia (FGFR1; n=2, 2%). involvement and severity of the disease. Conclusion:ThisistheﬁrststudyinIndiaonthegenetic H. Chouk: None. M. Ben rejeb: None. Y. Halleb: None. basisofRRanditsuggeststhathypophosphatemicricketsis H. El mabrouk: None. M. Ben jomaa: None. S. Nadjar: the chief form of RR in Indian children. None. M. Denguezli:None. A.Saad:None. L. Boussofara: B. Marik: None. A. Bagga: None. A. Sinha: None. P. None. D. Hmida: None. Khandelwal: None. P. Hari: None. A. Sharma: None. E-P24.53 E-P24.52 Feasibility of Identifying Familial Hypercholesterolae- SLC29A3 founder mutation and founder haplotype mia in Malaysian Primary Care shared by H syndrome Tunisian patients H.Abdul-Hamid1,2,S.Weng1,J.Kai1,A.Ramli2,H.Mohd H. Chouk1,2, M. Ben rejeb3, Y. Halleb2, Nawawi2, N. Qureshi1 H. El mabrouk1,2, M. Ben jomaa2, S. Nadjar2, M. Denguezli3, A. SAAD2, L. Boussofara3, D. Hmida2 1University of Nottingham, Nottingham, United Kingdom, 2Universiti Teknologi MARA, Selangor, Malaysia 1Higher Institut of Biotechnology of Monastir, Sousse, Tunisia, 2Laboratory of Cytogenetics, Molecular Genetics Introduction: Familial Hypercholesterolaemia (FH) iden- and Biology of Human Reproduction, Sousse, Tunisia, tiﬁcation has been low worldwide, including in Malaysia. Sousse, Tunisia, 3Service of Dermatology, Farhat Hached Primary care as initial contact for patients can play a vital Hospital, Sousse, Tunisia, Sousse, Tunisia role in the identiﬁcation of individuals with FH. Methods: Patients attending two Primary CareClinics in Introduction: H syndrome and Rosai-Dorfman disease MalaysiabetweenJulytoDecember2019wererecruitedto (RDD) are rare autosomal recessive genodermatoses with the study. Consented patients were required toﬁll in socio- multisystemicmanifestationsmainlycausedbymutationsin demographic and family history questionnaires, and the SLC29A3 gene which encodes the equilibrative patients’ lipid proﬁle were obtained from their clinical nucleoside transporter hENT3. notes. Patients’ risk of FH were calculated using Simon Materials and methods: Mutations analysis of Broome(SB), Dutch Lipid Clinic Criteria(DLCC) and SLC29A3 gene, was performed, using direct Sanger FAMCAT criteria. Patients with high risk of FH(SB sequencing, for three unrelated Tunisian family with possible and deﬁnite, DLCC≥6, and FAMCAT> 1 in 200) phenotypic overlap, associating features of RDD and H were then referred to the Specialist Lipid Clinic for syndrome. conﬁrmation through genetic testing. Results: In this study, molecular analysis revealed the Results:1,191patientswereapproachedduringthestudy presence of a known homozygous missense mutation period, out of which 637 (53.48%) patients agreed to c.1088G> A: p.Arg363Gln in 6 patients, 5 of whom were participate. Only 619 (51.97%) patients met the eligibility related. A heterozygous compound mutation c.300 + 1G> criteria. 65 (5.46%) patients had high risk of FH and A/1088G>AwasalsonotedinapatientwithHsyndrome. required referral to Lipid Clinic, however, only 52 (4.37%) Fiveofourpatientscarryingthesamemutationc.1088G>A patients agreed to be referred. Among the 619 patients and belonging to the same family have presented with recruited, the mean age was 58.09 (SD 12.44), male 310 distinctclinicalmanifestations,indeed4werecarriersofthe (50.08%), majority is of Malay ethnicity (542, 87.56%), H syndrome, whereas the 5th patient was diagnosed with married (548, 88.53%), and had tertiary education (297,1016 J.delPicchia 47.98%). The mean lipid parameters for these patients (in heterogeneity of our patients, further molecular investiga- mmol/L)were:TC:5.34(SD1.29);LDL-C:3.27(SD1.16); tions are required. triglycerides: 1.66 (SD 1.10); and HDL-C: 1.34 (0.34). H. El Mabrouk: None. H. Chouk: None. M. Denguezli: Conclusions / Implications:Recruitment of patients for None. A. Saad: None. L. Boussofara: None. D. FHassessmentinMalaysianprimarycaresettingisfeasible. H’mida: None. Increasedtrainingandawarenessamongthephysiciansand public are vital to increase identiﬁcation. E-P24.56 H.Abdul-Hamid:None.S.Weng:None.J.Kai:None.A. Smith-Lemli-Opitz: About 1 case Ramli: None. H. Mohd Nawawi: None. N. Qureshi: None. M. Ben Jemaa E-P24.54 Porokeratosis of Mebelli in the Tunisian population Farhat Hached Hospital, Sousse, Tunisia H.ElMabrouk1,2,H.Chouk1,2,M.Denguezli3,4,A.Saad3,2, Introduction:Smith-Lemli-Opitzsyndrome(SLO)isarare L. Boussofara3,4, D. H’mida3,2 autosomalrecessivediseasecausedbymutationsinDHCR7 gene, resulting in deﬁciency of 7-dehydrocholesterol 1Higher Institute of Biotechnology, Monastir, Tunisia, reductase (7-DHC) enzyme. Clinical phenotype is hetero- 2Laboratory of Human Cytogenetics, Molecular Genetics geneous ranging from dysmorphia with behavioral dis- and Reproductive Biology, Farhat Hached University orders, to severe malformations. Hospital, Sousse, Tunisia, 3Faculty of Medicine Ibn El Patients and methods:Our patient is dysmorphic with Jazzar, Sousse, Tunisia, 4Department of Dermatology and hands polydactyly, syndactyly of the 2-3e toes bilaterally, Venerology, Farhat Hached University Hospital, Sousse, feet deformation, bilateral cataract, pyloric stenosis, horse- Tunisia shoe kidneys, micropenis, hypospadias, microcephaly, growthandpsychomotordelay.Cholesterolemiaislowered Introduction: Porokeratosis (PK) is a rare group of and 7DHC is raised. acquired or hereditary genodermatoses characterized by an Results: The karyotype was normal. Molecular analysis epidermal differentiation disorder and sharing common of DHCR7 gene revealed the presence of compound histology. Their etiopathogenesis still not fully understood. heterozygous mutation c.278 C> T: p.Thr93Met and c.724 To date, several genes such as PMVK, MVK, MVD and C> T: p.Arg242Cys respectively in exon 4 and 7. The FDPS, members of the mevalonate pathway, involved in diagnosisofSLOhasbeenconﬁrmed,theparentshavebeen PK are identiﬁed. To date, several phenotypic variants of reconvened for genetic counseling and a proposal for a PKaredescribedandrarearethegeneticstudiescarriedout DPN, and cholesterol and simvastatin supplementation has in Tunisia. been suggested to the pediatrician. Materials and methods: 5 PK patients belonging to a Discussion: Over 130 different DHCR7 mutations have cohort of 3 families from central Tunisia were sequenced been identiﬁed, such as c.964-1G> C responsible for 28% for PMVK and MVK genes by the Sanger technique. of SLOS, p.T93M (10%), p.W151X (6%), p.R404C (5%) Results: Direct sequencing provides genetic evidence of and p.V326L (5%). Sequencing of exons 6–9 identiﬁes PK. Weidentiﬁed aknown nonsense variant, c.412C> Tat approximately 85% of DHCR7 mutations. Sterol analysis a heterozygous state in exon 4 of the PMVK gene in 4 demonstrating elevated blood or tissue 7DHC levels patients. A second synonym variant, newly described, conﬁrms SLO diagnosis. Mutation analysis is used to c.147A>G was identiﬁed at a heterozygous state in exon 2 resolve borderline biochemical results. In rare cases, sterol ofthesamegenein3patientswithporokeratosisofMibelli analysis of ﬁbroblasts or lymphoblasts are used. These (PM) and 3 of their relatives. techniques can be performed on amniotic ﬂuid for prenatal Discussion: The same mutation noticed among our diagnosis. patients, members of 2 unrelated families from 2 different Conclusion: SLO is a metabolic disease with various Tunisian regions, very likely a founder mutation in our phenotypes and weak genotype-phenotype correlation. population. The newly described synonym variant found Biochemical and molecular tests are important for the exclusively in our PM patients, could be a modiﬁer gene. diagnosis, and eventually for the decision of cholesterol Conclusion: We report the ﬁrst genetic study of PK in supplementation. the Tunisian population. Given the phenotypic M. Ben Jemaa: None.